SAMPLE_ID;CANCER_TYPE;SEX;SAMPLE_TYPE;SOMATIC_STATUS;ONCOTREE_CODE;OS_STATUS;AJCC_PATHOLOGIC_TUMOR_STAGE;AGE
TCGA-OR-A5J1-01;Adrenocortical Carcinoma;Male;Primary;Matched;ACC;1:DECEASED;Stage II;58
TCGA-OR-A5J2-01;Adrenocortical Carcinoma;Female;Primary;Matched;ACC;1:DECEASED;Stage IV;44
TCGA-OR-A5J3-01;Adrenocortical Carcinoma;Female;Primary;Matched;ACC;0:LIVING;Stage III;23
TCGA-OR-A5J4-01;Adrenocortical Carcinoma;Female;Primary;Matched;ACC;1:DECEASED;Stage IV;23
TCGA-OR-A5J5-01;Adrenocortical Carcinoma;Male;Primary;Matched;ACC;1:DECEASED;Stage III;30
TCGA-OR-A5J6-01;Adrenocortical Carcinoma;Female;Primary;Matched;ACC;0:LIVING;Stage II;29
TCGA-OR-A5J7-01;Adrenocortical Carcinoma;Female;Primary;Matched;ACC;1:DECEASED;Stage III;30
TCGA-OR-A5J8-01;Adrenocortical Carcinoma;Male;Primary;Matched;ACC;1:DECEASED;Stage III;66
TCGA-OR-A5J9-01;Adrenocortical Carcinoma;Female;Primary;Matched;ACC;0:LIVING;Stage II;22
TCGA-OR-A5JA-01;Adrenocortical Carcinoma;Female;Primary;Matched;ACC;Venous Invasion Present;Stage IV;NO
TCGA-OR-A5JB-01;Adrenocortical Carcinoma;Male;Primary;Matched;ACC;[Not Available];Stage IV;NO
TCGA-OR-A5JC-01;Adrenocortical Carcinoma;Male;Primary;Matched;ACC;1:DECEASED;[Not Available];37
TCGA-OR-A5JD-01;Adrenocortical Carcinoma;Female;Primary;Matched;ACC;0:LIVING;Stage II;57
TCGA-OR-A5JE-01;Adrenocortical Carcinoma;Female;Primary;Matched;ACC;1:DECEASED;Stage I;17
TCGA-OR-A5JF-01;Adrenocortical Carcinoma;Female;Primary;Matched;ACC;0:LIVING;Stage II;69
TCGA-OR-A5JG-01;Adrenocortical Carcinoma;Male;Primary;Matched;ACC;Venous Invasion Present;Stage IV;[Not Available]
TCGA-OR-A5JI-01;Adrenocortical Carcinoma;Female;Primary;Matched;ACC;0:LIVING;Stage II;32
TCGA-OR-A5JJ-01;Adrenocortical Carcinoma;Male;Primary;Matched;ACC;0:LIVING;Stage I;22
TCGA-OR-A5JK-01;Adrenocortical Carcinoma;Male;Primary;Matched;ACC;1:DECEASED;Stage IV;65
TCGA-OR-A5JL-01;Adrenocortical Carcinoma;Male;Primary;Matched;ACC;0:LIVING;Stage IV;49
TCGA-OR-A5JM-01;Adrenocortical Carcinoma;Female;Primary;Matched;ACC;0:LIVING;Stage I;36
TCGA-OR-A5JO-01;Adrenocortical Carcinoma;Female;Primary;Matched;ACC;Venous Invasion Present;Stage IV;YES
TCGA-OR-A5JP-01;Adrenocortical Carcinoma;Female;Primary;Matched;ACC;0:LIVING;Stage I;26
TCGA-OR-A5JQ-01;Adrenocortical Carcinoma;Male;Primary;Matched;ACC;0:LIVING;Stage II;40
TCGA-OR-A5JR-01;Adrenocortical Carcinoma;Female;Primary;Matched;ACC;0:LIVING;Stage II;26
TCGA-OR-A5JS-01;Adrenocortical Carcinoma;Male;Primary;Matched;ACC;0:LIVING;Stage I;45
TCGA-OR-A5JT-01;Adrenocortical Carcinoma;Female;Primary;Matched;ACC;0:LIVING;Stage II;65
TCGA-OR-A5JV-01;Adrenocortical Carcinoma;Female;Primary;Matched;ACC;0:LIVING;Stage II;65
TCGA-OR-A5JW-01;Adrenocortical Carcinoma;Female;Primary;Matched;ACC;1:DECEASED;Stage III;58
TCGA-OR-A5JX-01;Adrenocortical Carcinoma;Male;Primary;Matched;ACC;0:LIVING;Stage II;55
TCGA-OR-A5JY-01;Adrenocortical Carcinoma;Male;Primary;Matched;ACC;0:LIVING;Stage II;47
TCGA-OR-A5JZ-01;Adrenocortical Carcinoma;Male;Primary;Matched;ACC;0:LIVING;Stage III;50
TCGA-OR-A5K0-01;Adrenocortical Carcinoma;Female;Primary;Matched;ACC;Venous Invasion Present;Stage IV;YES
TCGA-OR-A5K1-01;Adrenocortical Carcinoma;Male;Primary;Matched;ACC;0:LIVING;Stage II;60
TCGA-OR-A5K2-01;Adrenocortical Carcinoma;Female;Primary;Matched;ACC;0:LIVING;Stage II;69
TCGA-OR-A5K3-01;Adrenocortical Carcinoma;Male;Primary;Matched;ACC;0:LIVING;Stage II;48
TCGA-OR-A5K4-01;Adrenocortical Carcinoma;Female;Primary;Matched;ACC;1:DECEASED;Stage III;32
TCGA-OR-A5K5-01;Adrenocortical Carcinoma;Male;Primary;Matched;ACC;0:LIVING;Stage II;53
TCGA-OR-A5K6-01;Adrenocortical Carcinoma;Female;Primary;Matched;ACC;0:LIVING;Stage III;64
TCGA-OR-A5K8-01;Adrenocortical Carcinoma;Female;Primary;Matched;ACC;1:DECEASED;Stage III;59
TCGA-OR-A5K9-01;Adrenocortical Carcinoma;Female;Primary;Matched;ACC;0:LIVING;Stage II;56
TCGA-OR-A5KO-01;Adrenocortical Carcinoma;Male;Primary;Matched;ACC;0:LIVING;Stage II;39
TCGA-OR-A5KT-01;Adrenocortical Carcinoma;Female;Primary;Matched;ACC;1:DECEASED;Stage II;61
TCGA-OR-A5KU-01;Adrenocortical Carcinoma;Female;Primary;Matched;ACC;0:LIVING;Stage II;61
TCGA-OR-A5KV-01;Adrenocortical Carcinoma;Female;Primary;Matched;ACC;0:LIVING;Stage IV;39
TCGA-OR-A5KW-01;Adrenocortical Carcinoma;Female;Primary;Matched;ACC;0:LIVING;Stage II;45
TCGA-OR-A5KX-01;Adrenocortical Carcinoma;Female;Primary;Matched;ACC;0:LIVING;Stage II;20
TCGA-OR-A5KY-01;Adrenocortical Carcinoma;Male;Primary;Matched;ACC;0:LIVING;Stage II;72
TCGA-OR-A5KZ-01;Adrenocortical Carcinoma;Female;Primary;Matched;ACC;0:LIVING;Stage I;44
TCGA-OR-A5L3-01;Adrenocortical Carcinoma;Female;Primary;Matched;ACC;0:LIVING;Stage II;37
TCGA-OR-A5L4-01;Adrenocortical Carcinoma;Female;Primary;Matched;ACC;0:LIVING;Stage III;17
TCGA-OR-A5L5-01;Adrenocortical Carcinoma;Female;Primary;Matched;ACC;0:LIVING;Stage III;55
TCGA-OR-A5L6-01;Adrenocortical Carcinoma;Female;Primary;Matched;ACC;0:LIVING;Stage III;25
TCGA-OR-A5L8-01;Adrenocortical Carcinoma;Female;Primary;Matched;ACC;1:DECEASED;Stage IV;23
TCGA-OR-A5L9-01;Adrenocortical Carcinoma;Male;Primary;Matched;ACC;1:DECEASED;Stage II;42
TCGA-OR-A5LA-01;Adrenocortical Carcinoma;Female;Primary;Matched;ACC;0:LIVING;Stage II;37
TCGA-OR-A5LB-01;Adrenocortical Carcinoma;Female;Primary;Matched;ACC;1:DECEASED;Stage II;83
TCGA-OR-A5LC-01;Adrenocortical Carcinoma;Female;Primary;Matched;ACC;0:LIVING;Stage I;67
TCGA-OR-A5LD-01;Adrenocortical Carcinoma;Female;Primary;Matched;ACC;0:LIVING;Stage III;48
TCGA-OR-A5LE-01;Adrenocortical Carcinoma;Female;Primary;Matched;ACC;0:LIVING;Stage I;77
TCGA-OR-A5LG-01;Adrenocortical Carcinoma;Male;Primary;Matched;ACC;0:LIVING;Stage II;60
TCGA-OR-A5LH-01;Adrenocortical Carcinoma;Female;Primary;Matched;ACC;0:LIVING;Stage II;36
TCGA-OR-A5LJ-01;Adrenocortical Carcinoma;Female;Primary;Matched;ACC;0:LIVING;Stage II;53
TCGA-OR-A5LK-01;Adrenocortical Carcinoma;Female;Primary;Matched;ACC;0:LIVING;Stage II;52
TCGA-OR-A5LL-01;Adrenocortical Carcinoma;Male;Primary;Matched;ACC;[Not Available];Stage IV;NO
TCGA-OR-A5LM-01;Adrenocortical Carcinoma;Female;Primary;Matched;ACC;1:DECEASED;Stage IV;71
TCGA-OR-A5LN-01;Adrenocortical Carcinoma;Male;Primary;Matched;ACC;1:DECEASED;Stage III;52
TCGA-OR-A5LO-01;Adrenocortical Carcinoma;Male;Primary;Matched;ACC;1:DECEASED;Stage II;14
TCGA-OR-A5LP-01;Adrenocortical Carcinoma;Female;Primary;Matched;ACC;1:DECEASED;Stage III;74
TCGA-OR-A5LR-01;Adrenocortical Carcinoma;Male;Primary;Matched;ACC;0:LIVING;Stage III;46
TCGA-OR-A5LS-01;Adrenocortical Carcinoma;Female;Primary;Matched;ACC;1:DECEASED;Stage II;36
TCGA-OR-A5LT-01;Adrenocortical Carcinoma;Female;Primary;Matched;ACC;1:DECEASED;Stage IV;42
TCGA-OU-A5PI-01;Adrenocortical Carcinoma;Female;Primary;Matched;ACC;Venous Invasion Present;Stage IV;YES
TCGA-P6-A5OF-01;Adrenocortical Carcinoma;Male;Primary;Matched;ACC;0:LIVING;Stage II;62
TCGA-P6-A5OG-01;Adrenocortical Carcinoma;Female;Primary;Matched;ACC;1:DECEASED;Stage II;75
TCGA-PA-A5YG-01;Adrenocortical Carcinoma;Male;Primary;Matched;ACC;0:LIVING;Stage II;23
TCGA-PK-A5H8-01;Adrenocortical Carcinoma;Female;Primary;Matched;ACC;0:LIVING;Stage II;31
TCGA-PK-A5H9-01;Adrenocortical Carcinoma;Female;Primary;Matched;ACC;1:DECEASED;Stage II;61
TCGA-PK-A5HA-01;Adrenocortical Carcinoma;Female;Primary;Matched;ACC;0:LIVING;Stage II;37
TCGA-PK-A5HB-01;Adrenocortical Carcinoma;Female;Primary;Matched;ACC;0:LIVING;Stage II;30
TCGA-OR-A5JH-01;Adrenocortical Carcinoma;Female;Primary;Matched;ACC;0:LIVING;Stage II;34
TCGA-OR-A5JU-01;Adrenocortical Carcinoma;Male;Primary;Matched;ACC;0:LIVING;Stage III;57
TCGA-OR-A5KB-01;Adrenocortical Carcinoma;Female;Primary;Matched;ACC;Venous Invasion Absent;Stage IV;YES
TCGA-OR-A5KP-01;Adrenocortical Carcinoma;Female;Primary;Matched;ACC;1:DECEASED;Stage III;55
TCGA-OR-A5KQ-01;Adrenocortical Carcinoma;Female;Primary;Matched;ACC;1:DECEASED;Stage IV;45
TCGA-OR-A5KS-01;Adrenocortical Carcinoma;Female;Primary;Matched;ACC;1:DECEASED;Stage IV;59
TCGA-OR-A5L1-01;Adrenocortical Carcinoma;Male;Primary;Matched;ACC;0:LIVING;Stage II;51
TCGA-OR-A5L2-01;Adrenocortical Carcinoma;Male;Primary;Matched;ACC;0:LIVING;Stage II;42
TCGA-OR-A5LF-01;Adrenocortical Carcinoma;Female;Primary;Matched;ACC;0:LIVING;Stage II;27
TCGA-OR-A5LI-01;Adrenocortical Carcinoma;Male;Primary;Matched;ACC;0:LIVING;Stage I;63
TCGA-P6-A5OH-01;Adrenocortical Carcinoma;Male;Primary;Matched;ACC;0:LIVING;[Not Available];63
TCGA-PK-A5HC-01;Adrenocortical Carcinoma;Female;Primary;Matched;ACC;0:LIVING;Stage III;44
TCGA-3C-AAAU-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE X;55
TCGA-3C-AALI-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;50
TCGA-3C-AALJ-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;62
TCGA-3C-AALK-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IA;52
TCGA-4H-AAAK-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIIA;50
TCGA-5L-AAT0-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIA;42
TCGA-5T-A9QA-01;Breast Cancer;Female;Primary;Matched;BRCNOS;0:LIVING;STAGE IIA;52
TCGA-A1-A0SB-01;Breast Cancer;Female;Primary;Matched;BRCNOS;0:LIVING;STAGE I;70
TCGA-A1-A0SD-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;59
TCGA-A1-A0SE-01;Breast Cancer;Female;Primary;Matched;BRCNOS;0:LIVING;STAGE I;56
TCGA-A1-A0SF-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;54
TCGA-A1-A0SG-01;Breast Cancer;Female;Primary;Matched;BRCNOS;0:LIVING;STAGE IIB;61
TCGA-A1-A0SH-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;39
TCGA-A1-A0SI-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;52
TCGA-A1-A0SJ-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;39
TCGA-A1-A0SK-01;Breast Cancer;Female;Primary;Matched;BRCNOS;1:DECEASED;STAGE IIA;54
TCGA-A1-A0SM-01;Breast Cancer;Male;Primary;Matched;IDC;0:LIVING;STAGE IIA;77
TCGA-A1-A0SN-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;50
TCGA-A1-A0SO-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;67
TCGA-A1-A0SP-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;40
TCGA-A1-A0SQ-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;45
TCGA-A2-A04N-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IA;66
TCGA-A2-A04P-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIIC;36
TCGA-A2-A04Q-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IA;48
TCGA-A2-A04R-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IA;36
TCGA-A2-A04T-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;62
TCGA-A2-A04U-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;47
TCGA-A2-A04V-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIA;39
TCGA-A2-A04W-01;Breast Cancer;Female;Primary;Matched;BRCNOS;0:LIVING;STAGE IIB;50
TCGA-A2-A04X-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;34
TCGA-A2-A04Y-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;53
TCGA-A2-A0CK-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIIA;60
TCGA-A2-A0CL-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;37
TCGA-A2-A0CM-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIA;40
TCGA-A2-A0CO-01;Breast Cancer;Female;Primary;Matched;ILC;1:DECEASED;STAGE IIB;85
TCGA-A2-A0CP-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IA;60
TCGA-A2-A0CQ-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IA;62
TCGA-A2-A0CR-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIB;54
TCGA-A2-A0CS-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IV;73
TCGA-A2-A0CT-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;71
TCGA-A2-A0CU-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIA;73
TCGA-A2-A0CV-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;41
TCGA-A2-A0CW-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;67
TCGA-A2-A0CX-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;52
TCGA-A2-A0CZ-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;46
TCGA-A2-A0D0-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;60
TCGA-A2-A0D1-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;76
TCGA-A2-A0D2-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;45
TCGA-A2-A0D3-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IA;42
TCGA-A2-A0D4-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;37
TCGA-A2-A0EM-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IA;73
TCGA-A2-A0EN-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIA;70
TCGA-A2-A0EO-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IA;54
TCGA-A2-A0EP-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE I;56
TCGA-A2-A0EQ-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;64
TCGA-A2-A0ER-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IB;63
TCGA-A2-A0ES-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIA;52
TCGA-A2-A0ET-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;58
TCGA-A2-A0EU-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IA;79
TCGA-A2-A0EV-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IA;80
TCGA-A2-A0EW-01;Breast Cancer;Female;Primary;Matched;ILC;1:DECEASED;STAGE IIIC;53
TCGA-A2-A0EX-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIB;46
TCGA-A2-A0EY-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;62
TCGA-A2-A0ST-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;62
TCGA-A2-A0SU-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;66
TCGA-A2-A0SV-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IV;63
TCGA-A2-A0SW-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IV;82
TCGA-A2-A0SX-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IA;48
TCGA-A2-A0SY-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIIA;62
TCGA-A2-A0T0-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;59
TCGA-A2-A0T1-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIC;55
TCGA-A2-A0T2-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IV;66
TCGA-A2-A0T3-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IB;37
TCGA-A2-A0T4-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIA;62
TCGA-A2-A0T5-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;39
TCGA-A2-A0T6-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIB;50
TCGA-A2-A0T7-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;51
TCGA-A2-A0YC-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;59
TCGA-A2-A0YD-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIB;63
TCGA-A2-A0YE-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;48
TCGA-A2-A0YF-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE I;67
TCGA-A2-A0YG-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIC;63
TCGA-A2-A0YH-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;53
TCGA-A2-A0YI-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE I;62
TCGA-A2-A0YJ-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;39
TCGA-A2-A0YK-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIA;61
TCGA-A2-A0YL-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIIA;48
TCGA-A2-A0YM-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;67
TCGA-A2-A0YT-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIIB;56
TCGA-A2-A1FV-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIB;74
TCGA-A2-A1FW-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;62
TCGA-A2-A1FX-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;61
TCGA-A2-A1FZ-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;63
TCGA-A2-A1G0-01;Breast Cancer;Female;Primary;Matched;BRCNOS;0:LIVING;STAGE IIB;49
TCGA-A2-A1G1-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;85
TCGA-A2-A1G4-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;71
TCGA-A2-A1G6-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;50
TCGA-A2-A259-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE I;70
TCGA-A2-A25A-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIA;44
TCGA-A2-A25B-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;39
TCGA-A2-A25C-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;50
TCGA-A2-A25D-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIIC;90
TCGA-A2-A25E-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;34
TCGA-A2-A25F-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;66
TCGA-A2-A3KC-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIB;55
TCGA-A2-A3KD-01;Breast Cancer;Female;Primary;Matched;IMMC;0:LIVING;STAGE IIIA;47
TCGA-A2-A3XS-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIIA;62
TCGA-A2-A3XT-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;45
TCGA-A2-A3XU-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIB;35
TCGA-A2-A3XV-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;46
TCGA-A2-A3XW-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;42
TCGA-A2-A3XX-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIA;49
TCGA-A2-A3XY-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIB;49
TCGA-A2-A3XZ-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE I;46
TCGA-A2-A3Y0-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;57
TCGA-A2-A4RW-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIIC;49
TCGA-A2-A4RX-01;Breast Cancer;Female;Primary;Matched;MBC;0:LIVING;STAGE IIA;67
TCGA-A2-A4RY-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIIC;46
TCGA-A2-A4S0-01;Breast Cancer;Female;Primary;Matched;IMMC;0:LIVING;STAGE IIA;77
TCGA-A2-A4S1-01;Breast Cancer;Female;Primary;Matched;MBC;0:LIVING;STAGE IIA;66
TCGA-A2-A4S2-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIIA;62
TCGA-A2-A4S3-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;59
TCGA-A7-A0CD-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE I;66
TCGA-A7-A0CE-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;57
TCGA-A7-A0CG-01;Breast Cancer;Female;Primary;Matched;BRCNOS;0:LIVING;STAGE IIA;78
TCGA-A7-A0CH-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;79
TCGA-A7-A0CJ-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;57
TCGA-A7-A0D9-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;37
TCGA-A7-A0DA-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;62
TCGA-A7-A0DB-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;56
TCGA-A7-A0DC-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IA;63
TCGA-A7-A13D-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;46
TCGA-A7-A13E-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIB;62
TCGA-A7-A13F-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;44
TCGA-A7-A13G-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;79
TCGA-A7-A13H-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIB;61
TCGA-A7-A26E-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIIA;71
TCGA-A7-A26F-01;Breast Cancer;Female;Primary;Matched;BRCNOS;0:LIVING;STAGE IA;55
TCGA-A7-A26G-01;Breast Cancer;Female;Primary;Matched;BRCNOS;0:LIVING;STAGE IIA;50
TCGA-A7-A26H-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;72
TCGA-A7-A26I-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;65
TCGA-A7-A26J-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;49
TCGA-A7-A2KD-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;53
TCGA-A7-A3IY-01;Breast Cancer;Female;Primary;Matched;IMMC;0:LIVING;STAGE I;71
TCGA-A7-A3IZ-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIA;62
TCGA-A7-A3J0-01;Breast Cancer;Female;Primary;Matched;IMMC;0:LIVING;STAGE IIA;62
TCGA-A7-A3J1-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IA;63
TCGA-A7-A3RF-01;Breast Cancer;Female;Primary;Matched;IMMC;0:LIVING;STAGE IIA;79
TCGA-A7-A425-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIIC;70
TCGA-A7-A426-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIIC;50
TCGA-A7-A4SA-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIB;40
TCGA-A7-A4SB-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIIA;56
TCGA-A7-A4SC-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIB;62
TCGA-A7-A4SD-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;52
TCGA-A7-A4SE-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;54
TCGA-A7-A4SF-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;54
TCGA-A7-A56D-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;84
TCGA-A7-A5ZV-01;Breast Cancer;Female;Primary;Matched;BRCNOS;0:LIVING;STAGE IIA;62
TCGA-A7-A5ZW-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;47
TCGA-A7-A5ZX-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIIC;48
TCGA-A7-A6VV-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;51
TCGA-A7-A6VW-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;48
TCGA-A7-A6VX-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;68
TCGA-A7-A6VY-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;48
TCGA-A8-A06N-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIB;66
TCGA-A8-A06O-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE I;60
TCGA-A8-A06P-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;63
TCGA-A8-A06Q-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;63
TCGA-A8-A06R-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;69
TCGA-A8-A06T-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;75
TCGA-A8-A06U-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIB;80
TCGA-A8-A06X-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIB;77
TCGA-A8-A06Y-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;66
TCGA-A8-A06Z-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;84
TCGA-A8-A075-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;42
TCGA-A8-A076-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;66
TCGA-A8-A079-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIB;69
TCGA-A8-A07B-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;69
TCGA-A8-A07C-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;57
TCGA-A8-A07E-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE X;81
TCGA-A8-A07F-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;65
TCGA-A8-A07G-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;65
TCGA-A8-A07I-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;69
TCGA-A8-A07J-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;35
TCGA-A8-A07L-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;58
TCGA-A8-A07O-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;51
TCGA-A8-A07P-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;68
TCGA-A8-A07R-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIC;80
TCGA-A8-A07S-01;Breast Cancer;Female;Primary;Matched;BRCNOS;0:LIVING;STAGE IIA;73
TCGA-A8-A07U-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;66
TCGA-A8-A07W-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IV;76
TCGA-A8-A07Z-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;85
TCGA-A8-A081-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;80
TCGA-A8-A082-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;58
TCGA-A8-A083-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;67
TCGA-A8-A085-01;Breast Cancer;Male;Primary;Matched;IDC;0:LIVING;STAGE IIB;44
TCGA-A8-A086-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;59
TCGA-A8-A08A-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE I;89
TCGA-A8-A08B-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;52
TCGA-A8-A08C-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;65
TCGA-A8-A08G-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;41
TCGA-A8-A08H-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;66
TCGA-A8-A08I-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;53
TCGA-A8-A08J-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IV;52
TCGA-A8-A08L-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIIA;89
TCGA-A8-A08O-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IV;45
TCGA-A8-A08P-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;70
TCGA-A8-A08R-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;52
TCGA-A8-A08T-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IV;64
TCGA-A8-A08X-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIC;43
TCGA-A8-A08Z-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIB;76
TCGA-A8-A090-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;74
TCGA-A8-A091-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;61
TCGA-A8-A092-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;48
TCGA-A8-A093-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;61
TCGA-A8-A094-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;75
TCGA-A8-A095-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE I;45
TCGA-A8-A096-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;73
TCGA-A8-A097-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;65
TCGA-A8-A099-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE X;76
TCGA-A8-A09A-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE X;40
TCGA-A8-A09B-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIB;58
TCGA-A8-A09C-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE X;69
TCGA-A8-A09D-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;47
TCGA-A8-A09G-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIC;79
TCGA-A8-A09I-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;84
TCGA-A8-A09M-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIC;75
TCGA-A8-A09N-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIC;57
TCGA-A8-A09Q-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIB;83
TCGA-A8-A09R-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;82
TCGA-A8-A09T-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE X;68
TCGA-A8-A09V-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIA;51
TCGA-A8-A09W-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIIB;70
TCGA-A8-A09X-01;Breast Cancer;Female;Primary;Matched;ILC;1:DECEASED;STAGE IIIC;62
TCGA-A8-A09Z-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIB;83
TCGA-A8-A0A1-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIA;84
TCGA-A8-A0A2-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIA;66
TCGA-A8-A0A4-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIA;73
TCGA-A8-A0A6-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIIC;64
TCGA-A8-A0A7-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIB;57
TCGA-A8-A0A9-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;80
TCGA-A8-A0AB-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIA;54
TCGA-A8-A0AD-01;Breast Cancer;Female;Primary;Matched;BRCNOS;0:LIVING;STAGE I;83
TCGA-AC-A23C-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;62
TCGA-AC-A23E-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;50
TCGA-AC-A23G-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIA;76
TCGA-AC-A23H-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIA;90
TCGA-AC-A2B8-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIB;84
TCGA-AC-A2BK-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;78
TCGA-AC-A2BM-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;41
TCGA-AC-A2FB-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIA;65
TCGA-AC-A2FE-01;Breast Cancer;Female;Primary;Matched;ILC;1:DECEASED;STAGE IIIC;62
TCGA-AC-A2FF-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIB;40
TCGA-AC-A2FG-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIB;79
TCGA-AC-A2FK-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIIC;45
TCGA-AC-A2FM-01;Breast Cancer;Female;Primary;Matched;ILC;1:DECEASED;STAGE IIB;87
TCGA-AC-A2FO-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIB;65
TCGA-AC-A2QH-01;Breast Cancer;Female;Primary;Matched;MBC;0:LIVING;STAGE IIB;58
TCGA-AC-A2QI-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIIA;76
TCGA-AC-A2QJ-01;Breast Cancer;Female;Primary;Matched;MBC;1:DECEASED;STAGE IIIB;48
TCGA-AC-A3BB-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIIA;46
TCGA-AC-A3EH-01;Breast Cancer;Female;Primary;Matched;ILC;1:DECEASED;STAGE IIIC;79
TCGA-AC-A3HN-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIB;87
TCGA-AC-A3OD-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIB;68
TCGA-AC-A3QP-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIB;79
TCGA-AC-A3QQ-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IA;54
TCGA-AC-A3TM-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIIA;50
TCGA-AC-A3TN-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIB;75
TCGA-AC-A3W5-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIA;65
TCGA-AC-A3W6-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIIA;90
TCGA-AC-A3W7-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIB;66
TCGA-AC-A3YI-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIIC;74
TCGA-AC-A3YJ-01;Breast Cancer;Female;Primary;Matched;BRCNOS;0:LIVING;STAGE IIA;66
TCGA-AC-A4ZE-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIB;63
TCGA-AC-A5EH-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;76
TCGA-AC-A5EI-01;Breast Cancer;Female;Primary;Matched;BRCNOS;0:LIVING;STAGE IB;88
TCGA-AC-A5XS-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIA;74
TCGA-AC-A5XU-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;74
TCGA-AC-A62V-01;Breast Cancer;Male;Primary;Matched;IDC;1:DECEASED;STAGE IV;58
TCGA-AC-A62X-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;72
TCGA-AC-A62Y-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIB;79
TCGA-AC-A6IV-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIB;47
TCGA-AC-A6IW-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;73
TCGA-AC-A6IX-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIIC;49
TCGA-AC-A6NO-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;43
TCGA-AC-A7VB-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;51
TCGA-AC-A7VC-01;Breast Cancer;Female;Primary;Matched;MBC;0:LIVING;STAGE IIB;56
TCGA-AC-A8OP-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IA;72
TCGA-AC-A8OQ-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;72
TCGA-AC-A8OR-01;Breast Cancer;Female;Primary;Matched;IMMC;0:LIVING;STAGE IA;75
TCGA-AC-A8OS-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIA;71
TCGA-AN-A03X-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;74
TCGA-AN-A03Y-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;66
TCGA-AN-A041-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;29
TCGA-AN-A046-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;68
TCGA-AN-A049-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;62
TCGA-AN-A04A-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;36
TCGA-AN-A04C-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;51
TCGA-AN-A04D-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;58
TCGA-AN-A0AJ-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;79
TCGA-AN-A0AK-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;76
TCGA-AN-A0AL-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIB;41
TCGA-AN-A0AM-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;56
TCGA-AN-A0AR-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;55
TCGA-AN-A0AS-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;70
TCGA-AN-A0AT-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;62
TCGA-AN-A0FD-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;71
TCGA-AN-A0FF-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IA;32
TCGA-AN-A0FJ-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IV;59
TCGA-AN-A0FK-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIB;88
TCGA-AN-A0FL-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;62
TCGA-AN-A0FN-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IA;61
TCGA-AN-A0FS-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IA;55
TCGA-AN-A0FT-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;63
TCGA-AN-A0FV-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;58
TCGA-AN-A0FW-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;67
TCGA-AN-A0FX-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;52
TCGA-AN-A0FY-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IA;55
TCGA-AN-A0FZ-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;45
TCGA-AN-A0G0-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;56
TCGA-AN-A0XL-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;61
TCGA-AN-A0XN-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;68
TCGA-AN-A0XO-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;59
TCGA-AN-A0XP-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;69
TCGA-AN-A0XR-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;55
TCGA-AN-A0XS-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;63
TCGA-AN-A0XT-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;54
TCGA-AN-A0XU-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;54
TCGA-AN-A0XV-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;67
TCGA-AN-A0XW-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;36
TCGA-AO-A03L-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;34
TCGA-AO-A03M-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE I;29
TCGA-AO-A03N-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;59
TCGA-AO-A03O-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIA;69
TCGA-AO-A03P-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIB;54
TCGA-AO-A03R-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;57
TCGA-AO-A03T-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;42
TCGA-AO-A03U-01;Breast Cancer;Female;Primary;Matched;BRCNOS;1:DECEASED;STAGE I;31
TCGA-AO-A03V-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE I;41
TCGA-AO-A0J2-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IA;41
TCGA-AO-A0J3-01;Breast Cancer;Female;Primary;Matched;BRCNOS;0:LIVING;STAGE IIB;67
TCGA-AO-A0J4-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IA;41
TCGA-AO-A0J5-01;Breast Cancer;Female;Primary;Matched;BRCNOS;1:DECEASED;STAGE IV;48
TCGA-AO-A0J6-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;61
TCGA-AO-A0J7-01;Breast Cancer;Female;Primary;Matched;BRCNOS;0:LIVING;STAGE IIB;71
TCGA-AO-A0J8-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIA;61
TCGA-AO-A0J9-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIIC;61
TCGA-AO-A0JA-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIC;36
TCGA-AO-A0JB-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;50
TCGA-AO-A0JC-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;64
TCGA-AO-A0JD-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;59
TCGA-AO-A0JE-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;53
TCGA-AO-A0JF-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;68
TCGA-AO-A0JG-01;Breast Cancer;Female;Primary;Matched;BRCNOS;0:LIVING;STAGE IIIA;49
TCGA-AO-A0JI-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;56
TCGA-AO-A0JJ-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIB;54
TCGA-AO-A0JL-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;59
TCGA-AO-A0JM-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;40
TCGA-AO-A124-01;Breast Cancer;Female;Primary;Matched;BRCNOS;0:LIVING;STAGE IIA;38
TCGA-AO-A125-01;Breast Cancer;Female;Primary;Matched;BRCNOS;0:LIVING;STAGE IIA;72
TCGA-AO-A126-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;39
TCGA-AO-A128-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;61
TCGA-AO-A129-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;29
TCGA-AO-A12A-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;47
TCGA-AO-A12B-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;63
TCGA-AO-A12D-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;43
TCGA-AO-A12E-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIB;51
TCGA-AO-A12F-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;36
TCGA-AO-A12G-01;Breast Cancer;Female;Primary;Matched;BRCNOS;0:LIVING;STAGE IIA;75
TCGA-AO-A12H-01;Breast Cancer;Female;Primary;Matched;BRCNOS;0:LIVING;STAGE IIA;69
TCGA-AO-A1KO-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIB;46
TCGA-AO-A1KP-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;77
TCGA-AO-A1KQ-01;Breast Cancer;Male;Primary;Matched;IDC;0:LIVING;STAGE IIIB;84
TCGA-AO-A1KR-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;51
TCGA-AO-A1KS-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIA;69
TCGA-AO-A1KT-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;78
TCGA-AQ-A04H-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;61
TCGA-AQ-A04J-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;45
TCGA-AQ-A04L-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;48
TCGA-AQ-A0Y5-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIIA;70
TCGA-AQ-A1H2-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;84
TCGA-AQ-A1H3-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIC;49
TCGA-AQ-A54N-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;51
TCGA-AQ-A54O-01;Breast Cancer;Male;Primary;Matched;IDC;0:LIVING;STAGE IIA;51
TCGA-AQ-A7U7-01;Breast Cancer;Female;Primary;Matched;ILC;1:DECEASED;STAGE IIIA;55
TCGA-AR-A0TP-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;43
TCGA-AR-A0TQ-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;27
TCGA-AR-A0TR-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIB;68
TCGA-AR-A0TS-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;46
TCGA-AR-A0TT-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;53
TCGA-AR-A0TU-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;35
TCGA-AR-A0TV-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;66
TCGA-AR-A0TW-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;50
TCGA-AR-A0TX-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;64
TCGA-AR-A0TY-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIA;54
TCGA-AR-A0TZ-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIIA;43
TCGA-AR-A0U0-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;73
TCGA-AR-A0U1-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;36
TCGA-AR-A0U2-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIIA;47
TCGA-AR-A0U3-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;59
TCGA-AR-A0U4-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;54
TCGA-AR-A1AH-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;51
TCGA-AR-A1AI-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;47
TCGA-AR-A1AJ-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE I;83
TCGA-AR-A1AK-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE I;70
TCGA-AR-A1AL-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIIA;60
TCGA-AR-A1AM-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIIA;52
TCGA-AR-A1AN-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;46
TCGA-AR-A1AO-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;47
TCGA-AR-A1AP-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE I;80
TCGA-AR-A1AQ-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;49
TCGA-AR-A1AR-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIIA;50
TCGA-AR-A1AS-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;54
TCGA-AR-A1AT-01;Breast Cancer;Female;Primary;Matched;ILC;1:DECEASED;STAGE IIA;62
TCGA-AR-A1AU-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;39
TCGA-AR-A1AV-01;Breast Cancer;Male;Primary;Matched;IDC;0:LIVING;STAGE IIB;68
TCGA-AR-A1AW-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;65
TCGA-AR-A1AX-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE I;64
TCGA-AR-A1AY-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE I;65
TCGA-AR-A24H-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIA;65
TCGA-AR-A24K-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;46
TCGA-AR-A24L-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIB;26
TCGA-AR-A24M-01;Breast Cancer;Female;Primary;Matched;BRCNOS;0:LIVING;STAGE IIIA;38
TCGA-AR-A24N-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE I;54
TCGA-AR-A24O-01;Breast Cancer;Female;Primary;Matched;BRCNOS;0:LIVING;STAGE IIIA;43
TCGA-AR-A24P-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE I;47
TCGA-AR-A24Q-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;49
TCGA-AR-A24R-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;45
TCGA-AR-A24S-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE I;61
TCGA-AR-A24T-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIIC;46
TCGA-AR-A24U-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;47
TCGA-AR-A24V-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;52
TCGA-AR-A24W-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;55
TCGA-AR-A24X-01;Breast Cancer;Female;Primary;Matched;BRCNOS;0:LIVING;STAGE IIA;52
TCGA-AR-A24Z-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;57
TCGA-AR-A250-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;58
TCGA-AR-A251-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;51
TCGA-AR-A252-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE I;50
TCGA-AR-A254-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;50
TCGA-AR-A255-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE I;62
TCGA-AR-A256-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIA;45
TCGA-AR-A2LE-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE I;69
TCGA-AR-A2LH-01;Breast Cancer;Female;Primary;Matched;ILC;1:DECEASED;STAGE III;55
TCGA-AR-A2LJ-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIIA;40
TCGA-AR-A2LK-01;Breast Cancer;Female;Primary;Matched;ILC;1:DECEASED;STAGE III;62
TCGA-AR-A2LM-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE II;49
TCGA-AR-A2LN-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIA;65
TCGA-AR-A2LO-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIB;46
TCGA-AR-A2LQ-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIB;59
TCGA-AR-A5QM-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIA;62
TCGA-AR-A5QN-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIIC;68
TCGA-AR-A5QP-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIB;54
TCGA-AR-A5QQ-01;Breast Cancer;Female;Primary;Matched;BRCNOS;1:DECEASED;STAGE IIIA;68
TCGA-B6-A0I1-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIA;73
TCGA-B6-A0I2-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IA;45
TCGA-B6-A0I5-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;49
TCGA-B6-A0I6-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIA;49
TCGA-B6-A0I8-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE X;46
TCGA-B6-A0I9-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IV;62
TCGA-B6-A0IA-01;Breast Cancer;Female;Primary;Matched;BRCNOS;0:LIVING;STAGE IIA;51
TCGA-B6-A0IB-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IV;64
TCGA-B6-A0IC-01;Breast Cancer;Female;Primary;Matched;BRCNOS;1:DECEASED;STAGE X;90
TCGA-B6-A0IE-01;Breast Cancer;Female;Primary;Matched;BRCNOS;1:DECEASED;STAGE IIIA;38
TCGA-B6-A0IG-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIB;50
TCGA-B6-A0IH-01;Breast Cancer;Female;Primary;Matched;ILC;1:DECEASED;STAGE IIIA;81
TCGA-B6-A0IJ-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;42
TCGA-B6-A0IK-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIIB;63
TCGA-B6-A0IM-01;Breast Cancer;Female;Primary;Matched;BRCNOS;1:DECEASED;STAGE IIB;75
TCGA-B6-A0IN-01;Breast Cancer;Female;Primary;Matched;BRCNOS;1:DECEASED;STAGE X;45
TCGA-B6-A0IO-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;66
TCGA-B6-A0IP-01;Breast Cancer;Female;Primary;Matched;ILC;1:DECEASED;STAGE IA;74
TCGA-B6-A0IQ-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;40
TCGA-B6-A0RE-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE X;61
TCGA-B6-A0RG-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;26
TCGA-B6-A0RH-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIA;51
TCGA-B6-A0RI-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIB;44
TCGA-B6-A0RL-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIA;60
TCGA-B6-A0RM-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE X;57
TCGA-B6-A0RN-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IA;60
TCGA-B6-A0RO-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIB;71
TCGA-B6-A0RP-01;Breast Cancer;Female;Primary;Matched;BRCNOS;1:DECEASED;STAGE IIIB;73
TCGA-B6-A0RQ-01;Breast Cancer;Female;Primary;Matched;ILC;1:DECEASED;STAGE IIB;68
TCGA-B6-A0RS-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIA;38
TCGA-B6-A0RT-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;39
TCGA-B6-A0RU-01;Breast Cancer;Female;Primary;Matched;BRCNOS;0:LIVING;STAGE IA;40
TCGA-B6-A0RV-01;Breast Cancer;Female;Primary;Matched;BRCNOS;0:LIVING;STAGE IIIA;42
TCGA-B6-A0WS-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE X;58
TCGA-B6-A0WT-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;61
TCGA-B6-A0WV-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIB;67
TCGA-B6-A0WW-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE X;58
TCGA-B6-A0WX-01;Breast Cancer;Female;Primary;Matched;BRCNOS;1:DECEASED;STAGE IIIA;40
TCGA-B6-A0WY-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIIA;40
TCGA-B6-A0WZ-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE II;50
TCGA-B6-A0X0-01;Breast Cancer;Female;Primary;Matched;BRCNOS;1:DECEASED;STAGE I;54
TCGA-B6-A0X1-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIB;48
TCGA-B6-A0X4-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIB;62
TCGA-B6-A0X5-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIB;61
TCGA-B6-A0X7-01;Breast Cancer;Female;Primary;Matched;BRCNOS;1:DECEASED;STAGE X;62
TCGA-B6-A1KC-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;67
TCGA-B6-A1KF-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;68
TCGA-B6-A1KI-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE I;63
TCGA-B6-A1KN-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIB;57
TCGA-B6-A2IU-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIA;62
TCGA-B6-A3ZX-01;Breast Cancer;Female;Primary;Matched;BRCNOS;1:DECEASED;STAGE IV;50
TCGA-B6-A400-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;43
TCGA-B6-A401-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;47
TCGA-B6-A402-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE I;47
TCGA-B6-A408-01;Breast Cancer;Female;Primary;Matched;BRCNOS;0:LIVING;STAGE IIIC;55
TCGA-B6-A409-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIIA;44
TCGA-B6-A40B-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE I;76
TCGA-B6-A40C-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIB;51
TCGA-BH-A0AU-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;45
TCGA-BH-A0AV-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE I;52
TCGA-BH-A0AW-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;56
TCGA-BH-A0AY-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;62
TCGA-BH-A0AZ-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;47
TCGA-BH-A0B0-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE I;56
TCGA-BH-A0B1-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;66
TCGA-BH-A0B2-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE I;43
TCGA-BH-A0B3-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;53
TCGA-BH-A0B4-01;Breast Cancer;Male;Primary;Matched;IDC;0:LIVING;STAGE IIIA;65
TCGA-BH-A0B5-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIIA;40
TCGA-BH-A0B7-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;42
TCGA-BH-A0B8-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE I;64
TCGA-BH-A0B9-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IA;44
TCGA-BH-A0BA-01;Breast Cancer;Female;Primary;Matched;BRCNOS;0:LIVING;STAGE IIIC;51
TCGA-BH-A0BC-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIC;60
TCGA-BH-A0BD-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;47
TCGA-BH-A0BF-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIB;56
TCGA-BH-A0BG-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE I;73
TCGA-BH-A0BJ-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;41
TCGA-BH-A0BL-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE I;35
TCGA-BH-A0BM-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;54
TCGA-BH-A0BO-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE I;54
TCGA-BH-A0BP-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE I;76
TCGA-BH-A0BQ-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE I;39
TCGA-BH-A0BR-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE I;59
TCGA-BH-A0BS-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;55
TCGA-BH-A0BT-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;56
TCGA-BH-A0BV-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;78
TCGA-BH-A0BW-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE I;71
TCGA-BH-A0BZ-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;59
TCGA-BH-A0C0-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;62
TCGA-BH-A0C1-01;Breast Cancer;Female;Primary;Matched;ILC;1:DECEASED;STAGE IIIA;61
TCGA-BH-A0C3-01;Breast Cancer;Female;Primary;Matched;BRCNOS;0:LIVING;STAGE I;47
TCGA-BH-A0C7-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;48
TCGA-BH-A0DD-01;Breast Cancer;Male;Primary;Matched;IDC;0:LIVING;STAGE IIB;58
TCGA-BH-A0DE-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;62
TCGA-BH-A0DG-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;30
TCGA-BH-A0DH-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;63
TCGA-BH-A0DI-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;63
TCGA-BH-A0DK-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;49
TCGA-BH-A0DL-01;Breast Cancer;Female;Primary;Matched;BRCNOS;0:LIVING;STAGE IIA;64
TCGA-BH-A0DO-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE I;78
TCGA-BH-A0DP-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIB;60
TCGA-BH-A0DQ-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;42
TCGA-BH-A0DS-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;71
TCGA-BH-A0DT-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;41
TCGA-BH-A0DV-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;54
TCGA-BH-A0DX-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE I;62
TCGA-BH-A0DZ-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;43
TCGA-BH-A0E0-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIC;38
TCGA-BH-A0E1-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;52
TCGA-BH-A0E2-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;49
TCGA-BH-A0E6-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IA;69
TCGA-BH-A0E7-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;79
TCGA-BH-A0E9-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIB;53
TCGA-BH-A0EA-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIA;72
TCGA-BH-A0EB-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IA;69
TCGA-BH-A0EE-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;68
TCGA-BH-A0EI-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;51
TCGA-BH-A0GY-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;67
TCGA-BH-A0GZ-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;62
TCGA-BH-A0H0-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IA;69
TCGA-BH-A0H3-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE I;46
TCGA-BH-A0H5-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE I;45
TCGA-BH-A0H6-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE I;82
TCGA-BH-A0H7-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;65
TCGA-BH-A0H9-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;69
TCGA-BH-A0HA-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE I;31
TCGA-BH-A0HB-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IA;55
TCGA-BH-A0HF-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IA;77
TCGA-BH-A0HI-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IA;78
TCGA-BH-A0HK-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;81
TCGA-BH-A0HL-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;56
TCGA-BH-A0HN-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IA;67
TCGA-BH-A0HO-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;48
TCGA-BH-A0HP-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIIA;65
TCGA-BH-A0HQ-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;56
TCGA-BH-A0HU-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IA;52
TCGA-BH-A0HW-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IA;62
TCGA-BH-A0HX-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;54
TCGA-BH-A0HY-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE I;60
TCGA-BH-A0RX-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;59
TCGA-BH-A0W3-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;58
TCGA-BH-A0W4-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;46
TCGA-BH-A0W5-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;77
TCGA-BH-A0W7-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE I;49
TCGA-BH-A0WA-01;Breast Cancer;Female;Primary;Matched;BRCA;0:LIVING;STAGE I;82
TCGA-BH-A18F-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;50
TCGA-BH-A18G-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IA;81
TCGA-BH-A18H-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IA;63
TCGA-BH-A18I-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;53
TCGA-BH-A18J-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IV;56
TCGA-BH-A18K-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE I;46
TCGA-BH-A18L-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIIA;50
TCGA-BH-A18M-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIIA;39
TCGA-BH-A18N-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIA;88
TCGA-BH-A18P-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE I;60
TCGA-BH-A18Q-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIB;56
TCGA-BH-A18R-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIA;50
TCGA-BH-A18S-01;Breast Cancer;Female;Primary;Matched;IMMC;1:DECEASED;STAGE I;79
TCGA-BH-A18T-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIA;70
TCGA-BH-A18U-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIIA;72
TCGA-BH-A18V-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIB;48
TCGA-BH-A1EN-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIA;78
TCGA-BH-A1EO-01;Breast Cancer;Female;Primary;Matched;BRCNOS;1:DECEASED;STAGE IIA;68
TCGA-BH-A1ES-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIB;35
TCGA-BH-A1ET-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE I;55
TCGA-BH-A1EU-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE I;83
TCGA-BH-A1EV-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIIA;45
TCGA-BH-A1EW-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIA;38
TCGA-BH-A1EX-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIB;67
TCGA-BH-A1EY-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIA;79
TCGA-BH-A1F0-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIA;80
TCGA-BH-A1F2-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIIB;53
TCGA-BH-A1F5-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIA;62
TCGA-BH-A1F6-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;[Not Available];51
TCGA-BH-A1F8-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIIB;90
TCGA-BH-A1FB-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIB;60
TCGA-BH-A1FC-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIA;78
TCGA-BH-A1FD-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE I;68
TCGA-BH-A1FE-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIB;31
TCGA-BH-A1FG-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE I;88
TCGA-BH-A1FH-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IV;47
TCGA-BH-A1FJ-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIIA;66
TCGA-BH-A1FL-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIB;69
TCGA-BH-A1FM-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIIA;44
TCGA-BH-A1FN-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIA;34
TCGA-BH-A1FR-01;Breast Cancer;Female;Primary;Matched;BRCNOS;1:DECEASED;STAGE IIIB;73
TCGA-BH-A1FU-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IA;44
TCGA-BH-A201-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IA;64
TCGA-BH-A202-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE II;60
TCGA-BH-A203-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIB;78
TCGA-BH-A204-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIB;80
TCGA-BH-A208-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIB;48
TCGA-BH-A209-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE I;77
TCGA-BH-A28O-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIIC;50
TCGA-BH-A28Q-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIB;46
TCGA-BH-A2L8-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIA;45
TCGA-BH-A42T-01;Breast Cancer;Female;Primary;Matched;ILC;1:DECEASED;STAGE IIA;75
TCGA-BH-A42U-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIA;80
TCGA-BH-A42V-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IB;41
TCGA-BH-A5IZ-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;51
TCGA-BH-A5J0-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IA;63
TCGA-BH-A6R8-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;46
TCGA-BH-A6R9-01;Breast Cancer;Female;Primary;Matched;MBC;0:LIVING;STAGE IIA;61
TCGA-BH-A8FY-01;Breast Cancer;Female;Primary;Matched;ILC;1:DECEASED;STAGE IA;87
TCGA-BH-A8FZ-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IA;58
TCGA-BH-A8G0-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIB;54
TCGA-BH-AB28-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIIA;53
TCGA-C8-A12K-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;80
TCGA-C8-A12L-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;67
TCGA-C8-A12M-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;70
TCGA-C8-A12N-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;58
TCGA-C8-A12O-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;50
TCGA-C8-A12P-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;55
TCGA-C8-A12Q-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIIA;78
TCGA-C8-A12T-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;43
TCGA-C8-A12U-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;46
TCGA-C8-A12V-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;55
TCGA-C8-A12W-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIB;49
TCGA-C8-A12X-01;Breast Cancer;Female;Primary;Matched;IMMC;0:LIVING;STAGE IIB;62
TCGA-C8-A12Y-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;44
TCGA-C8-A12Z-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;45
TCGA-C8-A130-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;52
TCGA-C8-A131-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;82
TCGA-C8-A132-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;56
TCGA-C8-A133-01;Breast Cancer;Female;Primary;Matched;BRCNOS;0:LIVING;STAGE IIIA;65
TCGA-C8-A134-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;52
TCGA-C8-A135-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;64
TCGA-C8-A137-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;34
TCGA-C8-A138-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;54
TCGA-C8-A1HE-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;59
TCGA-C8-A1HF-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;48
TCGA-C8-A1HG-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;50
TCGA-C8-A1HI-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;40
TCGA-C8-A1HJ-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;53
TCGA-C8-A1HK-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;53
TCGA-C8-A1HL-01;Breast Cancer;Female;Primary;Matched;BRCNOS;0:LIVING;STAGE IIIA;38
TCGA-C8-A1HM-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;74
TCGA-C8-A1HN-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;56
TCGA-C8-A1HO-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIC;34
TCGA-C8-A26V-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;47
TCGA-C8-A26W-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;58
TCGA-C8-A26X-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;58
TCGA-C8-A26Y-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;90
TCGA-C8-A26Z-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;59
TCGA-C8-A273-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;29
TCGA-C8-A274-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;63
TCGA-C8-A275-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;56
TCGA-C8-A278-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;61
TCGA-C8-A27A-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;48
TCGA-C8-A27B-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;48
TCGA-C8-A3M7-01;Breast Cancer;Female;Primary;Matched;ILC;1:DECEASED;STAGE IIIB;60
TCGA-C8-A3M8-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IA;68
TCGA-C8-A8HP-01;Breast Cancer;Female;Primary;Matched;MBC;0:LIVING;STAGE IIIA;59
TCGA-C8-A8HQ-01;Breast Cancer;Female;Primary;Matched;IMMC;0:LIVING;STAGE IIB;53
TCGA-C8-A8HR-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIIA;49
TCGA-C8-A9FZ-01;Breast Cancer;Female;Primary;Matched;BRCNOS;0:LIVING;STAGE IIB;49
TCGA-D8-A13Y-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IA;52
TCGA-D8-A13Z-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;[Not Available];51
TCGA-D8-A140-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;62
TCGA-D8-A141-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;[Not Available];40
TCGA-D8-A142-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;74
TCGA-D8-A143-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;51
TCGA-D8-A145-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;80
TCGA-D8-A147-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;[Not Available];45
TCGA-D8-A1J8-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;77
TCGA-D8-A1J9-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IA;48
TCGA-D8-A1JA-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;[Not Available];60
TCGA-D8-A1JB-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;54
TCGA-D8-A1JC-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;59
TCGA-D8-A1JD-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;41
TCGA-D8-A1JE-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;62
TCGA-D8-A1JF-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;79
TCGA-D8-A1JG-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;62
TCGA-D8-A1JH-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IA;56
TCGA-D8-A1JI-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;54
TCGA-D8-A1JJ-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;54
TCGA-D8-A1JK-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;90
TCGA-D8-A1JL-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;72
TCGA-D8-A1JM-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;59
TCGA-D8-A1JN-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIIC;80
TCGA-D8-A1JP-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IA;73
TCGA-D8-A1JS-01;Breast Cancer;Female;Primary;Matched;BRCNOS;0:LIVING;STAGE IA;77
TCGA-D8-A1JT-01;Breast Cancer;Female;Primary;Matched;BRCNOS;0:LIVING;STAGE IIA;70
TCGA-D8-A1JU-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IA;51
TCGA-D8-A1X5-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIC;81
TCGA-D8-A1X6-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;80
TCGA-D8-A1X7-01;Breast Cancer;Female;Primary;Matched;BRCNOS;0:LIVING;STAGE IIA;40
TCGA-D8-A1X8-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIIA;62
TCGA-D8-A1X9-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;66
TCGA-D8-A1XA-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IA;64
TCGA-D8-A1XB-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;62
TCGA-D8-A1XC-01;Breast Cancer;Female;Primary;Matched;IMMC;1:DECEASED;STAGE IIIB;85
TCGA-D8-A1XD-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;36
TCGA-D8-A1XF-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;45
TCGA-D8-A1XG-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIB;86
TCGA-D8-A1XJ-01;Breast Cancer;Female;Primary;Matched;BRCNOS;0:LIVING;STAGE IIIA;76
TCGA-D8-A1XK-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;55
TCGA-D8-A1XL-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;34
TCGA-D8-A1XM-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IA;57
TCGA-D8-A1XO-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIB;56
TCGA-D8-A1XQ-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;69
TCGA-D8-A1XR-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;56
TCGA-D8-A1XS-01;Breast Cancer;Male;Primary;Matched;BRCNOS;0:LIVING;STAGE IIIC;48
TCGA-D8-A1XT-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;61
TCGA-D8-A1XU-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IA;56
TCGA-D8-A1XV-01;Breast Cancer;Female;Primary;Matched;IMMC;0:LIVING;STAGE IIA;84
TCGA-D8-A1XW-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;53
TCGA-D8-A1XY-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;74
TCGA-D8-A1XZ-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;81
TCGA-D8-A1Y0-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;65
TCGA-D8-A1Y1-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIIA;80
TCGA-D8-A1Y2-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;71
TCGA-D8-A1Y3-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;61
TCGA-D8-A27E-01;Breast Cancer;Female;Primary;Matched;BRCNOS;0:LIVING;STAGE IA;66
TCGA-D8-A27F-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;40
TCGA-D8-A27G-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIA;75
TCGA-D8-A27H-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;72
TCGA-D8-A27I-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIIA;58
TCGA-D8-A27K-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;47
TCGA-D8-A27L-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;49
TCGA-D8-A27M-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IA;59
TCGA-D8-A27N-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;36
TCGA-D8-A27P-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IA;64
TCGA-D8-A27R-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIC;41
TCGA-D8-A27T-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIIC;53
TCGA-D8-A27V-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIA;62
TCGA-D8-A27W-01;Breast Cancer;Female;Primary;Matched;IMMC;0:LIVING;STAGE IIIB;55
TCGA-D8-A3Z5-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIIC;54
TCGA-D8-A3Z6-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIIC;56
TCGA-D8-A4Z1-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IA;68
TCGA-D8-A73U-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIA;88
TCGA-D8-A73W-01;Breast Cancer;Female;Primary;Matched;IMMC;1:DECEASED;STAGE IIIA;79
TCGA-D8-A73X-01;Breast Cancer;Female;Primary;Matched;BRCNOS;0:LIVING;STAGE IIA;53
TCGA-E2-A105-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;79
TCGA-E2-A107-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIIA;54
TCGA-E2-A108-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;64
TCGA-E2-A109-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;64
TCGA-E2-A10A-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;41
TCGA-E2-A10B-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;67
TCGA-E2-A10C-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;54
TCGA-E2-A10E-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;64
TCGA-E2-A10F-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIA;47
TCGA-E2-A14N-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;37
TCGA-E2-A14O-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;76
TCGA-E2-A14P-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIC;79
TCGA-E2-A14Q-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;50
TCGA-E2-A14R-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;62
TCGA-E2-A14S-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE I;65
TCGA-E2-A14T-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;52
TCGA-E2-A14U-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE I;74
TCGA-E2-A14V-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;53
TCGA-E2-A14W-01;Breast Cancer;Male;Primary;Matched;IDC;0:LIVING;STAGE IIA;78
TCGA-E2-A14X-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;55
TCGA-E2-A14Y-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;35
TCGA-E2-A14Z-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE I;64
TCGA-E2-A150-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;48
TCGA-E2-A152-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE I;56
TCGA-E2-A153-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;51
TCGA-E2-A154-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE I;68
TCGA-E2-A155-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;58
TCGA-E2-A156-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE I;61
TCGA-E2-A158-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;43
TCGA-E2-A159-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;50
TCGA-E2-A15A-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIC;45
TCGA-E2-A15C-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE I;61
TCGA-E2-A15D-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;47
TCGA-E2-A15E-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;40
TCGA-E2-A15F-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE I;64
TCGA-E2-A15G-01;Breast Cancer;Female;Primary;Matched;BRCNOS;0:LIVING;STAGE IIA;76
TCGA-E2-A15H-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;38
TCGA-E2-A15I-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;44
TCGA-E2-A15J-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE I;51
TCGA-E2-A15K-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;58
TCGA-E2-A15L-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIA;65
TCGA-E2-A15M-01;Breast Cancer;Female;Primary;Matched;ILC;1:DECEASED;STAGE IIA;66
TCGA-E2-A15O-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE I;89
TCGA-E2-A15P-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IA;61
TCGA-E2-A15R-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;64
TCGA-E2-A15S-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;34
TCGA-E2-A15T-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;65
TCGA-E2-A1AZ-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;63
TCGA-E2-A1B0-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;50
TCGA-E2-A1B1-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;45
TCGA-E2-A1B4-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIIA;74
TCGA-E2-A1B5-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIA;46
TCGA-E2-A1B6-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;44
TCGA-E2-A1BC-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IA;63
TCGA-E2-A1BD-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;53
TCGA-E2-A1IE-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;61
TCGA-E2-A1IF-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE I;74
TCGA-E2-A1IG-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;45
TCGA-E2-A1IH-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE I;80
TCGA-E2-A1II-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE I;51
TCGA-E2-A1IJ-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE I;57
TCGA-E2-A1IK-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;71
TCGA-E2-A1IL-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIA;78
TCGA-E2-A1IN-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE I;60
TCGA-E2-A1IO-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE I;37
TCGA-E2-A1IU-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IA;60
TCGA-E2-A1L6-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;44
TCGA-E2-A1L7-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;40
TCGA-E2-A1L8-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIB;52
TCGA-E2-A1L9-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;40
TCGA-E2-A1LA-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;59
TCGA-E2-A1LB-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;41
TCGA-E2-A1LE-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIIC;71
TCGA-E2-A1LG-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIA;50
TCGA-E2-A1LH-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE I;59
TCGA-E2-A1LI-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;57
TCGA-E2-A1LK-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIIC;84
TCGA-E2-A1LL-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;73
TCGA-E2-A1LS-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IA;46
TCGA-E2-A2P5-01;Breast Cancer;Female;Primary;Matched;ILC;1:DECEASED;STAGE IIIC;78
TCGA-E2-A2P6-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIB;77
TCGA-E2-A3DX-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIIC;43
TCGA-E2-A56Z-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;69
TCGA-E2-A570-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IB;47
TCGA-E2-A573-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IA;48
TCGA-E2-A574-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;44
TCGA-E2-A576-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IA;69
TCGA-E2-A9RU-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIC;90
TCGA-E9-A1N3-01;Breast Cancer;Female;Primary;Matched;BRCNOS;0:LIVING;STAGE IIIA;70
TCGA-E9-A1N4-01;Breast Cancer;Female;Primary;Matched;BRCNOS;0:LIVING;STAGE IIIA;41
TCGA-E9-A1N5-01;Breast Cancer;Female;Primary;Matched;BRCNOS;0:LIVING;STAGE IIB;45
TCGA-E9-A1N6-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIB;52
TCGA-E9-A1N8-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;48
TCGA-E9-A1N9-01;Breast Cancer;Female;Primary;Matched;BRCNOS;0:LIVING;STAGE IIA;58
TCGA-E9-A1NA-01;Breast Cancer;Female;Primary;Matched;BRCNOS;0:LIVING;STAGE IIA;58
TCGA-E9-A1NC-01;Breast Cancer;Female;Primary;Matched;BRCNOS;0:LIVING;STAGE IIB;61
TCGA-E9-A1ND-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;75
TCGA-E9-A1NE-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;28
TCGA-E9-A1NF-01;Breast Cancer;Female;Primary;Matched;BRCNOS;1:DECEASED;STAGE IIA;60
TCGA-E9-A1NG-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIA;62
TCGA-E9-A1NH-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;71
TCGA-E9-A1NI-01;Breast Cancer;Female;Primary;Matched;BRCNOS;0:LIVING;STAGE IIA;51
TCGA-E9-A1QZ-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;61
TCGA-E9-A1R0-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;58
TCGA-E9-A1R2-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIC;51
TCGA-E9-A1R3-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIC;70
TCGA-E9-A1R4-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IA;66
TCGA-E9-A1R5-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IA;63
TCGA-E9-A1R6-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;63
TCGA-E9-A1R7-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;64
TCGA-E9-A1RA-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IA;48
TCGA-E9-A1RB-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIA;40
TCGA-E9-A1RC-01;Breast Cancer;Female;Primary;Matched;BRCNOS;0:LIVING;STAGE IIIC;56
TCGA-E9-A1RD-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;67
TCGA-E9-A1RE-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;74
TCGA-E9-A1RF-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;68
TCGA-E9-A1RG-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;62
TCGA-E9-A1RH-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;63
TCGA-E9-A1RI-01;Breast Cancer;Female;Primary;Matched;BRCNOS;0:LIVING;STAGE IIIA;43
TCGA-E9-A226-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIIA;45
TCGA-E9-A227-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;42
TCGA-E9-A228-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;58
TCGA-E9-A229-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IA;37
TCGA-E9-A22A-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;74
TCGA-E9-A22B-01;Breast Cancer;Female;Primary;Matched;BRCNOS;0:LIVING;STAGE IA;71
TCGA-E9-A22D-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;38
TCGA-E9-A22E-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;56
TCGA-E9-A22G-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;47
TCGA-E9-A22H-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;42
TCGA-E9-A243-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;52
TCGA-E9-A244-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;54
TCGA-E9-A245-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;47
TCGA-E9-A247-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IA;59
TCGA-E9-A248-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;51
TCGA-E9-A249-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;45
TCGA-E9-A24A-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;69
TCGA-E9-A295-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIA;71
TCGA-E9-A2JS-01;Breast Cancer;Female;Primary;Matched;ILC;1:DECEASED;STAGE IIB;72
TCGA-E9-A2JT-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIA;63
TCGA-E9-A3HO-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIA;49
TCGA-E9-A3Q9-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIIC;78
TCGA-E9-A3QA-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;33
TCGA-E9-A3X8-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIB;48
TCGA-E9-A54X-01;Breast Cancer;Female;Primary;Matched;IMMC;0:LIVING;STAGE IA;85
TCGA-E9-A54Y-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIIA;63
TCGA-E9-A5FK-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIIC;60
TCGA-E9-A5FL-01;Breast Cancer;Female;Primary;Matched;MBC;0:LIVING;STAGE IIB;65
TCGA-E9-A5UO-01;Breast Cancer;Female;Primary;Matched;IMMC;0:LIVING;STAGE IIA;41
TCGA-E9-A5UP-01;Breast Cancer;Female;Primary;Matched;BRCNOS;0:LIVING;STAGE IIA;63
TCGA-E9-A6HE-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIIC;45
TCGA-EW-A1IW-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIB;80
TCGA-EW-A1IX-01;Breast Cancer;Female;Primary;Matched;BRCNOS;0:LIVING;STAGE IIA;48
TCGA-EW-A1IY-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE I;38
TCGA-EW-A1IZ-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;53
TCGA-EW-A1J1-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;38
TCGA-EW-A1J2-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIB;50
TCGA-EW-A1J3-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IA;61
TCGA-EW-A1J5-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIB;59
TCGA-EW-A1J6-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE I;70
TCGA-EW-A1OV-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;56
TCGA-EW-A1OW-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;58
TCGA-EW-A1OX-01;Breast Cancer;Female;Primary;Matched;IMMC;0:LIVING;STAGE IIA;43
TCGA-EW-A1OY-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;63
TCGA-EW-A1OZ-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;56
TCGA-EW-A1P0-01;Breast Cancer;Female;Primary;Matched;BRCNOS;0:LIVING;STAGE IIB;55
TCGA-EW-A1P1-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIC;68
TCGA-EW-A1P3-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;48
TCGA-EW-A1P4-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;43
TCGA-EW-A1P5-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;77
TCGA-EW-A1P6-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;64
TCGA-EW-A1P7-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;59
TCGA-EW-A1P8-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIIC;58
TCGA-EW-A1PA-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;59
TCGA-EW-A1PB-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;70
TCGA-EW-A1PC-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;66
TCGA-EW-A1PD-01;Breast Cancer;Male;Primary;Matched;IDC;0:LIVING;STAGE IIA;61
TCGA-EW-A1PE-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;56
TCGA-EW-A1PF-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IA;50
TCGA-EW-A1PG-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIB;53
TCGA-EW-A1PH-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;52
TCGA-EW-A2FR-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIC;59
TCGA-EW-A2FS-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;41
TCGA-EW-A2FV-01;Breast Cancer;Female;Primary;Matched;BRCNOS;0:LIVING;STAGE IIIC;39
TCGA-EW-A2FW-01;Breast Cancer;Female;Primary;Matched;BRCNOS;0:LIVING;STAGE IIA;52
TCGA-EW-A3E8-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIB;60
TCGA-EW-A3U0-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;61
TCGA-EW-A423-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIA;75
TCGA-EW-A424-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIIA;51
TCGA-EW-A6S9-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;34
TCGA-EW-A6SA-01;Breast Cancer;Male;Primary;Matched;IDC;0:LIVING;STAGE II;59
TCGA-EW-A6SB-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE II;62
TCGA-EW-A6SC-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIA;60
TCGA-EW-A6SD-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;32
TCGA-GI-A2C8-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIB;63
TCGA-GI-A2C9-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;58
TCGA-GM-A2D9-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE I;69
TCGA-GM-A2DA-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIB;46
TCGA-GM-A2DB-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;62
TCGA-GM-A2DC-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;57
TCGA-GM-A2DD-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE I;53
TCGA-GM-A2DF-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;53
TCGA-GM-A2DH-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE I;58
TCGA-GM-A2DI-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE I;52
TCGA-GM-A2DK-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE I;58
TCGA-GM-A2DL-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE I;50
TCGA-GM-A2DM-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;57
TCGA-GM-A2DN-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;58
TCGA-GM-A2DO-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE I;54
TCGA-GM-A3NW-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIA;63
TCGA-GM-A3NY-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIB;72
TCGA-GM-A3XG-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIIA;46
TCGA-GM-A3XL-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;49
TCGA-GM-A3XN-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIIA;44
TCGA-GM-A4E0-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIIC;67
TCGA-GM-A5PV-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIB;63
TCGA-GM-A5PX-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIB;65
TCGA-HN-A2NL-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIA;56
TCGA-HN-A2OB-01;Breast Cancer;Female;Primary;Matched;ILC;1:DECEASED;STAGE IIB;45
TCGA-JL-A3YW-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIB;49
TCGA-JL-A3YX-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIA;46
TCGA-LD-A66U-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIB;44
TCGA-LD-A74U-01;Breast Cancer;Female;Primary;Matched;BRCNOS;0:LIVING;STAGE IIIC;79
TCGA-LD-A7W5-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIC;52
TCGA-LD-A7W6-01;Breast Cancer;Female;Primary;Matched;BRCNOS;0:LIVING;STAGE IIB;54
TCGA-LD-A9QF-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IA;73
TCGA-LL-A440-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IA;61
TCGA-LL-A441-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IA;62
TCGA-LL-A442-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;56
TCGA-LL-A50Y-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIA;84
TCGA-LL-A5YL-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIB;64
TCGA-LL-A5YM-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIB;88
TCGA-LL-A5YN-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;46
TCGA-LL-A5YO-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IA;50
TCGA-LL-A5YP-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;49
TCGA-LL-A6FP-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIA;90
TCGA-LL-A6FQ-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;77
TCGA-LL-A6FR-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;50
TCGA-LL-A73Y-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IA;67
TCGA-LL-A73Z-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IV;55
TCGA-LL-A740-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IA;61
TCGA-LL-A7SZ-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;49
TCGA-LL-A7T0-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;70
TCGA-LL-A8F5-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;61
TCGA-LL-A9Q3-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIIC;69
TCGA-LQ-A4E4-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIIA;73
TCGA-MS-A51U-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIB;44
TCGA-OK-A5Q2-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE II;59
TCGA-OL-A5D6-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IIA;71
TCGA-OL-A5D7-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;70
TCGA-OL-A5D8-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;40
TCGA-OL-A5DA-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIA;61
TCGA-OL-A5RU-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;63
TCGA-OL-A5RV-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIC;43
TCGA-OL-A5RW-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;40
TCGA-OL-A5RX-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IA;51
TCGA-OL-A5RY-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;52
TCGA-OL-A5RZ-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IA;57
TCGA-OL-A5S0-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;66
TCGA-OL-A66H-01;Breast Cancer;Female;Primary;Matched;IMMC;0:LIVING;STAGE IB;74
TCGA-OL-A66I-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;36
TCGA-OL-A66J-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE I;80
TCGA-OL-A66K-01;Breast Cancer;Female;Primary;Matched;ILC;1:DECEASED;STAGE IIA;72
TCGA-OL-A66L-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IA;71
TCGA-OL-A66N-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIIC;59
TCGA-OL-A66O-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;39
TCGA-OL-A66P-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;75
TCGA-OL-A6VO-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IA;43
TCGA-OL-A6VQ-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIA;49
TCGA-OL-A6VR-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IA;48
TCGA-OL-A97C-01;Breast Cancer;Female;Primary;Matched;BRCNOS;0:LIVING;STAGE IIB;67
TCGA-PE-A5DC-01;Breast Cancer;Female;Primary;Matched;ILC;1:DECEASED;STAGE IIIA;72
TCGA-PE-A5DD-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIA;64
TCGA-PE-A5DE-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIA;41
TCGA-PL-A8LV-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIB;54
TCGA-PL-A8LX-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IV;35
TCGA-PL-A8LY-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;30
TCGA-PL-A8LZ-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIB;29
TCGA-S3-A6ZF-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;64
TCGA-S3-A6ZG-01;Breast Cancer;Female;Primary;Matched;BRCNOS;0:LIVING;STAGE IIB;71
TCGA-S3-A6ZH-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIC;29
TCGA-S3-AA0Z-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;63
TCGA-S3-AA10-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;65
TCGA-S3-AA11-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;67
TCGA-S3-AA12-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;82
TCGA-S3-AA14-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE I;47
TCGA-S3-AA15-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;51
TCGA-S3-AA17-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;64
TCGA-UL-AAZ6-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIA;73
TCGA-UU-A93S-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;STAGE IV;63
TCGA-V7-A7HQ-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIIA;75
TCGA-W8-A86G-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIA;66
TCGA-WT-AB41-01;Breast Cancer;Female;Primary;Matched;IDC;0:LIVING;STAGE IIB;55
TCGA-WT-AB44-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IA;77
TCGA-XX-A899-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIIA;46
TCGA-XX-A89A-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIB;68
TCGA-Z7-A8R5-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE IIIA;61
TCGA-Z7-A8R6-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;STAGE I;46
TCGA-A2-A0CY-01;Breast Cancer;Female;Primary;Matched;BRCA;0:LIVING;No_Conversion;63.0
TCGA-E2-A106-01;Breast Cancer;Female;Primary;Matched;BRCA;0:LIVING;No_Conversion;34.0
TCGA-AO-A12C-01;Breast Cancer;Female;Primary;Matched;BRCA;0:LIVING;No_Conversion;42.0
TCGA-A8-A084-01;Breast Cancer;Female;Primary;Matched;BRCA;0:LIVING;No_Conversion;81.0
TCGA-A8-A08F-01;Breast Cancer;Female;Primary;Matched;BRCA;0:LIVING;Stage IIIC;59.0
TCGA-A8-A08S-01;Breast Cancer;Female;Primary;Matched;BRCA;0:LIVING;Stage IIA;71.0
TCGA-A8-A09E-01;Breast Cancer;Female;Primary;Matched;BRCA;0:LIVING;Stage IIIB;73.0
TCGA-A8-A09K-01;Breast Cancer;Female;Primary;Matched;BRCA;0:LIVING;Stage IIA;68.0
TCGA-D8-A146-01;Breast Cancer;Female;Primary;Matched;BRCA;0:LIVING;Stage IIA;57.0
TCGA-E2-A1IP-01;Breast Cancer;Female;Primary;Matched;BRCA;0:LIVING;Stage IIB;42.0
TCGA-BH-A0B6-01;Invasive Breast Carcinoma;Female;Primary;Matched;IDC;0:LIVING;Stage I;47
TCGA-BH-A1ES-06;Invasive Breast Carcinoma;[Not Available];Metastasis;Matched;BRCA;[Not Available];[Not Available];[Not Available]
TCGA-C5-A1BE-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];51.0
TCGA-C5-A1BF-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];31.0
TCGA-C5-A1BI-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];53.0
TCGA-C5-A1BJ-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];48.0
TCGA-C5-A1BK-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];49.0
TCGA-C5-A1BL-01;Cervical Cancer;Female;Primary;Matched;CESC;1:DECEASED;[Not Available];21.0
TCGA-C5-A1BM-01;Cervical Cancer;Female;Primary;Matched;CESC;1:DECEASED;[Not Available];64.0
TCGA-C5-A1M5-01;Cervical Cancer;Female;Primary;Matched;CESC;1:DECEASED;[Not Available];46.0
TCGA-C5-A1M6-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];31.0
TCGA-C5-A1M7-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];34.0
TCGA-C5-A1M8-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];36.0
TCGA-C5-A1M9-01;Cervical Cancer;Female;Primary;Matched;ECAD;0:LIVING;[Not Available];32.0
TCGA-C5-A1ME-01;Cervical Cancer;Female;Primary;Matched;ECAD;1:DECEASED;[Not Available];78.0
TCGA-C5-A1MF-01;Cervical Cancer;Female;Primary;Matched;CESC;1:DECEASED;[Not Available];26.0
TCGA-EX-A1H5-01;Cervical Cancer;Female;Primary;Matched;CESC;1:DECEASED;[Not Available];65.0
TCGA-BI-A20A-01;Cervical Cancer;Female;Primary;Matched;CESC;1:DECEASED;[Not Available];53.0
TCGA-C5-A0TN-01;Cervical Cancer;Female;Primary;Matched;CESC;1:DECEASED;[Not Available];55.0
TCGA-C5-A1BN-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];37.0
TCGA-C5-A1MH-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];43.0
TCGA-C5-A1MI-01;Cervical Cancer;Female;Primary;Matched;CESC;1:DECEASED;[Not Available];46.0
TCGA-C5-A1MJ-01;Cervical Cancer;Female;Primary;Matched;ECAD;0:LIVING;[Not Available];40.0
TCGA-C5-A1MK-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];49.0
TCGA-C5-A1ML-01;Cervical Cancer;Female;Primary;Matched;CESC;1:DECEASED;[Not Available];71.0
TCGA-C5-A1MN-01;Cervical Cancer;Female;Primary;Matched;CESC;1:DECEASED;[Not Available];50.0
TCGA-C5-A1MP-01;Cervical Cancer;Female;Primary;Matched;CESC;1:DECEASED;[Not Available];61.0
TCGA-C5-A1MQ-01;Cervical Cancer;Female;Primary;Matched;CESC;1:DECEASED;[Not Available];79.0
TCGA-DS-A1O9-01;Cervical Cancer;Female;Primary;Matched;CESC;1:DECEASED;[Not Available];49.0
TCGA-DS-A1OA-01;Cervical Cancer;Female;Primary;Matched;CESC;1:DECEASED;[Not Available];42.0
TCGA-DS-A1OB-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];34.0
TCGA-DS-A1OC-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];35.0
TCGA-DS-A1OD-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];37.0
TCGA-EA-A1QT-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];38.0
TCGA-FU-A23K-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];36.0
TCGA-FU-A23L-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];54.0
TCGA-DG-A2KK-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];30.0
TCGA-DG-A2KL-01;Cervical Cancer;Female;Primary;Matched;CESC;1:DECEASED;[Not Available];65.0
TCGA-DG-A2KM-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];37.0
TCGA-EK-A2GZ-01;Cervical Cancer;Female;Primary;Matched;CESC;1:DECEASED;[Not Available];56.0
TCGA-EK-A2H0-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];51.0
TCGA-EK-A2H1-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];44.0
TCGA-EK-A2IP-01;Cervical Cancer;Female;Primary;Matched;CESC;1:DECEASED;[Not Available];24.0
TCGA-EK-A2IR-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];76.0
TCGA-C5-A2LT-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];55.0
TCGA-C5-A2LV-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];43.0
TCGA-C5-A2LX-01;Cervical Cancer;Female;Primary;Matched;CESC;1:DECEASED;[Not Available];42.0
TCGA-C5-A2LY-01;Cervical Cancer;Female;Primary;Matched;CESC;1:DECEASED;[Not Available];58.0
TCGA-C5-A2M1-01;Cervical Cancer;Female;Primary;Matched;ECAD;1:DECEASED;[Not Available];48.0
TCGA-C5-A2M2-01;Cervical Cancer;Female;Primary;Matched;ECAD;0:LIVING;[Not Available];35.0
TCGA-DG-A2KJ-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];68.0
TCGA-EK-A2PG-01;Cervical Cancer;Female;Primary;Matched;CESC;1:DECEASED;[Not Available];48.0
TCGA-EK-A2PI-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];45.0
TCGA-EK-A2PK-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];55.0
TCGA-EK-A2PL-01;Cervical Cancer;Female;Primary;Matched;CESC;1:DECEASED;[Not Available];42.0
TCGA-EK-A2PM-01;Cervical Cancer;Female;Primary;Matched;CESC;1:DECEASED;[Not Available];70.0
TCGA-EK-A2R7-01;Cervical Cancer;Female;Primary;Matched;CESC;1:DECEASED;[Not Available];72.0
TCGA-EK-A2R8-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];35.0
TCGA-EK-A2R9-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];26.0
TCGA-EK-A2RA-01;Cervical Cancer;Female;Primary;Matched;CESC;1:DECEASED;[Not Available];39.0
TCGA-EK-A2RB-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];69.0
TCGA-EK-A2RC-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];74.0
TCGA-EK-A2RE-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];30.0
TCGA-EK-A2RJ-01;Cervical Cancer;Female;Primary;Matched;CESC;1:DECEASED;[Not Available];79.0
TCGA-EK-A2RK-01;Cervical Cancer;Female;Primary;Matched;CESC;1:DECEASED;[Not Available];56.0
TCGA-EK-A2RL-01;Cervical Cancer;Female;Primary;Matched;ECAD;1:DECEASED;[Not Available];36.0
TCGA-EK-A2RM-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];41.0
TCGA-EK-A2RO-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];44.0
TCGA-FU-A2QG-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];35.0
TCGA-C5-A1BQ-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];37.0
TCGA-C5-A2LZ-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];47.0
TCGA-C5-A3HD-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];25.0
TCGA-C5-A3HF-01;Cervical Cancer;Female;Primary;Matched;CEMU;0:LIVING;[Not Available];50.0
TCGA-C5-A3HL-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];51.0
TCGA-EA-A3HQ-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];53.0
TCGA-EA-A3HR-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];46.0
TCGA-EA-A3HS-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];53.0
TCGA-EA-A3HU-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];61.0
TCGA-EK-A2RD-01;Cervical Cancer;Female;Primary;Matched;CESC;1:DECEASED;[Not Available];45.0
TCGA-EK-A2RN-01;Cervical Cancer;Female;Primary;Matched;CESC;1:DECEASED;[Not Available];25.0
TCGA-EK-A3GJ-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];51.0
TCGA-EK-A3GK-01;Cervical Cancer;Female;Primary;Matched;ECAD;0:LIVING;[Not Available];47.0
TCGA-EK-A3GM-01;Cervical Cancer;Female;Primary;Matched;ECAD;1:DECEASED;[Not Available];75.0
TCGA-EK-A3GN-01;Cervical Cancer;Female;Primary;Matched;CESC;1:DECEASED;[Not Available];77.0
TCGA-FU-A3EO-01;Cervical Cancer;Female;Primary;Matched;ECAD;1:DECEASED;[Not Available];45.0
TCGA-FU-A3HZ-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];47.0
TCGA-HG-A2PA-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];49.0
TCGA-IR-A3L7-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];46.0
TCGA-IR-A3LC-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];80.0
TCGA-IR-A3LH-01;Cervical Cancer;Female;Primary;Matched;CESC;1:DECEASED;[Not Available];41.0
TCGA-IR-A3LI-01;Cervical Cancer;Female;Primary;Matched;ECAD;0:LIVING;[Not Available];34.0
TCGA-IR-A3LK-01;Cervical Cancer;Female;Primary;Matched;CESC;1:DECEASED;[Not Available];43.0
TCGA-IR-A3LL-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];46.0
TCGA-DS-A3LQ-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];47.0
TCGA-EA-A3HT-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];60.0
TCGA-EA-A3QE-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];57.0
TCGA-EX-A3L1-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];35.0
TCGA-FU-A3HY-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];68.0
TCGA-FU-A3NI-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];43.0
TCGA-HM-A3JJ-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];59.0
TCGA-HM-A3JK-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];45.0
TCGA-JX-A3PZ-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];40.0
TCGA-JX-A3Q0-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];51.0
TCGA-JX-A3Q8-01;Cervical Cancer;Female;Primary;Matched;ECAD;0:LIVING;[Not Available];50.0
TCGA-C5-A2LS-01;Cervical Cancer;Female;Primary;Matched;ECAD;0:LIVING;[Not Available];50.0
TCGA-C5-A3HE-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];43.0
TCGA-DG-A2KH-01;Cervical Cancer;Female;Primary;Matched;CEAS;0:LIVING;[Not Available];31.0
TCGA-EA-A1QS-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];49.0
TCGA-EA-A3QD-01;Cervical Cancer;Female;Primary;Matched;CESC;1:DECEASED;[Not Available];45.0
TCGA-EX-A1H6-01;Cervical Cancer;Female;Primary;Matched;ECAD;0:LIVING;[Not Available];38.0
TCGA-FU-A3TQ-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];59.0
TCGA-FU-A3TX-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];39.0
TCGA-FU-A3WB-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];40.0
TCGA-FU-A3YQ-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];54.0
TCGA-IR-A3LA-01;Cervical Cancer;Female;Primary;Matched;CEEN;0:LIVING;[Not Available];56.0
TCGA-IR-A3LF-01;Cervical Cancer;Female;Primary;Matched;ECAD;0:LIVING;[Not Available];49.0
TCGA-EA-A3Y4-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];54.0
TCGA-EA-A410-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];38.0
TCGA-EA-A411-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];64.0
TCGA-EA-A439-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];24.0
TCGA-EA-A43B-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];20.0
TCGA-EX-A449-01;Cervical Cancer;Female;Primary;Matched;ECAD;0:LIVING;[Not Available];28.0
TCGA-FU-A40J-01;Cervical Cancer;Female;Primary;Matched;ECAD;0:LIVING;[Not Available];48.0
TCGA-IR-A3LB-01;Cervical Cancer;Female;Primary;Matched;ECAD;0:LIVING;[Not Available];88.0
TCGA-LP-A4AU-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];44.0
TCGA-LP-A4AV-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];43.0
TCGA-LP-A4AW-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];36.0
TCGA-LP-A4AX-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];81.0
TCGA-EA-A44S-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];45.0
TCGA-EA-A4BA-01;Cervical Cancer;Female;Primary;Matched;ECAD;0:LIVING;[Not Available];48.0
TCGA-EA-A50E-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];58.0
TCGA-EA-A556-01;Cervical Cancer;Female;Primary;Matched;CEEN;0:LIVING;[Not Available];74.0
TCGA-FU-A57G-01;Cervical Cancer;Female;Primary;Matched;ECAD;0:LIVING;[Not Available];48.0
TCGA-HM-A4S6-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];33.0
TCGA-MU-A51Y-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];47.0
TCGA-MY-A5BD-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];26.0
TCGA-MY-A5BE-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];51.0
TCGA-MY-A5BF-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];67.0
TCGA-DS-A5RQ-01;Cervical Cancer;Female;Primary;Matched;CESC;1:DECEASED;[Not Available];32.0
TCGA-EA-A5FO-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];40.0
TCGA-EA-A5O9-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];45.0
TCGA-EA-A5ZD-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];59.0
TCGA-EA-A5ZE-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];51.0
TCGA-EA-A5ZF-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];33.0
TCGA-FU-A5XV-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];65.0
TCGA-JW-A5VG-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];47.0
TCGA-JW-A5VH-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];58.0
TCGA-JW-A5VI-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];38.0
TCGA-JW-A5VJ-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];32.0
TCGA-JW-A5VK-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];42.0
TCGA-JW-A5VL-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];41.0
TCGA-JX-A5QV-01;Cervical Cancer;Female;Primary;Matched;CESC;1:DECEASED;[Not Available];62.0
TCGA-LP-A5U2-01;Cervical Cancer;Female;Primary;Matched;ECAD;0:LIVING;[Not Available];44.0
TCGA-LP-A5U3-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];28.0
TCGA-Q1-A5R1-01;Cervical Cancer;Female;Primary;Matched;CEMU;0:LIVING;[Not Available];60.0
TCGA-Q1-A5R2-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];29.0
TCGA-Q1-A5R3-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];55.0
TCGA-C5-A7CG-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];47.0
TCGA-C5-A7CJ-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];64.0
TCGA-C5-A7CK-01;Cervical Cancer;Female;Primary;Matched;CESC;1:DECEASED;[Not Available];45.0
TCGA-C5-A7CL-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];55.0
TCGA-EA-A78R-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];78.0
TCGA-EX-A69L-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];43.0
TCGA-EX-A69M-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];35.0
TCGA-JW-A69B-01;Cervical Cancer;Female;Primary;Matched;ECAD;0:LIVING;[Not Available];38.0
TCGA-MU-A5YI-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];49.0
TCGA-Q1-A6DT-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];32.0
TCGA-Q1-A6DV-01;Cervical Cancer;Female;Primary;Matched;CEMU;0:LIVING;[Not Available];33.0
TCGA-Q1-A6DW-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];27.0
TCGA-Q1-A73O-01;Cervical Cancer;Female;Primary;Matched;CESC;1:DECEASED;[Not Available];38.0
TCGA-Q1-A73P-01;Cervical Cancer;Female;Primary;Matched;ECAD;0:LIVING;[Not Available];49.0
TCGA-Q1-A73Q-01;Cervical Cancer;Female;Primary;Matched;CESC;1:DECEASED;[Not Available];40.0
TCGA-R2-A69V-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];64.0
TCGA-C5-A7CH-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];51.0
TCGA-C5-A7CM-01;Cervical Cancer;Female;Primary;Matched;ECAD;0:LIVING;[Not Available];34.0
TCGA-C5-A7UE-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];37.0
TCGA-EA-A6QX-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];60.0
TCGA-FU-A770-01;Cervical Cancer;Female;Primary;Matched;ECAD;1:DECEASED;[Not Available];53.0
TCGA-HM-A6W2-01;Cervical Cancer;Female;Primary;Matched;CEAS;0:LIVING;[Not Available];40.0
TCGA-LP-A7HU-01;Cervical Cancer;Female;Primary;Matched;ECAD;0:LIVING;[Not Available];64.0
TCGA-Q1-A73R-01;Cervical Cancer;Female;Primary;Matched;ECAD;0:LIVING;[Not Available];49.0
TCGA-Q1-A73S-01;Cervical Cancer;Female;Primary;Matched;CEAS;0:LIVING;[Not Available];48.0
TCGA-RA-A741-01;Cervical Cancer;Female;Primary;Matched;CESC;1:DECEASED;[Not Available];69.0
TCGA-C5-A7CO-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];60.0
TCGA-C5-A7UC-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];35.0
TCGA-C5-A7UH-01;Cervical Cancer;Female;Primary;Matched;CESC;1:DECEASED;[Not Available];53.0
TCGA-C5-A7X3-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];45.0
TCGA-DS-A7WF-01;Cervical Cancer;Female;Primary;Matched;CEAS;0:LIVING;[Not Available];56.0
TCGA-DS-A7WH-01;Cervical Cancer;Female;Primary;Matched;CEMU;0:LIVING;[Not Available];43.0
TCGA-DS-A7WI-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];37.0
TCGA-JW-A852-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];44.0
TCGA-UC-A7PD-01;Cervical Cancer;Female;Primary;Matched;CESC;1:DECEASED;[Not Available];42.0
TCGA-UC-A7PF-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];46.0
TCGA-WL-A834-01;Cervical Cancer;Female;Primary;Matched;CESC;1:DECEASED;[Not Available];25.0
TCGA-C5-A7UI-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];63.0
TCGA-C5-A7X5-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];40.0
TCGA-C5-A7X8-01;Cervical Cancer;Female;Primary;Matched;CEMU;0:LIVING;[Not Available];37.0
TCGA-MU-A8JM-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];35.0
TCGA-PN-A8M9-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];63.0
TCGA-PN-A8MA-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];52.0
TCGA-VS-A8EB-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];45.0
TCGA-VS-A8EC-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];30.0
TCGA-VS-A8EG-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];40.0
TCGA-VS-A8EH-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];53.0
TCGA-XS-A8TJ-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];54.0
TCGA-2W-A8YY-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];50.0
TCGA-C5-A8XH-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];48.0
TCGA-C5-A8XI-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];43.0
TCGA-C5-A8XJ-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];33.0
TCGA-C5-A8XK-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];75.0
TCGA-C5-A8YQ-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];48.0
TCGA-C5-A8YR-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];27.0
TCGA-C5-A8YT-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];60.0
TCGA-C5-A8ZZ-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];46.0
TCGA-C5-A901-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];62.0
TCGA-C5-A902-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];42.0
TCGA-C5-A905-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];68.0
TCGA-C5-A907-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];28.0
TCGA-EX-A8YF-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];43.0
TCGA-GH-A9DA-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];32.0
TCGA-MY-A913-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];64.0
TCGA-VS-A8EI-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];56.0
TCGA-VS-A8EJ-01;Cervical Cancer;Female;Primary;Matched;CESC;1:DECEASED;[Not Available];55.0
TCGA-VS-A8EK-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];36.0
TCGA-VS-A8EL-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];44.0
TCGA-VS-A8Q8-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];37.0
TCGA-VS-A8Q9-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];45.0
TCGA-VS-A8QA-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];46.0
TCGA-VS-A8QC-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];45.0
TCGA-VS-A8QF-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];33.0
TCGA-VS-A8QH-01;Cervical Cancer;Female;Primary;Matched;CEMU;0:LIVING;[Not Available];42.0
TCGA-VS-A8QM-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];34.0
TCGA-VS-A94W-01;Cervical Cancer;Female;Primary;Matched;CESC;1:DECEASED;[Not Available];21.0
TCGA-ZJ-A8QO-01;Cervical Cancer;Female;Primary;Matched;CESC;1:DECEASED;[Not Available];44.0
TCGA-ZJ-A8QQ-01;Cervical Cancer;Female;Primary;Matched;CESC;1:DECEASED;[Not Available];44.0
TCGA-ZJ-A8QR-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];44.0
TCGA-4J-AA1J-01;Cervical Cancer;Female;Primary;Matched;CESC;1:DECEASED;[Not Available];41.0
TCGA-C5-A7XC-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];55.0
TCGA-EA-A97N-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];36.0
TCGA-JW-AAVH-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];56.0
TCGA-MA-AA3W-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];38.0
TCGA-MA-AA3Y-01;Cervical Cancer;Female;Primary;Matched;CESC;1:DECEASED;[Not Available];60.0
TCGA-MA-AA3Z-01;Cervical Cancer;Female;Primary;Matched;CESC;1:DECEASED;[Not Available];65.0
TCGA-MA-AA41-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];38.0
TCGA-MA-AA42-01;Cervical Cancer;Female;Primary;Matched;CESC;1:DECEASED;[Not Available];26.0
TCGA-VS-A94X-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];79.0
TCGA-VS-A94Y-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];44.0
TCGA-VS-A94Z-01;Cervical Cancer;Female;Primary;Matched;CESC;1:DECEASED;[Not Available];51.0
TCGA-VS-A952-01;Cervical Cancer;Female;Primary;Matched;CEMU;0:LIVING;[Not Available];42.0
TCGA-VS-A953-01;Cervical Cancer;Female;Primary;Matched;CESC;1:DECEASED;[Not Available];76.0
TCGA-VS-A954-01;Cervical Cancer;Female;Primary;Matched;CESC;1:DECEASED;[Not Available];47.0
TCGA-HG-A9SC-01;Cervical Cancer;Female;Primary;Matched;CEAS;0:LIVING;[Not Available];39.0
TCGA-MA-AA3X-01;Cervical Cancer;Female;Primary;Matched;CESC;1:DECEASED;[Not Available];40.0
TCGA-MA-AA43-01;Cervical Cancer;Female;Primary;Matched;CESC;1:DECEASED;[Not Available];47.0
TCGA-UC-A7PG-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];38.0
TCGA-UC-A7PI-01;Cervical Cancer;Female;Primary;Matched;CEEN;0:LIVING;[Not Available];42.0
TCGA-VS-A950-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];66.0
TCGA-VS-A957-01;Cervical Cancer;Female;Primary;Matched;CESC;1:DECEASED;[Not Available];63.0
TCGA-VS-A958-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];67.0
TCGA-VS-A959-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];64.0
TCGA-VS-A9U5-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];46.0
TCGA-VS-A9U6-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];76.0
TCGA-VS-A9U7-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];57.0
TCGA-VS-A9UA-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];52.0
TCGA-VS-A9UB-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];30.0
TCGA-VS-A9UC-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];60.0
TCGA-VS-A9UD-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];54.0
TCGA-VS-A9UH-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];32.0
TCGA-VS-A9UI-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];73.0
TCGA-VS-A9UJ-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];53.0
TCGA-VS-A9UL-01;Cervical Cancer;Female;Primary;Matched;CESC;1:DECEASED;[Not Available];76.0
TCGA-VS-A9UM-01;Cervical Cancer;Female;Primary;Matched;CESC;1:DECEASED;[Not Available];55.0
TCGA-VS-A9UO-01;Cervical Cancer;Female;Primary;Matched;CEMU;1:DECEASED;[Not Available];79.0
TCGA-VS-A9UP-01;Cervical Cancer;Female;Primary;Matched;CEMU;1:DECEASED;[Not Available];39.0
TCGA-VS-A9UQ-01;Cervical Cancer;Female;Primary;Matched;CEMU;0:LIVING;[Not Available];43.0
TCGA-VS-A9UR-01;Cervical Cancer;Female;Primary;Matched;CEMU;0:LIVING;[Not Available];43.0
TCGA-VS-A9UT-01;Cervical Cancer;Female;Primary;Matched;CEMU;0:LIVING;[Not Available];32.0
TCGA-VS-A9UU-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];53.0
TCGA-VS-A9UV-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];72.0
TCGA-VS-A9UY-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];42.0
TCGA-VS-A9UZ-01;Cervical Cancer;Female;Primary;Matched;CEMU;1:DECEASED;[Not Available];74.0
TCGA-VS-A9V0-01;Cervical Cancer;Female;Primary;Matched;CEMU;1:DECEASED;[Not Available];29.0
TCGA-VS-A9V1-01;Cervical Cancer;Female;Primary;Matched;CEMU;0:LIVING;[Not Available];61.0
TCGA-VS-A9V2-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];58.0
TCGA-VS-A9V3-01;Cervical Cancer;Female;Primary;Matched;CESC;1:DECEASED;[Not Available];46.0
TCGA-VS-A9V4-01;Cervical Cancer;Female;Primary;Matched;CEMU;0:LIVING;[Not Available];29.0
TCGA-VS-A9V5-01;Cervical Cancer;Female;Primary;Matched;CEMU;0:LIVING;[Not Available];62.0
TCGA-VS-AA62-01;Cervical Cancer;Female;Primary;Matched;CESC;1:DECEASED;[Not Available];63.0
TCGA-ZJ-AAX4-01;Cervical Cancer;Female;Primary;Matched;CESC;1:DECEASED;[Not Available];50.0
TCGA-ZJ-AAX8-01;Cervical Cancer;Female;Primary;Matched;CESC;1:DECEASED;[Not Available];51.0
TCGA-ZJ-AAXA-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];57.0
TCGA-ZJ-AAXB-01;Cervical Cancer;Female;Primary;Matched;ECAD;0:LIVING;[Not Available];41.0
TCGA-ZJ-AAXD-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];73.0
TCGA-ZJ-AAXF-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];24.0
TCGA-ZJ-AAXI-01;Cervical Cancer;Female;Primary;Matched;CESC;1:DECEASED;[Not Available];38.0
TCGA-ZJ-AAXJ-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];85.0
TCGA-ZJ-AAXN-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];58.0
TCGA-ZJ-AAXT-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];64.0
TCGA-ZJ-AAXU-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];42.0
TCGA-ZJ-AB0H-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];35.0
TCGA-ZJ-AB0I-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];62.0
TCGA-ZX-AA5X-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];67.0
TCGA-BI-A0VR-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];43.0
TCGA-BI-A0VS-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];34.0
TCGA-DR-A0ZL-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];54.0
TCGA-DR-A0ZM-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];51.0
TCGA-DS-A0VK-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];48.0
TCGA-DS-A0VL-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];25.0
TCGA-DS-A0VM-01;Cervical Cancer;Female;Primary;Matched;CESC;0:LIVING;[Not Available];64.0
TCGA-DS-A0VN-01;Cervical Cancer;[Not Available];Primary;Matched;CESC;[Not Available];[Not Available];[Not Available]
TCGA-HM-A6W2-06;Cervical Cancer, NOS;[Not Available];Metastasis;Matched;CERVIX;[Not Available];[Not Available];[Not Available]
TCGA-UC-A7PG-06;Cervical Cancer, NOS;[Not Available];Metastasis;Matched;CERVIX;[Not Available];[Not Available];[Not Available]
TCGA-3X-AAV9-01;Cholangiocarcinoma;Male;Primary;Matched;CHOL;1:DECEASED;Stage I;72.0
TCGA-3X-AAVA-01;Hepatobiliary Cancer;Female;Primary;Matched;IHCH;1:DECEASED;Stage II;50.0
TCGA-3X-AAVB-01;Hepatobiliary Cancer;Female;Primary;Matched;EHCH;0:LIVING;Stage IVB;70.0
TCGA-3X-AAVC-01;Hepatobiliary Cancer;Female;Primary;Matched;PHCH;0:LIVING;Stage I;72.0
TCGA-3X-AAVE-01;Hepatobiliary Cancer;Male;Primary;Matched;IHCH;0:LIVING;Stage II;60.0
TCGA-4G-AAZO-01;Hepatobiliary Cancer;Female;Primary;Matched;IHCH;0:LIVING;Stage III;74.0
TCGA-4G-AAZT-01;Hepatobiliary Cancer;Male;Primary;Matched;IHCH;0:LIVING;Stage III;75.0
TCGA-W5-AA2G-01;Hepatobiliary Cancer;Female;Primary;Matched;IHCH;0:LIVING;Stage II;71.0
TCGA-W5-AA2H-01;Hepatobiliary Cancer;Male;Primary;Matched;EHCH;1:DECEASED;Stage II;74.0
TCGA-W5-AA2I-01;Hepatobiliary Cancer;Male;Primary;Matched;IHCH;0:LIVING;Stage I;62.0
TCGA-W5-AA2O-01;Hepatobiliary Cancer;Female;Primary;Matched;IHCH;0:LIVING;Stage I;62.0
TCGA-W5-AA2Q-01;Hepatobiliary Cancer;Female;Primary;Matched;IHCH;0:LIVING;Stage III;70.0
TCGA-W5-AA2R-01;Hepatobiliary Cancer;Male;Primary;Matched;IHCH;1:DECEASED;Stage I;66.0
TCGA-W5-AA2T-01;Hepatobiliary Cancer;Female;Primary;Matched;IHCH;0:LIVING;Stage IVA;66.0
TCGA-W5-AA2U-01;Hepatobiliary Cancer;Female;Primary;Matched;IHCH;1:DECEASED;Stage I;75.0
TCGA-W5-AA2W-01;Hepatobiliary Cancer;Male;Primary;Matched;IHCH;1:DECEASED;Stage IVB;49.0
TCGA-W5-AA2X-01;Hepatobiliary Cancer;Male;Primary;Matched;PHCH;1:DECEASED;Stage I;57.0
TCGA-W5-AA2Z-01;Hepatobiliary Cancer;Male;Primary;Matched;IHCH;0:LIVING;Stage II;68.0
TCGA-W5-AA30-01;Hepatobiliary Cancer;Female;Primary;Matched;IHCH;0:LIVING;Stage I;77.0
TCGA-W5-AA31-01;Hepatobiliary Cancer;Female;Primary;Matched;IHCH;1:DECEASED;Stage II;64.0
TCGA-W5-AA33-01;Hepatobiliary Cancer;Female;Primary;Matched;IHCH;1:DECEASED;Stage I;78.0
TCGA-W5-AA34-01;Hepatobiliary Cancer;Female;Primary;Matched;IHCH;1:DECEASED;Stage IVA;31.0
TCGA-W5-AA36-01;Hepatobiliary Cancer;Male;Primary;Matched;PHCH;1:DECEASED;Stage IVB;67.0
TCGA-W5-AA38-01;Hepatobiliary Cancer;Female;Primary;Matched;IHCH;0:LIVING;Stage II;29.0
TCGA-W5-AA39-01;Hepatobiliary Cancer;Male;Primary;Matched;IHCH;0:LIVING;Stage I;82.0
TCGA-W6-AA0S-01;Hepatobiliary Cancer;Male;Primary;Matched;IHCH;0:LIVING;Stage I;71.0
TCGA-WD-A7RX-01;Hepatobiliary Cancer;Male;Primary;Matched;IHCH;0:LIVING;Stage I;60.0
TCGA-YR-A95A-01;Hepatobiliary Cancer;Female;Primary;Matched;PHCH;1:DECEASED;Stage I;75.0
TCGA-ZD-A8I3-01;Hepatobiliary Cancer;Female;Primary;Matched;IHCH;1:DECEASED;Stage IV;51.0
TCGA-ZH-A8Y1-01;Hepatobiliary Cancer;Female;Primary;Matched;IHCH;0:LIVING;Stage I;55.0
TCGA-ZH-A8Y2-01;Hepatobiliary Cancer;Male;Primary;Matched;IHCH;1:DECEASED;Stage II;81.0
TCGA-ZH-A8Y4-01;Hepatobiliary Cancer;Female;Primary;Matched;IHCH;0:LIVING;Stage I;46.0
TCGA-ZH-A8Y5-01;Hepatobiliary Cancer;Female;Primary;Matched;IHCH;0:LIVING;Stage III;62.0
TCGA-ZH-A8Y6-01;Hepatobiliary Cancer;Female;Primary;Matched;IHCH;1:DECEASED;Stage II;71.0
TCGA-ZH-A8Y8-01;Hepatobiliary Cancer;Male;Primary;Matched;IHCH;1:DECEASED;Stage IV;52.0
TCGA-ZU-A8S4-01;Hepatobiliary Cancer;Female;Primary;Matched;IHCH;1:DECEASED;Stage II;73.0
TCGA-4G-AAZF-01;Hepatobiliary Cancer;Female;Primary;Matched;IHCH;1:DECEASED;Stage IVA;74.0
TCGA-4G-AAZG-01;Hepatobiliary Cancer;Female;Primary;Matched;IHCH;1:DECEASED;Stage I;59.0
TCGA-4G-AAZR-01;Hepatobiliary Cancer;Female;Primary;Matched;PHCH;1:DECEASED;Stage II;61.0
TCGA-5A-A8ZF-01;Cholangiocarcinoma;Male;Primary;Matched;CHOL;1:DECEASED;Stage I;58.0
TCGA-5A-A8ZG-01;Cholangiocarcinoma;Male;Primary;Matched;CHOL;0:LIVING;Stage IVB;69.0
TCGA-W5-AA2J-01;Hepatobiliary Cancer;Female;Primary;Matched;PHCH;0:LIVING;Stage I;41.0
TCGA-W5-AA2K-01;Hepatobiliary Cancer;Male;Primary;Matched;IHCH;0:LIVING;Stage IVB;59.0
TCGA-W5-AA2M-01;Hepatobiliary Cancer;Male;Primary;Matched;PHCH;0:LIVING;Stage I;73.0
TCGA-W6-AA0T-01;Hepatobiliary Cancer;Male;Primary;Matched;IHCH;1:DECEASED;Stage I;52.0
TCGA-W7-A93N-01;Cholangiocarcinoma;[Not Available];Primary;Matched;CHOL;[Not Available];[Not Available];[Not Available]
TCGA-W7-A93O-01;Cholangiocarcinoma;[Not Available];Primary;Matched;CHOL;[Not Available];[Not Available];[Not Available]
TCGA-W7-A93P-01;Cholangiocarcinoma;[Not Available];Primary;Matched;CHOL;[Not Available];[Not Available];[Not Available]
TCGA-ZH-A8Y3-01;Hepatobiliary Cancer;[Not Available];Primary;Matched;IHCH;[Not Available];[Not Available];[Not Available]
TCGA-ZH-A8Y7-01;Hepatobiliary Cancer;[Not Available];Primary;Matched;IHCH;[Not Available];[Not Available];[Not Available]
TCGA-ZK-AAYZ-01;Cholangiocarcinoma;[Not Available];Primary;Matched;CHOL;[Not Available];[Not Available];[Not Available]
TCGA-A6-2675-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIIC;57.0
TCGA-A6-5667-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage I;61.0
TCGA-AA-3655-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIIB;67.0
TCGA-AA-3660-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIA;42.0
TCGA-AA-3662-01;Colorectal Cancer;Male;Primary;Matched;COAD;1:DECEASED;Stage IV;74.0
TCGA-AA-3663-01;Colorectal Cancer;Female;Primary;Matched;COAD;1:DECEASED;Stage IV;40.0
TCGA-AA-3697-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIA;76.0
TCGA-AA-3712-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIA;45.0
TCGA-AA-3713-01;Colorectal Cancer;Male;Primary;Matched;COAD;1:DECEASED;Stage IV;85.0
TCGA-AU-3779-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIIB;82.0
TCGA-AU-6004-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IV;71.0
TCGA-AY-6196-01;Colorectal Cancer;Male;Primary;Matched;MACR;0:LIVING;Stage IIA;78.0
TCGA-AY-6197-01;Colorectal Cancer;Female;Primary;Matched;COAD;1:DECEASED;Stage IIB;75.0
TCGA-AY-6386-01;Colorectal Cancer;Female;Primary;Matched;COAD;1:DECEASED;Stage IIIC;68.0
TCGA-AZ-5407-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIIB;43.0
TCGA-CK-4950-01;Colorectal Cancer;Female;Primary;Matched;MACR;0:LIVING;Stage IIB;73.0
TCGA-CK-4952-01;Colorectal Cancer;Female;Primary;Matched;MACR;0:LIVING;Stage II;72.0
TCGA-CM-4743-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIA;73.0
TCGA-CM-5344-01;Colorectal Cancer;Male;Primary;Matched;COAD;1:DECEASED;Stage IV;70.0
TCGA-CM-5348-01;Colorectal Cancer;Female;Primary;Matched;COAD;1:DECEASED;Stage IV;57.0
TCGA-CM-5349-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage I;75.0
TCGA-D5-6530-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIA;48.0
TCGA-D5-6531-01;Colorectal Cancer;Female;Primary;Matched;COAD;1:DECEASED;Stage IIA;81.0
TCGA-D5-6532-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIIC;53.0
TCGA-D5-6533-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIA;73.0
TCGA-D5-6535-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIB;71.0
TCGA-D5-6536-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIA;62.0
TCGA-D5-6537-01;Colorectal Cancer;Male;Primary;Matched;COAD;1:DECEASED;Stage IIA;79.0
TCGA-D5-6538-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIIB;57.0
TCGA-D5-6539-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage I;74.0
TCGA-D5-6540-01;Colorectal Cancer;Male;Primary;Matched;MACR;0:LIVING;Stage IIIB;65.0
TCGA-D5-6541-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage I;82.0
TCGA-F4-6463-01;Colorectal Cancer;Male;Primary;Matched;MACR;0:LIVING;Stage IIIC;73.0
TCGA-G4-6293-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIA;80.0
TCGA-G4-6295-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IVA;46.0
TCGA-G4-6297-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIIC;80.0
TCGA-G4-6298-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIA;84.0
TCGA-G4-6302-01;Colorectal Cancer;Male;Primary;Matched;MACR;0:LIVING;Stage IIC;78.0
TCGA-G4-6307-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIIB;40.0
TCGA-G4-6310-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIIB;55.0
TCGA-G4-6311-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage I;61.0
TCGA-G4-6314-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIA;62.0
TCGA-G4-6315-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIA;31.0
TCGA-G4-6317-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IVA;56.0
TCGA-G4-6320-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IVA;56.0
TCGA-G4-6321-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIIB;66.0
TCGA-G4-6322-01;Colorectal Cancer;Female;Primary;Matched;MACR;0:LIVING;Stage IIA;69.0
TCGA-G4-6323-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIIB;55.0
TCGA-A6-4105-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IVA;59.0
TCGA-A6-6137-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage I;82.0
TCGA-A6-6138-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIIB;65.0
TCGA-A6-6140-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIA;74.0
TCGA-A6-6141-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIIC;43.0
TCGA-A6-6142-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIB;82.0
TCGA-A6-6648-01;Colorectal Cancer;Female;Primary;Matched;COAD;1:DECEASED;Stage IIIC;34.0
TCGA-A6-6649-01;Colorectal Cancer;Female;Primary;Matched;COAD;1:DECEASED;Stage IIIB;55.0
TCGA-A6-6650-01;Colorectal Cancer;Male;Primary;Matched;COAD;1:DECEASED;Stage IV;56.0
TCGA-A6-6652-01;Colorectal Cancer;Male;Primary;Matched;COAD;1:DECEASED;Stage IIIB;57.0
TCGA-A6-6653-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIIB;59.0
TCGA-AZ-6598-01;Colorectal Cancer;Male;Primary;Matched;COAD;1:DECEASED;Stage IV;58.0
TCGA-AZ-6599-01;Colorectal Cancer;Male;Primary;Matched;COAD;1:DECEASED;Stage II;75.0
TCGA-AZ-6600-01;Colorectal Cancer;Female;Primary;Matched;COAD;1:DECEASED;Stage II;90.0
TCGA-AZ-6601-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IV;55.0
TCGA-D5-6529-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage I;79.0
TCGA-F4-6459-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage II;83.0
TCGA-F4-6460-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage I;73.0
TCGA-F4-6461-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage I;77.0
TCGA-F4-6569-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage II;54.0
TCGA-F4-6570-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage II;70.0
TCGA-G4-6294-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage II;64.0
TCGA-G4-6299-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage I;81.0
TCGA-G4-6303-01;Colorectal Cancer;Female;Primary;Matched;COAD;1:DECEASED;Stage III;74.0
TCGA-G4-6306-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIA;60.0
TCGA-G4-6586-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIA;81.0
TCGA-G4-6588-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage III;63.0
TCGA-G4-6625-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage II;86.0
TCGA-G4-6626-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage II;87.0
TCGA-G4-6627-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIA;67.0
TCGA-DM-A0X9-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage II;85.0
TCGA-DM-A0XD-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIIB;90.0
TCGA-DM-A0XF-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage I;57.0
TCGA-DM-A1D0-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIA;90.0
TCGA-DM-A1D4-01;Colorectal Cancer;Female;Primary;Matched;COAD;1:DECEASED;Stage IIIC;78.0
TCGA-DM-A1D6-01;Colorectal Cancer;Male;Primary;Matched;MACR;0:LIVING;Stage I;80.0
TCGA-DM-A1D7-01;Colorectal Cancer;Female;Primary;Matched;MACR;0:LIVING;Stage IIA;75.0
TCGA-DM-A1D8-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIA;63.0
TCGA-DM-A1D9-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIA;78.0
TCGA-DM-A1DA-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage I;54.0
TCGA-DM-A1DB-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIIC;69.0
TCGA-DM-A1HA-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage I;84.0
TCGA-A6-5656-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage I;68.0
TCGA-A6-5664-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIIC;71.0
TCGA-A6-6651-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage I;69.0
TCGA-A6-6654-01;Colorectal Cancer;Male;Primary;Matched;COAD;1:DECEASED;Stage IIIC;85.0
TCGA-A6-6780-01;Colorectal Cancer;Female;Primary;Matched;MACR;0:LIVING;Stage I;61.0
TCGA-A6-6782-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIA;62.0
TCGA-AA-3489-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIA;81.0
TCGA-AA-3496-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage I;78.0
TCGA-AA-3511-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage I;70.0
TCGA-AD-6548-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIIC;72.0
TCGA-AZ-4323-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIA;72.0
TCGA-AZ-4616-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIIC;82.0
TCGA-AZ-6603-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage II;68.0
TCGA-AZ-6605-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage II;51.0
TCGA-AZ-6606-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IV;80.0
TCGA-AZ-6607-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage II;42.0
TCGA-AZ-6608-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage II;74.0
TCGA-CA-5254-01;Colorectal Cancer;Male;Primary;Matched;COAD;1:DECEASED;Stage III;68.0
TCGA-CA-5255-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage I;36.0
TCGA-CA-6715-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage III;90.0
TCGA-CA-6716-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage II;53.0
TCGA-CA-6717-01;Colorectal Cancer;Male;Primary;Matched;MACR;0:LIVING;Stage II;84.0
TCGA-CA-6718-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage III;60.0
TCGA-CA-6719-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IV;59.0
TCGA-CK-6746-01;Colorectal Cancer;Female;Primary;Matched;COAD;1:DECEASED;Stage IV;67.0
TCGA-CK-6747-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage III;77.0
TCGA-CK-6748-01;Colorectal Cancer;Female;Primary;Matched;MACR;0:LIVING;Stage IV;65.0
TCGA-CK-6751-01;Colorectal Cancer;Male;Primary;Matched;MACR;0:LIVING;Stage II;69.0
TCGA-CM-4751-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IV;80.0
TCGA-CM-5863-01;Colorectal Cancer;Female;Primary;Matched;MACR;1:DECEASED;Stage IV;47.0
TCGA-CM-6674-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IV;77.0
TCGA-CM-6675-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IV;63.0
TCGA-CM-6676-01;Colorectal Cancer;Female;Primary;Matched;COAD;1:DECEASED;Stage IV;75.0
TCGA-CM-6677-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage II;77.0
TCGA-CM-6678-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIA;80.0
TCGA-CM-6679-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage III;65.0
TCGA-CM-6680-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IV;68.0
TCGA-F4-6703-01;Colorectal Cancer;Male;Primary;Matched;COAD;1:DECEASED;Stage II;77.0
TCGA-F4-6704-01;Colorectal Cancer;Female;Primary;Matched;MACR;1:DECEASED;Stage III;84.0
TCGA-F4-6805-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIA;82.0
TCGA-F4-6806-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIA;85.0
TCGA-F4-6807-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIA;65.0
TCGA-F4-6808-01;Colorectal Cancer;Female;Primary;Matched;COAD;1:DECEASED;Stage IIA;78.0
TCGA-F4-6809-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIA;41.0
TCGA-G4-6309-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage I;81.0
TCGA-G4-6628-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIA;66.0
TCGA-DM-A280-01;Colorectal Cancer;Female;Primary;Matched;MACR;0:LIVING;Stage IIA;63.0
TCGA-DM-A282-01;Colorectal Cancer;Male;Primary;Matched;MACR;0:LIVING;Stage IIA;67.0
TCGA-DM-A285-01;Colorectal Cancer;Male;Primary;Matched;MACR;0:LIVING;Stage IIA;66.0
TCGA-DM-A288-01;Colorectal Cancer;Male;Primary;Matched;MACR;0:LIVING;Stage IIIA;51.0
TCGA-DM-A28A-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIIC;78.0
TCGA-DM-A28C-01;Colorectal Cancer;Female;Primary;Matched;COAD;1:DECEASED;Stage IIA;86.0
TCGA-DM-A28E-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIA;74.0
TCGA-DM-A28F-01;Colorectal Cancer;Female;Primary;Matched;COAD;1:DECEASED;Stage IIIC;82.0
TCGA-DM-A28G-01;Colorectal Cancer;Male;Primary;Matched;COAD;1:DECEASED;Stage I;74.0
TCGA-DM-A28H-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIA;74.0
TCGA-DM-A28K-01;Colorectal Cancer;Male;Primary;Matched;MACR;1:DECEASED;Stage IIA;88.0
TCGA-DM-A28M-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage I;71.0
TCGA-A6-6781-01;Colorectal Cancer;Male;Primary;Matched;MACR;0:LIVING;Stage I;72.0
TCGA-AD-6888-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIA;59.0
TCGA-AD-6889-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage I;67.0
TCGA-AD-6890-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIIB;53.0
TCGA-AD-6895-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIA;72.0
TCGA-AD-6899-01;Colorectal Cancer;Male;Primary;Matched;MACR;0:LIVING;Stage IIA;82.0
TCGA-AD-6901-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage II;71.0
TCGA-AD-6963-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage I;78.0
TCGA-AD-6964-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IV;74.0
TCGA-AD-6965-01;Colorectal Cancer;Male;Primary;Matched;COAD;1:DECEASED;Stage IV;76.0
TCGA-D5-5537-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IV;71.0
TCGA-D5-6534-01;Colorectal Cancer;Male;Primary;Matched;MACR;0:LIVING;Stage IV;45.0
TCGA-D5-6898-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage I;78.0
TCGA-D5-6920-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage I;83.0
TCGA-D5-6922-01;Colorectal Cancer;Male;Primary;Matched;COAD;1:DECEASED;Stage IV;66.0
TCGA-D5-6923-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIA;83.0
TCGA-D5-6924-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IVA;84.0
TCGA-D5-6926-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIB;60.0
TCGA-D5-6927-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIIB;87.0
TCGA-D5-6928-01;Colorectal Cancer;Female;Primary;Matched;MACR;0:LIVING;Stage IIA;79.0
TCGA-D5-6929-01;Colorectal Cancer;Male;Primary;Matched;COAD;1:DECEASED;Stage IIIC;68.0
TCGA-D5-6930-01;Colorectal Cancer;Male;Primary;Matched;MACR;0:LIVING;Stage IIIB;38.0
TCGA-D5-6931-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIA;65.0
TCGA-D5-6932-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIA;89.0
TCGA-D5-7000-01;Colorectal Cancer;Male;Primary;Matched;MACR;0:LIVING;Stage IIIB;77.0
TCGA-F4-6854-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage I;55.0
TCGA-F4-6855-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIA;65.0
TCGA-F4-6856-01;Colorectal Cancer;Male;Primary;Matched;MACR;0:LIVING;Stage III;58.0
TCGA-F4-6857-01;Colorectal Cancer;Male;Primary;Matched;COADREAD;0:LIVING;Stage IV;72.0
TCGA-G4-6304-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IV;69.0
TCGA-DM-A1HB-01;Colorectal Cancer;Male;Primary;Matched;MACR;0:LIVING;Stage I;80.0
TCGA-DM-A286-01;Colorectal Cancer;Male;Primary;Matched;COADREAD;0:LIVING;Stage IIIA;70.0
TCGA-A6-2670-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;[Not Available];65.0
TCGA-A6-2674-01;Colorectal Cancer;Male;Primary;Matched;MACR;0:LIVING;Stage IIA;84.0
TCGA-A6-2677-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage I;89.0
TCGA-A6-2678-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIIB;75.0
TCGA-A6-2683-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIA;61.0
TCGA-AA-3514-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage I;73.0
TCGA-AA-3517-01;Colorectal Cancer;Male;Primary;Matched;COAD;1:DECEASED;Stage IV;84.0
TCGA-AA-3519-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIIB;69.0
TCGA-AA-3520-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIA;76.0
TCGA-AA-3521-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIA;80.0
TCGA-AA-3522-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage I;70.0
TCGA-AA-3524-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIA;65.0
TCGA-AA-3526-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIIC;66.0
TCGA-AA-3527-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIIB;80.0
TCGA-AA-3529-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIA;79.0
TCGA-AA-3531-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIA;66.0
TCGA-AA-3532-01;Colorectal Cancer;Male;Primary;Matched;COAD;1:DECEASED;Stage IIB;75.0
TCGA-AA-3534-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIIC;83.0
TCGA-AA-3538-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIIB;66.0
TCGA-AA-3542-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage I;64.0
TCGA-AA-3544-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIIB;50.0
TCGA-AA-3548-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage I;80.0
TCGA-AA-3549-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIA;70.0
TCGA-AA-3552-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIB;46.0
TCGA-AA-3553-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIA;57.0
TCGA-AA-3555-01;Colorectal Cancer;Male;Primary;Matched;MACR;0:LIVING;Stage IIIA;75.0
TCGA-AA-3556-01;Colorectal Cancer;Female;Primary;Matched;MACR;1:DECEASED;Stage IIIC;47.0
TCGA-AA-3558-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIIB;72.0
TCGA-AA-3560-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIA;63.0
TCGA-AA-3561-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage I;76.0
TCGA-AA-3562-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIIC;74.0
TCGA-A6-2672-01;Colorectal Cancer;Female;Primary;Matched;COAD;1:DECEASED;Stage III;80.0
TCGA-A6-2676-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage II;48.0
TCGA-AA-3516-01;Colorectal Cancer;Male;Primary;Matched;MACR;0:LIVING;Stage III;47.0
TCGA-AA-3518-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage III;47.0
TCGA-AA-3525-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage III;63.0
TCGA-AA-3543-01;Colorectal Cancer;Male;Primary;Matched;MACR;0:LIVING;Stage I;59.0
TCGA-AA-3554-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage III;80.0
TCGA-AA-A00A-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage II;68.0
TCGA-AA-A00D-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage II;88.0
TCGA-AA-A00E-01;Colorectal Cancer;Male;Primary;Matched;COAD;1:DECEASED;Stage II;81.0
TCGA-AA-A00F-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage II;67.0
TCGA-AA-A00J-01;Colorectal Cancer;Female;Primary;Matched;MACR;1:DECEASED;Stage IV;82.0
TCGA-AA-A00K-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IV;68.0
TCGA-AA-A00L-01;Colorectal Cancer;Female;Primary;Matched;COAD;1:DECEASED;Stage IV;74.0
TCGA-AA-A00Q-01;Colorectal Cancer;Female;Primary;Matched;COAD;1:DECEASED;Stage IV;70.0
TCGA-AA-A00R-01;Colorectal Cancer;Male;Primary;Matched;COAD;1:DECEASED;Stage IV;50.0
TCGA-AA-A00U-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage II;82.0
TCGA-AA-A00W-01;Colorectal Cancer;Female;Primary;Matched;COAD;1:DECEASED;Stage IIA;84.0
TCGA-AA-A00Z-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage I;73.0
TCGA-AA-A01F-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage I;73.0
TCGA-AA-A01G-01;Colorectal Cancer;Female;Primary;Matched;MACR;1:DECEASED;Stage III;90.0
TCGA-AA-A01Q-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage I;65.0
TCGA-A6-A565-01;Colorectal Cancer;Male;Primary;Matched;MACR;0:LIVING;Stage I;67.0
TCGA-A6-A566-01;Colorectal Cancer;Female;Primary;Matched;MACR;0:LIVING;Stage I;81.0
TCGA-A6-A567-01;Colorectal Cancer;Male;Primary;Matched;COAD;1:DECEASED;Stage IIIB;73.0
TCGA-A6-A56B-01;Colorectal Cancer;Male;Primary;Matched;COAD;1:DECEASED;Stage IIA;76.0
TCGA-A6-A5ZU-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;[Not Available];65.0
TCGA-AD-A5EJ-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIIB;84.0
TCGA-AD-A5EK-01;Colorectal Cancer;Male;Primary;Matched;COAD;1:DECEASED;Stage IIIC;84.0
TCGA-AY-A54L-01;Colorectal Cancer;Male;Primary;Matched;COAD;1:DECEASED;[Not Available];78.0
TCGA-NH-A50T-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;[Not Available];58.0
TCGA-NH-A50V-01;Colorectal Cancer;Male;Primary;Matched;COAD;1:DECEASED;[Not Available];58.0
TCGA-QG-A5YV-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIIC;62.0
TCGA-QG-A5YW-01;Colorectal Cancer;Female;Primary;Matched;MACR;0:LIVING;Stage IIA;74.0
TCGA-QG-A5YX-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage I;51.0
TCGA-QG-A5Z1-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IVA;59.0
TCGA-QG-A5Z2-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIA;68.0
TCGA-AA-A004-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIA;80.0
TCGA-AA-A00N-01;Colorectal Cancer;Female;Primary;Matched;MACR;0:LIVING;Stage I;69.0
TCGA-AA-A00O-01;Colorectal Cancer;Female;Primary;Matched;COAD;1:DECEASED;Stage IIIC;50.0
TCGA-AA-A010-01;Colorectal Cancer;Female;Primary;Matched;COAD;1:DECEASED;Stage I;63.0
TCGA-AA-A017-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IVA;65.0
TCGA-AA-A01C-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIIC;47.0
TCGA-AA-A01D-01;Colorectal Cancer;Male;Primary;Matched;MACR;0:LIVING;Stage IIA;60.0
TCGA-AA-A01I-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIIB;66.0
TCGA-AA-A01K-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage I;74.0
TCGA-AA-A024-01;Colorectal Cancer;Female;Primary;Matched;MACR;0:LIVING;Stage IIA;55.0
TCGA-AA-A029-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage I;54.0
TCGA-AA-A02E-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IVA;44.0
TCGA-AA-A02F-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIIB;47.0
TCGA-AA-A02H-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage I;51.0
TCGA-AA-A02J-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIA;61.0
TCGA-AA-A02R-01;Colorectal Cancer;Male;Primary;Matched;COAD;1:DECEASED;Stage IV;37.0
TCGA-AA-A02W-01;Colorectal Cancer;Female;Primary;Matched;COAD;1:DECEASED;Stage IVA;71.0
TCGA-AA-3664-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIIB;84.0
TCGA-AA-3666-01;Colorectal Cancer;Female;Primary;Matched;COAD;1:DECEASED;Stage IV;82.0
TCGA-AA-3667-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIA;79.0
TCGA-AA-3672-01;Colorectal Cancer;Male;Primary;Matched;COAD;1:DECEASED;Stage IVA;61.0
TCGA-AA-3673-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IVA;49.0
TCGA-AA-3675-01;Colorectal Cancer;Male;Primary;Matched;COAD;1:DECEASED;Stage II;43.0
TCGA-AA-3678-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage I;51.0
TCGA-AA-3679-01;Colorectal Cancer;Female;Primary;Matched;COAD;1:DECEASED;Stage II;77.0
TCGA-AA-3680-01;Colorectal Cancer;Male;Primary;Matched;COAD;1:DECEASED;Stage I;72.0
TCGA-AA-3681-01;Colorectal Cancer;Male;Primary;Matched;COAD;1:DECEASED;Stage IV;64.0
TCGA-AA-3684-01;Colorectal Cancer;Male;Primary;Matched;MACR;1:DECEASED;Stage II;68.0
TCGA-AA-3685-01;Colorectal Cancer;Female;Primary;Matched;COAD;1:DECEASED;[Not Available];77.0
TCGA-AA-3688-01;Colorectal Cancer;Male;Primary;Matched;COAD;1:DECEASED;Stage IIIB;77.0
TCGA-AA-3692-01;Colorectal Cancer;Male;Primary;Matched;MACR;1:DECEASED;Stage IV;81.0
TCGA-AA-3693-01;Colorectal Cancer;Male;Primary;Matched;COAD;1:DECEASED;Stage IV;69.0
TCGA-AA-3695-01;Colorectal Cancer;Female;Primary;Matched;COAD;1:DECEASED;Stage IIIA;55.0
TCGA-AA-3696-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIA;42.0
TCGA-AA-3715-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIA;45.0
TCGA-AA-3812-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIA;54.0
TCGA-AA-3814-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIA;52.0
TCGA-AA-3818-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIA;56.0
TCGA-AA-3819-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIIB;63.0
TCGA-AA-3831-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIA;65.0
TCGA-AA-3833-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIA;57.0
TCGA-AA-3837-01;Colorectal Cancer;Male;Primary;Matched;MACR;1:DECEASED;Stage IIA;46.0
TCGA-AA-3841-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIA;77.0
TCGA-AA-3848-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIIB;46.0
TCGA-AA-3852-01;Colorectal Cancer;Female;Primary;Matched;MACR;0:LIVING;Stage III;45.0
TCGA-AA-3854-01;Colorectal Cancer;Female;Primary;Matched;MACR;0:LIVING;Stage IIIB;68.0
TCGA-AA-3856-01;Colorectal Cancer;Female;Primary;Matched;COAD;1:DECEASED;Stage IIA;79.0
TCGA-AA-3858-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIIC;48.0
TCGA-AA-3860-01;Colorectal Cancer;Male;Primary;Matched;COAD;1:DECEASED;Stage I;81.0
TCGA-AA-3875-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIA;58.0
TCGA-3L-AA1B-01;Colorectal Cancer;Male;Primary;Matched;COADREAD;0:LIVING;Stage IIIB;81.0
TCGA-4N-A93T-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage I;63.0
TCGA-AY-A69D-01;Colorectal Cancer;Female;Primary;Matched;COAD;1:DECEASED;Stage I;71.0
TCGA-AY-A71X-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIB;84.0
TCGA-NH-A50U-01;Colorectal Cancer;Female;Primary;Matched;MACR;0:LIVING;Stage IIA;87.0
TCGA-NH-A5IV-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IV;45.0
TCGA-NH-A6GA-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage I;88.0
TCGA-NH-A6GB-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIA;69.0
TCGA-RU-A8FL-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage I;69.0
TCGA-SS-A7HO-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage I;61.0
TCGA-T9-A92H-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IVA;47.0
TCGA-A6-3807-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIIB;53.0
TCGA-A6-3808-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIIA;34.0
TCGA-A6-3809-01;Colorectal Cancer;Male;Primary;Matched;MACR;0:LIVING;Stage IIIB;62.0
TCGA-A6-3810-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIA;58.0
TCGA-AA-3530-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIIA;82.0
TCGA-AA-3710-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIIB;39.0
TCGA-AA-3811-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIIB;72.0
TCGA-AA-3815-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIA;68.0
TCGA-AA-3821-01;Colorectal Cancer;Male;Primary;Matched;MACR;0:LIVING;Stage IIA;44.0
TCGA-AA-3842-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIA;63.0
TCGA-AA-3844-01;Colorectal Cancer;Male;Primary;Matched;COAD;1:DECEASED;Stage IVA;80.0
TCGA-AA-3845-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIIB;60.0
TCGA-AA-3846-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage I;60.0
TCGA-AA-3850-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IVA;59.0
TCGA-AA-3851-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage I;36.0
TCGA-AA-3855-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIIB;48.0
TCGA-AA-3861-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage I;74.0
TCGA-AA-3862-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIA;46.0
TCGA-AA-3864-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIA;74.0
TCGA-AA-3866-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage I;48.0
TCGA-AA-3867-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIIC;57.0
TCGA-AA-3869-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIA;84.0
TCGA-AA-3870-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIA;67.0
TCGA-AA-3872-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage I;73.0
TCGA-AA-3877-01;Colorectal Cancer;Female;Primary;Matched;MACR;0:LIVING;Stage I;77.0
TCGA-AA-3930-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIIB;70.0
TCGA-AA-3939-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIA;39.0
TCGA-AA-3941-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IVB;35.0
TCGA-AA-3947-01;Colorectal Cancer;Male;Primary;Matched;MACR;0:LIVING;Stage I;82.0
TCGA-AA-3949-01;Colorectal Cancer;Female;Primary;Matched;MACR;0:LIVING;Stage IIA;75.0
TCGA-AA-3950-01;Colorectal Cancer;Female;Primary;Matched;MACR;0:LIVING;Stage IVA;63.0
TCGA-AA-3952-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIA;58.0
TCGA-AA-3955-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIIB;78.0
TCGA-AA-3956-01;Colorectal Cancer;Male;Primary;Matched;COAD;1:DECEASED;[Discrepancy];83.0
TCGA-AA-3968-01;Colorectal Cancer;Female;Primary;Matched;COAD;1:DECEASED;Stage IIIB;60.0
TCGA-AA-3970-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIIA;60.0
TCGA-AA-3971-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIA;73.0
TCGA-AA-3972-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIIB;63.0
TCGA-AA-3973-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIA;69.0
TCGA-AA-3975-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage I;53.0
TCGA-AA-3976-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIA;75.0
TCGA-AA-3977-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIA;61.0
TCGA-AA-3979-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;[Discrepancy];68.0
TCGA-AA-3980-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIA;62.0
TCGA-AA-3982-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIIB;80.0
TCGA-AA-3984-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIA;73.0
TCGA-AA-3986-01;Colorectal Cancer;Male;Primary;Matched;COAD;1:DECEASED;Stage IIIB;64.0
TCGA-AA-3989-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIIB;79.0
TCGA-4T-AA8H-01;Colorectal Cancer;Female;Primary;Matched;MACR;0:LIVING;[Discrepancy];45.0
TCGA-5M-AAT4-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage I;66.0
TCGA-5M-AAT5-01;Colorectal Cancer;Male;Primary;Matched;COADREAD;0:LIVING;Stage IIA;49.0
TCGA-5M-AAT6-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage I;51.0
TCGA-5M-AATA-01;Colorectal Cancer;Female;Primary;Matched;COADREAD;0:LIVING;Stage IIA;77.0
TCGA-5M-AATE-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIIA;76.0
TCGA-AY-A8YK-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage I;57.0
TCGA-NH-A6GC-01;Colorectal Cancer;Male;Primary;Matched;MACR;0:LIVING;Stage IIA;68.0
TCGA-NH-A8F7-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIIB;65.0
TCGA-NH-A8F8-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIA;34.0
TCGA-QL-A97D-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIA;80.0
TCGA-WS-AB45-01;Colorectal Cancer;Female;Primary;Matched;MACR;0:LIVING;Stage IV;49.0
TCGA-AA-3966-01;Colorectal Cancer;Male;Primary;Matched;MACR;0:LIVING;Stage IIA;67.0
TCGA-AA-3967-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIIC;77.0
TCGA-AA-3994-01;Colorectal Cancer;Male;Primary;Matched;MACR;0:LIVING;Stage IIA;69.0
TCGA-AY-4070-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage I;79.0
TCGA-AY-4071-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIA;71.0
TCGA-AA-A01P-01;Colorectal Cancer;Male;Primary;Matched;COAD;1:DECEASED;Stage IIA;65.0
TCGA-AA-A01R-01;Colorectal Cancer;Female;Primary;Matched;MACR;1:DECEASED;Stage IIIC;68.0
TCGA-AA-A01S-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIA;79.0
TCGA-AA-A01T-01;Colorectal Cancer;Male;Primary;Matched;COAD;1:DECEASED;Stage IIA;80.0
TCGA-AA-A01V-01;Colorectal Cancer;Male;Primary;Matched;COAD;1:DECEASED;Stage IIA;88.0
TCGA-AA-A01X-01;Colorectal Cancer;Male;Primary;Matched;COAD;1:DECEASED;Stage IIA;82.0
TCGA-AA-A01Z-01;Colorectal Cancer;Female;Primary;Matched;COAD;1:DECEASED;[Not Available];50.0
TCGA-AA-A022-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIA;67.0
TCGA-AA-A02K-01;Colorectal Cancer;Female;Primary;Matched;COAD;1:DECEASED;Stage IIIC;71.0
TCGA-AA-A02O-01;Colorectal Cancer;Male;Primary;Matched;COAD;1:DECEASED;Stage IIA;68.0
TCGA-AA-A02Y-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIIC;82.0
TCGA-AA-A03F-01;Colorectal Cancer;Male;Primary;Matched;MACR;0:LIVING;Stage IIIB;75.0
TCGA-AA-A03J-01;Colorectal Cancer;Female;Primary;Matched;COAD;1:DECEASED;Stage IIA;70.0
TCGA-A6-2671-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIA;60.0
TCGA-A6-2679-01;Colorectal Cancer;Female;Primary;Matched;COAD;1:DECEASED;Stage IV;71.0
TCGA-A6-2680-01;Colorectal Cancer;Male;Primary;Matched;COAD;1:DECEASED;Stage IIIC;68.0
TCGA-A6-2681-01;Colorectal Cancer;Male;Primary;Matched;COAD;1:DECEASED;Stage IIIC;78.0
TCGA-A6-2682-01;Colorectal Cancer;Male;Primary;Matched;COAD;1:DECEASED;Stage IIA;74.0
TCGA-A6-2684-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIA;72.0
TCGA-A6-2685-01;Colorectal Cancer;Male;Primary;Matched;COAD;1:DECEASED;Stage IIIB;73.0
TCGA-A6-2686-01;Colorectal Cancer;Male;Primary;Matched;COAD;1:DECEASED;Stage IIA;75.0
TCGA-A6-4107-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIIC;50.0
TCGA-AA-3488-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIA;75.0
TCGA-AA-3492-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIA;63.0
TCGA-AA-3494-01;Colorectal Cancer;Female;Primary;Matched;COAD;1:DECEASED;Stage IIIB;61.0
TCGA-AA-3495-01;Colorectal Cancer;Female;Primary;Matched;COAD;1:DECEASED;Stage IIIB;51.0
TCGA-AA-3502-01;Colorectal Cancer;Female;Primary;Matched;COAD;1:DECEASED;Stage IIIC;41.0
TCGA-AA-3506-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIA;51.0
TCGA-AA-3509-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage I;60.0
TCGA-AA-3510-01;Colorectal Cancer;Female;Primary;Matched;COAD;1:DECEASED;Stage IIA;78.0
TCGA-AZ-4308-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIA;64.0
TCGA-AZ-4313-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIIC;60.0
TCGA-AZ-4315-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIA;58.0
TCGA-AZ-4614-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage I;59.0
TCGA-AZ-4615-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIIC;51.0
TCGA-AZ-4681-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage I;54.0
TCGA-AZ-4682-01;Colorectal Cancer;Female;Primary;Matched;COAD;1:DECEASED;Stage IVA;52.0
TCGA-AZ-4684-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIA;77.0
TCGA-CA-5256-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIA;70.0
TCGA-CK-4951-01;Colorectal Cancer;Male;Primary;Matched;MACR;0:LIVING;Stage I;45.0
TCGA-CM-4744-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage III;49.0
TCGA-CM-4746-01;Colorectal Cancer;Male;Primary;Matched;COAD;1:DECEASED;Stage IV;75.0
TCGA-CM-4747-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage II;70.0
TCGA-CM-4748-01;Colorectal Cancer;Female;Primary;Matched;MACR;0:LIVING;Stage IV;55.0
TCGA-CM-4750-01;Colorectal Cancer;Male;Primary;Matched;COAD;1:DECEASED;Stage IIIB;90.0
TCGA-CM-4752-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIIC;69.0
TCGA-CM-5341-01;Colorectal Cancer;Female;Primary;Matched;COAD;1:DECEASED;Stage IIA;90.0
TCGA-A6-5657-01;Colorectal Cancer;Female;Primary;Matched;COAD;1:DECEASED;Stage IV;54.0
TCGA-A6-5659-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIB;66.0
TCGA-A6-5660-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;[Discrepancy];71.0
TCGA-A6-5661-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIIB;37.0
TCGA-A6-5662-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIIB;40.0
TCGA-A6-5665-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIIB;69.0
TCGA-A6-5666-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage III;80.0
TCGA-AD-5900-01;Colorectal Cancer;Female;Primary;Matched;MACR;0:LIVING;Stage IV;76.0
TCGA-AM-5820-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IV;66.0
TCGA-AM-5821-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIIC;51.0
TCGA-AY-5543-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage III;73.0
TCGA-AZ-5403-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage III;60.0
TCGA-CA-5796-01;Colorectal Cancer;Male;Primary;Matched;MACR;0:LIVING;Stage IIIB;65.0
TCGA-CA-5797-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IA;50.0
TCGA-CK-4947-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIA;73.0
TCGA-CK-4948-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIA;58.0
TCGA-CK-5912-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIA;77.0
TCGA-CK-5913-01;Colorectal Cancer;Male;Primary;Matched;COAD;1:DECEASED;Stage IIA;90.0
TCGA-CK-5914-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIA;84.0
TCGA-CK-5915-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage I;78.0
TCGA-CK-5916-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIA;68.0
TCGA-CM-5860-01;Colorectal Cancer;Male;Primary;Matched;COAD;1:DECEASED;Stage IVA;42.0
TCGA-CM-5861-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIIB;69.0
TCGA-CM-5862-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIA;90.0
TCGA-CM-5864-01;Colorectal Cancer;Male;Primary;Matched;COAD;1:DECEASED;Stage IIIC;58.0
TCGA-CM-5868-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIIC;71.0
TCGA-CM-6161-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IVB;66.0
TCGA-CM-6162-01;Colorectal Cancer;Female;Primary;Matched;MACR;0:LIVING;Stage IIA;53.0
TCGA-CM-6163-01;Colorectal Cancer;Male;Primary;Matched;COAD;1:DECEASED;Stage IV;79.0
TCGA-CM-6164-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIIC;64.0
TCGA-CM-6165-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIIC;55.0
TCGA-CM-6166-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIA;61.0
TCGA-CM-6167-01;Colorectal Cancer;Male;Primary;Matched;COAD;1:DECEASED;Stage IIIB;71.0
TCGA-CM-6168-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage I;61.0
TCGA-CM-6169-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage I;84.0
TCGA-CM-6170-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIIB;51.0
TCGA-CM-6171-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIB;44.0
TCGA-CM-6172-01;Colorectal Cancer;Male;Primary;Matched;COAD;0:LIVING;Stage IIA;82.0
TCGA-D5-5538-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage IIA;52.0
TCGA-D5-5539-01;Colorectal Cancer;Female;Primary;Matched;MACR;1:DECEASED;Stage IV;41.0
TCGA-D5-5540-01;Colorectal Cancer;Female;Primary;Matched;COAD;1:DECEASED;Stage IIIC;76.0
TCGA-D5-5541-01;Colorectal Cancer;Female;Primary;Matched;COAD;0:LIVING;Stage I;48.0
TCGA-AF-3911-01;Colorectal Cancer;Female;Primary;Matched;READ;0:LIVING;Stage IIA;54.0
TCGA-AG-3901-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;Stage I;75.0
TCGA-AG-3898-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;Stage IIA;54.0
TCGA-AF-2692-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;Stage IIIC;48.0
TCGA-AG-A026-01;Colorectal Cancer;Male;Primary;Matched;READ;1:DECEASED;Stage IV;60.0
TCGA-CL-4957-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;Stage IIIB;39.0
TCGA-AG-3882-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;Stage IVA;77.0
TCGA-AG-3894-01;Colorectal Cancer;Female;Primary;Matched;READ;1:DECEASED;Stage I;73.0
TCGA-AG-3896-01;Colorectal Cancer;Female;Primary;Matched;READ;0:LIVING;Stage IIIB;72.0
TCGA-AF-2689-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;Stage IIIA;66.0
TCGA-AF-6784-01;Colorectal Cancer;Male;Primary;Matched;COADREAD;0:LIVING;Stage IV;43.0
TCGA-F5-6571-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;Stage IIA;56.0
TCGA-AG-3909-01;Colorectal Cancer;Female;Primary;Matched;READ;0:LIVING;Stage IIIC;48.0
TCGA-AG-A011-01;Colorectal Cancer;Female;Primary;Matched;READ;0:LIVING;Stage IIA;47.0
TCGA-CI-6622-01;Colorectal Cancer;Female;Primary;Matched;READ;1:DECEASED;Stage II;89.0
TCGA-EI-6506-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;Stage II;51.0
TCGA-AG-3601-01;Colorectal Cancer;Female;Primary;Matched;READ;0:LIVING;Stage IIA;76.0
TCGA-EI-6512-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;Stage I;67.0
TCGA-AG-A036-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;Stage I;63.0
TCGA-DC-4745-01;Colorectal Cancer;Male;Primary;Matched;READ;1:DECEASED;Stage IV;75.0
TCGA-AF-A56K-01;Colorectal Cancer;Male;Primary;Matched;READ;1:DECEASED;Stage IV;66.0
TCGA-AG-3593-01;Colorectal Cancer;Male;Primary;Matched;READ;1:DECEASED;Stage IV;60.0
TCGA-AG-3587-01;Colorectal Cancer;Female;Primary;Matched;READ;0:LIVING;Stage III;72.0
TCGA-DC-6157-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;Stage I;65.0
TCGA-AF-6655-01;Colorectal Cancer;Female;Primary;Matched;READ;0:LIVING;Stage IIA;66.0
TCGA-EI-6513-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;Stage IIA;68.0
TCGA-AF-2687-01;Colorectal Cancer;Female;Primary;Matched;COADREAD;0:LIVING;Stage IIA;72.0
TCGA-AG-3892-01;Colorectal Cancer;Male;Primary;Matched;READ;1:DECEASED;Stage IIA;77.0
TCGA-AG-A016-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;Stage IIA;69.0
TCGA-AH-6547-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;Stage I;70.0
TCGA-AG-3999-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;Stage IIIC;62.0
TCGA-DC-6155-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;Stage IIIB;68.0
TCGA-F5-6864-01;Colorectal Cancer;Female;Primary;Matched;READ;0:LIVING;Stage IIIC;66.0
TCGA-AG-3611-01;Colorectal Cancer;Female;Primary;Matched;READ;0:LIVING;Stage IV;85.0
TCGA-EI-6509-01;Colorectal Cancer;Female;Primary;Matched;READ;0:LIVING;Stage IIA;79.0
TCGA-F5-6861-01;Colorectal Cancer;Female;Primary;Matched;READ;0:LIVING;Stage IIIC;65.0
TCGA-F5-6814-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;Stage IIA;72.0
TCGA-AG-A01W-01;Colorectal Cancer;Female;Primary;Matched;READ;0:LIVING;Stage IIIB;55.0
TCGA-F5-6813-01;Colorectal Cancer;Female;Primary;Matched;READ;0:LIVING;Stage III;90.0
TCGA-AG-3732-01;Colorectal Cancer;Female;Primary;Matched;READ;0:LIVING;Stage I;63.0
TCGA-EI-6885-01;Colorectal Cancer;Female;Primary;Matched;READ;0:LIVING;Stage III;78.0
TCGA-AF-3914-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;Stage IIIB;73.0
TCGA-DY-A1H8-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;Stage IV;65.0
TCGA-AG-3726-01;Colorectal Cancer;Female;Primary;Matched;READ;0:LIVING;Stage I;78.0
TCGA-AG-3598-01;Colorectal Cancer;Female;Primary;Matched;READ;0:LIVING;Stage I;85.0
TCGA-DC-4749-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;Stage I;64.0
TCGA-DT-5265-01;Colorectal Cancer;Female;Primary;Matched;READ;0:LIVING;Stage IIA;83.0
TCGA-DY-A1DE-01;Colorectal Cancer;Female;Primary;Matched;READ;0:LIVING;Stage I;66.0
TCGA-DC-6160-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;Stage I;69.0
TCGA-AG-3608-01;Colorectal Cancer;Female;Primary;Matched;READ;0:LIVING;Stage IIIB;71.0
TCGA-F5-6863-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;Stage IIA;68.0
TCGA-AF-A56L-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;Stage I;62.0
TCGA-AG-3902-01;Colorectal Cancer;Female;Primary;Matched;READ;0:LIVING;Stage I;66.0
TCGA-EI-6511-01;Colorectal Cancer;Female;Primary;Matched;READ;0:LIVING;Stage I;57.0
TCGA-AH-6644-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;Stage IIIB;74.0
TCGA-AF-2693-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;Stage IIA;65.0
TCGA-AF-3400-01;Colorectal Cancer;Female;Primary;Matched;READ;0:LIVING;Stage I;85.0
TCGA-AF-4110-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;Stage IIA;61.0
TCGA-AG-A032-01;Colorectal Cancer;Female;Primary;Matched;READ;0:LIVING;Stage IIIB;67.0
TCGA-CI-6620-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;Stage IIA;61.0
TCGA-DC-6156-01;Colorectal Cancer;Female;Primary;Matched;READ;0:LIVING;Stage I;67.0
TCGA-AG-3581-01;Colorectal Cancer;Female;Primary;Matched;READ;0:LIVING;Stage IIIB;69.0
TCGA-DC-6158-01;Colorectal Cancer;Female;Primary;Matched;READ;0:LIVING;Stage IIIC;61.0
TCGA-AG-3742-01;Colorectal Cancer;Female;Primary;Matched;READ;0:LIVING;Stage IIA;74.0
TCGA-AG-3600-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;Stage IV;64.0
TCGA-CI-6624-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;Stage IV;87.0
TCGA-AG-4007-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;Stage IIA;63.0
TCGA-AG-3591-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;Stage I;83.0
TCGA-AH-6643-01;Colorectal Cancer;Female;Primary;Matched;READ;0:LIVING;Stage IIA;85.0
TCGA-F5-6812-01;Colorectal Cancer;Female;Primary;Matched;READ;1:DECEASED;Stage IV;84.0
TCGA-DY-A1DG-01;Colorectal Cancer;Female;Primary;Matched;READ;0:LIVING;Stage II;59.0
TCGA-EI-6884-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;Stage I;35.0
TCGA-AG-3890-01;Colorectal Cancer;Female;Primary;Matched;READ;0:LIVING;Stage I;50.0
TCGA-AG-A002-01;Colorectal Cancer;Female;Primary;Matched;READ;0:LIVING;Stage IIIB;49.0
TCGA-F5-6810-01;Colorectal Cancer;Male;Primary;Matched;COADREAD;0:LIVING;Stage IIA;75.0
TCGA-AG-3727-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;Stage IIA;68.0
TCGA-DC-6681-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;Stage IIA;80.0
TCGA-AG-4022-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;Stage I;86.0
TCGA-EI-6514-01;Colorectal Cancer;Female;Primary;Matched;READ;0:LIVING;Stage I;64.0
TCGA-DY-A1DC-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;Stage IV;55.0
TCGA-AG-3887-01;Colorectal Cancer;Female;Primary;Matched;READ;0:LIVING;Stage IIA;59.0
TCGA-DC-5869-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;Stage IIIB;58.0
TCGA-AG-3885-01;Colorectal Cancer;Female;Primary;Matched;READ;0:LIVING;Stage IV;68.0
TCGA-EI-7004-01;Colorectal Cancer;Female;Primary;Matched;READ;0:LIVING;Stage II;67.0
TCGA-AG-4015-01;Colorectal Cancer;Female;Primary;Matched;READ;0:LIVING;Stage II;49.0
TCGA-AG-4021-01;Colorectal Cancer;Female;Primary;Matched;READ;0:LIVING;Stage III;57.0
TCGA-AG-A025-01;Colorectal Cancer;Female;Primary;Matched;READ;1:DECEASED;Stage IV;62.0
TCGA-AG-3578-01;Colorectal Cancer;Female;Primary;Matched;READ;0:LIVING;Stage I;62.0
TCGA-AG-A020-01;Colorectal Cancer;Male;Primary;Matched;READ;1:DECEASED;Stage II;66.0
TCGA-AF-2691-01;Colorectal Cancer;Male;Primary;Matched;READ;1:DECEASED;Stage IV;66.0
TCGA-AG-A01Y-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;Stage II;67.0
TCGA-AH-6903-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;Stage I;77.0
TCGA-AG-3881-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;Stage IIIB;68.0
TCGA-G5-6235-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;Stage III;71.0
TCGA-DC-5337-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;[Not Available];60.0
TCGA-AG-A01N-01;Colorectal Cancer;Female;Primary;Matched;READ;1:DECEASED;[Not Available];79.0
TCGA-AH-6544-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;[Not Available];66.0
TCGA-AG-A01L-01;Colorectal Cancer;Male;Primary;Matched;READ;1:DECEASED;Stage IIIC;50.0
TCGA-CI-6621-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;[Not Available];73.0
TCGA-AG-3878-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;Stage I;48.0
TCGA-AG-3582-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;Stage IIIB;46.0
TCGA-CL-5917-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;Stage IIIB;73.0
TCGA-AG-3731-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;Stage IV;41.0
TCGA-AG-3580-01;Colorectal Cancer;Female;Primary;Matched;READ;0:LIVING;Stage IVA;41.0
TCGA-AG-3605-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;Stage IIIB;63.0
TCGA-DC-6683-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;Stage IIB;74.0
TCGA-AG-4008-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;Stage I;44.0
TCGA-AG-3891-01;Colorectal Cancer;Female;Primary;Matched;READ;0:LIVING;Stage I;53.0
TCGA-EI-6882-01;Colorectal Cancer;Female;Primary;Matched;READ;1:DECEASED;[Discrepancy];79.0
TCGA-DY-A1DF-01;Colorectal Cancer;Female;Primary;Matched;READ;0:LIVING;Stage IIIC;71.0
TCGA-AG-3612-01;Colorectal Cancer;Female;Primary;Matched;READ;0:LIVING;Stage IIA;90.0
TCGA-AG-A02N-01;Colorectal Cancer;Female;Primary;Matched;READ;0:LIVING;Stage IIIB;49.0
TCGA-DC-6154-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;Stage I;57.0
TCGA-F5-6811-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;Stage I;69.0
TCGA-AG-4001-01;Colorectal Cancer;Female;Primary;Matched;READ;0:LIVING;Stage IIIB;62.0
TCGA-AF-A56N-01;Colorectal Cancer;Female;Primary;Matched;READ;0:LIVING;Stage IVA;57.0
TCGA-AF-6672-01;Colorectal Cancer;Female;Primary;Matched;READ;0:LIVING;Stage IIIA;31.0
TCGA-AG-A00C-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;Stage IVA;62.0
TCGA-AG-3574-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;Stage I;48.0
TCGA-F5-6464-01;Colorectal Cancer;Male;Primary;Matched;READ;1:DECEASED;Stage I;70.0
TCGA-AG-4005-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;Stage I;68.0
TCGA-AF-3913-01;Colorectal Cancer;Female;Primary;Matched;READ;0:LIVING;Stage IVA;70.0
TCGA-AG-3584-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;Stage IIA;57.0
TCGA-EI-7002-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;Stage IIIB;43.0
TCGA-AF-2690-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;Stage II;51.0
TCGA-EI-6510-01;Colorectal Cancer;Female;Primary;Matched;READ;0:LIVING;Stage IIA;57.0
TCGA-AG-A015-01;Colorectal Cancer;Female;Primary;Matched;READ;1:DECEASED;Stage IIA;72.0
TCGA-G5-6572-01;Colorectal Cancer;Female;Primary;Matched;READ;1:DECEASED;Stage IIIB;77.0
TCGA-G5-6572-02;Colorectal Cancer;Female;Recurrence;Matched;COADREAD;0:LIVING;Stage IIA;56.0
TCGA-EI-6883-01;Colorectal Cancer;Female;Primary;Matched;READ;1:DECEASED;Stage IIIC;73.0
TCGA-EF-5830-01;Colorectal Cancer;Male;Primary;Matched;READ;1:DECEASED;Stage IVA;75.0
TCGA-DY-A0XA-01;Colorectal Cancer;Female;Primary;Matched;READ;1:DECEASED;Stage IIIA;77.0
TCGA-AG-3725-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;Stage IIB;54.0
TCGA-CL-5918-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;Stage IIA;72.0
TCGA-CI-6623-01;Colorectal Cancer;Female;Primary;Matched;READ;0:LIVING;Stage IIA;78.0
TCGA-AG-A008-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;Stage IIA;60.0
TCGA-AG-A023-01;Colorectal Cancer;Female;Primary;Matched;READ;0:LIVING;Stage IIIB;48.0
TCGA-AF-5654-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;Stage IIIC;53.0
TCGA-AG-A02X-01;Colorectal Cancer;Female;Primary;Matched;READ;0:LIVING;[Discrepancy];77.0
TCGA-AG-3594-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;Stage IIIB;52.0
TCGA-AG-3883-01;Colorectal Cancer;Female;Primary;Matched;READ;0:LIVING;Stage IIIB;64.0
TCGA-AG-3609-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;Stage IIIB;59.0
TCGA-EI-6917-01;Colorectal Cancer;Female;Primary;Matched;READ;0:LIVING;Stage IIA;59.0
TCGA-AG-A00H-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;Stage IIIA;60.0
TCGA-AG-A02G-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;Stage IIA;59.0
TCGA-F5-6702-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;Stage IIC;63.0
TCGA-AH-6549-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;Stage IIIA;71.0
TCGA-AH-6897-01;Colorectal Cancer;Female;Primary;Matched;READ;0:LIVING;Stage IV;57.0
TCGA-EI-6507-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;Stage IIIA;33.0
TCGA-DC-6682-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;Stage IV;58.0
TCGA-AG-3602-01;Colorectal Cancer;Female;Primary;Matched;READ;0:LIVING;[Discrepancy];37.0
TCGA-G5-6233-01;Colorectal Cancer;Female;Primary;Matched;READ;1:DECEASED;Stage IIIC;77.0
TCGA-BM-6198-01;Colorectal Cancer;Female;Primary;Matched;READ;0:LIVING;Stage IIA;64.0
TCGA-AG-3575-01;Colorectal Cancer;Female;Primary;Matched;READ;0:LIVING;Stage IIA;62.0
TCGA-F5-6465-01;Colorectal Cancer;Male;Primary;Matched;READ;1:DECEASED;Stage IVA;71.0
TCGA-AG-3583-01;Colorectal Cancer;Female;Primary;Matched;READ;0:LIVING;Stage IIA;72.0
TCGA-AG-3592-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;Stage IIA;67.0
TCGA-G5-6641-01;Colorectal Cancer;Male;Primary;Matched;READ;1:DECEASED;Stage IIIC;70.0
TCGA-AG-3893-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;Stage IIA;57.0
TCGA-AG-A01J-01;Colorectal Cancer;Female;Primary;Matched;READ;0:LIVING;Stage IIA;60.0
TCGA-EI-6508-01;Colorectal Cancer;Female;Primary;Matched;READ;1:DECEASED;Stage IIIB;71.0
TCGA-AG-3728-01;Colorectal Cancer;Female;Primary;Matched;READ;0:LIVING;Stage IIIB;74.0
TCGA-CI-6619-01;Colorectal Cancer;Male;Primary;Matched;READ;1:DECEASED;[Discrepancy];74.0
TCGA-EI-6881-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;Stage IIIB;72.0
TCGA-AG-A014-01;Colorectal Cancer;Male;Primary;Matched;READ;1:DECEASED;[Not Available];56.0
TCGA-AG-3586-01;Colorectal Cancer;Male;Primary;Matched;READ;0:LIVING;Stage IIIA;67.0
TCGA-AG-A00Y-01;Colorectal Cancer;[Not Available];Primary;Matched;READ;[Not Available];[Not Available];[Not Available]
TCGA-AG-3599-01;Colorectal Cancer;[Not Available];Primary;Matched;READ;[Not Available];[Not Available];[Not Available]
TCGA-AF-6136-01;Colorectal Cancer;[Not Available];Primary;Matched;READ;[Not Available];[Not Available];[Not Available]
TCGA-EF-5831-01;Colorectal Cancer;[Not Available];Primary;Matched;READ;[Not Available];[Not Available];[Not Available]
TCGA-DY-A1DD-01;Colorectal Cancer;[Not Available];Primary;Matched;READ;[Not Available];[Not Available];[Not Available]
TCGA-AF-3912-01;Colorectal Cancer;[Not Available];Primary;Matched;COADREAD;[Not Available];[Not Available];[Not Available]
TCGA-AG-3906-01;Colorectal Cancer;[Not Available];Primary;Matched;READ;[Not Available];[Not Available];[Not Available]
TCGA-AG-4009-01;Colorectal Cancer;[Not Available];Primary;Matched;READ;[Not Available];[Not Available];[Not Available]
TCGA-G4-6317-02;Colorectal Cancer;[Not Available];Recurrence;Matched;COADREAD;[Not Available];[Not Available];[Not Available]
TCGA-NH-A8F7-06;Colorectal Cancer;[Not Available];Metastasis;Matched;COADREAD;[Not Available];[Not Available];[Not Available]
TCGA-NH-A6GC-06;Colorectal Cancer;[Not Available];Metastasis;Matched;COADREAD;[Not Available];[Not Available];[Not Available]
TCGA-OR-A5OG-01;Adrenocortical Carcinoma;Female;Primary;Matched;ACC;[Not Available];STAGE IV;45
TCGA-BL-A13I-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage IV;63.0
TCGA-CF-A1HR-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage IV;66.0
TCGA-CF-A1HS-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage III;69.0
TCGA-DK-A1A3-01;Bladder Cancer;Female;Primary;Matched;BLCA;1:DECEASED;Stage III;59.0
TCGA-DK-A1A5-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage II;83.0
TCGA-DK-A1A6-01;Bladder Cancer;Female;Primary;Matched;BLCA;1:DECEASED;Stage III;67.0
TCGA-DK-A1A7-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage III;65.0
TCGA-DK-A1AA-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage III;65.0
TCGA-DK-A1AB-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage II;64.0
TCGA-DK-A1AC-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage III;79.0
TCGA-DK-A1AD-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage IV;73.0
TCGA-DK-A1AE-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage III;66.0
TCGA-DK-A1AF-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage II;55.0
TCGA-DK-A1AG-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage II;60.0
TCGA-BT-A20J-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage II;73.0
TCGA-BT-A20N-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage II;80.0
TCGA-BT-A20O-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage IV;59.0
TCGA-BT-A20P-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage II;52.0
TCGA-BT-A20Q-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage IV;61.0
TCGA-BT-A20T-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage IV;66.0
TCGA-BT-A20U-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage III;72.0
TCGA-BT-A20V-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage IV;60.0
TCGA-BT-A20W-01;Bladder Cancer;Female;Primary;Matched;BLCA;1:DECEASED;Stage III;76.0
TCGA-BT-A20R-01;Bladder Cancer;Female;Primary;Matched;BLCA;1:DECEASED;Stage III;73.0
TCGA-BT-A20X-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage I;73.0
TCGA-CF-A27C-01;Bladder Cancer;Female;Primary;Matched;BLCA;1:DECEASED;Stage III;57.0
TCGA-DK-A2I1-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage IV;65.0
TCGA-DK-A2I2-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage III;62.0
TCGA-G2-A2EC-01;Bladder Cancer;Female;Primary;Matched;BLCA;0:LIVING;Stage III;80.0
TCGA-G2-A2EJ-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage III;75.0
TCGA-G2-A2EO-01;Bladder Cancer;Female;Primary;Matched;BLCA;1:DECEASED;Stage III;70.0
TCGA-G2-A2ES-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage II;75.0
TCGA-GD-A2C5-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage III;72.0
TCGA-H4-A2HO-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage III;75.0
TCGA-H4-A2HQ-01;Bladder Cancer;Female;Primary;Matched;BLCA;1:DECEASED;Stage III;81.0
TCGA-BT-A2LA-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage IV;73.0
TCGA-BT-A2LB-01;Bladder Cancer;Female;Primary;Matched;BLCA;1:DECEASED;Stage IV;79.0
TCGA-DK-A2HX-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage IV;63.0
TCGA-DK-A2I6-01;Bladder Cancer;Female;Primary;Matched;BLCA;1:DECEASED;Stage III;70.0
TCGA-G2-A2EF-01;Bladder Cancer;Female;Primary;Matched;BLCA;1:DECEASED;Stage IV;59.0
TCGA-G2-A2EK-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage II;71.0
TCGA-G2-A2EL-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage IV;56.0
TCGA-E5-A2PC-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage III;54.0
TCGA-FD-A3B3-01;Bladder Cancer;Female;Primary;Matched;BLCA;1:DECEASED;Stage III;73.0
TCGA-FD-A3B4-01;Bladder Cancer;Female;Primary;Matched;BLCA;1:DECEASED;Stage IV;78.0
TCGA-FT-A3EE-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage IV;76.0
TCGA-HQ-A2OE-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage III;76.0
TCGA-BT-A2LD-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage II;80.0
TCGA-CF-A3MG-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage IV;59.0
TCGA-CF-A3MH-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage II;64.0
TCGA-CF-A3MI-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage III;74.0
TCGA-DK-A3IL-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage IV;64.0
TCGA-DK-A3IM-01;Bladder Cancer;Female;Primary;Matched;BLCA;1:DECEASED;Stage IV;69.0
TCGA-DK-A3IN-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage II;60.0
TCGA-DK-A3IQ-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage III;71.0
TCGA-DK-A3IT-01;Bladder Cancer;Female;Primary;Matched;BLCA;0:LIVING;Stage III;82.0
TCGA-DK-A3IU-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage IV;77.0
TCGA-FD-A3B5-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage III;62.0
TCGA-FD-A3B6-01;Bladder Cancer;Female;Primary;Matched;BLCA;0:LIVING;Stage III;75.0
TCGA-FD-A3B7-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage III;52.0
TCGA-FD-A3B8-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage III;34.0
TCGA-G2-A3IB-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage II;48.0
TCGA-G2-A3IE-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage II;75.0
TCGA-GC-A3I6-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage II;62.0
TCGA-GV-A3JW-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage II;41.0
TCGA-GV-A3JX-01;Bladder Cancer;Female;Primary;Matched;BLCA;1:DECEASED;Stage II;58.0
TCGA-BL-A3JM-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage II;52.0
TCGA-CF-A3MF-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage II;42.0
TCGA-CU-A3KJ-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage II;60.0
TCGA-DK-A2I4-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage II;55.0
TCGA-DK-A3IK-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage II;59.0
TCGA-DK-A3IS-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage II;67.0
TCGA-DK-A3IV-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage II;54.0
TCGA-FD-A3N5-01;Bladder Cancer;Female;Primary;Matched;BLCA;0:LIVING;Stage II;55.0
TCGA-FD-A3N6-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage II;59.0
TCGA-FD-A3NA-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage II;52.0
TCGA-GV-A3JZ-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage II;85.0
TCGA-BT-A3PH-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage III;85.0
TCGA-BT-A3PJ-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage I;50.0
TCGA-BT-A3PK-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage III;60.0
TCGA-GC-A3RB-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage IV;84.0
TCGA-GD-A3OP-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage IV;83.0
TCGA-GD-A3OQ-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage III;75.0
TCGA-GD-A3OS-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage IV;58.0
TCGA-GV-A3JV-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage III;67.0
TCGA-GV-A3QG-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage III;70.0
TCGA-GV-A3QH-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage IV;76.0
TCGA-GV-A3QI-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage IV;60.0
TCGA-CU-A3QU-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage II;79.0
TCGA-CU-A3YL-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage IV;53.0
TCGA-DK-A3WX-01;Bladder Cancer;Female;Primary;Matched;BLCA;0:LIVING;Stage IV;67.0
TCGA-DK-A3WY-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage III;57.0
TCGA-DK-A3X1-01;Bladder Cancer;Female;Primary;Matched;BLCA;1:DECEASED;Stage IV;74.0
TCGA-DK-A3X2-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage III;72.0
TCGA-E7-A3X6-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage IV;69.0
TCGA-E7-A3Y1-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage III;84.0
TCGA-FD-A3SJ-01;Bladder Cancer;Female;Primary;Matched;BLCA;0:LIVING;Stage IV;84.0
TCGA-FD-A3SL-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage III;65.0
TCGA-FD-A3SM-01;Bladder Cancer;Female;Primary;Matched;BLCA;1:DECEASED;Stage IV;80.0
TCGA-FD-A3SN-01;Bladder Cancer;Female;Primary;Matched;BLCA;0:LIVING;Stage II;73.0
TCGA-FD-A3SO-01;Bladder Cancer;Female;Primary;Matched;BLCA;1:DECEASED;Stage IV;63.0
TCGA-FD-A3SP-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage III;79.0
TCGA-FD-A3SQ-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage IV;81.0
TCGA-FD-A3SR-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage IV;87.0
TCGA-FD-A3SS-01;Bladder Cancer;Female;Primary;Matched;BLCA;1:DECEASED;Stage IV;79.0
TCGA-G2-A3VY-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage III;76.0
TCGA-GC-A3BM-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage III;72.0
TCGA-GC-A3OO-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage III;74.0
TCGA-GC-A3RC-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage II;68.0
TCGA-GC-A3RD-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage III;62.0
TCGA-GC-A3WC-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage II;58.0
TCGA-GV-A3QF-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage II;60.0
TCGA-K4-A3WS-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage III;57.0
TCGA-K4-A3WV-01;Bladder Cancer;Female;Primary;Matched;BLCA;1:DECEASED;Stage III;67.0
TCGA-BT-A42B-01;Bladder Cancer;Female;Primary;Matched;BLCA;0:LIVING;Stage III;67.0
TCGA-BT-A42C-01;Bladder Cancer;Female;Primary;Matched;BLCA;0:LIVING;Stage III;78.0
TCGA-DK-A3WW-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage IV;85.0
TCGA-FJ-A3Z7-01;Bladder Cancer;Female;Primary;Matched;BLCA;0:LIVING;Stage II;82.0
TCGA-FJ-A3ZE-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage II;70.0
TCGA-FJ-A3ZF-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage II;61.0
TCGA-GC-A3YS-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage II;67.0
TCGA-GU-A42R-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage IV;70.0
TCGA-GV-A3QK-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage IV;45.0
TCGA-GV-A40E-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage II;57.0
TCGA-GV-A40G-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage IV;48.0
TCGA-K4-A3WU-01;Bladder Cancer;Female;Primary;Matched;BLCA;0:LIVING;Stage II;64.0
TCGA-BT-A42E-01;Bladder Cancer;Female;Primary;Matched;BLCA;0:LIVING;Stage II;72.0
TCGA-BT-A42F-01;Bladder Cancer;Female;Primary;Matched;BLCA;1:DECEASED;Stage IV;61.0
TCGA-CF-A47S-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage IV;68.0
TCGA-CF-A47T-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage III;60.0
TCGA-CF-A47V-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage II;63.0
TCGA-CF-A47W-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage II;64.0
TCGA-CF-A47X-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage II;78.0
TCGA-CF-A47Y-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage II;63.0
TCGA-FD-A43N-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage II;71.0
TCGA-FD-A43P-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage III;75.0
TCGA-FD-A43S-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage III;82.0
TCGA-FD-A43U-01;Bladder Cancer;Female;Primary;Matched;BLCA;0:LIVING;Stage II;64.0
TCGA-FD-A43X-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage II;61.0
TCGA-GU-A42P-01;Bladder Cancer;Female;Primary;Matched;BLCA;0:LIVING;Stage IV;61.0
TCGA-GU-A42Q-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage IV;64.0
TCGA-E7-A4IJ-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage II;72.0
TCGA-E7-A4XJ-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage II;70.0
TCGA-E7-A519-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage II;57.0
TCGA-E7-A541-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage II;56.0
TCGA-FD-A43Y-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage II;66.0
TCGA-FD-A5BR-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage II;72.0
TCGA-FD-A5BS-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage II;66.0
TCGA-FD-A5BT-01;Bladder Cancer;Female;Primary;Matched;BLCA;0:LIVING;Stage II;78.0
TCGA-FD-A5BU-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage II;67.0
TCGA-FD-A5BV-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage II;81.0
TCGA-FD-A5BX-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage III;55.0
TCGA-FJ-A3Z9-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage IV;66.0
TCGA-GC-A4ZW-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage II;75.0
TCGA-HQ-A2OF-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage II;37.0
TCGA-HQ-A5ND-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage III;73.0
TCGA-K4-A4AC-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage IV;44.0
TCGA-K4-A54R-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage III;63.0
TCGA-MV-A51V-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage III;66.0
TCGA-CF-A5U8-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage III;64.0
TCGA-CF-A5UA-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage II;52.0
TCGA-CU-A5W6-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage II;59.0
TCGA-E7-A5KE-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage II;73.0
TCGA-E7-A5KF-01;Bladder Cancer;Female;Primary;Matched;BLCA;1:DECEASED;Stage IV;60.0
TCGA-FD-A5BY-01;Bladder Cancer;Female;Primary;Matched;BLCA;1:DECEASED;Stage III;74.0
TCGA-FD-A5BZ-01;Bladder Cancer;Female;Primary;Matched;BLCA;1:DECEASED;Stage III;55.0
TCGA-FD-A5C0-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage IV;86.0
TCGA-FD-A5C1-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage II;75.0
TCGA-HQ-A5NE-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage III;66.0
TCGA-K4-A4AB-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage II;56.0
TCGA-K4-A5RI-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage II;69.0
TCGA-K4-A5RJ-01;Bladder Cancer;Female;Primary;Matched;BLCA;0:LIVING;Stage II;43.0
TCGA-LT-A5Z6-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage II;60.0
TCGA-BL-A5ZZ-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage IV;59.0
TCGA-DK-A6AV-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage IV;60.0
TCGA-DK-A6AW-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage IV;70.0
TCGA-DK-A6B1-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage III;79.0
TCGA-DK-A6B2-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage IV;68.0
TCGA-DK-A6B6-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage III;60.0
TCGA-E7-A677-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage IV;62.0
TCGA-E7-A678-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage IV;68.0
TCGA-FD-A62N-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage IV;66.0
TCGA-FD-A62O-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage III;76.0
TCGA-FD-A62P-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage II;74.0
TCGA-FD-A62S-01;Bladder Cancer;Female;Primary;Matched;BLCA;0:LIVING;Stage III;71.0
TCGA-FT-A61P-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage IV;70.0
TCGA-K4-A5RH-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage II;84.0
TCGA-LC-A66R-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage III;65.0
TCGA-R3-A69X-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage II;57.0
TCGA-DK-A6B0-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage III;68.0
TCGA-DK-A6B5-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage III;84.0
TCGA-E5-A4TZ-01;Bladder Cancer;Female;Primary;Matched;BLCA;0:LIVING;Stage II;76.0
TCGA-E5-A4U1-01;Bladder Cancer;Female;Primary;Matched;BLCA;1:DECEASED;Stage III;47.0
TCGA-GC-A6I1-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage IV;82.0
TCGA-GC-A6I3-01;Bladder Cancer;Female;Primary;Matched;BLCA;0:LIVING;Stage III;63.0
TCGA-GD-A6C6-01;Bladder Cancer;Female;Primary;Matched;BLCA;1:DECEASED;Stage IV;77.0
TCGA-K4-A6FZ-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage IV;61.0
TCGA-K4-A6MB-01;Bladder Cancer;Female;Primary;Matched;BLCA;0:LIVING;Stage III;61.0
TCGA-PQ-A6FI-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage III;69.0
TCGA-PQ-A6FN-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage IV;74.0
TCGA-S5-A6DX-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage II;76.0
TCGA-E7-A6ME-01;Bladder Cancer;Female;Primary;Matched;BLCA;1:DECEASED;Stage III;60.0
TCGA-E7-A6MF-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage IV;58.0
TCGA-E7-A7DU-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage III;82.0
TCGA-FD-A6TF-01;Bladder Cancer;Female;Primary;Matched;BLCA;0:LIVING;Stage III;79.0
TCGA-FD-A6TG-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage III;77.0
TCGA-FD-A6TH-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage IV;54.0
TCGA-FD-A6TI-01;Bladder Cancer;Female;Primary;Matched;BLCA;1:DECEASED;Stage IV;80.0
TCGA-GD-A76B-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage IV;73.0
TCGA-GU-A763-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage IV;63.0
TCGA-GU-A766-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage IV;73.0
TCGA-GU-A767-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage III;60.0
TCGA-CU-A72E-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage IV;76.0
TCGA-E7-A7DV-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;[Not Available];72.0
TCGA-FD-A6TA-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage IV;65.0
TCGA-FD-A6TB-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage III;73.0
TCGA-FD-A6TC-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage III;49.0
TCGA-FD-A6TD-01;Bladder Cancer;Female;Primary;Matched;BLCA;1:DECEASED;Stage III;80.0
TCGA-FD-A6TE-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage IV;76.0
TCGA-FD-A6TK-01;Bladder Cancer;Female;Primary;Matched;BLCA;1:DECEASED;Stage II;58.0
TCGA-GU-A762-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage II;50.0
TCGA-GV-A6ZA-01;Bladder Cancer;Female;Primary;Matched;BLCA;0:LIVING;Stage II;56.0
TCGA-KQ-A41N-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage II;57.0
TCGA-KQ-A41P-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage II;77.0
TCGA-KQ-A41Q-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage III;69.0
TCGA-KQ-A41S-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage II;85.0
TCGA-UY-A78K-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage II;66.0
TCGA-UY-A78L-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage II;51.0
TCGA-UY-A78N-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage II;66.0
TCGA-UY-A78O-01;Bladder Cancer;Female;Primary;Matched;BLCA;0:LIVING;Stage II;75.0
TCGA-CF-A7I0-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage IV;66.0
TCGA-E7-A6MD-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage IV;60.0
TCGA-E7-A7PW-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage IV;77.0
TCGA-E7-A7XN-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage II;70.0
TCGA-E7-A85H-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage III;45.0
TCGA-FJ-A871-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage II;79.0
TCGA-GU-A764-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage III;54.0
TCGA-K4-A83P-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage II;59.0
TCGA-KQ-A41O-01;Bladder Cancer;Female;Primary;Matched;BLCA;0:LIVING;Stage III;83.0
TCGA-KQ-A41R-01;Bladder Cancer;Female;Primary;Matched;BLCA;0:LIVING;Stage III;80.0
TCGA-UY-A78M-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage IV;61.0
TCGA-CF-A8HX-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage III;71.0
TCGA-CF-A8HY-01;Bladder Cancer;Female;Primary;Matched;BLCA;1:DECEASED;Stage II;90.0
TCGA-E7-A8O7-01;Bladder Cancer;Female;Primary;Matched;BLCA;0:LIVING;Stage IV;90.0
TCGA-E7-A8O8-01;Bladder Cancer;Female;Primary;Matched;BLCA;0:LIVING;Stage IV;53.0
TCGA-LT-A8JT-01;Bladder Cancer;Female;Primary;Matched;BLCA;0:LIVING;Stage IV;84.0
TCGA-UY-A78P-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage IV;48.0
TCGA-UY-A8OC-01;Bladder Cancer;Female;Primary;Matched;BLCA;0:LIVING;Stage II;54.0
TCGA-UY-A8OD-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage III;64.0
TCGA-XF-A8HB-01;Bladder Cancer;Female;Primary;Matched;BLCA;1:DECEASED;Stage II;86.0
TCGA-XF-A8HC-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage IV;72.0
TCGA-XF-A8HD-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage III;67.0
TCGA-XF-A8HE-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage IV;68.0
TCGA-XF-A8HF-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage IV;87.0
TCGA-XF-A8HG-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage III;72.0
TCGA-YC-A89H-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage II;66.0
TCGA-2F-A9KO-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage II;62.0
TCGA-2F-A9KP-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage IV;81.0
TCGA-2F-A9KQ-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage IV;75.0
TCGA-2F-A9KR-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage IV;74.0
TCGA-2F-A9KT-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage III;68.0
TCGA-2F-A9KW-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage IV;66.0
TCGA-CF-A9FF-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage II;74.0
TCGA-CF-A9FH-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage III;59.0
TCGA-CF-A9FL-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage IV;55.0
TCGA-CF-A9FM-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage IV;79.0
TCGA-E7-A97P-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage IV;65.0
TCGA-E7-A97Q-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage II;67.0
TCGA-K4-AAQO-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage III;47.0
TCGA-S5-AA26-01;Bladder Cancer;Female;Primary;Matched;BLCA;0:LIVING;Stage IV;56.0
TCGA-SY-A9G0-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage II;75.0
TCGA-SY-A9G5-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage II;77.0
TCGA-UY-A9PA-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage II;54.0
TCGA-UY-A9PB-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage III;53.0
TCGA-UY-A9PD-01;Bladder Cancer;Female;Primary;Matched;BLCA;0:LIVING;Stage IV;64.0
TCGA-UY-A9PE-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;[Not Available];69.0
TCGA-UY-A9PF-01;Bladder Cancer;Female;Primary;Matched;BLCA;0:LIVING;Stage III;52.0
TCGA-UY-A9PH-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage IV;78.0
TCGA-XF-A8HH-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage III;57.0
TCGA-XF-A8HI-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage III;66.0
TCGA-YC-A8S6-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage III;87.0
TCGA-YF-AA3L-01;Bladder Cancer;Female;Primary;Matched;BLCA;0:LIVING;Stage II;77.0
TCGA-ZF-A9R0-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage III;76.0
TCGA-ZF-A9R3-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage II;83.0
TCGA-ZF-A9R4-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage II;59.0
TCGA-ZF-A9R7-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage III;69.0
TCGA-ZF-A9R9-01;Bladder Cancer;Female;Primary;Matched;BLCA;1:DECEASED;Stage III;67.0
TCGA-ZF-A9RC-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage II;75.0
TCGA-ZF-A9RE-01;Bladder Cancer;Female;Primary;Matched;BLCA;0:LIVING;Stage III;75.0
TCGA-ZF-A9RF-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage IV;64.0
TCGA-ZF-A9RL-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage IV;77.0
TCGA-ZF-A9RM-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage III;56.0
TCGA-ZF-AA4N-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage III;73.0
TCGA-ZF-AA4R-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage IV;84.0
TCGA-ZF-AA4T-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage IV;76.0
TCGA-ZF-AA4U-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage III;89.0
TCGA-ZF-AA4V-01;Bladder Cancer;Female;Primary;Matched;BLCA;0:LIVING;Stage II;80.0
TCGA-ZF-AA4W-01;Bladder Cancer;Female;Primary;Matched;BLCA;0:LIVING;Stage III;87.0
TCGA-ZF-AA4X-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage IV;78.0
TCGA-4Z-AA7M-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage II;56.0
TCGA-4Z-AA7N-01;Bladder Cancer;Female;Primary;Matched;BLCA;0:LIVING;Stage II;69.0
TCGA-4Z-AA7O-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage III;75.0
TCGA-4Z-AA7Q-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage II;70.0
TCGA-4Z-AA7R-01;Bladder Cancer;Female;Primary;Matched;BLCA;0:LIVING;Stage III;78.0
TCGA-4Z-AA7S-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage III;70.0
TCGA-4Z-AA7W-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage IV;83.0
TCGA-4Z-AA7Y-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage III;46.0
TCGA-4Z-AA80-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage IV;82.0
TCGA-4Z-AA81-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage III;66.0
TCGA-4Z-AA82-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage IV;60.0
TCGA-4Z-AA83-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage IV;62.0
TCGA-4Z-AA84-01;Bladder Cancer;Female;Primary;Matched;BLCA;1:DECEASED;Stage IV;81.0
TCGA-4Z-AA86-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage IV;80.0
TCGA-4Z-AA87-01;Bladder Cancer;Female;Primary;Matched;BLCA;0:LIVING;Stage II;75.0
TCGA-4Z-AA89-01;Bladder Cancer;Female;Primary;Matched;BLCA;0:LIVING;Stage II;78.0
TCGA-DK-AA6L-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage IV;63.0
TCGA-DK-AA6M-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage IV;90.0
TCGA-DK-AA6P-01;Bladder Cancer;Female;Primary;Matched;BLCA;0:LIVING;Stage II;68.0
TCGA-DK-AA6Q-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage III;48.0
TCGA-DK-AA6S-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage III;49.0
TCGA-DK-AA6T-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage III;80.0
TCGA-DK-AA6U-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage IV;86.0
TCGA-DK-AA6W-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage IV;77.0
TCGA-DK-AA71-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage II;73.0
TCGA-DK-AA74-01;Bladder Cancer;Female;Primary;Matched;BLCA;0:LIVING;Stage II;50.0
TCGA-DK-AA75-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage IV;79.0
TCGA-DK-AA76-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage III;77.0
TCGA-DK-AA77-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage III;47.0
TCGA-G2-AA3B-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage III;80.0
TCGA-G2-AA3C-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage III;69.0
TCGA-G2-AA3D-01;Bladder Cancer;Female;Primary;Matched;BLCA;1:DECEASED;Stage IV;61.0
TCGA-GU-AATO-01;Bladder Cancer;Female;Primary;Matched;BLCA;1:DECEASED;Stage IV;57.0
TCGA-GU-AATP-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage II;81.0
TCGA-GU-AATQ-01;Bladder Cancer;Female;Primary;Matched;BLCA;1:DECEASED;Stage II;65.0
TCGA-XF-A9SH-01;Bladder Cancer;Female;Primary;Matched;BLCA;0:LIVING;Stage II;73.0
TCGA-XF-A9SI-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage IV;83.0
TCGA-XF-A9SJ-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage IV;65.0
TCGA-XF-A9SL-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage IV;69.0
TCGA-XF-A9SP-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage III;76.0
TCGA-XF-A9SU-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage III;59.0
TCGA-XF-A9SX-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage III;68.0
TCGA-XF-A9SZ-01;Bladder Cancer;Female;Primary;Matched;BLCA;1:DECEASED;Stage IV;74.0
TCGA-XF-A9T0-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage IV;82.0
TCGA-XF-A9T4-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage IV;85.0
TCGA-XF-A9T8-01;Bladder Cancer;Female;Primary;Matched;BLCA;1:DECEASED;Stage IV;63.0
TCGA-YC-A9TC-01;Bladder Cancer;Female;Primary;Matched;BLCA;0:LIVING;Stage IV;60.0
TCGA-ZF-A9R1-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage IV;79.0
TCGA-ZF-A9R2-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage III;68.0
TCGA-ZF-AA51-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage III;54.0
TCGA-ZF-AA52-01;Bladder Cancer;Female;Primary;Matched;BLCA;0:LIVING;Stage IV;69.0
TCGA-ZF-AA53-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage IV;48.0
TCGA-ZF-AA54-01;Bladder Cancer;Female;Primary;Matched;BLCA;0:LIVING;Stage IV;78.0
TCGA-ZF-AA56-01;Bladder Cancer;Female;Primary;Matched;BLCA;0:LIVING;Stage III;88.0
TCGA-ZF-AA5H-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage III;64.0
TCGA-ZF-AA5P-01;Bladder Cancer;Female;Primary;Matched;BLCA;1:DECEASED;Stage II;64.0
TCGA-5N-A9KI-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage IV;68.0
TCGA-5N-A9KM-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage III;49.0
TCGA-DK-AA6R-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage IV;80.0
TCGA-DK-AA6X-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage III;70.0
TCGA-G2-AA3F-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage II;75.0
TCGA-UY-A8OB-01;Bladder Cancer;Female;Primary;Matched;BLCA;0:LIVING;Stage II;59.0
TCGA-XF-A9SG-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage III;48.0
TCGA-XF-A9SK-01;Bladder Cancer;Female;Primary;Matched;BLCA;1:DECEASED;Stage IV;75.0
TCGA-XF-A9SM-01;Bladder Cancer;Female;Primary;Matched;BLCA;1:DECEASED;Stage IV;79.0
TCGA-XF-A9ST-01;Bladder Cancer;Female;Primary;Matched;BLCA;1:DECEASED;Stage III;87.0
TCGA-XF-A9SV-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage III;78.0
TCGA-XF-A9SW-01;Bladder Cancer;Female;Primary;Matched;BLCA;1:DECEASED;Stage IV;81.0
TCGA-XF-A9SY-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage IV;68.0
TCGA-XF-A9T2-01;Bladder Cancer;Female;Primary;Matched;BLCA;1:DECEASED;Stage III;75.0
TCGA-XF-A9T3-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage II;73.0
TCGA-XF-A9T5-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage IV;76.0
TCGA-XF-A9T6-01;Bladder Cancer;Female;Primary;Matched;BLCA;1:DECEASED;Stage III;77.0
TCGA-XF-AAME-01;Bladder Cancer;Female;Primary;Matched;BLCA;0:LIVING;Stage III;61.0
TCGA-XF-AAMF-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage IV;60.0
TCGA-XF-AAMG-01;Bladder Cancer;Female;Primary;Matched;BLCA;1:DECEASED;Stage III;74.0
TCGA-XF-AAMH-01;Bladder Cancer;Female;Primary;Matched;BLCA;0:LIVING;Stage II;78.0
TCGA-XF-AAMJ-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage II;71.0
TCGA-XF-AAML-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage IV;71.0
TCGA-XF-AAMQ-01;Bladder Cancer;Female;Primary;Matched;BLCA;0:LIVING;Stage II;47.0
TCGA-XF-AAMR-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage II;57.0
TCGA-XF-AAMT-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage III;82.0
TCGA-XF-AAMW-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage IV;81.0
TCGA-XF-AAMX-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage II;75.0
TCGA-XF-AAMY-01;Bladder Cancer;Female;Primary;Matched;BLCA;1:DECEASED;Stage II;53.0
TCGA-XF-AAMZ-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage II;83.0
TCGA-XF-AAN0-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage III;59.0
TCGA-XF-AAN1-01;Bladder Cancer;Female;Primary;Matched;BLCA;0:LIVING;Stage II;76.0
TCGA-XF-AAN2-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage IV;58.0
TCGA-XF-AAN3-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage III;77.0
TCGA-XF-AAN4-01;Bladder Cancer;Female;Primary;Matched;BLCA;1:DECEASED;Stage IV;75.0
TCGA-XF-AAN5-01;Bladder Cancer;Female;Primary;Matched;BLCA;1:DECEASED;Stage II;78.0
TCGA-XF-AAN7-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage II;74.0
TCGA-XF-AAN8-01;Bladder Cancer;Female;Primary;Matched;BLCA;0:LIVING;Stage III;70.0
TCGA-YF-AA3M-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage II;61.0
TCGA-ZF-A9R5-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage II;70.0
TCGA-ZF-A9RD-01;Bladder Cancer;Female;Primary;Matched;BLCA;1:DECEASED;Stage III;67.0
TCGA-ZF-A9RG-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage II;74.0
TCGA-ZF-A9RN-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage IV;67.0
TCGA-ZF-AA58-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage IV;65.0
TCGA-ZF-AA5N-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage III;70.0
TCGA-BL-A0C8-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage III;66.0
TCGA-BL-A13J-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage III;56.0
TCGA-BT-A0S7-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage II;56.0
TCGA-BT-A0YX-01;Bladder Cancer;Female;Primary;Matched;BLCA;0:LIVING;Stage II;69.0
TCGA-C4-A0EZ-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage III;70.0
TCGA-C4-A0F0-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage II;60.0
TCGA-C4-A0F1-01;Bladder Cancer;Male;Primary;Matched;BLCA;1:DECEASED;Stage III;71.0
TCGA-C4-A0F6-01;Bladder Cancer;Female;Primary;Matched;BLCA;1:DECEASED;Stage III;79.0
TCGA-C4-A0F7-01;Bladder Cancer;Female;Primary;Matched;BLCA;0:LIVING;Stage IV;61.0
TCGA-CU-A0YN-01;Bladder Cancer;Female;Primary;Matched;BLCA;0:LIVING;Stage IV;60.0
TCGA-CU-A0YO-01;Bladder Cancer;Female;Primary;Matched;BLCA;1:DECEASED;Stage IV;62.0
TCGA-CU-A0YR-01;Bladder Cancer;Male;Primary;Matched;BLCA;0:LIVING;Stage IV;65.0
TCGA-DK-A1A6-06;Bladder Cancer;[Not Available];Metastasis;Matched;BLCA;[Not Available];[Not Available];[Not Available]
TCGA-AR-A2LL-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;Stage IIB;29
TCGA-AR-A2LR-01;Breast Cancer;Female;Primary;Matched;MBC;0:LIVING;Stage IA;32
TCGA-E2-A572-01;Breast Cancer;Female;Primary;Matched;IDC;1:DECEASED;[Discrepancy];73
TCGA-5L-AAT1-01;Breast Cancer;Female;Primary;Matched;ILC;0:LIVING;Stage I;47
TCGA-AN-A0FE-01;[Not Available];Female;Primary;Matched;BRCA;1:DECEASED;Stage IA;87
TCGA-AN-A0FG-01;[Not Available];Female;Primary;Matched;BRCA;0:LIVING;Stage IA;58
TCGA-BH-A1FE-06;Breast Cancer, NOS;[Not Available];Metastasis;Matched;BREAST;[Not Available];[Not Available];[Not Available]
TCGA-E2-A15A-06;Breast Cancer, NOS;[Not Available];Metastasis;Matched;BREAST;[Not Available];[Not Available];[Not Available]
TCGA-BH-A18V-06;Breast Cancer, NOS;[Not Available];Metastasis;Matched;BREAST;[Not Available];[Not Available];[Not Available]
TCGA-E2-A15K-06;Breast Cancer, NOS;[Not Available];Metastasis;Matched;BREAST;[Not Available];[Not Available];[Not Available]
TCGA-E2-A15E-06;Breast Cancer, NOS;[Not Available];Metastasis;Matched;BREAST;[Not Available];[Not Available];[Not Available]
TCGA-AC-A6IX-06;Breast Cancer, NOS;[Not Available];Metastasis;Matched;BREAST;[Not Available];[Not Available];[Not Available]
TCGA-IG-A3I8-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;1:DECEASED;Stage III;67.0
TCGA-IG-A3QL-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;1:DECEASED;Stage III;66.0
TCGA-IG-A3Y9-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;1:DECEASED;Stage IIB;44.0
TCGA-IG-A3YA-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;1:DECEASED;Stage III;68.0
TCGA-IG-A3YB-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;1:DECEASED;Stage I;57.0
TCGA-IG-A3YC-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;1:DECEASED;Stage III;43.0
TCGA-L5-A43C-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;1:DECEASED;Stage III;74.0
TCGA-L5-A43E-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;1:DECEASED;Stage IIB;53.0
TCGA-L5-A43H-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;1:DECEASED;Stage III;70.0
TCGA-L5-A43I-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;1:DECEASED;Stage IVA;58.0
TCGA-L5-A43J-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;1:DECEASED;Stage III;80.0
TCGA-L5-A43M-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;1:DECEASED;Stage IIA;80.0
TCGA-LN-A49K-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;0:LIVING;Stage IIB;59.0
TCGA-LN-A49L-01;Esophagogastric Cancer;Female;Primary;Matched;ESCC;0:LIVING;Stage IA;69.0
TCGA-LN-A49N-01;Esophagogastric Cancer;Female;Primary;Matched;ESCC;0:LIVING;Stage IIA;51.0
TCGA-LN-A49O-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;0:LIVING;Stage IIA;54.0
TCGA-LN-A49P-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;1:DECEASED;Stage IIIA;72.0
TCGA-LN-A49R-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;0:LIVING;Stage IIIA;53.0
TCGA-LN-A49S-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;0:LIVING;Stage IIIA;61.0
TCGA-LN-A49V-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;0:LIVING;Stage IIIA;62.0
TCGA-IG-A4P3-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;1:DECEASED;Stage IIB;48.0
TCGA-IG-A4QS-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;1:DECEASED;Stage IIIB;71.0
TCGA-IG-A4QT-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;1:DECEASED;Stage IIA;56.0
TCGA-IG-A50L-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;0:LIVING;Stage IIIA;58.0
TCGA-IG-A51D-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;0:LIVING;Stage IIB;63.0
TCGA-L5-A4OE-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;1:DECEASED;Stage IB;72.0
TCGA-L5-A4OF-01;Esophagogastric Cancer;Female;Primary;Matched;ESCA;0:LIVING;Stage IIB;69.0
TCGA-L5-A4OG-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;1:DECEASED;Stage IIIB;60.0
TCGA-L5-A4OH-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;1:DECEASED;Stage IIB;54.0
TCGA-L5-A4OI-01;Esophagogastric Cancer;Female;Primary;Matched;ESCA;0:LIVING;Stage IIIA;50.0
TCGA-L5-A4OJ-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;1:DECEASED;Stage IIIB;62.0
TCGA-L5-A4OM-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;0:LIVING;Stage IIA;36.0
TCGA-L5-A4ON-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;0:LIVING;Stage IIA;58.0
TCGA-L5-A4OO-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;0:LIVING;Stage I;56.0
TCGA-L5-A4OP-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;1:DECEASED;Stage IIB;51.0
TCGA-L5-A4OQ-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;0:LIVING;Stage I;77.0
TCGA-L5-A4OR-01;Esophagogastric Cancer;Female;Primary;Matched;ESCA;0:LIVING;Stage IIA;51.0
TCGA-L7-A56G-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;1:DECEASED;Stage III;49.0
TCGA-LN-A49M-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;1:DECEASED;Stage III;50.0
TCGA-LN-A49U-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;0:LIVING;Stage IIB;53.0
TCGA-LN-A49W-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;0:LIVING;Stage IIB;75.0
TCGA-LN-A49X-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;0:LIVING;Stage IIB;77.0
TCGA-LN-A49Y-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;0:LIVING;Stage IIIB;47.0
TCGA-LN-A4A1-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;1:DECEASED;Stage IIIC;51.0
TCGA-LN-A4A2-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;0:LIVING;Stage IIIA;61.0
TCGA-LN-A4A3-01;Esophagogastric Cancer;Female;Primary;Matched;ESCC;0:LIVING;Stage IB;58.0
TCGA-LN-A4A4-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;0:LIVING;Stage IA;82.0
TCGA-LN-A4A5-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;0:LIVING;[Not Available];81.0
TCGA-LN-A4A6-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;0:LIVING;Stage I;74.0
TCGA-LN-A4A8-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;1:DECEASED;Stage III;75.0
TCGA-IG-A5B8-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;1:DECEASED;Stage IIIA;77.0
TCGA-IG-A5S3-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;1:DECEASED;Stage IIB;90.0
TCGA-L5-A4OS-01;Esophagogastric Cancer;Female;Primary;Matched;ESCA;0:LIVING;[Not Available];84.0
TCGA-L5-A4OT-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;1:DECEASED;Stage IIIB;81.0
TCGA-L5-A4OU-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;1:DECEASED;Stage IIB;63.0
TCGA-L5-A4OW-01;Esophagogastric Cancer;Female;Primary;Matched;ESCA;0:LIVING;Stage I;79.0
TCGA-L5-A4OX-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;0:LIVING;Stage I;71.0
TCGA-LN-A4A9-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;0:LIVING;Stage IIIC;79.0
TCGA-LN-A4MQ-01;Esophagogastric Cancer;Female;Primary;Matched;ESCC;0:LIVING;Stage I;70.0
TCGA-LN-A4MR-01;Esophagogastric Cancer;Female;Primary;Matched;ESCC;1:DECEASED;Stage IA;54.0
TCGA-LN-A5U5-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;1:DECEASED;Stage IIB;65.0
TCGA-LN-A5U6-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;0:LIVING;Stage IIIC;75.0
TCGA-M9-A5M8-01;Esophagogastric Cancer;Female;Primary;Matched;ESCA;0:LIVING;Stage IA;67.0
TCGA-IG-A625-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;1:DECEASED;Stage IIIA;75.0
TCGA-LN-A5U7-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;1:DECEASED;Stage IA;83.0
TCGA-Q9-A6FU-01;Esophagogastric Cancer;Female;Primary;Matched;ESCC;0:LIVING;Stage IIB;86.0
TCGA-Q9-A6FW-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;1:DECEASED;Stage IV;77.0
TCGA-R6-A6DN-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;0:LIVING;Stage IIA;81.0
TCGA-R6-A6DQ-01;Esophagogastric Cancer;Female;Primary;Matched;ESCA;1:DECEASED;Stage IIB;56.0
TCGA-R6-A6KZ-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;1:DECEASED;Stage IIB;60.0
TCGA-R6-A6L4-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;0:LIVING;Stage IB;84.0
TCGA-S8-A6BV-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;0:LIVING;Stage IIB;86.0
TCGA-S8-A6BW-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;0:LIVING;Stage III;60.0
TCGA-IC-A6RE-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;1:DECEASED;Stage IIA;67.0
TCGA-IC-A6RF-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;0:LIVING;[Not Available];76.0
TCGA-IG-A6QS-01;Esophagogastric Cancer;Female;Primary;Matched;ESCC;0:LIVING;Stage IIA;70.0
TCGA-IG-A7DP-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;0:LIVING;[Not Available];51.0
TCGA-JY-A6F8-01;Esophagogastric Cancer;Female;Primary;Matched;ESCA;0:LIVING;Stage I;71.0
TCGA-JY-A6FA-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;0:LIVING;Stage IIB;77.0
TCGA-JY-A6FB-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;1:DECEASED;Stage IVA;57.0
TCGA-JY-A6FD-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;0:LIVING;Stage III;77.0
TCGA-JY-A6FE-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;1:DECEASED;Stage IV;54.0
TCGA-JY-A6FG-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;1:DECEASED;Stage III;79.0
TCGA-JY-A6FH-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;0:LIVING;Stage III;77.0
TCGA-KH-A6WC-01;Esophagogastric Cancer;Female;Primary;Matched;ESCC;0:LIVING;Stage IIA;84.0
TCGA-L7-A6VZ-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;0:LIVING;Stage III;56.0
TCGA-LN-A7HX-01;Esophagogastric Cancer;Female;Primary;Matched;ESCC;1:DECEASED;Stage IIB;84.0
TCGA-R6-A6L6-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;0:LIVING;Stage III;81.0
TCGA-R6-A6XG-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;1:DECEASED;Stage IIA;71.0
TCGA-R6-A6XQ-01;Esophagogastric Cancer;Female;Primary;Matched;ESCA;0:LIVING;Stage III;81.0
TCGA-R6-A6Y0-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;0:LIVING;Stage IIB;76.0
TCGA-R6-A6Y2-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;0:LIVING;Stage IIB;69.0
TCGA-RE-A7BO-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;1:DECEASED;Stage IIA;84.0
TCGA-L5-A88T-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;1:DECEASED;Stage IIA;75.0
TCGA-L5-A88V-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;1:DECEASED;[Discrepancy];55.0
TCGA-L5-A88W-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;1:DECEASED;[Not Available];65.0
TCGA-L5-A88Y-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;0:LIVING;Stage IIIC;62.0
TCGA-LN-A7HV-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;1:DECEASED;Stage IIA;66.0
TCGA-LN-A7HW-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;1:DECEASED;Stage IIA;44.0
TCGA-LN-A7HY-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;0:LIVING;Stage IIA;62.0
TCGA-LN-A7HZ-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;0:LIVING;Stage IIB;50.0
TCGA-V5-A7RB-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;0:LIVING;Stage IIA;47.0
TCGA-V5-A7RE-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;0:LIVING;Stage IIA;71.0
TCGA-IG-A8O2-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;0:LIVING;Stage III;46.0
TCGA-L5-A88S-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;0:LIVING;Stage IIA;59.0
TCGA-L5-A88Z-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;0:LIVING;Stage IIA;62.0
TCGA-L5-A891-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;0:LIVING;Stage IIA;49.0
TCGA-L5-A893-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;0:LIVING;Stage III;73.0
TCGA-L5-A8NJ-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;0:LIVING;Stage IIA;44.0
TCGA-L5-A8NQ-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;0:LIVING;Stage IIA;77.0
TCGA-L5-A8NU-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;0:LIVING;Stage IIA;60.0
TCGA-LN-A8HZ-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;0:LIVING;Stage IIA;57.0
TCGA-LN-A8I0-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;0:LIVING;Stage III;61.0
TCGA-LN-A8I1-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;0:LIVING;Stage III;36.0
TCGA-VR-A8EO-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;1:DECEASED;Stage IIA;49.0
TCGA-VR-A8EQ-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;0:LIVING;Stage II;65.0
TCGA-VR-A8ER-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;0:LIVING;Stage IIA;52.0
TCGA-VR-A8EU-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;1:DECEASED;Stage IIA;58.0
TCGA-VR-A8EW-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;0:LIVING;Stage III;46.0
TCGA-VR-A8EX-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;0:LIVING;Stage IIA;57.0
TCGA-VR-A8EY-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;1:DECEASED;Stage IV;57.0
TCGA-VR-A8EZ-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;0:LIVING;Stage IIB;54.0
TCGA-XP-A8T6-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;0:LIVING;Stage IIA;46.0
TCGA-XP-A8T7-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;0:LIVING;Stage IIA;58.0
TCGA-XP-A8T8-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;0:LIVING;Stage IIA;59.0
TCGA-Z6-A8JD-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;0:LIVING;Stage IIA;72.0
TCGA-2H-A9GF-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;0:LIVING;Stage III;50.0
TCGA-2H-A9GG-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;0:LIVING;Stage IIA;49.0
TCGA-2H-A9GH-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;0:LIVING;Stage IIA;56.0
TCGA-2H-A9GI-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;0:LIVING;Stage IIA;52.0
TCGA-2H-A9GJ-01;Esophagogastric Cancer;Female;Primary;Matched;ESCA;0:LIVING;Stage IIA;67.0
TCGA-2H-A9GK-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;0:LIVING;Stage IIA;42.0
TCGA-2H-A9GL-01;Esophagogastric Cancer;Female;Primary;Matched;ESCA;0:LIVING;Stage IIA;60.0
TCGA-2H-A9GM-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;0:LIVING;Stage IIA;62.0
TCGA-2H-A9GN-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;0:LIVING;Stage IIB;70.0
TCGA-2H-A9GO-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;0:LIVING;Stage IIA;58.0
TCGA-2H-A9GQ-01;Esophagogastric Cancer;Female;Primary;Matched;ESCA;1:DECEASED;Stage IIIB;57.0
TCGA-2H-A9GR-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;0:LIVING;Stage IIIB;61.0
TCGA-JY-A938-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;1:DECEASED;[Not Available];58.0
TCGA-JY-A939-01;Esophagogastric Cancer;Female;Primary;Matched;ESCA;1:DECEASED;[Not Available];74.0
TCGA-JY-A93E-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;1:DECEASED;[Not Available];42.0
TCGA-JY-A93F-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;1:DECEASED;[Not Available];27.0
TCGA-L5-A8NE-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;1:DECEASED;[Not Available];68.0
TCGA-L5-A8NF-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;0:LIVING;[Not Available];64.0
TCGA-L5-A8NG-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;1:DECEASED;[Not Available];58.0
TCGA-L5-A8NH-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;0:LIVING;[Not Available];54.0
TCGA-L5-A8NI-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;1:DECEASED;[Not Available];71.0
TCGA-L5-A8NK-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;1:DECEASED;Stage IVA;60.0
TCGA-L5-A8NL-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;1:DECEASED;[Not Available];72.0
TCGA-L5-A8NM-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;0:LIVING;[Not Available];56.0
TCGA-L5-A8NN-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;1:DECEASED;[Not Available];60.0
TCGA-L5-A8NR-01;Esophagogastric Cancer;Female;Primary;Matched;ESCA;1:DECEASED;Stage IIB;72.0
TCGA-L5-A8NS-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;0:LIVING;Stage IIIA;76.0
TCGA-L5-A8NT-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;0:LIVING;Stage IB;51.0
TCGA-L5-A8NV-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;1:DECEASED;[Not Available];59.0
TCGA-L5-A8NW-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;1:DECEASED;[Not Available];55.0
TCGA-R6-A8W5-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;0:LIVING;Stage IB;45.0
TCGA-R6-A8W8-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;0:LIVING;Stage IIB;67.0
TCGA-R6-A8WC-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;0:LIVING;[Not Available];72.0
TCGA-R6-A8WG-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;0:LIVING;[Not Available];74.0
TCGA-VR-A8Q7-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;0:LIVING;Stage IIA;49.0
TCGA-VR-AA4D-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;0:LIVING;Stage IIIB;51.0
TCGA-VR-AA4G-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;1:DECEASED;Stage III;73.0
TCGA-Z6-A8JE-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;1:DECEASED;Stage III;54.0
TCGA-Z6-A9VB-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;1:DECEASED;Stage IIA;64.0
TCGA-IG-A97H-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;1:DECEASED;Stage IV;51.0
TCGA-IG-A97I-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;1:DECEASED;Stage IIIB;57.0
TCGA-JY-A93C-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;1:DECEASED;Stage IVA;63.0
TCGA-JY-A93D-01;Esophagogastric Cancer;Female;Primary;Matched;ESCA;0:LIVING;Stage IIA;44.0
TCGA-LN-A9FO-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;1:DECEASED;Stage IIIC;47.0
TCGA-LN-A9FP-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;0:LIVING;Stage IIIA;60.0
TCGA-LN-A9FQ-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;1:DECEASED;Stage IIB;53.0
TCGA-LN-A9FR-01;Esophagogastric Cancer;Female;Primary;Matched;ESCC;0:LIVING;Stage IIIA;51.0
TCGA-V5-AASV-01;Esophagogastric Cancer;Female;Primary;Matched;ESCC;0:LIVING;Stage IV;65.0
TCGA-V5-AASX-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;1:DECEASED;Stage IIIC;58.0
TCGA-ZR-A9CJ-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;1:DECEASED;Stage III;70.0
TCGA-V5-A7RC-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;0:LIVING;[Not Available];69.0
TCGA-V5-AASW-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;1:DECEASED;Stage IIB;54.0
TCGA-VR-A8EP-01;Esophagogastric Cancer;Female;Primary;Matched;ESCC;0:LIVING;Stage IIA;63.0
TCGA-VR-A8ET-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;0:LIVING;Stage IIB;49.0
TCGA-VR-AA7B-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;0:LIVING;Stage IIB;53.0
TCGA-VR-AA7D-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;0:LIVING;Stage IIIA;57.0
TCGA-VR-AA7I-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;0:LIVING;Stage IIIA;53.0
TCGA-X8-AAAR-01;Esophagogastric Cancer;Male;Primary;Matched;ESCA;0:LIVING;Stage IIA;57.0
TCGA-Z6-AAPN-01;Esophagogastric Cancer;Male;Primary;Matched;ESCC;1:DECEASED;Stage IIIC;65.0
TCGA-V5-A7RC-06;Esophageal/Stomach Cancer, NOS;[Not Available];Metastasis;Matched;STOMACH;[Not Available];[Not Available];[Not Available]
TCGA-02-0001-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;44.0
TCGA-02-0003-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;50.0
TCGA-02-0006-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;59.0
TCGA-02-0007-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;56.0
TCGA-02-0009-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;40.0
TCGA-02-0010-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;61.0
TCGA-02-0011-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;20.0
TCGA-02-0014-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;18.0
TCGA-02-0021-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;25.0
TCGA-02-0024-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;50.0
TCGA-02-0027-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;50.0
TCGA-02-0028-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;43.0
TCGA-02-0033-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;38.0
TCGA-02-0034-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;35.0
TCGA-02-0037-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;47.0
TCGA-02-0038-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;27.0
TCGA-02-0043-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;33.0
TCGA-02-0046-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;39.0
TCGA-02-0047-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;54.0
TCGA-02-0052-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;60.0
TCGA-02-0054-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;74.0
TCGA-02-0055-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;48.0
TCGA-02-0057-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;54.0
TCGA-02-0058-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;54.0
TCGA-02-0060-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;61.0
TCGA-06-0875-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;78.0
TCGA-06-0876-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;80.0
TCGA-06-0877-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;43.0
TCGA-06-0878-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;49.0
TCGA-06-0879-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;44.0
TCGA-06-0881-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;62.0
TCGA-06-0882-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;66.0
TCGA-12-0670-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;28.0
TCGA-12-0818-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;68.0
TCGA-12-0819-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;66.0
TCGA-12-0820-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;50.0
TCGA-12-0821-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;57.0
TCGA-12-0822-01;Glioma;Female;Primary;Matched;GBM;0:LIVING;NA;31.0
TCGA-12-0826-01;Glioma;Male;Primary;Matched;GBM;0:LIVING;NA;70.0
TCGA-12-0827-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;53.0
TCGA-12-0828-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;68.0
TCGA-12-0829-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;63.0
TCGA-14-0787-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;57.0
TCGA-14-0789-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;28.0
TCGA-14-0813-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;59.0
TCGA-14-0817-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;36.0
TCGA-14-0867-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;63.0
TCGA-14-0871-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;45.0
TCGA-16-0846-01;Glioma;Female;Primary;Matched;GBM;0:LIVING;NA;27.0
TCGA-16-0848-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;52.0
TCGA-16-0849-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;46.0
TCGA-16-0850-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;42.0
TCGA-16-0861-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;29.0
TCGA-06-0650-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;54.0
TCGA-06-1804-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;56.0
TCGA-06-5408-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;56.0
TCGA-06-5410-01;Glioma;Female;Primary;Matched;GBM;0:LIVING;NA;43.0
TCGA-06-5411-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;37.0
TCGA-06-5412-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;52.0
TCGA-06-5413-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;51.0
TCGA-06-5856-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;36.0
TCGA-06-5858-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;54.0
TCGA-06-5859-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;14.0
TCGA-06-6389-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;68.0
TCGA-06-6390-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;26.0
TCGA-06-6391-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;78.0
TCGA-14-0781-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;50.0
TCGA-15-1444-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;57.0
TCGA-19-5947-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;49.0
TCGA-19-5950-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;40.0
TCGA-19-5951-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;74.0
TCGA-19-5952-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;69.0
TCGA-19-5954-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;61.0
TCGA-19-5955-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;82.0
TCGA-19-5956-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;51.0
TCGA-19-5958-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;46.0
TCGA-19-5959-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;77.0
TCGA-19-5960-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;48.0
TCGA-26-1442-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;41.0
TCGA-28-2501-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;67.0
TCGA-28-2510-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;50.0
TCGA-28-6450-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;67.0
TCGA-32-1979-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;36.0
TCGA-32-1980-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;70.0
TCGA-41-5651-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;62.0
TCGA-76-6191-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;61.0
TCGA-76-6192-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;62.0
TCGA-76-6193-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;67.0
TCGA-76-6282-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;61.0
TCGA-76-6285-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;57.0
TCGA-81-5910-01;Glioma;Male;Primary;Matched;GBM;0:LIVING;NA;43.0
TCGA-87-5896-01;Glioma;Male;Primary;Matched;GBM;0:LIVING;NA;53.0
TCGA-06-1806-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;64.0
TCGA-06-6388-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;81.0
TCGA-06-6693-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;84.0
TCGA-06-6694-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;67.0
TCGA-06-6695-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;63.0
TCGA-06-6697-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;86.0
TCGA-06-6698-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;67.0
TCGA-06-6699-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;66.0
TCGA-06-6700-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;30.0
TCGA-06-6701-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;54.0
TCGA-14-0740-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;49.0
TCGA-14-0862-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;64.0
TCGA-14-1043-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;63.0
TCGA-14-1395-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;43.0
TCGA-14-1450-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;40.0
TCGA-19-5953-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;86.0
TCGA-26-6173-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;62.0
TCGA-26-6174-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;81.0
TCGA-28-5211-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;58.0
TCGA-41-6646-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;53.0
TCGA-74-6573-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;33.0
TCGA-74-6575-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;51.0
TCGA-74-6577-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;76.0
TCGA-74-6578-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;74.0
TCGA-74-6581-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;45.0
TCGA-74-6584-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;32.0
TCGA-76-6280-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;68.0
TCGA-76-6283-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;54.0
TCGA-76-6286-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;61.0
TCGA-76-6656-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;57.0
TCGA-76-6657-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;63.0
TCGA-76-6660-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;73.0
TCGA-76-6661-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;74.0
TCGA-76-6662-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;56.0
TCGA-76-6663-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;47.0
TCGA-76-6664-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;47.0
TCGA-81-5911-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;52.0
TCGA-06-0155-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;51.0
TCGA-06-1084-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;44.0
TCGA-06-1086-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;59.0
TCGA-06-1087-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;68.0
TCGA-12-1088-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;65.0
TCGA-12-1089-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;72.0
TCGA-12-1090-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;54.0
TCGA-12-1091-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;69.0
TCGA-12-1092-01;Glioma;Male;Primary;Matched;GBM;0:LIVING;NA;34.0
TCGA-12-1093-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;64.0
TCGA-12-1094-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;38.0
TCGA-12-1095-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;64.0
TCGA-12-1096-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;76.0
TCGA-12-1097-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;63.0
TCGA-12-1098-01;Glioma;Male;Primary;Matched;GBM;0:LIVING;NA;54.0
TCGA-12-1099-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;69.0
TCGA-14-0736-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;71.0
TCGA-14-0783-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;55.0
TCGA-14-0786-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;62.0
TCGA-14-1034-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;58.0
TCGA-14-1396-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;37.0
TCGA-14-1401-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;63.0
TCGA-14-1402-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;65.0
TCGA-14-1451-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;51.0
TCGA-14-1452-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;40.0
TCGA-14-1453-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;52.0
TCGA-14-1454-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;76.0
TCGA-14-1459-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;72.0
TCGA-15-1446-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;47.0
TCGA-15-1447-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;55.0
TCGA-15-1449-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;66.0
TCGA-16-1045-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;61.0
TCGA-16-1047-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;67.0
TCGA-16-1055-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;31.0
TCGA-16-1056-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;75.0
TCGA-16-1060-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;46.0
TCGA-16-1062-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;57.0
TCGA-16-1063-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;65.0
TCGA-19-0955-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;51.0
TCGA-19-0960-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;57.0
TCGA-19-0962-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;71.0
TCGA-19-0963-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;43.0
TCGA-19-0964-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;76.0
TCGA-19-1392-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;56.0
TCGA-26-1438-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;77.0
TCGA-26-1440-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;63.0
TCGA-26-1443-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;71.0
TCGA-19-4065-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;55.0
TCGA-02-0064-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;60.0
TCGA-02-0069-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;77.0
TCGA-02-0071-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;73.0
TCGA-02-0074-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;39.0
TCGA-02-0075-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;53.0
TCGA-02-0080-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;69.0
TCGA-02-0083-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;66.0
TCGA-02-0085-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;59.0
TCGA-02-0086-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;53.0
TCGA-02-0089-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;50.0
TCGA-02-0099-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;43.0
TCGA-02-0102-01;Glioma;Female;Primary;Matched;GBM;0:LIVING;NA;61.0
TCGA-02-0107-01;Glioma;Female;Primary;Matched;GBM;0:LIVING;NA;72.0
TCGA-02-0113-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;78.0
TCGA-02-0114-01;Glioma;Male;Primary;Matched;GBM;0:LIVING;NA;74.0
TCGA-02-0115-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;52.0
TCGA-02-0116-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;50.0
TCGA-06-1800-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;30.0
TCGA-06-1801-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;79.0
TCGA-06-1802-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;54.0
TCGA-06-1805-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;42.0
TCGA-12-1598-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;75.0
TCGA-12-1599-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;61.0
TCGA-12-1600-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;56.0
TCGA-12-1601-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;61.0
TCGA-12-1602-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;81.0
TCGA-14-0812-01;Glioma;Female;Primary;Matched;GBM;0:LIVING;NA;28.0
TCGA-14-0865-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;47.0
TCGA-14-0866-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;76.0
TCGA-14-1037-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;75.0
TCGA-14-1455-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;83.0
TCGA-14-1458-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;53.0
TCGA-14-1794-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;81.0
TCGA-14-1795-01;Glioma;Female;Primary;Matched;GBM;0:LIVING;NA;72.0
TCGA-14-1821-01;Glioma;Male;Primary;Matched;GBM;0:LIVING;NA;50.0
TCGA-14-1823-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;59.0
TCGA-14-1825-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;23.0
TCGA-14-1827-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;65.0
TCGA-14-1829-01;Glioma;Female;Primary;Matched;GBM;0:LIVING;NA;24.0
TCGA-16-1460-01;Glioma;Female;Primary;Matched;GBM;0:LIVING;NA;21.0
TCGA-19-0957-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;54.0
TCGA-19-1385-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;72.0
TCGA-19-1386-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;51.0
TCGA-19-1387-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;78.0
TCGA-19-1388-01;Glioma;Male;Primary;Matched;GBM;0:LIVING;NA;67.0
TCGA-19-1389-01;Glioma;Male;Primary;Matched;GBM;0:LIVING;NA;61.0
TCGA-19-1786-01;Glioma;Male;Primary;Matched;GBM;0:LIVING;NA;60.0
TCGA-19-1788-01;Glioma;Female;Primary;Matched;GBM;0:LIVING;NA;23.0
TCGA-19-1789-01;Glioma;Female;Primary;Matched;GBM;0:LIVING;NA;45.0
TCGA-19-1791-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;75.0
TCGA-26-1799-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;58.0
TCGA-27-1830-01;Glioma;Female;Primary;Matched;GBM;0:LIVING;NA;45.0
TCGA-27-1832-01;Glioma;Male;Primary;Matched;GBM;0:LIVING;NA;63.0
TCGA-27-1833-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;64.0
TCGA-27-1834-01;Glioma;Female;Primary;Matched;GBM;0:LIVING;NA;49.0
TCGA-28-1745-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;58.0
TCGA-28-1746-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;44.0
TCGA-28-1749-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;64.0
TCGA-28-1750-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;76.0
TCGA-28-1751-01;Glioma;Male;Primary;Matched;GBM;0:LIVING;NA;64.0
TCGA-28-1752-01;Glioma;Male;Primary;Matched;GBM;0:LIVING;NA;65.0
TCGA-28-1755-01;Glioma;Female;Primary;Matched;GBM;0:LIVING;NA;53.0
TCGA-28-1757-01;Glioma;Female;Primary;Matched;GBM;0:LIVING;NA;58.0
TCGA-28-1760-01;Glioma;Male;Primary;Matched;GBM;0:LIVING;NA;76.0
TCGA-02-2466-01;Glioma;Male;Primary;Matched;GBM;0:LIVING;NA;60.0
TCGA-02-2470-01;Glioma;Female;Primary;Matched;GBM;0:LIVING;NA;21.0
TCGA-02-2483-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;78.0
TCGA-02-2485-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;79.0
TCGA-02-2486-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;53.0
TCGA-06-2557-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;64.0
TCGA-06-2558-01;Glioma;Female;Primary;Matched;GBM;0:LIVING;NA;30.0
TCGA-06-2559-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;62.0
TCGA-06-2561-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;31.0
TCGA-06-2562-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;57.0
TCGA-06-2563-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;66.0
TCGA-06-2564-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;71.0
TCGA-06-2565-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;69.0
TCGA-06-2566-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;50.0
TCGA-06-2567-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;63.0
TCGA-06-2569-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;46.0
TCGA-06-2570-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;32.0
TCGA-14-0790-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;40.0
TCGA-14-1456-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;79.0
TCGA-14-2554-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;58.0
TCGA-27-1831-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;52.0
TCGA-27-1835-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;30.0
TCGA-27-1836-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;59.0
TCGA-27-1837-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;49.0
TCGA-27-1838-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;50.0
TCGA-27-2518-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;59.0
TCGA-27-2519-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;76.0
TCGA-27-2521-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;69.0
TCGA-27-2523-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;51.0
TCGA-27-2524-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;74.0
TCGA-27-2526-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;71.0
TCGA-27-2527-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;74.0
TCGA-27-2528-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;59.0
TCGA-28-1747-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;69.0
TCGA-28-1753-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;60.0
TCGA-28-1756-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;63.0
TCGA-28-2499-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;75.0
TCGA-28-2502-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;69.0
TCGA-28-2506-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;48.0
TCGA-28-2509-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;69.0
TCGA-28-2512-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;14.0
TCGA-28-2513-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;34.0
TCGA-28-2514-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;60.0
TCGA-32-1970-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;70.0
TCGA-32-1976-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;17.0
TCGA-32-1982-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;61.0
TCGA-32-1986-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;17.0
TCGA-06-0119-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;52.0
TCGA-06-0121-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;56.0
TCGA-06-0122-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;64.0
TCGA-06-0124-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;78.0
TCGA-06-0125-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;36.0
TCGA-06-0126-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;49.0
TCGA-06-0128-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;60.0
TCGA-06-0129-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;57.0
TCGA-06-0130-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;65.0
TCGA-06-0131-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;48.0
TCGA-06-0133-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;48.0
TCGA-06-0137-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;69.0
TCGA-06-0139-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;51.0
TCGA-06-0140-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;60.0
TCGA-06-0141-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;74.0
TCGA-06-0142-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;63.0
TCGA-06-0143-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;75.0
TCGA-06-0145-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;46.0
TCGA-06-0147-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;55.0
TCGA-06-0148-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;52.0
TCGA-06-0169-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;46.0
TCGA-06-A5U0-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;24.0
TCGA-06-A5U1-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;75.0
TCGA-06-A6S0-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;52.0
TCGA-06-A6S1-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;53.0
TCGA-19-A60I-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;51.0
TCGA-19-A6J4-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;45.0
TCGA-19-A6J5-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;49.0
TCGA-OX-A56R-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;40.0
TCGA-RR-A6KA-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;62.0
TCGA-RR-A6KB-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;46.0
TCGA-RR-A6KC-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;38.0
TCGA-12-1597-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;38.0
TCGA-12-3644-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;57.0
TCGA-12-3646-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;75.0
TCGA-12-3648-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;53.0
TCGA-12-3649-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;64.0
TCGA-12-3650-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;58.0
TCGA-12-3651-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;10.0
TCGA-12-3652-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;58.0
TCGA-12-3653-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;66.0
TCGA-14-2555-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;56.0
TCGA-14-3477-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;65.0
TCGA-19-1390-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;55.0
TCGA-19-1787-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;61.0
TCGA-19-2619-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;75.0
TCGA-19-2620-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;68.0
TCGA-19-2621-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;62.0
TCGA-19-2623-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;75.0
TCGA-19-2624-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;47.0
TCGA-19-2625-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;86.0
TCGA-19-2629-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;58.0
TCGA-32-2615-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;47.0
TCGA-32-2616-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;59.0
TCGA-32-2632-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;61.0
TCGA-32-2634-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;76.0
TCGA-32-2638-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;46.0
TCGA-41-2571-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;77.0
TCGA-41-2573-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;60.0
TCGA-41-2575-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;34.0
TCGA-41-3392-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;60.0
TCGA-06-0132-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;56.0
TCGA-06-0138-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;59.0
TCGA-06-0150-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;49.0
TCGA-06-0151-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;70.0
TCGA-06-0154-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;49.0
TCGA-06-0156-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;36.0
TCGA-06-0157-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;50.0
TCGA-06-0158-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;69.0
TCGA-06-0159-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;54.0
TCGA-06-0160-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;64.0
TCGA-06-0165-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;65.0
TCGA-06-0166-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;78.0
TCGA-06-0167-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;69.0
TCGA-06-0168-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;60.0
TCGA-06-0171-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;67.0
TCGA-06-0173-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;55.0
TCGA-06-0174-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;67.0
TCGA-06-0176-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;74.0
TCGA-06-0178-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;60.0
TCGA-06-0184-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;66.0
TCGA-06-0185-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;61.0
TCGA-06-0187-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;52.0
TCGA-06-0188-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;78.0
TCGA-06-0189-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;54.0
TCGA-06-0190-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;58.0
TCGA-06-0195-01;Glioma;Female;Primary;Matched;GBM;0:LIVING;NA;57.0
TCGA-06-0197-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;39.0
TCGA-06-0201-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;60.0
TCGA-06-0206-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;69.0
TCGA-06-0208-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;54.0
TCGA-06-0209-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;61.0
TCGA-06-0210-01;Glioma;Male;Primary;Matched;GBM;0:LIVING;NA;23.0
TCGA-06-0211-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;54.0
TCGA-06-0213-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;63.0
TCGA-06-0214-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;59.0
TCGA-06-0219-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;66.0
TCGA-06-0221-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;31.0
TCGA-06-0237-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;58.0
TCGA-06-0240-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;70.0
TCGA-06-0241-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;51.0
TCGA-06-A7TK-01;Glioma;Male;Primary;Matched;GBM;0:LIVING;NA;57.0
TCGA-06-A7TL-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;52.0
TCGA-26-A7UX-01;Glioma;Female;Primary;Matched;GBM;0:LIVING;NA;44.0
TCGA-4W-AA9R-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;74.0
TCGA-4W-AA9S-01;Glioma;Female;Primary;Matched;GBM;0:LIVING;NA;38.0
TCGA-4W-AA9T-01;Glioma;Male;Primary;Matched;GBM;0:LIVING;NA;40.0
TCGA-02-0087-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;65.0
TCGA-02-0106-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;21.0
TCGA-02-0111-01;Glioma;Male;Primary;Matched;GBM;0:LIVING;NA;55.0
TCGA-02-0250-01;Glioma;Female;Primary;Matched;GBM;0:LIVING;NA;36.0
TCGA-02-0258-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;65.0
TCGA-02-0260-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;85.0
TCGA-02-0266-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;57.0
TCGA-02-0269-01;Glioma;Male;Primary;Matched;GBM;0:LIVING;NA;54.0
TCGA-02-0271-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;52.0
TCGA-02-0281-01;Glioma;Male;Primary;Matched;GBM;[Not Available];NA;65.0
TCGA-02-0285-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;49.0
TCGA-02-0289-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;66.0
TCGA-02-0290-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;48.0
TCGA-02-0317-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;55.0
TCGA-02-0321-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;70.0
TCGA-02-0324-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;57.0
TCGA-02-0325-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;72.0
TCGA-02-0326-01;Glioma;Female;Primary;Matched;GBM;0:LIVING;NA;36.0
TCGA-02-0329-01;Glioma;Male;Primary;Matched;GBM;0:LIVING;NA;71.0
TCGA-02-0330-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;48.0
TCGA-02-0332-01;Glioma;Female;Primary;Matched;GBM;0:LIVING;NA;83.0
TCGA-02-0333-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;77.0
TCGA-02-0336-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;61.0
TCGA-02-0337-01;Glioma;Male;Primary;Matched;GBM;0:LIVING;NA;70.0
TCGA-02-0338-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;69.0
TCGA-02-0339-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;51.0
TCGA-02-0422-01;Glioma;Male;Primary;Matched;GBM;0:LIVING;NA;81.0
TCGA-02-0430-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;58.0
TCGA-02-0432-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;51.0
TCGA-02-0439-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;63.0
TCGA-02-0440-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;72.0
TCGA-02-0446-01;Glioma;Female;Primary;Matched;GBM;0:LIVING;NA;64.0
TCGA-02-0451-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;48.0
TCGA-02-0456-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;39.0
TCGA-06-0146-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;69.0
TCGA-06-0149-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;56.0
TCGA-06-0162-01;Glioma;Female;Primary;Matched;GBM;0:LIVING;NA;82.0
TCGA-06-0164-01;Glioma;Female;Primary;Matched;GBM;0:LIVING;NA;55.0
TCGA-06-0175-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;70.0
TCGA-06-0177-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;83.0
TCGA-06-0179-01;Glioma;Male;Primary;Matched;GBM;0:LIVING;NA;65.0
TCGA-06-0182-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;51.0
TCGA-06-0194-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;76.0
TCGA-06-0394-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;60.0
TCGA-06-0397-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;74.0
TCGA-06-0402-01;Glioma;Male;Primary;Matched;GBM;0:LIVING;NA;36.0
TCGA-06-0409-01;Glioma;Female;Primary;Matched;GBM;0:LIVING;NA;68.0
TCGA-06-0410-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;47.0
TCGA-06-0412-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;52.0
TCGA-06-0413-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;76.0
TCGA-06-0414-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;62.0
TCGA-08-0509-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;58.0
TCGA-08-0510-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;72.0
TCGA-08-0511-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;83.0
TCGA-08-0512-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;53.0
TCGA-08-0514-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;56.0
TCGA-08-0516-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;77.0
TCGA-08-0517-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;56.0
TCGA-08-0518-01;Glioma;Male;Primary;Matched;GBM;0:LIVING;NA;39.0
TCGA-08-0520-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;68.0
TCGA-08-0521-01;Glioma;Male;Primary;Matched;GBM;0:LIVING;NA;40.0
TCGA-08-0522-01;Glioma;Male;Primary;Matched;GBM;0:LIVING;NA;36.0
TCGA-08-0524-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;63.0
TCGA-08-0525-01;Glioma;Male;Primary;Matched;GBM;0:LIVING;NA;48.0
TCGA-08-0529-01;Glioma;Male;Primary;Matched;GBM;0:LIVING;NA;43.0
TCGA-08-0531-01;Glioma;Female;Primary;Matched;GBM;0:LIVING;NA;60.0
TCGA-02-0004-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;68.0
TCGA-02-0015-01;Glioma;Male;Primary;Matched;GBM;0:LIVING;NA;74.0
TCGA-02-0016-01;Glioma;Male;Primary;Matched;GBM;0:LIVING;NA;59.0
TCGA-02-0023-01;Glioma;Male;Primary;Matched;GBM;0:LIVING;NA;74.0
TCGA-02-0025-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;72.0
TCGA-02-0026-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;78.0
TCGA-02-0039-01;Glioma;Female;Primary;Matched;GBM;0:LIVING;NA;65.0
TCGA-02-0048-01;Glioma;Male;Primary;Matched;GBM;0:LIVING;NA;57.0
TCGA-02-0051-01;Glioma;Female;Primary;Matched;GBM;0:LIVING;NA;65.0
TCGA-02-0059-01;Glioma;Male;Primary;Matched;GBM;0:LIVING;NA;47.0
TCGA-02-0068-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;57.0
TCGA-02-0070-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;66.0
TCGA-02-0104-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;59.0
TCGA-08-0244-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;67.0
TCGA-08-0245-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;56.0
TCGA-08-0246-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;53.0
TCGA-08-0344-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;33.0
TCGA-08-0346-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;36.0
TCGA-08-0347-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;59.0
TCGA-08-0348-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;52.0
TCGA-08-0350-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;48.0
TCGA-08-0351-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;34.0
TCGA-08-0353-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;63.0
TCGA-08-0354-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;56.0
TCGA-08-0355-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;79.0
TCGA-08-0356-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;81.0
TCGA-08-0357-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;62.0
TCGA-08-0359-01;Glioma;Male;Primary;Matched;GBM;0:LIVING;NA;76.0
TCGA-08-0360-01;Glioma;Female;Primary;Matched;GBM;0:LIVING;NA;77.0
TCGA-08-0375-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;44.0
TCGA-08-0380-01;Glioma;Male;Primary;Matched;GBM;0:LIVING;NA;73.0
TCGA-08-0385-01;Glioma;Female;Primary;Matched;GBM;0:LIVING;NA;40.0
TCGA-08-0389-01;Glioma;Female;Primary;Matched;GBM;0:LIVING;NA;61.0
TCGA-08-0390-01;Glioma;Female;Primary;Matched;GBM;0:LIVING;NA;42.0
TCGA-08-0392-01;Glioma;Male;Primary;Matched;GBM;0:LIVING;NA;53.0
TCGA-06-0939-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;52.0
TCGA-14-3476-01;Glioma;Male;Primary;Matched;GBM;0:LIVING;NA;78.0
TCGA-14-4157-01;Glioma;Male;Primary;Matched;GBM;0:LIVING;NA;71.0
TCGA-16-1048-01;Glioma;Male;Primary;Matched;GBM;0:LIVING;NA;48.0
TCGA-19-1790-01;Glioma;Male;Primary;Matched;GBM;[Not Available];NA;59.0
TCGA-19-2631-01;Glioma;Male;Primary;Matched;GBM;0:LIVING;NA;65.0
TCGA-19-4068-01;Glioma;Female;Primary;Matched;GBM;0:LIVING;NA;63.0
TCGA-26-1439-01;Glioma;Female;Primary;Matched;GBM;0:LIVING;NA;77.0
TCGA-32-1973-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;37.0
TCGA-32-1977-01;Glioma;Female;Primary;Matched;GBM;0:LIVING;NA;69.0
TCGA-32-1978-01;Glioma;Male;Primary;Matched;GBM;0:LIVING;NA;45.0
TCGA-32-1987-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;72.0
TCGA-32-1991-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;71.0
TCGA-32-2491-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;52.0
TCGA-32-2494-01;Glioma;Female;Primary;Matched;GBM;0:LIVING;NA;66.0
TCGA-32-2495-01;Glioma;Male;Primary;Matched;GBM;0:LIVING;NA;42.0
TCGA-32-2498-01;Glioma;Male;Primary;Matched;GBM;0:LIVING;NA;72.0
TCGA-32-4208-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;53.0
TCGA-32-4209-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;62.0
TCGA-32-4210-01;Glioma;Male;Primary;Matched;GBM;0:LIVING;NA;52.0
TCGA-32-4211-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;63.0
TCGA-32-4213-01;Glioma;Female;Primary;Matched;GBM;0:LIVING;NA;47.0
TCGA-32-4719-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;67.0
TCGA-41-2572-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;60.0
TCGA-41-3393-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;59.0
TCGA-41-3915-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;21.0
TCGA-41-4097-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;65.0
TCGA-02-0079-01;Glioma;Female;Primary;Matched;GBM;0:LIVING;NA;63.0
TCGA-02-0084-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;57.0
TCGA-06-0127-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;69.0
TCGA-06-0152-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;72.0
TCGA-06-0238-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;76.0
TCGA-06-0644-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;68.0
TCGA-06-0645-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;49.0
TCGA-06-0646-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;60.0
TCGA-06-0648-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;63.0
TCGA-08-0345-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;58.0
TCGA-08-0349-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;59.0
TCGA-08-0352-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;62.0
TCGA-08-0358-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;48.0
TCGA-08-0373-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;80.0
TCGA-08-0386-01;Glioma;Male;Primary;Matched;GBM;0:LIVING;NA;82.0
TCGA-12-0615-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;67.0
TCGA-12-0616-01;Glioma;Male;Primary;Matched;GBM;0:LIVING;NA;25.0
TCGA-12-0618-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;40.0
TCGA-12-0619-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;73.0
TCGA-12-0620-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;56.0
TCGA-06-5414-01;Glioma;Female;Primary;Matched;GBM;0:LIVING;NA;47.0
TCGA-06-5415-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;73.0
TCGA-06-5416-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;66.0
TCGA-06-5417-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;89.0
TCGA-06-5418-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;67.0
TCGA-12-5295-01;Glioma;Male;Primary;Matched;GBM;0:LIVING;NA;59.0
TCGA-12-5299-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;75.0
TCGA-12-5301-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;88.0
TCGA-26-5132-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;81.0
TCGA-26-5133-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;48.0
TCGA-26-5134-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;63.0
TCGA-26-5135-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;59.0
TCGA-26-5136-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;73.0
TCGA-26-5139-01;Glioma;Male;Primary;Matched;GBM;0:LIVING;NA;61.0
TCGA-28-5204-01;Glioma;Male;Primary;Matched;GBM;0:LIVING;NA;69.0
TCGA-28-5207-01;Glioma;Female;Primary;Matched;GBM;0:LIVING;NA;54.0
TCGA-28-5208-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;67.0
TCGA-28-5209-01;Glioma;Female;Primary;Matched;GBM;0:LIVING;NA;73.0
TCGA-28-5213-01;Glioma;Male;Primary;Matched;GBM;0:LIVING;NA;51.0
TCGA-28-5214-01;Glioma;Male;Primary;Matched;GBM;0:LIVING;NA;58.0
TCGA-28-5215-01;Glioma;Male;Primary;Matched;GBM;0:LIVING;NA;77.0
TCGA-28-5216-01;Glioma;Female;Primary;Matched;GBM;0:LIVING;NA;55.0
TCGA-28-5218-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;76.0
TCGA-28-5219-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;68.0
TCGA-28-5220-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;58.0
TCGA-32-5222-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;85.0
TCGA-76-4925-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;76.0
TCGA-76-4926-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;70.0
TCGA-76-4927-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;50.0
TCGA-76-4928-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;66.0
TCGA-76-4929-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;52.0
TCGA-76-4931-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;57.0
TCGA-76-4932-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;74.0
TCGA-76-4934-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;78.0
TCGA-76-4935-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;57.0
TCGA-06-0192-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;63.0
TCGA-06-0216-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;71.0
TCGA-06-0649-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;64.0
TCGA-06-0686-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;60.0
TCGA-06-0743-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;66.0
TCGA-06-0744-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;74.0
TCGA-06-0745-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;73.0
TCGA-06-0747-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;54.0
TCGA-06-0749-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;58.0
TCGA-06-0750-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;44.0
TCGA-12-0653-01;Glioma;Female;Primary;Matched;GBM;0:LIVING;NA;49.0
TCGA-12-0654-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;64.0
TCGA-12-0656-01;Glioma;Male;Primary;Matched;GBM;0:LIVING;NA;33.0
TCGA-12-0657-01;Glioma;Female;Primary;Matched;GBM;0:LIVING;NA;50.0
TCGA-12-0662-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;68.0
TCGA-12-0688-01;Glioma;Female;Primary;Matched;GBM;1:DECEASED;NA;72.0
TCGA-12-0691-01;Glioma;Male;Primary;Matched;GBM;0:LIVING;NA;51.0
TCGA-12-0692-01;Glioma;Male;Primary;Matched;GBM;1:DECEASED;NA;55.0
TCGA-12-0703-01;Glioma;[Not Available];Primary;Matched;GBM;[Not Available];NA;[Not Available]
TCGA-12-0707-01;Glioma;[Not Available];Primary;Matched;GBM;[Not Available];NA;[Not Available]
TCGA-12-0769-01;Glioma;[Not Available];Primary;Matched;GBM;[Not Available];NA;[Not Available]
TCGA-12-0772-01;Glioma;[Not Available];Primary;Matched;GBM;[Not Available];NA;[Not Available]
TCGA-12-0773-01;Glioma;[Not Available];Primary;Matched;GBM;[Not Available];NA;[Not Available]
TCGA-12-0775-01;Glioma;[Not Available];Primary;Matched;GBM;[Not Available];NA;[Not Available]
TCGA-12-0776-01;Glioma;[Not Available];Primary;Matched;GBM;[Not Available];NA;[Not Available]
TCGA-12-0778-01;Glioma;[Not Available];Primary;Matched;GBM;[Not Available];NA;[Not Available]
TCGA-12-0780-01;Glioma;[Not Available];Primary;Matched;GBM;[Not Available];NA;[Not Available]
TCGA-15-0742-01;Glioma;[Not Available];Primary;Matched;GBM;[Not Available];NA;[Not Available]
TCGA-06-0125-02;Glioma;[Not Available];Recurrence;Matched;GBM;[Not Available];NA;[Not Available]
TCGA-06-0152-02;Glioma;[Not Available];Recurrence;Matched;GBM;[Not Available];NA;[Not Available]
TCGA-06-0171-02;Glioma;[Not Available];Recurrence;Matched;GBM;[Not Available];NA;[Not Available]
TCGA-06-0190-02;Glioma;[Not Available];Recurrence;Matched;GBM;[Not Available];NA;[Not Available]
TCGA-06-0210-02;Glioma;[Not Available];Recurrence;Matched;GBM;[Not Available];NA;[Not Available]
TCGA-06-0221-02;Glioma;[Not Available];Recurrence;Matched;GBM;[Not Available];NA;[Not Available]
TCGA-14-0736-02;Glioma;[Not Available];Recurrence;Matched;GBM;[Not Available];NA;[Not Available]
TCGA-14-1034-02;Glioma;[Not Available];Recurrence;Matched;GBM;[Not Available];NA;[Not Available]
TCGA-19-0957-02;Glioma;[Not Available];Recurrence;Matched;GBM;[Not Available];NA;[Not Available]
TCGA-19-1389-02;Glioma;[Not Available];Recurrence;Matched;GBM;[Not Available];NA;[Not Available]
TCGA-19-4065-02;Glioma;[Not Available];Recurrence;Matched;GBM;[Not Available];NA;[Not Available]
TCGA-06-0211-02;Glioma;[Not Available];Recurrence;Matched;GBM;[Not Available];NA;[Not Available]
TCGA-14-1402-02;Glioma;[Not Available];Recurrence;Matched;GBM;[Not Available];NA;[Not Available]
TCGA-CN-6010-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;66
TCGA-CN-6011-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;69
TCGA-CN-6012-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage III;49
TCGA-CN-6013-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;[Not Available];39
TCGA-CN-6016-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;1:DECEASED;Stage IVA;45
TCGA-CN-6017-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;[Not Available];83
TCGA-CN-6018-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;47
TCGA-CN-6019-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;72
TCGA-CN-6020-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;56
TCGA-CN-6021-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;[Not Available];51
TCGA-CN-6022-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;54
TCGA-CN-6023-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;0:LIVING;Stage II;58
TCGA-CN-6024-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;0:LIVING;Stage III;41
TCGA-CQ-5323-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;[Not Available];65
TCGA-CQ-5324-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;[Not Available];71
TCGA-CQ-5325-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;[Not Available];53
TCGA-CQ-5327-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage III;62
TCGA-CQ-5329-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;1:DECEASED;[Not Available];60
TCGA-CQ-5330-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;[Not Available];75
TCGA-CQ-5332-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;[Not Available];47
TCGA-CQ-5334-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;28
TCGA-CV-5430-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage III;61
TCGA-CV-5432-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;[Not Available];59
TCGA-CV-5434-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;[Not Available];77
TCGA-CV-5435-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;[Discrepancy];57
TCGA-CV-5439-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage II;46
TCGA-CV-5966-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;59
TCGA-CV-5970-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;0:LIVING;Stage IVA;41
TCGA-CV-5971-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;0:LIVING;Stage I;24
TCGA-CV-5973-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;44
TCGA-CV-5976-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;0:LIVING;Stage II;70
TCGA-CV-5977-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;1:DECEASED;Stage IVA;80
TCGA-CV-5978-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;[Not Available];49
TCGA-CV-5979-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;[Not Available];62
TCGA-CV-6003-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;62
TCGA-CV-6433-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;[Not Available];59
TCGA-CV-6436-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVB;50
TCGA-CV-6441-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;68
TCGA-BA-5152-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;48
TCGA-BA-6869-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;52
TCGA-BA-6870-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;[Not Available];73
TCGA-BA-6871-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;66
TCGA-BA-6872-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage III;50
TCGA-BA-6873-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage III;56
TCGA-BB-4227-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;67
TCGA-CN-4733-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;0:LIVING;Stage III;43
TCGA-CQ-5326-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;61
TCGA-CQ-5331-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;[Not Available];40
TCGA-CR-6467-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;58
TCGA-CR-6470-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;0:LIVING;Stage IVA;64
TCGA-CR-6471-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage I;63
TCGA-CR-6472-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;0:LIVING;Stage IVA;69
TCGA-CR-6473-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage III;84
TCGA-CR-6474-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;47
TCGA-CR-6477-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;64
TCGA-CR-6478-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;65
TCGA-CR-6480-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage III;52
TCGA-CR-6481-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;1:DECEASED;Stage IVA;61
TCGA-CR-6482-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;1:DECEASED;Stage III;72
TCGA-CR-6484-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;0:LIVING;Stage III;45
TCGA-CR-6487-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;0:LIVING;Stage II;61
TCGA-CR-6491-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;67
TCGA-CR-6493-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage II;60
TCGA-D6-6515-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;68
TCGA-D6-6516-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;56
TCGA-D6-6517-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;56
TCGA-DQ-5624-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage III;73
TCGA-DQ-5625-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;62
TCGA-DQ-5629-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;1:DECEASED;Stage IVA;63
TCGA-DQ-5630-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage III;61
TCGA-DQ-5631-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage II;70
TCGA-BA-6868-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;52
TCGA-CN-6988-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;1:DECEASED;[Not Available];70
TCGA-CN-6989-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;19
TCGA-CN-6992-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;53
TCGA-CN-6994-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;71
TCGA-CN-6996-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;1:DECEASED;Stage IVA;79
TCGA-CQ-6218-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;75
TCGA-CQ-6219-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;1:DECEASED;Stage IVA;48
TCGA-CQ-6220-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;64
TCGA-CQ-6222-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage III;56
TCGA-CQ-6223-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage II;60
TCGA-CQ-6224-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;59
TCGA-CQ-6225-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;68
TCGA-CQ-6227-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;80
TCGA-CQ-6228-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVB;48
TCGA-CQ-6229-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;55
TCGA-CV-6933-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVB;38
TCGA-CV-6934-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;51
TCGA-CV-6935-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;1:DECEASED;Stage IVA;60
TCGA-CV-6936-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;1:DECEASED;Stage IVA;90
TCGA-CV-6938-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage III;78
TCGA-CV-6939-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;0:LIVING;Stage I;55
TCGA-CV-6940-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;1:DECEASED;Stage IVA;56
TCGA-CV-6941-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;53
TCGA-CV-6943-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;57
TCGA-CV-6945-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;66
TCGA-CV-6948-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;56
TCGA-CV-6950-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;64
TCGA-CV-6951-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;55
TCGA-CV-6952-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;1:DECEASED;Stage IVA;85
TCGA-CV-6953-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;61
TCGA-CV-6954-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage III;58
TCGA-CV-6959-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;1:DECEASED;[Not Available];63
TCGA-CV-6961-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;49
TCGA-CV-6962-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;73
TCGA-D6-6823-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;66
TCGA-D6-6824-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;47
TCGA-D6-6825-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;64
TCGA-D6-6826-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;61
TCGA-D6-6827-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;67
TCGA-BA-7269-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;78
TCGA-CN-5370-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;1:DECEASED;Stage IVA;58
TCGA-CN-6995-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;66
TCGA-CN-6997-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;53
TCGA-CN-6998-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage III;63
TCGA-CR-5247-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;1:DECEASED;Stage III;61
TCGA-CR-5248-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;0:LIVING;Stage II;60
TCGA-CR-7364-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVB;60
TCGA-CR-7365-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage III;71
TCGA-CR-7367-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;[Not Available];67
TCGA-CR-7371-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;60
TCGA-CR-7372-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;50
TCGA-CR-7373-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;59
TCGA-CR-7374-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;1:DECEASED;Stage IVA;48
TCGA-CR-7377-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage II;46
TCGA-CR-7379-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;1:DECEASED;Stage IVA;40
TCGA-CR-7380-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;47
TCGA-CR-7385-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVB;57
TCGA-CR-7386-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;57
TCGA-CR-7388-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;59
TCGA-CR-7389-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;61
TCGA-CR-7390-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;59
TCGA-CR-7391-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;40
TCGA-CR-7392-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage I;82
TCGA-CR-7393-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage III;59
TCGA-CR-7394-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage I;65
TCGA-CR-7395-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;67
TCGA-CR-7397-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;0:LIVING;Stage IVA;61
TCGA-CR-7398-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;0:LIVING;Stage II;46
TCGA-CR-7399-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;0:LIVING;Stage IVA;69
TCGA-CR-7401-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;0:LIVING;[Not Available];73
TCGA-CR-7402-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage III;87
TCGA-CV-6937-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage II;74
TCGA-CV-6942-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;87
TCGA-CV-6955-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;0:LIVING;Stage IVA;52
TCGA-CV-6956-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;1:DECEASED;Stage IVA;50
TCGA-CV-6960-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage III;69
TCGA-CV-7089-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;[Not Available];79
TCGA-CV-7090-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;63
TCGA-CV-7091-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage II;69
TCGA-CV-7095-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;52
TCGA-CV-7097-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage III;65
TCGA-CV-7099-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;77
TCGA-CV-7100-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;1:DECEASED;Stage IVA;71
TCGA-CV-7101-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage II;61
TCGA-CV-7102-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;0:LIVING;Stage I;59
TCGA-CV-7103-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;0:LIVING;Stage III;83
TCGA-CV-7104-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage II;40
TCGA-CV-7177-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;0:LIVING;Stage I;75
TCGA-CV-7178-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;0:LIVING;Stage II;80
TCGA-CV-7180-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;0:LIVING;Stage II;77
TCGA-CV-7183-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;0:LIVING;Stage III;76
TCGA-CV-7235-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage II;51
TCGA-CV-7236-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage II;63
TCGA-CV-7238-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage III;88
TCGA-CV-7242-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage III;56
TCGA-CV-7243-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage II;[Not Available]
TCGA-CV-7245-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage III;59
TCGA-CV-7247-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;69
TCGA-CV-7248-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;0:LIVING;Stage II;76
TCGA-CV-7250-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;1:DECEASED;Stage III;78
TCGA-CV-7252-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage II;58
TCGA-CV-7253-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage III;73
TCGA-CV-7254-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;[Not Available];51
TCGA-CV-7255-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;[Not Available];48
TCGA-CV-7261-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;[Not Available];53
TCGA-CV-7263-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;0:LIVING;Stage II;35
TCGA-CX-7082-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;[Not Available];71
TCGA-CX-7085-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage III;59
TCGA-CX-7219-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage II;38
TCGA-HD-7229-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;58
TCGA-BB-4217-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;[Not Available];59
TCGA-CQ-6221-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;[Not Available];68
TCGA-CQ-7065-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;51
TCGA-CQ-7068-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;0:LIVING;[Not Available];56
TCGA-CR-6488-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;1:DECEASED;[Not Available];66
TCGA-CR-6492-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;[Not Available];53
TCGA-CV-7406-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;[Not Available];47
TCGA-CV-7407-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;[Not Available];62
TCGA-CV-7410-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;0:LIVING;Stage IVA;67
TCGA-CV-7411-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage I;50
TCGA-CV-7413-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;0:LIVING;Stage II;68
TCGA-CV-7414-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;60
TCGA-CV-7415-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage III;78
TCGA-CV-7416-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;69
TCGA-CV-7418-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage III;66
TCGA-CV-7421-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;60
TCGA-CV-7422-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;52
TCGA-CV-7423-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;54
TCGA-CV-7424-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;59
TCGA-CV-7425-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;0:LIVING;[Not Available];72
TCGA-CV-7427-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;1:DECEASED;Stage III;45
TCGA-CX-7086-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage I;45
TCGA-DQ-7588-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;66
TCGA-DQ-7591-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;0:LIVING;[Not Available];67
TCGA-DQ-7592-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage III;83
TCGA-H7-7774-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;58
TCGA-HD-7753-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;0:LIVING;Stage IVA;78
TCGA-HD-7754-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVB;58
TCGA-IQ-7630-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;49
TCGA-IQ-7631-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;1:DECEASED;Stage I;79
TCGA-IQ-7632-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;[Not Available];42
TCGA-CR-7368-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;69
TCGA-CR-7369-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;1:DECEASED;[Not Available];70
TCGA-CR-7370-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;[Not Available];55
TCGA-CR-7376-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;67
TCGA-CR-7382-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;0:LIVING;Stage I;36
TCGA-CR-7383-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;0:LIVING;Stage IVA;67
TCGA-CR-7404-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage III;26
TCGA-CV-7428-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;70
TCGA-CV-7429-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;0:LIVING;Stage II;80
TCGA-CV-7430-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;44
TCGA-CV-7432-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;0:LIVING;Stage II;53
TCGA-CV-7433-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;0:LIVING;Stage IVA;60
TCGA-CV-7434-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage I;64
TCGA-CV-7435-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;[Not Available];68
TCGA-CV-7437-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;[Not Available];53
TCGA-CV-7438-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;61
TCGA-CV-7440-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;73
TCGA-CV-7446-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage III;68
TCGA-CV-7568-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;60
TCGA-F7-7848-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;57
TCGA-HD-7831-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;65
TCGA-HD-7832-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;62
TCGA-BB-7861-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;52
TCGA-BB-7862-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;58
TCGA-BB-7863-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;0:LIVING;Stage IVA;76
TCGA-BB-7864-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage III;63
TCGA-BB-7866-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;64
TCGA-BB-7870-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;1:DECEASED;Stage IVA;63
TCGA-BB-7871-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;59
TCGA-BB-7872-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;60
TCGA-CQ-7067-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;0:LIVING;Stage III;62
TCGA-CV-7409-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;50
TCGA-DQ-7589-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;66
TCGA-DQ-7590-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;1:DECEASED;Stage IVB;53
TCGA-DQ-7593-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;26
TCGA-DQ-7594-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;0:LIVING;Stage III;50
TCGA-DQ-7595-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage II;57
TCGA-DQ-7596-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;62
TCGA-HD-7917-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage III;60
TCGA-HL-7533-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage III;53
TCGA-BB-8596-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;1:DECEASED;Stage IVA;66
TCGA-BB-8601-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;67
TCGA-CQ-5333-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;68
TCGA-CQ-7063-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage II;71
TCGA-CQ-7064-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage II;87
TCGA-CQ-7069-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;60
TCGA-D6-8568-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;1:DECEASED;Stage III;80
TCGA-D6-8569-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage III;51
TCGA-F7-8298-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;0:LIVING;Stage II;73
TCGA-F7-8489-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage III;74
TCGA-H7-8501-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;41
TCGA-H7-8502-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;1:DECEASED;Stage IVB;79
TCGA-HD-8224-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;64
TCGA-HD-8314-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;57
TCGA-HD-8634-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;1:DECEASED;Stage IVA;65
TCGA-HD-8635-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;1:DECEASED;Stage III;80
TCGA-C9-A47Z-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;59
TCGA-C9-A480-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;1:DECEASED;Stage II;74
TCGA-CN-A497-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage III;67
TCGA-CN-A498-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage III;48
TCGA-CN-A499-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage III;49
TCGA-CN-A49A-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage II;61
TCGA-CN-A49B-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;65
TCGA-CN-A49C-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;74
TCGA-CV-A45O-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage II;39
TCGA-CV-A45P-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage I;54
TCGA-CV-A45Q-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;1:DECEASED;Stage II;87
TCGA-CV-A45R-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage II;53
TCGA-CV-A45T-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;1:DECEASED;Stage II;85
TCGA-CV-A45U-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage III;66
TCGA-HD-A4C1-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage II;80
TCGA-CQ-A4C6-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;1:DECEASED;Stage IVA;76
TCGA-CQ-A4C7-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;49
TCGA-CQ-A4C9-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;1:DECEASED;Stage IVA;61
TCGA-CQ-A4CA-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;1:DECEASED;Stage II;82
TCGA-CQ-A4CB-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;1:DECEASED;Stage IVA;64
TCGA-CQ-A4CD-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage II;34
TCGA-CV-A45V-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage II;53
TCGA-CV-A45W-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage II;67
TCGA-CV-A45X-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;1:DECEASED;Stage IVA;77
TCGA-CV-A45Y-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;0:LIVING;Stage II;69
TCGA-CV-A45Z-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;0:LIVING;Stage II;60
TCGA-CV-A460-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage III;50
TCGA-CX-A4AQ-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;62
TCGA-D6-A4Z9-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage III;55
TCGA-D6-A4ZB-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;1:DECEASED;Stage IVA;63
TCGA-BA-A4IF-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;64
TCGA-BA-A4IG-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;1:DECEASED;Stage IVA;62
TCGA-BA-A4IH-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;58
TCGA-BA-A4II-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage II;55
TCGA-CQ-A4CE-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;1:DECEASED;Stage IVA;32
TCGA-CQ-A4CG-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;57
TCGA-CQ-A4CH-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage II;64
TCGA-CQ-A4CI-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage II;49
TCGA-CV-A461-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;1:DECEASED;Stage II;67
TCGA-CV-A463-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVB;43
TCGA-CV-A464-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage III;61
TCGA-CV-A465-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;1:DECEASED;Stage IVA;64
TCGA-CV-A468-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;1:DECEASED;Stage II;74
TCGA-F7-A50G-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;78
TCGA-MT-A51W-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;60
TCGA-MT-A51X-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;1:DECEASED;Stage IVA;29
TCGA-BB-A5HU-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;62
TCGA-BB-A5HY-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;76
TCGA-BB-A5HZ-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;1:DECEASED;Stage IVA;60
TCGA-CN-A63T-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage II;65
TCGA-CN-A63V-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;67
TCGA-F7-A50I-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;1:DECEASED;Stage III;77
TCGA-F7-A50J-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;1:DECEASED;Stage II;73
TCGA-F7-A61S-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;47
TCGA-F7-A61V-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;55
TCGA-F7-A61W-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;56
TCGA-F7-A620-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage II;79
TCGA-F7-A622-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;49
TCGA-F7-A623-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;64
TCGA-HD-A633-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;1:DECEASED;Stage IVA;57
TCGA-HD-A634-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage II;77
TCGA-P3-A5Q5-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;1:DECEASED;Stage I;87
TCGA-P3-A5Q6-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage II;38
TCGA-P3-A5QA-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;66
TCGA-P3-A5QE-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;1:DECEASED;Stage IVA;48
TCGA-P3-A5QF-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;[Not Available];57
TCGA-BA-A6DB-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;0:LIVING;Stage I;82
TCGA-BA-A6DF-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;1:DECEASED;[Not Available];69
TCGA-BA-A6DG-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage III;46
TCGA-BA-A6DI-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;1:DECEASED;[Discrepancy];64
TCGA-BA-A6DJ-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;59
TCGA-BA-A6DL-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;1:DECEASED;Stage IVA;87
TCGA-CN-A63U-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage II;75
TCGA-CN-A63W-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;47
TCGA-CN-A63Y-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;61
TCGA-CN-A640-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;[Discrepancy];75
TCGA-CN-A641-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;[Discrepancy];72
TCGA-CN-A642-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;[Not Available];65
TCGA-CQ-7071-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;1:DECEASED;Stage IVA;82
TCGA-CQ-7072-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage III;48
TCGA-F7-A624-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage III;24
TCGA-H7-A6C4-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;42
TCGA-H7-A6C5-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;1:DECEASED;[Not Available];82
TCGA-IQ-A61E-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;[Not Available];78
TCGA-IQ-A61G-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;[Not Available];85
TCGA-IQ-A61H-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;[Not Available];53
TCGA-IQ-A61I-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;69
TCGA-IQ-A61J-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage II;65
TCGA-IQ-A61K-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;0:LIVING;Stage IVB;61
TCGA-IQ-A61L-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;69
TCGA-IQ-A61O-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage II;68
TCGA-KU-A66S-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage I;58
TCGA-KU-A66T-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;65
TCGA-MT-A67A-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;79
TCGA-MT-A67D-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;82
TCGA-MT-A67F-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;0:LIVING;Stage I;77
TCGA-MT-A67G-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage III;53
TCGA-QK-A64Z-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;47
TCGA-QK-A652-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;56
TCGA-BA-A6D8-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;1:DECEASED;Stage II;82
TCGA-BA-A6DA-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage I;69
TCGA-BA-A6DD-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage III;59
TCGA-BA-A6DE-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage II;50
TCGA-CV-A6JD-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;61
TCGA-CV-A6JE-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage I;73
TCGA-CV-A6JM-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;1:DECEASED;Stage IVA;64
TCGA-CV-A6JN-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;0:LIVING;Stage I;55
TCGA-CV-A6JT-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage II;62
TCGA-CV-A6JU-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage II;52
TCGA-CV-A6JY-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;59
TCGA-CV-A6JZ-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage III;61
TCGA-CV-A6K0-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage III;67
TCGA-CV-A6K1-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;0:LIVING;Stage III;65
TCGA-CV-A6K2-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage III;71
TCGA-D6-A6EK-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;44
TCGA-D6-A6EM-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage III;62
TCGA-D6-A6EN-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;57
TCGA-D6-A6EO-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;50
TCGA-D6-A6EP-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;67
TCGA-D6-A6EQ-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;0:LIVING;[Not Available];43
TCGA-D6-A6ES-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;1:DECEASED;[Not Available];52
TCGA-HD-A6HZ-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;[Not Available];64
TCGA-HD-A6I0-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;[Not Available];73
TCGA-KU-A6H7-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;[Not Available];52
TCGA-MZ-A6I9-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;[Not Available];66
TCGA-QK-A6IF-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;[Not Available];70
TCGA-QK-A6IG-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;[Not Available];51
TCGA-QK-A6IH-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;[Not Available];62
TCGA-QK-A6II-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;[Not Available];57
TCGA-QK-A6IJ-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;[Not Available];58
TCGA-BB-A6UM-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;[Not Available];47
TCGA-BB-A6UO-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;[Not Available];53
TCGA-CN-A6UY-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;[Not Available];48
TCGA-CN-A6V1-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;47
TCGA-CN-A6V3-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage I;58
TCGA-CN-A6V6-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage II;48
TCGA-CN-A6V7-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage III;66
TCGA-CV-A6JO-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;72
TCGA-D6-A74Q-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;0:LIVING;Stage III;67
TCGA-H7-A76A-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage III;62
TCGA-IQ-A6SG-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage II;54
TCGA-IQ-A6SH-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;51
TCGA-KU-A6H8-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage III;47
TCGA-MT-A7BN-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage III;75
TCGA-MZ-A5BI-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;70
TCGA-MZ-A7D7-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage II;73
TCGA-P3-A6SW-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;0:LIVING;Stage IVA;75
TCGA-P3-A6SX-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;54
TCGA-P3-A6T0-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;50
TCGA-P3-A6T2-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;1:DECEASED;Stage IVA;35
TCGA-P3-A6T3-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage II;65
TCGA-P3-A6T4-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;[Not Available];57
TCGA-P3-A6T5-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;60
TCGA-P3-A6T6-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage I;62
TCGA-P3-A6T7-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;69
TCGA-P3-A6T8-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;74
TCGA-QK-A6V9-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;52
TCGA-QK-A6VB-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage II;62
TCGA-QK-A6VC-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;63
TCGA-RS-A6TO-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage III;58
TCGA-RS-A6TP-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;1:DECEASED;Stage I;51
TCGA-T2-A6WX-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;0:LIVING;Stage III;61
TCGA-T2-A6WZ-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;0:LIVING;Stage IVA;41
TCGA-T2-A6X0-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;74
TCGA-T2-A6X2-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;56
TCGA-TN-A7HI-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;0:LIVING;Stage III;79
TCGA-TN-A7HJ-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;56
TCGA-TN-A7HL-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;[Not Available];65
TCGA-UF-A718-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage II;49
TCGA-UF-A719-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;0:LIVING;Stage II;60
TCGA-UF-A71A-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;0:LIVING;Stage IVA;68
TCGA-UF-A71B-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;0:LIVING;Stage III;55
TCGA-UF-A71D-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;57
TCGA-UF-A71E-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage II;76
TCGA-UF-A7J9-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;63
TCGA-UF-A7JA-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;54
TCGA-UF-A7JC-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;1:DECEASED;Stage IVA;70
TCGA-UF-A7JD-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;0:LIVING;Stage II;72
TCGA-UF-A7JF-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;43
TCGA-UF-A7JH-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;0:LIVING;Stage III;61
TCGA-UF-A7JJ-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage III;55
TCGA-UF-A7JK-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;1:DECEASED;Stage III;69
TCGA-UF-A7JO-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;0:LIVING;Stage IVA;53
TCGA-UF-A7JS-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;0:LIVING;Stage IVA;55
TCGA-UF-A7JT-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;41
TCGA-UF-A7JV-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;0:LIVING;Stage I;52
TCGA-UP-A6WW-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;30
TCGA-WA-A7GZ-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;0:LIVING;Stage I;85
TCGA-WA-A7H4-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage II;55
TCGA-4P-AA8J-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;0:LIVING;Stage IVA;60
TCGA-BA-A8YP-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;0:LIVING;Stage IVA;53
TCGA-QK-A8Z7-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;74
TCGA-QK-A8Z8-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;[Not Available];53
TCGA-QK-A8Z9-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;[Not Available];68
TCGA-QK-A8ZA-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;51
TCGA-QK-A8ZB-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;54
TCGA-QK-AA3J-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;49
TCGA-QK-AA3K-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage I;41
TCGA-T3-A92M-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage III;49
TCGA-T3-A92N-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;49
TCGA-BA-4074-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVB;50
TCGA-BA-4075-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage III;67
TCGA-BA-4076-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;0:LIVING;Stage IVA;47
TCGA-BA-4077-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;45
TCGA-BA-4078-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;49
TCGA-BA-5151-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;54
TCGA-BA-5153-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;1:DECEASED;Stage IVA;79
TCGA-BB-4223-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;53
TCGA-BB-4224-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;55
TCGA-BB-4225-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;54
TCGA-BB-4228-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;1:DECEASED;Stage IVA;79
TCGA-CN-4722-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage III;60
TCGA-CN-4723-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;[Not Available];61
TCGA-CN-4725-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage III;69
TCGA-CN-4726-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;0:LIVING;Stage IVB;65
TCGA-CN-4727-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;52
TCGA-CN-4728-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage III;71
TCGA-CN-4729-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage II;56
TCGA-CN-4730-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;66
TCGA-CN-4731-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;0:LIVING;Stage IVA;62
TCGA-CN-4734-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;59
TCGA-CN-4735-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;1:DECEASED;Stage IVC;60
TCGA-CN-4736-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;56
TCGA-CN-4737-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;[Not Available];60
TCGA-CN-4740-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;68
TCGA-CN-4741-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage I;69
TCGA-CN-5355-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;60
TCGA-CN-5356-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;1:DECEASED;Stage IVA;82
TCGA-CN-5359-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage II;58
TCGA-CN-5360-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;1:DECEASED;[Not Available];73
TCGA-CN-5361-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;[Not Available];53
TCGA-CN-5363-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;[Not Available];49
TCGA-CN-5364-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage III;82
TCGA-CN-5365-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;52
TCGA-CN-5366-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;79
TCGA-CN-5367-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;56
TCGA-CN-5369-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;51
TCGA-CN-5373-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;59
TCGA-CN-5374-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;62
TCGA-BA-5149-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage II;54
TCGA-BA-5555-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;67
TCGA-BA-5556-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;50
TCGA-BA-5557-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;0:LIVING;Stage IVA;54
TCGA-BA-5558-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;63
TCGA-BA-5559-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;75
TCGA-CN-4738-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;0:LIVING;Stage IVA;66
TCGA-CN-4739-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;42
TCGA-CN-4742-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;71
TCGA-CN-5358-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;80
TCGA-CR-5243-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;59
TCGA-CR-5249-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage IVA;68
TCGA-CR-5250-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;59
TCGA-CV-5431-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;1:DECEASED;Stage IVA;79
TCGA-CV-5436-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;Stage IVA;59
TCGA-CV-5440-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;1:DECEASED;Stage IVA;72
TCGA-CV-5441-01;Head and Neck Cancer;Female;Primary;Matched;HNSC;1:DECEASED;Stage IVA;62
TCGA-CV-5442-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;[Not Available];58
TCGA-CV-5443-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;1:DECEASED;[Not Available];58
TCGA-CV-5444-01;Head and Neck Cancer;Male;Primary;Matched;HNSC;0:LIVING;Stage II;69
TCGA-KU-A6H7-06;Head and Neck Cancer;[Not Available];Metastasis;Matched;HNSC;[Not Available];[Not Available];[Not Available]
TCGA-UF-A71A-06;Head and Neck Cancer;[Not Available];Metastasis;Matched;HNSC;[Not Available];[Not Available];[Not Available]
TCGA-KL-8323-01;Renal Cell Carcinoma;Female;Primary;Matched;CHRCC;1:DECEASED;Stage III;57
TCGA-KL-8324-01;Renal Cell Carcinoma;Female;Primary;Matched;CHRCC;0:LIVING;Stage II;67
TCGA-KL-8325-01;Renal Cell Carcinoma;Female;Primary;Matched;CHRCC;1:DECEASED;Stage II;56
TCGA-KL-8326-01;Renal Cell Carcinoma;Male;Primary;Matched;CHRCC;0:LIVING;Stage III;69
TCGA-KL-8327-01;Renal Cell Carcinoma;Female;Primary;Matched;CHRCC;0:LIVING;Stage I;46
TCGA-KL-8328-01;Renal Cell Carcinoma;Male;Primary;Matched;CHRCC;0:LIVING;Stage II;60
TCGA-KL-8329-01;Renal Cell Carcinoma;Female;Primary;Matched;CHRCC;0:LIVING;Stage I;57
TCGA-KL-8330-01;Renal Cell Carcinoma;Female;Primary;Matched;CHRCC;0:LIVING;Stage II;44
TCGA-KL-8331-01;Renal Cell Carcinoma;Female;Primary;Matched;CHRCC;0:LIVING;Stage II;48
TCGA-KL-8332-01;Renal Cell Carcinoma;Male;Primary;Matched;CHRCC;0:LIVING;Stage I;55
TCGA-KL-8333-01;Renal Cell Carcinoma;Male;Primary;Matched;CHRCC;0:LIVING;Stage II;69
TCGA-KL-8334-01;Renal Cell Carcinoma;Female;Primary;Matched;CHRCC;0:LIVING;Stage III;37
TCGA-KL-8335-01;Renal Cell Carcinoma;Male;Primary;Matched;CHRCC;0:LIVING;Stage III;67
TCGA-KL-8336-01;Renal Cell Carcinoma;Female;Primary;Matched;CHRCC;1:DECEASED;Stage IV;51
TCGA-KL-8337-01;Renal Cell Carcinoma;Male;Primary;Matched;CHRCC;0:LIVING;Stage II;26
TCGA-KL-8338-01;Renal Cell Carcinoma;Male;Primary;Matched;CHRCC;0:LIVING;Stage III;51
TCGA-KL-8339-01;Renal Cell Carcinoma;Male;Primary;Matched;CHRCC;1:DECEASED;Stage IV;67
TCGA-KL-8340-01;Renal Cell Carcinoma;Male;Primary;Matched;CHRCC;0:LIVING;Stage II;34
TCGA-KL-8341-01;Renal Cell Carcinoma;Male;Primary;Matched;CHRCC;1:DECEASED;Stage IV;41
TCGA-KL-8342-01;Renal Cell Carcinoma;Female;Primary;Matched;CHRCC;0:LIVING;Stage II;45
TCGA-KL-8343-01;Renal Cell Carcinoma;Male;Primary;Matched;CHRCC;1:DECEASED;Stage III;72
TCGA-KL-8344-01;Renal Cell Carcinoma;Male;Primary;Matched;CHRCC;0:LIVING;Stage III;51
TCGA-KL-8345-01;Renal Cell Carcinoma;Male;Primary;Matched;CHRCC;0:LIVING;Stage III;75
TCGA-KL-8346-01;Renal Cell Carcinoma;Male;Primary;Matched;CHRCC;0:LIVING;Stage II;62
TCGA-KM-8438-01;Renal Cell Carcinoma;Female;Primary;Matched;CHRCC;0:LIVING;Stage II;45
TCGA-KM-8439-01;Renal Cell Carcinoma;Male;Primary;Matched;CHRCC;0:LIVING;Stage I;30
TCGA-KM-8440-01;Renal Cell Carcinoma;Male;Primary;Matched;CHRCC;0:LIVING;Stage III;37
TCGA-KM-8441-01;Renal Cell Carcinoma;Female;Primary;Matched;CHRCC;0:LIVING;Stage I;61
TCGA-KM-8442-01;Renal Cell Carcinoma;Male;Primary;Matched;CHRCC;0:LIVING;Stage II;38
TCGA-KM-8443-01;Renal Cell Carcinoma;Male;Primary;Matched;CHRCC;0:LIVING;Stage II;57
TCGA-KM-8476-01;Renal Cell Carcinoma;Male;Primary;Matched;CHRCC;0:LIVING;Stage I;47
TCGA-KM-8477-01;Renal Cell Carcinoma;Male;Primary;Matched;CHRCC;0:LIVING;Stage I;56
TCGA-KN-8418-01;Renal Cell Carcinoma;Male;Primary;Matched;CHRCC;0:LIVING;Stage I;67
TCGA-KN-8419-01;Renal Cell Carcinoma;Male;Primary;Matched;CHRCC;0:LIVING;Stage I;36
TCGA-KN-8421-01;Renal Cell Carcinoma;Female;Primary;Matched;CHRCC;0:LIVING;Stage I;45
TCGA-KN-8422-01;Renal Cell Carcinoma;Male;Primary;Matched;CHRCC;1:DECEASED;Stage III;45
TCGA-KN-8423-01;Renal Cell Carcinoma;Male;Primary;Matched;CHRCC;0:LIVING;Stage I;55
TCGA-KN-8424-01;Renal Cell Carcinoma;Male;Primary;Matched;CHRCC;0:LIVING;Stage II;18
TCGA-KN-8425-01;Renal Cell Carcinoma;Male;Primary;Matched;CHRCC;0:LIVING;Stage I;47
TCGA-KN-8426-01;Renal Cell Carcinoma;Female;Primary;Matched;CHRCC;0:LIVING;Stage I;33
TCGA-KN-8427-01;Renal Cell Carcinoma;Female;Primary;Matched;CHRCC;0:LIVING;Stage I;57
TCGA-KN-8428-01;Renal Cell Carcinoma;Female;Primary;Matched;CHRCC;0:LIVING;Stage I;59
TCGA-KN-8429-01;Renal Cell Carcinoma;Female;Primary;Matched;CHRCC;0:LIVING;Stage I;55
TCGA-KN-8430-01;Renal Cell Carcinoma;Male;Primary;Matched;CHRCC;0:LIVING;Stage I;39
TCGA-KN-8431-01;Renal Cell Carcinoma;Female;Primary;Matched;CHRCC;0:LIVING;Stage I;50
TCGA-KN-8432-01;Renal Cell Carcinoma;Male;Primary;Matched;CHRCC;0:LIVING;Stage I;67
TCGA-KN-8433-01;Renal Cell Carcinoma;Male;Primary;Matched;CHRCC;0:LIVING;Stage I;53
TCGA-KN-8434-01;Renal Cell Carcinoma;Female;Primary;Matched;CHRCC;0:LIVING;Stage I;36
TCGA-KN-8435-01;Renal Cell Carcinoma;Female;Primary;Matched;CHRCC;0:LIVING;Stage II;41
TCGA-KN-8436-01;Renal Cell Carcinoma;Male;Primary;Matched;CHRCC;0:LIVING;Stage II;43
TCGA-KN-8437-01;Renal Cell Carcinoma;Female;Primary;Matched;CHRCC;0:LIVING;Stage II;47
TCGA-KO-8403-01;Renal Cell Carcinoma;Female;Primary;Matched;CHRCC;0:LIVING;Stage I;28
TCGA-KO-8404-01;Renal Cell Carcinoma;Male;Primary;Matched;CHRCC;0:LIVING;Stage I;44
TCGA-KO-8405-01;Renal Cell Carcinoma;Female;Primary;Matched;CHRCC;0:LIVING;Stage I;42
TCGA-KO-8406-01;Renal Cell Carcinoma;Male;Primary;Matched;CHRCC;0:LIVING;Stage I;53
TCGA-KO-8407-01;Renal Cell Carcinoma;Male;Primary;Matched;CHRCC;0:LIVING;Stage IV;50
TCGA-KO-8408-01;Renal Cell Carcinoma;Male;Primary;Matched;CHRCC;0:LIVING;Stage IV;54
TCGA-KO-8409-01;Renal Cell Carcinoma;Male;Primary;Matched;CHRCC;1:DECEASED;Stage II;71
TCGA-KO-8410-01;Renal Cell Carcinoma;Female;Primary;Matched;CHRCC;0:LIVING;Stage III;38
TCGA-KO-8411-01;Renal Cell Carcinoma;Male;Primary;Matched;CHRCC;1:DECEASED;Stage I;75
TCGA-KO-8413-01;Renal Cell Carcinoma;Female;Primary;Matched;CHRCC;0:LIVING;Stage II;35
TCGA-KO-8414-01;Renal Cell Carcinoma;Female;Primary;Matched;CHRCC;0:LIVING;Stage II;86
TCGA-KO-8415-01;Renal Cell Carcinoma;Female;Primary;Matched;CHRCC;0:LIVING;Stage III;46
TCGA-KO-8416-01;Renal Cell Carcinoma;Female;Primary;Matched;CHRCC;0:LIVING;Stage II;65
TCGA-KO-8417-01;Renal Cell Carcinoma;Male;Primary;Matched;CHRCC;0:LIVING;Stage II;59
TCGA-KM-8639-01;Renal Cell Carcinoma;Male;Primary;Matched;CHRCC;0:LIVING;Stage II;62
TCGA-KM-A7Q6-01;Renal Cell Carcinoma;Female;Primary;Matched;CHRCC;0:LIVING;Stage I;42
TCGA-KM-A7Q7-01;Renal Cell Carcinoma;Male;Primary;Matched;CHRCC;0:LIVING;Stage I;49
TCGA-KM-A7Q8-01;Renal Cell Carcinoma;Male;Primary;Matched;CHRCC;1:DECEASED;Stage IV;78
TCGA-KM-A7Q9-01;Renal Cell Carcinoma;Male;Primary;Matched;CHRCC;0:LIVING;Stage III;29
TCGA-KM-A7QA-01;Renal Cell Carcinoma;Female;Primary;Matched;CHRCC;0:LIVING;Stage I;17
TCGA-KM-A7QB-01;Renal Cell Carcinoma;Male;Primary;Matched;CHRCC;0:LIVING;Stage II;42
TCGA-KM-A7QC-01;Renal Cell Carcinoma;Male;Primary;Matched;CHRCC;1:DECEASED;Stage III;47
TCGA-KM-A7QD-01;Renal Cell Carcinoma;Male;Primary;Matched;CHRCC;0:LIVING;Stage II;69
TCGA-KM-A7QE-01;Renal Cell Carcinoma;Female;Primary;Matched;CHRCC;0:LIVING;Stage I;74
TCGA-KM-A7QG-01;Renal Cell Carcinoma;Male;Primary;Matched;CHRCC;0:LIVING;Stage I;58
TCGA-KM-A7QH-01;Renal Cell Carcinoma;Male;Primary;Matched;CHRCC;0:LIVING;Stage I;46
TCGA-KM-A7QI-01;Renal Cell Carcinoma;Female;Primary;Matched;CHRCC;0:LIVING;Stage II;50
TCGA-KM-A7QJ-01;Renal Cell Carcinoma;Female;Primary;Matched;CHRCC;0:LIVING;Stage I;44
TCGA-KM-A7QK-01;Renal Cell Carcinoma;Male;Primary;Matched;CHRCC;0:LIVING;Stage III;41
TCGA-KM-A7QL-01;Renal Cell Carcinoma;Female;Primary;Matched;CHRCC;0:LIVING;Stage I;30
TCGA-NP-A5B3-01;Renal Cell Carcinoma;Male;Primary;Matched;CHRCC;0:LIVING;Stage I;74
TCGA-NP-A5GY-01;Renal Cell Carcinoma;Female;Primary;Matched;CHRCC;1:DECEASED;Stage I;75
TCGA-NP-A5GZ-01;Renal Cell Carcinoma;Female;Primary;Matched;CHRCC;0:LIVING;Stage II;50
TCGA-NP-A5H1-01;Renal Cell Carcinoma;Female;Primary;Matched;CHRCC;0:LIVING;Stage I;66
TCGA-NP-A5H5-01;Renal Cell Carcinoma;Female;Primary;Matched;CHRCC;0:LIVING;Stage I;79
TCGA-NP-A5H6-01;Renal Cell Carcinoma;Male;Primary;Matched;CHRCC;0:LIVING;Stage II;49
TCGA-NP-A5H7-01;Renal Cell Carcinoma;Female;Primary;Matched;CHRCC;0:LIVING;Stage II;40
TCGA-UW-A72H-01;Renal Cell Carcinoma;Male;Primary;Matched;CHRCC;0:LIVING;Stage III;48
TCGA-UW-A72I-01;Renal Cell Carcinoma;Female;Primary;Matched;CHRCC;0:LIVING;Stage I;50
TCGA-UW-A72J-01;Renal Cell Carcinoma;Female;Primary;Matched;CHRCC;0:LIVING;Stage I;42
TCGA-UW-A72K-01;Renal Cell Carcinoma;Male;Primary;Matched;CHRCC;0:LIVING;Stage I;52
TCGA-UW-A72L-01;Renal Cell Carcinoma;Female;Primary;Matched;CHRCC;0:LIVING;Stage I;51
TCGA-UW-A72M-01;Renal Cell Carcinoma;Male;Primary;Matched;CHRCC;0:LIVING;Stage I;44
TCGA-UW-A72N-01;Renal Cell Carcinoma;Male;Primary;Matched;CHRCC;0:LIVING;Stage I;45
TCGA-UW-A72O-01;Renal Cell Carcinoma;Male;Primary;Matched;CHRCC;0:LIVING;Stage I;38
TCGA-UW-A72P-01;Renal Cell Carcinoma;Female;Primary;Matched;CHRCC;0:LIVING;Stage I;61
TCGA-UW-A72Q-01;Renal Cell Carcinoma;Male;Primary;Matched;CHRCC;0:LIVING;Stage I;56
TCGA-UW-A72R-01;Renal Cell Carcinoma;Female;Primary;Matched;CHRCC;0:LIVING;Stage I;29
TCGA-UW-A72S-01;Renal Cell Carcinoma;Female;Primary;Matched;CHRCC;0:LIVING;Stage I;43
TCGA-UW-A72T-01;Renal Cell Carcinoma;Male;Primary;Matched;CHRCC;0:LIVING;Stage III;57
TCGA-UW-A7GC-01;Renal Cell Carcinoma;Female;Primary;Matched;CHRCC;1:DECEASED;Stage I;75
TCGA-UW-A7GG-01;Renal Cell Carcinoma;Female;Primary;Matched;CHRCC;0:LIVING;Stage II;44
TCGA-UW-A7GI-01;Renal Cell Carcinoma;Male;Primary;Matched;CHRCC;0:LIVING;Stage I;58
TCGA-UW-A7GJ-01;Renal Cell Carcinoma;Female;Primary;Matched;CHRCC;0:LIVING;Stage III;52
TCGA-UW-A7GK-01;Renal Cell Carcinoma;Female;Primary;Matched;CHRCC;0:LIVING;Stage I;74
TCGA-UW-A7GL-01;Renal Cell Carcinoma;Male;Primary;Matched;CHRCC;0:LIVING;Stage II;47
TCGA-UW-A7GN-01;Renal Cell Carcinoma;Male;Primary;Matched;CHRCC;0:LIVING;Stage III;31
TCGA-UW-A7GP-01;Renal Cell Carcinoma;Male;Primary;Matched;CHRCC;0:LIVING;Stage II;40
TCGA-UW-A7GR-01;Renal Cell Carcinoma;Female;Primary;Matched;CHRCC;0:LIVING;Stage IV;44
TCGA-UW-A7GU-01;Renal Cell Carcinoma;Male;Primary;Matched;CHRCC;0:LIVING;Stage I;75
TCGA-UW-A7GX-01;Renal Cell Carcinoma;Male;Primary;Matched;CHRCC;0:LIVING;Stage II;45
TCGA-UW-A7GY-01;Renal Cell Carcinoma;Female;Primary;Matched;CHRCC;0:LIVING;Stage I;57
TCGA-B0-5698-01;Renal Cell Carcinoma;MALE;Primary;Matched;CCRCC;0:LIVING;Stage I;69.0
TCGA-B0-5710-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;68.0
TCGA-B0-5711-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;67.0
TCGA-B0-5712-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage III;66.0
TCGA-B0-5713-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage III;77.0
TCGA-B0-5812-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage I;57.0
TCGA-B4-5832-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage I;59.0
TCGA-B4-5834-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage II;57.0
TCGA-B4-5835-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage II;67.0
TCGA-B4-5836-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;70.0
TCGA-B4-5838-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;52.0
TCGA-B4-5843-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;51.0
TCGA-B4-5844-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;53.0
TCGA-B8-4146-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;51.0
TCGA-B8-4153-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage I;52.0
TCGA-B8-5545-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;47.0
TCGA-B8-5552-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;79.0
TCGA-CJ-5686-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;75.0
TCGA-CJ-6027-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;86.0
TCGA-CJ-6028-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage II;41.0
TCGA-CJ-6030-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;75.0
TCGA-CJ-6031-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage II;79.0
TCGA-CJ-6032-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage I;68.0
TCGA-CJ-6033-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;1:DECEASED;Stage III;76.0
TCGA-CW-5580-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;34.0
TCGA-CW-6087-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage II;42.0
TCGA-CW-6088-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage III;74.0
TCGA-CW-6090-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage II;62.0
TCGA-CW-6093-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;57.0
TCGA-CW-6096-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;82.0
TCGA-CW-6097-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;60.0
TCGA-CZ-5982-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage II;50.0
TCGA-CZ-5984-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;46.0
TCGA-CZ-5985-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;72.0
TCGA-CZ-5986-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;48.0
TCGA-CZ-5987-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage III;64.0
TCGA-CZ-5988-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;54.0
TCGA-CZ-5989-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;51.0
TCGA-EU-5904-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage I;51.0
TCGA-EU-5905-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;60.0
TCGA-EU-5906-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;54.0
TCGA-EU-5907-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;69.0
TCGA-B2-A4SR-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;52.0
TCGA-B8-A54D-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;46.0
TCGA-B8-A54E-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;49.0
TCGA-B8-A54F-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;47.0
TCGA-B8-A54G-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;57.0
TCGA-DV-A4VX-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;49.0
TCGA-DV-A4VZ-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;78.0
TCGA-DV-A4W0-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;59.0
TCGA-MM-A563-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;74.0
TCGA-MM-A564-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;75.0
TCGA-MW-A4EC-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage III;37.0
TCGA-A3-3306-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;65.0
TCGA-A3-3307-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;68.0
TCGA-A3-3308-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage III;37.0
TCGA-A3-3311-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;65.0
TCGA-A3-3313-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage III;62.0
TCGA-A3-3316-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage II;54.0
TCGA-A3-3317-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage III;61.0
TCGA-A3-3319-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;1:DECEASED;Stage II;62.0
TCGA-A3-3320-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage II;48.0
TCGA-A3-3322-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;72.0
TCGA-A3-3323-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage IV;40.0
TCGA-A3-3324-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;58.0
TCGA-A3-3325-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage II;45.0
TCGA-A3-3326-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;80.0
TCGA-A3-3328-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage III;69.0
TCGA-A3-3329-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage II;83.0
TCGA-A3-3331-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;85.0
TCGA-A3-3335-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage II;48.0
TCGA-A3-3336-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage II;58.0
TCGA-A3-3343-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;84.0
TCGA-A3-3346-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;1:DECEASED;Stage III;71.0
TCGA-A3-3352-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage II;48.0
TCGA-A3-3359-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;48.0
TCGA-A3-3363-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;58.0
TCGA-A3-3365-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;72.0
TCGA-A3-3372-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;71.0
TCGA-A3-3374-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;63.0
TCGA-A3-3378-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;35.0
TCGA-A3-3380-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage IV;46.0
TCGA-A3-3382-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage IV;65.0
TCGA-A3-3383-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage IV;55.0
TCGA-AK-3427-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;1:DECEASED;Stage III;72.0
TCGA-AK-3440-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage III;72.0
TCGA-AK-3443-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage III;58.0
TCGA-AK-3444-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;1:DECEASED;Stage IV;46.0
TCGA-AK-3447-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage IV;75.0
TCGA-AK-3453-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage IV;74.0
TCGA-AK-3455-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage IV;60.0
TCGA-AK-3465-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;1:DECEASED;Stage IV;66.0
TCGA-AS-3777-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage IV;51.0
TCGA-AS-3778-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage III;61.0
TCGA-A3-A6NI-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage III;63.0
TCGA-A3-A6NJ-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage III;75.0
TCGA-A3-A6NL-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage IV;76.0
TCGA-A3-A6NN-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;1:DECEASED;Stage III;76.0
TCGA-B8-A54H-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage IV;81.0
TCGA-B8-A54I-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage III;57.0
TCGA-B8-A54J-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage III;47.0
TCGA-B8-A54K-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage III;48.0
TCGA-G6-A5PC-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage III;68.0
TCGA-GK-A6C7-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage IV;58.0
TCGA-3Z-A93Z-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage III;65.0
TCGA-6D-AA2E-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage II;49.0
TCGA-A3-A8CQ-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage III;81.0
TCGA-A3-A8OU-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;1:DECEASED;Stage II;68.0
TCGA-A3-A8OV-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;1:DECEASED;Stage IV;60.0
TCGA-A3-A8OW-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;1:DECEASED;Stage III;68.0
TCGA-A3-A8OX-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage II;78.0
TCGA-B8-A7U6-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage I;88.0
TCGA-G6-A8L6-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;1:DECEASED;Stage I;49.0
TCGA-G6-A8L7-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;1:DECEASED;Stage III;77.0
TCGA-G6-A8L8-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage IV;79.0
TCGA-MM-A84U-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;1:DECEASED;Stage I;82.0
TCGA-T7-A92I-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage I;49.0
TCGA-B8-A8YJ-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage IV;61.0
TCGA-A3-3347-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage I;63.0
TCGA-A3-3349-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;1:DECEASED;Stage I;69.0
TCGA-A3-3351-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;1:DECEASED;Stage I;80.0
TCGA-A3-3362-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage IV;63.0
TCGA-AK-3426-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;1:DECEASED;Stage III;73.0
TCGA-AK-3429-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage III;57.0
TCGA-AK-3430-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage IV;60.0
TCGA-AK-3436-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage IV;70.0
TCGA-AK-3451-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage IV;52.0
TCGA-AK-3456-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage IV;60.0
TCGA-B2-3923-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage III;54.0
TCGA-B2-3924-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage III;51.0
TCGA-B2-4098-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;1:DECEASED;Stage II;78.0
TCGA-B2-4099-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;1:DECEASED;Stage I;75.0
TCGA-B2-4102-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;1:DECEASED;Stage III;77.0
TCGA-B8-4143-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage I;77.0
TCGA-B8-4148-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage IV;63.0
TCGA-B8-4151-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;1:DECEASED;Stage III;79.0
TCGA-B8-4154-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage I;63.0
TCGA-B8-4619-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage IV;33.0
TCGA-B8-4620-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;1:DECEASED;Stage III;76.0
TCGA-BP-4161-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage I;53.0
TCGA-BP-4162-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;1:DECEASED;Stage IV;53.0
TCGA-BP-4163-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage IV;62.0
TCGA-BP-4164-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage III;81.0
TCGA-BP-4167-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;1:DECEASED;Stage III;72.0
TCGA-CJ-4634-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage III;59.0
TCGA-CJ-4636-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;1:DECEASED;Stage I;53.0
TCGA-CJ-4637-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;1:DECEASED;Stage III;88.0
TCGA-CJ-4638-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage III;72.0
TCGA-CJ-4639-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;1:DECEASED;Stage I;74.0
TCGA-CJ-4640-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;1:DECEASED;Stage I;90.0
TCGA-CJ-4641-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage I;64.0
TCGA-CJ-4643-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;1:DECEASED;Stage IV;65.0
TCGA-CJ-4644-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage III;54.0
TCGA-AK-3425-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage III;69.0
TCGA-AK-3428-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;71.0
TCGA-AK-3431-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage III;69.0
TCGA-AK-3433-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage IV;43.0
TCGA-AK-3434-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage III;52.0
TCGA-AK-3445-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;40.0
TCGA-AK-3450-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;61.0
TCGA-AK-3454-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;72.0
TCGA-AK-3460-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;56.0
TCGA-AK-3461-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;46.0
TCGA-B0-4688-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage III;59.0
TCGA-B0-4690-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage IV;64.0
TCGA-B0-4691-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;53.0
TCGA-B0-4693-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;66.0
TCGA-B0-4694-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage III;66.0
TCGA-B0-4696-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;47.0
TCGA-B0-4697-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage III;71.0
TCGA-B0-4699-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;61.0
TCGA-B0-4701-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage III;69.0
TCGA-B0-4703-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;50.0
TCGA-B0-4707-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;77.0
TCGA-B0-4713-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;53.0
TCGA-B0-4714-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;77.0
TCGA-B0-4718-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage III;65.0
TCGA-B0-4813-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;71.0
TCGA-B0-4814-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;73.0
TCGA-B0-4817-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;65.0
TCGA-B0-4819-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage II;45.0
TCGA-B0-4822-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;39.0
TCGA-B0-4824-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage III;62.0
TCGA-B0-4828-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;57.0
TCGA-B0-4841-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage III;50.0
TCGA-B0-4843-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage IV;68.0
TCGA-B0-4844-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage III;75.0
TCGA-B0-4845-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;53.0
TCGA-B0-4846-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage II;59.0
TCGA-B0-4847-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;73.0
TCGA-B0-4848-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;1:DECEASED;Stage I;72.0
TCGA-B0-4849-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;83.0
TCGA-B2-4101-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage II;52.0
TCGA-B8-4622-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;61.0
TCGA-BP-4158-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;56.0
TCGA-BP-4159-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;74.0
TCGA-BP-4160-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;79.0
TCGA-BP-4165-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage IV;46.0
TCGA-BP-4166-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;79.0
TCGA-BP-4169-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage II;61.0
TCGA-BP-4170-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage IV;68.0
TCGA-BP-4173-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;62.0
TCGA-BP-4174-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage III;65.0
TCGA-BP-4176-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;59.0
TCGA-BP-4325-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;64.0
TCGA-BP-4326-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;61.0
TCGA-BP-4327-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;[Discrepancy];52.0
TCGA-BP-4329-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;45.0
TCGA-BP-4330-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage II;61.0
TCGA-BP-4331-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;1:DECEASED;Stage IV;66.0
TCGA-BP-4332-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;41.0
TCGA-BP-4334-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;63.0
TCGA-BP-4335-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage III;51.0
TCGA-BP-4337-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage III;74.0
TCGA-BP-4338-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;73.0
TCGA-BP-4340-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;58.0
TCGA-BP-4341-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage III;70.0
TCGA-BP-4342-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;63.0
TCGA-BP-4343-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage IV;57.0
TCGA-BP-4344-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage III;56.0
TCGA-BP-4345-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;61.0
TCGA-BP-4346-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage II;62.0
TCGA-BP-4347-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage III;63.0
TCGA-BP-4349-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage III;65.0
TCGA-BP-4351-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;43.0
TCGA-BP-4352-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;42.0
TCGA-BP-4353-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;38.0
TCGA-BP-4354-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;53.0
TCGA-BP-4355-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage III;71.0
TCGA-BP-4756-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;65.0
TCGA-BP-4758-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;41.0
TCGA-BP-4759-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;67.0
TCGA-BP-4761-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage III;69.0
TCGA-BP-4762-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;62.0
TCGA-BP-4763-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;49.0
TCGA-BP-4765-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;50.0
TCGA-BP-4766-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage II;69.0
TCGA-BP-4768-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;48.0
TCGA-BP-4769-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage II;60.0
TCGA-BP-4771-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;61.0
TCGA-BP-4774-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;54.0
TCGA-BP-4775-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;60.0
TCGA-BP-4776-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;69.0
TCGA-BP-4777-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage I;70.0
TCGA-B0-4833-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage III;67.0
TCGA-B0-4834-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;74.0
TCGA-B0-4836-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;65.0
TCGA-B0-4837-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage III;60.0
TCGA-B0-4838-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;1:DECEASED;Stage III;51.0
TCGA-B0-4839-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;64.0
TCGA-BP-4781-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage III;69.0
TCGA-BP-4784-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage III;59.0
TCGA-BP-4787-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;1:DECEASED;Stage II;76.0
TCGA-BP-4789-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;1:DECEASED;Stage I;72.0
TCGA-BP-4790-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage II;47.0
TCGA-BP-4797-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage II;49.0
TCGA-BP-4798-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;64.0
TCGA-BP-4799-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;65.0
TCGA-BP-4803-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;64.0
TCGA-BP-4804-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;1:DECEASED;Stage I;53.0
TCGA-BP-4807-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;1:DECEASED;Stage II;75.0
TCGA-CJ-4635-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage III;75.0
TCGA-CJ-4642-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage III;60.0
TCGA-CJ-4868-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage I;52.0
TCGA-CJ-4870-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage III;36.0
TCGA-CJ-4871-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage III;56.0
TCGA-CJ-4872-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;1:DECEASED;Stage IV;65.0
TCGA-CJ-4873-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;1:DECEASED;Stage III;76.0
TCGA-CJ-4874-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;43.0
TCGA-CJ-4875-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;1:DECEASED;Stage I;70.0
TCGA-CJ-4876-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage III;67.0
TCGA-CJ-4878-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage II;79.0
TCGA-CJ-4881-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage III;64.0
TCGA-CJ-4884-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;75.0
TCGA-CJ-4885-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage III;62.0
TCGA-CJ-4886-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage III;57.0
TCGA-CJ-4887-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage III;74.0
TCGA-CJ-4888-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;68.0
TCGA-CJ-4889-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage III;51.0
TCGA-CJ-4890-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;1:DECEASED;Stage IV;74.0
TCGA-CJ-4891-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage I;61.0
TCGA-CJ-4892-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage IV;40.0
TCGA-CJ-4893-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;1:DECEASED;Stage III;59.0
TCGA-CJ-4894-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;62.0
TCGA-CJ-4895-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;40.0
TCGA-CZ-4854-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;50.0
TCGA-CZ-4857-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;69.0
TCGA-CZ-4858-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage III;57.0
TCGA-CZ-4860-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage I;42.0
TCGA-CZ-4861-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;1:DECEASED;Stage I;79.0
TCGA-CZ-4862-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;43.0
TCGA-A3-3357-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;43.0
TCGA-A3-3367-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;72.0
TCGA-A3-3370-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;63.0
TCGA-A3-3373-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;1:DECEASED;Stage IV;73.0
TCGA-A3-3376-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage IV;62.0
TCGA-A3-3385-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;57.0
TCGA-B0-4823-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;55.0
TCGA-B0-4827-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;52.0
TCGA-B0-4842-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;46.0
TCGA-B0-4945-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;78.0
TCGA-B0-5083-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;55.0
TCGA-B0-5092-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;67.0
TCGA-B0-5094-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;1:DECEASED;Stage IV;59.0
TCGA-B0-5095-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;48.0
TCGA-B0-5096-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage I;76.0
TCGA-B0-5097-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;74.0
TCGA-B0-5098-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage III;34.0
TCGA-B0-5099-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;[Discrepancy];74.0
TCGA-B0-5100-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage III;70.0
TCGA-B0-5102-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;57.0
TCGA-B0-5104-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage III;79.0
TCGA-B0-5106-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;59.0
TCGA-B0-5107-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;42.0
TCGA-B0-5108-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;49.0
TCGA-B0-5109-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage II;46.0
TCGA-B0-5110-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;47.0
TCGA-B0-5113-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage II;58.0
TCGA-B0-5115-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;63.0
TCGA-B0-5116-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;54.0
TCGA-B0-5117-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;46.0
TCGA-B0-5119-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage III;76.0
TCGA-B0-5120-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;40.0
TCGA-B0-5121-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;63.0
TCGA-B8-5158-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage III;44.0
TCGA-B8-5159-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage III;40.0
TCGA-B8-5162-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage III;43.0
TCGA-B8-5163-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage III;47.0
TCGA-B8-5164-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage IV;58.0
TCGA-B8-5165-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;40.0
TCGA-BP-4177-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;77.0
TCGA-BP-4760-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;57.0
TCGA-BP-4782-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;1:DECEASED;Stage III;75.0
TCGA-BP-4795-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;42.0
TCGA-BP-4801-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage III;67.0
TCGA-BP-4993-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage III;72.0
TCGA-BP-5010-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;75.0
TCGA-BP-5168-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;41.0
TCGA-B0-5075-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage I;72.0
TCGA-B0-5077-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage III;58.0
TCGA-B0-5081-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;54.0
TCGA-B0-5084-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;66.0
TCGA-B0-5085-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;58.0
TCGA-B0-5088-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;54.0
TCGA-BP-4959-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;68.0
TCGA-BP-4960-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;49.0
TCGA-BP-4961-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;56.0
TCGA-BP-4962-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;40.0
TCGA-BP-4963-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;43.0
TCGA-BP-4964-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;53.0
TCGA-BP-4965-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;61.0
TCGA-BP-4967-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage II;45.0
TCGA-BP-4968-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;46.0
TCGA-BP-4969-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage I;52.0
TCGA-BP-4970-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage III;63.0
TCGA-BP-4971-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage I;75.0
TCGA-BP-4972-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;70.0
TCGA-BP-4973-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;55.0
TCGA-BP-4974-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage I;75.0
TCGA-BP-4975-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;45.0
TCGA-BP-4976-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;60.0
TCGA-BP-4977-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;1:DECEASED;Stage I;78.0
TCGA-BP-4981-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;46.0
TCGA-BP-4982-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage IV;71.0
TCGA-BP-4983-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;53.0
TCGA-BP-4985-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;58.0
TCGA-BP-4986-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;56.0
TCGA-BP-4987-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage III;57.0
TCGA-BP-4988-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;54.0
TCGA-BP-4989-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;56.0
TCGA-BP-4991-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;50.0
TCGA-BP-4992-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;54.0
TCGA-BP-4994-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage I;60.0
TCGA-BP-4995-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;61.0
TCGA-BP-4998-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage III;79.0
TCGA-BP-4999-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;59.0
TCGA-BP-5000-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;39.0
TCGA-BP-5001-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;75.0
TCGA-BP-5004-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;53.0
TCGA-BP-5006-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage III;72.0
TCGA-BP-5007-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage II;58.0
TCGA-BP-5008-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage II;44.0
TCGA-BP-5009-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage IV;63.0
TCGA-CJ-4899-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage III;75.0
TCGA-CJ-4900-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;60.0
TCGA-BP-5169-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;48.0
TCGA-BP-5170-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage III;51.0
TCGA-BP-5173-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;1:DECEASED;Stage IV;52.0
TCGA-BP-5174-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;1:DECEASED;Stage IV;46.0
TCGA-BP-5175-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage II;49.0
TCGA-BP-5176-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage III;49.0
TCGA-BP-5177-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;1:DECEASED;Stage IV;55.0
TCGA-BP-5178-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage II;47.0
TCGA-BP-5180-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage II;67.0
TCGA-BP-5181-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;1:DECEASED;Stage IV;48.0
TCGA-BP-5182-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage IV;42.0
TCGA-BP-5183-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage III;49.0
TCGA-BP-5184-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage III;58.0
TCGA-BP-5185-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage IV;63.0
TCGA-BP-5186-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;51.0
TCGA-BP-5187-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage III;85.0
TCGA-BP-5189-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;73.0
TCGA-BP-5190-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage IV;67.0
TCGA-BP-5191-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage II;57.0
TCGA-BP-5192-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage III;71.0
TCGA-BP-5194-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage III;41.0
TCGA-BP-5195-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage III;57.0
TCGA-BP-5196-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage III;72.0
TCGA-BP-5198-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage IV;64.0
TCGA-BP-5199-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;42.0
TCGA-BP-5200-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage IV;48.0
TCGA-BP-5201-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage IV;59.0
TCGA-BP-5202-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;63.0
TCGA-CJ-4869-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage IV;72.0
TCGA-CJ-4882-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;1:DECEASED;Stage III;57.0
TCGA-CJ-4897-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;65.0
TCGA-CJ-4901-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;76.0
TCGA-CJ-4902-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage III;58.0
TCGA-CJ-4903-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage IV;62.0
TCGA-CJ-4904-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage III;79.0
TCGA-CJ-4905-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;42.0
TCGA-CJ-4907-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;1:DECEASED;Stage IV;69.0
TCGA-CJ-4908-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage III;47.0
TCGA-CJ-4912-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage III;61.0
TCGA-CJ-4913-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;50.0
TCGA-CJ-4916-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage IV;60.0
TCGA-CJ-4918-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;62.0
TCGA-CJ-4920-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage III;58.0
TCGA-CJ-4923-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;38.0
TCGA-CZ-4853-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage II;61.0
TCGA-CZ-4856-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;1:DECEASED;Stage III;45.0
TCGA-CZ-4859-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage III;69.0
TCGA-AK-3458-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage IV;64.0
TCGA-B0-4698-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;1:DECEASED;Stage I;64.0
TCGA-B0-4706-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;1:DECEASED;Stage IV;63.0
TCGA-B0-4710-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;51.0
TCGA-B0-4712-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage I;84.0
TCGA-B0-4810-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage II;70.0
TCGA-B0-4811-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage III;47.0
TCGA-B0-4815-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;1:DECEASED;Stage IV;54.0
TCGA-B0-4816-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage IV;62.0
TCGA-B0-4818-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage III;73.0
TCGA-B0-4821-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;1:DECEASED;Stage IV;65.0
TCGA-B0-4852-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;1:DECEASED;Stage IV;44.0
TCGA-B0-5080-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage IV;60.0
TCGA-B0-5399-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;78.0
TCGA-B0-5400-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage III;61.0
TCGA-B0-5402-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;59.0
TCGA-B4-5377-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage I;90.0
TCGA-B4-5378-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage I;77.0
TCGA-B8-4621-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage IV;58.0
TCGA-BP-4770-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage I;65.0
TCGA-CZ-4863-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;54.0
TCGA-CZ-4864-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage II;63.0
TCGA-CZ-4865-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;1:DECEASED;Stage IV;54.0
TCGA-CZ-4866-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;1:DECEASED;Stage IV;73.0
TCGA-CZ-5451-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;44.0
TCGA-CZ-5452-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;51.0
TCGA-CZ-5453-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage III;74.0
TCGA-CZ-5454-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage IV;51.0
TCGA-CZ-5455-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage III;62.0
TCGA-CZ-5456-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;78.0
TCGA-CZ-5457-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;52.0
TCGA-CZ-5458-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage IV;51.0
TCGA-CZ-5459-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage IV;56.0
TCGA-CZ-5460-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage IV;61.0
TCGA-CZ-5461-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;60.0
TCGA-CZ-5462-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;68.0
TCGA-CZ-5463-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;73.0
TCGA-CZ-5464-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;44.0
TCGA-CZ-5465-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage III;32.0
TCGA-CZ-5466-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;82.0
TCGA-CZ-5467-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage I;68.0
TCGA-CZ-5468-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;62.0
TCGA-CZ-5469-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage IV;56.0
TCGA-CZ-5470-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage II;39.0
TCGA-A3-3358-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;59.0
TCGA-A3-3387-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage IV;60.0
TCGA-B0-4700-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage II;63.0
TCGA-B0-5690-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;46.0
TCGA-B0-5691-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage III;51.0
TCGA-B0-5692-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage II;86.0
TCGA-B0-5693-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;1:DECEASED;Stage I;70.0
TCGA-B0-5694-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;79.0
TCGA-B0-5695-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage II;74.0
TCGA-B0-5696-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage II;69.0
TCGA-B0-5697-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage II;67.0
TCGA-B0-5699-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage IV;63.0
TCGA-B0-5700-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage IV;63.0
TCGA-B0-5701-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage II;57.0
TCGA-B0-5702-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage III;62.0
TCGA-B0-5703-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage III;43.0
TCGA-B0-5705-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage III;63.0
TCGA-B0-5706-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage IV;55.0
TCGA-B0-5707-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage IV;52.0
TCGA-B0-5709-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage IV;83.0
TCGA-B2-5633-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage II;76.0
TCGA-B2-5635-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage IV;69.0
TCGA-B2-5636-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;1:DECEASED;Stage III;76.0
TCGA-B2-5639-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage III;67.0
TCGA-B2-5641-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;1:DECEASED;Stage III;86.0
TCGA-B8-5546-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage IV;84.0
TCGA-B8-5549-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage II;41.0
TCGA-B8-5550-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage II;72.0
TCGA-B8-5551-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;59.0
TCGA-B8-5553-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;51.0
TCGA-CJ-5671-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage II;58.0
TCGA-CJ-5672-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;61.0
TCGA-CJ-5675-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage IV;60.0
TCGA-CJ-5676-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;38.0
TCGA-CJ-5677-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage II;60.0
TCGA-CJ-5678-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;59.0
TCGA-CJ-5679-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;67.0
TCGA-CJ-5680-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;40.0
TCGA-CJ-5681-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;26.0
TCGA-CJ-5682-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;29.0
TCGA-CJ-5683-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;41.0
TCGA-CJ-5684-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;37.0
TCGA-CJ-5689-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;52.0
TCGA-CW-5581-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;1:DECEASED;Stage I;55.0
TCGA-CW-5583-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage IV;59.0
TCGA-CW-5584-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;53.0
TCGA-CW-5585-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;55.0
TCGA-CW-5587-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;47.0
TCGA-CW-5588-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;67.0
TCGA-CW-5589-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage I;55.0
TCGA-CW-5590-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage III;81.0
TCGA-CW-5591-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;1:DECEASED;Stage IV;54.0
TCGA-DV-5565-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;1:DECEASED;Stage IV;55.0
TCGA-DV-5566-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;81.0
TCGA-DV-5567-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;1:DECEASED;Stage I;62.0
TCGA-DV-5568-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;76.0
TCGA-DV-5569-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;[Discrepancy];41.0
TCGA-DV-5573-01;Renal Cell Carcinoma;Male;Primary;Matched;CCRCC;0:LIVING;Stage II;68.0
TCGA-DV-5574-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;58.0
TCGA-DV-5575-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;72.0
TCGA-DV-5576-01;Renal Cell Carcinoma;Female;Primary;Matched;CCRCC;0:LIVING;Stage I;47.0
TCGA-DV-A4W0-05;Renal Cell Carcinoma;[Not Available];Primary;Matched;CCRCC;[Not Available];[Not Available];[Not Available]
TCGA-BQ-5887-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage II;53
TCGA-BQ-7044-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;71
TCGA-BQ-7045-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;0:LIVING;Stage I;71
TCGA-BQ-7046-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;1:DECEASED;Stage II;67
TCGA-BQ-7048-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage II;80
TCGA-BQ-7049-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;60
TCGA-BQ-7050-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;1:DECEASED;Stage IV;63
TCGA-BQ-7051-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;50
TCGA-BQ-7053-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;77
TCGA-BQ-7055-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;66
TCGA-BQ-7056-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;59
TCGA-BQ-7058-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;64
TCGA-BQ-7059-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage III;38
TCGA-BQ-7060-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;0:LIVING;Stage I;69
TCGA-BQ-7061-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage III;50
TCGA-BQ-7062-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;47
TCGA-DZ-6131-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;28
TCGA-DZ-6132-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;0:LIVING;Stage I;50
TCGA-DZ-6133-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;0:LIVING;Stage I;56
TCGA-DZ-6134-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;63
TCGA-DZ-6135-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;66
TCGA-G7-6789-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;57
TCGA-G7-6790-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;1:DECEASED;Stage I;74
TCGA-G7-6792-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;71
TCGA-G7-6793-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;0:LIVING;Stage I;66
TCGA-G7-6795-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage IV;58
TCGA-G7-6796-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;0:LIVING;Stage II;63
TCGA-G7-6797-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage III;81
TCGA-GL-6846-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;[Not Available];49
TCGA-HE-7128-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;[Not Available];64
TCGA-HE-7129-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;1:DECEASED;[Not Available];79
TCGA-HE-7130-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;0:LIVING;[Not Available];51
TCGA-A4-7286-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;[Not Available];75
TCGA-A4-7287-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;[Not Available];62
TCGA-A4-7288-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;1:DECEASED;[Not Available];59
TCGA-A4-7583-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;[Not Available];54
TCGA-A4-7584-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;[Not Available];64
TCGA-A4-7585-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;0:LIVING;[Not Available];51
TCGA-A4-7732-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;1:DECEASED;[Not Available];59
TCGA-A4-7734-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;[Not Available];61
TCGA-A4-7828-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;0:LIVING;[Not Available];51
TCGA-AL-7173-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;[Not Available];70
TCGA-B1-7332-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;[Not Available];53
TCGA-B9-7268-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;[Not Available];77
TCGA-DW-7834-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;[Not Available];42
TCGA-DW-7836-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;1:DECEASED;Stage I;75
TCGA-DW-7837-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;0:LIVING;[Not Available];71
TCGA-DW-7838-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;60
TCGA-DW-7839-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;59
TCGA-DW-7840-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;1:DECEASED;Stage III;67
TCGA-DW-7841-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;[Not Available];55
TCGA-DW-7842-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;0:LIVING;Stage I;53
TCGA-GL-7773-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;0:LIVING;Stage I;74
TCGA-J7-6720-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;0:LIVING;Stage II;35
TCGA-A4-7915-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;0:LIVING;Stage I;61
TCGA-A4-7996-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;67
TCGA-A4-7997-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;73
TCGA-G7-7501-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage III;58
TCGA-G7-7502-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;60
TCGA-GL-7966-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;60
TCGA-A4-8098-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;47
TCGA-A4-8310-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage III;62
TCGA-A4-8311-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;71
TCGA-A4-8312-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;48
TCGA-A4-8515-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;0:LIVING;Stage I;59
TCGA-A4-8516-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;84
TCGA-A4-8517-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;0:LIVING;Stage I;71
TCGA-A4-8518-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;1:DECEASED;Stage IV;59
TCGA-A4-8630-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;0:LIVING;Stage I;45
TCGA-B3-8121-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;0:LIVING;Stage II;65
TCGA-GL-8500-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;0:LIVING;Stage I;61
TCGA-IZ-8195-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;1:DECEASED;Stage III;75
TCGA-IZ-8196-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;66
TCGA-J7-8537-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;39
TCGA-A4-A48D-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage III;71
TCGA-B1-A47M-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;1:DECEASED;Stage IV;41
TCGA-B1-A47N-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;0:LIVING;[Not Available];54
TCGA-B1-A47O-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;1:DECEASED;Stage II;74
TCGA-B9-A44B-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;1:DECEASED;Stage I;74
TCGA-F9-A4JJ-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;[Not Available];57
TCGA-GL-A4EM-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage II;55
TCGA-IA-A40U-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;0:LIVING;Stage IV;72
TCGA-IA-A40X-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;1:DECEASED;Stage III;54
TCGA-IA-A40Y-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;77
TCGA-A4-A4ZT-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage III;73
TCGA-A4-A57E-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;0:LIVING;Stage II;60
TCGA-AL-A5DJ-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage III;79
TCGA-GL-A59R-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;62
TCGA-HE-A5NF-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;0:LIVING;Stage I;54
TCGA-HE-A5NH-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;0:LIVING;Stage I;43
TCGA-HE-A5NI-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;0:LIVING;Stage I;77
TCGA-HE-A5NJ-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;64
TCGA-HE-A5NK-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;54
TCGA-HE-A5NL-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage III;52
TCGA-MH-A55W-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;0:LIVING;Stage I;59
TCGA-MH-A55Z-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;56
TCGA-MH-A560-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage II;75
TCGA-MH-A561-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;0:LIVING;Stage I;48
TCGA-MH-A562-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;43
TCGA-A4-A5DU-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;1:DECEASED;Stage I;64
TCGA-A4-A5Y1-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;[Not Available];49
TCGA-AT-A5NU-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;53
TCGA-B9-A5W8-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;0:LIVING;[Not Available];75
TCGA-B9-A5W9-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;0:LIVING;[Not Available];48
TCGA-DW-7963-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;[Not Available];41
TCGA-GL-A59T-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage III;71
TCGA-P4-A5E6-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;[Not Available];51
TCGA-P4-A5E7-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage II;59
TCGA-P4-A5E8-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage III;70
TCGA-P4-A5EA-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;47
TCGA-P4-A5EB-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage II;50
TCGA-P4-A5ED-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;40
TCGA-PJ-A5Z8-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage III;71
TCGA-PJ-A5Z9-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;52
TCGA-Q2-A5QZ-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;79
TCGA-A4-A5XZ-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;0:LIVING;Stage III;66
TCGA-A4-A5Y0-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;75
TCGA-A4-A6HP-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;1:DECEASED;Stage IV;60
TCGA-B1-A654-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;0:LIVING;Stage III;79
TCGA-B1-A655-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;1:DECEASED;Stage III;32
TCGA-B1-A656-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;1:DECEASED;Stage III;79
TCGA-B1-A657-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;69
TCGA-B9-A5W7-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;1:DECEASED;Stage III;54
TCGA-B9-A69E-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;0:LIVING;Stage I;79
TCGA-G7-A4TM-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;0:LIVING;Stage I;59
TCGA-IZ-A6M8-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage III;63
TCGA-IZ-A6M9-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage III;75
TCGA-KV-A6GD-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage III;54
TCGA-KV-A6GE-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;0:LIVING;Stage I;74
TCGA-A4-A772-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;1:DECEASED;Stage IV;63
TCGA-B3-A6W5-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage III;69
TCGA-F9-A7VF-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;0:LIVING;Stage III;57
TCGA-KV-A74V-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;51
TCGA-O9-A75Z-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;1:DECEASED;Stage IV;61
TCGA-SX-A71R-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage IV;42
TCGA-SX-A71S-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage III;73
TCGA-SX-A71U-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;1:DECEASED;Stage I;78
TCGA-SX-A71V-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;61
TCGA-V9-A7HT-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage III;64
TCGA-A4-A7UZ-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;1:DECEASED;Stage I;45
TCGA-IA-A83S-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;0:LIVING;Stage I;53
TCGA-IA-A83T-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage II;74
TCGA-IA-A83V-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;0:LIVING;Stage III;57
TCGA-IA-A83W-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;73
TCGA-MH-A854-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;0:LIVING;Stage III;75
TCGA-MH-A855-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;1:DECEASED;Stage III;81
TCGA-MH-A856-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;71
TCGA-MH-A857-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;53
TCGA-SX-A71W-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;0:LIVING;Stage I;83
TCGA-SX-A7SL-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;64
TCGA-SX-A7SM-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;0:LIVING;Stage I;38
TCGA-SX-A7SN-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;51
TCGA-SX-A7SO-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;53
TCGA-SX-A7SP-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;55
TCGA-Y8-A898-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;43
TCGA-F9-A7Q0-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;66
TCGA-F9-A8NY-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;0:LIVING;Stage I;58
TCGA-G7-A8LB-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;60
TCGA-G7-A8LC-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;61
TCGA-G7-A8LD-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;52
TCGA-G7-A8LE-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;43
TCGA-J7-A8I2-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage III;31
TCGA-PJ-A8JU-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;69
TCGA-SX-A7SQ-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;1:DECEASED;Stage I;66
TCGA-SX-A7SR-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;69
TCGA-SX-A7SS-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;45
TCGA-SX-A7SU-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;0:LIVING;Stage I;47
TCGA-Y8-A894-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;58
TCGA-Y8-A895-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;57
TCGA-Y8-A896-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;1:DECEASED;Stage III;35
TCGA-Y8-A897-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;0:LIVING;Stage I;37
TCGA-4A-A93W-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;0:LIVING;Stage I;75
TCGA-4A-A93X-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;0:LIVING;Stage IV;38
TCGA-4A-A93Y-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage III;79
TCGA-B9-A8YH-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;1:DECEASED;Stage IV;53
TCGA-B9-A8YI-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;57
TCGA-GL-A9DC-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;40
TCGA-GL-A9DD-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;1:DECEASED;Stage IV;60
TCGA-GL-A9DE-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;56
TCGA-WN-A9G9-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;58
TCGA-Y8-A8RY-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage III;46
TCGA-Y8-A8RZ-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;1:DECEASED;Stage III;55
TCGA-Y8-A8S0-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;83
TCGA-Y8-A8S1-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;40
TCGA-2K-A9WE-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage IV;70
TCGA-2Z-A9J1-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;61
TCGA-2Z-A9J2-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;1:DECEASED;Stage III;71
TCGA-2Z-A9J3-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;62
TCGA-2Z-A9J5-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage IV;52
TCGA-2Z-A9J6-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;63
TCGA-2Z-A9J7-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;0:LIVING;Stage III;28
TCGA-F9-A97G-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;63
TCGA-UN-AAZ9-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;61
TCGA-UZ-A9PJ-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage III;79
TCGA-UZ-A9PK-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;46
TCGA-UZ-A9PL-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;0:LIVING;Stage I;66
TCGA-UZ-A9PM-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;69
TCGA-UZ-A9PN-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;74
TCGA-UZ-A9PO-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;[Not Available]
TCGA-2Z-A9J8-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage II;[Not Available]
TCGA-2Z-A9J9-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;0:LIVING;Stage III;[Not Available]
TCGA-2Z-A9JD-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;58
TCGA-2Z-A9JE-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;62
TCGA-2Z-A9JG-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;73
TCGA-2Z-A9JI-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;[Not Available];58
TCGA-2Z-A9JJ-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;[Not Available];82
TCGA-2Z-A9JK-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;51
TCGA-2Z-A9JL-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage III;56
TCGA-2Z-A9JM-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;0:LIVING;Stage I;49
TCGA-2Z-A9JN-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;0:LIVING;Stage III;60
TCGA-2Z-A9JO-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;1:DECEASED;[Discrepancy];81
TCGA-2Z-A9JP-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;1:DECEASED;[Discrepancy];80
TCGA-2Z-A9JQ-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;1:DECEASED;Stage I;63
TCGA-2Z-A9JR-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;1:DECEASED;Stage I;70
TCGA-2Z-A9JS-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage II;82
TCGA-2Z-A9JT-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;50
TCGA-5P-A9JU-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;69
TCGA-5P-A9JV-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;63
TCGA-5P-A9JW-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;42
TCGA-5P-A9JY-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;1:DECEASED;Stage III;37
TCGA-5P-A9JZ-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;75
TCGA-5P-A9K0-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;85
TCGA-5P-A9K2-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;65
TCGA-5P-A9K3-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;40
TCGA-5P-A9K4-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;50
TCGA-5P-A9K6-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;65
TCGA-5P-A9K8-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;62
TCGA-5P-A9K9-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;66
TCGA-5P-A9KA-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;57
TCGA-5P-A9KC-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;0:LIVING;Stage I;62
TCGA-5P-A9KE-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;0:LIVING;Stage II;52
TCGA-5P-A9KF-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;54
TCGA-5P-A9KH-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;63
TCGA-P4-AAVK-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;44
TCGA-P4-AAVL-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage III;67
TCGA-P4-AAVM-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;0:LIVING;Stage I;74
TCGA-P4-AAVO-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;1:DECEASED;Stage III;57
TCGA-UZ-A9PP-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;1:DECEASED;Stage III;54
TCGA-UZ-A9PQ-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;83
TCGA-UZ-A9PR-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;51
TCGA-UZ-A9PS-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage III;74
TCGA-UZ-A9PU-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;1:DECEASED;Stage III;85
TCGA-UZ-A9PV-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;69
TCGA-UZ-A9PX-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;69
TCGA-UZ-A9PZ-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;0:LIVING;Stage I;60
TCGA-UZ-A9Q0-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;0:LIVING;Stage I;80
TCGA-UZ-A9Q1-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;0:LIVING;Stage I;81
TCGA-WN-AB4C-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;0:LIVING;Stage III;61
TCGA-AL-3466-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;51
TCGA-AL-3467-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;0:LIVING;Stage I;66
TCGA-AL-3468-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;57
TCGA-AL-3471-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;80
TCGA-AL-3472-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;66
TCGA-AL-3473-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;74
TCGA-B3-3925-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;1:DECEASED;Stage IV;60
TCGA-B3-3926-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;52
TCGA-B3-4103-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;64
TCGA-B3-4104-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;1:DECEASED;Stage I;66
TCGA-B9-4113-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;48
TCGA-B9-4114-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage II;66
TCGA-B9-4115-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;67
TCGA-B9-4116-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;47
TCGA-B9-4117-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;0:LIVING;Stage I;76
TCGA-B9-4617-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;1:DECEASED;Stage I;78
TCGA-B1-5398-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;71
TCGA-B9-5155-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage II;59
TCGA-B9-5156-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage II;62
TCGA-BQ-5875-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;1:DECEASED;Stage III;54
TCGA-BQ-5876-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;80
TCGA-BQ-5877-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;60
TCGA-BQ-5878-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;1:DECEASED;Stage III;59
TCGA-BQ-5879-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;84
TCGA-BQ-5880-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;0:LIVING;Stage II;62
TCGA-BQ-5881-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;1:DECEASED;Stage I;77
TCGA-BQ-5882-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;65
TCGA-BQ-5883-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;73
TCGA-BQ-5884-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage III;65
TCGA-BQ-5885-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;60
TCGA-BQ-5886-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;0:LIVING;Stage I;88
TCGA-BQ-5888-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage II;67
TCGA-BQ-5889-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;55
TCGA-BQ-5890-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;0:LIVING;Stage I;60
TCGA-BQ-5891-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;0:LIVING;Stage I;57
TCGA-BQ-5892-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;74
TCGA-BQ-5893-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage III;62
TCGA-BQ-5894-01;Renal Cell Carcinoma;Female;Primary;Matched;PRCC;0:LIVING;Stage I;68
TCGA-DW-5560-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;69
TCGA-DW-5561-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;63
TCGA-EV-5901-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;55
TCGA-EV-5902-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;58
TCGA-EV-5903-01;Renal Cell Carcinoma;Male;Primary;Matched;PRCC;0:LIVING;Stage I;61
TCGA-2Z-A9JC-01;Renal Cell Carcinoma;[Not Available];Primary;Matched;PRCC;[Not Available];[Not Available];[Not Available]
TCGA-UZ-A9PS-05;Renal Cell Carcinoma;[Not Available];Primary;Matched;PRCC;[Not Available];[Not Available];[Not Available]
TCGA-AB-2802-03;Leukemia;Male;Primary;Matched;AML;1:DECEASED;[Not Available];50
TCGA-AB-2803-03;Leukemia;Female;Primary;Matched;AML;1:DECEASED;[Not Available];61
TCGA-AB-2804-03;Leukemia;Male;Primary;Matched;AML;0:LIVING;[Not Available];30
TCGA-AB-2805-03;Leukemia;Male;Primary;Matched;AML;1:DECEASED;[Not Available];77
TCGA-AB-2806-03;Leukemia;Male;Primary;Matched;AML;1:DECEASED;[Not Available];46
TCGA-AB-2807-03;Leukemia;Female;Primary;Matched;AML;1:DECEASED;[Not Available];68
TCGA-AB-2808-03;Leukemia;Male;Primary;Matched;AML;0:LIVING;[Not Available];23
TCGA-AB-2809-03;Leukemia;Female;Primary;Matched;AML;1:DECEASED;[Not Available];64
TCGA-AB-2810-03;Leukemia;Female;Primary;Matched;AML;1:DECEASED;[Not Available];76
TCGA-AB-2811-03;Leukemia;Male;Primary;Matched;AML;1:DECEASED;[Not Available];81
TCGA-AB-2812-03;Leukemia;Female;Primary;Matched;AML;1:DECEASED;[Not Available];25
TCGA-AB-2813-03;Leukemia;Male;Primary;Matched;AML;1:DECEASED;[Not Available];78
TCGA-AB-2814-03;Leukemia;Female;Primary;Matched;AML;1:DECEASED;[Not Available];39
TCGA-AB-2815-03;Leukemia;Male;Primary;Matched;AML;1:DECEASED;[Not Available];49
TCGA-AB-2816-03;Leukemia;Female;Primary;Matched;AML;1:DECEASED;[Not Available];57
TCGA-AB-2817-03;Leukemia;Male;Primary;Matched;AML;1:DECEASED;[Not Available];64
TCGA-AB-2818-03;Leukemia;Female;Primary;Matched;AML;1:DECEASED;[Not Available];62
TCGA-AB-2819-03;Leukemia;Female;Primary;Matched;AML;0:LIVING;[Not Available];52
TCGA-AB-2820-03;Leukemia;Male;Primary;Matched;AML;1:DECEASED;[Not Available];76
TCGA-AB-2821-03;Leukemia;Male;Primary;Matched;AML;1:DECEASED;[Not Available];64
TCGA-AB-2822-03;Leukemia;Male;Primary;Matched;AML;1:DECEASED;[Not Available];65
TCGA-AB-2823-03;Leukemia;Female;Primary;Matched;AML;1:DECEASED;[Not Available];61
TCGA-AB-2824-03;Leukemia;Male;Primary;Matched;AML;1:DECEASED;[Not Available];45
TCGA-AB-2825-03;Leukemia;Female;Primary;Matched;AML;1:DECEASED;[Not Available];31
TCGA-AB-2826-03;Leukemia;Female;Primary;Matched;AML;1:DECEASED;[Not Available];64
TCGA-AB-2827-03;Leukemia;Male;Primary;Matched;AML;1:DECEASED;[Not Available];33
TCGA-AB-2828-03;Leukemia;Male;Primary;Matched;AML;0:LIVING;[Not Available];55
TCGA-AB-2829-03;Leukemia;Male;Primary;Matched;AML;1:DECEASED;[Not Available];50
TCGA-AB-2830-03;Leukemia;Female;Primary;Matched;AML;1:DECEASED;[Not Available];64
TCGA-AB-2831-03;Leukemia;Male;Primary;Matched;AML;1:DECEASED;[Not Available];59
TCGA-AB-2832-03;Leukemia;Female;Primary;Matched;AML;1:DECEASED;[Not Available];60
TCGA-AB-2833-03;Leukemia;Male;Primary;Matched;AML;1:DECEASED;[Not Available];77
TCGA-AB-2834-03;Leukemia;Male;Primary;Matched;AML;1:DECEASED;[Not Available];33
TCGA-AB-2835-03;Leukemia;Male;Primary;Matched;AML;0:LIVING;[Not Available];48
TCGA-AB-2836-03;Leukemia;Male;Primary;Matched;AML;1:DECEASED;[Not Available];35
TCGA-AB-2837-03;Leukemia;Female;Primary;Matched;AML;1:DECEASED;[Not Available];66
TCGA-AB-2838-03;Leukemia;Male;Primary;Matched;AML;1:DECEASED;[Not Available];67
TCGA-AB-2839-03;Leukemia;Female;Primary;Matched;AML;1:DECEASED;[Not Available];51
TCGA-AB-2840-03;Leukemia;Male;Primary;Matched;AML;1:DECEASED;[Not Available];74
TCGA-AB-2841-03;Leukemia;Female;Primary;Matched;AML;1:DECEASED;[Not Available];51
TCGA-AB-2842-03;Leukemia;Male;Primary;Matched;AML;1:DECEASED;[Not Available];65
TCGA-AB-2843-03;Leukemia;Male;Primary;Matched;AML;1:DECEASED;[Not Available];77
TCGA-AB-2844-03;Leukemia;Male;Primary;Matched;AML;1:DECEASED;[Not Available];63
TCGA-AB-2845-03;Leukemia;Female;Primary;Matched;AML;1:DECEASED;[Not Available];37
TCGA-AB-2846-03;Leukemia;Female;Primary;Matched;AML;1:DECEASED;[Not Available];57
TCGA-AB-2847-03;Leukemia;Male;Primary;Matched;AML;1:DECEASED;[Not Available];53
TCGA-AB-2848-03;Leukemia;Male;Primary;Matched;AML;1:DECEASED;[Not Available];62
TCGA-AB-2849-03;Leukemia;Male;Primary;Matched;AML;0:LIVING;[Not Available];39
TCGA-AB-2850-03;Leukemia;Female;Primary;Matched;AML;1:DECEASED;[Not Available];72
TCGA-AB-2851-03;Leukemia;Female;Primary;Matched;AML;1:DECEASED;[Not Available];66
TCGA-AB-2853-03;Leukemia;Male;Primary;Matched;AML;1:DECEASED;[Not Available];51
TCGA-AB-2854-03;Leukemia;Female;Primary;Matched;AML;1:DECEASED;[Not Available];51
TCGA-AB-2855-03;Leukemia;Male;Primary;Matched;AML;1:DECEASED;[Not Available];18
TCGA-AB-2856-03;Leukemia;Male;Primary;Matched;AML;1:DECEASED;[Not Available];63
TCGA-AB-2857-03;Leukemia;Male;Primary;Matched;AML;1:DECEASED;[Not Available];54
TCGA-AB-2858-03;Leukemia;Female;Primary;Matched;AML;1:DECEASED;[Not Available];75
TCGA-AB-2859-03;Leukemia;Male;Primary;Matched;AML;1:DECEASED;[Not Available];40
TCGA-AB-2860-03;Leukemia;Female;Primary;Matched;AML;1:DECEASED;[Not Available];60
TCGA-AB-2861-03;Leukemia;Male;Primary;Matched;AML;1:DECEASED;[Not Available];76
TCGA-AB-2862-03;Leukemia;Female;Primary;Matched;AML;0:LIVING;[Not Available];33
TCGA-AB-2863-03;Leukemia;Male;Primary;Matched;AML;1:DECEASED;[Not Available];63
TCGA-AB-2864-03;Leukemia;Female;Primary;Matched;AML;1:DECEASED;[Not Available];54
TCGA-AB-2865-03;Leukemia;Male;Primary;Matched;AML;1:DECEASED;[Not Available];75
TCGA-AB-2866-03;Leukemia;Male;Primary;Matched;AML;1:DECEASED;[Not Available];67
TCGA-AB-2867-03;Leukemia;Female;Primary;Matched;AML;1:DECEASED;[Not Available];66
TCGA-AB-2868-03;Leukemia;Male;Primary;Matched;AML;1:DECEASED;[Not Available];77
TCGA-AB-2869-03;Leukemia;Female;Primary;Matched;AML;0:LIVING;[Not Available];64
TCGA-AB-2870-03;Leukemia;Male;Primary;Matched;AML;1:DECEASED;[Not Available];76
TCGA-AB-2871-03;Leukemia;Male;Primary;Matched;AML;0:LIVING;[Not Available];51
TCGA-AB-2872-03;Leukemia;Male;Primary;Matched;AML;0:LIVING;[Not Available];42
TCGA-AB-2873-03;Leukemia;Female;Primary;Matched;AML;0:LIVING;[Not Available];51
TCGA-AB-2874-03;Leukemia;Male;Primary;Matched;AML;0:LIVING;[Not Available];59
TCGA-AB-2875-03;Leukemia;Male;Primary;Matched;AML;0:LIVING;[Not Available];43
TCGA-AB-2876-03;Leukemia;Female;Primary;Matched;AML;0:LIVING;[Not Available];45
TCGA-AB-2877-03;Leukemia;Female;Primary;Matched;AML;0:LIVING;[Not Available];60
TCGA-AB-2878-03;Leukemia;Female;Primary;Matched;AML;1:DECEASED;[Not Available];47
TCGA-AB-2879-03;Leukemia;Female;Primary;Matched;AML;0:LIVING;[Not Available];68
TCGA-AB-2880-03;Leukemia;Male;Primary;Matched;AML;1:DECEASED;[Not Available];24
TCGA-AB-2881-03;Leukemia;Female;Primary;Matched;AML;0:LIVING;[Not Available];48
TCGA-AB-2882-03;Leukemia;Female;Primary;Matched;AML;1:DECEASED;[Not Available];73
TCGA-AB-2883-03;Leukemia;Male;Primary;Matched;AML;0:LIVING;[Not Available];60
TCGA-AB-2884-03;Leukemia;Female;Primary;Matched;AML;1:DECEASED;[Not Available];44
TCGA-AB-2885-03;Leukemia;Male;Primary;Matched;AML;1:DECEASED;[Not Available];71
TCGA-AB-2886-03;Leukemia;Male;Primary;Matched;AML;0:LIVING;[Not Available];26
TCGA-AB-2887-03;Leukemia;Female;Primary;Matched;AML;1:DECEASED;[Not Available];60
TCGA-AB-2888-03;Leukemia;Male;Primary;Matched;AML;0:LIVING;[Not Available];57
TCGA-AB-2889-03;Leukemia;Male;Primary;Matched;AML;0:LIVING;[Not Available];55
TCGA-AB-2890-03;Leukemia;Male;Primary;Matched;AML;1:DECEASED;[Not Available];69
TCGA-AB-2891-03;Leukemia;Male;Primary;Matched;AML;1:DECEASED;[Not Available];42
TCGA-AB-2892-03;Leukemia;Female;Primary;Matched;AML;0:LIVING;[Not Available];42
TCGA-AB-2893-03;Leukemia;Male;Primary;Matched;AML;1:DECEASED;[Not Available];45
TCGA-AB-2894-03;Leukemia;Female;Primary;Matched;AML;1:DECEASED;[Not Available];50
TCGA-AB-2895-03;Leukemia;Female;Primary;Matched;AML;1:DECEASED;[Not Available];41
TCGA-AB-2896-03;Leukemia;Female;Primary;Matched;AML;1:DECEASED;[Not Available];21
TCGA-AB-2897-03;Leukemia;Female;Primary;Matched;AML;0:LIVING;[Not Available];50
TCGA-AB-2898-03;Leukemia;Female;Primary;Matched;AML;0:LIVING;[Not Available];69
TCGA-AB-2899-03;Leukemia;Female;Primary;Matched;AML;1:DECEASED;[Not Available];76
TCGA-AB-2900-03;Leukemia;Male;Primary;Matched;AML;1:DECEASED;[Not Available];70
TCGA-AB-2901-03;Leukemia;Male;Primary;Matched;AML;0:LIVING;[Not Available];27
TCGA-AB-2903-03;Leukemia;Female;Primary;Matched;AML;1:DECEASED;[Not Available];76
TCGA-AB-2904-03;Leukemia;Male;Primary;Matched;AML;1:DECEASED;[Not Available];65
TCGA-AB-2905-03;Leukemia;Male;Primary;Matched;AML;0:LIVING;[Not Available];48
TCGA-AB-2906-03;Leukemia;Male;Primary;Matched;AML;0:LIVING;[Not Available];59
TCGA-AB-2907-03;Leukemia;Male;Primary;Matched;AML;1:DECEASED;[Not Available];69
TCGA-AB-2908-03;Leukemia;Male;Primary;Matched;AML;1:DECEASED;[Not Available];81
TCGA-AB-2909-03;Leukemia;Male;Primary;Matched;AML;0:LIVING;[Not Available];22
TCGA-AB-2910-03;Leukemia;Female;Primary;Matched;AML;1:DECEASED;[Not Available];61
TCGA-AB-2911-03;Leukemia;Female;Primary;Matched;AML;0:LIVING;[Not Available];51
TCGA-AB-2912-03;Leukemia;Male;Primary;Matched;AML;1:DECEASED;[Not Available];63
TCGA-AB-2913-03;Leukemia;Male;Primary;Matched;AML;0:LIVING;[Not Available];61
TCGA-AB-2914-03;Leukemia;Female;Primary;Matched;AML;0:LIVING;[Not Available];22
TCGA-AB-2915-03;Leukemia;Female;Primary;Matched;AML;1:DECEASED;[Not Available];73
TCGA-AB-2916-03;Leukemia;Female;Primary;Matched;AML;0:LIVING;[Not Available];48
TCGA-AB-2917-03;Leukemia;Female;Primary;Matched;AML;0:LIVING;[Not Available];41
TCGA-AB-2918-03;Leukemia;Female;Primary;Matched;AML;1:DECEASED;[Not Available];47
TCGA-AB-2919-03;Leukemia;Female;Primary;Matched;AML;0:LIVING;[Not Available];54
TCGA-AB-2920-03;Leukemia;Male;Primary;Matched;AML;1:DECEASED;[Not Available];44
TCGA-AB-2921-03;Leukemia;Female;Primary;Matched;AML;1:DECEASED;[Not Available];56
TCGA-AB-2922-03;Leukemia;Male;Primary;Matched;AML;1:DECEASED;[Not Available];83
TCGA-AB-2923-03;Leukemia;Male;Primary;Matched;AML;1:DECEASED;[Not Available];78
TCGA-AB-2924-03;Leukemia;Male;Primary;Matched;AML;0:LIVING;[Not Available];59
TCGA-AB-2925-03;Leukemia;Male;Primary;Matched;AML;1:DECEASED;[Not Available];57
TCGA-AB-2926-03;Leukemia;Female;Primary;Matched;AML;1:DECEASED;[Not Available];57
TCGA-AB-2927-03;Leukemia;Female;Primary;Matched;AML;1:DECEASED;[Not Available];88
TCGA-AB-2928-03;Leukemia;Female;Primary;Matched;AML;1:DECEASED;[Not Available];43
TCGA-AB-2929-03;Leukemia;Female;Primary;Matched;AML;1:DECEASED;[Not Available];71
TCGA-AB-2930-03;Leukemia;Female;Primary;Matched;AML;1:DECEASED;[Not Available];63
TCGA-AB-2931-03;Leukemia;Male;Primary;Matched;AML;1:DECEASED;[Not Available];75
TCGA-AB-2932-03;Leukemia;Male;Primary;Matched;AML;0:LIVING;[Not Available];62
TCGA-AB-2933-03;Leukemia;Male;Primary;Matched;AML;1:DECEASED;[Not Available];58
TCGA-AB-2934-03;Leukemia;Male;Primary;Matched;AML;0:LIVING;[Not Available];65
TCGA-AB-2935-03;Leukemia;Male;Primary;Matched;AML;1:DECEASED;[Not Available];66
TCGA-AB-2936-03;Leukemia;Female;Primary;Matched;AML;0:LIVING;[Not Available];61
TCGA-AB-2937-03;Leukemia;Female;Primary;Matched;AML;1:DECEASED;[Not Available];36
TCGA-AB-2938-03;Leukemia;Male;Primary;Matched;AML;1:DECEASED;[Not Available];76
TCGA-AB-2939-03;Leukemia;Male;Primary;Matched;AML;0:LIVING;[Not Available];72
TCGA-AB-2940-03;Leukemia;Male;Primary;Matched;AML;1:DECEASED;[Not Available];35
TCGA-AB-2941-03;Leukemia;Male;Primary;Matched;AML;1:DECEASED;[Not Available];73
TCGA-AB-2942-03;Leukemia;Female;Primary;Matched;AML;0:LIVING;[Not Available];67
TCGA-AB-2943-03;Leukemia;Female;Primary;Matched;AML;1:DECEASED;[Not Available];70
TCGA-AB-2944-03;Leukemia;Male;Primary;Matched;AML;1:DECEASED;[Not Available];48
TCGA-AB-2945-03;Leukemia;Female;Primary;Matched;AML;1:DECEASED;[Not Available];65
TCGA-AB-2946-03;Leukemia;Male;Primary;Matched;AML;0:LIVING;[Not Available];41
TCGA-AB-2947-03;Leukemia;Male;Primary;Matched;AML;0:LIVING;[Not Available];52
TCGA-AB-2948-03;Leukemia;Male;Primary;Matched;AML;1:DECEASED;[Not Available];67
TCGA-AB-2949-03;Leukemia;Male;Primary;Matched;AML;0:LIVING;[Not Available];58
TCGA-AB-2950-03;Leukemia;Female;Primary;Matched;AML;0:LIVING;[Not Available];34
TCGA-AB-2952-03;Leukemia;Female;Primary;Matched;AML;1:DECEASED;[Not Available];60
TCGA-AB-2954-03;Leukemia;Female;Primary;Matched;AML;0:LIVING;[Not Available];55
TCGA-AB-2955-03;Leukemia;Female;Primary;Matched;AML;1:DECEASED;[Not Available];56
TCGA-AB-2956-03;Leukemia;Male;Primary;Matched;AML;1:DECEASED;[Not Available];61
TCGA-AB-2957-03;Leukemia;Male;Primary;Matched;AML;0:LIVING;[Not Available];31
TCGA-AB-2959-03;Leukemia;Male;Primary;Matched;AML;1:DECEASED;[Not Available];71
TCGA-AB-2963-03;Leukemia;Male;Primary;Matched;AML;1:DECEASED;[Not Available];56
TCGA-AB-2964-03;Leukemia;Female;Primary;Matched;AML;0:LIVING;[Not Available];58
TCGA-AB-2965-03;Leukemia;Male;Primary;Matched;AML;1:DECEASED;[Not Available];60
TCGA-AB-2966-03;Leukemia;Female;Primary;Matched;AML;1:DECEASED;[Not Available];57
TCGA-AB-2967-03;Leukemia;Male;Primary;Matched;AML;0:LIVING;[Not Available];58
TCGA-AB-2968-03;Leukemia;Male;Primary;Matched;AML;1:DECEASED;[Not Available];79
TCGA-AB-2969-03;Leukemia;Male;Primary;Matched;AML;0:LIVING;[Not Available];55
TCGA-AB-2970-03;Leukemia;Female;Primary;Matched;AML;1:DECEASED;[Not Available];34
TCGA-AB-2971-03;Leukemia;Female;Primary;Matched;AML;1:DECEASED;[Not Available];76
TCGA-AB-2972-03;Leukemia;Female;Primary;Matched;AML;1:DECEASED;[Not Available];82
TCGA-AB-2973-03;Leukemia;Female;Primary;Matched;AML;1:DECEASED;[Not Available];68
TCGA-AB-2974-03;Leukemia;Female;Primary;Matched;AML;1:DECEASED;[Not Available];67
TCGA-AB-2975-03;Leukemia;Male;Primary;Matched;AML;1:DECEASED;[Not Available];54
TCGA-AB-2976-03;Leukemia;Male;Primary;Matched;AML;1:DECEASED;[Not Available];53
TCGA-AB-2977-03;Leukemia;Female;Primary;Matched;AML;1:DECEASED;[Not Available];71
TCGA-AB-2978-03;Leukemia;Female;Primary;Matched;AML;0:LIVING;[Not Available];61
TCGA-AB-2979-03;Leukemia;Female;Primary;Matched;AML;0:LIVING;[Not Available];30
TCGA-AB-2980-03;Leukemia;Male;Primary;Matched;AML;0:LIVING;[Not Available];50
TCGA-AB-2981-03;Leukemia;Female;Primary;Matched;AML;0:LIVING;[Not Available];35
TCGA-AB-2982-03;Leukemia;Female;Primary;Matched;AML;0:LIVING;[Not Available];29
TCGA-AB-2983-03;Leukemia;Male;Primary;Matched;AML;1:DECEASED;[Not Available];45
TCGA-AB-2984-03;Leukemia;Male;Primary;Matched;AML;0:LIVING;[Not Available];38
TCGA-AB-2985-03;Leukemia;Female;Primary;Matched;AML;1:DECEASED;[Not Available];81
TCGA-AB-2986-03;Leukemia;Female;Primary;Matched;AML;1:DECEASED;[Not Available];31
TCGA-AB-2987-03;Leukemia;Female;Primary;Matched;AML;1:DECEASED;[Not Available];75
TCGA-AB-2988-03;Leukemia;Female;Primary;Matched;AML;1:DECEASED;[Not Available];67
TCGA-AB-2989-03;Leukemia;Male;Primary;Matched;AML;1:DECEASED;[Not Available];29
TCGA-AB-2990-03;Leukemia;Male;Primary;Matched;AML;0:LIVING;[Not Available];51
TCGA-AB-2991-03;Leukemia;Female;Primary;Matched;AML;0:LIVING;[Not Available];40
TCGA-AB-2992-03;Leukemia;Female;Primary;Matched;AML;1:DECEASED;[Not Available];32
TCGA-AB-2993-03;Leukemia;Female;Primary;Matched;AML;1:DECEASED;[Not Available];57
TCGA-AB-2994-03;Leukemia;Male;Primary;Matched;AML;0:LIVING;[Not Available];25
TCGA-AB-2995-03;Leukemia;Male;Primary;Matched;AML;0:LIVING;[Not Available];63
TCGA-AB-2996-03;Leukemia;Male;Primary;Matched;AML;0:LIVING;[Not Available];74
TCGA-AB-2997-03;Leukemia;Female;Primary;Matched;AML;1:DECEASED;[Not Available];25
TCGA-AB-2998-03;Leukemia;Female;Primary;Matched;AML;1:DECEASED;[Not Available];68
TCGA-AB-2999-03;Leukemia;Male;Primary;Matched;AML;0:LIVING;[Not Available];62
TCGA-AB-3000-03;Leukemia;Male;Primary;Matched;AML;0:LIVING;[Not Available];25
TCGA-AB-3001-03;Leukemia;Female;Primary;Matched;AML;0:LIVING;[Not Available];31
TCGA-AB-3002-03;Leukemia;Male;Primary;Matched;AML;1:DECEASED;[Not Available];68
TCGA-AB-3005-03;Leukemia;Male;Primary;Matched;AML;0:LIVING;[Not Available];45
TCGA-AB-3006-03;Leukemia;Male;Primary;Matched;AML;1:DECEASED;[Not Available];61
TCGA-AB-3007-03;Leukemia;Male;Primary;Matched;AML;0:LIVING;[Not Available];35
TCGA-AB-3008-03;Leukemia;Male;Primary;Matched;AML;1:DECEASED;[Not Available];22
TCGA-AB-3009-03;Leukemia;Male;Primary;Matched;AML;1:DECEASED;[Not Available];23
TCGA-AB-3011-03;Leukemia;Female;Primary;Matched;AML;0:LIVING;[Not Available];21
TCGA-AB-3012-03;Leukemia;Male;Primary;Matched;AML;0:LIVING;[Not Available];53
TCGA-CS-6290-01;Glioma;Female;Primary;Matched;AASTR;0:LIVING;[Not Available];31.0
TCGA-DU-5847-01;Glioma;Male;Primary;Matched;AASTR;1:DECEASED;[Not Available];67.0
TCGA-DU-5849-01;Glioma;Female;Primary;Matched;ODG;1:DECEASED;[Not Available];44.0
TCGA-DU-5852-01;Glioma;Male;Primary;Matched;OAST;1:DECEASED;[Not Available];37.0
TCGA-DU-5854-01;Glioma;Male;Primary;Matched;AASTR;0:LIVING;[Not Available];50.0
TCGA-DU-5855-01;Glioma;Female;Primary;Matched;OAST;1:DECEASED;[Not Available];47.0
TCGA-DU-5870-01;Glioma;Male;Primary;Matched;ODG;0:LIVING;[Not Available];39.0
TCGA-DU-5870-02;Glioma;Male;Recurrence;Matched;ODG;0:LIVING;[Not Available];40.0
TCGA-DU-5871-01;Glioma;Male;Primary;Matched;OAST;1:DECEASED;[Not Available];43.0
TCGA-DU-5872-01;Glioma;Female;Primary;Matched;OAST;0:LIVING;[Not Available];53.0
TCGA-DU-5872-02;Glioma;Female;Recurrence;Matched;OAST;1:DECEASED;[Not Available];54.0
TCGA-DU-5874-01;Glioma;Male;Primary;Matched;ODG;1:DECEASED;[Not Available];58.0
TCGA-DU-6392-01;Glioma;Male;Primary;Matched;AASTR;1:DECEASED;[Not Available];48.0
TCGA-DU-6393-01;Glioma;Male;Primary;Matched;AOAST;1:DECEASED;[Not Available];31.0
TCGA-DU-6394-01;Glioma;Female;Primary;Matched;AOAST;0:LIVING;[Not Available];51.0
TCGA-DU-6395-01;Glioma;Male;Primary;Matched;OAST;0:LIVING;[Not Available];22.0
TCGA-DU-6396-01;Glioma;Female;Primary;Matched;OAST;0:LIVING;[Not Available];39.0
TCGA-DU-6397-01;Glioma;Female;Primary;Matched;AOAST;0:LIVING;[Not Available];57.0
TCGA-DU-6397-02;Glioma;Female;Recurrence;Matched;ODG;0:LIVING;[Not Available];26.0
TCGA-DU-6399-01;Glioma;Male;Primary;Matched;ODG;0:LIVING;[Not Available];43.0
TCGA-DU-6400-01;Glioma;Female;Primary;Matched;ODG;0:LIVING;[Not Available];38.0
TCGA-DU-6401-01;Glioma;Male;Primary;Matched;ODG;0:LIVING;[Not Available];33.0
TCGA-DU-6402-01;Glioma;Female;Primary;Matched;AASTR;0:LIVING;[Not Available];37.0
TCGA-DU-6403-01;Glioma;Male;Primary;Matched;OAST;0:LIVING;[Not Available];36.0
TCGA-DU-6404-01;Glioma;Male;Primary;Matched;AOAST;0:LIVING;[Not Available];32.0
TCGA-DU-6404-02;Glioma;Male;Recurrence;Matched;ODG;1:DECEASED;[Not Available];34.0
TCGA-DU-6405-01;Glioma;Male;Primary;Matched;AASTR;0:LIVING;[Not Available];17.0
TCGA-DU-6406-01;Glioma;Male;Primary;Matched;OAST;0:LIVING;[Not Available];59.0
TCGA-DU-6407-01;Glioma;Male;Primary;Matched;ODG;0:LIVING;[Not Available];43.0
TCGA-DU-6407-02;Glioma;Male;Recurrence;Matched;ODG;0:LIVING;[Not Available];61.0
TCGA-DU-6408-01;Glioma;Female;Primary;Matched;AOAST;0:LIVING;[Not Available];33.0
TCGA-FG-5963-01;Glioma;Male;Primary;Matched;AASTR;0:LIVING;[Not Available];30.0
TCGA-FG-5963-02;Glioma;Male;Recurrence;Matched;ASTR;0:LIVING;[Not Available];38.0
TCGA-FG-5964-01;Glioma;Male;Primary;Matched;ODG;0:LIVING;[Not Available];26.0
TCGA-CS-4938-01;Glioma;Male;Primary;Matched;ASTR;0:LIVING;[Not Available];32.0
TCGA-CS-5397-01;Glioma;Female;Primary;Matched;AASTR;0:LIVING;[Not Available];27.0
TCGA-CS-6188-01;Glioma;Female;Primary;Matched;AASTR;0:LIVING;[Not Available];41.0
TCGA-CS-6665-01;Glioma;Male;Primary;Matched;AASTR;0:LIVING;[Not Available];34.0
TCGA-CS-6666-01;Glioma;Female;Primary;Matched;AASTR;0:LIVING;[Not Available];53.0
TCGA-CS-6668-01;Glioma;Female;Primary;Matched;ODG;0:LIVING;[Not Available];67.0
TCGA-CS-6669-01;Glioma;Male;Primary;Matched;ODG;1:DECEASED;[Not Available];59.0
TCGA-CS-6670-01;Glioma;Male;Primary;Matched;AOAST;0:LIVING;[Not Available];40.0
TCGA-DU-5851-01;Glioma;Female;Primary;Matched;OAST;0:LIVING;[Not Available];31.0
TCGA-DU-5853-01;Glioma;Female;Primary;Matched;OAST;0:LIVING;[Not Available];24.0
TCGA-DU-6410-01;Glioma;Male;Primary;Matched;AOAST;0:LIVING;[Not Available];20.0
TCGA-DU-6542-01;Glioma;Female;Primary;Matched;OAST;0:LIVING;[Not Available];38.0
TCGA-E1-5305-01;Glioma;Male;Primary;Matched;AASTR;0:LIVING;[Not Available];54.0
TCGA-E1-5307-01;Glioma;Female;Primary;Matched;AASTR;1:DECEASED;[Not Available];65.0
TCGA-E1-5319-01;Glioma;Female;Primary;Matched;ODG;0:LIVING;[Not Available];56.0
TCGA-FG-5962-01;Glioma;Female;Primary;Matched;AOAST;0:LIVING;[Not Available];55.0
TCGA-FG-5965-01;Glioma;Female;Primary;Matched;OAST;0:LIVING;[Not Available];36.0
TCGA-FG-5965-02;Glioma;Male;Recurrence;Matched;OAST;0:LIVING;[Not Available];47.0
TCGA-FG-6688-01;Glioma;Male;Primary;Matched;AASTR;0:LIVING;[Not Available];29.0
TCGA-FG-6689-01;Glioma;Female;Primary;Matched;ASTR;0:LIVING;[Not Available];25.0
TCGA-FG-6690-01;Glioma;Female;Primary;Matched;ODG;1:DECEASED;[Not Available];38.0
TCGA-FG-6691-01;Glioma;Male;Primary;Matched;ASTR;0:LIVING;[Not Available];32.0
TCGA-FG-6692-01;Glioma;Male;Primary;Matched;AOAST;0:LIVING;[Not Available];29.0
TCGA-CS-6186-01;Glioma;Male;Primary;Matched;OAST;0:LIVING;[Not Available];30.0
TCGA-CS-6667-01;Glioma;Female;Primary;Matched;ASTR;0:LIVING;[Not Available];56.0
TCGA-DU-7006-01;Glioma;Male;Primary;Matched;AASTR;1:DECEASED;[Not Available];70.0
TCGA-DU-7007-01;Glioma;Male;Primary;Matched;ASTR;0:LIVING;[Not Available];52.0
TCGA-DU-7008-01;Glioma;Female;Primary;Matched;ODG;0:LIVING;[Not Available];43.0
TCGA-DU-7009-01;Glioma;Male;Primary;Matched;ODG;0:LIVING;[Not Available];49.0
TCGA-DU-7010-01;Glioma;Female;Primary;Matched;AASTR;0:LIVING;[Not Available];49.0
TCGA-DU-7011-01;Glioma;Female;Primary;Matched;OAST;0:LIVING;[Not Available];59.0
TCGA-DU-7012-01;Glioma;Male;Primary;Matched;AASTR;0:LIVING;[Not Available];50.0
TCGA-DU-7013-01;Glioma;Male;Primary;Matched;AASTR;1:DECEASED;[Not Available];30.0
TCGA-DU-7014-01;Glioma;Male;Primary;Matched;ODG;0:LIVING;[Not Available];43.0
TCGA-DU-7015-01;Glioma;Male;Primary;Matched;ODG;0:LIVING;[Not Available];49.0
TCGA-DU-7018-01;Glioma;Female;Primary;Matched;AOAST;0:LIVING;[Not Available];34.0
TCGA-DU-7019-01;Glioma;Male;Primary;Matched;OAST;0:LIVING;[Not Available];48.0
TCGA-DU-7290-01;Glioma;Female;Primary;Matched;AASTR;0:LIVING;[Not Available];40.0
TCGA-DU-7292-01;Glioma;Female;Primary;Matched;AASTR;1:DECEASED;[Not Available];61.0
TCGA-DU-7294-01;Glioma;Male;Primary;Matched;ODG;0:LIVING;[Not Available];29.0
TCGA-DU-7298-01;Glioma;Female;Primary;Matched;AASTR;0:LIVING;[Not Available];57.0
TCGA-DU-7299-01;Glioma;Female;Primary;Matched;AASTR;0:LIVING;[Not Available];49.0
TCGA-EZ-7264-01;Glioma;Female;Primary;Matched;ODG;0:LIVING;[Not Available];34.0
TCGA-HT-7467-01;Glioma;Female;Primary;Matched;ODG;0:LIVING;[Not Available];37.0
TCGA-HT-7468-01;Glioma;Female;Primary;Matched;AOAST;0:LIVING;[Not Available];43.0
TCGA-HT-7472-01;Glioma;Female;Primary;Matched;ODG;0:LIVING;[Not Available];62.0
TCGA-HT-7473-01;Glioma;Female;Primary;Matched;OAST;0:LIVING;[Not Available];35.0
TCGA-HT-7474-01;Glioma;Male;Primary;Matched;OAST;1:DECEASED;[Not Available];66.0
TCGA-HT-7475-01;Glioma;Male;Primary;Matched;OAST;1:DECEASED;[Not Available];53.0
TCGA-HT-7476-01;Glioma;Male;Primary;Matched;ASTR;1:DECEASED;[Not Available];31.0
TCGA-HT-7478-01;Glioma;Female;Primary;Matched;ASTR;1:DECEASED;[Not Available];31.0
TCGA-HT-7479-01;Glioma;Male;Primary;Matched;AASTR;1:DECEASED;[Not Available];45.0
TCGA-HT-7481-01;Glioma;Male;Primary;Matched;ODG;1:DECEASED;[Not Available];54.0
TCGA-HT-7482-01;Glioma;Female;Primary;Matched;OAST;1:DECEASED;[Not Available];66.0
TCGA-HT-7483-01;Glioma;Female;Primary;Matched;OAST;1:DECEASED;[Not Available];31.0
TCGA-HT-7485-01;Glioma;Male;Primary;Matched;ASTR;1:DECEASED;[Not Available];52.0
TCGA-HW-7486-01;Glioma;Female;Primary;Matched;ODG;1:DECEASED;[Not Available];60.0
TCGA-HW-7487-01;Glioma;Female;Primary;Matched;ODG;1:DECEASED;[Not Available];24.0
TCGA-HW-7489-01;Glioma;Female;Primary;Matched;OAST;1:DECEASED;[Not Available];51.0
TCGA-HW-7490-01;Glioma;Female;Primary;Matched;ASTR;1:DECEASED;[Not Available];59.0
TCGA-HW-7491-01;Glioma;Female;Primary;Matched;ODG;1:DECEASED;[Not Available];35.0
TCGA-HW-7493-01;Glioma;Female;Primary;Matched;ASTR;1:DECEASED;[Not Available];23.0
TCGA-HW-7495-01;Glioma;Male;Primary;Matched;ODG;0:LIVING;[Not Available];56.0
TCGA-DU-7300-01;Glioma;Male;Primary;Matched;AOAST;0:LIVING;[Not Available];25.0
TCGA-DU-7301-01;Glioma;Female;Primary;Matched;ODG;1:DECEASED;[Not Available];60.0
TCGA-DU-7302-01;Glioma;Male;Primary;Matched;AOAST;1:DECEASED;[Not Available];33.0
TCGA-DU-7304-01;Glioma;Female;Primary;Matched;OAST;0:LIVING;[Not Available];41.0
TCGA-DU-7304-02;Glioma;Female;Recurrence;Matched;OAST;1:DECEASED;[Not Available];32.0
TCGA-DU-7306-01;Glioma;Female;Primary;Matched;OAST;1:DECEASED;[Not Available];58.0
TCGA-DU-7309-01;Glioma;Male;Primary;Matched;AOAST;1:DECEASED;[Not Available];25.0
TCGA-FG-7634-01;Glioma;Female;Primary;Matched;ODG;1:DECEASED;[Not Available];74.0
TCGA-FG-7636-01;Glioma;Male;Primary;Matched;AASTR;1:DECEASED;[Not Available];59.0
TCGA-FG-7637-01;Glioma;Male;Primary;Matched;OAST;1:DECEASED;[Not Available];59.0
TCGA-FG-7638-01;Glioma;Female;Primary;Matched;AOAST;0:LIVING;[Not Available];41.0
TCGA-FG-7643-01;Glioma;Female;Primary;Matched;OAST;1:DECEASED;[Not Available];57.0
TCGA-FN-7833-01;Glioma;Male;Primary;Matched;OAST;0:LIVING;[Not Available];39.0
TCGA-HT-7470-01;Glioma;Female;Primary;Matched;AOAST;1:DECEASED;[Not Available];45.0
TCGA-HT-7480-01;Glioma;Male;Primary;Matched;ODG;1:DECEASED;[Not Available];69.0
TCGA-HT-7601-01;Glioma;Female;Primary;Matched;AASTR;0:LIVING;[Not Available];53.0
TCGA-HT-7602-01;Glioma;Female;Primary;Matched;ODG;1:DECEASED;[Not Available];38.0
TCGA-HT-7603-01;Glioma;Male;Primary;Matched;ODG;1:DECEASED;[Not Available];33.0
TCGA-HT-7604-01;Glioma;Female;Primary;Matched;ASTR;1:DECEASED;[Not Available];53.0
TCGA-HT-7605-01;Glioma;Male;Primary;Matched;ODG;1:DECEASED;[Not Available];53.0
TCGA-HT-7606-01;Glioma;Female;Primary;Matched;ASTR;0:LIVING;[Not Available];48.0
TCGA-HT-7607-01;Glioma;Male;Primary;Matched;ASTR;1:DECEASED;[Not Available];43.0
TCGA-HT-7608-01;Glioma;Male;Primary;Matched;OAST;0:LIVING;[Not Available];67.0
TCGA-HT-7609-01;Glioma;Female;Primary;Matched;OAST;0:LIVING;[Not Available];41.0
TCGA-HT-7610-01;Glioma;Female;Primary;Matched;OAST;1:DECEASED;[Not Available];57.0
TCGA-IK-7675-01;Glioma;Female;Primary;Matched;ODG;1:DECEASED;[Not Available];63.0
TCGA-DU-8158-01;Glioma;Female;Primary;Matched;AASTR;1:DECEASED;[Not Available];61.0
TCGA-DU-8161-01;Glioma;Male;Primary;Matched;OAST;0:LIVING;[Not Available];29.0
TCGA-DU-8162-01;Glioma;Male;Primary;Matched;OAST;0:LIVING;[Not Available];51.0
TCGA-DU-8163-01;Glioma;Female;Primary;Matched;OAST;0:LIVING;[Not Available];60.0
TCGA-DU-8164-01;Glioma;Female;Primary;Matched;ODG;0:LIVING;[Not Available];29.0
TCGA-DU-8165-01;Glioma;Female;Primary;Matched;ODG;0:LIVING;[Not Available];69.0
TCGA-DU-8166-01;Glioma;Female;Primary;Matched;OAST;0:LIVING;[Not Available];55.0
TCGA-DU-8167-01;Glioma;Male;Primary;Matched;OAST;0:LIVING;[Not Available];33.0
TCGA-DU-8168-01;Glioma;Male;Primary;Matched;AOAST;0:LIVING;[Not Available];51.0
TCGA-FG-7641-01;Glioma;Male;Primary;Matched;ODG;0:LIVING;[Not Available];42.0
TCGA-FG-8181-01;Glioma;Male;Primary;Matched;OAST;0:LIVING;[Not Available];70.0
TCGA-FG-8182-01;Glioma;Female;Primary;Matched;ODG;0:LIVING;[Not Available];62.0
TCGA-FG-8185-01;Glioma;Female;Primary;Matched;AASTR;0:LIVING;[Not Available];33.0
TCGA-FG-8186-01;Glioma;Female;Primary;Matched;OAST;1:DECEASED;[Not Available];46.0
TCGA-FG-8187-01;Glioma;Female;Primary;Matched;OAST;0:LIVING;[Not Available];37.0
TCGA-FG-8188-01;Glioma;Male;Primary;Matched;OAST;0:LIVING;[Not Available];60.0
TCGA-FG-8191-01;Glioma;Female;Primary;Matched;AOAST;0:LIVING;[Not Available];35.0
TCGA-HT-7469-01;Glioma;Female;Primary;Matched;AOAST;0:LIVING;[Not Available];27.0
TCGA-HT-7471-01;Glioma;Female;Primary;Matched;AOAST;0:LIVING;[Not Available];74.0
TCGA-HT-7616-01;Glioma;Male;Primary;Matched;AOAST;1:DECEASED;[Not Available];87.0
TCGA-HT-7620-01;Glioma;Male;Primary;Matched;AOAST;1:DECEASED;[Not Available];54.0
TCGA-HT-7677-01;Glioma;Male;Primary;Matched;AOAST;0:LIVING;[Not Available];30.0
TCGA-HT-7680-01;Glioma;Male;Primary;Matched;ASTR;1:DECEASED;[Not Available];51.0
TCGA-HT-7684-01;Glioma;Female;Primary;Matched;OAST;1:DECEASED;[Not Available];73.0
TCGA-HT-7686-01;Glioma;Male;Primary;Matched;AASTR;1:DECEASED;[Not Available];35.0
TCGA-HT-7687-01;Glioma;Male;Primary;Matched;AOAST;0:LIVING;[Not Available];32.0
TCGA-HT-7688-01;Glioma;Male;Primary;Matched;AOAST;0:LIVING;[Not Available];56.0
TCGA-HT-7689-01;Glioma;Male;Primary;Matched;ODG;0:LIVING;[Not Available];32.0
TCGA-HT-7690-01;Glioma;Male;Primary;Matched;OAST;1:DECEASED;[Not Available];52.0
TCGA-HT-7691-01;Glioma;Male;Primary;Matched;ASTR;1:DECEASED;[Not Available];40.0
TCGA-HT-7692-01;Glioma;Male;Primary;Matched;OAST;1:DECEASED;[Not Available];32.0
TCGA-HT-7693-01;Glioma;Male;Primary;Matched;ODG;0:LIVING;[Not Available];55.0
TCGA-HT-7694-01;Glioma;Male;Primary;Matched;AOAST;1:DECEASED;[Not Available];41.0
TCGA-HT-7695-01;Glioma;Male;Primary;Matched;ODG;1:DECEASED;[Not Available];38.0
TCGA-HT-7854-01;Glioma;Male;Primary;Matched;ASTR;1:DECEASED;[Not Available];42.0
TCGA-IK-8125-01;Glioma;Male;Primary;Matched;OAST;1:DECEASED;[Not Available];34.0
TCGA-HT-7611-01;Glioma;Female;Primary;Matched;OAST;1:DECEASED;[Not Available];62.0
TCGA-HT-7676-01;Glioma;Male;Primary;Matched;ODG;1:DECEASED;[Not Available];31.0
TCGA-HT-7681-01;Glioma;Female;Primary;Matched;OAST;1:DECEASED;[Not Available];42.0
TCGA-HT-7855-01;Glioma;Female;Primary;Matched;AASTR;1:DECEASED;[Not Available];48.0
TCGA-HT-7856-01;Glioma;Female;Primary;Matched;AOAST;1:DECEASED;[Not Available];38.0
TCGA-HT-7857-01;Glioma;Male;Primary;Matched;AASTR;1:DECEASED;[Not Available];57.0
TCGA-HT-7858-01;Glioma;Female;Primary;Matched;ASTR;1:DECEASED;[Not Available];32.0
TCGA-HT-7860-01;Glioma;Female;Primary;Matched;AASTR;1:DECEASED;[Not Available];47.0
TCGA-HT-7873-01;Glioma;Female;Primary;Matched;OAST;1:DECEASED;[Not Available];33.0
TCGA-HT-7874-01;Glioma;Male;Primary;Matched;AOAST;1:DECEASED;[Not Available];55.0
TCGA-HT-7875-01;Glioma;Male;Primary;Matched;ODG;1:DECEASED;[Not Available];52.0
TCGA-HT-7877-01;Glioma;Male;Primary;Matched;ODG;1:DECEASED;[Not Available];46.0
TCGA-HT-7879-01;Glioma;Male;Primary;Matched;OAST;1:DECEASED;[Not Available];63.0
TCGA-HT-7880-01;Glioma;Female;Primary;Matched;OAST;1:DECEASED;[Not Available];63.0
TCGA-HT-7881-01;Glioma;Male;Primary;Matched;ODG;1:DECEASED;[Not Available];45.0
TCGA-HT-7882-01;Glioma;Female;Primary;Matched;AOAST;1:DECEASED;[Not Available];58.0
TCGA-HT-7884-01;Glioma;Male;Primary;Matched;ASTR;1:DECEASED;[Not Available];71.0
TCGA-HT-7902-01;Glioma;Male;Primary;Matched;OAST;1:DECEASED;[Not Available];42.0
TCGA-HT-8010-01;Glioma;Female;Primary;Matched;ODG;1:DECEASED;[Not Available];26.0
TCGA-HT-8011-01;Glioma;Male;Primary;Matched;AASTR;1:DECEASED;[Not Available];28.0
TCGA-HT-8012-01;Glioma;Female;Primary;Matched;ODG;1:DECEASED;[Not Available];27.0
TCGA-HT-8013-01;Glioma;Female;Primary;Matched;OAST;1:DECEASED;[Not Available];58.0
TCGA-HT-8018-01;Glioma;Female;Primary;Matched;OAST;1:DECEASED;[Not Available];31.0
TCGA-HT-8019-01;Glioma;Male;Primary;Matched;AOAST;1:DECEASED;[Not Available];35.0
TCGA-HT-8104-01;Glioma;Female;Primary;Matched;AASTR;1:DECEASED;[Not Available];41.0
TCGA-HT-8105-01;Glioma;Female;Primary;Matched;AOAST;0:LIVING;[Not Available];47.0
TCGA-HT-8106-01;Glioma;Male;Primary;Matched;AASTR;0:LIVING;[Not Available];34.0
TCGA-HT-8107-01;Glioma;Male;Primary;Matched;ODG;0:LIVING;[Not Available];44.0
TCGA-HT-8108-01;Glioma;Male;Primary;Matched;ODG;0:LIVING;[Not Available];54.0
TCGA-HT-8109-01;Glioma;Male;Primary;Matched;AOAST;1:DECEASED;[Not Available];23.0
TCGA-HT-8110-01;Glioma;Male;Primary;Matched;AASTR;0:LIVING;[Not Available];62.0
TCGA-HT-8111-01;Glioma;Female;Primary;Matched;OAST;1:DECEASED;[Not Available];39.0
TCGA-HT-8113-01;Glioma;Female;Primary;Matched;ODG;0:LIVING;[Not Available];59.0
TCGA-HT-8114-01;Glioma;Male;Primary;Matched;OAST;0:LIVING;[Not Available];30.0
TCGA-HT-8558-01;Glioma;Male;Primary;Matched;ODG;0:LIVING;[Not Available];70.0
TCGA-HT-8563-01;Glioma;Female;Primary;Matched;AASTR;0:LIVING;[Not Available];23.0
TCGA-HT-8564-01;Glioma;Male;Primary;Matched;AASTR;1:DECEASED;[Not Available];63.0
TCGA-HW-8319-01;Glioma;Male;Primary;Matched;AASTR;0:LIVING;[Not Available];28.0
TCGA-HW-8320-01;Glioma;Male;Primary;Matched;AASTR;0:LIVING;[Not Available];48.0
TCGA-HW-8321-01;Glioma;Male;Primary;Matched;ASTR;0:LIVING;[Not Available];49.0
TCGA-HW-8322-01;Glioma;Female;Primary;Matched;ODG;0:LIVING;[Not Available];31.0
TCGA-DB-A4X9-01;Glioma;Male;Primary;Matched;OAST;0:LIVING;[Not Available];31.0
TCGA-DB-A4XA-01;Glioma;Female;Primary;Matched;OAST;0:LIVING;[Not Available];49.0
TCGA-DB-A4XB-01;Glioma;Male;Primary;Matched;AASTR;0:LIVING;[Not Available];23.0
TCGA-DB-A4XC-01;Glioma;Male;Primary;Matched;OAST;0:LIVING;[Not Available];35.0
TCGA-FG-A4MT-01;Glioma;Male;Primary;Matched;ODG;0:LIVING;[Not Available];37.0
TCGA-FG-A4MT-02;Glioma;Female;Recurrence;Matched;ODG;0:LIVING;[Not Available];42.0
TCGA-FG-A4MW-01;Glioma;Male;Primary;Matched;OAST;0:LIVING;[Not Available];31.0
TCGA-FG-A4MX-01;Glioma;Male;Primary;Matched;ASTR;0:LIVING;[Not Available];41.0
TCGA-FG-A4MY-01;Glioma;Female;Primary;Matched;OAST;0:LIVING;[Not Available];33.0
TCGA-HT-A4DS-01;Glioma;Male;Primary;Matched;AASTR;0:LIVING;[Not Available];30.0
TCGA-HT-A4DV-01;Glioma;Female;Primary;Matched;AOAST;0:LIVING;[Not Available];27.0
TCGA-DB-A4XD-01;Glioma;Male;Primary;Matched;AASTR;0:LIVING;[Not Available];58.0
TCGA-DB-A4XE-01;Glioma;Male;Primary;Matched;OAST;1:DECEASED;[Not Available];63.0
TCGA-DB-A4XF-01;Glioma;Male;Primary;Matched;AASTR;0:LIVING;[Not Available];47.0
TCGA-DB-A4XG-01;Glioma;Female;Primary;Matched;AOAST;0:LIVING;[Not Available];44.0
TCGA-DB-A4XH-01;Glioma;Female;Primary;Matched;OAST;0:LIVING;[Not Available];47.0
TCGA-HW-A5KJ-01;Glioma;Female;Primary;Matched;AOAST;0:LIVING;[Not Available];34.0
TCGA-HW-A5KK-01;Glioma;Female;Primary;Matched;AASTR;0:LIVING;[Not Available];34.0
TCGA-HW-A5KL-01;Glioma;Male;Primary;Matched;ASTR;0:LIVING;[Not Available];60.0
TCGA-HW-A5KM-01;Glioma;Female;Primary;Matched;ASTR;0:LIVING;[Not Available];44.0
TCGA-P5-A5ET-01;Glioma;Female;Primary;Matched;ODG;0:LIVING;[Not Available];52.0
TCGA-P5-A5EU-01;Glioma;Female;Primary;Matched;AASTR;0:LIVING;[Not Available];20.0
TCGA-P5-A5EV-01;Glioma;Female;Primary;Matched;ASTR;0:LIVING;[Not Available];53.0
TCGA-P5-A5EW-01;Glioma;Female;Primary;Matched;ASTR;0:LIVING;[Not Available];50.0
TCGA-P5-A5EY-01;Glioma;Female;Primary;Matched;ASTR;1:DECEASED;[Not Available];33.0
TCGA-P5-A5EZ-01;Glioma;Female;Primary;Matched;AASTR;0:LIVING;[Not Available];74.0
TCGA-DU-A5TP-01;Glioma;Female;Primary;Matched;AASTR;0:LIVING;[Not Available];37.0
TCGA-DU-A5TR-01;Glioma;Female;Primary;Matched;OAST;0:LIVING;[Not Available];61.0
TCGA-DU-A5TS-01;Glioma;Male;Primary;Matched;ODG;0:LIVING;[Not Available];25.0
TCGA-DU-A5TT-01;Glioma;Male;Primary;Matched;AOAST;0:LIVING;[Not Available];54.0
TCGA-DU-A5TU-01;Glioma;Male;Primary;Matched;ASTR;0:LIVING;[Not Available];30.0
TCGA-DU-A5TW-01;Glioma;Male;Primary;Matched;AASTR;1:DECEASED;[Not Available];30.0
TCGA-DU-A5TY-01;Glioma;Male;Primary;Matched;AASTR;1:DECEASED;[Not Available];37.0
TCGA-FG-8189-01;Glioma;Female;Primary;Matched;ODG;0:LIVING;[Not Available];37.0
TCGA-FG-A4MU-01;Glioma;Male;Primary;Matched;OAST;0:LIVING;[Not Available];38.0
TCGA-FG-A60J-01;Glioma;Male;Primary;Matched;OAST;0:LIVING;[Not Available];28.0
TCGA-HT-7477-01;Glioma;Male;Primary;Matched;AASTR;0:LIVING;[Not Available];52.0
TCGA-HT-8015-01;Glioma;Male;Primary;Matched;ASTR;0:LIVING;[Not Available];67.0
TCGA-HT-A5R5-01;Glioma;Male;Primary;Matched;ODG;0:LIVING;[Not Available];26.0
TCGA-HT-A5R7-01;Glioma;Male;Primary;Matched;AASTR;0:LIVING;[Not Available];62.0
TCGA-HT-A5R9-01;Glioma;Male;Primary;Matched;AOAST;0:LIVING;[Not Available];36.0
TCGA-HT-A5RA-01;Glioma;Male;Primary;Matched;AASTR;0:LIVING;[Not Available];44.0
TCGA-HT-A5RB-01;Glioma;Male;Primary;Matched;ASTR;0:LIVING;[Not Available];33.0
TCGA-HT-A5RC-01;Glioma;Male;Primary;Matched;AASTR;0:LIVING;[Not Available];39.0
TCGA-P5-A5EX-01;Glioma;Female;Primary;Matched;AOAST;0:LIVING;[Not Available];18.0
TCGA-P5-A5F0-01;Glioma;Male;Primary;Matched;ODG;0:LIVING;[Not Available];14.0
TCGA-P5-A5F1-01;Glioma;Male;Primary;Matched;ASTR;0:LIVING;[Not Available];42.0
TCGA-P5-A5F2-01;Glioma;Female;Primary;Matched;ASTR;0:LIVING;[Not Available];30.0
TCGA-P5-A5F4-01;Glioma;Male;Primary;Matched;AOAST;0:LIVING;[Not Available];21.0
TCGA-P5-A5F6-01;Glioma;Male;Primary;Matched;ODG;0:LIVING;[Not Available];29.0
TCGA-DB-A64L-01;Glioma;Male;Primary;Matched;ODG;0:LIVING;[Not Available];50.0
TCGA-DB-A64O-01;Glioma;Male;Primary;Matched;OAST;0:LIVING;[Not Available];38.0
TCGA-DB-A64P-01;Glioma;Female;Primary;Matched;AOAST;0:LIVING;[Not Available];30.0
TCGA-DB-A64Q-01;Glioma;Female;Primary;Matched;OAST;1:DECEASED;[Not Available];61.0
TCGA-DB-A64R-01;Glioma;Male;Primary;Matched;ODG;0:LIVING;[Not Available];61.0
TCGA-DB-A64S-01;Glioma;Male;Primary;Matched;OAST;0:LIVING;[Not Available];34.0
TCGA-DB-A64U-01;Glioma;Female;Primary;Matched;OAST;0:LIVING;[Not Available];25.0
TCGA-DB-A64V-01;Glioma;Male;Primary;Matched;ODG;0:LIVING;[Not Available];36.0
TCGA-DB-A64W-01;Glioma;Male;Primary;Matched;OAST;1:DECEASED;[Not Available];75.0
TCGA-DB-A64X-01;Glioma;Male;Primary;Matched;AASTR;0:LIVING;[Not Available];40.0
TCGA-DH-A66B-01;Glioma;Male;Primary;Matched;AASTR;0:LIVING;[Not Available];26.0
TCGA-DH-A66F-01;Glioma;Male;Primary;Matched;ODG;0:LIVING;[Not Available];53.0
TCGA-FG-A60K-01;Glioma;Female;Primary;Matched;OAST;0:LIVING;[Not Available];32.0
TCGA-HT-A614-01;Glioma;Female;Primary;Matched;OAST;0:LIVING;[Not Available];29.0
TCGA-HT-A615-01;Glioma;Male;Primary;Matched;ODG;0:LIVING;[Not Available];58.0
TCGA-HT-A616-01;Glioma;Female;Primary;Matched;ASTR;0:LIVING;[Not Available];29.0
TCGA-HT-A617-01;Glioma;Male;Primary;Matched;ODG;0:LIVING;[Not Available];74.0
TCGA-HT-A618-01;Glioma;Male;Primary;Matched;AASTR;0:LIVING;[Not Available];59.0
TCGA-HT-A619-01;Glioma;Female;Primary;Matched;AOAST;0:LIVING;[Not Available];58.0
TCGA-HT-A61A-01;Glioma;Male;Primary;Matched;ODG;0:LIVING;[Not Available];29.0
TCGA-HT-A61B-01;Glioma;Female;Primary;Matched;AASTR;0:LIVING;[Not Available];31.0
TCGA-HT-A61C-01;Glioma;Male;Primary;Matched;AOAST;0:LIVING;[Not Available];43.0
TCGA-QH-A65S-01;Glioma;Female;Primary;Matched;OAST;0:LIVING;[Not Available];51.0
TCGA-QH-A65V-01;Glioma;Male;Primary;Matched;ODG;0:LIVING;[Not Available];60.0
TCGA-QH-A65Z-01;Glioma;Female;Primary;Matched;ODG;0:LIVING;[Not Available];29.0
TCGA-DH-A669-01;Glioma;Male;Primary;Matched;AOAST;0:LIVING;[Not Available];62.0
TCGA-DH-A669-02;Glioma;Male;Recurrence;Matched;ODG;0:LIVING;[Not Available];39.0
TCGA-DH-A66D-01;Glioma;Male;Primary;Matched;AASTR;0:LIVING;[Not Available];35.0
TCGA-DH-A66G-01;Glioma;Female;Primary;Matched;AOAST;0:LIVING;[Not Available];24.0
TCGA-FG-A60L-01;Glioma;Male;Primary;Matched;ASTR;0:LIVING;[Not Available];28.0
TCGA-FG-A6IZ-01;Glioma;Female;Primary;Matched;ODG;0:LIVING;[Not Available];60.0
TCGA-FG-A6J1-01;Glioma;Male;Primary;Matched;ODG;0:LIVING;[Not Available];29.0
TCGA-FG-A6J3-01;Glioma;Female;Primary;Matched;AASTR;0:LIVING;[Not Available];41.0
TCGA-QH-A65R-01;Glioma;Male;Primary;Matched;AOAST;0:LIVING;[Not Available];56.0
TCGA-QH-A6CS-01;Glioma;Female;Primary;Matched;AASTR;0:LIVING;[Not Available];20.0
TCGA-QH-A6CU-01;Glioma;Male;Primary;Matched;AOAST;0:LIVING;[Not Available];31.0
TCGA-QH-A6CV-01;Glioma;Male;Primary;Matched;OAST;0:LIVING;[Not Available];30.0
TCGA-DB-A75K-01;Glioma;Male;Primary;Matched;OAST;0:LIVING;[Not Available];38.0
TCGA-DB-A75L-01;Glioma;Male;Primary;Matched;AASTR;1:DECEASED;[Not Available];66.0
TCGA-DB-A75M-01;Glioma;Female;Primary;Matched;ASTR;0:LIVING;[Not Available];44.0
TCGA-DB-A75O-01;Glioma;Female;Primary;Matched;AASTR;0:LIVING;[Not Available];30.0
TCGA-DB-A75P-01;Glioma;Female;Primary;Matched;ASTR;0:LIVING;[Not Available];64.0
TCGA-DU-A6S2-01;Glioma;Male;Primary;Matched;ODG;0:LIVING;[Not Available];55.0
TCGA-DU-A6S3-01;Glioma;Female;Primary;Matched;ODG;0:LIVING;[Not Available];30.0
TCGA-DU-A6S6-01;Glioma;Female;Primary;Matched;OAST;1:DECEASED;[Not Available];37.0
TCGA-DU-A6S7-01;Glioma;Male;Primary;Matched;AASTR;0:LIVING;[Not Available];21.0
TCGA-DU-A6S8-01;Glioma;Female;Primary;Matched;AOAST;1:DECEASED;[Not Available];40.0
TCGA-DU-A76L-01;Glioma;Female;Primary;Matched;AOAST;0:LIVING;[Not Available];34.0
TCGA-DU-A76O-01;Glioma;Female;Primary;Matched;ASTR;0:LIVING;[Not Available];51.0
TCGA-DU-A76R-01;Glioma;Male;Primary;Matched;AOAST;0:LIVING;[Not Available];54.0
TCGA-FG-A713-01;Glioma;Male;Primary;Matched;OAST;0:LIVING;[Not Available];53.0
TCGA-HT-A74H-01;Glioma;Male;Primary;Matched;AASTR;0:LIVING;[Not Available];62.0
TCGA-HT-A74J-01;Glioma;Female;Primary;Matched;OAST;0:LIVING;[Not Available];26.0
TCGA-HT-A74K-01;Glioma;Male;Primary;Matched;AOAST;0:LIVING;[Not Available];64.0
TCGA-HT-A74L-01;Glioma;Male;Primary;Matched;OAST;0:LIVING;[Not Available];57.0
TCGA-HT-A74O-01;Glioma;Male;Primary;Matched;AASTR;0:LIVING;[Not Available];32.0
TCGA-KT-A74X-01;Glioma;Female;Primary;Matched;OAST;0:LIVING;[Not Available];49.0
TCGA-P5-A72U-01;Glioma;Male;Primary;Matched;AOAST;0:LIVING;[Not Available];36.0
TCGA-P5-A72W-01;Glioma;Female;Primary;Matched;AASTR;0:LIVING;[Not Available];29.0
TCGA-P5-A72X-01;Glioma;Female;Primary;Matched;AASTR;0:LIVING;[Not Available];30.0
TCGA-P5-A72Z-01;Glioma;Male;Primary;Matched;AOAST;0:LIVING;[Not Available];47.0
TCGA-P5-A730-01;Glioma;Female;Primary;Matched;OAST;0:LIVING;[Not Available];55.0
TCGA-P5-A731-01;Glioma;Female;Primary;Matched;OAST;0:LIVING;[Not Available];51.0
TCGA-P5-A733-01;Glioma;Female;Primary;Matched;ASTR;0:LIVING;[Not Available];33.0
TCGA-P5-A735-01;Glioma;Female;Primary;Matched;ASTR;0:LIVING;[Not Available];33.0
TCGA-P5-A736-01;Glioma;Female;Primary;Matched;AASTR;0:LIVING;[Not Available];48.0
TCGA-P5-A737-01;Glioma;Female;Primary;Matched;OAST;0:LIVING;[Not Available];65.0
TCGA-P5-A77W-01;Glioma;Male;Primary;Matched;OAST;0:LIVING;[Not Available];24.0
TCGA-P5-A77X-01;Glioma;Female;Primary;Matched;OAST;1:DECEASED;[Not Available];70.0
TCGA-P5-A780-01;Glioma;Male;Primary;Matched;AASTR;0:LIVING;[Not Available];47.0
TCGA-P5-A781-01;Glioma;Female;Primary;Matched;AASTR;0:LIVING;[Not Available];38.0
TCGA-QH-A65X-01;Glioma;Female;Primary;Matched;OAST;0:LIVING;[Not Available];36.0
TCGA-QH-A6CW-01;Glioma;Male;Primary;Matched;OAST;0:LIVING;[Not Available];47.0
TCGA-QH-A6CX-01;Glioma;Female;Primary;Matched;ASTR;0:LIVING;[Not Available];37.0
TCGA-QH-A6CY-01;Glioma;Female;Primary;Matched;OAST;0:LIVING;[Not Available];51.0
TCGA-QH-A6CZ-01;Glioma;Female;Primary;Matched;OAST;0:LIVING;[Not Available];20.0
TCGA-QH-A6X3-01;Glioma;Male;Primary;Matched;OAST;0:LIVING;[Not Available];22.0
TCGA-QH-A6X4-01;Glioma;Male;Primary;Matched;OAST;1:DECEASED;[Not Available];66.0
TCGA-QH-A6X5-01;Glioma;Male;Primary;Matched;OAST;0:LIVING;[Not Available];62.0
TCGA-QH-A6X8-01;Glioma;Male;Primary;Matched;AOAST;0:LIVING;[Not Available];33.0
TCGA-QH-A6X9-01;Glioma;Female;Primary;Matched;ODG;0:LIVING;[Not Available];58.0
TCGA-QH-A6XA-01;Glioma;Female;Primary;Matched;OAST;0:LIVING;[Not Available];22.0
TCGA-QH-A6XC-01;Glioma;Male;Primary;Matched;AASTR;0:LIVING;[Not Available];34.0
TCGA-R8-A6MK-01;Glioma;Male;Primary;Matched;ODG;0:LIVING;[Not Available];37.0
TCGA-R8-A6ML-01;Glioma;Male;Primary;Matched;AOAST;0:LIVING;[Not Available];39.0
TCGA-R8-A6YH-01;Glioma;Male;Primary;Matched;DIFG;1:DECEASED;[Not Available];38.0
TCGA-R8-A73M-01;Glioma;Male;Primary;Matched;ODG;0:LIVING;[Not Available];41.0
TCGA-S9-A6TU-01;Glioma;Male;Primary;Matched;ASTR;0:LIVING;[Not Available];35.0
TCGA-S9-A6TW-01;Glioma;Female;Primary;Matched;AOAST;0:LIVING;[Not Available];40.0
TCGA-S9-A6TX-01;Glioma;Female;Primary;Matched;AOAST;0:LIVING;[Not Available];45.0
TCGA-S9-A6TY-01;Glioma;Female;Primary;Matched;ODG;1:DECEASED;[Not Available];34.0
TCGA-S9-A6TZ-01;Glioma;Male;Primary;Matched;ASTR;0:LIVING;[Not Available];36.0
TCGA-S9-A6U0-01;Glioma;Male;Primary;Matched;AASTR;0:LIVING;[Not Available];31.0
TCGA-S9-A6U9-01;Glioma;Male;Primary;Matched;AASTR;0:LIVING;[Not Available];39.0
TCGA-TM-A7C3-01;Glioma;Male;Primary;Matched;AASTR;1:DECEASED;[Not Available];68.0
TCGA-TM-A7C4-01;Glioma;Male;Primary;Matched;ASTR;1:DECEASED;[Not Available];64.0
TCGA-TM-A7C5-01;Glioma;Female;Primary;Matched;OAST;0:LIVING;[Not Available];42.0
TCGA-TM-A7CF-01;Glioma;Male;Primary;Matched;ASTR;0:LIVING;[Not Available];35.0
TCGA-TM-A7CF-02;Glioma;Male;Recurrence;Matched;ASTR;1:DECEASED;[Not Available];43.0
TCGA-DH-A7UR-01;Glioma;Male;Primary;Matched;AOAST;0:LIVING;[Not Available];62.0
TCGA-DH-A7US-01;Glioma;Male;Primary;Matched;ODG;0:LIVING;[Not Available];26.0
TCGA-DU-A76K-01;Glioma;Female;Primary;Matched;ODG;0:LIVING;[Not Available];45.0
TCGA-DU-A7T6-01;Glioma;Male;Primary;Matched;AOAST;0:LIVING;[Not Available];27.0
TCGA-DU-A7TA-01;Glioma;Male;Primary;Matched;ODG;0:LIVING;[Not Available];35.0
TCGA-DU-A7TB-01;Glioma;Male;Primary;Matched;ODG;0:LIVING;[Not Available];39.0
TCGA-DU-A7TI-01;Glioma;Female;Primary;Matched;AASTR;0:LIVING;[Not Available];20.0
TCGA-FG-A70Z-01;Glioma;Female;Primary;Matched;OAST;0:LIVING;[Not Available];41.0
TCGA-FG-A710-01;Glioma;Male;Primary;Matched;ODG;0:LIVING;[Not Available];21.0
TCGA-FG-A711-01;Glioma;Male;Primary;Matched;ODG;0:LIVING;[Not Available];39.0
TCGA-R8-A6MO-01;Glioma;Male;Primary;Matched;ODG;0:LIVING;[Not Available];33.0
TCGA-S9-A6TS-01;Glioma;Male;Primary;Matched;AASTR;0:LIVING;[Not Available];30.0
TCGA-S9-A6U1-01;Glioma;Female;Primary;Matched;AASTR;0:LIVING;[Not Available];36.0
TCGA-S9-A6U2-01;Glioma;Female;Primary;Matched;ODG;0:LIVING;[Not Available];35.0
TCGA-S9-A6U5-01;Glioma;Male;Primary;Matched;ASTR;0:LIVING;[Not Available];26.0
TCGA-S9-A6U6-01;Glioma;Female;Primary;Matched;AASTR;0:LIVING;[Not Available];71.0
TCGA-S9-A6U8-01;Glioma;Male;Primary;Matched;ASTR;0:LIVING;[Not Available];35.0
TCGA-S9-A6UA-01;Glioma;Male;Primary;Matched;AASTR;0:LIVING;[Not Available];21.0
TCGA-S9-A6UB-01;Glioma;Female;Primary;Matched;ODG;0:LIVING;[Not Available];64.0
TCGA-S9-A6WD-01;Glioma;Male;Primary;Matched;AOAST;0:LIVING;[Not Available];22.0
TCGA-S9-A6WE-01;Glioma;Female;Primary;Matched;ODG;0:LIVING;[Not Available];59.0
TCGA-S9-A6WG-01;Glioma;Female;Primary;Matched;AASTR;0:LIVING;[Not Available];52.0
TCGA-S9-A6WH-01;Glioma;Female;Primary;Matched;OAST;0:LIVING;[Not Available];38.0
TCGA-S9-A6WI-01;Glioma;Female;Primary;Matched;OAST;0:LIVING;[Not Available];44.0
TCGA-S9-A6WL-01;Glioma;Male;Primary;Matched;AASTR;0:LIVING;[Not Available];47.0
TCGA-S9-A6WM-01;Glioma;Female;Primary;Matched;AASTR;0:LIVING;[Not Available];37.0
TCGA-S9-A6WN-01;Glioma;Female;Primary;Matched;AASTR;0:LIVING;[Not Available];55.0
TCGA-TM-A7CA-01;Glioma;Female;Primary;Matched;ASTR;0:LIVING;[Not Available];44.0
TCGA-TQ-A7RF-01;Glioma;Female;Primary;Matched;AOAST;0:LIVING;[Not Available];34.0
TCGA-TQ-A7RG-01;Glioma;Female;Primary;Matched;OAST;0:LIVING;[Not Available];38.0
TCGA-TQ-A7RI-01;Glioma;Female;Primary;Matched;ODG;0:LIVING;[Not Available];32.0
TCGA-TQ-A7RJ-01;Glioma;Female;Primary;Matched;OAST;0:LIVING;[Not Available];43.0
TCGA-TQ-A7RK-01;Glioma;Female;Primary;Matched;OAST;0:LIVING;[Not Available];28.0
TCGA-TQ-A7RK-02;Glioma;Male;Recurrence;Matched;OAST;0:LIVING;[Not Available];54.0
TCGA-TQ-A7RM-01;Glioma;Male;Primary;Matched;OAST;0:LIVING;[Not Available];41.0
TCGA-TQ-A7RN-01;Glioma;Female;Primary;Matched;ODG;0:LIVING;[Not Available];52.0
TCGA-TQ-A7RO-01;Glioma;Male;Primary;Matched;OAST;0:LIVING;[Not Available];51.0
TCGA-TQ-A7RQ-01;Glioma;Male;Primary;Matched;ODG;0:LIVING;[Not Available];43.0
TCGA-TQ-A7RS-01;Glioma;Male;Primary;Matched;ODG;1:DECEASED;[Not Available];66.0
TCGA-TQ-A7RW-01;Glioma;Male;Primary;Matched;ODG;0:LIVING;[Not Available];38.0
TCGA-VW-A7QS-01;Glioma;Male;Primary;Matched;AOAST;0:LIVING;[Not Available];38.0
TCGA-DH-A7UT-01;Glioma;Male;Primary;Matched;AASTR;0:LIVING;[Not Available];27.0
TCGA-DH-A7UU-01;Glioma;Male;Primary;Matched;AASTR;0:LIVING;[Not Available];47.0
TCGA-DH-A7UV-01;Glioma;Female;Primary;Matched;AASTR;0:LIVING;[Not Available];58.0
TCGA-DU-A7T8-01;Glioma;Female;Primary;Matched;OAST;0:LIVING;[Not Available];56.0
TCGA-DU-A7TC-01;Glioma;Female;Primary;Matched;ASTR;0:LIVING;[Not Available];73.0
TCGA-DU-A7TD-01;Glioma;Female;Primary;Matched;OAST;0:LIVING;[Not Available];23.0
TCGA-DU-A7TG-01;Glioma;Male;Primary;Matched;ODG;0:LIVING;[Not Available];48.0
TCGA-DU-A7TJ-01;Glioma;Male;Primary;Matched;AASTR;0:LIVING;[Not Available];33.0
TCGA-E1-A7YD-01;Glioma;Female;Primary;Matched;AASTR;0:LIVING;[Not Available];38.0
TCGA-E1-A7YE-01;Glioma;Male;Primary;Matched;AASTR;0:LIVING;[Not Available];40.0
TCGA-E1-A7YH-01;Glioma;Male;Primary;Matched;AASTR;0:LIVING;[Not Available];52.0
TCGA-E1-A7YI-01;Glioma;Female;Primary;Matched;AASTR;0:LIVING;[Not Available];53.0
TCGA-E1-A7YJ-01;Glioma;Female;Primary;Matched;AASTR;0:LIVING;[Not Available];48.0
TCGA-E1-A7YK-01;Glioma;Female;Primary;Matched;AASTR;0:LIVING;[Not Available];46.0
TCGA-E1-A7YL-01;Glioma;Male;Primary;Matched;AASTR;0:LIVING;[Not Available];45.0
TCGA-E1-A7YM-01;Glioma;Female;Primary;Matched;AASTR;0:LIVING;[Not Available];54.0
TCGA-E1-A7YN-01;Glioma;Male;Primary;Matched;AASTR;0:LIVING;[Not Available];47.0
TCGA-E1-A7YO-01;Glioma;Male;Primary;Matched;AOAST;0:LIVING;[Not Available];30.0
TCGA-E1-A7YQ-01;Glioma;Female;Primary;Matched;AOAST;0:LIVING;[Not Available];40.0
TCGA-E1-A7YS-01;Glioma;Male;Primary;Matched;AOAST;0:LIVING;[Not Available];45.0
TCGA-E1-A7YU-01;Glioma;Female;Primary;Matched;OAST;1:DECEASED;[Not Available];48.0
TCGA-E1-A7YV-01;Glioma;Male;Primary;Matched;OAST;0:LIVING;[Not Available];38.0
TCGA-E1-A7YW-01;Glioma;Male;Primary;Matched;OAST;0:LIVING;[Not Available];50.0
TCGA-E1-A7YY-01;Glioma;Male;Primary;Matched;ODG;0:LIVING;[Not Available];40.0
TCGA-E1-A7Z2-01;Glioma;Male;Primary;Matched;ODG;0:LIVING;[Not Available];46.0
TCGA-E1-A7Z3-01;Glioma;Male;Primary;Matched;ASTR;0:LIVING;[Not Available];50.0
TCGA-E1-A7Z4-01;Glioma;Female;Primary;Matched;ASTR;0:LIVING;[Not Available];39.0
TCGA-E1-A7Z6-01;Glioma;Male;Primary;Matched;ASTR;1:DECEASED;[Not Available];46.0
TCGA-FG-A70Y-01;Glioma;Female;Primary;Matched;ODG;0:LIVING;[Not Available];22.0
TCGA-KT-A7W1-01;Glioma;Female;Primary;Matched;AASTR;0:LIVING;[Not Available];48.0
TCGA-S9-A6TV-01;Glioma;Male;Primary;Matched;OAST;0:LIVING;[Not Available];33.0
TCGA-S9-A6WO-01;Glioma;Male;Primary;Matched;ASTR;0:LIVING;[Not Available];28.0
TCGA-S9-A6WP-01;Glioma;Male;Primary;Matched;OAST;1:DECEASED;[Not Available];24.0
TCGA-S9-A6WQ-01;Glioma;Male;Primary;Matched;OAST;0:LIVING;[Not Available];36.0
TCGA-S9-A7IQ-01;Glioma;Male;Primary;Matched;OAST;1:DECEASED;[Not Available];66.0
TCGA-S9-A7IS-01;Glioma;Male;Primary;Matched;AASTR;0:LIVING;[Not Available];52.0
TCGA-S9-A7IX-01;Glioma;Male;Primary;Matched;AASTR;0:LIVING;[Not Available];58.0
TCGA-S9-A7IY-01;Glioma;Male;Primary;Matched;OAST;0:LIVING;[Not Available];34.0
TCGA-S9-A7IZ-01;Glioma;Male;Primary;Matched;AASTR;0:LIVING;[Not Available];31.0
TCGA-S9-A7J0-01;Glioma;Female;Primary;Matched;AOAST;0:LIVING;[Not Available];73.0
TCGA-S9-A7J1-01;Glioma;Female;Primary;Matched;ODG;0:LIVING;[Not Available];56.0
TCGA-S9-A7J2-01;Glioma;Male;Primary;Matched;AOAST;0:LIVING;[Not Available];52.0
TCGA-S9-A7J3-01;Glioma;Female;Primary;Matched;AOAST;0:LIVING;[Not Available];59.0
TCGA-S9-A7QW-01;Glioma;Female;Primary;Matched;AASTR;0:LIVING;[Not Available];38.0
TCGA-S9-A7QX-01;Glioma;Male;Primary;Matched;AASTR;0:LIVING;[Not Available];29.0
TCGA-S9-A7QY-01;Glioma;Male;Primary;Matched;OAST;0:LIVING;[Not Available];42.0
TCGA-S9-A7QZ-01;Glioma;Female;Primary;Matched;ODG;0:LIVING;[Not Available];57.0
TCGA-S9-A7R1-01;Glioma;Female;Primary;Matched;ODG;0:LIVING;[Not Available];45.0
TCGA-S9-A7R2-01;Glioma;Female;Primary;Matched;AASTR;1:DECEASED;[Not Available];33.0
TCGA-S9-A7R3-01;Glioma;Male;Primary;Matched;ASTR;1:DECEASED;[Not Available];57.0
TCGA-S9-A7R4-01;Glioma;Male;Primary;Matched;AASTR;0:LIVING;[Not Available];39.0
TCGA-S9-A7R7-01;Glioma;Female;Primary;Matched;ASTR;0:LIVING;[Not Available];48.0
TCGA-S9-A7R8-01;Glioma;Female;Primary;Matched;AASTR;0:LIVING;[Not Available];30.0
TCGA-TQ-A7RH-01;Glioma;Male;Primary;Matched;OAST;0:LIVING;[Not Available];43.0
TCGA-TQ-A7RP-01;Glioma;Male;Primary;Matched;OAST;0:LIVING;[Not Available];25.0
TCGA-TQ-A7RR-01;Glioma;Female;Primary;Matched;OAST;0:LIVING;[Not Available];52.0
TCGA-TQ-A7RU-01;Glioma;Female;Primary;Matched;ODG;0:LIVING;[Not Available];54.0
TCGA-TQ-A7RV-01;Glioma;Female;Primary;Matched;ASTR;0:LIVING;[Not Available];36.0
TCGA-TQ-A7RV-02;Glioma;Female;Recurrence;Matched;ASTR;0:LIVING;[Not Available];35.0
TCGA-F6-A8O3-01;Glioma;Male;Primary;Matched;ODG;0:LIVING;[Not Available];41.0
TCGA-F6-A8O4-01;Glioma;Male;Primary;Matched;ASTR;1:DECEASED;[Not Available];35.0
TCGA-FG-A87N-01;Glioma;Male;Primary;Matched;AASTR;1:DECEASED;[Not Available];69.0
TCGA-FG-A87Q-01;Glioma;Female;Primary;Matched;AASTR;0:LIVING;[Not Available];28.0
TCGA-QH-A86X-01;Glioma;Male;Primary;Matched;ODG;0:LIVING;[Not Available];46.0
TCGA-QH-A870-01;Glioma;Male;Primary;Matched;OAST;0:LIVING;[Not Available];27.0
TCGA-RY-A83X-01;Glioma;Female;Primary;Matched;ODG;1:DECEASED;[Not Available];44.0
TCGA-RY-A83Y-01;Glioma;Male;Primary;Matched;ODG;0:LIVING;[Not Available];70.0
TCGA-RY-A83Z-01;Glioma;Male;Primary;Matched;AASTR;0:LIVING;[Not Available];40.0
TCGA-RY-A840-01;Glioma;Female;Primary;Matched;AOAST;1:DECEASED;[Not Available];43.0
TCGA-RY-A843-01;Glioma;Female;Primary;Matched;AASTR;0:LIVING;[Not Available];39.0
TCGA-RY-A845-01;Glioma;Male;Primary;Matched;OAST;0:LIVING;[Not Available];30.0
TCGA-RY-A847-01;Glioma;Male;Primary;Matched;ODG;0:LIVING;[Not Available];44.0
TCGA-S9-A89V-01;Glioma;Female;Primary;Matched;AASTR;0:LIVING;[Not Available];41.0
TCGA-S9-A89Z-01;Glioma;Male;Primary;Matched;AASTR;1:DECEASED;[Not Available];40.0
TCGA-TM-A84B-01;Glioma;Male;Primary;Matched;AASTR;1:DECEASED;[Not Available];32.0
TCGA-TM-A84C-01;Glioma;Male;Primary;Matched;ASTR;0:LIVING;[Not Available];48.0
TCGA-TM-A84F-01;Glioma;Female;Primary;Matched;AASTR;0:LIVING;[Not Available];54.0
TCGA-TM-A84G-01;Glioma;Female;Primary;Matched;AOAST;0:LIVING;[Not Available];44.0
TCGA-TM-A84H-01;Glioma;Male;Primary;Matched;OAST;0:LIVING;[Not Available];30.0
TCGA-TM-A84I-01;Glioma;Male;Primary;Matched;AASTR;0:LIVING;[Not Available];63.0
TCGA-TM-A84J-01;Glioma;Male;Primary;Matched;AOAST;1:DECEASED;[Not Available];31.0
TCGA-TM-A84L-01;Glioma;Male;Primary;Matched;OAST;0:LIVING;[Not Available];40.0
TCGA-TM-A84M-01;Glioma;Female;Primary;Matched;AOAST;1:DECEASED;[Not Available];61.0
TCGA-TM-A84O-01;Glioma;Male;Primary;Matched;AOAST;0:LIVING;[Not Available];31.0
TCGA-TM-A84Q-01;Glioma;Male;Primary;Matched;ASTR;0:LIVING;[Not Available];46.0
TCGA-TM-A84R-01;Glioma;Male;Primary;Matched;ODG;0:LIVING;[Not Available];36.0
TCGA-TM-A84S-01;Glioma;Male;Primary;Matched;AOAST;0:LIVING;[Not Available];19.0
TCGA-TM-A84T-01;Glioma;Female;Primary;Matched;OAST;0:LIVING;[Not Available];27.0
TCGA-TQ-A8XE-01;Glioma;Male;Primary;Matched;ODG;0:LIVING;[Not Available];36.0
TCGA-TQ-A8XE-02;Glioma;Male;Recurrence;Matched;ODG;0:LIVING;[Not Available];39.0
TCGA-VM-A8C8-01;Glioma;Female;Primary;Matched;ODG;0:LIVING;[Not Available];37.0
TCGA-VM-A8C9-01;Glioma;Female;Primary;Matched;ASTR;0:LIVING;[Not Available];25.0
TCGA-VM-A8CA-01;Glioma;Male;Primary;Matched;ODG;0:LIVING;[Not Available];29.0
TCGA-VM-A8CB-01;Glioma;Female;Primary;Matched;AOAST;0:LIVING;[Not Available];41.0
TCGA-VM-A8CD-01;Glioma;Male;Primary;Matched;AASTR;0:LIVING;[Not Available];32.0
TCGA-VM-A8CE-01;Glioma;Male;Primary;Matched;ODG;0:LIVING;[Not Available];29.0
TCGA-VM-A8CF-01;Glioma;Male;Primary;Matched;AASTR;0:LIVING;[Not Available];66.0
TCGA-VM-A8CH-01;Glioma;Female;Primary;Matched;ASTR;0:LIVING;[Not Available];38.0
TCGA-VV-A829-01;Glioma;Male;Primary;Matched;OAST;0:LIVING;[Not Available];38.0
TCGA-VV-A86M-01;Glioma;Female;Primary;Matched;AASTR;0:LIVING;[Not Available];25.0
TCGA-VW-A8FI-01;Glioma;Male;Primary;Matched;AASTR;0:LIVING;[Not Available];51.0
TCGA-W9-A837-01;Glioma;Male;Primary;Matched;ODG;0:LIVING;[Not Available];27.0
TCGA-WH-A86K-01;Glioma;Male;Primary;Matched;ASTR;1:DECEASED;[Not Available];32.0
TCGA-WY-A858-01;Glioma;Female;Primary;Matched;AASTR;1:DECEASED;[Not Available];42.0
TCGA-WY-A859-01;Glioma;Female;Primary;Matched;ASTR;0:LIVING;[Not Available];50.0
TCGA-WY-A85A-01;Glioma;Female;Primary;Matched;ASTR;0:LIVING;[Not Available];37.0
TCGA-WY-A85B-01;Glioma;Male;Primary;Matched;ASTR;0:LIVING;[Not Available];54.0
TCGA-WY-A85C-01;Glioma;Male;Primary;Matched;ASTR;0:LIVING;[Not Available];33.0
TCGA-WY-A85D-01;Glioma;Male;Primary;Matched;OAST;1:DECEASED;[Not Available];58.0
TCGA-WY-A85E-01;Glioma;Male;Primary;Matched;OAST;0:LIVING;[Not Available];25.0
TCGA-CS-4941-01;Glioma;Female;Primary;Matched;AASTR;0:LIVING;[Not Available];44.0
TCGA-CS-4942-01;Glioma;Female;Primary;Matched;AASTR;0:LIVING;[Not Available];24.0
TCGA-CS-4943-01;Glioma;Male;Primary;Matched;AASTR;0:LIVING;[Not Available];44.0
TCGA-CS-4944-01;Glioma;Female;Primary;Matched;ASTR;0:LIVING;[Not Available];36.0
TCGA-CS-5390-01;Glioma;Female;Primary;Matched;ODG;0:LIVING;[Not Available];35.0
TCGA-CS-5393-01;Glioma;Male;Primary;Matched;AASTR;1:DECEASED;[Not Available];66.0
TCGA-CS-5394-01;Glioma;Male;Primary;Matched;AASTR;0:LIVING;[Not Available];47.0
TCGA-CS-5395-01;Glioma;Male;Primary;Matched;ODG;0:LIVING;[Not Available];65.0
TCGA-CS-5396-01;Glioma;Female;Primary;Matched;AOAST;0:LIVING;[Not Available];32.0
TCGA-DB-5270-01;Glioma;Female;Primary;Matched;OAST;0:LIVING;[Not Available];34.0
TCGA-DB-5273-01;Glioma;Male;Primary;Matched;AASTR;0:LIVING;[Not Available];20.0
TCGA-DB-5274-01;Glioma;Male;Primary;Matched;OAST;0:LIVING;[Not Available];24.0
TCGA-DB-5275-01;Glioma;Male;Primary;Matched;OAST;0:LIVING;[Not Available];36.0
TCGA-DB-5276-01;Glioma;Male;Primary;Matched;OAST;0:LIVING;[Not Available];60.0
TCGA-DB-5277-01;Glioma;Female;Primary;Matched;AASTR;0:LIVING;[Not Available];48.0
TCGA-DB-5278-01;Glioma;[Not Available];Primary;Matched;ODG;[Not Available];[Not Available];[Not Available]
TCGA-DB-5279-01;Glioma;[Not Available];Primary;Matched;ODG;[Not Available];[Not Available];[Not Available]
TCGA-DB-5280-01;Glioma;[Not Available];Primary;Matched;OAST;[Not Available];[Not Available];[Not Available]
TCGA-DB-5281-01;Glioma;[Not Available];Primary;Matched;OAST;[Not Available];[Not Available];[Not Available]
TCGA-DH-5140-01;Glioma;[Not Available];Primary;Matched;OAST;[Not Available];[Not Available];[Not Available]
TCGA-DH-5141-01;Glioma;[Not Available];Primary;Matched;AOAST;[Not Available];[Not Available];[Not Available]
TCGA-DH-5142-01;Glioma;[Not Available];Primary;Matched;AASTR;[Not Available];[Not Available];[Not Available]
TCGA-DH-5143-01;Glioma;[Not Available];Primary;Matched;OAST;[Not Available];[Not Available];[Not Available]
TCGA-DH-5144-01;Glioma;[Not Available];Primary;Matched;AOAST;[Not Available];[Not Available];[Not Available]
TCGA-E1-5302-01;Glioma;[Not Available];Primary;Matched;AASTR;[Not Available];[Not Available];[Not Available]
TCGA-E1-5303-01;Glioma;[Not Available];Primary;Matched;AASTR;[Not Available];[Not Available];[Not Available]
TCGA-E1-5304-01;Glioma;[Not Available];Primary;Matched;AASTR;[Not Available];[Not Available];[Not Available]
TCGA-E1-5311-01;Glioma;[Not Available];Primary;Matched;AOAST;[Not Available];[Not Available];[Not Available]
TCGA-E1-5318-01;Glioma;[Not Available];Primary;Matched;ODG;[Not Available];[Not Available];[Not Available]
TCGA-E1-5322-01;Glioma;[Not Available];Primary;Matched;OAST;[Not Available];[Not Available];[Not Available]
TCGA-2V-A95S-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE II;[Not Available]
TCGA-2Y-A9GS-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;STAGE IV;58.0
TCGA-2Y-A9GT-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;STAGE I;51.0
TCGA-2Y-A9GU-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;0:LIVING;STAGE I;55.0
TCGA-2Y-A9GV-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;1:DECEASED;STAGE I;54.0
TCGA-2Y-A9GW-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;STAGE I;64.0
TCGA-2Y-A9GX-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;68.0
TCGA-2Y-A9GY-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;1:DECEASED;STAGE II;64.0
TCGA-2Y-A9GZ-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;1:DECEASED;STAGE II;82.0
TCGA-2Y-A9H0-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE IIIA;49.0
TCGA-2Y-A9H1-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;STAGE I;58.0
TCGA-2Y-A9H2-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;0:LIVING;STAGE I;64.0
TCGA-2Y-A9H3-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE II;45.0
TCGA-2Y-A9H4-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;68.0
TCGA-2Y-A9H5-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;1:DECEASED;STAGE I;59.0
TCGA-2Y-A9H6-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;0:LIVING;STAGE I;68.0
TCGA-2Y-A9H7-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;0:LIVING;STAGE I;81.0
TCGA-2Y-A9H8-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;1:DECEASED;STAGE II;85.0
TCGA-2Y-A9H9-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;70.0
TCGA-2Y-A9HA-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;STAGE II;70.0
TCGA-2Y-A9HB-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;66.0
TCGA-3K-AAZ8-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE IIIB;65.0
TCGA-4R-AA8I-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;STAGE II;66.0
TCGA-5C-A9VG-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE II;58.0
TCGA-5C-A9VH-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;70.0
TCGA-5C-AAPD-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE II;61.0
TCGA-5R-AA1C-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE II;57.0
TCGA-5R-AA1D-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;0:LIVING;STAGE IIIA;17.0
TCGA-5R-AAAM-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;1:DECEASED;STAGE II;65.0
TCGA-BC-4072-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;1:DECEASED;STAGE IIIA;74.0
TCGA-BC-4073-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE IIIA;73.0
TCGA-BC-A10Q-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;1:DECEASED;[Not Available];72.0
TCGA-BC-A10R-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;1:DECEASED;[Not Available];66.0
TCGA-BC-A10S-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;[Not Available];81.0
TCGA-BC-A10T-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;[Not Available];76.0
TCGA-BC-A10U-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;[Not Available];69.0
TCGA-BC-A10W-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;[Not Available];50.0
TCGA-BC-A10X-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;1:DECEASED;STAGE IIIA;52.0
TCGA-BC-A10Y-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;[Not Available];76.0
TCGA-BC-A10Z-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;1:DECEASED;STAGE I;62.0
TCGA-BC-A110-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;1:DECEASED;[Not Available];51.0
TCGA-BC-A112-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;[Not Available];80.0
TCGA-BC-A216-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;0:LIVING;STAGE IIIA;62.0
TCGA-BC-A217-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;1:DECEASED;STAGE II;75.0
TCGA-BC-A3KF-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;0:LIVING;STAGE I;66.0
TCGA-BC-A3KG-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;0:LIVING;STAGE II;68.0
TCGA-BC-A5W4-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;STAGE IIIA;69.0
TCGA-BC-A69H-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE II;64.0
TCGA-BC-A69I-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;69.0
TCGA-BC-A8YO-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;0:LIVING;STAGE IIIC;66.0
TCGA-BD-A2L6-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;[Not Available];69.0
TCGA-BD-A3EP-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;0:LIVING;STAGE I;75.0
TCGA-BW-A5NO-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE IIIA;50.0
TCGA-BW-A5NP-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;0:LIVING;STAGE IV;26.0
TCGA-BW-A5NQ-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;63.0
TCGA-CC-5258-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;STAGE II;48.0
TCGA-CC-5259-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;0:LIVING;STAGE IIIC;60.0
TCGA-CC-5260-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;1:DECEASED;STAGE IIIC;61.0
TCGA-CC-5261-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;STAGE II;44.0
TCGA-CC-5262-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;STAGE IIIC;67.0
TCGA-CC-5263-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;STAGE IIIA;35.0
TCGA-CC-5264-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;STAGE IIIA;71.0
TCGA-CC-A123-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;0:LIVING;STAGE IIIA;24.0
TCGA-CC-A1HT-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;STAGE IIIA;50.0
TCGA-CC-A3M9-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;STAGE IIIA;45.0
TCGA-CC-A3MA-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;STAGE IIIA;61.0
TCGA-CC-A3MB-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;STAGE IIIA;36.0
TCGA-CC-A3MC-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE IIIA;54.0
TCGA-CC-A5UC-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;STAGE IIIA;63.0
TCGA-CC-A5UD-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;STAGE IIIA;45.0
TCGA-CC-A5UE-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;STAGE IIIB;48.0
TCGA-CC-A7IE-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;STAGE IIIA;57.0
TCGA-CC-A7IF-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;STAGE IIIA;59.0
TCGA-CC-A7IG-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;STAGE II;47.0
TCGA-CC-A7IH-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE IIIA;58.0
TCGA-CC-A7II-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE IIIA;54.0
TCGA-CC-A7IJ-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE II;56.0
TCGA-CC-A7IK-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;STAGE IIIA;59.0
TCGA-CC-A7IL-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;STAGE IIIA;61.0
TCGA-CC-A8HT-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;STAGE IIIA;74.0
TCGA-CC-A8HU-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;1:DECEASED;STAGE IIIA;39.0
TCGA-CC-A8HV-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;1:DECEASED;STAGE II;51.0
TCGA-CC-A9FS-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE II;55.0
TCGA-CC-A9FU-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;0:LIVING;STAGE IIIA;52.0
TCGA-CC-A9FV-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE IIIA;57.0
TCGA-CC-A9FW-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE IIIA;68.0
TCGA-DD-A113-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;0:LIVING;STAGE II;55.0
TCGA-DD-A114-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;STAGE II;42.0
TCGA-DD-A115-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;STAGE IIIA;53.0
TCGA-DD-A116-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;STAGE IIIA;68.0
TCGA-DD-A118-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;0:LIVING;STAGE II;77.0
TCGA-DD-A119-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;STAGE IV;40.0
TCGA-DD-A11A-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;67.0
TCGA-DD-A11B-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;STAGE I;73.0
TCGA-DD-A11C-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;69.0
TCGA-DD-A11D-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;1:DECEASED;STAGE I;57.0
TCGA-DD-A1E9-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;STAGE I;70.0
TCGA-DD-A1EA-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE II;68.0
TCGA-DD-A1EB-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;0:LIVING;STAGE I;72.0
TCGA-DD-A1EC-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;0:LIVING;STAGE I;20.0
TCGA-DD-A1ED-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;68.0
TCGA-DD-A1EE-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;STAGE IIIA;73.0
TCGA-DD-A1EF-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;1:DECEASED;STAGE I;57.0
TCGA-DD-A1EG-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;STAGE I;76.0
TCGA-DD-A1EH-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE III;23.0
TCGA-DD-A1EI-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;46.0
TCGA-DD-A1EJ-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;1:DECEASED;STAGE IIIC;71.0
TCGA-DD-A1EK-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;1:DECEASED;STAGE IVB;64.0
TCGA-DD-A1EL-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;STAGE II;23.0
TCGA-DD-A39V-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;STAGE II;77.0
TCGA-DD-A39W-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;1:DECEASED;STAGE III;29.0
TCGA-DD-A39X-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;1:DECEASED;STAGE I;78.0
TCGA-DD-A39Y-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;STAGE I;67.0
TCGA-DD-A39Z-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;1:DECEASED;STAGE II;43.0
TCGA-DD-A3A0-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;STAGE I;70.0
TCGA-DD-A3A1-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;STAGE IIIA;65.0
TCGA-DD-A3A2-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;1:DECEASED;STAGE I;76.0
TCGA-DD-A3A3-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;STAGE I;45.0
TCGA-DD-A3A4-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;STAGE IIIA;37.0
TCGA-DD-A3A5-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;1:DECEASED;STAGE III;66.0
TCGA-DD-A3A6-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;1:DECEASED;STAGE II;72.0
TCGA-DD-A3A7-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;STAGE IIIB;67.0
TCGA-DD-A3A8-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;STAGE II;75.0
TCGA-DD-A3A9-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;1:DECEASED;STAGE IVB;64.0
TCGA-DD-A4NA-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;0:LIVING;STAGE IIIC;67.0
TCGA-DD-A4NB-01;Hepatobiliary Cancer;Male;Primary;Matched;FLC;0:LIVING;STAGE I;25.0
TCGA-DD-A4ND-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;0:LIVING;STAGE I;56.0
TCGA-DD-A4NE-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;1:DECEASED;STAGE IIIA;75.0
TCGA-DD-A4NF-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;72.0
TCGA-DD-A4NG-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;STAGE IIIA;77.0
TCGA-DD-A4NH-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;0:LIVING;STAGE IIIB;65.0
TCGA-DD-A4NI-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE II;67.0
TCGA-DD-A4NJ-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;0:LIVING;STAGE II;54.0
TCGA-DD-A4NK-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;1:DECEASED;STAGE IIIA;80.0
TCGA-DD-A4NL-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;46.0
TCGA-DD-A4NN-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;1:DECEASED;STAGE I;56.0
TCGA-DD-A4NO-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;65.0
TCGA-DD-A4NP-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;32.0
TCGA-DD-A4NQ-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;STAGE II;60.0
TCGA-DD-A4NR-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;1:DECEASED;STAGE I;85.0
TCGA-DD-A4NS-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;1:DECEASED;STAGE I;61.0
TCGA-DD-A4NV-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE IIIA;61.0
TCGA-DD-A73A-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;71.0
TCGA-DD-A73B-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;1:DECEASED;STAGE I;72.0
TCGA-DD-A73C-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;0:LIVING;STAGE IIIA;65.0
TCGA-DD-A73D-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;0:LIVING;STAGE II;68.0
TCGA-DD-A73E-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;66.0
TCGA-DD-A73F-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;0:LIVING;STAGE I;77.0
TCGA-DD-A73G-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;0:LIVING;STAGE I;73.0
TCGA-DD-AA3A-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;1:DECEASED;STAGE I;81.0
TCGA-DD-AAC8-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;STAGE I;72.0
TCGA-DD-AAC9-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;51.0
TCGA-DD-AACA-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;65.0
TCGA-DD-AACB-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;0:LIVING;STAGE I;74.0
TCGA-DD-AACC-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;STAGE I;61.0
TCGA-DD-AACD-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;STAGE I;48.0
TCGA-DD-AACE-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;62.0
TCGA-DD-AACF-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;STAGE I;68.0
TCGA-DD-AACG-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;STAGE II;52.0
TCGA-DD-AACH-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;STAGE II;69.0
TCGA-DD-AACI-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE II;69.0
TCGA-DD-AACJ-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE II;75.0
TCGA-DD-AACK-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;70.0
TCGA-DD-AACL-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;1:DECEASED;STAGE I;66.0
TCGA-DD-AACM-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE II;48.0
TCGA-DD-AACN-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;32.0
TCGA-DD-AACO-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;40.0
TCGA-DD-AACP-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;64.0
TCGA-DD-AACQ-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;STAGE II;50.0
TCGA-DD-AACS-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;39.0
TCGA-DD-AACT-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;0:LIVING;STAGE I;69.0
TCGA-DD-AACU-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;59.0
TCGA-DD-AACV-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;53.0
TCGA-DD-AACW-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;43.0
TCGA-DD-AACX-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE II;66.0
TCGA-DD-AACY-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;61.0
TCGA-DD-AACZ-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;1:DECEASED;STAGE I;63.0
TCGA-DD-AAD0-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;0:LIVING;STAGE I;73.0
TCGA-DD-AAD1-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;0:LIVING;STAGE I;51.0
TCGA-DD-AAD2-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;66.0
TCGA-DD-AAD3-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;43.0
TCGA-DD-AAD5-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;54.0
TCGA-DD-AAD6-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE IIIA;66.0
TCGA-DD-AAD8-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;0:LIVING;STAGE I;73.0
TCGA-DD-AADA-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;0:LIVING;STAGE I;66.0
TCGA-DD-AADB-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;51.0
TCGA-DD-AADC-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;STAGE I;53.0
TCGA-DD-AADD-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;51.0
TCGA-DD-AADE-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;50.0
TCGA-DD-AADF-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;1:DECEASED;STAGE I;64.0
TCGA-DD-AADG-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE IIIA;70.0
TCGA-DD-AADI-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;0:LIVING;STAGE I;43.0
TCGA-DD-AADJ-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;0:LIVING;STAGE I;70.0
TCGA-DD-AADK-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;0:LIVING;STAGE II;68.0
TCGA-DD-AADL-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;58.0
TCGA-DD-AADM-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;STAGE II;58.0
TCGA-DD-AADN-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;59.0
TCGA-DD-AADO-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;55.0
TCGA-DD-AADP-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;45.0
TCGA-DD-AADQ-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE II;59.0
TCGA-DD-AADR-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;58.0
TCGA-DD-AADS-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;63.0
TCGA-DD-AADU-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE II;60.0
TCGA-DD-AADV-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;50.0
TCGA-DD-AADW-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;48.0
TCGA-DD-AADY-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;0:LIVING;STAGE I;55.0
TCGA-DD-AAE0-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;0:LIVING;STAGE IIIA;45.0
TCGA-DD-AAE1-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;52.0
TCGA-DD-AAE2-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;51.0
TCGA-DD-AAE3-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;50.0
TCGA-DD-AAE4-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;0:LIVING;STAGE I;49.0
TCGA-DD-AAE6-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;0:LIVING;STAGE I;59.0
TCGA-DD-AAE7-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;72.0
TCGA-DD-AAE8-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;45.0
TCGA-DD-AAE9-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;69.0
TCGA-DD-AAEA-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;65.0
TCGA-DD-AAEB-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;60.0
TCGA-DD-AAED-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;51.0
TCGA-DD-AAEE-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;55.0
TCGA-DD-AAEG-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;0:LIVING;STAGE I;59.0
TCGA-DD-AAEH-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;73.0
TCGA-DD-AAEI-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;72.0
TCGA-DD-AAEK-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE II;51.0
TCGA-DD-AAVP-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;48.0
TCGA-DD-AAVQ-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;38.0
TCGA-DD-AAVR-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;44.0
TCGA-DD-AAVS-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;56.0
TCGA-DD-AAVU-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE II;46.0
TCGA-DD-AAVV-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE II;56.0
TCGA-DD-AAVW-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;35.0
TCGA-DD-AAVX-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE II;38.0
TCGA-DD-AAVY-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE IIIA;56.0
TCGA-DD-AAVZ-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;38.0
TCGA-DD-AAW0-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;54.0
TCGA-DD-AAW1-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE IIIA;55.0
TCGA-DD-AAW2-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;69.0
TCGA-DD-AAW3-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;69.0
TCGA-ED-A459-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE II;47.0
TCGA-ED-A4XI-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE II;58.0
TCGA-ED-A5KG-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;0:LIVING;STAGE II;60.0
TCGA-ED-A627-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;74.0
TCGA-ED-A66X-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE IIIA;35.0
TCGA-ED-A66Y-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;1:DECEASED;STAGE IIIA;51.0
TCGA-ED-A7PX-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;0:LIVING;STAGE II;48.0
TCGA-ED-A7PY-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;0:LIVING;STAGE II;20.0
TCGA-ED-A7PZ-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE II;61.0
TCGA-ED-A7XO-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE IIIA;29.0
TCGA-ED-A7XP-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;0:LIVING;STAGE II;53.0
TCGA-ED-A82E-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;0:LIVING;STAGE IIIA;60.0
TCGA-ED-A8O5-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;0:LIVING;STAGE IIIA;59.0
TCGA-ED-A8O6-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;1:DECEASED;STAGE IIIA;50.0
TCGA-ED-A97K-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE IIIA;54.0
TCGA-EP-A12J-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;62.0
TCGA-EP-A26S-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;70.0
TCGA-EP-A2KA-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;1:DECEASED;STAGE IIIA;52.0
TCGA-EP-A2KB-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;1:DECEASED;STAGE I;46.0
TCGA-EP-A2KC-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;STAGE I;62.0
TCGA-EP-A3JL-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;76.0
TCGA-EP-A3RK-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE IIIA;73.0
TCGA-ES-A2HS-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;STAGE I;80.0
TCGA-ES-A2HT-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;STAGE I;54.0
TCGA-FV-A23B-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;1:DECEASED;STAGE II;70.0
TCGA-FV-A2QQ-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;80.0
TCGA-FV-A2QR-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;STAGE I;75.0
TCGA-FV-A3I0-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;0:LIVING;STAGE II;76.0
TCGA-FV-A3I1-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;1:DECEASED;STAGE II;81.0
TCGA-FV-A3R2-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;STAGE I;75.0
TCGA-FV-A3R3-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;1:DECEASED;STAGE I;38.0
TCGA-FV-A495-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;0:LIVING;STAGE II;51.0
TCGA-FV-A496-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;0:LIVING;STAGE I;84.0
TCGA-FV-A4ZP-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;STAGE IIIA;78.0
TCGA-FV-A4ZQ-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;52.0
TCGA-G3-A25S-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;STAGE I;64.0
TCGA-G3-A25T-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;0:LIVING;STAGE IIIA;45.0
TCGA-G3-A25U-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;0:LIVING;STAGE I;63.0
TCGA-G3-A25V-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;68.0
TCGA-G3-A25W-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;0:LIVING;STAGE IIIB;79.0
TCGA-G3-A25X-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE II;73.0
TCGA-G3-A25Y-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;1:DECEASED;STAGE I;52.0
TCGA-G3-A25Z-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;58.0
TCGA-G3-A3CH-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE IIIA;53.0
TCGA-G3-A3CI-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;71.0
TCGA-G3-A3CJ-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE II;52.0
TCGA-G3-A3CK-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;61.0
TCGA-G3-A5SI-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;STAGE II;44.0
TCGA-G3-A5SJ-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;59.0
TCGA-G3-A5SK-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;58.0
TCGA-G3-A5SL-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE II;70.0
TCGA-G3-A5SM-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE II;58.0
TCGA-G3-A6UC-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE IIIB;65.0
TCGA-G3-A7M5-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;76.0
TCGA-G3-A7M6-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;0:LIVING;STAGE I;60.0
TCGA-G3-A7M7-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;65.0
TCGA-G3-A7M8-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;31.0
TCGA-G3-A7M9-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;STAGE IIIB;70.0
TCGA-G3-AAUZ-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;48.0
TCGA-G3-AAV0-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;58.0
TCGA-G3-AAV1-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;STAGE IIIC;51.0
TCGA-G3-AAV2-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;50.0
TCGA-G3-AAV3-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;0:LIVING;STAGE II;58.0
TCGA-G3-AAV4-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;1:DECEASED;STAGE I;83.0
TCGA-G3-AAV5-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE II;67.0
TCGA-G3-AAV6-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;1:DECEASED;STAGE IIIA;53.0
TCGA-G3-AAV7-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE II;38.0
TCGA-GJ-A3OU-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;59.0
TCGA-GJ-A6C0-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;1:DECEASED;STAGE II;75.0
TCGA-GJ-A9DB-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;STAGE I;68.0
TCGA-HP-A5MZ-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;STAGE I;78.0
TCGA-HP-A5N0-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;1:DECEASED;[Not Available];90.0
TCGA-K7-A5RF-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;64.0
TCGA-K7-A5RG-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;66.0
TCGA-K7-A6G5-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;66.0
TCGA-K7-AAU7-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE II;61.0
TCGA-KR-A7K0-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;STAGE I;65.0
TCGA-KR-A7K2-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;64.0
TCGA-KR-A7K7-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;0:LIVING;STAGE II;61.0
TCGA-KR-A7K8-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;57.0
TCGA-LG-A6GG-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;0:LIVING;STAGE II;79.0
TCGA-LG-A9QC-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;48.0
TCGA-LG-A9QD-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE IIIA;68.0
TCGA-MI-A75C-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;64.0
TCGA-MI-A75E-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE IIIC;61.0
TCGA-MI-A75G-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE II;63.0
TCGA-MI-A75H-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;[Not Available];77.0
TCGA-MI-A75I-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;[Not Available];61.0
TCGA-MR-A520-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;58.0
TCGA-MR-A8JO-01;Hepatobiliary Cancer;Male;Primary;Matched;FLC;0:LIVING;STAGE I;34.0
TCGA-NI-A4U2-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;STAGE IIIA;71.0
TCGA-NI-A8LF-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;74.0
TCGA-O8-A75V-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;54.0
TCGA-PD-A5DF-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;1:DECEASED;STAGE IIIB;58.0
TCGA-QA-A7B7-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE II;48.0
TCGA-RC-A6M3-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE II;24.0
TCGA-RC-A6M4-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;0:LIVING;STAGE IIIA;74.0
TCGA-RC-A6M5-01;Hepatobiliary Cancer;Female;Primary;Matched;FLC;0:LIVING;STAGE IVA;20.0
TCGA-RC-A6M6-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE II;75.0
TCGA-RC-A7S9-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;0:LIVING;STAGE I;47.0
TCGA-RC-A7SB-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE II;53.0
TCGA-RC-A7SF-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;66.0
TCGA-RC-A7SH-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE II;42.0
TCGA-RC-A7SK-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;59.0
TCGA-RG-A7D4-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE II;69.0
TCGA-UB-A7MA-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;0:LIVING;STAGE II;62.0
TCGA-UB-A7MB-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE II;24.0
TCGA-UB-A7MC-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE IIIA;59.0
TCGA-UB-A7MD-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;STAGE I;67.0
TCGA-UB-A7ME-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;51.0
TCGA-UB-A7MF-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;STAGE IIIA;56.0
TCGA-UB-AA0U-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE II;60.0
TCGA-UB-AA0V-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;0:LIVING;STAGE I;69.0
TCGA-WJ-A86L-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;0:LIVING;STAGE I;68.0
TCGA-WQ-A9G7-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;0:LIVING;[Not Available];71.0
TCGA-WQ-AB4B-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE II;62.0
TCGA-WX-AA44-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;0:LIVING;STAGE I;64.0
TCGA-WX-AA46-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE II;61.0
TCGA-WX-AA47-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;1:DECEASED;STAGE IIIA;33.0
TCGA-XR-A8TD-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;0:LIVING;STAGE IIIB;49.0
TCGA-XR-A8TE-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE IIIA;16.0
TCGA-XR-A8TF-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;STAGE I;74.0
TCGA-XR-A8TG-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE I;58.0
TCGA-YA-A8S7-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;STAGE IIIA;68.0
TCGA-ZP-A9CV-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;[Not Available];59.0
TCGA-ZP-A9CY-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;0:LIVING;[Not Available];66.0
TCGA-ZP-A9CZ-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;[Not Available];72.0
TCGA-ZP-A9D0-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;0:LIVING;[Not Available];67.0
TCGA-ZP-A9D1-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;0:LIVING;[Not Available];56.0
TCGA-ZP-A9D2-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;[Not Available];51.0
TCGA-ZP-A9D4-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;0:LIVING;[Not Available];64.0
TCGA-ZS-A9CD-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;1:DECEASED;STAGE II;73.0
TCGA-ZS-A9CE-01;Hepatobiliary Cancer;Female;Primary;Matched;HCC;0:LIVING;STAGE II;79.0
TCGA-ZS-A9CF-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE II;64.0
TCGA-ZS-A9CG-01;Hepatobiliary Cancer;Male;Primary;Matched;HCC;0:LIVING;STAGE II;55.0
TCGA-FF-8041-01;Non-Hodgkin Lymphoma;Male;Primary;Matched;DLBCLNOS;0:LIVING;[Not Applicable];75
TCGA-FF-8042-01;Non-Hodgkin Lymphoma;Male;Primary;Matched;DLBCLNOS;0:LIVING;[Not Applicable];67
TCGA-FF-8043-01;Non-Hodgkin Lymphoma;Male;Primary;Matched;DLBCLNOS;1:DECEASED;[Not Applicable];40
TCGA-FF-8046-01;Non-Hodgkin Lymphoma;Male;Primary;Matched;DLBCLNOS;1:DECEASED;[Not Applicable];73
TCGA-FF-8047-01;Non-Hodgkin Lymphoma;Female;Primary;Matched;DLBCLNOS;0:LIVING;[Not Applicable];58
TCGA-FF-8061-01;Non-Hodgkin Lymphoma;Female;Primary;Matched;DLBCLNOS;0:LIVING;[Not Applicable];54
TCGA-FF-8062-01;Non-Hodgkin Lymphoma;Female;Primary;Matched;DLBCLNOS;1:DECEASED;[Not Applicable];61
TCGA-FM-8000-01;Non-Hodgkin Lymphoma;Female;Primary;Matched;DLBCLNOS;0:LIVING;[Not Applicable];48
TCGA-G8-6324-01;Non-Hodgkin Lymphoma;Female;Primary;Matched;DLBCLNOS;0:LIVING;[Not Applicable];64
TCGA-G8-6325-01;Non-Hodgkin Lymphoma;Female;Primary;Matched;DLBCLNOS;0:LIVING;[Not Applicable];28
TCGA-G8-6326-01;Non-Hodgkin Lymphoma;Female;Primary;Matched;DLBCLNOS;0:LIVING;[Not Applicable];57
TCGA-G8-6906-01;Non-Hodgkin Lymphoma;Female;Primary;Matched;DLBCLNOS;0:LIVING;[Not Applicable];70
TCGA-G8-6907-01;Non-Hodgkin Lymphoma;Male;Primary;Matched;DLBCLNOS;0:LIVING;[Not Applicable];51
TCGA-G8-6909-01;Non-Hodgkin Lymphoma;Female;Primary;Matched;DLBCLNOS;0:LIVING;[Not Applicable];38
TCGA-G8-6914-01;Non-Hodgkin Lymphoma;Male;Primary;Matched;DLBCLNOS;0:LIVING;[Not Applicable];42
TCGA-GR-7351-01;Non-Hodgkin Lymphoma;Female;Primary;Matched;DLBCLNOS;0:LIVING;[Not Applicable];60
TCGA-GR-7353-01;Non-Hodgkin Lymphoma;Male;Primary;Matched;DLBCLNOS;0:LIVING;[Not Applicable];74
TCGA-FA-8693-01;Lymphoid Cancer;Male;Primary;Matched;MBN;1:DECEASED;[Not Applicable];61
TCGA-FA-A4BB-01;Non-Hodgkin Lymphoma;Male;Primary;Matched;DLBCLNOS;0:LIVING;[Not Applicable];72
TCGA-FA-A4XK-01;Non-Hodgkin Lymphoma;Male;Primary;Matched;DLBCLNOS;0:LIVING;[Not Applicable];46
TCGA-FA-A6HN-01;Non-Hodgkin Lymphoma;Female;Primary;Matched;DLBCLNOS;0:LIVING;[Not Applicable];70
TCGA-FA-A6HO-01;Non-Hodgkin Lymphoma;Female;Primary;Matched;DLBCLNOS;1:DECEASED;[Not Applicable];43
TCGA-GR-A4D4-01;Non-Hodgkin Lymphoma;Male;Primary;Matched;DLBCLNOS;0:LIVING;[Not Applicable];69
TCGA-GR-A4D5-01;Non-Hodgkin Lymphoma;Male;Primary;Matched;DLBCLNOS;0:LIVING;[Not Applicable];52
TCGA-GR-A4D6-01;Non-Hodgkin Lymphoma;Male;Primary;Matched;DLBCLNOS;1:DECEASED;[Not Applicable];58
TCGA-GR-A4D9-01;Non-Hodgkin Lymphoma;Female;Primary;Matched;DLBCLNOS;1:DECEASED;[Not Applicable];57
TCGA-RQ-A68N-01;Non-Hodgkin Lymphoma;Male;Primary;Matched;DLBCLNOS;1:DECEASED;[Not Applicable];67
TCGA-RQ-A6JB-01;Non-Hodgkin Lymphoma;Male;Primary;Matched;DLBCLNOS;0:LIVING;[Not Applicable];67
TCGA-FA-A7DS-01;Non-Hodgkin Lymphoma;Female;Primary;Matched;DLBCLNOS;0:LIVING;[Not Applicable];56
TCGA-FA-A7Q1-01;Non-Hodgkin Lymphoma;Male;Primary;Matched;DLBCLNOS;0:LIVING;[Not Applicable];36
TCGA-FA-A82F-01;Non-Hodgkin Lymphoma;Female;Primary;Matched;DLBCLNOS;0:LIVING;[Not Applicable];57
TCGA-FA-A86F-01;Non-Hodgkin Lymphoma;Female;Primary;Matched;DLBCLNOS;0:LIVING;[Not Applicable];46
TCGA-FF-A7CQ-01;Non-Hodgkin Lymphoma;Female;Primary;Matched;DLBCLNOS;0:LIVING;[Not Applicable];54
TCGA-FF-A7CR-01;Non-Hodgkin Lymphoma;Female;Primary;Matched;DLBCLNOS;0:LIVING;[Not Applicable];66
TCGA-FF-A7CW-01;Non-Hodgkin Lymphoma;Female;Primary;Matched;DLBCLNOS;0:LIVING;[Not Applicable];69
TCGA-FF-A7CX-01;Non-Hodgkin Lymphoma;Male;Primary;Matched;DLBCLNOS;0:LIVING;[Not Applicable];70
TCGA-GS-A9TQ-01;Non-Hodgkin Lymphoma;Male;Primary;Matched;DLBCLNOS;0:LIVING;[Not Applicable];45
TCGA-GS-A9TT-01;Non-Hodgkin Lymphoma;Female;Primary;Matched;DLBCLNOS;0:LIVING;[Not Applicable];40
TCGA-GS-A9TU-01;Non-Hodgkin Lymphoma;Female;Primary;Matched;DLBCLNOS;0:LIVING;[Not Applicable];23
TCGA-GS-A9TV-01;Non-Hodgkin Lymphoma;Male;Primary;Matched;DLBCLNOS;0:LIVING;[Not Applicable];37
TCGA-GS-A9TW-01;Non-Hodgkin Lymphoma;Female;Primary;Matched;DLBCLNOS;0:LIVING;[Not Applicable];82
TCGA-GS-A9TX-01;Non-Hodgkin Lymphoma;Male;Primary;Matched;DLBCLNOS;0:LIVING;[Not Applicable];51
TCGA-VB-A8QN-01;Non-Hodgkin Lymphoma;Female;Primary;Matched;DLBCLNOS;0:LIVING;[Not Applicable];77
TCGA-GS-A9TY-01;Non-Hodgkin Lymphoma;Female;Primary;Matched;DLBCLNOS;1:DECEASED;[Not Applicable];27
TCGA-GS-A9TZ-01;Non-Hodgkin Lymphoma;Male;Primary;Matched;DLBCLNOS;0:LIVING;[Not Applicable];63
TCGA-GS-A9U3-01;Non-Hodgkin Lymphoma;Female;Primary;Matched;DLBCLNOS;0:LIVING;[Not Applicable];62
TCGA-GS-A9U4-01;Non-Hodgkin Lymphoma;Female;Primary;Matched;DLBCLNOS;0:LIVING;[Not Applicable];63
TCGA-RQ-AAAT-01;Non-Hodgkin Lymphoma;Male;Primary;Matched;DLBCLNOS;0:LIVING;[Not Applicable];55
TCGA-05-4244-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IV;70.0
TCGA-05-4249-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IB;67.0
TCGA-05-4250-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IIIA;79.0
TCGA-05-4382-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IB;68.0
TCGA-05-4384-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IIIA;66.0
TCGA-05-4389-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IA;70.0
TCGA-05-4390-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IB;58.0
TCGA-05-4395-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IIIB;76.0
TCGA-05-4396-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IIIB;76.0
TCGA-05-4397-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IIB;65.0
TCGA-05-4398-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IIIB;47.0
TCGA-05-4402-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IV;57.0
TCGA-05-4403-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IB;76.0
TCGA-05-4405-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IB;74.0
TCGA-05-4410-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IB;62.0
TCGA-05-4415-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IIIB;57.0
TCGA-05-4417-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IB;51.0
TCGA-05-4418-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IIIA;69.0
TCGA-05-4420-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IB;41.0
TCGA-05-4422-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IB;68.0
TCGA-05-4424-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IIB;70.0
TCGA-05-4425-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IV;70.0
TCGA-05-4426-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IB;71.0
TCGA-05-4427-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IIB;65.0
TCGA-05-4430-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IB;59.0
TCGA-05-4432-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IIB;66.0
TCGA-05-4433-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IB;82.0
TCGA-05-4434-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IV;67.0
TCGA-05-5423-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IIB;65.0
TCGA-05-5425-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IIB;68.0
TCGA-05-5428-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IIA;57.0
TCGA-05-5429-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IIIA;60.0
TCGA-05-5715-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IB;69.0
TCGA-35-3615-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IB;57.0
TCGA-35-4122-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IA;69.0
TCGA-35-4123-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IA;38.0
TCGA-35-5375-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IIIA;61.0
TCGA-38-4625-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IB;66.0
TCGA-38-4626-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IIA;57.0
TCGA-38-4627-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IIA;64.0
TCGA-38-4628-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IIB;65.0
TCGA-38-4631-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IB;72.0
TCGA-38-4632-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IV;42.0
TCGA-38-6178-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IIIA;70.0
TCGA-38-7271-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IA;72.0
TCGA-38-A44F-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IB;80.0
TCGA-44-2655-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IA;65.0
TCGA-44-2656-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IB;59.0
TCGA-44-2657-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IB;74.0
TCGA-44-2659-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IIB;65.0
TCGA-44-2662-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IB;65.0
TCGA-44-2665-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IIB;55.0
TCGA-44-2666-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IB;43.0
TCGA-44-2668-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IB;51.0
TCGA-44-3396-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IIIA;74.0
TCGA-44-3398-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IA;77.0
TCGA-44-3917-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IB;33.0
TCGA-44-3918-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IA;60.0
TCGA-44-3919-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IA;71.0
TCGA-44-4112-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IB;60.0
TCGA-44-5643-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IIIA;53.0
TCGA-44-5644-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IB;51.0
TCGA-44-5645-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IA;61.0
TCGA-44-6144-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IA;58.0
TCGA-44-6145-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IA;62.0
TCGA-44-6146-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IIB;64.0
TCGA-44-6148-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IA;60.0
TCGA-44-6774-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IIIA;56.0
TCGA-44-6775-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IB;72.0
TCGA-44-6776-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IA;60.0
TCGA-44-6777-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IB;85.0
TCGA-44-6778-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IA;59.0
TCGA-44-6779-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IIB;50.0
TCGA-44-7659-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IA;70.0
TCGA-44-7660-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IB;72.0
TCGA-44-7661-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IB;69.0
TCGA-44-7662-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IB;61.0
TCGA-44-7667-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IIB;49.0
TCGA-44-7669-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IIA;59.0
TCGA-44-7670-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IIA;47.0
TCGA-44-7671-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IB;64.0
TCGA-44-7672-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IA;52.0
TCGA-44-8117-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IB;54.0
TCGA-44-8119-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IIB;73.0
TCGA-44-8120-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IB;58.0
TCGA-44-A479-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IB;73.0
TCGA-44-A47A-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IB;78.0
TCGA-44-A47B-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IB;79.0
TCGA-44-A47F-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IIB;74.0
TCGA-44-A47G-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IA;73.0
TCGA-44-A4SS-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IA;73.0
TCGA-44-A4SU-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IA;67.0
TCGA-49-4486-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IA;72.0
TCGA-49-4487-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IA;72.0
TCGA-49-4488-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IA;74.0
TCGA-49-4490-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IIIA;45.0
TCGA-49-4494-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IIIA;77.0
TCGA-49-4501-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IB;67.0
TCGA-49-4505-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IIB;61.0
TCGA-49-4506-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IIB;68.0
TCGA-49-4507-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IIIA;73.0
TCGA-49-4510-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IIB;51.0
TCGA-49-4512-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IIIA;69.0
TCGA-49-4514-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IA;79.0
TCGA-49-6742-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IIA;70.0
TCGA-49-6743-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IIIA;81.0
TCGA-49-6744-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IIA;64.0
TCGA-49-6745-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IIIA;82.0
TCGA-49-6761-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IIIA;68.0
TCGA-49-6767-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IIB;46.0
TCGA-49-AAQV-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE II;63.0
TCGA-49-AAR0-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IA;57.0
TCGA-49-AAR2-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IB;64.0
TCGA-49-AAR3-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IIB;69.0
TCGA-49-AAR4-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IIIA;51.0
TCGA-49-AAR9-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IIB;61.0
TCGA-49-AARE-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IA;51.0
TCGA-49-AARN-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IA;56.0
TCGA-49-AARO-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IA;39.0
TCGA-49-AARQ-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE I;41.0
TCGA-49-AARR-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IA;68.0
TCGA-4B-A93V-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IA;52.0
TCGA-50-5044-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IIIB;72.0
TCGA-50-5045-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IA;57.0
TCGA-50-5049-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IA;70.0
TCGA-50-5051-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IIIA;42.0
TCGA-50-5055-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IIA;79.0
TCGA-50-5066-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IB;72.0
TCGA-50-5068-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IIB;59.0
TCGA-50-5072-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IIIA;74.0
TCGA-50-5930-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IIIA;47.0
TCGA-50-5931-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IB;75.0
TCGA-50-5932-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IIB;75.0
TCGA-50-5933-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IIIB;72.0
TCGA-50-5935-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IA;86.0
TCGA-50-5936-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IIIA;58.0
TCGA-50-5939-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IB;85.0
TCGA-50-5941-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IIIA;55.0
TCGA-50-5942-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IA;67.0
TCGA-50-5944-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IA;69.0
TCGA-50-5946-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IA;62.0
TCGA-50-6590-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IB;72.0
TCGA-50-6591-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IV;63.0
TCGA-50-6592-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IB;71.0
TCGA-50-6593-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IIIA;49.0
TCGA-50-6594-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IIIA;79.0
TCGA-50-6595-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IIIA;74.0
TCGA-50-6597-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IB;79.0
TCGA-50-6673-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE I;84.0
TCGA-50-7109-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IA;60.0
TCGA-50-8457-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IA;63.0
TCGA-50-8459-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IIB;68.0
TCGA-50-8460-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IA;74.0
TCGA-53-7624-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IV;40.0
TCGA-53-7626-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IIA;76.0
TCGA-53-7813-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IIIB;51.0
TCGA-53-A4EZ-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IIA;63.0
TCGA-55-1592-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IA;65.0
TCGA-55-1594-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IIIA;68.0
TCGA-55-1595-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IA;74.0
TCGA-55-1596-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IIB;55.0
TCGA-55-5899-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IA;58.0
TCGA-55-6543-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IA;60.0
TCGA-55-6642-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IB;63.0
TCGA-55-6712-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IIA;71.0
TCGA-55-6968-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IV;61.0
TCGA-55-6969-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IB;52.0
TCGA-55-6970-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IIIA;67.0
TCGA-55-6971-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IB;59.0
TCGA-55-6972-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IB;72.0
TCGA-55-6975-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IIB;61.0
TCGA-55-6978-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IIA;81.0
TCGA-55-6979-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IIB;59.0
TCGA-55-6980-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IA;56.0
TCGA-55-6981-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IIIA;53.0
TCGA-55-6982-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IIB;79.0
TCGA-55-6983-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IIB;81.0
TCGA-55-6984-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IIB;71.0
TCGA-55-6985-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IB;58.0
TCGA-55-6986-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IB;74.0
TCGA-55-6987-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IA;77.0
TCGA-55-7227-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IIIA;77.0
TCGA-55-7281-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IA;70.0
TCGA-55-7283-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IIIA;76.0
TCGA-55-7284-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IIB;74.0
TCGA-55-7570-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IA;60.0
TCGA-55-7573-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IA;72.0
TCGA-55-7574-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IB;64.0
TCGA-55-7576-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IB;54.0
TCGA-55-7724-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IB;76.0
TCGA-55-7725-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IA;68.0
TCGA-55-7726-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IA;72.0
TCGA-55-7727-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IIIA;70.0
TCGA-55-7728-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IB;64.0
TCGA-55-7815-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IB;76.0
TCGA-55-7816-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IV;49.0
TCGA-55-7903-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IA;64.0
TCGA-55-7907-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IIA;77.0
TCGA-55-7910-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IIA;50.0
TCGA-55-7911-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IA;70.0
TCGA-55-7913-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IA;61.0
TCGA-55-7914-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IIA;71.0
TCGA-55-7994-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IIB;81.0
TCGA-55-7995-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IA;73.0
TCGA-55-8085-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IA;64.0
TCGA-55-8087-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IB;59.0
TCGA-55-8089-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IA;56.0
TCGA-55-8090-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IA;80.0
TCGA-55-8091-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IB;74.0
TCGA-55-8092-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IIB;75.0
TCGA-55-8094-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IV;51.0
TCGA-55-8096-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IB;67.0
TCGA-55-8097-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IA;60.0
TCGA-55-8203-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IA;69.0
TCGA-55-8204-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IB;87.0
TCGA-55-8205-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IIA;76.0
TCGA-55-8206-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IA;56.0
TCGA-55-8207-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IB;73.0
TCGA-55-8208-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IA;73.0
TCGA-55-8299-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IA;61.0
TCGA-55-8301-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IB;58.0
TCGA-55-8302-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IB;54.0
TCGA-55-8505-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IIIA;62.0
TCGA-55-8506-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IIB;62.0
TCGA-55-8507-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IA;53.0
TCGA-55-8508-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IIA;60.0
TCGA-55-8510-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IB;55.0
TCGA-55-8511-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IB;73.0
TCGA-55-8512-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IV;41.0
TCGA-55-8513-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IIB;77.0
TCGA-55-8514-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IB;70.0
TCGA-55-8614-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IB;76.0
TCGA-55-8615-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IIIA;67.0
TCGA-55-8616-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IB;58.0
TCGA-55-8619-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IIB;72.0
TCGA-55-8620-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IV;60.0
TCGA-55-8621-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IA;75.0
TCGA-55-A48X-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IIA;63.0
TCGA-55-A48Y-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IIA;69.0
TCGA-55-A48Z-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IIIB;60.0
TCGA-55-A490-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IIA;78.0
TCGA-55-A491-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IA;81.0
TCGA-55-A492-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IA;70.0
TCGA-55-A493-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IB;54.0
TCGA-55-A494-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IB;61.0
TCGA-55-A4DF-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IA;88.0
TCGA-55-A4DG-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IA;71.0
TCGA-55-A57B-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IA;80.0
TCGA-62-8394-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IIIB;65.0
TCGA-62-8395-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IIB;80.0
TCGA-62-8397-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IIB;70.0
TCGA-62-8398-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IIIA;55.0
TCGA-62-8399-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IIIA;62.0
TCGA-62-8402-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IIIA;73.0
TCGA-62-A46O-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IB;65.0
TCGA-62-A46P-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IB;65.0
TCGA-62-A46R-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IB;54.0
TCGA-62-A46S-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IB;73.0
TCGA-62-A46U-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IIB;71.0
TCGA-62-A46V-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IB;78.0
TCGA-62-A46Y-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IIIA;70.0
TCGA-62-A470-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IB;84.0
TCGA-62-A471-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IIB;64.0
TCGA-62-A472-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IIB;70.0
TCGA-64-1676-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IA;58.0
TCGA-64-1677-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IIIA;77.0
TCGA-64-1678-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IIA;70.0
TCGA-64-1679-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IIIA;58.0
TCGA-64-1680-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IV;63.0
TCGA-64-1681-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IA;61.0
TCGA-64-5774-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IB;60.0
TCGA-64-5775-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IIIA;71.0
TCGA-64-5778-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IB;60.0
TCGA-64-5779-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IIIA;61.0
TCGA-64-5781-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IB;55.0
TCGA-64-5815-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IIB;74.0
TCGA-67-3770-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IA;70.0
TCGA-67-3771-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IA;77.0
TCGA-67-3772-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IB;82.0
TCGA-67-3773-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IB;84.0
TCGA-67-3774-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IB;73.0
TCGA-67-4679-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;[Not Available];69.0
TCGA-67-6215-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IB;52.0
TCGA-67-6216-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IA;57.0
TCGA-67-6217-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IIA;73.0
TCGA-69-7760-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IIB;73.0
TCGA-69-7761-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IB;84.0
TCGA-69-7763-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IA;69.0
TCGA-69-7764-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IA;75.0
TCGA-69-7765-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IV;56.0
TCGA-69-7973-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IB;42.0
TCGA-69-7974-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IIIA;54.0
TCGA-69-7978-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IIB;59.0
TCGA-69-7979-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IB;71.0
TCGA-69-7980-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE I;70.0
TCGA-69-8253-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IIA;59.0
TCGA-69-8254-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;[Not Available];85.0
TCGA-69-8255-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IA;71.0
TCGA-69-8453-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IIB;77.0
TCGA-69-A59K-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IIB;60.0
TCGA-71-6725-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IB;48.0
TCGA-71-8520-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IB;60.0
TCGA-73-4658-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IB;80.0
TCGA-73-4659-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IIIA;66.0
TCGA-73-4662-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IA;65.0
TCGA-73-4666-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IV;52.0
TCGA-73-4668-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IIB;66.0
TCGA-73-4670-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IV;69.0
TCGA-73-4675-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IIIA;59.0
TCGA-73-4676-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IIA;45.0
TCGA-73-4677-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IA;74.0
TCGA-73-7498-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IA;58.0
TCGA-73-7499-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IB;81.0
TCGA-73-A9RS-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IIB;41.0
TCGA-75-5122-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IB;[Not Available]
TCGA-75-5125-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IIB;[Not Available]
TCGA-75-5126-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IIIA;[Not Available]
TCGA-75-5146-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IB;[Not Available]
TCGA-75-5147-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IB;[Not Available]
TCGA-75-6203-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IIIA;[Not Available]
TCGA-75-6205-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IB;[Not Available]
TCGA-75-6206-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IB;[Not Available]
TCGA-75-6207-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IIIA;[Not Available]
TCGA-75-6211-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IB;[Not Available]
TCGA-75-6212-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IIB;[Not Available]
TCGA-75-6214-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IIIA;[Not Available]
TCGA-75-7025-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IB;[Not Available]
TCGA-75-7027-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IB;[Not Available]
TCGA-75-7030-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IIB;[Not Available]
TCGA-75-7031-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IB;[Not Available]
TCGA-78-7143-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IB;62.0
TCGA-78-7145-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IV;52.0
TCGA-78-7146-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IIIA;71.0
TCGA-78-7147-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IIB;67.0
TCGA-78-7148-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IIB;71.0
TCGA-78-7149-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IIIB;71.0
TCGA-78-7150-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IIB;59.0
TCGA-78-7152-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IB;65.0
TCGA-78-7153-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IB;65.0
TCGA-78-7154-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IIIA;72.0
TCGA-78-7155-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IB;68.0
TCGA-78-7156-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IV;62.0
TCGA-78-7158-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IIIB;59.0
TCGA-78-7159-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IA;60.0
TCGA-78-7160-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IV;61.0
TCGA-78-7161-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IIB;69.0
TCGA-78-7162-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IA;75.0
TCGA-78-7163-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IB;60.0
TCGA-78-7166-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IIB;84.0
TCGA-78-7167-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IV;77.0
TCGA-78-7220-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IIIA;53.0
TCGA-78-7535-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IB;45.0
TCGA-78-7536-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IIIA;69.0
TCGA-78-7537-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IB;72.0
TCGA-78-7539-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IIA;75.0
TCGA-78-7540-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IB;66.0
TCGA-78-7542-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IB;56.0
TCGA-78-7633-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IB;67.0
TCGA-78-8640-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IIA;59.0
TCGA-78-8648-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IIB;58.0
TCGA-78-8655-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IA;77.0
TCGA-78-8660-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IIB;69.0
TCGA-78-8662-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IB;53.0
TCGA-80-5607-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IIB;[Not Available]
TCGA-80-5608-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IA;[Not Available]
TCGA-80-5611-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IB;[Not Available]
TCGA-83-5908-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IA;59.0
TCGA-86-6562-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IIA;52.0
TCGA-86-6851-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IIA;73.0
TCGA-86-7701-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IV;66.0
TCGA-86-7711-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IIA;70.0
TCGA-86-7713-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IIA;70.0
TCGA-86-7714-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IIIA;61.0
TCGA-86-7953-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IA;69.0
TCGA-86-7954-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IB;68.0
TCGA-86-7955-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IB;62.0
TCGA-86-8054-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IIB;61.0
TCGA-86-8055-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IIA;79.0
TCGA-86-8056-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IIIA;63.0
TCGA-86-8073-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IB;58.0
TCGA-86-8074-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IIA;62.0
TCGA-86-8075-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IB;66.0
TCGA-86-8076-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IA;42.0
TCGA-86-8278-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IIB;63.0
TCGA-86-8279-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IIA;46.0
TCGA-86-8280-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IIA;54.0
TCGA-86-8281-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IA;75.0
TCGA-86-8358-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IB;44.0
TCGA-86-8359-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IIIA;52.0
TCGA-86-8585-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IB;57.0
TCGA-86-8668-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IA;61.0
TCGA-86-8669-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IA;64.0
TCGA-86-8671-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IIB;72.0
TCGA-86-8672-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IIB;59.0
TCGA-86-8673-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IB;61.0
TCGA-86-8674-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IIA;50.0
TCGA-86-A456-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IA;78.0
TCGA-86-A4D0-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IIA;48.0
TCGA-86-A4JF-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IIB;56.0
TCGA-86-A4P7-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IB;63.0
TCGA-86-A4P8-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IIIA;59.0
TCGA-91-6828-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IA;70.0
TCGA-91-6829-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IB;78.0
TCGA-91-6830-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IIA;65.0
TCGA-91-6831-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IB;66.0
TCGA-91-6835-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IA;81.0
TCGA-91-6836-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IB;52.0
TCGA-91-6840-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IA;59.0
TCGA-91-6847-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IB;62.0
TCGA-91-6848-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IIIA;59.0
TCGA-91-6849-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IIIA;75.0
TCGA-91-7771-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IIB;62.0
TCGA-91-8496-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IB;63.0
TCGA-91-8497-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IA;75.0
TCGA-91-8499-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IA;76.0
TCGA-91-A4BC-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IIA;59.0
TCGA-91-A4BD-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IIA;78.0
TCGA-93-7347-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IA;76.0
TCGA-93-7348-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IA;75.0
TCGA-93-8067-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IB;77.0
TCGA-93-A4JN-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IV;71.0
TCGA-93-A4JO-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IA;70.0
TCGA-93-A4JP-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IV;64.0
TCGA-93-A4JQ-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IA;49.0
TCGA-95-7039-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IIB;54.0
TCGA-95-7043-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IA;63.0
TCGA-95-7562-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IIA;71.0
TCGA-95-7567-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IIB;61.0
TCGA-95-7944-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IA;71.0
TCGA-95-7947-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IA;67.0
TCGA-95-7948-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IB;42.0
TCGA-95-8039-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IA;72.0
TCGA-95-8494-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IIA;67.0
TCGA-95-A4VK-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IIIA;74.0
TCGA-95-A4VN-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IIA;62.0
TCGA-95-A4VP-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IIIA;66.0
TCGA-97-7546-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IA;76.0
TCGA-97-7547-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IB;67.0
TCGA-97-7552-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IB;70.0
TCGA-97-7553-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IA;58.0
TCGA-97-7554-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IIIA;83.0
TCGA-97-7937-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IB;65.0
TCGA-97-7938-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IA;76.0
TCGA-97-7941-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IA;72.0
TCGA-97-8171-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IV;81.0
TCGA-97-8172-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IB;75.0
TCGA-97-8174-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IIA;67.0
TCGA-97-8175-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IB;55.0
TCGA-97-8176-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IIIA;63.0
TCGA-97-8177-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IB;59.0
TCGA-97-8179-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IA;72.0
TCGA-97-8547-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IIIA;78.0
TCGA-97-8552-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE I;55.0
TCGA-97-A4LX-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IB;81.0
TCGA-97-A4M0-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IB;60.0
TCGA-97-A4M1-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IA;52.0
TCGA-97-A4M2-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IA;66.0
TCGA-97-A4M3-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IA;69.0
TCGA-97-A4M5-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IA;83.0
TCGA-97-A4M6-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IA;45.0
TCGA-97-A4M7-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IA;74.0
TCGA-99-7458-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IIIA;74.0
TCGA-99-8025-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IIIA;72.0
TCGA-99-8028-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IA;50.0
TCGA-99-8032-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IA;61.0
TCGA-99-8033-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IV;74.0
TCGA-99-AA5R-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IA;70.0
TCGA-J2-8192-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IIA;65.0
TCGA-J2-8194-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IIB;69.0
TCGA-J2-A4AD-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IA;61.0
TCGA-J2-A4AE-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IA;77.0
TCGA-J2-A4AG-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IA;66.0
TCGA-L4-A4E5-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE I;48.0
TCGA-L4-A4E6-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IA;67.0
TCGA-L9-A443-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IA;63.0
TCGA-L9-A444-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IA;60.0
TCGA-L9-A50W-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IIA;75.0
TCGA-L9-A5IP-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IV;40.0
TCGA-L9-A743-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IIA;56.0
TCGA-L9-A7SV-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IIA;69.0
TCGA-L9-A8F4-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IB;64.0
TCGA-MN-A4N1-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IIA;60.0
TCGA-MN-A4N4-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IA;57.0
TCGA-MN-A4N5-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IA;63.0
TCGA-MP-A4SV-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IB;67.0
TCGA-MP-A4SW-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IIB;53.0
TCGA-MP-A4SY-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IIB;61.0
TCGA-MP-A4T2-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IA;71.0
TCGA-MP-A4T4-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IIB;68.0
TCGA-MP-A4T6-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IIIA;76.0
TCGA-MP-A4T7-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IV;75.0
TCGA-MP-A4T8-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IIIA;68.0
TCGA-MP-A4T9-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IIIA;54.0
TCGA-MP-A4TA-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IA;75.0
TCGA-MP-A4TC-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IIIA;77.0
TCGA-MP-A4TD-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IIIA;71.0
TCGA-MP-A4TE-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IIA;56.0
TCGA-MP-A4TF-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IIA;58.0
TCGA-MP-A4TH-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IA;70.0
TCGA-MP-A4TI-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;1:DECEASED;STAGE IIA;72.0
TCGA-MP-A4TJ-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IA;62.0
TCGA-MP-A4TK-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IIB;56.0
TCGA-MP-A5C7-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IB;76.0
TCGA-NJ-A4YF-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IA;50.0
TCGA-NJ-A4YG-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IB;65.0
TCGA-NJ-A4YI-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IIIA;87.0
TCGA-NJ-A4YP-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IB;52.0
TCGA-NJ-A4YQ-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IA;69.0
TCGA-NJ-A55A-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IB;76.0
TCGA-NJ-A55O-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IIA;56.0
TCGA-NJ-A55R-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IA;67.0
TCGA-NJ-A7XG-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;STAGE IIIA;49.0
TCGA-O1-A52J-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;1:DECEASED;STAGE IA;74.0
TCGA-S2-AA1A-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;STAGE IA;68.0
TCGA-17-Z053-01;Non-Small Cell Lung Cancer;[Not Available];Primary;Matched;LUAD;[Not Available];[Not Available];[Not Available]
TCGA-17-Z025-01;Non-Small Cell Lung Cancer;[Not Available];Primary;Matched;LUAD;[Not Available];[Not Available];[Not Available]
TCGA-17-Z002-01;Non-Small Cell Lung Cancer;[Not Available];Primary;Matched;LUAD;[Not Available];[Not Available];[Not Available]
TCGA-17-Z055-01;Non-Small Cell Lung Cancer;[Not Available];Primary;Matched;LUAD;[Not Available];[Not Available];[Not Available]
TCGA-17-Z021-01;Non-Small Cell Lung Cancer;[Not Available];Primary;Matched;LUAD;[Not Available];[Not Available];[Not Available]
TCGA-17-Z000-01;Non-Small Cell Lung Cancer;[Not Available];Primary;Matched;LUAD;[Not Available];[Not Available];[Not Available]
TCGA-17-Z057-01;Non-Small Cell Lung Cancer;[Not Available];Primary;Matched;LUAD;[Not Available];[Not Available];[Not Available]
TCGA-17-Z061-01;Non-Small Cell Lung Cancer;[Not Available];Primary;Matched;LUAD;[Not Available];[Not Available];[Not Available]
TCGA-17-Z016-01;Non-Small Cell Lung Cancer;[Not Available];Primary;Matched;LUAD;[Not Available];[Not Available];[Not Available]
TCGA-17-Z032-01;Non-Small Cell Lung Cancer;[Not Available];Primary;Matched;LUAD;[Not Available];[Not Available];[Not Available]
TCGA-17-Z023-01;Non-Small Cell Lung Cancer;[Not Available];Primary;Matched;LUAD;[Not Available];[Not Available];[Not Available]
TCGA-17-Z015-01;Non-Small Cell Lung Cancer;[Not Available];Primary;Matched;LUAD;[Not Available];[Not Available];[Not Available]
TCGA-17-Z043-01;Non-Small Cell Lung Cancer;[Not Available];Primary;Matched;LUAD;[Not Available];[Not Available];[Not Available]
TCGA-17-Z028-01;Non-Small Cell Lung Cancer;[Not Available];Primary;Matched;LUAD;[Not Available];[Not Available];[Not Available]
TCGA-17-Z005-01;Non-Small Cell Lung Cancer;[Not Available];Primary;Matched;LUAD;[Not Available];[Not Available];[Not Available]
TCGA-17-Z010-01;Non-Small Cell Lung Cancer;[Not Available];Primary;Matched;LUAD;[Not Available];[Not Available];[Not Available]
TCGA-17-Z047-01;Non-Small Cell Lung Cancer;[Not Available];Primary;Matched;LUAD;[Not Available];[Not Available];[Not Available]
TCGA-17-Z020-01;Non-Small Cell Lung Cancer;[Not Available];Primary;Matched;LUAD;[Not Available];[Not Available];[Not Available]
TCGA-17-Z052-01;Non-Small Cell Lung Cancer;[Not Available];Primary;Matched;LUAD;[Not Available];[Not Available];[Not Available]
TCGA-17-Z018-01;Non-Small Cell Lung Cancer;[Not Available];Primary;Matched;LUAD;[Not Available];[Not Available];[Not Available]
TCGA-17-Z056-01;Non-Small Cell Lung Cancer;[Not Available];Primary;Matched;LUAD;[Not Available];[Not Available];[Not Available]
TCGA-17-Z009-01;Non-Small Cell Lung Cancer;[Not Available];Primary;Matched;LUAD;[Not Available];[Not Available];[Not Available]
TCGA-17-Z004-01;Non-Small Cell Lung Cancer;[Not Available];Primary;Matched;LUAD;[Not Available];[Not Available];[Not Available]
TCGA-17-Z058-01;Non-Small Cell Lung Cancer;[Not Available];Primary;Matched;LUAD;[Not Available];[Not Available];[Not Available]
TCGA-17-Z033-01;Non-Small Cell Lung Cancer;[Not Available];Primary;Matched;LUAD;[Not Available];[Not Available];[Not Available]
TCGA-17-Z036-01;Non-Small Cell Lung Cancer;[Not Available];Primary;Matched;LUAD;[Not Available];[Not Available];[Not Available]
TCGA-17-Z026-01;Non-Small Cell Lung Cancer;[Not Available];Primary;Matched;LUAD;[Not Available];[Not Available];[Not Available]
TCGA-17-Z042-01;Non-Small Cell Lung Cancer;[Not Available];Primary;Matched;LUAD;[Not Available];[Not Available];[Not Available]
TCGA-17-Z011-01;Non-Small Cell Lung Cancer;[Not Available];Primary;Matched;LUAD;[Not Available];[Not Available];[Not Available]
TCGA-17-Z019-01;Non-Small Cell Lung Cancer;[Not Available];Primary;Matched;LUAD;[Not Available];[Not Available];[Not Available]
TCGA-17-Z013-01;Non-Small Cell Lung Cancer;[Not Available];Primary;Matched;LUAD;[Not Available];[Not Available];[Not Available]
TCGA-17-Z001-01;Non-Small Cell Lung Cancer;[Not Available];Primary;Matched;LUAD;[Not Available];[Not Available];[Not Available]
TCGA-17-Z022-01;Non-Small Cell Lung Cancer;[Not Available];Primary;Matched;LUAD;[Not Available];[Not Available];[Not Available]
TCGA-17-Z059-01;Non-Small Cell Lung Cancer;[Not Available];Primary;Matched;LUAD;[Not Available];[Not Available];[Not Available]
TCGA-17-Z007-01;Non-Small Cell Lung Cancer;[Not Available];Primary;Matched;LUAD;[Not Available];[Not Available];[Not Available]
TCGA-17-Z050-01;Non-Small Cell Lung Cancer;[Not Available];Primary;Matched;LUAD;[Not Available];[Not Available];[Not Available]
TCGA-17-Z037-01;Non-Small Cell Lung Cancer;[Not Available];Primary;Matched;LUAD;[Not Available];[Not Available];[Not Available]
TCGA-17-Z027-01;Non-Small Cell Lung Cancer;[Not Available];Primary;Matched;LUAD;[Not Available];[Not Available];[Not Available]
TCGA-17-Z062-01;Non-Small Cell Lung Cancer;[Not Available];Primary;Matched;LUAD;[Not Available];[Not Available];[Not Available]
TCGA-17-Z030-01;Non-Small Cell Lung Cancer;[Not Available];Primary;Matched;LUAD;[Not Available];[Not Available];[Not Available]
TCGA-17-Z044-01;Non-Small Cell Lung Cancer;[Not Available];Primary;Matched;LUAD;[Not Available];[Not Available];[Not Available]
TCGA-17-Z048-01;Non-Small Cell Lung Cancer;[Not Available];Primary;Matched;LUAD;[Not Available];[Not Available];[Not Available]
TCGA-17-Z017-01;Non-Small Cell Lung Cancer;[Not Available];Primary;Matched;LUAD;[Not Available];[Not Available];[Not Available]
TCGA-17-Z003-01;Non-Small Cell Lung Cancer;[Not Available];Primary;Matched;LUAD;[Not Available];[Not Available];[Not Available]
TCGA-17-Z051-01;Non-Small Cell Lung Cancer;[Not Available];Primary;Matched;LUAD;[Not Available];[Not Available];[Not Available]
TCGA-17-Z041-01;Non-Small Cell Lung Cancer;[Not Available];Primary;Matched;LUAD;[Not Available];[Not Available];[Not Available]
TCGA-17-Z054-01;Non-Small Cell Lung Cancer;[Not Available];Primary;Matched;LUAD;[Not Available];[Not Available];[Not Available]
TCGA-17-Z045-01;Non-Small Cell Lung Cancer;[Not Available];Primary;Matched;LUAD;[Not Available];[Not Available];[Not Available]
TCGA-17-Z031-01;Non-Small Cell Lung Cancer;[Not Available];Primary;Matched;LUAD;[Not Available];[Not Available];[Not Available]
TCGA-17-Z049-01;Non-Small Cell Lung Cancer;[Not Available];Primary;Matched;LUAD;[Not Available];[Not Available];[Not Available]
TCGA-17-Z060-01;Non-Small Cell Lung Cancer;[Not Available];Primary;Matched;LUAD;[Not Available];[Not Available];[Not Available]
TCGA-17-Z014-01;Non-Small Cell Lung Cancer;[Not Available];Primary;Matched;LUAD;[Not Available];[Not Available];[Not Available]
TCGA-05-5420-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUAD;0:LIVING;Stage IIIA;67
TCGA-44-2661-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;Stage IA;69
TCGA-44-6147-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUAD;0:LIVING;Stage IA;67
[Not Available];[Not Available];[Not Available];[Not Available];[Not Available];[Not Available];[Not Available];[Not Available];[Not Available]
TCGA-18-5592-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IA;67
TCGA-18-5595-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IB;72
TCGA-21-5782-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;1:DECEASED;Stage IB;77
TCGA-21-5784-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IA;74
TCGA-21-5786-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIB;81
TCGA-21-5787-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IIIA;63
TCGA-22-5471-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IB;52
TCGA-22-5472-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IV;73
TCGA-22-5473-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IB;77
TCGA-22-5474-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIB;83
TCGA-22-5477-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IV;65
TCGA-22-5478-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIB;73
TCGA-22-5480-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IB;65
TCGA-22-5482-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIB;63
TCGA-22-5485-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IB;64
TCGA-22-5489-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IA;74
TCGA-22-5491-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIB;57
TCGA-22-5492-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IB;50
TCGA-34-5234-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IIIA;60
TCGA-37-5819-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IB;67
TCGA-43-5668-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IB;75
TCGA-56-5897-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIB;57
TCGA-56-5898-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IB;54
TCGA-22-4593-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIB;64
TCGA-22-5483-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IB;77
TCGA-33-6737-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIIA;71
TCGA-34-5231-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IB;66
TCGA-34-5232-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIB;69
TCGA-34-5236-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IB;61
TCGA-34-5239-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IA;75
TCGA-34-5927-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;1:DECEASED;Stage IB;68
TCGA-34-5928-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IB;76
TCGA-34-5929-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IB;80
TCGA-39-5019-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IB;64
TCGA-39-5022-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIIA;65
TCGA-39-5024-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IA;77
TCGA-39-5027-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIA;71
TCGA-43-6143-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IB;61
TCGA-43-6647-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IB;76
TCGA-43-6770-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IA;69
TCGA-43-6771-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IA;63
TCGA-46-6025-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IB;73
TCGA-46-6026-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;1:DECEASED;Stage IB;80
TCGA-56-6545-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IB;65
TCGA-56-6546-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IA;62
TCGA-60-2709-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIIA;80
TCGA-63-6202-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIA;77
TCGA-70-6722-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;1:DECEASED;Stage IIIA;60
TCGA-70-6723-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIIA;57
TCGA-85-6175-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;1:DECEASED;Stage IB;69
TCGA-85-6560-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;1:DECEASED;Stage IB;73
TCGA-85-6561-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;1:DECEASED;Stage IIIA;73
TCGA-22-5479-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIA;73
TCGA-22-5481-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;1:DECEASED;Stage IB;78
TCGA-33-6738-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IB;75
TCGA-34-7107-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IA;81
TCGA-43-6773-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;1:DECEASED;Stage IA;73
TCGA-63-7020-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IB;75
TCGA-63-7021-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IB;67
TCGA-63-7022-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;[Discrepancy];78
TCGA-63-7023-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IB;74
TCGA-77-6842-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IA;65
TCGA-77-6843-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IB;79
TCGA-77-6844-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IB;64
TCGA-77-6845-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;1:DECEASED;Stage IA;66
TCGA-79-5596-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;1:DECEASED;Stage IIB;72
TCGA-85-6798-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IB;81
TCGA-90-6837-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIA;74
TCGA-94-7033-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;1:DECEASED;Stage IA;58
TCGA-51-6867-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IA;64
TCGA-56-7221-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IA;74
TCGA-56-7222-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;1:DECEASED;Stage IIIA;73
TCGA-56-7223-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIA;70
TCGA-56-7579-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IB;68
TCGA-56-7580-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IB;76
TCGA-56-7582-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIIA;66
TCGA-60-2703-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IB;68
TCGA-60-2704-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IB;40
TCGA-77-7138-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IA;55
TCGA-77-7139-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IA;73
TCGA-77-7140-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIIA;57
TCGA-77-7141-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;1:DECEASED;Stage IB;63
TCGA-77-7142-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;1:DECEASED;Stage IIB;62
TCGA-77-7335-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIIA;71
TCGA-77-7337-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIIA;80
TCGA-77-7338-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IB;60
TCGA-77-7463-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIA;67
TCGA-77-7465-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;1:DECEASED;Stage IA;59
TCGA-92-7340-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IB;66
TCGA-92-7341-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IA;83
TCGA-96-7544-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;1:DECEASED;Stage IIB;65
TCGA-96-7545-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IB;60
TCGA-98-7454-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;1:DECEASED;Stage IA;57
TCGA-22-4605-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIB;70
TCGA-22-4609-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;1:DECEASED;Stage IA;76
TCGA-33-4587-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;1:DECEASED;Stage IB;81
TCGA-39-5040-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIIB;76
TCGA-43-5670-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IB;84
TCGA-43-7656-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIB;81
TCGA-43-7657-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IA;72
TCGA-43-7658-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IIA;75
TCGA-52-7622-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IA;71
TCGA-52-7809-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIB;60
TCGA-52-7810-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIIA;75
TCGA-52-7811-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IIB;73
TCGA-52-7812-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IB;79
TCGA-56-7730-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IA;70
TCGA-56-7731-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IIB;83
TCGA-56-7822-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;1:DECEASED;Stage IB;78
TCGA-60-2697-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage II;70
TCGA-68-7755-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IIIA;62
TCGA-68-7756-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IV;67
TCGA-85-7696-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IIA;71
TCGA-85-7697-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIB;80
TCGA-85-7698-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIIA;51
TCGA-85-7699-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IB;65
TCGA-85-7710-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IB;69
TCGA-85-7843-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IA;52
TCGA-85-7844-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IA;56
TCGA-90-7766-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IV;61
TCGA-90-7767-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIIA;63
TCGA-90-7769-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IB;68
TCGA-94-7557-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IA;65
TCGA-21-5783-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIIA;64
TCGA-77-8007-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIB;53
TCGA-77-8008-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage II;49
TCGA-77-8009-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIIB;59
TCGA-85-7950-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IA;70
TCGA-90-7964-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIA;44
TCGA-94-7943-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IB;70
TCGA-43-8115-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IB;70
TCGA-43-8116-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IB;76
TCGA-56-7823-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IIIA;65
TCGA-56-8082-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IB;73
TCGA-56-8083-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIIA;75
TCGA-56-8201-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIIA;67
TCGA-77-8128-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;1:DECEASED;Stage IIIA;81
TCGA-77-8130-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;1:DECEASED;Stage IA;76
TCGA-77-8131-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;1:DECEASED;Stage IIB;73
TCGA-77-8133-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IA;72
TCGA-77-8136-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IB;73
TCGA-77-8138-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIA;65
TCGA-77-8139-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIA;76
TCGA-77-8140-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIIA;59
TCGA-77-8143-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IIIA;62
TCGA-77-8144-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;1:DECEASED;Stage IA;59
TCGA-77-8145-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IIIA;47
TCGA-77-8146-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IB;52
TCGA-77-8148-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IB;71
TCGA-77-8150-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIA;78
TCGA-77-8154-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIA;70
TCGA-77-8156-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IB;70
TCGA-85-8048-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IIB;69
TCGA-85-8049-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IB;59
TCGA-85-8052-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IB;85
TCGA-85-8070-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIB;76
TCGA-85-8071-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IA;71
TCGA-85-8072-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IA;68
TCGA-92-8063-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;1:DECEASED;Stage IA;75
TCGA-92-8064-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IIA;72
TCGA-92-8065-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IA;73
TCGA-94-8035-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;1:DECEASED;Stage IA;55
TCGA-98-8020-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIA;66
TCGA-98-8021-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IIB;67
TCGA-98-8022-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IA;76
TCGA-98-8023-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIIA;61
TCGA-56-8305-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IA;59
TCGA-56-8307-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IA;62
TCGA-56-8308-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IA;76
TCGA-56-8309-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIIA;58
TCGA-58-8386-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;[Discrepancy];57
TCGA-58-8387-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIB;71
TCGA-68-7757-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIB;81
TCGA-68-8250-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;1:DECEASED;Stage IB;73
TCGA-68-8251-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIIB;65
TCGA-85-8276-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIB;55
TCGA-85-8277-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;1:DECEASED;Stage I;72
TCGA-85-8287-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IA;62
TCGA-85-8288-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IB;74
TCGA-85-8350-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IIB;60
TCGA-85-8351-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IB;67
TCGA-85-8353-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;[Discrepancy];68
TCGA-85-8355-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IB;58
TCGA-96-8169-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IA;74
TCGA-96-8170-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IA;69
TCGA-21-1070-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IB;77
TCGA-21-1071-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIA;67
TCGA-21-1072-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IB;79
TCGA-21-1075-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IB;60
TCGA-21-1076-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIIA;66
TCGA-21-1077-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIIA;61
TCGA-21-1078-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IB;84
TCGA-21-1079-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IB;83
TCGA-21-1080-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIA;73
TCGA-21-1081-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;1:DECEASED;Stage IB;66
TCGA-21-1082-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIB;75
TCGA-21-1083-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IIA;58
TCGA-22-0940-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IIA;80
TCGA-22-0944-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IB;56
TCGA-22-1000-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIB;74
TCGA-22-1002-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IA;73
TCGA-22-1005-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IB;72
TCGA-22-1011-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IIB;55
TCGA-22-1012-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIB;79
TCGA-22-1016-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IA;66
TCGA-22-1017-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IIB;76
TCGA-56-1622-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IB;74
TCGA-34-8454-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IB;68
TCGA-34-8455-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IB;71
TCGA-34-8456-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIB;84
TCGA-56-8304-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;1:DECEASED;Stage IIIA;66
TCGA-58-8388-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IA;59
TCGA-58-8390-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IA;78
TCGA-58-8391-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIA;63
TCGA-58-8392-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIIA;67
TCGA-58-8393-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIA;55
TCGA-85-8352-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIA;70
TCGA-85-8354-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IB;66
TCGA-85-8479-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IA;75
TCGA-85-8481-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IB;76
TCGA-94-8490-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IA;81
TCGA-94-8491-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IB;72
TCGA-43-8118-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIA;78
TCGA-56-8503-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IV;75
TCGA-56-8504-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIA;60
TCGA-56-8622-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IB;60
TCGA-56-8623-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIA;70
TCGA-56-8624-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IIIA;57
TCGA-56-8625-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IB;70
TCGA-56-8626-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IB;68
TCGA-56-8628-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIB;64
TCGA-56-8629-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIIA;59
TCGA-77-8153-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIIA;73
TCGA-85-8580-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIB;61
TCGA-85-8582-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IB;52
TCGA-85-8584-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IB;74
TCGA-85-8664-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;1:DECEASED;Stage IIA;76
TCGA-85-8666-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIA;41
TCGA-43-A474-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIB;62
TCGA-43-A475-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIB;73
TCGA-56-A49D-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIB;73
TCGA-56-A4BW-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IA;58
TCGA-56-A4BX-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IB;70
TCGA-56-A4BY-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IIB;64
TCGA-58-A46J-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IB;69
TCGA-58-A46K-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IIA;67
TCGA-58-A46L-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IB;64
TCGA-58-A46M-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;1:DECEASED;Stage IIB;79
TCGA-58-A46N-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IB;64
TCGA-85-A4CN-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IIB;66
TCGA-J1-A4AH-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IA;51
TCGA-85-A4JC-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIB;39
TCGA-85-A4PA-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IB;83
TCGA-85-A4QR-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IB;60
TCGA-90-A4ED-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IB;73
TCGA-90-A4EE-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIB;66
TCGA-94-A4VJ-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IB;74
TCGA-96-A4JK-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIIA;47
TCGA-96-A4JL-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IB;74
TCGA-L3-A4E7-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIA;56
TCGA-LA-A446-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IB;[Not Available]
TCGA-33-A4WN-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIB;[Not Available]
TCGA-56-A4ZJ-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIA;[Not Available]
TCGA-56-A4ZK-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IA;[Not Available]
TCGA-68-A59I-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IA;[Not Available]
TCGA-85-A4JB-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IA;[Not Available]
TCGA-85-A4QQ-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIA;[Not Available]
TCGA-85-A50M-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IIB;[Not Available]
TCGA-85-A50Z-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IB;62
TCGA-85-A511-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IB;68
TCGA-98-A538-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IA;68
TCGA-98-A539-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIIA;65
TCGA-98-A53A-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIB;54
TCGA-98-A53B-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IB;68
TCGA-98-A53C-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;1:DECEASED;Stage IIB;69
TCGA-98-A53D-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;1:DECEASED;Stage IIB;78
TCGA-98-A53H-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIB;56
TCGA-98-A53I-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IB;70
TCGA-L3-A524-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IB;78
TCGA-MF-A522-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIB;74
TCGA-O2-A52S-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIB;48
TCGA-O2-A52V-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIA;69
TCGA-21-A5DI-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IB;76
TCGA-37-A5EL-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IA;63
TCGA-37-A5EN-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;1:DECEASED;Stage IB;55
TCGA-43-A56U-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IB;62
TCGA-43-A56V-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIB;72
TCGA-63-A5M9-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IV;70
TCGA-63-A5MB-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIB;71
TCGA-63-A5MM-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IB;69
TCGA-63-A5MP-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIIA;67
TCGA-63-A5MS-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IB;63
TCGA-63-A5MT-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIIB;68
TCGA-63-A5MU-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;1:DECEASED;Stage IA;65
TCGA-63-A5MV-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IB;71
TCGA-63-A5MW-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIIA;66
TCGA-63-A5MY-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IB;63
TCGA-68-A59J-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IB;64
TCGA-85-A4CL-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIIA;54
TCGA-85-A510-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIIB;62
TCGA-85-A512-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIB;57
TCGA-85-A513-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIIB;75
TCGA-85-A53L-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IB;79
TCGA-85-A5B5-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIB;60
TCGA-90-A59Q-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IB;69
TCGA-94-A5I4-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IB;71
TCGA-98-A53J-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IIIB;68
TCGA-NC-A5HD-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IB;65
TCGA-NC-A5HE-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IB;67
TCGA-NC-A5HF-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIB;71
TCGA-NC-A5HG-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIIB;67
TCGA-NC-A5HH-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IB;65
TCGA-NC-A5HI-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IA;68
TCGA-NC-A5HJ-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IA;57
TCGA-NC-A5HK-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IB;56
TCGA-NC-A5HL-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIIB;73
TCGA-NC-A5HM-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIB;72
TCGA-NC-A5HN-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIIB;66
TCGA-NC-A5HO-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIB;58
TCGA-NC-A5HP-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIIB;68
TCGA-NC-A5HQ-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIIB;64
TCGA-NC-A5HR-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIIB;68
TCGA-NC-A5HT-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIIB;70
TCGA-NK-A5CR-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IIA;60
TCGA-NK-A5CT-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIIA;84
TCGA-NK-A5CX-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IA;74
TCGA-NK-A5D1-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IA;66
TCGA-O2-A52N-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IB;78
TCGA-O2-A52Q-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IIIA;73
TCGA-O2-A52W-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IB;74
TCGA-22-A5C4-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;1:DECEASED;Stage IB;73
TCGA-33-A5GW-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIIA;47
TCGA-34-A5IX-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIA;65
TCGA-37-A5EM-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIB;79
TCGA-56-A5DR-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIA;74
TCGA-56-A5DS-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIIA;74
TCGA-63-A5MG-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIB;69
TCGA-63-A5MH-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IB;67
TCGA-63-A5MI-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIB;56
TCGA-63-A5MJ-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;1:DECEASED;Stage IIB;69
TCGA-63-A5ML-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IB;64
TCGA-63-A5MN-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IB;59
TCGA-63-A5MR-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;1:DECEASED;Stage IIIB;62
TCGA-77-A5FZ-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIB;65
TCGA-77-A5G1-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IB;64
TCGA-77-A5G3-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IB;75
TCGA-77-A5G6-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIA;58
TCGA-77-A5G7-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIB;68
TCGA-77-A5G8-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IB;68
TCGA-77-A5GA-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIB;68
TCGA-77-A5GB-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIIA;60
TCGA-77-A5GF-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIB;69
TCGA-77-A5GH-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IB;72
TCGA-94-A5I6-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIA;74
TCGA-O2-A5IB-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;1:DECEASED;Stage IIB;74
TCGA-O2-A5IC-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IB;74
TCGA-34-2596-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIB;72
TCGA-34-2600-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;1:DECEASED;Stage IIB;66
TCGA-34-2604-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIIA;76
TCGA-34-2605-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IB;70
TCGA-34-2608-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIIB;73
TCGA-34-2609-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IA;72
TCGA-43-2576-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIIA;68
TCGA-43-2578-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIIA;64
TCGA-43-2581-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IB;77
TCGA-60-2695-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IA;67
TCGA-60-2696-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IB;60
TCGA-60-2698-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIIB;64
TCGA-60-2706-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIIA;75
TCGA-60-2707-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIB;63
TCGA-60-2708-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIIA;66
TCGA-60-2710-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IA;63
TCGA-60-2711-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIB;70
TCGA-60-2712-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IB;76
TCGA-60-2713-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IB;90
TCGA-60-2714-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIA;70
TCGA-60-2715-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IB;81
TCGA-60-2716-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIIA;[Not Available]
TCGA-60-2719-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;1:DECEASED;Stage IIB;63
TCGA-60-2720-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIA;59
TCGA-60-2721-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IB;66
TCGA-60-2722-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIIA;57
TCGA-60-2723-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IA;64
TCGA-60-2724-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIB;49
TCGA-60-2726-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IA;48
TCGA-66-2755-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIIA;73
TCGA-66-2756-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IA;59
TCGA-66-2757-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIA;50
TCGA-66-2758-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IB;71
TCGA-66-2759-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IB;46
TCGA-66-2763-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IA;62
TCGA-66-2765-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IB;57
TCGA-66-2766-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIB;53
TCGA-66-2767-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IB;71
TCGA-66-2768-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIA;52
TCGA-66-2769-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IA;60
TCGA-66-2770-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIA;62
TCGA-66-2778-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIIA;70
TCGA-66-2780-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IA;72
TCGA-66-2781-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIA;70
TCGA-66-2782-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IA;61
TCGA-66-2785-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIA;72
TCGA-66-2786-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIIA;67
TCGA-18-3406-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIIA;72
TCGA-18-3407-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IB;53
TCGA-18-3408-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IA;63
TCGA-18-3409-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IA;66
TCGA-18-3410-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIB;70
TCGA-18-3411-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IB;52
TCGA-18-3412-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IA;49
TCGA-18-3414-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIA;71
TCGA-18-3415-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIB;73
TCGA-18-3416-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IB;65
TCGA-18-3419-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IA;65
TCGA-18-3421-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IIB;56
TCGA-37-3789-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIB;74
TCGA-37-3792-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIA;84
TCGA-43-3394-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IB;61
TCGA-43-3920-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IB;68
TCGA-46-3765-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IB;67
TCGA-46-3766-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIA;47
TCGA-46-3767-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIA;57
TCGA-46-3768-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IIB;74
TCGA-46-3769-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIB;62
TCGA-66-2727-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIA;46
TCGA-66-2734-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IA;60
TCGA-66-2737-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIA;63
TCGA-66-2742-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IA;58
TCGA-66-2744-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIB;64
TCGA-66-2746-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IA;66
TCGA-66-2747-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIB;56
TCGA-66-2750-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIB;55
TCGA-66-2751-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IB;70
TCGA-66-2752-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IB;69
TCGA-66-2753-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIA;53
TCGA-66-2754-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;1:DECEASED;Stage IIA;61
TCGA-66-2771-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IIA;45
TCGA-66-2787-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IB;71
TCGA-66-2788-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIIA;52
TCGA-66-2789-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;[Discrepancy];58
TCGA-66-2790-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IIB;74
TCGA-66-2791-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IB;73
TCGA-66-2792-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IB;73
TCGA-66-2795-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IA;80
TCGA-33-AAS8-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIB;64
TCGA-33-AASB-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIB;70
TCGA-33-AASD-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIA;73
TCGA-33-AASI-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IA;71
TCGA-33-AASJ-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIA;61
TCGA-33-AASL-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIB;62
TCGA-56-A62T-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIB;83
TCGA-6A-AB49-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IA;73
TCGA-LA-A7SW-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IA;67
TCGA-NK-A7XE-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IIA;75
TCGA-XC-AA0X-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIA;65
TCGA-18-4083-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IIA;78
TCGA-18-4086-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IB;73
TCGA-37-4129-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;1:DECEASED;Stage IIIA;56
TCGA-37-4130-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IA;75
TCGA-37-4132-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IA;61
TCGA-37-4133-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIIA;70
TCGA-37-4135-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIB;67
TCGA-37-4141-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIB;63
TCGA-51-4079-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IB;70
TCGA-51-4080-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IB;69
TCGA-51-4081-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IA;77
TCGA-22-4591-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIB;68
TCGA-22-4594-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IA;76
TCGA-22-4595-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIA;64
TCGA-22-4596-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IB;77
TCGA-22-4604-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIA;70
TCGA-22-4607-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IB;71
TCGA-33-4532-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;1:DECEASED;Stage IIB;45
TCGA-33-4533-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IA;68
TCGA-33-4538-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIIA;71
TCGA-33-4547-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IB;54
TCGA-37-3783-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIB;79
TCGA-60-2725-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIB;60
TCGA-66-2773-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIIB;74
TCGA-66-2777-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIIA;59
TCGA-66-2783-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IA;53
TCGA-66-2793-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IB;68
TCGA-66-2794-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIB;59
TCGA-66-2800-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IIB;58
TCGA-18-3417-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIA;73
TCGA-18-4721-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IB;76
TCGA-22-4599-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIA;77
TCGA-22-4601-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IIIA;70
TCGA-22-4613-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IV;69
TCGA-33-4566-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage IIIA;70
TCGA-33-4579-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;0:LIVING;Stage IIA;75
TCGA-33-4582-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIIA;69
TCGA-33-4583-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IB;77
TCGA-33-4586-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IA;70
TCGA-33-4589-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIA;73
TCGA-34-5240-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIA;57
TCGA-34-5241-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;0:LIVING;Stage IIIB;66
TCGA-39-5011-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage I;78
TCGA-39-5016-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;1:DECEASED;Stage III;44
TCGA-39-5021-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;1:DECEASED;Stage III;57
TCGA-39-5028-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;1:DECEASED;Stage II;75
TCGA-39-5029-01;Non-Small Cell Lung Cancer;Male;Primary;Matched;LUSC;1:DECEASED;Stage I;63
TCGA-39-5030-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;1:DECEASED;Stage III;71
TCGA-39-5031-01;Non-Small Cell Lung Cancer;Female;Primary;Matched;LUSC;1:DECEASED;Stage IA;77
TCGA-39-5034-01;Non-Small Cell Lung Cancer;[Not Available];Primary;Matched;LUSC;[Not Available];[Not Available];[Not Available]
TCGA-39-5035-01;Non-Small Cell Lung Cancer;[Not Available];Primary;Matched;LUSC;[Not Available];[Not Available];[Not Available]
TCGA-39-5036-01;Non-Small Cell Lung Cancer;[Not Available];Primary;Matched;LUSC;[Not Available];[Not Available];[Not Available]
TCGA-39-5037-01;Non-Small Cell Lung Cancer;[Not Available];Primary;Matched;LUSC;[Not Available];[Not Available];[Not Available]
TCGA-39-5039-01;Non-Small Cell Lung Cancer;[Not Available];Primary;Matched;LUSC;[Not Available];[Not Available];[Not Available]
TCGA-63-5128-01;Non-Small Cell Lung Cancer;[Not Available];Primary;Matched;LUSC;[Not Available];[Not Available];[Not Available]
TCGA-63-5131-01;Non-Small Cell Lung Cancer;[Not Available];Primary;Matched;LUSC;[Not Available];[Not Available];[Not Available]
TCGA-LK-A4NW-01;Mesothelioma;Male;Primary;Matched;PLMESO;1:DECEASED;Stage II;64
TCGA-LK-A4NY-01;Mesothelioma;Male;Primary;Matched;PLBMESO;1:DECEASED;Stage III;60
TCGA-LK-A4NZ-01;Mesothelioma;Female;Primary;Matched;PLEMESO;1:DECEASED;Stage III;53
TCGA-LK-A4O0-01;Mesothelioma;Male;Primary;Matched;PLSMESO;1:DECEASED;Stage III;58
TCGA-LK-A4O2-01;Mesothelioma;Male;Primary;Matched;PLEMESO;1:DECEASED;Stage II;69
TCGA-LK-A4O4-01;Mesothelioma;Male;Primary;Matched;PLEMESO;1:DECEASED;Stage I;79
TCGA-LK-A4O5-01;Mesothelioma;Male;Primary;Matched;PLEMESO;1:DECEASED;Stage III;71
TCGA-LK-A4O6-01;Mesothelioma;Male;Primary;Matched;PLBMESO;0:LIVING;Stage III;62
TCGA-LK-A4O7-01;Mesothelioma;Male;Primary;Matched;PLEMESO;1:DECEASED;Stage III;80
TCGA-MQ-A4KX-01;Mesothelioma;Female;Primary;Matched;PLEMESO;0:LIVING;Stage IV;71
TCGA-MQ-A4LC-01;Mesothelioma;Male;Primary;Matched;PLEMESO;1:DECEASED;Stage III;73
TCGA-MQ-A4LI-01;Mesothelioma;Male;Primary;Matched;PLEMESO;1:DECEASED;Stage IV;71
TCGA-MQ-A4LJ-01;Mesothelioma;Male;Primary;Matched;PLEMESO;1:DECEASED;Stage IV;57
TCGA-MQ-A4LM-01;Mesothelioma;Male;Primary;Matched;PLBMESO;1:DECEASED;Stage IV;68
TCGA-MQ-A4LP-01;Mesothelioma;Male;Primary;Matched;PLBMESO;1:DECEASED;Stage III;55
TCGA-MQ-A4LV-01;Mesothelioma;Male;Primary;Matched;PLBMESO;1:DECEASED;Stage IV;60
TCGA-MQ-A6BL-01;Mesothelioma;Female;Primary;Matched;PLBMESO;1:DECEASED;Stage III;66
TCGA-MQ-A6BN-01;Mesothelioma;Male;Primary;Matched;PLEMESO;1:DECEASED;Stage II;75
TCGA-MQ-A6BQ-01;Mesothelioma;Male;Primary;Matched;PLEMESO;1:DECEASED;Stage IA;81
TCGA-MQ-A6BR-01;Mesothelioma;Female;Primary;Matched;PLEMESO;1:DECEASED;Stage III;56
TCGA-MQ-A6BS-01;Mesothelioma;Male;Primary;Matched;PLEMESO;1:DECEASED;Stage III;69
TCGA-NQ-A57I-01;Mesothelioma;Female;Primary;Matched;PLBMESO;1:DECEASED;Stage III;68
TCGA-NQ-A638-01;Mesothelioma;Female;Primary;Matched;PLEMESO;1:DECEASED;Stage III;66
TCGA-SC-A6LM-01;Mesothelioma;Male;Primary;Matched;PLEMESO;1:DECEASED;Stage III;64
TCGA-SC-A6LN-01;Mesothelioma;Male;Primary;Matched;PLBMESO;1:DECEASED;Stage I;55
TCGA-SC-A6LP-01;Mesothelioma;Male;Primary;Matched;PLBMESO;1:DECEASED;Stage II;54
TCGA-SC-A6LQ-01;Mesothelioma;Female;Primary;Matched;PLEMESO;1:DECEASED;Stage II;60
TCGA-SC-A6LR-01;Mesothelioma;Male;Primary;Matched;PLEMESO;1:DECEASED;Stage III;53
TCGA-SH-A7BC-01;Mesothelioma;Male;Primary;Matched;PLEMESO;1:DECEASED;Stage III;67
TCGA-SH-A7BD-01;Mesothelioma;Male;Primary;Matched;PLEMESO;1:DECEASED;Stage III;67
TCGA-SH-A7BH-01;Mesothelioma;Male;Primary;Matched;PLBMESO;1:DECEASED;Stage III;63
TCGA-TS-A7OY-01;Mesothelioma;Male;Primary;Matched;PLEMESO;1:DECEASED;Stage II;78
TCGA-TS-A7P0-01;Mesothelioma;Female;Primary;Matched;PLEMESO;1:DECEASED;Stage III;73
TCGA-TS-A7P3-01;Mesothelioma;Male;Primary;Matched;PLEMESO;0:LIVING;Stage II;58
TCGA-TS-A7P6-01;Mesothelioma;Female;Primary;Matched;PLEMESO;0:LIVING;Stage III;55
TCGA-TS-A7P8-01;Mesothelioma;Male;Primary;Matched;PLEMESO;1:DECEASED;Stage II;55
TCGA-TS-A7PB-01;Mesothelioma;Male;Primary;Matched;PLBMESO;1:DECEASED;Stage IB;71
TCGA-3H-AB3K-01;Mesothelioma;Male;Primary;Matched;PLMESO;0:LIVING;Stage II;66
TCGA-3H-AB3L-01;Mesothelioma;Female;Primary;Matched;PLEMESO;1:DECEASED;Stage IV;64
TCGA-3H-AB3M-01;Mesothelioma;Male;Primary;Matched;PLEMESO;1:DECEASED;Stage III;76
TCGA-3H-AB3O-01;Mesothelioma;Male;Primary;Matched;PLEMESO;1:DECEASED;Stage II;58
TCGA-3H-AB3S-01;Mesothelioma;Female;Primary;Matched;PLEMESO;1:DECEASED;Stage III;60
TCGA-3H-AB3T-01;Mesothelioma;Male;Primary;Matched;PLBMESO;0:LIVING;Stage III;73
TCGA-3H-AB3U-01;Mesothelioma;Male;Primary;Matched;PLEMESO;0:LIVING;Stage IV;54
TCGA-3H-AB3X-01;Mesothelioma;Male;Primary;Matched;PLEMESO;1:DECEASED;Stage III;66
TCGA-3U-A98D-01;Mesothelioma;Male;Primary;Matched;PLBMESO;1:DECEASED;Stage IV;68
TCGA-3U-A98E-01;Mesothelioma;Female;Primary;Matched;PLEMESO;1:DECEASED;Stage III;65
TCGA-3U-A98F-01;Mesothelioma;Male;Primary;Matched;PLBMESO;1:DECEASED;Stage II;67
TCGA-3U-A98G-01;Mesothelioma;Male;Primary;Matched;PLBMESO;1:DECEASED;Stage IV;60
TCGA-3U-A98H-01;Mesothelioma;Male;Primary;Matched;PLBMESO;1:DECEASED;Stage IV;56
TCGA-3U-A98I-01;Mesothelioma;Male;Primary;Matched;PLBMESO;1:DECEASED;Stage IV;62
TCGA-3U-A98J-01;Mesothelioma;Male;Primary;Matched;PLEMESO;1:DECEASED;Stage III;67
TCGA-SC-AA5Z-01;Mesothelioma;Male;Primary;Matched;PLEMESO;1:DECEASED;Stage III;42
TCGA-SH-A9CT-01;Mesothelioma;Male;Primary;Matched;PLEMESO;1:DECEASED;Stage I;52
TCGA-SH-A9CU-01;Mesothelioma;Male;Primary;Matched;PLEMESO;1:DECEASED;Stage III;57
TCGA-TS-A7OU-01;Mesothelioma;Male;Primary;Matched;PLEMESO;1:DECEASED;Stage III;61
TCGA-TS-A7OZ-01;Mesothelioma;Male;Primary;Matched;PLEMESO;1:DECEASED;Stage III;62
TCGA-TS-A7P1-01;Mesothelioma;Male;Primary;Matched;PLEMESO;1:DECEASED;Stage III;80
TCGA-TS-A7P7-01;Mesothelioma;Male;Primary;Matched;PLEMESO;1:DECEASED;Stage III;62
TCGA-TS-A8AF-01;Mesothelioma;Male;Primary;Matched;PLEMESO;1:DECEASED;Stage III;69
TCGA-TS-A8AI-01;Mesothelioma;Male;Primary;Matched;PLEMESO;1:DECEASED;Stage IV;58
TCGA-TS-A8AS-01;Mesothelioma;Male;Primary;Matched;PLEMESO;1:DECEASED;Stage IA;77
TCGA-TS-A8AV-01;Mesothelioma;Male;Primary;Matched;PLSMESO;1:DECEASED;Stage III;55
TCGA-TS-A8AY-01;Mesothelioma;Female;Primary;Matched;PLEMESO;1:DECEASED;Stage III;48
TCGA-UD-AABY-01;Mesothelioma;Male;Primary;Matched;PLMESO;1:DECEASED;Stage III;50
TCGA-UD-AABZ-01;Mesothelioma;Male;Primary;Matched;PLEMESO;1:DECEASED;Stage II;46
TCGA-UD-AAC1-01;Mesothelioma;Female;Primary;Matched;PLEMESO;1:DECEASED;Stage III;71
TCGA-UD-AAC4-01;Mesothelioma;Male;Primary;Matched;PLMESO;1:DECEASED;Stage III;65
TCGA-UD-AAC5-01;Mesothelioma;Male;Primary;Matched;PLEMESO;1:DECEASED;Stage I;66
TCGA-UD-AAC6-01;Mesothelioma;Male;Primary;Matched;PLBMESO;1:DECEASED;Stage II;67
TCGA-UD-AAC7-01;Mesothelioma;Male;Primary;Matched;PLEMESO;1:DECEASED;Stage II;47
TCGA-UT-A88C-01;Mesothelioma;Male;Primary;Matched;PLEMESO;1:DECEASED;Stage III;62
TCGA-UT-A88D-01;Mesothelioma;Male;Primary;Matched;PLEMESO;1:DECEASED;Stage II;66
TCGA-UT-A88E-01;Mesothelioma;Male;Primary;Matched;PLEMESO;1:DECEASED;Stage I;74
TCGA-UT-A88G-01;Mesothelioma;Male;Primary;Matched;PLBMESO;1:DECEASED;Stage III;73
TCGA-UT-A97Y-01;Mesothelioma;Female;Primary;Matched;PLEMESO;1:DECEASED;Stage I;81
TCGA-XT-AASU-01;Mesothelioma;Male;Primary;Matched;PLBMESO;1:DECEASED;Stage III;60
TCGA-YS-A95B-01;Mesothelioma;Female;Primary;Matched;PLEMESO;1:DECEASED;Stage IV;28
TCGA-YS-A95C-01;Mesothelioma;Male;Primary;Matched;PLEMESO;1:DECEASED;Stage III;54
TCGA-YS-AA4M-01;Mesothelioma;Male;Primary;Matched;PLMESO;1:DECEASED;Stage IV;66
TCGA-ZN-A9VO-01;Mesothelioma;Male;Primary;Matched;PLEMESO;0:LIVING;Stage IV;36
TCGA-ZN-A9VP-01;Mesothelioma;Male;Primary;Matched;PLEMESO;0:LIVING;Stage III;51
TCGA-ZN-A9VQ-01;Mesothelioma;Male;Primary;Matched;PLBMESO;0:LIVING;Stage I;61
TCGA-ZN-A9VS-01;Mesothelioma;Male;Primary;Matched;PLEMESO;0:LIVING;Stage III;67
TCGA-ZN-A9VU-01;Mesothelioma;Male;Primary;Matched;PLEMESO;0:LIVING;Stage II;70
TCGA-ZN-A9VV-01;Mesothelioma;Male;Primary;Matched;PLBMESO;0:LIVING;Stage III;68
TCGA-ZN-A9VW-01;Mesothelioma;Male;Primary;Matched;PLBMESO;1:DECEASED;Stage IV;61
TCGA-04-1331-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];78.0
TCGA-04-1332-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];70.0
TCGA-04-1335-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];60.0
TCGA-04-1336-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];55.0
TCGA-04-1337-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];78.0
TCGA-04-1338-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];78.0
TCGA-04-1341-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];85.0
TCGA-04-1342-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];80.0
TCGA-04-1343-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];72.0
TCGA-04-1346-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];73.0
TCGA-04-1347-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];81.0
TCGA-04-1348-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];44.0
TCGA-04-1349-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];69.0
TCGA-04-1350-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];46.0
TCGA-04-1351-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];76.0
TCGA-04-1353-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];64.0
TCGA-04-1356-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];62.0
TCGA-04-1357-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];52.0
TCGA-04-1360-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];65.0
TCGA-04-1361-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];57.0
TCGA-04-1362-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];59.0
TCGA-04-1364-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];61.0
TCGA-04-1365-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];87.0
TCGA-04-1367-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];50.0
TCGA-04-1369-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];53.0
TCGA-04-1371-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];58.0
TCGA-04-1514-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];45.0
TCGA-04-1516-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];48.0
TCGA-04-1517-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];79.0
TCGA-04-1519-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];48.0
TCGA-04-1525-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];47.0
TCGA-04-1530-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];68.0
TCGA-04-1536-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];60.0
TCGA-04-1542-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];52.0
TCGA-04-1638-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];57.0
TCGA-04-1644-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];48.0
TCGA-04-1646-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];60.0
TCGA-04-1648-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];57.0
TCGA-04-1649-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];74.0
TCGA-04-1651-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];53.0
TCGA-04-1652-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];76.0
TCGA-04-1654-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];69.0
TCGA-04-1655-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];49.0
TCGA-09-1659-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];51.0
TCGA-09-1661-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];75.0
TCGA-09-1662-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];58.0
TCGA-09-1664-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];37.0
TCGA-09-1665-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];73.0
TCGA-09-1666-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];57.0
TCGA-09-1667-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];61.0
TCGA-09-1668-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];57.0
TCGA-09-1669-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];54.0
TCGA-09-1670-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];57.0
TCGA-09-1672-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];78.0
TCGA-09-1673-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];50.0
TCGA-09-1674-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];79.0
TCGA-09-1675-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];50.0
TCGA-09-2043-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];69.0
TCGA-09-2044-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];77.0
TCGA-09-2045-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];50.0
TCGA-09-2049-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];64.0
TCGA-09-2050-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];65.0
TCGA-09-2051-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];42.0
TCGA-09-2053-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];72.0
TCGA-09-2054-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];58.0
TCGA-09-2055-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];48.0
TCGA-13-1403-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];48.0
TCGA-13-1404-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];48.0
TCGA-13-1405-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];49.0
TCGA-13-1407-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];51.0
TCGA-13-1408-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];59.0
TCGA-13-1409-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];73.0
TCGA-13-1410-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];57.0
TCGA-13-1411-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];81.0
TCGA-13-1412-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];41.0
TCGA-13-1477-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];49.0
TCGA-13-1481-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];76.0
TCGA-13-1482-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];52.0
TCGA-13-1483-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];61.0
TCGA-13-1484-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];62.0
TCGA-13-1485-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];48.0
TCGA-13-1487-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];74.0
TCGA-13-1488-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];59.0
TCGA-13-1489-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];70.0
TCGA-13-1491-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];55.0
TCGA-13-1492-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];66.0
TCGA-13-1494-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];43.0
TCGA-13-1495-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];60.0
TCGA-13-1496-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];65.0
TCGA-13-1497-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];47.0
TCGA-13-1498-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];73.0
TCGA-13-1499-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];56.0
TCGA-13-1500-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];71.0
TCGA-13-1501-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];50.0
TCGA-13-1504-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];68.0
TCGA-13-1505-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];63.0
TCGA-13-1506-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];45.0
TCGA-13-1507-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];77.0
TCGA-13-1509-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];64.0
TCGA-13-1510-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];62.0
TCGA-13-1511-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];52.0
TCGA-13-1512-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];49.0
TCGA-13-1817-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];56.0
TCGA-13-1819-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];59.0
TCGA-13-2057-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];59.0
TCGA-13-2059-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];50.0
TCGA-13-2060-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];51.0
TCGA-13-2061-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];58.0
TCGA-13-2065-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];71.0
TCGA-13-2066-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];49.0
TCGA-13-2071-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];63.0
TCGA-13-A5FT-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];67.0
TCGA-13-A5FU-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];60.0
TCGA-20-1682-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];56.0
TCGA-20-1683-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];65.0
TCGA-20-1684-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];51.0
TCGA-20-1685-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];45.0
TCGA-20-1686-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];75.0
TCGA-20-1687-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];46.0
TCGA-23-1021-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];45.0
TCGA-23-1022-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];67.0
TCGA-23-1023-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];65.0
TCGA-23-1024-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];52.0
TCGA-23-1026-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];45.0
TCGA-23-1027-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];48.0
TCGA-23-1028-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];43.0
TCGA-23-1029-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];46.0
TCGA-23-1030-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];64.0
TCGA-23-1031-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];60.0
TCGA-23-1032-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];73.0
TCGA-23-1109-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];62.0
TCGA-23-1110-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];42.0
TCGA-23-1111-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];63.0
TCGA-23-1113-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];48.0
TCGA-23-1114-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];55.0
TCGA-23-1116-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];83.0
TCGA-23-1117-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];42.0
TCGA-23-1118-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];45.0
TCGA-23-1119-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];64.0
TCGA-23-1120-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];60.0
TCGA-23-1121-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];51.0
TCGA-23-1122-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];53.0
TCGA-23-1123-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];59.0
TCGA-23-1124-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];62.0
TCGA-23-1809-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];63.0
TCGA-23-2072-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];58.0
TCGA-23-2077-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];45.0
TCGA-23-2078-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];66.0
TCGA-23-2079-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];46.0
TCGA-23-2081-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];49.0
TCGA-23-2084-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];45.0
TCGA-23-2641-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];85.0
TCGA-23-2643-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];74.0
TCGA-23-2645-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];54.0
TCGA-23-2647-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];49.0
TCGA-23-2649-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];60.0
TCGA-24-1103-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];50.0
TCGA-24-1104-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];56.0
TCGA-24-1105-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];36.0
TCGA-24-1413-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];51.0
TCGA-24-1416-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];34.0
TCGA-24-1417-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];54.0
TCGA-24-1418-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];68.0
TCGA-24-1419-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];62.0
TCGA-24-1422-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];82.0
TCGA-24-1423-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];61.0
TCGA-24-1424-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];67.0
TCGA-24-1425-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];45.0
TCGA-24-1426-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];43.0
TCGA-24-1427-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];58.0
TCGA-24-1428-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];50.0
TCGA-24-1430-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];68.0
TCGA-24-1431-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];67.0
TCGA-24-1434-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];59.0
TCGA-24-1435-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];57.0
TCGA-24-1436-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];57.0
TCGA-24-1463-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];70.0
TCGA-24-1464-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];70.0
TCGA-24-1466-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];74.0
TCGA-24-1467-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];51.0
TCGA-24-1469-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];71.0
TCGA-24-1470-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];54.0
TCGA-24-1471-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];60.0
TCGA-24-1474-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];57.0
TCGA-24-1544-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];71.0
TCGA-24-1545-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];69.0
TCGA-24-1546-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];46.0
TCGA-24-1548-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];57.0
TCGA-24-1549-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];58.0
TCGA-24-1550-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];49.0
TCGA-24-1551-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];53.0
TCGA-24-1552-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];77.0
TCGA-24-1553-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];53.0
TCGA-24-1555-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];50.0
TCGA-24-1556-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];50.0
TCGA-24-1557-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];49.0
TCGA-24-1558-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];73.0
TCGA-24-1560-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];51.0
TCGA-24-1562-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];67.0
TCGA-24-1563-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];66.0
TCGA-24-1564-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];67.0
TCGA-24-1565-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];74.0
TCGA-24-1567-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];54.0
TCGA-24-1603-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];53.0
TCGA-24-1604-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];66.0
TCGA-24-1614-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];57.0
TCGA-24-1616-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];56.0
TCGA-24-1842-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];49.0
TCGA-24-1843-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];66.0
TCGA-24-1844-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];64.0
TCGA-24-1845-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];42.0
TCGA-24-1846-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];45.0
TCGA-24-1847-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];45.0
TCGA-24-1849-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];80.0
TCGA-24-1850-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];72.0
TCGA-24-1852-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];55.0
TCGA-24-1920-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];74.0
TCGA-24-1923-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];51.0
TCGA-24-1924-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];65.0
TCGA-24-1927-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];59.0
TCGA-24-1928-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];77.0
TCGA-24-1930-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];53.0
TCGA-24-2019-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];46.0
TCGA-24-2020-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];67.0
TCGA-24-2023-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];54.0
TCGA-24-2024-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];72.0
TCGA-24-2026-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];79.0
TCGA-24-2027-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];51.0
TCGA-24-2029-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];75.0
TCGA-24-2030-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];87.0
TCGA-24-2033-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];87.0
TCGA-24-2035-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];65.0
TCGA-24-2038-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];68.0
TCGA-24-2254-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];66.0
TCGA-24-2260-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];74.0
TCGA-24-2261-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];76.0
TCGA-24-2262-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];57.0
TCGA-24-2267-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];58.0
TCGA-24-2271-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];55.0
TCGA-24-2280-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];74.0
TCGA-24-2281-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];68.0
TCGA-24-2288-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];70.0
TCGA-24-2289-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];68.0
TCGA-24-2290-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];56.0
TCGA-24-2293-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];47.0
TCGA-24-2295-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];69.0
TCGA-24-2297-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];56.0
TCGA-24-2298-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];55.0
TCGA-25-1312-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];69.0
TCGA-25-1313-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];62.0
TCGA-25-1314-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];42.0
TCGA-25-1315-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];50.0
TCGA-25-1316-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];55.0
TCGA-25-1317-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];66.0
TCGA-25-1318-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];54.0
TCGA-25-1319-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];73.0
TCGA-25-1320-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];65.0
TCGA-25-1321-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];65.0
TCGA-25-1322-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];62.0
TCGA-25-1323-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];72.0
TCGA-25-1324-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];74.0
TCGA-25-1326-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];61.0
TCGA-25-1328-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];38.0
TCGA-25-1329-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];76.0
TCGA-25-1623-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];71.0
TCGA-25-1625-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];66.0
TCGA-25-1626-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];65.0
TCGA-25-1627-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];73.0
TCGA-25-1628-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];67.0
TCGA-25-1630-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];73.0
TCGA-25-1631-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];73.0
TCGA-25-1632-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];68.0
TCGA-25-1633-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];64.0
TCGA-25-1634-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];75.0
TCGA-25-1635-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];71.0
TCGA-25-1870-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];59.0
TCGA-25-1871-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];70.0
TCGA-25-1877-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];81.0
TCGA-25-1878-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];60.0
TCGA-25-2042-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];60.0
TCGA-25-2391-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];57.0
TCGA-25-2392-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];75.0
TCGA-25-2393-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];81.0
TCGA-25-2396-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];71.0
TCGA-25-2397-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];59.0
TCGA-25-2398-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];71.0
TCGA-25-2399-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];80.0
TCGA-25-2400-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];76.0
TCGA-25-2401-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];64.0
TCGA-25-2404-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];38.0
TCGA-25-2408-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];37.0
TCGA-25-2409-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];71.0
TCGA-29-1688-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];39.0
TCGA-29-1690-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];66.0
TCGA-29-1691-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];51.0
TCGA-29-1692-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];58.0
TCGA-29-1693-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];72.0
TCGA-29-1694-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];45.0
TCGA-29-1695-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];62.0
TCGA-29-1696-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];43.0
TCGA-29-1697-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];62.0
TCGA-29-1698-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];53.0
TCGA-29-1699-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];57.0
TCGA-29-1701-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];56.0
TCGA-29-1702-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];84.0
TCGA-29-1703-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];56.0
TCGA-29-1704-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];61.0
TCGA-29-1705-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];47.0
TCGA-29-1707-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];41.0
TCGA-29-1710-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];54.0
TCGA-29-1711-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];45.0
TCGA-29-1761-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];80.0
TCGA-29-1762-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];59.0
TCGA-29-1763-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];43.0
TCGA-29-1764-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];49.0
TCGA-29-1766-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];74.0
TCGA-29-1768-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];50.0
TCGA-29-1769-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];40.0
TCGA-29-1770-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];54.0
TCGA-29-1771-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];76.0
TCGA-29-1774-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];82.0
TCGA-29-1775-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];51.0
TCGA-29-1776-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];63.0
TCGA-29-1777-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];47.0
TCGA-29-1778-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];77.0
TCGA-29-1781-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];69.0
TCGA-29-1783-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];58.0
TCGA-29-1784-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];55.0
TCGA-29-1785-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];55.0
TCGA-29-2425-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];60.0
TCGA-29-2427-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];60.0
TCGA-29-2428-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];58.0
TCGA-29-2429-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];79.0
TCGA-29-2431-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];59.0
TCGA-29-2432-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];61.0
TCGA-29-2434-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];52.0
TCGA-29-2436-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];36.0
TCGA-29-A5NZ-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];66.0
TCGA-30-1714-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];68.0
TCGA-30-1718-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];44.0
TCGA-30-1853-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];58.0
TCGA-30-1855-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];61.0
TCGA-30-1856-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];56.0
TCGA-30-1857-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];64.0
TCGA-30-1859-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];56.0
TCGA-30-1860-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];58.0
TCGA-30-1861-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];74.0
TCGA-30-1862-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];65.0
TCGA-30-1866-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];61.0
TCGA-30-1867-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];46.0
TCGA-30-1880-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];56.0
TCGA-30-1887-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];67.0
TCGA-30-1891-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];61.0
TCGA-30-1892-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];52.0
TCGA-31-1944-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];47.0
TCGA-31-1946-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];30.0
TCGA-31-1950-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];76.0
TCGA-31-1951-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];58.0
TCGA-31-1953-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];52.0
TCGA-31-1955-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];43.0
TCGA-31-1956-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];60.0
TCGA-31-1959-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];49.0
TCGA-36-1568-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];52.0
TCGA-36-1569-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];52.0
TCGA-36-1570-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];49.0
TCGA-36-1571-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];53.0
TCGA-36-1574-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];48.0
TCGA-36-1575-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];83.0
TCGA-36-1576-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];76.0
TCGA-36-1577-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];43.0
TCGA-36-1578-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];63.0
TCGA-36-1580-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];82.0
TCGA-36-1581-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];63.0
TCGA-36-2529-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];71.0
TCGA-36-2530-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];38.0
TCGA-36-2532-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];61.0
TCGA-36-2533-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;[Not Available];[Not Available];55.0
TCGA-36-2534-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];72.0
TCGA-36-2537-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];39.0
TCGA-36-2538-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];37.0
TCGA-36-2540-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];26.0
TCGA-36-2542-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];59.0
TCGA-36-2543-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];85.0
TCGA-36-2544-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];58.0
TCGA-36-2545-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];42.0
TCGA-36-2547-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];64.0
TCGA-36-2548-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];57.0
TCGA-36-2549-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];54.0
TCGA-36-2551-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];57.0
TCGA-36-2552-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];64.0
TCGA-3P-A9WA-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];55.0
TCGA-42-2582-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];49.0
TCGA-42-2587-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];75.0
TCGA-42-2588-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];61.0
TCGA-42-2589-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];54.0
TCGA-42-2590-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];57.0
TCGA-42-2591-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];51.0
TCGA-42-2593-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];67.0
TCGA-57-1582-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];50.0
TCGA-57-1583-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];57.0
TCGA-57-1584-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];47.0
TCGA-57-1585-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];57.0
TCGA-57-1586-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];66.0
TCGA-57-1992-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];62.0
TCGA-57-1993-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];56.0
TCGA-57-1994-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];63.0
TCGA-59-2348-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];59.0
TCGA-59-2349-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];71.0
TCGA-59-2350-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];44.0
TCGA-59-2351-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];51.0
TCGA-59-2352-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];78.0
TCGA-59-2354-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];63.0
TCGA-59-2355-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];58.0
TCGA-59-2363-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];40.0
TCGA-59-2372-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];73.0
TCGA-59-A5PD-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];55.0
TCGA-5X-AA5U-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];61.0
TCGA-61-1721-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];38.0
TCGA-61-1722-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];89.0
TCGA-61-1724-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];47.0
TCGA-61-1725-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];40.0
TCGA-61-1727-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];74.0
TCGA-61-1728-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];59.0
TCGA-61-1730-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];78.0
TCGA-61-1733-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];71.0
TCGA-61-1734-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];52.0
TCGA-61-1736-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];45.0
TCGA-61-1737-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];42.0
TCGA-61-1738-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];60.0
TCGA-61-1740-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];71.0
TCGA-61-1741-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];76.0
TCGA-61-1743-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];53.0
TCGA-61-1895-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];52.0
TCGA-61-1899-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];81.0
TCGA-61-1900-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];51.0
TCGA-61-1901-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];65.0
TCGA-61-1903-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];55.0
TCGA-61-1904-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];60.0
TCGA-61-1906-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];55.0
TCGA-61-1907-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];63.0
TCGA-61-1910-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];56.0
TCGA-61-1911-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];55.0
TCGA-61-1913-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];48.0
TCGA-61-1914-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];65.0
TCGA-61-1915-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];50.0
TCGA-61-1917-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];60.0
TCGA-61-1918-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];45.0
TCGA-61-1919-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];58.0
TCGA-61-1995-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];43.0
TCGA-61-1998-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];48.0
TCGA-61-2000-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];67.0
TCGA-61-2002-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];46.0
TCGA-61-2003-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];53.0
TCGA-61-2008-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];40.0
TCGA-61-2009-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];65.0
TCGA-61-2012-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];81.0
TCGA-61-2016-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];51.0
TCGA-61-2017-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];64.0
TCGA-61-2018-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];62.0
TCGA-61-2087-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];49.0
TCGA-61-2088-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];51.0
TCGA-61-2092-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];57.0
TCGA-61-2094-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];63.0
TCGA-61-2095-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];54.0
TCGA-61-2096-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];56.0
TCGA-61-2097-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];71.0
TCGA-61-2098-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];62.0
TCGA-61-2101-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];55.0
TCGA-61-2102-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];74.0
TCGA-61-2104-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];53.0
TCGA-61-2109-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];40.0
TCGA-61-2110-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];56.0
TCGA-61-2111-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];61.0
TCGA-61-2113-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];53.0
TCGA-61-2610-02;Ovarian Epithelial Tumor;Female;Recurrence;Matched;SOC;1:DECEASED;[Not Available];61.0
TCGA-61-2611-02;Ovarian Epithelial Tumor;Female;Recurrence;Matched;SOC;1:DECEASED;[Not Available];40.0
TCGA-61-2612-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];63.0
TCGA-61-2613-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];73.0
TCGA-61-2614-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];71.0
TCGA-OY-A56P-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];48.0
TCGA-OY-A56Q-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;0:LIVING;[Not Available];78.0
TCGA-VG-A8LO-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];55.0
TCGA-WR-A838-01;Ovarian Epithelial Tumor;Female;Primary;Matched;SOC;1:DECEASED;[Not Available];72.0
TCGA-72-4238-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;[Not Available];[Not Available];[Not Available]
TCGA-13-0924-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;0:LIVING;[Not Available];[Not Available]
TCGA-24-0982-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;1:DECEASED;[Not Available];[Not Available]
TCGA-13-0791-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;1:DECEASED;[Not Available];[Not Available]
TCGA-13-0766-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;1:DECEASED;[Not Available];[Not Available]
TCGA-20-0987-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;1:DECEASED;[Not Available];[Not Available]
TCGA-10-0931-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;1:DECEASED;[Not Available];[Not Available]
TCGA-13-0795-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;1:DECEASED;[Not Available];[Not Available]
TCGA-72-4236-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;[Not Available];[Not Available];[Not Available]
TCGA-09-0365-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;1:DECEASED;[Not Available];[Not Available]
TCGA-13-0885-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;0:LIVING;[Not Available];[Not Available]
TCGA-13-0804-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;1:DECEASED;[Not Available];[Not Available]
TCGA-13-0912-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;1:DECEASED;[Not Available];[Not Available]
TCGA-13-0903-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;0:LIVING;[Not Available];[Not Available]
TCGA-13-0802-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;1:DECEASED;[Not Available];[Not Available]
TCGA-13-0751-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;1:DECEASED;[Not Available];[Not Available]
TCGA-13-0894-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;1:DECEASED;[Not Available];[Not Available]
TCGA-10-0927-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;1:DECEASED;[Not Available];[Not Available]
TCGA-13-0890-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;0:LIVING;[Not Available];[Not Available]
TCGA-13-0920-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;1:DECEASED;[Not Available];[Not Available]
TCGA-13-0714-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;1:DECEASED;[Not Available];[Not Available]
TCGA-24-0968-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;1:DECEASED;[Not Available];[Not Available]
TCGA-72-4234-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;[Not Available];[Not Available];[Not Available]
TCGA-13-0727-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;1:DECEASED;[Not Available];[Not Available]
TCGA-13-0919-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;0:LIVING;[Not Available];[Not Available]
TCGA-10-0933-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;1:DECEASED;[Not Available];[Not Available]
TCGA-13-0768-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;1:DECEASED;[Not Available];[Not Available]
TCGA-10-0926-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;1:DECEASED;[Not Available];[Not Available]
TCGA-13-0794-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;1:DECEASED;[Not Available];[Not Available]
TCGA-10-0937-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;1:DECEASED;[Not Available];[Not Available]
TCGA-13-0884-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;1:DECEASED;[Not Available];[Not Available]
TCGA-10-0936-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;1:DECEASED;[Not Available];[Not Available]
TCGA-13-0913-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;0:LIVING;[Not Available];[Not Available]
TCGA-13-0803-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;1:DECEASED;[Not Available];[Not Available]
TCGA-13-0805-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;1:DECEASED;[Not Available];[Not Available]
TCGA-10-0925-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;1:DECEASED;[Not Available];[Not Available]
TCGA-13-0899-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;1:DECEASED;[Not Available];[Not Available]
TCGA-13-0889-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;1:DECEASED;[Not Available];[Not Available]
TCGA-72-4241-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;[Not Available];[Not Available];[Not Available]
TCGA-13-0906-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;0:LIVING;[Not Available];[Not Available]
TCGA-24-0979-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;1:DECEASED;[Not Available];[Not Available]
TCGA-13-0726-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;1:DECEASED;[Not Available];[Not Available]
TCGA-13-0792-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;0:LIVING;[Not Available];[Not Available]
TCGA-24-0970-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;1:DECEASED;[Not Available];[Not Available]
TCGA-09-0367-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;1:DECEASED;[Not Available];[Not Available]
TCGA-24-0975-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;1:DECEASED;[Not Available];[Not Available]
TCGA-13-0908-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;1:DECEASED;[Not Available];[Not Available]
TCGA-13-0762-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;0:LIVING;[Not Available];[Not Available]
TCGA-20-0991-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;0:LIVING;[Not Available];[Not Available]
TCGA-13-0807-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;1:DECEASED;[Not Available];[Not Available]
TCGA-13-0916-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;0:LIVING;[Not Available];[Not Available]
TCGA-13-0901-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;0:LIVING;[Not Available];[Not Available]
TCGA-13-0886-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;0:LIVING;[Not Available];[Not Available]
TCGA-13-0730-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;1:DECEASED;[Not Available];[Not Available]
TCGA-13-0801-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;1:DECEASED;[Not Available];[Not Available]
TCGA-13-0888-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;1:DECEASED;[Not Available];[Not Available]
TCGA-10-0934-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;1:DECEASED;[Not Available];[Not Available]
TCGA-72-4235-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;[Not Available];[Not Available];[Not Available]
TCGA-13-0717-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;1:DECEASED;[Not Available];[Not Available]
TCGA-24-0980-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;1:DECEASED;[Not Available];[Not Available]
TCGA-13-0764-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;1:DECEASED;[Not Available];[Not Available]
TCGA-09-0366-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;1:DECEASED;[Not Available];[Not Available]
TCGA-20-0990-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;0:LIVING;[Not Available];[Not Available]
TCGA-13-0793-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;0:LIVING;[Not Available];[Not Available]
TCGA-13-0897-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;1:DECEASED;[Not Available];[Not Available]
TCGA-10-0938-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;1:DECEASED;[Not Available];[Not Available]
TCGA-13-0893-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;1:DECEASED;[Not Available];[Not Available]
TCGA-13-0910-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;0:LIVING;[Not Available];[Not Available]
TCGA-13-0900-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;0:LIVING;[Not Available];[Not Available]
TCGA-13-0725-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;1:DECEASED;[Not Available];[Not Available]
TCGA-09-0364-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;1:DECEASED;[Not Available];[Not Available]
TCGA-13-0720-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;1:DECEASED;[Not Available];[Not Available]
TCGA-13-0923-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;0:LIVING;[Not Available];[Not Available]
TCGA-13-0904-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;1:DECEASED;[Not Available];[Not Available]
TCGA-72-4240-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;[Not Available];[Not Available];[Not Available]
TCGA-13-0724-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;1:DECEASED;[Not Available];[Not Available]
TCGA-13-0758-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;1:DECEASED;[Not Available];[Not Available]
TCGA-13-0883-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;1:DECEASED;[Not Available];[Not Available]
TCGA-13-0760-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;1:DECEASED;[Not Available];[Not Available]
TCGA-13-0797-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;0:LIVING;[Not Available];[Not Available]
TCGA-13-0887-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;1:DECEASED;[Not Available];[Not Available]
TCGA-13-0755-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;1:DECEASED;[Not Available];[Not Available]
TCGA-13-0921-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;1:DECEASED;[Not Available];[Not Available]
TCGA-72-4231-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;[Not Available];[Not Available];[Not Available]
TCGA-13-0799-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;0:LIVING;[Not Available];[Not Available]
TCGA-72-4237-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;[Not Available];[Not Available];[Not Available]
TCGA-09-0369-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;1:DECEASED;[Not Available];[Not Available]
TCGA-20-0996-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;0:LIVING;[Not Available];[Not Available]
TCGA-10-0930-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;1:DECEASED;[Not Available];[Not Available]
TCGA-24-0966-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;0:LIVING;[Not Available];[Not Available]
TCGA-13-0800-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;0:LIVING;[Not Available];[Not Available]
TCGA-13-0765-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;1:DECEASED;[Not Available];[Not Available]
TCGA-72-4233-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;[Not Available];[Not Available];[Not Available]
TCGA-10-0928-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;1:DECEASED;[Not Available];[Not Available]
TCGA-13-0905-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;0:LIVING;[Not Available];[Not Available]
TCGA-13-0911-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;1:DECEASED;[Not Available];[Not Available]
TCGA-13-0757-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;1:DECEASED;[Not Available];[Not Available]
TCGA-13-0891-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;1:DECEASED;[Not Available];[Not Available]
TCGA-13-0761-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;1:DECEASED;[Not Available];[Not Available]
TCGA-72-4232-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;[Not Available];[Not Available];[Not Available]
TCGA-10-0935-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;1:DECEASED;[Not Available];[Not Available]
TCGA-13-0723-01;Ovarian Epithelial Tumor;[Not Available];Primary;Matched;SOC;1:DECEASED;[Not Available];[Not Available]
TCGA-FZ-5919-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;1:DECEASED;Stage IIB;65.0
TCGA-FZ-5920-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;0:LIVING;Stage IIB;48.0
TCGA-FZ-5921-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;1:DECEASED;Stage IIA;75.0
TCGA-FZ-5922-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;0:LIVING;Stage IIB;71.0
TCGA-FZ-5923-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;1:DECEASED;Stage IIB;70.0
TCGA-FZ-5924-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;1:DECEASED;Stage IIB;55.0
TCGA-FZ-5926-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;0:LIVING;Stage IIA;73.0
TCGA-F2-6879-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;1:DECEASED;Stage IIB;73.0
TCGA-F2-6880-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;0:LIVING;Stage IIA;61.0
TCGA-F2-7273-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;0:LIVING;Stage IIA;55.0
TCGA-F2-7276-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;0:LIVING;Stage IIB;71.0
TCGA-HZ-7289-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;0:LIVING;Stage IIB;43.0
TCGA-HZ-7918-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;0:LIVING;Stage IIB;58.0
TCGA-HZ-7919-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;0:LIVING;Stage IIA;60.0
TCGA-HZ-7922-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;0:LIVING;Stage IIB;72.0
TCGA-HZ-7923-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;1:DECEASED;Stage IIB;56.0
TCGA-HZ-7924-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;1:DECEASED;Stage IIB;74.0
TCGA-HZ-7925-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;1:DECEASED;Stage IIB;76.0
TCGA-HZ-7926-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;1:DECEASED;Stage IIB;56.0
TCGA-IB-7644-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;1:DECEASED;Stage IIB;66.0
TCGA-IB-7646-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;1:DECEASED;Stage III;49.0
TCGA-IB-7647-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;1:DECEASED;Stage IIB;82.0
TCGA-IB-7649-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;0:LIVING;Stage IIB;52.0
TCGA-IB-7651-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;0:LIVING;[Discrepancy];57.0
TCGA-IB-7652-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;0:LIVING;Stage IIB;45.0
TCGA-IB-7654-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;1:DECEASED;Stage IIA;67.0
TCGA-IB-7885-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;1:DECEASED;Stage IIB;69.0
TCGA-IB-7886-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;1:DECEASED;Stage IIB;61.0
TCGA-IB-7887-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;0:LIVING;Stage IA;66.0
TCGA-IB-7888-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;0:LIVING;Stage IB;65.0
TCGA-IB-7889-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;0:LIVING;Stage I;39.0
TCGA-HZ-7920-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;0:LIVING;Stage IB;62.0
TCGA-HZ-8001-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;0:LIVING;[Not Available];55.0
TCGA-HZ-8002-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;0:LIVING;Stage IB;64.0
TCGA-HZ-8003-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;0:LIVING;Stage IB;67.0
TCGA-HZ-8005-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;1:DECEASED;Stage IIB;65.0
TCGA-IB-7645-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;0:LIVING;Stage IB;59.0
TCGA-IB-7890-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;0:LIVING;Stage IA;40.0
TCGA-IB-7891-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;1:DECEASED;Stage IIB;47.0
TCGA-IB-7893-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;0:LIVING;Stage IIB;75.0
TCGA-IB-7897-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;0:LIVING;Stage IIB;67.0
TCGA-H6-8124-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;1:DECEASED;Stage IIA;71.0
TCGA-HZ-8315-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;1:DECEASED;Stage IIB;57.0
TCGA-HZ-8317-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;0:LIVING;Stage IIB;70.0
TCGA-HZ-8519-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;1:DECEASED;Stage IIB;54.0
TCGA-HZ-8636-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;1:DECEASED;Stage IIB;64.0
TCGA-HZ-8637-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;1:DECEASED;Stage IIB;79.0
TCGA-HZ-8638-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;0:LIVING;Stage IIA;65.0
TCGA-IB-8126-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;1:DECEASED;Stage IIB;77.0
TCGA-IB-8127-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;0:LIVING;Stage IIA;76.0
TCGA-F2-A44G-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;1:DECEASED;Stage IIB;69.0
TCGA-F2-A44H-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;0:LIVING;Stage IIB;54.0
TCGA-FB-A4P5-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;1:DECEASED;Stage IIB;72.0
TCGA-FB-A4P6-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;1:DECEASED;Stage IB;74.0
TCGA-FB-A545-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;1:DECEASED;Stage IIB;71.0
TCGA-H6-A45N-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;1:DECEASED;Stage IIA;48.0
TCGA-HV-A5A3-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;1:DECEASED;Stage IIB;71.0
TCGA-HV-A5A4-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;1:DECEASED;Stage IIB;65.0
TCGA-HV-A5A5-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;0:LIVING;Stage IIB;62.0
TCGA-HV-A5A6-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;1:DECEASED;Stage IIA;41.0
TCGA-HZ-A49G-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;1:DECEASED;Stage IIB;71.0
TCGA-HZ-A49H-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;0:LIVING;Stage IIB;54.0
TCGA-HZ-A49I-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;1:DECEASED;Stage IIA;68.0
TCGA-HZ-A4BH-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;1:DECEASED;Stage IIB;49.0
TCGA-HZ-A4BK-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;1:DECEASED;Stage IIB;81.0
TCGA-M8-A5N4-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;1:DECEASED;Stage IIB;65.0
TCGA-FB-A5VM-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;1:DECEASED;Stage IA;85.0
TCGA-FB-A78T-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;1:DECEASED;Stage IIB;59.0
TCGA-H8-A6C1-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;1:DECEASED;Stage IIB;52.0
TCGA-IB-A5SO-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;1:DECEASED;Stage IIB;85.0
TCGA-IB-A5SP-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;1:DECEASED;Stage IIA;81.0
TCGA-IB-A5SQ-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;1:DECEASED;Stage IV;71.0
TCGA-IB-A5SS-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;1:DECEASED;Stage IIA;83.0
TCGA-IB-A5ST-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;1:DECEASED;Stage III;73.0
TCGA-OE-A75W-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;0:LIVING;Stage IIB;56.0
TCGA-PZ-A5RE-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;1:DECEASED;Stage IIB;88.0
TCGA-Q3-A5QY-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;0:LIVING;Stage IIA;53.0
TCGA-US-A774-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;1:DECEASED;Stage IIA;50.0
TCGA-US-A779-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;0:LIVING;Stage IIA;72.0
TCGA-US-A77E-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;0:LIVING;Stage IIB;61.0
TCGA-US-A77G-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;1:DECEASED;Stage IIB;65.0
TCGA-US-A77J-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;0:LIVING;Stage IIA;70.0
TCGA-FB-A7DR-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;0:LIVING;Stage IIB;72.0
TCGA-HV-A7OL-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;0:LIVING;Stage IIB;50.0
TCGA-HV-A7OP-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;1:DECEASED;Stage IIB;75.0
TCGA-HZ-A77O-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;1:DECEASED;Stage IIB;77.0
TCGA-HZ-A77P-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;0:LIVING;Stage IIB;72.0
TCGA-IB-A6UF-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;1:DECEASED;Stage IIB;52.0
TCGA-IB-A6UG-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;1:DECEASED;Stage IB;71.0
TCGA-LB-A7SX-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;0:LIVING;Stage IIB;61.0
TCGA-RB-A7B8-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;0:LIVING;Stage IIA;65.0
TCGA-US-A776-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;0:LIVING;Stage IIA;60.0
TCGA-HZ-A77Q-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;1:DECEASED;Stage IIB;66.0
TCGA-HZ-A8P0-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;1:DECEASED;Stage IIB;57.0
TCGA-IB-A7LX-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;0:LIVING;Stage III;69.0
TCGA-IB-A7M4-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;1:DECEASED;Stage IIB;61.0
TCGA-L1-A7W4-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;1:DECEASED;Stage IIB;65.0
TCGA-LB-A8F3-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;1:DECEASED;Stage IIB;81.0
TCGA-S4-A8RP-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;1:DECEASED;Stage IIA;54.0
TCGA-XN-A8T3-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;1:DECEASED;Stage IIB;69.0
TCGA-XN-A8T5-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;0:LIVING;Stage IA;73.0
TCGA-YB-A89D-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;1:DECEASED;Stage IV;58.0
TCGA-YY-A8LH-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;1:DECEASED;Stage IIB;76.0
TCGA-F2-A8YN-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;1:DECEASED;Stage IA;84.0
TCGA-HZ-A8P1-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;0:LIVING;Stage IIB;58.0
TCGA-IB-AAUM-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;0:LIVING;Stage IIB;68.0
TCGA-IB-AAUP-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;1:DECEASED;Stage IIB;77.0
TCGA-IB-AAUT-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;0:LIVING;Stage IIB;75.0
TCGA-IB-AAUU-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;0:LIVING;Stage IIB;72.0
TCGA-Q3-AA2A-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;1:DECEASED;Stage IIB;77.0
TCGA-S4-A8RM-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;0:LIVING;Stage IIB;77.0
TCGA-S4-A8RO-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;0:LIVING;Stage IIB;55.0
TCGA-YH-A8SY-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;0:LIVING;Stage IIB;76.0
TCGA-2L-AAQA-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;0:LIVING;Stage IB;81.0
TCGA-2L-AAQL-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;0:LIVING;Stage IV;70.0
TCGA-3A-A9I5-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;1:DECEASED;Stage IV;65.0
TCGA-3A-A9I7-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;1:DECEASED;Stage IIB;44.0
TCGA-3A-A9I9-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;1:DECEASED;Stage IIB;60.0
TCGA-3A-A9IC-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;1:DECEASED;Stage IIB;41.0
TCGA-3A-A9IL-01;Pancreatic Cancer;Female;Primary;Matched;PANET;1:DECEASED;Stage IIB;73.0
TCGA-3A-A9IO-01;Pancreatic Cancer;Female;Primary;Matched;PANET;1:DECEASED;Stage IIB;64.0
TCGA-3A-A9IR-01;Pancreatic Cancer;Female;Primary;Matched;PANET;0:LIVING;Stage IIB;49.0
TCGA-3E-AAAY-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;1:DECEASED;Stage IIB;80.0
TCGA-3E-AAAZ-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;0:LIVING;Stage IIB;78.0
TCGA-F2-A7TX-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;1:DECEASED;Stage IIB;80.0
TCGA-IB-AAUN-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;1:DECEASED;Stage IIB;62.0
TCGA-IB-AAUO-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;1:DECEASED;Stage IIA;66.0
TCGA-IB-AAUR-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;1:DECEASED;Stage IIB;85.0
TCGA-IB-AAUS-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;1:DECEASED;Stage IB;73.0
TCGA-IB-AAUV-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;1:DECEASED;Stage IIB;49.0
TCGA-IB-AAUW-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;1:DECEASED;Stage IIA;64.0
TCGA-2L-AAQE-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;1:DECEASED;Stage IIB;53.0
TCGA-2L-AAQI-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;0:LIVING;Stage III;79.0
TCGA-2L-AAQJ-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;0:LIVING;Stage IIB;59.0
TCGA-2L-AAQM-01;Pancreatic Cancer;Male;Primary;Matched;PANET;1:DECEASED;Stage IIB;71.0
TCGA-3A-A9IB-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;0:LIVING;Stage IIA;77.0
TCGA-3A-A9IH-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;1:DECEASED;Stage IB;56.0
TCGA-3A-A9IJ-01;Pancreatic Cancer;Female;Primary;Matched;PANET;1:DECEASED;Stage IIB;64.0
TCGA-3A-A9IN-01;Pancreatic Cancer;Female;Primary;Matched;PANET;0:LIVING;Stage IIB;64.0
TCGA-3A-A9IS-01;Pancreatic Cancer;Male;Primary;Matched;PANET;0:LIVING;Stage IIB;63.0
TCGA-3A-A9IU-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;1:DECEASED;Stage IIB;65.0
TCGA-FB-AAPS-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;1:DECEASED;Stage IIB;57.0
TCGA-HV-AA8X-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;0:LIVING;Stage IIB;81.0
TCGA-LB-A9Q5-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;0:LIVING;Stage IIB;76.0
TCGA-RB-AA9M-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;1:DECEASED;Stage IB;74.0
TCGA-RL-AAAS-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;1:DECEASED;Stage IIB;64.0
TCGA-XD-AAUL-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;0:LIVING;Stage IIB;68.0
TCGA-2J-AAB1-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;1:DECEASED;Stage IIB;50.0
TCGA-2J-AAB4-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;0:LIVING;Stage IIB;67.0
TCGA-2J-AAB6-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;0:LIVING;Stage IIB;84.0
TCGA-2J-AAB8-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;0:LIVING;Stage IIB;65.0
TCGA-2J-AAB9-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;0:LIVING;Stage IIB;35.0
TCGA-2J-AABA-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;0:LIVING;Stage IIB;49.0
TCGA-2J-AABE-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;1:DECEASED;Stage IIB;63.0
TCGA-2J-AABF-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;1:DECEASED;Stage IIB;48.0
TCGA-2J-AABH-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;1:DECEASED;Stage IIB;74.0
TCGA-2J-AABI-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;0:LIVING;Stage IIA;64.0
TCGA-2J-AABK-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;1:DECEASED;Stage IIB;63.0
TCGA-2J-AABO-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;0:LIVING;Stage IIA;48.0
TCGA-2J-AABP-01;Pancreatic Cancer;Male;Primary;Matched;UCP;1:DECEASED;Stage IIA;75.0
TCGA-2J-AABR-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;1:DECEASED;Stage IIB;44.0
TCGA-2J-AABT-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;0:LIVING;Stage IIB;58.0
TCGA-2J-AABU-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;0:LIVING;Stage IB;64.0
TCGA-2J-AABV-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;1:DECEASED;Stage IIB;81.0
TCGA-3A-A9IV-01;Pancreatic Cancer;Male;Primary;Matched;PANET;0:LIVING;Stage IIB;43.0
TCGA-3A-A9IX-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;0:LIVING;Stage IB;60.0
TCGA-3A-A9IZ-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;0:LIVING;Stage IIB;67.0
TCGA-3A-A9J0-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;0:LIVING;Stage IIB;75.0
TCGA-FB-AAPP-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;1:DECEASED;Stage IIB;77.0
TCGA-FB-AAPQ-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;1:DECEASED;Stage IIB;76.0
TCGA-FB-AAPU-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;0:LIVING;Stage IIA;61.0
TCGA-FB-AAPY-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;1:DECEASED;Stage IIB;54.0
TCGA-FB-AAPZ-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;1:DECEASED;Stage IIB;73.0
TCGA-FB-AAQ0-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;1:DECEASED;Stage IIB;64.0
TCGA-FB-AAQ1-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;1:DECEASED;Stage IIB;81.0
TCGA-FB-AAQ2-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;0:LIVING;Stage IV;66.0
TCGA-FB-AAQ3-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;0:LIVING;Stage IIB;57.0
TCGA-FB-AAQ6-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;1:DECEASED;Stage IIB;50.0
TCGA-HV-AA8V-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;0:LIVING;Stage IIA;56.0
TCGA-HZ-A9TJ-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;0:LIVING;Stage IB;67.0
TCGA-IB-AAUQ-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;0:LIVING;Stage IB;53.0
TCGA-XD-AAUG-01;Pancreatic Cancer;Male;Primary;Matched;PAAD;0:LIVING;Stage IIB;59.0
TCGA-XD-AAUH-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;0:LIVING;[Discrepancy];73.0
TCGA-XD-AAUI-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;0:LIVING;Stage IIB;61.0
TCGA-Z5-AAPL-01;Pancreatic Cancer;Female;Primary;Matched;PAAD;0:LIVING;Stage IIA;74.0
TCGA-HZ-A9TJ-06;Pancreatic Cancer, NOS;[Not Available];Metastasis;Matched;PANCREAS;[Not Available];[Not Available];[Not Available]
TCGA-P7-A5NX-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];78
TCGA-P7-A5NY-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];21
TCGA-P8-A5KC-01;Pheochromocytoma;Male;Primary;Matched;PHC;0:LIVING;[Not Available];48
TCGA-P8-A5KD-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];35
TCGA-P8-A6RX-01;Miscellaneous Neuroepithelial Tumor;Male;Primary;Matched;PGNG;0:LIVING;[Not Available];65
TCGA-P8-A6RY-01;Pheochromocytoma;Male;Primary;Matched;PHC;0:LIVING;[Not Available];55
TCGA-PR-A5PF-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];62
TCGA-PR-A5PG-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];42
TCGA-PR-A5PH-01;Pheochromocytoma;Male;Primary;Matched;PHC;0:LIVING;[Not Available];47
TCGA-QR-A6GO-01;Pheochromocytoma;Male;Primary;Matched;PHC;0:LIVING;[Not Available];43
TCGA-QR-A6GR-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];30
TCGA-QR-A6GS-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];51
TCGA-QR-A6GT-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];63
TCGA-QR-A6GU-01;Pheochromocytoma;Male;Primary;Matched;PHC;0:LIVING;[Not Available];31
TCGA-QR-A6GW-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];53
TCGA-QR-A6GX-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];28
TCGA-QR-A6GY-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];37
TCGA-QR-A6GZ-01;Pheochromocytoma;Male;Primary;Matched;PHC;0:LIVING;[Not Available];31
TCGA-QR-A6H0-01;Miscellaneous Neuroepithelial Tumor;Male;Primary;Matched;PGNG;0:LIVING;[Not Available];53
TCGA-QR-A6H1-01;Pheochromocytoma;Male;Primary;Matched;PHC;0:LIVING;[Not Available];55
TCGA-QR-A6H2-01;Pheochromocytoma;Male;Primary;Matched;PHC;0:LIVING;[Not Available];33
TCGA-QR-A6H3-01;Miscellaneous Neuroepithelial Tumor;Male;Primary;Matched;PGNG;0:LIVING;[Not Available];41
TCGA-QR-A6H4-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];56
TCGA-QR-A6H5-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];30
TCGA-QR-A6H6-01;Miscellaneous Neuroepithelial Tumor;Male;Primary;Matched;PGNG;0:LIVING;[Not Available];27
TCGA-QR-A6ZZ-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];30
TCGA-QR-A700-01;Pheochromocytoma;Male;Primary;Matched;PHC;0:LIVING;[Not Available];67
TCGA-QR-A702-01;Miscellaneous Neuroepithelial Tumor;Female;Primary;Matched;PGNG;0:LIVING;[Not Available];75
TCGA-QR-A703-01;Pheochromocytoma;Male;Primary;Matched;PHC;0:LIVING;[Not Available];23
TCGA-QR-A705-01;Miscellaneous Neuroepithelial Tumor;Female;Primary;Matched;PGNG;0:LIVING;[Not Available];63
TCGA-QR-A706-01;Miscellaneous Neuroepithelial Tumor;Female;Primary;Matched;PGNG;0:LIVING;[Not Available];50
TCGA-QR-A707-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];43
TCGA-QR-A708-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];44
TCGA-QR-A70A-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];54
TCGA-QR-A70C-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];51
TCGA-QR-A70D-01;Miscellaneous Neuroepithelial Tumor;Female;Primary;Matched;PGNG;0:LIVING;[Not Available];39
TCGA-QR-A70E-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];31
TCGA-QR-A70G-01;Pheochromocytoma;Male;Primary;Matched;PHC;0:LIVING;[Not Available];54
TCGA-QR-A70H-01;Pheochromocytoma;Male;Primary;Matched;PHC;0:LIVING;[Not Available];36
TCGA-QR-A70I-01;Miscellaneous Neuroepithelial Tumor;Male;Primary;Matched;PGNG;0:LIVING;[Not Available];24
TCGA-QR-A70J-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];42
TCGA-QR-A70K-01;Pheochromocytoma;Male;Primary;Matched;PHC;0:LIVING;[Not Available];61
TCGA-QR-A70M-01;Pheochromocytoma;Male;Primary;Matched;PHC;0:LIVING;[Not Available];38
TCGA-QR-A70N-01;Pheochromocytoma;Male;Primary;Matched;PHC;0:LIVING;[Not Available];32
TCGA-QR-A70O-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];35
TCGA-QR-A70P-01;Miscellaneous Neuroepithelial Tumor;Female;Primary;Matched;PGNG;1:DECEASED;[Not Available];45
TCGA-QR-A70Q-01;Miscellaneous Neuroepithelial Tumor;Male;Primary;Matched;PGNG;0:LIVING;[Not Available];33
TCGA-QR-A70R-01;Pheochromocytoma;Male;Primary;Matched;PHC;0:LIVING;[Not Available];43
TCGA-QR-A70T-01;Miscellaneous Neuroepithelial Tumor;Female;Primary;Matched;PGNG;0:LIVING;[Not Available];40
TCGA-QR-A70U-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];46
TCGA-QR-A70V-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];66
TCGA-QR-A70W-01;Pheochromocytoma;Male;Primary;Matched;PHC;0:LIVING;[Not Available];40
TCGA-QR-A70X-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];46
TCGA-QR-A7IN-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];52
TCGA-QR-A7IP-01;Miscellaneous Neuroepithelial Tumor;Male;Primary;Matched;PGNG;0:LIVING;[Not Available];30
TCGA-QT-A5XJ-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];42
TCGA-QT-A5XK-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];56
TCGA-QT-A5XL-01;Pheochromocytoma;Male;Primary;Matched;PHC;0:LIVING;[Not Available];27
TCGA-QT-A5XM-01;Pheochromocytoma;Male;Primary;Matched;PHC;0:LIVING;[Not Available];43
TCGA-QT-A5XN-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];51
TCGA-QT-A5XO-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];63
TCGA-QT-A5XP-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];57
TCGA-QT-A69Q-01;Pheochromocytoma;Male;Primary;Matched;PHC;0:LIVING;[Not Available];40
TCGA-QT-A7U0-01;Miscellaneous Neuroepithelial Tumor;Male;Primary;Matched;PGNG;0:LIVING;[Not Available];56
TCGA-RM-A68T-01;Miscellaneous Neuroepithelial Tumor;Male;Primary;Matched;PGNG;0:LIVING;[Not Available];46
TCGA-RM-A68W-01;Miscellaneous Neuroepithelial Tumor;Female;Primary;Matched;PGNG;0:LIVING;[Not Available];41
TCGA-RT-A6Y9-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];50
TCGA-RT-A6YA-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];71
TCGA-RT-A6YC-01;Pheochromocytoma;Male;Primary;Matched;PHC;0:LIVING;[Not Available];31
TCGA-RW-A67V-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];44
TCGA-RW-A67W-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];46
TCGA-RW-A67X-01;Pheochromocytoma;Male;Primary;Matched;PHC;0:LIVING;[Not Available];47
TCGA-RW-A67Y-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];43
TCGA-RW-A680-01;Miscellaneous Neuroepithelial Tumor;Female;Primary;Matched;PGNG;0:LIVING;[Not Available];57
TCGA-RW-A681-01;Pheochromocytoma;Male;Primary;Matched;PHC;0:LIVING;[Not Available];56
TCGA-RW-A684-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];64
TCGA-RW-A685-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];70
TCGA-RW-A686-01;Pheochromocytoma;Male;Primary;Matched;PHC;0:LIVING;[Not Available];62
TCGA-RW-A688-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];69
TCGA-RW-A689-01;Pheochromocytoma;Male;Primary;Matched;PHC;0:LIVING;[Not Available];58
TCGA-RW-A68A-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];19
TCGA-RW-A68B-01;Pheochromocytoma;Male;Primary;Matched;PHC;0:LIVING;[Not Available];31
TCGA-RW-A68C-01;Pheochromocytoma;Male;Primary;Matched;PHC;0:LIVING;[Not Available];43
TCGA-RW-A68D-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];31
TCGA-RW-A68F-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];51
TCGA-RW-A68G-01;Pheochromocytoma;Male;Primary;Matched;PHC;0:LIVING;[Not Available];49
TCGA-RW-A7CZ-01;Miscellaneous Neuroepithelial Tumor;Female;Primary;Matched;PGNG;0:LIVING;[Not Available];72
TCGA-RW-A7D0-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];47
TCGA-RW-A8AZ-01;Pheochromocytoma;Male;Primary;Matched;PHC;1:DECEASED;[Not Available];66
TCGA-RX-A8JQ-01;Miscellaneous Neuroepithelial Tumor;Male;Primary;Matched;PGNG;0:LIVING;[Not Available];44
TCGA-S7-A7WL-01;Pheochromocytoma;Male;Primary;Matched;PHC;0:LIVING;[Not Available];59
TCGA-S7-A7WM-01;Pheochromocytoma;Male;Primary;Matched;PHC;0:LIVING;[Not Available];76
TCGA-S7-A7WN-01;Pheochromocytoma;Male;Primary;Matched;PHC;0:LIVING;[Not Available];40
TCGA-S7-A7WO-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];76
TCGA-S7-A7WP-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];25
TCGA-S7-A7WQ-01;Pheochromocytoma;Male;Primary;Matched;PHC;0:LIVING;[Not Available];19
TCGA-S7-A7WR-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];32
TCGA-S7-A7WT-01;Pheochromocytoma;Male;Primary;Matched;PHC;0:LIVING;[Not Available];74
TCGA-S7-A7WU-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];63
TCGA-S7-A7WV-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];35
TCGA-S7-A7WW-01;Pheochromocytoma;Male;Primary;Matched;PHC;0:LIVING;[Not Available];34
TCGA-S7-A7WX-01;Pheochromocytoma;Male;Primary;Matched;PHC;0:LIVING;[Not Available];52
TCGA-S7-A7X0-01;Miscellaneous Neuroepithelial Tumor;Female;Primary;Matched;PGNG;0:LIVING;[Not Available];75
TCGA-S7-A7X1-01;Pheochromocytoma;Male;Primary;Matched;PHC;0:LIVING;[Not Available];23
TCGA-S7-A7X2-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];57
TCGA-SA-A6C2-01;Miscellaneous Neuroepithelial Tumor;Female;Primary;Matched;PGNG;0:LIVING;[Not Available];46
TCGA-SP-A6QC-01;Pheochromocytoma;Male;Primary;Matched;PHC;0:LIVING;[Not Available];46
TCGA-SP-A6QD-01;Pheochromocytoma;Male;Primary;Matched;PHC;0:LIVING;[Not Available];26
TCGA-SP-A6QF-01;Pheochromocytoma;Male;Primary;Matched;PHC;0:LIVING;[Not Available];48
TCGA-SP-A6QG-01;Miscellaneous Neuroepithelial Tumor;Female;Primary;Matched;PGNG;0:LIVING;[Not Available];35
TCGA-SP-A6QH-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];35
TCGA-SP-A6QI-01;Pheochromocytoma;Male;Primary;Matched;PHC;0:LIVING;[Not Available];47
TCGA-SP-A6QJ-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];64
TCGA-SP-A6QK-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];46
TCGA-SQ-A6I4-01;Pheochromocytoma;Male;Primary;Matched;PHC;0:LIVING;[Not Available];53
TCGA-SQ-A6I6-01;Pheochromocytoma;Male;Primary;Matched;PHC;0:LIVING;[Not Available];39
TCGA-SR-A6MP-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];30
TCGA-SR-A6MQ-01;Miscellaneous Neuroepithelial Tumor;Female;Primary;Matched;PGNG;0:LIVING;[Not Available];61
TCGA-SR-A6MR-01;Miscellaneous Neuroepithelial Tumor;Male;Primary;Matched;PGNG;0:LIVING;[Not Available];41
TCGA-SR-A6MS-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];35
TCGA-SR-A6MT-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];57
TCGA-SR-A6MU-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];49
TCGA-SR-A6MV-01;Miscellaneous Neuroepithelial Tumor;Female;Primary;Matched;PGNG;0:LIVING;[Not Available];35
TCGA-SR-A6MX-01;Miscellaneous Neuroepithelial Tumor;Male;Primary;Matched;PGNG;1:DECEASED;[Not Available];55
TCGA-SR-A6MY-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];54
TCGA-SR-A6MZ-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];46
TCGA-SR-A6N0-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];45
TCGA-TT-A6YJ-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];45
TCGA-TT-A6YK-01;Miscellaneous Neuroepithelial Tumor;Male;Primary;Matched;PGNG;0:LIVING;[Not Available];61
TCGA-TT-A6YN-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];37
TCGA-TT-A6YO-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];64
TCGA-TT-A6YP-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];19
TCGA-W2-A7H5-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];25
TCGA-W2-A7H7-01;Pheochromocytoma;Male;Primary;Matched;PHC;0:LIVING;[Not Available];59
TCGA-W2-A7HA-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];63
TCGA-W2-A7HB-01;Pheochromocytoma;Male;Primary;Matched;PHC;0:LIVING;[Not Available];24
TCGA-W2-A7HC-01;Pheochromocytoma;Male;Primary;Matched;PHC;0:LIVING;[Not Available];67
TCGA-W2-A7HD-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];76
TCGA-W2-A7HE-01;Pheochromocytoma;Male;Primary;Matched;PHC;0:LIVING;[Not Available];80
TCGA-W2-A7HF-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];28
TCGA-W2-A7HH-01;Miscellaneous Neuroepithelial Tumor;Female;Primary;Matched;PGNG;0:LIVING;[Not Available];69
TCGA-W2-A7UY-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];44
TCGA-WB-A80K-01;Pheochromocytoma;Male;Primary;Matched;PHC;0:LIVING;[Not Available];49
TCGA-WB-A80L-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];30
TCGA-WB-A80M-01;Pheochromocytoma;Male;Primary;Matched;PHC;0:LIVING;[Not Available];63
TCGA-WB-A80N-01;Pheochromocytoma;Male;Primary;Matched;PHC;0:LIVING;[Not Available];54
TCGA-WB-A80O-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];83
TCGA-WB-A80P-01;Miscellaneous Neuroepithelial Tumor;Male;Primary;Matched;PGNG;0:LIVING;[Not Available];20
TCGA-WB-A80Q-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];64
TCGA-WB-A80V-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];63
TCGA-WB-A80Y-01;Pheochromocytoma;Female;Primary;Matched;PHC;1:DECEASED;[Not Available];59
TCGA-WB-A814-01;Miscellaneous Neuroepithelial Tumor;Female;Primary;Matched;PGNG;0:LIVING;[Not Available];35
TCGA-WB-A815-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];68
TCGA-WB-A816-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];42
TCGA-WB-A817-01;Pheochromocytoma;Male;Primary;Matched;PHC;0:LIVING;[Not Available];27
TCGA-WB-A818-01;Pheochromocytoma;Male;Primary;Matched;PHC;0:LIVING;[Not Available];37
TCGA-WB-A819-01;Pheochromocytoma;Male;Primary;Matched;PHC;0:LIVING;[Not Available];36
TCGA-WB-A81A-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];65
TCGA-WB-A81D-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];82
TCGA-WB-A81E-01;Miscellaneous Neuroepithelial Tumor;Female;Primary;Matched;PGNG;0:LIVING;[Not Available];47
TCGA-WB-A81F-01;Pheochromocytoma;Male;Primary;Matched;PHC;0:LIVING;[Not Available];40
TCGA-WB-A81G-01;Pheochromocytoma;Male;Primary;Matched;PHC;0:LIVING;[Not Available];25
TCGA-WB-A81H-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];44
TCGA-WB-A81I-01;Pheochromocytoma;Male;Primary;Matched;PHC;0:LIVING;[Not Available];64
TCGA-WB-A81J-01;Pheochromocytoma;Male;Primary;Matched;PHC;0:LIVING;[Not Available];40
TCGA-WB-A81K-01;Pheochromocytoma;Male;Primary;Matched;PHC;0:LIVING;[Not Available];45
TCGA-WB-A81M-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];42
TCGA-WB-A81N-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];28
TCGA-WB-A81P-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];73
TCGA-WB-A81Q-01;Pheochromocytoma;Male;Primary;Matched;PHC;1:DECEASED;[Not Available];44
TCGA-WB-A81R-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];55
TCGA-WB-A81S-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];59
TCGA-WB-A81T-01;Pheochromocytoma;Male;Primary;Matched;PHC;0:LIVING;[Not Available];45
TCGA-WB-A81V-01;Pheochromocytoma;Male;Primary;Matched;PHC;0:LIVING;[Not Available];57
TCGA-WB-A81W-01;Pheochromocytoma;Male;Primary;Matched;PHC;0:LIVING;[Not Available];41
TCGA-WB-A821-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];73
TCGA-WB-A822-01;Pheochromocytoma;Male;Primary;Matched;PHC;0:LIVING;[Not Available];23
TCGA-XG-A823-01;Pheochromocytoma;Female;Primary;Matched;PHC;0:LIVING;[Not Available];25
TCGA-CH-5767-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];51.0
TCGA-G9-6332-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];57.0
TCGA-G9-6336-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];47.0
TCGA-G9-6348-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];52.0
TCGA-G9-6356-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];70.0
TCGA-G9-6362-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];54.0
TCGA-G9-6363-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];69.0
TCGA-G9-6364-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];57.0
TCGA-G9-6365-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];57.0
TCGA-G9-6367-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];56.0
TCGA-G9-6370-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];64.0
TCGA-G9-6371-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];73.0
TCGA-G9-6373-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];72.0
TCGA-G9-6378-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];65.0
TCGA-G9-6384-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];57.0
TCGA-G9-6385-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];56.0
TCGA-G9-6494-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];66.0
TCGA-G9-6496-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];64.0
TCGA-EJ-7123-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];68.0
TCGA-EJ-7125-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];57.0
TCGA-G9-6329-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];64.0
TCGA-G9-6333-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];72.0
TCGA-G9-6338-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];68.0
TCGA-G9-6342-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];66.0
TCGA-G9-6343-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];70.0
TCGA-G9-6351-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];65.0
TCGA-G9-6353-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];61.0
TCGA-G9-6361-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];60.0
TCGA-G9-6369-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];66.0
TCGA-G9-6377-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];66.0
TCGA-G9-6499-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];55.0
TCGA-HC-7075-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];55.0
TCGA-HC-7077-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];66.0
TCGA-HC-7079-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];72.0
TCGA-HC-7080-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];48.0
TCGA-HC-7081-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];63.0
TCGA-EJ-7115-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];63.0
TCGA-EJ-7314-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];69.0
TCGA-EJ-7315-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];61.0
TCGA-EJ-7317-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];64.0
TCGA-EJ-7327-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];72.0
TCGA-EJ-7328-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];57.0
TCGA-EJ-7330-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];65.0
TCGA-EJ-7331-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];50.0
TCGA-EJ-7781-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];68.0
TCGA-EJ-7782-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];59.0
TCGA-EJ-7783-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];47.0
TCGA-EJ-7784-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];56.0
TCGA-EJ-7785-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];61.0
TCGA-EJ-7786-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];55.0
TCGA-EJ-7788-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];50.0
TCGA-EJ-7789-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];50.0
TCGA-EJ-7791-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];65.0
TCGA-EJ-7792-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];57.0
TCGA-EJ-7794-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];67.0
TCGA-FC-7708-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];54.0
TCGA-G9-6366-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];65.0
TCGA-H9-7775-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];63.0
TCGA-HC-7078-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];48.0
TCGA-HC-7209-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];55.0
TCGA-HC-7210-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];46.0
TCGA-HC-7211-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];66.0
TCGA-HC-7212-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];60.0
TCGA-HC-7213-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];49.0
TCGA-HC-7230-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];55.0
TCGA-HC-7231-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];66.0
TCGA-HC-7232-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];64.0
TCGA-HC-7233-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];63.0
TCGA-HC-7736-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];51.0
TCGA-HC-7737-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];57.0
TCGA-HC-7738-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];67.0
TCGA-HC-7740-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];56.0
TCGA-HC-7742-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];69.0
TCGA-HC-7744-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];61.0
TCGA-HC-7745-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];62.0
TCGA-HC-7747-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];57.0
TCGA-HC-7748-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];60.0
TCGA-HC-7749-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];65.0
TCGA-HC-7750-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];59.0
TCGA-HC-7752-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];44.0
TCGA-HC-7818-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];71.0
TCGA-HC-7819-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];58.0
TCGA-HC-7820-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];62.0
TCGA-HC-7821-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];68.0
TCGA-HI-7168-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];71.0
TCGA-HI-7169-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];51.0
TCGA-HI-7170-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];57.0
TCGA-HI-7171-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];63.0
TCGA-EJ-7321-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];61.0
TCGA-EJ-7793-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];70.0
TCGA-EJ-7797-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];68.0
TCGA-G9-7510-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];64.0
TCGA-G9-7519-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];65.0
TCGA-G9-7521-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];71.0
TCGA-G9-7522-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];70.0
TCGA-G9-7523-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];63.0
TCGA-G9-7525-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];54.0
TCGA-HC-7741-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];62.0
TCGA-HC-8212-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];53.0
TCGA-HC-8256-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];66.0
TCGA-HC-8257-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];67.0
TCGA-HC-8258-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];53.0
TCGA-HC-8259-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];49.0
TCGA-HC-8260-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];67.0
TCGA-HC-8261-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];53.0
TCGA-HC-8262-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];63.0
TCGA-HC-8265-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];46.0
TCGA-HC-8266-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];58.0
TCGA-J4-8198-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];63.0
TCGA-EJ-8468-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];69.0
TCGA-EJ-8469-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];66.0
TCGA-EJ-8470-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];53.0
TCGA-EJ-8472-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];57.0
TCGA-EJ-8474-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];57.0
TCGA-HC-8264-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];71.0
TCGA-EJ-A46B-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];60.0
TCGA-EJ-A46D-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];57.0
TCGA-EJ-A46E-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];55.0
TCGA-EJ-A46F-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];66.0
TCGA-FC-A4JI-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];67.0
TCGA-HC-A48F-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];59.0
TCGA-KC-A4BL-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];57.0
TCGA-KC-A4BN-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];62.0
TCGA-KC-A4BO-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];65.0
TCGA-KC-A4BR-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];70.0
TCGA-EJ-A46G-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];64.0
TCGA-EJ-A46H-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];56.0
TCGA-EJ-A46I-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];64.0
TCGA-HC-A4ZV-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];56.0
TCGA-J9-A52B-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];59.0
TCGA-J9-A52C-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];58.0
TCGA-J9-A52E-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];64.0
TCGA-KC-A4BV-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];61.0
TCGA-KK-A59Y-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];58.0
TCGA-KK-A59Z-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];51.0
TCGA-EJ-A65E-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];59.0
TCGA-EJ-A65G-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];66.0
TCGA-EJ-A65M-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];64.0
TCGA-FC-7961-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];61.0
TCGA-FC-A5OB-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];51.0
TCGA-HC-7817-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];52.0
TCGA-HC-8213-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];62.0
TCGA-HC-8216-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];70.0
TCGA-HC-A631-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];53.0
TCGA-HC-A632-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];74.0
TCGA-J4-8200-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];77.0
TCGA-J9-A52D-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];68.0
TCGA-KK-A59V-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];67.0
TCGA-KK-A59X-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];55.0
TCGA-KK-A5A1-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];66.0
TCGA-EJ-A65B-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];57.0
TCGA-EJ-A65D-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];61.0
TCGA-FC-A66V-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];58.0
TCGA-H9-A6BY-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];61.0
TCGA-HC-A6AL-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];62.0
TCGA-HC-A6AN-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];59.0
TCGA-HC-A6AO-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];68.0
TCGA-HC-A6AP-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];51.0
TCGA-HC-A6AQ-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];58.0
TCGA-HC-A6AS-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];55.0
TCGA-J4-A67K-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];60.0
TCGA-J4-A67L-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];61.0
TCGA-J4-A67M-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];57.0
TCGA-J4-A67N-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];64.0
TCGA-J4-A67O-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];72.0
TCGA-J4-A67Q-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];71.0
TCGA-J4-A67R-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];61.0
TCGA-J4-A67S-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];60.0
TCGA-KK-A6E3-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];55.0
TCGA-KK-A6E4-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];52.0
TCGA-EJ-A65F-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];58.0
TCGA-EJ-A65J-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];68.0
TCGA-G9-6339-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];61.0
TCGA-G9-6354-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];54.0
TCGA-G9-6498-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];68.0
TCGA-H9-A6BX-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];53.0
TCGA-J4-A67T-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];66.0
TCGA-J4-A6G1-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];66.0
TCGA-J4-A6G3-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];61.0
TCGA-KK-A6DY-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];53.0
TCGA-KK-A6E0-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];66.0
TCGA-KK-A6E1-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];48.0
TCGA-KK-A6E2-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];66.0
TCGA-KK-A6E5-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];58.0
TCGA-KK-A6E6-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];52.0
TCGA-FC-A6HD-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];49.0
TCGA-G9-6347-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];44.0
TCGA-G9-6379-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];64.0
TCGA-HC-A6HX-01;Prostate Cancer;Male;Primary;Matched;PRAD;1:DECEASED;[Not Applicable];53.0
TCGA-HC-A6HY-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];62.0
TCGA-J4-A6M7-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];55.0
TCGA-KK-A6E7-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];68.0
TCGA-KK-A6E8-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];60.0
TCGA-QU-A6IL-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];63.0
TCGA-QU-A6IM-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];63.0
TCGA-QU-A6IN-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];64.0
TCGA-QU-A6IO-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];69.0
TCGA-QU-A6IP-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];51.0
TCGA-EJ-7218-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];66.0
TCGA-EJ-7312-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];62.0
TCGA-EJ-7318-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];60.0
TCGA-EJ-7325-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];74.0
TCGA-EJ-A6RC-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];62.0
TCGA-KK-A7AU-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];56.0
TCGA-KK-A7AV-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];53.0
TCGA-KK-A7AW-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];50.0
TCGA-KK-A7AZ-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];66.0
TCGA-KK-A7B0-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];66.0
TCGA-KK-A7B1-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];73.0
TCGA-KK-A7B2-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];59.0
TCGA-KK-A7B4-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];55.0
TCGA-M7-A71Y-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];58.0
TCGA-M7-A71Z-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];59.0
TCGA-M7-A720-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];67.0
TCGA-M7-A721-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];58.0
TCGA-M7-A723-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];46.0
TCGA-M7-A724-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];65.0
TCGA-M7-A725-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];52.0
TCGA-EJ-A6RA-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];60.0
TCGA-EJ-A7NF-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];70.0
TCGA-EJ-A7NG-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];50.0
TCGA-EJ-A7NH-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];61.0
TCGA-EJ-A7NM-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];52.0
TCGA-EJ-A7NN-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];66.0
TCGA-HC-A76W-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];53.0
TCGA-HC-A76X-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];72.0
TCGA-KC-A7F3-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];54.0
TCGA-KC-A7F5-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];53.0
TCGA-KC-A7F6-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];48.0
TCGA-KC-A7FA-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];58.0
TCGA-KC-A7FD-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];53.0
TCGA-KC-A7FE-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];70.0
TCGA-KK-A7AP-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];56.0
TCGA-KK-A7AQ-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];50.0
TCGA-KK-A7AY-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];43.0
TCGA-KK-A7B3-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];48.0
TCGA-SU-A7E7-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];57.0
TCGA-EJ-A7NJ-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];60.0
TCGA-EJ-A7NK-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];66.0
TCGA-EJ-A8FN-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];55.0
TCGA-EJ-A8FS-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];47.0
TCGA-J4-A83K-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];56.0
TCGA-J4-A83L-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];67.0
TCGA-J4-A83M-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];68.0
TCGA-J4-A83N-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];64.0
TCGA-J9-A8CK-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];67.0
TCGA-J9-A8CL-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];52.0
TCGA-J9-A8CM-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];61.0
TCGA-J9-A8CN-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];60.0
TCGA-J9-A8CP-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];70.0
TCGA-KK-A8IJ-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];55.0
TCGA-VN-A88I-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];51.0
TCGA-VN-A88K-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];73.0
TCGA-VN-A88L-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];62.0
TCGA-VN-A88M-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];63.0
TCGA-VN-A88O-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];61.0
TCGA-VN-A88P-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];68.0
TCGA-VN-A88Q-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];64.0
TCGA-VP-A872-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];58.0
TCGA-VP-A875-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];62.0
TCGA-VP-A876-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];55.0
TCGA-VP-A878-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];58.0
TCGA-VP-A879-01;Prostate Cancer;Male;Primary;Matched;PRAD;1:DECEASED;[Not Applicable];56.0
TCGA-VP-A87B-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];49.0
TCGA-VP-A87C-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];47.0
TCGA-VP-A87D-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];68.0
TCGA-VP-A87E-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];54.0
TCGA-VP-A87H-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];55.0
TCGA-VP-A87J-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];61.0
TCGA-VP-A87K-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];59.0
TCGA-XJ-A83F-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];77.0
TCGA-XJ-A83G-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];65.0
TCGA-XJ-A83H-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];63.0
TCGA-EJ-A8FO-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];63.0
TCGA-EJ-A8FP-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];68.0
TCGA-EJ-A8FU-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];57.0
TCGA-HC-A8CY-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];53.0
TCGA-HC-A8D0-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];63.0
TCGA-HC-A8D1-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];68.0
TCGA-J4-A83I-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];52.0
TCGA-J4-A83J-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];61.0
TCGA-KK-A8I4-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];64.0
TCGA-KK-A8I5-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];57.0
TCGA-KK-A8I6-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];71.0
TCGA-KK-A8I7-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];66.0
TCGA-KK-A8I8-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];59.0
TCGA-KK-A8I9-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];62.0
TCGA-KK-A8IA-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];57.0
TCGA-KK-A8IB-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];71.0
TCGA-KK-A8IC-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];65.0
TCGA-KK-A8ID-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];66.0
TCGA-KK-A8IF-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];66.0
TCGA-KK-A8IG-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];66.0
TCGA-KK-A8IH-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];53.0
TCGA-KK-A8II-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];66.0
TCGA-KK-A8IK-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];65.0
TCGA-KK-A8IL-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];55.0
TCGA-KK-A8IM-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];55.0
TCGA-M7-A722-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];75.0
TCGA-TK-A8OK-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];66.0
TCGA-V1-A8MF-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];67.0
TCGA-V1-A8MG-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];54.0
TCGA-V1-A8MJ-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];63.0
TCGA-V1-A8MK-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];63.0
TCGA-VN-A88N-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];62.0
TCGA-VN-A88R-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];62.0
TCGA-X4-A8KQ-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];64.0
TCGA-X4-A8KS-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];55.0
TCGA-XA-A8JR-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];56.0
TCGA-XQ-A8TA-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];66.0
TCGA-XQ-A8TB-01;Prostate Cancer;Male;Primary;Matched;PRAD;1:DECEASED;[Not Applicable];72.0
TCGA-YL-A8HJ-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];50.0
TCGA-YL-A8HK-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];59.0
TCGA-YL-A8HL-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];57.0
TCGA-YL-A8HM-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];54.0
TCGA-YL-A8HO-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];56.0
TCGA-2A-A8VL-01;Prostate Cancer;Male;Primary;Matched;PRAD;1:DECEASED;[Not Applicable];69.0
TCGA-2A-A8VO-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];63.0
TCGA-2A-A8VT-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];69.0
TCGA-2A-A8VV-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];46.0
TCGA-2A-A8VX-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];68.0
TCGA-2A-A8W1-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];55.0
TCGA-2A-A8W3-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];62.0
TCGA-FC-A8O0-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];63.0
TCGA-V1-A8ML-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];58.0
TCGA-V1-A8MM-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];57.0
TCGA-V1-A8MU-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];60.0
TCGA-V1-A8WL-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];56.0
TCGA-V1-A8WN-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];67.0
TCGA-V1-A8WS-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];65.0
TCGA-V1-A8WV-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];68.0
TCGA-V1-A8WW-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];62.0
TCGA-V1-A8X3-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];64.0
TCGA-WW-A8ZI-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];64.0
TCGA-XJ-A9DI-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];55.0
TCGA-XJ-A9DK-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];58.0
TCGA-XJ-A9DQ-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];55.0
TCGA-XJ-A9DX-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];69.0
TCGA-Y6-A8TL-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];61.0
TCGA-YJ-A8SW-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];69.0
TCGA-YL-A8S8-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];65.0
TCGA-YL-A8S9-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];54.0
TCGA-YL-A8SA-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];70.0
TCGA-YL-A8SB-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];57.0
TCGA-YL-A8SC-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];55.0
TCGA-YL-A8SF-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];50.0
TCGA-YL-A8SH-01;Prostate Cancer;Male;Primary;Matched;PRAD;1:DECEASED;[Not Applicable];61.0
TCGA-YL-A8SJ-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];59.0
TCGA-YL-A8SK-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];56.0
TCGA-YL-A8SL-01;Prostate Cancer;Male;Primary;Matched;PRAD;1:DECEASED;[Not Applicable];65.0
TCGA-YL-A8SO-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];55.0
TCGA-YL-A8SP-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];55.0
TCGA-YL-A8SQ-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];62.0
TCGA-YL-A8SR-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];53.0
TCGA-YL-A9WH-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];70.0
TCGA-YL-A9WI-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];65.0
TCGA-YL-A9WJ-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];54.0
TCGA-YL-A9WK-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];64.0
TCGA-ZG-A8QW-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];56.0
TCGA-ZG-A8QX-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];59.0
TCGA-ZG-A8QY-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];64.0
TCGA-ZG-A8QZ-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];59.0
TCGA-2A-AAYF-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];61.0
TCGA-2A-AAYO-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];53.0
TCGA-2A-AAYU-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];66.0
TCGA-4L-AA1F-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];60.0
TCGA-EJ-AB20-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];73.0
TCGA-EJ-AB27-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];64.0
TCGA-G9-7509-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];62.0
TCGA-G9-A9S0-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];65.0
TCGA-G9-A9S4-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];53.0
TCGA-G9-A9S7-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];58.0
TCGA-HC-A9TE-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];41.0
TCGA-HC-A9TH-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];63.0
TCGA-J4-AATV-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];60.0
TCGA-J4-AATZ-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];56.0
TCGA-J4-AAU2-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];64.0
TCGA-MG-AAMC-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];47.0
TCGA-TP-A8TT-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];56.0
TCGA-TP-A8TV-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];52.0
TCGA-V1-A9O5-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];59.0
TCGA-V1-A9O7-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];51.0
TCGA-V1-A9O9-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];64.0
TCGA-V1-A9OA-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];60.0
TCGA-V1-A9OF-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];56.0
TCGA-V1-A9OH-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];61.0
TCGA-V1-A9OL-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];49.0
TCGA-V1-A9OQ-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];63.0
TCGA-V1-A9OT-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];65.0
TCGA-V1-A9OX-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];67.0
TCGA-V1-A9OY-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];61.0
TCGA-V1-A9Z7-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];56.0
TCGA-V1-A9Z8-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];57.0
TCGA-V1-A9Z9-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];54.0
TCGA-V1-A9ZG-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];59.0
TCGA-V1-A9ZI-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];63.0
TCGA-V1-A9ZK-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];64.0
TCGA-V1-A9ZR-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];68.0
TCGA-VN-A943-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];68.0
TCGA-VP-AA1N-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];68.0
TCGA-XK-AAIR-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];59.0
TCGA-XK-AAIV-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];58.0
TCGA-XK-AAIW-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];54.0
TCGA-XK-AAJ3-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];55.0
TCGA-XK-AAJA-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];62.0
TCGA-XK-AAJP-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];49.0
TCGA-XK-AAJR-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];60.0
TCGA-XK-AAJT-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];60.0
TCGA-XK-AAJU-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];53.0
TCGA-XK-AAK1-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];71.0
TCGA-Y6-A9XI-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];60.0
TCGA-YL-A8SI-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];67.0
TCGA-YL-A9WL-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];46.0
TCGA-YL-A9WX-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];58.0
TCGA-YL-A9WY-01;Prostate Cancer;Male;Primary;Matched;PRAD;1:DECEASED;[Not Applicable];70.0
TCGA-ZG-A9KY-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];63.0
TCGA-ZG-A9L0-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];67.0
TCGA-ZG-A9L1-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];54.0
TCGA-ZG-A9L2-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];59.0
TCGA-ZG-A9L4-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];76.0
TCGA-ZG-A9L5-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];56.0
TCGA-ZG-A9L6-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];63.0
TCGA-ZG-A9L9-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];70.0
TCGA-ZG-A9LB-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];70.0
TCGA-ZG-A9LM-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];65.0
TCGA-ZG-A9LN-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];61.0
TCGA-ZG-A9LS-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];68.0
TCGA-ZG-A9LU-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];67.0
TCGA-ZG-A9LY-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];51.0
TCGA-ZG-A9LZ-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];57.0
TCGA-ZG-A9M4-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];62.0
TCGA-ZG-A9MC-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];63.0
TCGA-ZG-A9N3-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];48.0
TCGA-ZG-A9ND-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];51.0
TCGA-ZG-A9NI-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];75.0
TCGA-CH-5737-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];63.0
TCGA-CH-5738-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];78.0
TCGA-CH-5739-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];56.0
TCGA-CH-5740-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];62.0
TCGA-CH-5741-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];66.0
TCGA-CH-5743-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];61.0
TCGA-CH-5744-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];75.0
TCGA-CH-5745-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];65.0
TCGA-CH-5746-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];62.0
TCGA-CH-5748-01;Prostate Cancer;Male;Primary;Matched;PRAD;1:DECEASED;[Not Applicable];59.0
TCGA-CH-5750-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];67.0
TCGA-CH-5751-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];65.0
TCGA-CH-5752-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];72.0
TCGA-CH-5753-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];67.0
TCGA-CH-5754-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];58.0
TCGA-CH-5761-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];59.0
TCGA-CH-5762-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];58.0
TCGA-CH-5763-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];66.0
TCGA-CH-5764-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];67.0
TCGA-CH-5765-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];68.0
TCGA-CH-5766-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];63.0
TCGA-CH-5768-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];69.0
TCGA-CH-5769-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];62.0
TCGA-CH-5771-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];66.0
TCGA-CH-5772-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];62.0
TCGA-CH-5788-01;Prostate Cancer;Male;Primary;Matched;PRAD;1:DECEASED;[Not Applicable];69.0
TCGA-CH-5789-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];69.0
TCGA-CH-5790-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];60.0
TCGA-CH-5791-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];67.0
TCGA-CH-5792-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];74.0
TCGA-CH-5794-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];64.0
TCGA-EJ-5494-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];58.0
TCGA-EJ-5495-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];61.0
TCGA-EJ-5496-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];64.0
TCGA-EJ-5497-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];67.0
TCGA-EJ-5498-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];63.0
TCGA-EJ-5499-01;Prostate Cancer;Male;Primary;Matched;PRAD;1:DECEASED;[Not Applicable];47.0
TCGA-EJ-5501-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];63.0
TCGA-EJ-5502-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];59.0
TCGA-EJ-5503-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];68.0
TCGA-EJ-5504-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];57.0
TCGA-EJ-5505-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];72.0
TCGA-EJ-5506-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];56.0
TCGA-EJ-5507-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];67.0
TCGA-EJ-5508-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];65.0
TCGA-EJ-5509-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];73.0
TCGA-EJ-5510-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];71.0
TCGA-EJ-5511-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];66.0
TCGA-EJ-5512-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];70.0
TCGA-EJ-5514-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];61.0
TCGA-EJ-5515-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];58.0
TCGA-EJ-5516-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];64.0
TCGA-EJ-5517-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];60.0
TCGA-EJ-5518-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];72.0
TCGA-EJ-5519-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];72.0
TCGA-EJ-5521-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];57.0
TCGA-EJ-5522-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];64.0
TCGA-EJ-5524-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];67.0
TCGA-EJ-5525-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];60.0
TCGA-EJ-5526-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];66.0
TCGA-EJ-5527-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];65.0
TCGA-EJ-5530-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];69.0
TCGA-EJ-5531-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];73.0
TCGA-EJ-5532-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];55.0
TCGA-EJ-5542-01;Prostate Cancer;Male;Primary;Matched;PRAD;0:LIVING;[Not Applicable];73.0
TCGA-V1-A9O5-06;Prostate Cancer;[Not Available];Metastasis;Matched;PRAD;[Not Available];[Not Available];[Not Available]
TCGA-DX-A2IZ-01;Soft Tissue Sarcoma;Male;Primary;Matched;DDLS;0:LIVING;[Not Available];68.0
TCGA-DX-A2J0-01;Soft Tissue Sarcoma;Male;Primary;Matched;DDLS;0:LIVING;[Not Available];68.0
TCGA-DX-A2J1-01;Soft Tissue Sarcoma;Male;Primary;Matched;DDLS;1:DECEASED;[Not Available];67.0
TCGA-DX-A2J4-01;Soft Tissue Sarcoma;Male;Primary;Matched;DDLS;0:LIVING;[Not Available];75.0
TCGA-DX-A3LS-01;Soft Tissue Sarcoma;Female;Primary;Matched;DDLS;1:DECEASED;[Not Available];57.0
TCGA-DX-A3LT-01;Soft Tissue Sarcoma;Female;Primary;Matched;DDLS;0:LIVING;[Not Available];66.0
TCGA-DX-A3LU-01;Soft Tissue Sarcoma;Female;Primary;Matched;DDLS;1:DECEASED;[Not Available];38.0
TCGA-DX-A3LW-01;Soft Tissue Sarcoma;Male;Primary;Matched;DDLS;1:DECEASED;[Not Available];60.0
TCGA-FX-A2QS-01;Soft Tissue Sarcoma;Male;Primary;Matched;DDLS;0:LIVING;[Not Available];53.0
TCGA-FX-A3NJ-01;Soft Tissue Sarcoma;Female;Primary;Matched;LMS;0:LIVING;[Not Available];53.0
TCGA-FX-A3NK-01;Soft Tissue Sarcoma;Female;Primary;Matched;DDLS;1:DECEASED;[Not Available];48.0
TCGA-HB-A2OT-01;Soft Tissue Sarcoma;Female;Primary;Matched;MFH;0:LIVING;[Not Available];70.0
TCGA-HB-A3L4-01;Soft Tissue Sarcoma;Male;Primary;Matched;LMS;0:LIVING;[Not Available];49.0
TCGA-IS-A3K6-01;Soft Tissue Sarcoma;Male;Primary;Matched;LMS;0:LIVING;[Not Available];66.0
TCGA-IS-A3K7-01;Soft Tissue Sarcoma;Male;Primary;Matched;LMS;0:LIVING;[Not Available];33.0
TCGA-IS-A3K8-01;Soft Tissue Sarcoma;Female;Primary;Matched;LMS;1:DECEASED;[Not Available];56.0
TCGA-IS-A3KA-01;Soft Tissue Sarcoma;Male;Primary;Matched;LMS;0:LIVING;[Not Available];62.0
TCGA-IW-A3M4-01;Soft Tissue Sarcoma;Male;Primary;Matched;LMS;1:DECEASED;[Not Available];66.0
TCGA-IW-A3M5-01;Soft Tissue Sarcoma;Male;Primary;Matched;LMS;1:DECEASED;[Not Available];82.0
TCGA-IW-A3M6-01;Soft Tissue Sarcoma;Male;Primary;Matched;LMS;1:DECEASED;[Not Available];67.0
TCGA-K1-A3PO-01;Soft Tissue Sarcoma;Female;Primary;Matched;LMS;0:LIVING;[Not Available];67.0
TCGA-DX-A3M1-01;Soft Tissue Sarcoma;Male;Primary;Matched;DDLS;1:DECEASED;[Not Available];66.0
TCGA-DX-A3M2-01;Soft Tissue Sarcoma;Male;Primary;Matched;DDLS;0:LIVING;[Not Available];66.0
TCGA-DX-A3U5-01;Soft Tissue Sarcoma;Male;Primary;Matched;DDLS;1:DECEASED;[Not Available];58.0
TCGA-FX-A3RE-01;Soft Tissue Sarcoma;Male;Primary;Matched;LMS;1:DECEASED;[Not Available];60.0
TCGA-FX-A3TO-01;Soft Tissue Sarcoma;Male;Primary;Matched;MFH;0:LIVING;[Not Available];78.0
TCGA-IE-A3OV-01;Soft Tissue Sarcoma;Female;Primary;Matched;LMS;1:DECEASED;[Not Available];60.0
TCGA-IF-A3RQ-01;Soft Tissue Sarcoma;Male;Primary;Matched;DDLS;0:LIVING;[Not Available];60.0
TCGA-K1-A3PN-01;Soft Tissue Sarcoma;Female;Primary;Matched;LMS;0:LIVING;[Not Available];55.0
TCGA-DX-A1KU-01;Soft Tissue Sarcoma;Female;Primary;Matched;DDLS;1:DECEASED;[Not Available];40.0
TCGA-DX-A1KW-01;Soft Tissue Sarcoma;Male;Primary;Matched;DDLS;1:DECEASED;[Not Available];81.0
TCGA-DX-A1KX-01;Soft Tissue Sarcoma;Female;Primary;Matched;DDLS;1:DECEASED;[Not Available];57.0
TCGA-DX-A1KY-01;Soft Tissue Sarcoma;Male;Primary;Matched;DDLS;1:DECEASED;[Not Available];80.0
TCGA-DX-A1KZ-01;Soft Tissue Sarcoma;Male;Primary;Matched;DDLS;1:DECEASED;[Not Available];74.0
TCGA-DX-A1L0-01;Soft Tissue Sarcoma;Male;Primary;Matched;DDLS;0:LIVING;[Not Available];51.0
TCGA-DX-A1L1-01;Soft Tissue Sarcoma;Male;Primary;Matched;DDLS;0:LIVING;[Not Available];60.0
TCGA-DX-A1L2-01;Soft Tissue Sarcoma;Male;Primary;Matched;DDLS;1:DECEASED;[Not Available];61.0
TCGA-DX-A1L3-01;Soft Tissue Sarcoma;Male;Primary;Matched;DDLS;0:LIVING;[Not Available];53.0
TCGA-FX-A48G-01;Soft Tissue Sarcoma;Male;Primary;Matched;LMS;0:LIVING;[Not Available];60.0
TCGA-HB-A3YV-01;Soft Tissue Sarcoma;Female;Primary;Matched;MFH;1:DECEASED;[Not Available];78.0
TCGA-HB-A43Z-01;Soft Tissue Sarcoma;Male;Primary;Matched;LMS;0:LIVING;[Not Available];62.0
TCGA-IE-A4EH-01;Soft Tissue Sarcoma;Male;Primary;Matched;LMS;0:LIVING;[Not Available];60.0
TCGA-IE-A4EI-01;Soft Tissue Sarcoma;Male;Primary;Matched;LMS;0:LIVING;[Not Available];43.0
TCGA-IE-A4EJ-01;Soft Tissue Sarcoma;Male;Primary;Matched;MFH;0:LIVING;[Not Available];66.0
TCGA-IE-A4EK-01;Soft Tissue Sarcoma;Male;Primary;Matched;LMS;0:LIVING;[Not Available];79.0
TCGA-IF-A4AJ-01;Soft Tissue Sarcoma;Male;Primary;Matched;LMS;0:LIVING;[Not Available];59.0
TCGA-IF-A4AK-01;Soft Tissue Sarcoma;Male;Primary;Matched;LMS;0:LIVING;[Not Available];52.0
TCGA-K1-A42W-01;Soft Tissue Sarcoma;Female;Primary;Matched;LMS;1:DECEASED;[Not Available];63.0
TCGA-K1-A42X-01;Soft Tissue Sarcoma;Male;Primary;Matched;LMS;1:DECEASED;[Not Available];67.0
TCGA-KF-A41W-01;Soft Tissue Sarcoma;Male;Primary;Matched;LMS;1:DECEASED;[Not Available];43.0
TCGA-MO-A47P-01;Soft Tissue Sarcoma;Male;Primary;Matched;DDLS;1:DECEASED;[Not Available];84.0
TCGA-MO-A47R-01;Soft Tissue Sarcoma;Female;Primary;Matched;LMS;1:DECEASED;[Not Available];47.0
TCGA-DX-A1L4-01;Soft Tissue Sarcoma;Male;Primary;Matched;DDLS;0:LIVING;[Not Available];54.0
TCGA-DX-A23R-01;Soft Tissue Sarcoma;Female;Primary;Matched;DDLS;0:LIVING;[Not Available];37.0
TCGA-DX-A23T-01;Soft Tissue Sarcoma;Male;Primary;Matched;DDLS;0:LIVING;[Not Available];56.0
TCGA-DX-A23U-01;Soft Tissue Sarcoma;Female;Primary;Matched;DDLS;1:DECEASED;[Not Available];66.0
TCGA-HS-A5N7-01;Soft Tissue Sarcoma;Female;Primary;Matched;LMS;1:DECEASED;[Not Available];65.0
TCGA-HS-A5N8-01;Soft Tissue Sarcoma;Male;Primary;Matched;LMS;1:DECEASED;[Not Available];44.0
TCGA-HS-A5N9-01;Soft Tissue Sarcoma;Male;Primary;Matched;LMS;0:LIVING;[Not Available];65.0
TCGA-HS-A5NA-01;Soft Tissue Sarcoma;Female;Primary;Matched;LMS;1:DECEASED;[Not Available];49.0
TCGA-PC-A5DL-01;Soft Tissue Sarcoma;Male;Primary;Matched;LMS;0:LIVING;[Not Available];47.0
TCGA-PC-A5DO-01;Soft Tissue Sarcoma;Female;Primary;Matched;LMS;0:LIVING;[Not Available];63.0
TCGA-PC-A5DP-01;Soft Tissue Sarcoma;Female;Primary;Matched;LMS;0:LIVING;[Not Available];54.0
TCGA-DX-A23Y-01;Soft Tissue Sarcoma;Male;Primary;Matched;DDLS;0:LIVING;[Not Available];41.0
TCGA-DX-A23Z-01;Soft Tissue Sarcoma;Male;Primary;Matched;DDLS;0:LIVING;[Not Available];57.0
TCGA-DX-A240-01;Soft Tissue Sarcoma;Male;Primary;Matched;DDLS;0:LIVING;[Not Available];78.0
TCGA-DX-A3LY-01;Soft Tissue Sarcoma;Male;Primary;Matched;DDLS;0:LIVING;[Not Available];55.0
TCGA-KD-A5QS-01;Soft Tissue Sarcoma;Male;Primary;Matched;LMS;1:DECEASED;[Not Available];80.0
TCGA-KD-A5QT-01;Soft Tissue Sarcoma;Female;Primary;Matched;LMS;0:LIVING;[Not Available];45.0
TCGA-KD-A5QU-01;Soft Tissue Sarcoma;Female;Primary;Matched;LMS;0:LIVING;[Not Available];53.0
TCGA-PC-A5DK-01;Soft Tissue Sarcoma;Male;Primary;Matched;LMS;0:LIVING;[Not Available];74.0
TCGA-PC-A5DM-01;Soft Tissue Sarcoma;Male;Primary;Matched;LMS;0:LIVING;[Not Available];77.0
TCGA-PC-A5DN-01;Soft Tissue Sarcoma;Female;Primary;Matched;LMS;0:LIVING;[Not Available];82.0
TCGA-DX-A23V-01;Soft Tissue Sarcoma;Male;Primary;Matched;DDLS;0:LIVING;[Not Available];51.0
TCGA-DX-A3U6-01;Soft Tissue Sarcoma;Male;Primary;Matched;DDLS;0:LIVING;[Not Available];34.0
TCGA-DX-A3U7-01;Soft Tissue Sarcoma;Female;Primary;Matched;LMS;1:DECEASED;[Not Available];85.0
TCGA-DX-A3U8-01;Soft Tissue Sarcoma;Female;Primary;Matched;LMS;1:DECEASED;[Not Available];86.0
TCGA-HB-A5W3-01;Soft Tissue Sarcoma;Male;Primary;Matched;LMS;0:LIVING;[Not Available];75.0
TCGA-JV-A5VE-01;Soft Tissue Sarcoma;Male;Primary;Matched;LMS;0:LIVING;[Not Available];61.0
TCGA-JV-A5VF-01;Soft Tissue Sarcoma;Female;Primary;Matched;LMS;0:LIVING;[Not Available];31.0
TCGA-MB-A5Y8-01;Soft Tissue Sarcoma;Female;Primary;Matched;MFH;0:LIVING;[Not Available];50.0
TCGA-MB-A5Y9-01;Soft Tissue Sarcoma;Male;Primary;Matched;MFH;1:DECEASED;[Not Available];74.0
TCGA-MB-A5YA-01;Soft Tissue Sarcoma;Female;Primary;Matched;LMS;1:DECEASED;[Not Available];68.0
TCGA-DX-A3U9-01;Soft Tissue Sarcoma;Male;Primary;Matched;LMS;0:LIVING;[Not Available];59.0
TCGA-DX-A3UA-01;Soft Tissue Sarcoma;Female;Primary;Matched;LMS;1:DECEASED;[Not Available];78.0
TCGA-DX-A3UB-01;Soft Tissue Sarcoma;Female;Primary;Matched;LMS;0:LIVING;[Not Available];82.0
TCGA-DX-A3UC-01;Soft Tissue Sarcoma;Female;Primary;Matched;LMS;1:DECEASED;[Not Available];88.0
TCGA-DX-A3UD-01;Soft Tissue Sarcoma;Female;Primary;Matched;LMS;1:DECEASED;[Not Available];78.0
TCGA-DX-A3UE-01;Soft Tissue Sarcoma;Female;Primary;Matched;LMS;0:LIVING;[Not Available];56.0
TCGA-DX-A3UF-01;Soft Tissue Sarcoma;Male;Primary;Matched;LMS;0:LIVING;[Not Available];61.0
TCGA-DX-A48J-01;Soft Tissue Sarcoma;Female;Primary;Matched;LMS;0:LIVING;[Not Available];53.0
TCGA-DX-A48K-01;Soft Tissue Sarcoma;Female;Primary;Matched;LMS;0:LIVING;[Not Available];20.0
TCGA-DX-A48L-01;Soft Tissue Sarcoma;Male;Primary;Matched;LMS;1:DECEASED;[Not Available];72.0
TCGA-DX-A48N-01;Soft Tissue Sarcoma;Male;Primary;Matched;DDLS;1:DECEASED;[Not Available];69.0
TCGA-DX-A48O-01;Soft Tissue Sarcoma;Female;Primary;Matched;LMS;0:LIVING;[Not Available];50.0
TCGA-DX-A48P-01;Soft Tissue Sarcoma;Male;Primary;Matched;LMS;0:LIVING;[Not Available];71.0
TCGA-DX-A48R-01;Soft Tissue Sarcoma;Female;Primary;Matched;LMS;0:LIVING;[Not Available];79.0
TCGA-DX-A48U-01;Soft Tissue Sarcoma;Female;Primary;Matched;LMS;0:LIVING;[Not Available];83.0
TCGA-DX-A48V-01;Soft Tissue Sarcoma;Male;Primary;Matched;LMS;1:DECEASED;[Not Available];86.0
TCGA-DX-A6B7-01;Soft Tissue Sarcoma;Male;Primary;Matched;LMS;1:DECEASED;[Not Available];76.0
TCGA-DX-A6B8-01;Soft Tissue Sarcoma;Female;Primary;Matched;LMS;0:LIVING;[Not Available];61.0
TCGA-DX-A6BA-01;Soft Tissue Sarcoma;Male;Primary;Matched;LMS;0:LIVING;[Not Available];59.0
TCGA-DX-A6BF-01;Soft Tissue Sarcoma;Male;Primary;Matched;DDLS;0:LIVING;[Not Available];60.0
TCGA-DX-A6BG-01;Soft Tissue Sarcoma;Female;Primary;Matched;DDLS;0:LIVING;[Not Available];78.0
TCGA-DX-A6BH-01;Soft Tissue Sarcoma;Female;Primary;Matched;DDLS;0:LIVING;[Not Available];67.0
TCGA-DX-A6BK-01;Soft Tissue Sarcoma;Male;Primary;Matched;DDLS;0:LIVING;[Not Available];85.0
TCGA-IE-A6BZ-01;Soft Tissue Sarcoma;Male;Primary;Matched;MFH;0:LIVING;[Not Available];63.0
TCGA-LI-A67I-01;Soft Tissue Sarcoma;Female;Primary;Matched;MFS;0:LIVING;[Not Available];63.0
TCGA-MJ-A68H-01;Soft Tissue Sarcoma;Female;Primary;Matched;LMS;1:DECEASED;[Not Available];68.0
TCGA-MJ-A68J-01;Soft Tissue Sarcoma;Female;Primary;Matched;MFS;0:LIVING;[Not Available];63.0
TCGA-RN-A68Q-01;Nerve Sheath Tumor;Male;Primary;Matched;MPNST;1:DECEASED;[Not Available];58.0
TCGA-DX-A6B9-01;Soft Tissue Sarcoma;Male;Primary;Matched;LMS;1:DECEASED;[Not Available];57.0
TCGA-DX-A6BB-01;Soft Tissue Sarcoma;Male;Primary;Matched;LMS;1:DECEASED;[Not Available];52.0
TCGA-DX-A6BE-01;Soft Tissue Sarcoma;Female;Primary;Matched;DDLS;1:DECEASED;[Not Available];78.0
TCGA-JV-A75J-01;Soft Tissue Sarcoma;Male;Primary;Matched;LMS;1:DECEASED;[Not Available];72.0
TCGA-K1-A6RU-01;Soft Tissue Sarcoma;Male;Primary;Matched;MFS;0:LIVING;[Not Available];60.0
TCGA-K1-A6RV-01;Soft Tissue Sarcoma;Female;Primary;Matched;LMS;0:LIVING;[Not Available];76.0
TCGA-N1-A6IA-01;Soft Tissue Sarcoma;Male;Primary;Matched;LMS;0:LIVING;[Not Available];36.0
TCGA-QC-A6FX-01;Soft Tissue Sarcoma;Female;Primary;Matched;MFH;0:LIVING;[Not Available];80.0
TCGA-QQ-A5V2-01;Soft Tissue Sarcoma;Female;Primary;Matched;MFH;1:DECEASED;[Not Available];71.0
TCGA-QQ-A5V9-01;Soft Tissue Sarcoma;Male;Primary;Matched;MFH;0:LIVING;[Not Available];35.0
TCGA-QQ-A5VA-01;Soft Tissue Sarcoma;Female;Primary;Matched;DDLS;0:LIVING;[Not Available];78.0
TCGA-QQ-A5VC-01;Soft Tissue Sarcoma;Male;Primary;Matched;LMS;1:DECEASED;[Not Available];79.0
TCGA-QQ-A5VD-01;Soft Tissue Sarcoma;Female;Primary;Matched;LMS;0:LIVING;[Not Available];65.0
TCGA-SG-A6Z7-01;Soft Tissue Sarcoma;Female;Primary;Matched;DDLS;0:LIVING;[Not Available];53.0
TCGA-UE-A6QT-01;Soft Tissue Sarcoma;Female;Primary;Matched;PLLS;0:LIVING;[Not Available];54.0
TCGA-UE-A6QU-01;Soft Tissue Sarcoma;Male;Primary;Matched;PLLS;0:LIVING;[Not Available];81.0
TCGA-DX-A6YQ-01;Soft Tissue Sarcoma;Female;Primary;Matched;MFS;0:LIVING;[Not Available];62.0
TCGA-DX-A6YU-01;Soft Tissue Sarcoma;Female;Primary;Matched;MFS;1:DECEASED;[Not Available];73.0
TCGA-DX-A7EF-01;Soft Tissue Sarcoma;Female;Primary;Matched;MFH;0:LIVING;[Not Available];87.0
TCGA-DX-A7EI-01;Soft Tissue Sarcoma;Female;Primary;Matched;DDLS;1:DECEASED;[Not Available];53.0
TCGA-K1-A6RT-01;Soft Tissue Sarcoma;Male;Primary;Matched;LMS;0:LIVING;[Not Available];51.0
TCGA-QC-A7B5-01;Soft Tissue Sarcoma;Male;Primary;Matched;MFH;0:LIVING;[Not Available];65.0
TCGA-SG-A6Z4-01;Soft Tissue Sarcoma;Male;Primary;Matched;MFH;1:DECEASED;[Not Available];86.0
TCGA-SI-A71O-01;Nerve Sheath Tumor;Female;Primary;Matched;MPNST;1:DECEASED;[Not Available];73.0
TCGA-SI-A71P-01;Nerve Sheath Tumor;Male;Primary;Matched;MPNST;1:DECEASED;[Not Available];80.0
TCGA-SI-A71Q-01;Nerve Sheath Tumor;Female;Primary;Matched;MPNST;0:LIVING;[Not Available];28.0
TCGA-DX-A6YR-01;Soft Tissue Sarcoma;Male;Primary;Matched;MFS;0:LIVING;[Not Available];27.0
TCGA-DX-A6YS-01;Soft Tissue Sarcoma;Female;Primary;Matched;MFS;0:LIVING;[Not Available];61.0
TCGA-DX-A6YT-01;Soft Tissue Sarcoma;Male;Primary;Matched;MFS;0:LIVING;[Not Available];54.0
TCGA-DX-A6YV-01;Soft Tissue Sarcoma;Male;Primary;Matched;MFS;0:LIVING;[Not Available];53.0
TCGA-DX-A6YZ-01;Soft Tissue Sarcoma;Female;Primary;Matched;MFS;0:LIVING;[Not Available];65.0
TCGA-FX-A76Y-01;Soft Tissue Sarcoma;Male;Primary;Matched;LMS;0:LIVING;[Not Available];87.0
TCGA-MJ-A850-01;Soft Tissue Sarcoma;Female;Primary;Matched;SYNS;1:DECEASED;[Not Available];56.0
TCGA-SG-A849-01;Soft Tissue Sarcoma;Female;Primary;Matched;MFH;0:LIVING;[Not Available];49.0
TCGA-X6-A7W8-01;Soft Tissue Sarcoma;Female;Primary;Matched;MFS;1:DECEASED;[Not Available];31.0
TCGA-X6-A7WA-01;Soft Tissue Sarcoma;Female;Primary;Matched;LMS;0:LIVING;[Not Available];78.0
TCGA-X6-A7WB-01;Soft Tissue Sarcoma;Female;Primary;Matched;LMS;1:DECEASED;[Not Available];46.0
TCGA-X6-A7WC-01;Soft Tissue Sarcoma;Male;Primary;Matched;LMS;1:DECEASED;[Not Available];75.0
TCGA-X6-A7WD-01;Soft Tissue Sarcoma;Female;Primary;Matched;LMS;0:LIVING;[Not Available];58.0
TCGA-DX-A6Z0-01;Soft Tissue Sarcoma;Female;Primary;Matched;MFS;1:DECEASED;[Not Available];58.0
TCGA-DX-A6Z2-01;Soft Tissue Sarcoma;Female;Primary;Matched;LMS;0:LIVING;[Not Available];67.0
TCGA-DX-A7EL-01;Soft Tissue Sarcoma;Female;Primary;Matched;LMS;1:DECEASED;[Not Available];69.0
TCGA-DX-A7EM-01;Soft Tissue Sarcoma;Female;Primary;Matched;LMS;0:LIVING;[Not Available];58.0
TCGA-DX-A7EO-01;Soft Tissue Sarcoma;Female;Primary;Matched;SYNS;0:LIVING;[Not Available];65.0
TCGA-DX-A7ER-01;Soft Tissue Sarcoma;Male;Primary;Matched;SYNS;1:DECEASED;[Not Available];42.0
TCGA-DX-A7ET-01;Soft Tissue Sarcoma;Female;Primary;Matched;MFH;0:LIVING;[Not Available];35.0
TCGA-DX-A7EU-01;Soft Tissue Sarcoma;Female;Primary;Matched;MFS;0:LIVING;[Not Available];67.0
TCGA-FX-A8OO-01;Soft Tissue Sarcoma;Female;Primary;Matched;SYNS;0:LIVING;[Not Available];84.0
TCGA-MB-A8JK-01;Soft Tissue Sarcoma;Male;Primary;Matched;MFH;0:LIVING;[Not Available];54.0
TCGA-MB-A8JL-01;Soft Tissue Sarcoma;Female;Primary;Matched;LMS;0:LIVING;[Not Available];65.0
TCGA-QQ-A5VB-01;Soft Tissue Sarcoma;Female;Primary;Matched;LMS;1:DECEASED;[Not Available];70.0
TCGA-VT-A80G-01;Soft Tissue Sarcoma;Male;Primary;Matched;MFH;1:DECEASED;[Not Available];80.0
TCGA-VT-A80J-01;Soft Tissue Sarcoma;Female;Primary;Matched;MFH;0:LIVING;[Not Available];82.0
TCGA-X6-A8C2-01;Soft Tissue Sarcoma;Female;Primary;Matched;MFH;1:DECEASED;[Not Available];55.0
TCGA-X6-A8C3-01;Soft Tissue Sarcoma;Female;Primary;Matched;MFS;0:LIVING;[Not Available];63.0
TCGA-X6-A8C4-01;Soft Tissue Sarcoma;Female;Primary;Matched;MFH;0:LIVING;[Not Available];44.0
TCGA-X6-A8C5-01;Soft Tissue Sarcoma;Female;Primary;Matched;LMS;1:DECEASED;[Not Available];73.0
TCGA-X6-A8C6-01;Soft Tissue Sarcoma;Female;Primary;Matched;MFS;0:LIVING;[Not Available];48.0
TCGA-X6-A8C7-01;Soft Tissue Sarcoma;Female;Primary;Matched;SYNS;1:DECEASED;[Not Available];76.0
TCGA-3R-A8YX-01;Soft Tissue Sarcoma;Female;Primary;Matched;DDLS;0:LIVING;[Not Available];59.0
TCGA-DX-A8BH-01;Soft Tissue Sarcoma;Female;Primary;Matched;MFH;0:LIVING;[Not Available];60.0
TCGA-DX-A8BK-01;Soft Tissue Sarcoma;Female;Primary;Matched;MFH;1:DECEASED;[Not Available];69.0
TCGA-DX-A8BN-01;Soft Tissue Sarcoma;Female;Primary;Matched;MFH;1:DECEASED;[Not Available];43.0
TCGA-DX-A8BP-01;Soft Tissue Sarcoma;Female;Primary;Matched;MFH;0:LIVING;[Not Available];64.0
TCGA-DX-A8BQ-01;Soft Tissue Sarcoma;Male;Primary;Matched;MFH;0:LIVING;[Not Available];42.0
TCGA-DX-A8BS-01;Soft Tissue Sarcoma;Female;Primary;Matched;MFH;0:LIVING;[Not Available];65.0
TCGA-DX-A8BT-01;Soft Tissue Sarcoma;Female;Primary;Matched;MFH;0:LIVING;[Not Available];62.0
TCGA-DX-A8BU-01;Soft Tissue Sarcoma;Male;Primary;Matched;MFH;0:LIVING;[Not Available];48.0
TCGA-DX-A8BV-01;Soft Tissue Sarcoma;Female;Primary;Matched;MFS;1:DECEASED;[Not Available];66.0
TCGA-DX-A8BX-01;Soft Tissue Sarcoma;Male;Primary;Matched;MFH;0:LIVING;[Not Available];67.0
TCGA-DX-A8BZ-01;Soft Tissue Sarcoma;Female;Primary;Matched;LMS;1:DECEASED;[Not Available];55.0
TCGA-LI-A9QH-01;Soft Tissue Sarcoma;Female;Primary;Matched;MFH;0:LIVING;[Not Available];69.0
TCGA-PT-A8TR-01;Soft Tissue Sarcoma;Female;Primary;Matched;LMS;1:DECEASED;[Not Available];41.0
TCGA-QQ-A8VB-01;Nerve Sheath Tumor;Female;Primary;Matched;MPNST;0:LIVING;[Not Available];71.0
TCGA-QQ-A8VF-01;Soft Tissue Sarcoma;Female;Primary;Matched;LMS;0:LIVING;[Not Available];75.0
TCGA-QQ-A8VG-01;Nerve Sheath Tumor;Female;Primary;Matched;MPNST;1:DECEASED;[Not Available];72.0
TCGA-QQ-A8VH-01;Nerve Sheath Tumor;Female;Primary;Matched;MPNST;0:LIVING;[Not Available];60.0
TCGA-WK-A8XO-01;Soft Tissue Sarcoma;Male;Primary;Matched;DDLS;0:LIVING;[Not Available];90.0
TCGA-WK-A8XQ-01;Soft Tissue Sarcoma;Male;Primary;Matched;DDLS;0:LIVING;[Not Available];63.0
TCGA-WK-A8XS-01;Soft Tissue Sarcoma;Male;Primary;Matched;LMS;0:LIVING;[Not Available];49.0
TCGA-WK-A8XT-01;Soft Tissue Sarcoma;Female;Primary;Matched;SYNS;0:LIVING;[Not Available];53.0
TCGA-WK-A8XX-01;Soft Tissue Sarcoma;Female;Primary;Matched;LMS;0:LIVING;[Not Available];57.0
TCGA-WK-A8XY-01;Soft Tissue Sarcoma;Female;Primary;Matched;LMS;0:LIVING;[Not Available];55.0
TCGA-WK-A8XZ-01;Soft Tissue Sarcoma;Male;Primary;Matched;LMS;0:LIVING;[Not Available];28.0
TCGA-WP-A9GB-01;Soft Tissue Sarcoma;Female;Primary;Matched;LMS;0:LIVING;[Not Available];37.0
TCGA-X2-A95T-01;Soft Tissue Sarcoma;Female;Primary;Matched;LMS;1:DECEASED;[Not Available];75.0
TCGA-Z4-A8JB-01;Soft Tissue Sarcoma;Female;Primary;Matched;DES;1:DECEASED;[Not Available];41.0
TCGA-Z4-A9VC-01;Soft Tissue Sarcoma;Male;Primary;Matched;DDLS;0:LIVING;[Not Available];63.0
TCGA-3B-A9HI-01;Soft Tissue Sarcoma;Male;Primary;Matched;SARCNOS;1:DECEASED;[Not Available];67.0
TCGA-3B-A9HJ-01;Soft Tissue Sarcoma;Male;Primary;Matched;DDLS;1:DECEASED;[Not Available];73.0
TCGA-3B-A9HL-01;Soft Tissue Sarcoma;Female;Primary;Matched;DDLS;1:DECEASED;[Not Available];77.0
TCGA-3B-A9HO-01;Soft Tissue Sarcoma;Female;Primary;Matched;DDLS;1:DECEASED;[Not Available];59.0
TCGA-3B-A9HP-01;Soft Tissue Sarcoma;Female;Primary;Matched;LMS;1:DECEASED;[Not Available];72.0
TCGA-3B-A9HQ-01;Soft Tissue Sarcoma;Female;Primary;Matched;LMS;0:LIVING;[Not Available];57.0
TCGA-3B-A9HR-01;Soft Tissue Sarcoma;Male;Primary;Matched;LMS;0:LIVING;[Not Available];68.0
TCGA-DX-A7EQ-01;Soft Tissue Sarcoma;Male;Primary;Matched;SYNS;0:LIVING;[Not Available];75.0
TCGA-DX-AB2F-01;Soft Tissue Sarcoma;Female;Primary;Matched;DDLS;0:LIVING;[Not Available];53.0
TCGA-DX-AB2J-01;Soft Tissue Sarcoma;Male;Primary;Matched;MFH;0:LIVING;[Not Available];42.0
TCGA-DX-AB2P-01;Soft Tissue Sarcoma;Male;Primary;Matched;MFH;1:DECEASED;[Not Available];76.0
TCGA-DX-AB2T-01;Soft Tissue Sarcoma;Female;Primary;Matched;MFS;1:DECEASED;[Not Available];60.0
TCGA-DX-AB2X-01;Soft Tissue Sarcoma;Female;Primary;Matched;MFH;1:DECEASED;[Not Available];53.0
TCGA-DX-AB2Z-01;Soft Tissue Sarcoma;Female;Primary;Matched;MFH;0:LIVING;[Not Available];63.0
TCGA-SI-AA8B-01;Soft Tissue Sarcoma;Male;Primary;Matched;MFH;0:LIVING;[Not Available];52.0
TCGA-SI-AA8C-01;Nerve Sheath Tumor;Female;Primary;Matched;MPNST;0:LIVING;[Not Available];68.0
TCGA-X9-A971-01;Soft Tissue Sarcoma;Male;Primary;Matched;LMS;0:LIVING;[Not Available];56.0
TCGA-X9-A973-01;Soft Tissue Sarcoma;Male;Primary;Matched;MFH;0:LIVING;[Not Available];70.0
TCGA-3B-A9HS-01;Soft Tissue Sarcoma;Male;Primary;Matched;LMS;1:DECEASED;[Not Available];52.0
TCGA-3B-A9HT-01;Soft Tissue Sarcoma;Female;Primary;Matched;LMS;1:DECEASED;[Not Available];31.0
TCGA-3B-A9HU-01;Soft Tissue Sarcoma;Female;Primary;Matched;LMS;0:LIVING;[Not Available];62.0
TCGA-3B-A9HV-01;Soft Tissue Sarcoma;Male;Primary;Matched;LMS;0:LIVING;[Not Available];52.0
TCGA-3B-A9HX-01;Soft Tissue Sarcoma;Male;Primary;Matched;LMS;0:LIVING;[Not Available];47.0
TCGA-3B-A9HY-01;Soft Tissue Sarcoma;Female;Primary;Matched;LMS;1:DECEASED;[Not Available];44.0
TCGA-3B-A9HZ-01;Soft Tissue Sarcoma;Male;Primary;Matched;LMS;0:LIVING;[Not Available];78.0
TCGA-3B-A9I0-01;Soft Tissue Sarcoma;Male;Primary;Matched;LMS;1:DECEASED;[Not Available];29.0
TCGA-3B-A9I1-01;Soft Tissue Sarcoma;Male;Primary;Matched;LMS;0:LIVING;[Not Available];50.0
TCGA-3B-A9I3-01;Soft Tissue Sarcoma;Female;Primary;Matched;LMS;0:LIVING;[Not Available];34.0
TCGA-DX-A7EN-01;Soft Tissue Sarcoma;Female;Primary;Matched;LMS;1:DECEASED;[Not Available];80.0
TCGA-DX-A7ES-01;Soft Tissue Sarcoma;Female;Primary;Matched;DDLS;0:LIVING;[Not Available];20.0
TCGA-DX-AB2E-01;Soft Tissue Sarcoma;Female;Primary;Matched;MFS;0:LIVING;[Not Available];50.0
TCGA-DX-AB2G-01;Soft Tissue Sarcoma;Female;Primary;Matched;DDLS;0:LIVING;[Not Available];90.0
TCGA-DX-AB2H-01;Soft Tissue Sarcoma;Male;Primary;Matched;DDLS;0:LIVING;[Not Available];66.0
TCGA-DX-AB2O-01;Soft Tissue Sarcoma;Female;Primary;Matched;MFH;0:LIVING;[Not Available];49.0
TCGA-DX-AB2Q-01;Soft Tissue Sarcoma;Male;Primary;Matched;MFH;0:LIVING;[Not Available];71.0
TCGA-DX-AB2S-01;Soft Tissue Sarcoma;Female;Primary;Matched;MFS;1:DECEASED;[Not Available];66.0
TCGA-DX-AB2W-01;Soft Tissue Sarcoma;Male;Primary;Matched;MFH;1:DECEASED;[Not Available];57.0
TCGA-DX-AB30-01;Soft Tissue Sarcoma;Female;Primary;Matched;MFS;0:LIVING;[Not Available];58.0
TCGA-QC-AA9N-01;Soft Tissue Sarcoma;Female;Primary;Matched;MFH;1:DECEASED;[Not Available];40.0
TCGA-QQ-A8VD-01;Soft Tissue Sarcoma;Male;Primary;Matched;DES;1:DECEASED;[Not Available];70.0
TCGA-RN-AAAQ-01;Nerve Sheath Tumor;Female;Primary;Matched;MPNST;1:DECEASED;[Not Available];53.0
TCGA-Z4-AAPF-01;Soft Tissue Sarcoma;Female;Primary;Matched;SYNS;1:DECEASED;[Not Available];56.0
TCGA-Z4-AAPG-01;Soft Tissue Sarcoma;Female;Primary;Matched;MFH;1:DECEASED;[Not Available];49.0
TCGA-DX-A6YX-01;Soft Tissue Sarcoma;Female;Primary;Matched;MFS;1:DECEASED;[Not Available];59.0
TCGA-DX-A8BG-01;Soft Tissue Sarcoma;Female;Primary;Matched;MFS;0:LIVING;[Not Available];49.0
TCGA-DX-A8BJ-01;Soft Tissue Sarcoma;Male;Primary;Matched;MFH;1:DECEASED;[Not Available];89.0
TCGA-DX-A8BL-01;Soft Tissue Sarcoma;Female;Primary;Matched;MFH;0:LIVING;[Not Available];90.0
TCGA-DX-A8BM-01;Soft Tissue Sarcoma;Female;Primary;Matched;MFH;1:DECEASED;[Not Available];58.0
TCGA-DX-A8BO-01;Soft Tissue Sarcoma;Male;Primary;Matched;MFH;0:LIVING;[Not Available];74.0
TCGA-DX-A8BR-01;Soft Tissue Sarcoma;Female;Primary;Matched;MFH;0:LIVING;[Not Available];63.0
TCGA-DX-AATS-01;Soft Tissue Sarcoma;Male;Primary;Matched;MFH;0:LIVING;[Not Available];56.0
TCGA-DX-AB2L-01;Soft Tissue Sarcoma;Female;Primary;Matched;MFS;0:LIVING;[Not Available];59.0
TCGA-DX-AB2V-01;Soft Tissue Sarcoma;Female;Primary;Matched;MFS;1:DECEASED;[Not Available];70.0
TCGA-DX-AB32-01;Soft Tissue Sarcoma;Female;Primary;Matched;MFS;0:LIVING;[Not Available];63.0
TCGA-DX-AB35-01;Soft Tissue Sarcoma;Male;Primary;Matched;DDLS;1:DECEASED;[Not Available];55.0
TCGA-DX-AB36-01;Soft Tissue Sarcoma;Female;Primary;Matched;DDLS;0:LIVING;[Not Available];24.0
TCGA-DX-AB37-01;Soft Tissue Sarcoma;Female;Primary;Matched;DDLS;0:LIVING;[Not Available];52.0
TCGA-DX-AB3A-01;Soft Tissue Sarcoma;Male;Primary;Matched;DDLS;0:LIVING;[Not Available];55.0
TCGA-DX-AB3B-01;Soft Tissue Sarcoma;Female;Primary;Matched;SYNS;0:LIVING;[Not Available];24.0
TCGA-DX-AB3C-01;Soft Tissue Sarcoma;Male;Primary;Matched;SYNS;0:LIVING;[Not Available];37.0
TCGA-VT-AB3D-01;Soft Tissue Sarcoma;Female;Primary;Matched;MFH;0:LIVING;[Not Available];35.0
TCGA-WK-A8Y0-01;Soft Tissue Sarcoma;Female;Primary;Matched;MFH;0:LIVING;[Not Available];64.0
TCGA-K1-A3PN-02;Soft Tissue Cancer, NOS;[Not Available];Recurrence;Matched;SOFT_TISSUE;[Not Available];[Not Available];[Not Available]
TCGA-K1-A42X-02;Soft Tissue Cancer, NOS;[Not Available];Recurrence;Matched;SOFT_TISSUE;[Not Available];[Not Available];[Not Available]
TCGA-VT-A80J-02;Soft Tissue Cancer, NOS;[Not Available];Recurrence;Matched;SOFT_TISSUE;[Not Available];[Not Available];[Not Available]
TCGA-SI-A71O-06;Soft Tissue Cancer, NOS;[Not Available];Metastasis;Matched;SOFT_TISSUE;[Not Available];[Not Available];[Not Available]
TCGA-BF-A1PU-01;Melanoma;Male;Primary;Matched;SKCM;1:DECEASED;Stage IA;71
TCGA-BF-A1PV-01;Melanoma;Male;Primary;Matched;SKCM;0:LIVING;Stage IIA;82
TCGA-BF-A1PX-01;Melanoma;Male;Primary;Matched;SKCM;1:DECEASED;Stage IIIA;82
TCGA-BF-A1PZ-01;Melanoma;Female;Primary;Matched;SKCM;0:LIVING;Stage IIC;46
TCGA-BF-A1Q0-01;Melanoma;Female;Primary;Matched;SKCM;0:LIVING;Stage IIC;74
TCGA-D3-A1Q1-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIIB;56
TCGA-D3-A1Q3-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;Stage IIB;71
TCGA-D3-A1Q4-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IIC;80
TCGA-D3-A1Q5-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;Stage IIIB;36
TCGA-D3-A1Q6-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;Stage IIIB;84
TCGA-D3-A1Q6-07;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IIA;63
TCGA-D3-A1Q7-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;Stage IIIC;81
TCGA-D3-A1Q8-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IIC;65
TCGA-D3-A1Q9-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;Stage IIIC;75
TCGA-D3-A1QA-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IIC;63
TCGA-D3-A1QA-07;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IIC;63
TCGA-D3-A1QB-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;Stage IIC;76
TCGA-D3-A2J6-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IIC;77
TCGA-D3-A2J7-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;Stage IIC;73
TCGA-D3-A2J8-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IIC;83
TCGA-D3-A2J9-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;Stage IV;40
TCGA-D3-A2JA-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IIC;86
TCGA-D3-A2JB-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IIB;62
TCGA-D3-A2JC-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IIC;61
TCGA-D3-A2JD-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage III;55
TCGA-D3-A2JF-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;Stage IIC;76
TCGA-D3-A2JG-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IIC;58
TCGA-D3-A2JH-06;[Not Available];Female;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIIC;79
TCGA-D3-A2JK-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIC;64
TCGA-D3-A2JL-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;Stage IIIC;53
TCGA-D3-A2JN-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;I/II NOS;60
TCGA-D3-A2JO-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage III;55
TCGA-D3-A2JP-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;Stage IB;42
TCGA-D3-A3BZ-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage IV;33
TCGA-D3-A3C1-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIIB;72
TCGA-D3-A3C3-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IB;55
TCGA-D3-A3C6-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;Stage III;75
TCGA-D3-A3C7-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIB;65
TCGA-D3-A3C8-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIIC;67
TCGA-D3-A3CB-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage IB;48
TCGA-D3-A3CC-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIIC;75
TCGA-D3-A3CE-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IIIA;68
TCGA-D3-A3CF-06;[Not Available];Female;Metastasis;Matched;[Not Available];1:DECEASED;Stage 0;70
TCGA-D9-A148-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;Stage III;53
TCGA-D9-A149-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIIC;58
TCGA-D9-A1JW-06;[Not Available];Female;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIIC;75
TCGA-D9-A1JX-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IA;74
TCGA-D9-A1X3-06;[Not Available];Female;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIIA;30
TCGA-DA-A1HV-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IB;68
TCGA-DA-A1HW-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIIC;24
TCGA-DA-A1HY-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;I/II NOS;43
TCGA-DA-A1I1-06;[Not Available];Female;Metastasis;Matched;[Not Available];1:DECEASED;Stage III;46
TCGA-DA-A1I2-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;Stage IIIC;50
TCGA-DA-A1I4-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IIIC;37
TCGA-DA-A1I5-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IIB;63
TCGA-DA-A1I7-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;I/II NOS;[Not Available]
TCGA-DA-A1I8-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;I/II NOS;[Not Available]
TCGA-DA-A1IA-06;[Not Available];Female;Metastasis;Matched;[Not Available];1:DECEASED;Stage IB;54
TCGA-DA-A1IB-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;Stage III;57
TCGA-DA-A1IC-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;Stage IIIC;58
TCGA-EB-A1NK-01;Melanoma;Male;Primary;Matched;SKCM;0:LIVING;I/II NOS;39
TCGA-EB-A24C-01;Melanoma;Female;Primary;Matched;SKCM;0:LIVING;Stage IIC;69
TCGA-EB-A24D-01;Melanoma;Female;Primary;Matched;SKCM;1:DECEASED;Stage III;74
TCGA-EB-A299-01;Melanoma;Female;Primary;Matched;MEL;1:DECEASED;Stage IIIC;61
TCGA-EE-A17X-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIIA;70
TCGA-EE-A17Y-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage III;47
TCGA-EE-A17Z-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage III;42
TCGA-EE-A181-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IIIA;53
TCGA-EE-A182-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;Stage IIIB;38
TCGA-EE-A183-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;I/II NOS;39
TCGA-EE-A184-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IIIC;51
TCGA-EE-A185-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage 0;[Not Available]
TCGA-EE-A20B-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IIIC;60
TCGA-EE-A20C-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage III;19
TCGA-EE-A20F-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IIIB;51
TCGA-EE-A20H-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;Stage IV;56
TCGA-EE-A20I-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IIA;60
TCGA-EE-A29A-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;Stage IIIC;59
TCGA-EE-A29B-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IB;74
TCGA-EE-A29C-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;Stage I;15
TCGA-EE-A29D-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage II;61
TCGA-EE-A29E-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;Stage III;23
TCGA-EE-A29G-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IV;58
TCGA-EE-A29H-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IIIC;43
TCGA-EE-A29L-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IB;36
TCGA-EE-A29M-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIIB;48
TCGA-EE-A29N-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIIC;48
TCGA-EE-A29P-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;Stage IIIC;63
TCGA-EE-A29Q-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IV;26
TCGA-EE-A29R-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage IA;68
TCGA-EE-A29S-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage II;18
TCGA-EE-A29T-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IIA;45
TCGA-EE-A29V-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIIB;43
TCGA-EE-A29W-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIB;73
TCGA-EE-A29X-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;I/II NOS;27
TCGA-EE-A2A0-06;[Not Available];Female;Metastasis;Matched;[Not Available];1:DECEASED;I/II NOS;[Not Available]
TCGA-EE-A2A1-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage III;77
TCGA-EE-A2A2-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage II;66
TCGA-EE-A2A5-06;[Not Available];Female;Metastasis;Matched;[Not Available];1:DECEASED;Stage 0;54
TCGA-EE-A2A6-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage I;52
TCGA-EE-A2GB-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;I/II NOS;25
TCGA-EE-A2GC-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;[Not Available];40
TCGA-EE-A2GD-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;[Not Available];65
TCGA-EE-A2GE-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;[Not Available];82
TCGA-EE-A2GH-06;[Not Available];Female;Metastasis;Matched;[Not Available];1:DECEASED;[Not Available];80
TCGA-EE-A2GI-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;[Not Available];63
TCGA-EE-A2GJ-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIIC;66
TCGA-EE-A2GK-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;Stage IIIB;39
TCGA-EE-A2GL-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIIC;54
TCGA-EE-A2GM-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIIC;50
TCGA-EE-A2GN-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;Stage IIIC;73
TCGA-EE-A2GO-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IIB;68
TCGA-EE-A2GP-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIIC;54
TCGA-EE-A2GR-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;Stage IIIA;75
TCGA-EE-A2GS-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IIIC;70
TCGA-EE-A2GT-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IIIA;56
TCGA-EE-A2GU-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIIA;56
TCGA-EE-A2M5-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;Stage IIIB;75
TCGA-EE-A2M6-06;[Not Available];Female;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIIB;37
TCGA-EE-A2M7-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage III;42
TCGA-EE-A2M8-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage IV;63
TCGA-EE-A2MC-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage III;55
TCGA-EE-A2MD-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage III;45
TCGA-EE-A2ME-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIIC;51
TCGA-EE-A2MG-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;Stage IV;27
TCGA-EE-A2MH-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IIIB;62
TCGA-EE-A2MI-06;[Not Available];Female;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIC;63
TCGA-EE-A2MJ-06;[Not Available];Female;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIIB;32
TCGA-EE-A2MK-06;[Not Available];Female;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIIC;69
TCGA-EE-A2ML-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIIB;81
TCGA-EE-A2MM-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIIB;55
TCGA-EE-A2MN-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIIB;52
TCGA-EE-A2MP-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage I;45
TCGA-EE-A2MQ-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IIIB;39
TCGA-EE-A2MR-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;Stage IIC;83
TCGA-EE-A2MS-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IIIB;52
TCGA-EE-A2MT-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IB;62
TCGA-EE-A2MU-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIC;68
TCGA-EE-A3AA-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IV;87
TCGA-EE-A3AB-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IIB;73
TCGA-EE-A3AC-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IIC;48
TCGA-EE-A3AD-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;[Not Available];56
TCGA-EE-A3AE-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IIIB;72
TCGA-EE-A3AF-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IIA;63
TCGA-EE-A3AG-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IIC;37
TCGA-EE-A3AH-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage II;63
TCGA-ER-A193-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IIC;74
TCGA-ER-A194-01;Melanoma;Female;Primary;Matched;SKCM;0:LIVING;Stage IIC;53
TCGA-ER-A195-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;Stage IIA;77
TCGA-ER-A196-01;Melanoma;Male;Primary;Matched;ACRM;0:LIVING;Stage IIC;57
TCGA-ER-A197-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;Stage IIC;56
TCGA-ER-A198-06;[Not Available];Female;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIIB;86
TCGA-ER-A199-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IIC;90
TCGA-ER-A19A-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;Stage IIC;76
TCGA-ER-A19B-06;[Not Available];Female;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIC;73
TCGA-ER-A19C-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IIIC;49
TCGA-ER-A19D-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IIC;83
TCGA-ER-A19E-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IIC;34
TCGA-ER-A19F-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIC;59
TCGA-ER-A19G-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IIB;69
TCGA-ER-A19H-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;Stage IIC;58
TCGA-ER-A19J-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;Stage IIIC;51
TCGA-ER-A19K-01;Melanoma;Male;Primary;Matched;SKCM;1:DECEASED;Stage IIIB;52
TCGA-ER-A19L-06;[Not Available];Female;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIIB;42
TCGA-ER-A19N-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IIB;77
TCGA-ER-A19O-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;Stage IIIB;65
TCGA-ER-A19P-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;Stage IIIC;41
TCGA-ER-A19Q-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIC;82
TCGA-ER-A19S-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;Stage IIC;56
TCGA-ER-A19T-01;Melanoma;Male;Primary;Matched;ACRM;0:LIVING;Stage IIC;53
TCGA-ER-A19T-06;[Not Available];Female;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIC;75
TCGA-ER-A1A1-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;Stage IIIC;78
TCGA-ER-A2NB-01;Melanoma;Male;Primary;Matched;SKCM;0:LIVING;Stage IIC;62
TCGA-ER-A2NC-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIIB;56
TCGA-ER-A2ND-06;[Not Available];Female;Metastasis;Matched;[Not Available];1:DECEASED;Stage IV;65
TCGA-ER-A2NE-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage III;55
TCGA-ER-A2NF-01;Melanoma;Male;Primary;Matched;MEL;1:DECEASED;Stage IIB;73
TCGA-ER-A2NF-06;[Not Available];Female;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIC;78
TCGA-ER-A2NG-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;[Not Available];57
TCGA-ER-A2NH-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;Stage III;60
TCGA-FS-A1YW-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage III;71
TCGA-FS-A1YX-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;Stage IIC;48
TCGA-FS-A1YY-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IIC;49
TCGA-FS-A1Z0-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIIB;56
TCGA-FS-A1Z3-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;Stage IIIB;74
TCGA-FS-A1Z4-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IIIC;55
TCGA-FS-A1Z7-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IIC;71
TCGA-FS-A1ZA-06;[Not Available];Female;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIA;76
TCGA-FS-A1ZB-06;[Not Available];Female;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIC;58
TCGA-FS-A1ZC-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;Stage III;58
TCGA-FS-A1ZD-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;Stage IIC;70
TCGA-FS-A1ZE-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IIC;66
TCGA-FS-A1ZF-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;Stage IIB;66
TCGA-FS-A1ZG-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IIC;66
TCGA-FS-A1ZH-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage IA;54
TCGA-FS-A1ZJ-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIIB;69
TCGA-FS-A1ZK-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIB;57
TCGA-FS-A1ZM-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage III;69
TCGA-FS-A1ZN-01;Melanoma;Female;Primary;Matched;SKCM;1:DECEASED;Stage II;82
TCGA-FS-A1ZP-06;[Not Available];Female;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIIC;84
TCGA-FS-A1ZQ-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage 0;48
TCGA-FS-A1ZR-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage IB;72
TCGA-FS-A1ZS-06;[Not Available];Female;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIIC;55
TCGA-FS-A1ZT-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;Stage II;66
TCGA-FS-A1ZU-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage 0;59
TCGA-FS-A1ZW-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage I;53
TCGA-FS-A1ZY-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage I;56
TCGA-FS-A1ZZ-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage IV;79
TCGA-GF-A2C7-01;Melanoma;Male;Primary;Matched;SKCM;1:DECEASED;Stage IIIA;68
TCGA-GN-A261-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIB;67
TCGA-GN-A262-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage IB;20
TCGA-GN-A263-01;Melanoma;Male;Primary;Matched;SKCM;1:DECEASED;Stage IIIC;87
TCGA-GN-A264-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IIIB;54
TCGA-GN-A265-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIIA;53
TCGA-GN-A266-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;Stage IA;59
TCGA-GN-A267-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIIC;78
TCGA-GN-A268-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;Stage IB;33
TCGA-GN-A269-01;Melanoma;Male;Primary;Matched;MEL;1:DECEASED;I/II NOS;78
TCGA-GN-A26A-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;Stage IIC;73
TCGA-GN-A26C-01;Melanoma;Female;Primary;Matched;DESM;1:DECEASED;Stage IIB;70
TCGA-GN-A26D-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;Stage IIIC;48
TCGA-HR-A2OG-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIA;79
TCGA-HR-A2OH-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;[Not Available];51
TCGA-BF-A3DJ-01;Melanoma;Male;Primary;Matched;SKCM;1:DECEASED;Stage IIIC;85
TCGA-BF-A3DL-01;Melanoma;Male;Primary;Matched;SKCM;0:LIVING;Stage 0;42
TCGA-BF-A3DM-01;Melanoma;Female;Primary;Matched;SKCM;1:DECEASED;Stage IB;58
TCGA-BF-A3DN-01;Melanoma;Female;Primary;Matched;SKCM;1:DECEASED;Stage IIA;77
TCGA-DA-A1I0-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IB;46
TCGA-DA-A3F2-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IIIC;71
TCGA-DA-A3F3-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage IB;43
TCGA-DA-A3F5-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IA;43
TCGA-DA-A3F8-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IIIB;51
TCGA-EE-A3J3-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IIB;82
TCGA-EE-A3J4-06;[Not Available];Female;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIB;58
TCGA-EE-A3J5-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage I;44
TCGA-EE-A3J7-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage I;34
TCGA-EE-A3J8-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IA;39
TCGA-EE-A3JA-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage IA;83
TCGA-EE-A3JD-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;Stage I;46
TCGA-EE-A3JE-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;Stage IIA;40
TCGA-ER-A3ES-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;Stage IIC;70
TCGA-ER-A3ET-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIA;67
TCGA-ER-A3EV-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;Stage II;66
TCGA-IH-A3EA-01;Melanoma;Male;Primary;Matched;MEL;1:DECEASED;Stage IIIB;80
TCGA-D3-A3ML-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage II;78
TCGA-D3-A3MO-06;[Not Available];Female;Metastasis;Matched;[Not Available];1:DECEASED;Stage IB;28
TCGA-D3-A3MR-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IIA;77
TCGA-D3-A3MU-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;Stage IA;65
TCGA-D3-A3MV-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage I;49
TCGA-EB-A3HV-01;Melanoma;Male;Primary;Matched;MEL;0:LIVING;Stage I;61
TCGA-EE-A180-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage II;66
TCGA-EE-A2MF-06;[Not Available];Female;Metastasis;Matched;[Not Available];1:DECEASED;Stage III;54
TCGA-EE-A3JB-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage I;73
TCGA-EE-A3JH-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage II;52
TCGA-EE-A3JI-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage I;51
TCGA-FR-A2OS-01;Melanoma;Female;Primary;Matched;SKCM;1:DECEASED;Stage I;39
TCGA-FW-A3I3-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage I;23
TCGA-D9-A3Z1-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage III;66
TCGA-D9-A3Z3-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIB;43
TCGA-D9-A3Z4-01;Melanoma;Male;Primary;Matched;SKCM;1:DECEASED;Stage III;60
TCGA-EB-A3XB-01;Melanoma;Female;Primary;Matched;SKCM;0:LIVING;Stage III;18
TCGA-EB-A3XC-01;Melanoma;Male;Primary;Matched;SKCM;1:DECEASED;Stage II;35
TCGA-EB-A3XD-01;Melanoma;Female;Primary;Matched;SKCM;1:DECEASED;Stage I;63
TCGA-EB-A3XE-01;Melanoma;Male;Primary;Matched;SKCM;1:DECEASED;Stage I;58
TCGA-EB-A3XF-01;Melanoma;Female;Primary;Matched;SKCM;0:LIVING;Stage I;34
TCGA-EB-A3Y6-01;Melanoma;Female;Primary;Matched;SKCM;1:DECEASED;Stage IIIA;70
TCGA-EB-A3Y7-01;Melanoma;Male;Primary;Matched;SKCM;0:LIVING;Stage I;61
TCGA-ER-A19M-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage II;72
TCGA-ER-A19W-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IB;45
TCGA-ER-A3PL-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IA;71
TCGA-FR-A3R1-01;Melanoma;Male;Primary;Matched;MEL;0:LIVING;Stage III;47
TCGA-FR-A3YN-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage III;30
TCGA-FR-A3YO-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage III;47
TCGA-FW-A3R5-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage III;50
TCGA-FW-A3TU-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;Stage IA;52
TCGA-FW-A3TV-06;[Not Available];Female;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIIC;48
TCGA-GF-A3OT-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage III;25
TCGA-D9-A4Z2-01;Melanoma;Male;Primary;Matched;MEL;1:DECEASED;Stage II;30
TCGA-EB-A41A-01;Melanoma;Male;Primary;Matched;DESM;1:DECEASED;Stage IB;42
TCGA-EB-A41B-01;Melanoma;Male;Primary;Matched;MEL;1:DECEASED;Stage II;72
TCGA-EB-A42Y-01;Melanoma;Male;Primary;Matched;SKCM;1:DECEASED;Stage III;71
TCGA-EB-A42Z-01;Melanoma;Male;Primary;Matched;SKCM;0:LIVING;Stage I;43
TCGA-EB-A430-01;Melanoma;Male;Primary;Matched;MEL;1:DECEASED;Stage IIIA;59
TCGA-ER-A42H-01;Melanoma;Male;Primary;Matched;SKCM;1:DECEASED;Stage IB;44
TCGA-ER-A42K-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;Stage III;60
TCGA-ER-A42L-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage III;70
TCGA-FR-A44A-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IIIB;75
TCGA-FS-A4F0-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IB;54
TCGA-FS-A4F2-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage I;48
TCGA-FS-A4F9-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIB;62
TCGA-FS-A4FC-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;[Not Available];77
TCGA-GF-A4EO-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;[Not Available];46
TCGA-D3-A51E-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;Stage IIC;64
TCGA-D3-A51F-06;[Not Available];Female;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIIB;83
TCGA-D3-A51G-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;[Not Available];45
TCGA-D3-A51H-06;[Not Available];Female;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIIC;86
TCGA-D3-A51J-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IV;79
TCGA-D3-A51K-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;[Not Available];42
TCGA-D3-A51N-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage I;77
TCGA-D3-A51R-06;[Not Available];Female;Metastasis;Matched;[Not Available];1:DECEASED;Stage IB;46
TCGA-D3-A51T-06;[Not Available];Female;Metastasis;Matched;[Not Available];1:DECEASED;Stage IB;36
TCGA-D9-A4Z3-01;Melanoma;Male;Primary;Matched;MEL;1:DECEASED;[Not Available];82
TCGA-D9-A4Z5-01;Melanoma;Female;Primary;Matched;SKCM;0:LIVING;[Not Available];48
TCGA-D9-A4Z6-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;[Not Available];40
TCGA-EB-A431-01;Melanoma;Male;Primary;Matched;MEL;1:DECEASED;Stage IV;54
TCGA-EB-A44N-01;Melanoma;Female;Primary;Matched;MEL;1:DECEASED;Stage IIC;79
TCGA-EB-A44O-01;Melanoma;Male;Primary;Matched;SKCM;1:DECEASED;[Not Available];35
TCGA-EB-A44P-01;Melanoma;Male;Primary;Matched;SKCM;1:DECEASED;Stage IB;36
TCGA-EB-A44Q-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;[Not Available];47
TCGA-EB-A44R-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIIB;56
TCGA-EB-A4IQ-01;Melanoma;Female;Primary;Matched;SKCM;1:DECEASED;[Not Available];47
TCGA-EB-A4IS-01;Melanoma;Female;Primary;Matched;SKCM;1:DECEASED;[Not Available];37
TCGA-EB-A4OY-01;Melanoma;Female;Primary;Matched;SKCM;0:LIVING;[Not Available];81
TCGA-EB-A4OZ-01;Melanoma;Male;Primary;Matched;SKCM;1:DECEASED;Stage IV;51
TCGA-EB-A4P0-01;Melanoma;Female;Primary;Matched;MEL;1:DECEASED;[Not Available];48
TCGA-FS-A4F4-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IIIC;58
TCGA-FS-A4F5-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIIB;57
TCGA-FS-A4F8-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage IB;50
TCGA-FS-A4FB-06;[Not Available];Female;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIIC;57
TCGA-FS-A4FD-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage 0;39
TCGA-BF-A5EO-01;Melanoma;Male;Primary;Matched;SKCM;1:DECEASED;Stage IIIB;53
TCGA-BF-A5EP-01;Melanoma;Female;Primary;Matched;SKCM;1:DECEASED;Stage IIIC;43
TCGA-BF-A5EQ-01;Melanoma;Male;Primary;Matched;SKCM;0:LIVING;Stage IIIC;49
TCGA-BF-A5ER-01;Melanoma;Male;Primary;Matched;SKCM;1:DECEASED;[Not Available];25
TCGA-BF-A5ES-01;Melanoma;Female;Primary;Matched;SKCM;1:DECEASED;Stage IIIA;64
TCGA-D3-A5GL-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage III;55
TCGA-D3-A5GN-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IV;30
TCGA-D3-A5GO-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;[Not Available];76
TCGA-D3-A5GR-06;[Not Available];Female;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIIC;40
TCGA-D3-A5GS-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage II;49
TCGA-D3-A5GU-06;[Not Available];Female;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIC;49
TCGA-EB-A4XL-01;Melanoma;Male;Primary;Matched;MEL;0:LIVING;Stage IIC;69
TCGA-EB-A51B-01;Melanoma;Male;Primary;Matched;SKCM;0:LIVING;Stage IB;44
TCGA-EB-A550-01;Melanoma;Female;Primary;Matched;SKCM;0:LIVING;I/II NOS;[Not Available]
TCGA-EB-A551-01;Melanoma;Female;Primary;Matched;MEL;0:LIVING;Stage II;29
TCGA-EB-A553-01;Melanoma;Female;Primary;Matched;SKCM;0:LIVING;Stage IIIC;34
TCGA-EB-A5FP-01;Melanoma;Male;Primary;Matched;SKCM;1:DECEASED;Stage IIC;90
TCGA-EB-A5KH-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;Stage IIIB;54
TCGA-FW-A5DX-01;Melanoma;Female;Primary;Matched;SKCM;0:LIVING;Stage I;38
TCGA-HR-A5NC-01;Melanoma;Male;Primary;Matched;SKCM;0:LIVING;Stage IIIC;50
TCGA-D3-A5GT-01;Melanoma;Female;Primary;Matched;SKCM;0:LIVING;Stage IIIC;63
TCGA-D9-A6E9-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;Stage IB;65
TCGA-D9-A6EA-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIB;78
TCGA-D9-A6EC-06;[Not Available];Female;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIC;56
TCGA-EB-A57M-01;Melanoma;Male;Primary;Matched;SKCM;0:LIVING;Stage IA;41
TCGA-EB-A5SE-01;Melanoma;Male;Primary;Matched;MEL;1:DECEASED;Stage IB;52
TCGA-EB-A5SF-01;Melanoma;Female;Primary;Matched;MEL;1:DECEASED;Stage I;39
TCGA-EB-A5SG-06;[Not Available];Female;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIA;55
TCGA-EB-A5SH-06;[Not Available];Female;Metastasis;Matched;[Not Available];1:DECEASED;Stage IA;32
TCGA-EB-A5UL-06;[Not Available];Female;Metastasis;Matched;[Not Available];1:DECEASED;Stage IV;72
TCGA-EB-A5UM-01;Melanoma;Male;Primary;Matched;SKCM;1:DECEASED;Stage I;62
TCGA-EB-A5UN-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIIC;19
TCGA-FR-A69P-06;[Not Available];Female;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIIB;45
TCGA-FW-A5DY-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage II;57
TCGA-GF-A6C8-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;I/II NOS;51
TCGA-GF-A6C9-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIA;63
TCGA-QB-A6FS-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIC;40
TCGA-RP-A690-06;[Not Available];Female;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIC;78
TCGA-RP-A693-06;[Not Available];Female;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIIC;60
TCGA-RP-A694-06;[Not Available];Female;Metastasis;Matched;[Not Available];1:DECEASED;Stage IV;71
TCGA-RP-A695-06;[Not Available];Female;Metastasis;Matched;[Not Available];1:DECEASED;Stage I;75
TCGA-D9-A6EG-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage II;68
TCGA-EB-A5VU-01;Melanoma;Male;Primary;Matched;SKCM;0:LIVING;Stage III;74
TCGA-EB-A5VV-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIIA;43
TCGA-EB-A6L9-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage II;52
TCGA-EB-A6QY-01;Melanoma;Male;Primary;Matched;SKCM;1:DECEASED;I/II NOS;31
TCGA-EB-A6QZ-01;Melanoma;Male;Primary;Matched;SKCM;1:DECEASED;Stage II;36
TCGA-EB-A6R0-01;Melanoma;Male;Primary;Matched;SKCM;0:LIVING;Stage I;54
TCGA-FR-A726-01;Melanoma;Male;Primary;Matched;SKLMM;0:LIVING;Stage III;55
TCGA-FR-A728-01;Melanoma;Female;Primary;Matched;MEL;1:DECEASED;Stage IIC;70
TCGA-GF-A769-01;Melanoma;Male;Primary;Matched;MEL;0:LIVING;Stage IIIB;65
TCGA-GN-A4U3-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIB;71
TCGA-GN-A4U4-06;[Not Available];Female;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIB;54
TCGA-GN-A4U5-01;Melanoma;Female;Primary;Matched;SKCM;0:LIVING;Stage IIB;67
TCGA-GN-A4U7-06;[Not Available];Female;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIC;46
TCGA-GN-A4U8-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage II;64
TCGA-GN-A4U9-06;[Not Available];Female;Metastasis;Matched;[Not Available];1:DECEASED;Stage IB;77
TCGA-OD-A75X-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage I;52
TCGA-EB-A82B-01;Melanoma;Male;Primary;Matched;SKCM;0:LIVING;Stage IIIC;80
TCGA-EB-A82C-01;Melanoma;Female;Primary;Matched;SKCM;1:DECEASED;Stage III;46
TCGA-EB-A85I-01;Melanoma;Female;Primary;Matched;SKCM;1:DECEASED;Stage IIA;75
TCGA-EB-A85J-01;Melanoma;Male;Primary;Matched;SKCM;1:DECEASED;Stage IIIC;39
TCGA-FR-A729-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;Stage IV;59
TCGA-FR-A7U8-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage III;68
TCGA-FR-A7U9-06;[Not Available];Female;Metastasis;Matched;[Not Available];1:DECEASED;[Not Available];72
TCGA-FR-A7UA-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;Stage IIIB;57
TCGA-RP-A6K9-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IIIC;71
TCGA-W3-A824-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;Stage III;48
TCGA-W3-A825-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IIC;48
TCGA-W3-A828-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;Stage IIIC;58
TCGA-BF-A9VF-01;Melanoma;Female;Primary;Matched;DESM;0:LIVING;Stage IIIC;74
TCGA-D3-A2JE-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;Stage IIB;62
TCGA-D3-A8GB-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IIIB;78
TCGA-D3-A8GC-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIC;39
TCGA-D3-A8GD-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;[Not Available];47
TCGA-D3-A8GE-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage IV;24
TCGA-D3-A8GI-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;[Not Available];60
TCGA-D3-A8GJ-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;[Not Available];53
TCGA-D3-A8GK-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;[Not Available];45
TCGA-D3-A8GL-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIIA;38
TCGA-D3-A8GM-06;[Not Available];Female;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIB;83
TCGA-D3-A8GN-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIIC;70
TCGA-D3-A8GO-06;[Not Available];Female;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIIA;63
TCGA-D3-A8GP-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIIC;77
TCGA-D3-A8GQ-06;[Not Available];Female;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIC;72
TCGA-D3-A8GR-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage III;30
TCGA-D3-A8GS-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IIA;73
TCGA-D3-A8GV-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;Stage IB;61
TCGA-DA-A95V-06;[Not Available];Female;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIIC;56
TCGA-DA-A95W-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;[Not Available];51
TCGA-DA-A95X-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIIC;71
TCGA-DA-A95Y-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage IB;70
TCGA-DA-A95Z-06;[Not Available];Female;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIC;68
TCGA-DA-A960-01;Melanoma;Male;Primary;Matched;SKCM;0:LIVING;Stage IIC;68
TCGA-FR-A8YC-06;[Not Available];Female;Metastasis;Matched;[Not Available];1:DECEASED;Stage IA;59
TCGA-FR-A8YD-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;[Not Available];50
TCGA-FR-A8YE-06;[Not Available];Female;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIIB;46
TCGA-GN-A8LK-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;[Not Available];90
TCGA-GN-A8LL-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IIC;61
TCGA-GN-A8LN-01;Melanoma;Female;Primary;Matched;SKCM;0:LIVING;[Not Available];24
TCGA-WE-A8JZ-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;[Not Available];49
TCGA-WE-A8K1-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IIIC;49
TCGA-WE-A8K4-01;Melanoma;Male;Primary;Matched;MEL;1:DECEASED;Stage IIIC;73
TCGA-WE-A8K5-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;[Not Available];66
TCGA-WE-A8K6-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IV;77
TCGA-WE-A8ZM-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IV;71
TCGA-WE-A8ZN-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IV;[Not Available]
TCGA-WE-A8ZO-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;[Not Available];[Not Available]
TCGA-WE-A8ZQ-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage I;63
TCGA-WE-A8ZR-06;[Not Available];Female;Metastasis;Matched;[Not Available];1:DECEASED;Stage II;60
TCGA-WE-A8ZT-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage II;66
TCGA-WE-A8ZX-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage III;85
TCGA-WE-A8ZY-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage III;57
TCGA-YD-A89C-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage II;71
TCGA-Z2-A8RT-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage II;63
TCGA-3N-A9WB-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage II;64
TCGA-3N-A9WC-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage I;26
TCGA-3N-A9WD-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IIIB;70
TCGA-EB-A97M-01;Melanoma;Male;Primary;Matched;SKCM;0:LIVING;Stage IIIC;74
TCGA-LH-A9QB-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IIB;85
TCGA-W3-AA1O-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage IV;65
TCGA-W3-AA1Q-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IIIB;79
TCGA-W3-AA1W-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IIIB;70
TCGA-W3-AA21-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IIB;57
TCGA-WE-AA9Y-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;Stage IIIB;73
TCGA-WE-AAA0-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IIA;48
TCGA-WE-AAA3-06;[Not Available];Male;Metastasis;Matched;[Not Available];1:DECEASED;Stage IIIC;49
TCGA-WE-AAA4-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;Stage IV;25
TCGA-XV-A9VZ-01;Melanoma;Male;Primary;Matched;SKCM;0:LIVING;Stage IIIB;45
TCGA-XV-A9W5-01;Melanoma;Male;Primary;Matched;SKCM;1:DECEASED;Stage IIA;62
TCGA-YG-AA3N-01;Melanoma;Male;Primary;Matched;MEL;0:LIVING;Stage IIIC;37
TCGA-YG-AA3O-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IA;47
TCGA-YG-AA3P-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;Stage IIIC;84
TCGA-BF-AAOU-01;Melanoma;Female;Primary;Matched;MEL;0:LIVING;Stage IIIC;56
TCGA-BF-AAOX-01;Melanoma;Female;Primary;Matched;MEL;0:LIVING;Stage II;90
TCGA-BF-AAP0-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage I;81
TCGA-BF-AAP1-01;Melanoma;Male;Primary;Matched;MEL;0:LIVING;I/II NOS;51
TCGA-QB-AA9O-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;Stage II;56
TCGA-W3-AA1R-06;[Not Available];Female;Metastasis;Matched;[Not Available];1:DECEASED;Stage II;62
TCGA-XV-A9W2-01;Melanoma;Female;Primary;Matched;SKCM;0:LIVING;Stage IIIC;76
TCGA-YD-A9TA-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;Stage II;54
TCGA-Z2-AA3S-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;Stage IA;43
TCGA-Z2-AA3V-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;[Not Available];75
TCGA-BF-AAP2-01;Melanoma;Female;Primary;Matched;MEL;0:LIVING;[Not Available];[Not Available]
TCGA-BF-AAP4-01;Melanoma;Male;Primary;Matched;MEL;0:LIVING;Stage IIC;67
TCGA-BF-AAP6-01;Melanoma;Male;Primary;Matched;MEL;1:DECEASED;[Not Available];62
TCGA-BF-AAP7-01;Melanoma;Female;Primary;Matched;MEL;0:LIVING;Stage IIB;63
TCGA-BF-AAP8-01;Melanoma;Female;Primary;Matched;MEL;0:LIVING;Stage IIB;42
TCGA-GN-A9SD-06;[Not Available];Male;Metastasis;Matched;[Not Available];0:LIVING;Stage IA;58
TCGA-W3-AA1V-06;[Not Available];Female;Metastasis;Matched;[Not Available];0:LIVING;Stage IA;57
TCGA-XV-AAZV-01;Melanoma;[Not Available];Primary;Matched;SKCM;[Not Available];[Not Available];[Not Available]
TCGA-XV-AAZW-01;Melanoma;[Not Available];Primary;Matched;SKCM;[Not Available];[Not Available];[Not Available]
TCGA-XV-AAZY-01;Melanoma;[Not Available];Primary;Matched;SKCM;[Not Available];[Not Available];[Not Available]
TCGA-XV-AB01-06;[Not Available];[Not Available];Metastasis;Matched;[Not Available];[Not Available];[Not Available];[Not Available]
TCGA-YD-A9TB-06;[Not Available];[Not Available];Metastasis;Matched;[Not Available];[Not Available];[Not Available];[Not Available]
TCGA-D9-A1X3-01;Melanoma;[Not Available];Primary;Matched;SKCM;[Not Available];[Not Available];[Not Available]
TCGA-HR-A2OG-01;Melanoma;[Not Available];Primary;Matched;SKCM;[Not Available];[Not Available];[Not Available]
TCGA-HR-A2OH-01;Melanoma;[Not Available];Primary;Matched;SKCM;[Not Available];[Not Available];[Not Available]
TCGA-XV-AB01-01;Melanoma;[Not Available];Primary;Matched;SKCM;[Not Available];[Not Available];[Not Available]
TCGA-D9-A4Z6-01;[Not Available];[Not Available];Primary;Matched;[Not Available];[Not Available];[Not Available];[Not Available]
TCGA-BR-6452-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IB;70
TCGA-BR-6453-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;1:DECEASED;Stage IIIB;51
TCGA-BR-6454-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;0:LIVING;Stage IIB;51
TCGA-BR-6455-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IB;62
TCGA-BR-6456-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IIIC;52
TCGA-BR-6457-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IIB;74
TCGA-BR-6458-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IIIA;51
TCGA-BR-6565-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IIB;60
TCGA-BR-6566-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;1:DECEASED;Stage IIIA;55
TCGA-CG-4437-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;1:DECEASED;Stage IIIA;70
TCGA-CG-4441-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;1:DECEASED;[Not Available];56
TCGA-CG-5716-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;1:DECEASED;[Not Available];53
TCGA-D7-6518-01;Esophagogastric Cancer;Male;Primary;Matched;DSTAD;1:DECEASED;[Not Available];72
TCGA-D7-6519-01;Esophagogastric Cancer;Female;Primary;Matched;DSTAD;1:DECEASED;[Not Available];66
TCGA-D7-6520-01;Esophagogastric Cancer;Female;Primary;Matched;TSTAD;1:DECEASED;Stage IIIA;80
TCGA-D7-6521-01;Esophagogastric Cancer;Female;Primary;Matched;DSTAD;1:DECEASED;Stage IIIA;76
TCGA-D7-6522-01;Esophagogastric Cancer;Male;Primary;Matched;DSTAD;1:DECEASED;[Not Available];80
TCGA-D7-6524-01;Esophagogastric Cancer;Female;Primary;Matched;DSTAD;1:DECEASED;[Not Available];79
TCGA-D7-6525-01;Esophagogastric Cancer;Male;Primary;Matched;DSTAD;1:DECEASED;Stage IB;51
TCGA-D7-6526-01;Esophagogastric Cancer;Male;Primary;Matched;TSTAD;1:DECEASED;Stage II;43
TCGA-D7-6527-01;Esophagogastric Cancer;Female;Primary;Matched;PSTAD;1:DECEASED;Stage III;78
TCGA-D7-6528-01;Esophagogastric Cancer;Female;Primary;Matched;TSTAD;0:LIVING;[Not Available];73
TCGA-F1-6177-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;[Not Available];65
TCGA-BR-4288-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;[Not Available];58
TCGA-BR-6564-01;Esophagogastric Cancer;Female;Primary;Matched;DSTAD;0:LIVING;Stage IIIA;66
TCGA-BR-6705-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;0:LIVING;[Not Available];74
TCGA-BR-6706-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;0:LIVING;[Not Available];60
TCGA-BR-6707-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;[Not Available];87
TCGA-BR-6709-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;[Not Available];78
TCGA-BR-6710-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;0:LIVING;Stage IV;78
TCGA-BR-6801-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;[Not Available];75
TCGA-BR-6802-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;0:LIVING;[Not Available];74
TCGA-BR-6803-01;Esophagogastric Cancer;Female;Primary;Matched;DSTAD;0:LIVING;[Not Available];71
TCGA-BR-6852-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;0:LIVING;Stage IIA;78
TCGA-D7-6815-01;Esophagogastric Cancer;Male;Primary;Matched;TSTAD;0:LIVING;Stage IIA;54
TCGA-D7-6817-01;Esophagogastric Cancer;Male;Primary;Matched;TSTAD;0:LIVING;Stage IIA;58
TCGA-D7-6818-01;Esophagogastric Cancer;Male;Primary;Matched;DSTAD;1:DECEASED;Stage IIB;59
TCGA-D7-6820-01;Esophagogastric Cancer;Female;Primary;Matched;TSTAD;1:DECEASED;Stage IIB;74
TCGA-D7-6822-01;Esophagogastric Cancer;Male;Primary;Matched;TSTAD;0:LIVING;Stage IIA;69
TCGA-F1-6874-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;1:DECEASED;Stage IIB;57
TCGA-BR-6563-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IIB;60
TCGA-BR-7196-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;1:DECEASED;Stage IIIA;46
TCGA-BR-7703-01;Esophagogastric Cancer;Male;Primary;Matched;PSTAD;1:DECEASED;Stage IIB;67
TCGA-BR-7704-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;0:LIVING;Stage IIA;64
TCGA-BR-7707-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;1:DECEASED;Stage IIIB;68
TCGA-BR-7715-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;1:DECEASED;Stage IIIA;63
TCGA-BR-7716-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;1:DECEASED;Stage IIA;75
TCGA-BR-7717-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;1:DECEASED;Stage IIIB;57
TCGA-BR-7723-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IB;41
TCGA-CD-5804-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IIA;70
TCGA-F1-6875-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IIIA;65
TCGA-FP-7735-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;0:LIVING;Stage IIA;54
TCGA-FP-7829-01;Esophagogastric Cancer;Female;Primary;Matched;MSTAD;0:LIVING;Stage IIA;64
TCGA-HF-7131-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IV;64
TCGA-HF-7132-01;Esophagogastric Cancer;Male;Primary;Matched;MSTAD;0:LIVING;Stage II;69
TCGA-HF-7133-01;Esophagogastric Cancer;Male;Primary;Matched;MSTAD;0:LIVING;Stage IA;81
TCGA-HF-7134-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;0:LIVING;Stage II;69
TCGA-HF-7136-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;0:LIVING;Stage IB;69
TCGA-IN-7806-01;Esophagogastric Cancer;Male;Primary;Matched;DSTAD;0:LIVING;Stage IIA;65
TCGA-BR-7197-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;0:LIVING;Stage IIB;62
TCGA-BR-7722-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;1:DECEASED;Stage IV;63
TCGA-BR-7851-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;1:DECEASED;Stage IIB;62
TCGA-BR-7901-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;1:DECEASED;Stage IIIB;59
TCGA-BR-7957-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;1:DECEASED;Stage IIB;74
TCGA-FP-7916-01;Esophagogastric Cancer;Male;Primary;Matched;DSTAD;1:DECEASED;Stage IIB;74
TCGA-FP-7998-01;Esophagogastric Cancer;Female;Primary;Matched;DSTAD;1:DECEASED;Stage IV;50
TCGA-HJ-7597-01;Esophagogastric Cancer;Male;Primary;Matched;SSRCC;0:LIVING;Stage IIIB;60
TCGA-IN-7808-01;Esophagogastric Cancer;Male;Primary;Matched;DSTAD;0:LIVING;Stage IIIA;59
TCGA-IP-7968-01;Esophagogastric Cancer;Female;Primary;Matched;SSRCC;0:LIVING;Stage IIIB;53
TCGA-BR-7958-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;1:DECEASED;Stage III;72
TCGA-BR-7959-01;Esophagogastric Cancer;Female;Primary;Matched;MSTAD;1:DECEASED;Stage IIB;75
TCGA-BR-8058-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;0:LIVING;Stage IIIB;58
TCGA-BR-8059-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;0:LIVING;Stage IIB;70
TCGA-BR-8060-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;1:DECEASED;Stage IIIC;72
TCGA-BR-8077-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;0:LIVING;Stage IIB;71
TCGA-BR-8078-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;1:DECEASED;Stage IIIC;72
TCGA-BR-8080-01;Esophagogastric Cancer;Female;Primary;Matched;MSTAD;1:DECEASED;Stage IIIC;57
TCGA-BR-8081-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage II;49
TCGA-BR-8284-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;1:DECEASED;Stage IV;57
TCGA-BR-8285-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;1:DECEASED;Stage IIB;61
TCGA-BR-8286-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;1:DECEASED;Stage IIB;60
TCGA-BR-8289-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;1:DECEASED;Stage IIIC;58
TCGA-BR-8291-01;Esophagogastric Cancer;Male;Primary;Matched;DSTAD;0:LIVING;Stage IIIC;58
TCGA-BR-8295-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IIA;66
TCGA-BR-8296-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;0:LIVING;Stage IIIC;71
TCGA-BR-8297-01;Esophagogastric Cancer;Male;Primary;Matched;DSTAD;1:DECEASED;Stage IIIC;65
TCGA-BR-8360-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;1:DECEASED;Stage IB;73
TCGA-BR-8361-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;0:LIVING;Stage IIIC;42
TCGA-BR-8362-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;1:DECEASED;Stage IIA;70
TCGA-BR-8363-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;0:LIVING;Stage IIA;80
TCGA-BR-8364-01;Esophagogastric Cancer;Male;Primary;Matched;DSTAD;1:DECEASED;Stage IIIB;55
TCGA-BR-8365-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;0:LIVING;Stage IB;84
TCGA-BR-8366-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;0:LIVING;Stage IIIB;76
TCGA-BR-8367-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IIIB;64
TCGA-BR-8368-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;1:DECEASED;Stage IIIB;62
TCGA-BR-8369-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IIIC;63
TCGA-BR-8370-01;Esophagogastric Cancer;Female;Primary;Matched;DSTAD;0:LIVING;Stage IIIA;65
TCGA-BR-8371-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;1:DECEASED;Stage IIIC;55
TCGA-BR-8372-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IIB;51
TCGA-BR-8373-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;1:DECEASED;Stage IIIC;67
TCGA-BR-8380-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IIIC;69
TCGA-CD-8524-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IIIA;59
TCGA-CD-8525-01;Esophagogastric Cancer;Male;Primary;Matched;MSTAD;1:DECEASED;Stage IIIA;61
TCGA-CD-8526-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;0:LIVING;Stage IIIC;68
TCGA-CD-8527-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;0:LIVING;Stage IA;90
TCGA-CD-8528-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;0:LIVING;Stage IIA;64
TCGA-CD-8529-01;Esophagogastric Cancer;Female;Primary;Matched;MSTAD;0:LIVING;Stage IIB;55
TCGA-CD-8530-01;Esophagogastric Cancer;Male;Primary;Matched;DSTAD;0:LIVING;Stage IIIB;56
TCGA-CD-8531-01;Esophagogastric Cancer;Male;Primary;Matched;DSTAD;1:DECEASED;Stage IIIC;62
TCGA-CD-8532-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IIIC;79
TCGA-CD-8533-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;1:DECEASED;Stage IIIB;63
TCGA-CD-8534-01;Esophagogastric Cancer;Male;Primary;Matched;DSTAD;0:LIVING;Stage IIIB;59
TCGA-CD-8535-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;0:LIVING;Stage IIIB;74
TCGA-CD-8536-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IB;76
TCGA-D7-8570-01;Esophagogastric Cancer;Female;Primary;Matched;TSTAD;0:LIVING;Stage IB;63
TCGA-D7-8572-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IV;45
TCGA-D7-8573-01;Esophagogastric Cancer;Male;Primary;Matched;TSTAD;0:LIVING;Stage IIB;52
TCGA-D7-8574-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;1:DECEASED;Stage IIIB;75
TCGA-D7-8575-01;Esophagogastric Cancer;Male;Primary;Matched;TSTAD;1:DECEASED;Stage IIIB;69
TCGA-D7-8576-01;Esophagogastric Cancer;Female;Primary;Matched;TSTAD;1:DECEASED;Stage IIIC;67
TCGA-D7-8578-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;0:LIVING;Stage IIIB;54
TCGA-D7-8579-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;0:LIVING;Stage IIA;53
TCGA-EQ-8122-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;1:DECEASED;Stage IIIB;70
TCGA-FP-8099-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;1:DECEASED;Stage IIIA;57
TCGA-FP-8209-01;Esophagogastric Cancer;Male;Primary;Matched;DSTAD;1:DECEASED;Stage IV;51
TCGA-FP-8210-01;Esophagogastric Cancer;Male;Primary;Matched;DSTAD;0:LIVING;Stage IIIA;58
TCGA-FP-8211-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;0:LIVING;Stage IIIC;70
TCGA-HU-8238-01;Esophagogastric Cancer;Male;Primary;Matched;TSTAD;1:DECEASED;Stage IIIC;77
TCGA-HU-8243-01;Esophagogastric Cancer;Female;Primary;Matched;TSTAD;0:LIVING;Stage IIIA;34
TCGA-HU-8244-01;Esophagogastric Cancer;Male;Primary;Matched;TSTAD;1:DECEASED;Stage IIIB;47
TCGA-HU-8245-01;Esophagogastric Cancer;Male;Primary;Matched;PSTAD;0:LIVING;Stage IIB;58
TCGA-HU-8249-01;Esophagogastric Cancer;Female;Primary;Matched;TSTAD;1:DECEASED;Stage IIIB;45
TCGA-IN-8462-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;1:DECEASED;Stage IIIA;63
TCGA-BR-8381-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IIB;70
TCGA-BR-8382-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IIIB;39
TCGA-BR-8384-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IIIA;56
TCGA-BR-8483-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;0:LIVING;Stage IIA;69
TCGA-BR-8484-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IIB;49
TCGA-BR-8485-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;0:LIVING;Stage IIIB;71
TCGA-BR-8486-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IIA;55
TCGA-BR-8487-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;0:LIVING;Stage IIB;72
TCGA-BR-8588-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;0:LIVING;Stage IB;68
TCGA-BR-8589-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IIIB;72
TCGA-BR-8590-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;1:DECEASED;Stage IIA;70
TCGA-BR-8591-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;1:DECEASED;Stage IIIB;75
TCGA-BR-8592-01;Esophagogastric Cancer;Male;Primary;Matched;DSTAD;0:LIVING;Stage IIIA;65
TCGA-BR-8676-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage II;82
TCGA-BR-8677-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage II;45
TCGA-BR-8678-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;0:LIVING;Stage II;51
TCGA-BR-8679-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;1:DECEASED;Stage IIIA;69
TCGA-BR-8680-01;Esophagogastric Cancer;Male;Primary;Matched;TSTAD;0:LIVING;Stage II;58
TCGA-BR-8682-01;Esophagogastric Cancer;Female;Primary;Matched;MSTAD;1:DECEASED;Stage II;78
TCGA-BR-8683-01;Esophagogastric Cancer;Male;Primary;Matched;TSTAD;0:LIVING;[Discrepancy];90
TCGA-BR-8686-01;Esophagogastric Cancer;Male;Primary;Matched;TSTAD;1:DECEASED;Stage II;60
TCGA-BR-8687-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;0:LIVING;Stage II;61
TCGA-BR-8690-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;0:LIVING;Stage IIIA;82
TCGA-FP-8631-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;0:LIVING;Stage IIIA;73
TCGA-HU-8602-01;Esophagogastric Cancer;Female;Primary;Matched;DSTAD;1:DECEASED;Stage II;72
TCGA-HU-8604-01;Esophagogastric Cancer;Female;Primary;Matched;TSTAD;0:LIVING;Stage IIIA;43
TCGA-HU-8608-01;Esophagogastric Cancer;Male;Primary;Matched;DSTAD;0:LIVING;Stage IV;65
TCGA-HU-8610-01;Esophagogastric Cancer;Male;Primary;Matched;TSTAD;0:LIVING;Stage II;51
TCGA-IN-8663-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;0:LIVING;Stage IIIA;66
TCGA-BR-A44T-01;Esophagogastric Cancer;Male;Primary;Matched;DSTAD;1:DECEASED;Stage II;52
TCGA-BR-A44U-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage II;48
TCGA-BR-A453-01;Esophagogastric Cancer;Male;Primary;Matched;SSRCC;0:LIVING;Stage II;41
TCGA-BR-A4CR-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IIIA;59
TCGA-BR-A4CS-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage II;74
TCGA-CD-A486-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;1:DECEASED;Stage IIA;68
TCGA-CD-A487-01;Esophagogastric Cancer;Male;Primary;Matched;DSTAD;0:LIVING;Stage IIB;51
TCGA-CD-A489-01;Esophagogastric Cancer;Male;Primary;Matched;DSTAD;1:DECEASED;Stage IIA;58
TCGA-CD-A48A-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IIA;57
TCGA-CD-A48C-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;1:DECEASED;Stage IIB;79
TCGA-F1-A448-01;Esophagogastric Cancer;Male;Primary;Matched;MSTAD;1:DECEASED;Stage IIA;76
TCGA-FP-A4BE-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;0:LIVING;Stage IIA;86
TCGA-FP-A4BF-01;Esophagogastric Cancer;Male;Primary;Matched;SSRCC;1:DECEASED;Stage IIIA;62
TCGA-HU-A4G3-01;Esophagogastric Cancer;Male;Primary;Matched;TSTAD;0:LIVING;Stage IB;60
TCGA-HU-A4G6-01;Esophagogastric Cancer;Male;Primary;Matched;PSTAD;1:DECEASED;Stage IIIB;79
TCGA-HU-A4G9-01;Esophagogastric Cancer;Female;Primary;Matched;TSTAD;0:LIVING;Stage IV;75
TCGA-HU-A4GF-01;Esophagogastric Cancer;Male;Primary;Matched;TSTAD;0:LIVING;Stage IB;84
TCGA-HU-A4GH-01;Esophagogastric Cancer;Male;Primary;Matched;TSTAD;0:LIVING;Stage II;69
TCGA-HU-A4GY-01;Esophagogastric Cancer;Male;Primary;Matched;DSTAD;1:DECEASED;Stage IV;90
TCGA-BR-A452-01;Esophagogastric Cancer;Male;Primary;Matched;TSTAD;0:LIVING;Stage IB;57
TCGA-BR-A4CQ-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage II;83
TCGA-BR-A4IU-01;Esophagogastric Cancer;Male;Primary;Matched;DSTAD;0:LIVING;Stage IV;56
TCGA-BR-A4IV-01;Esophagogastric Cancer;Female;Primary;Matched;DSTAD;1:DECEASED;Stage IV;68
TCGA-BR-A4IY-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;1:DECEASED;Stage IIIA;83
TCGA-BR-A4IZ-01;Esophagogastric Cancer;Male;Primary;Matched;DSTAD;0:LIVING;Stage IB;85
TCGA-BR-A4J1-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IA;68
TCGA-BR-A4J2-01;Esophagogastric Cancer;Male;Primary;Matched;DSTAD;0:LIVING;Stage IIIA;76
TCGA-BR-A4J4-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage II;81
TCGA-BR-A4J5-01;Esophagogastric Cancer;Male;Primary;Matched;MSTAD;0:LIVING;Stage II;72
TCGA-BR-A4J6-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;1:DECEASED;Stage IV;66
TCGA-BR-A4J7-01;Esophagogastric Cancer;Female;Primary;Matched;MSTAD;1:DECEASED;Stage IV;72
TCGA-BR-A4J8-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;1:DECEASED;Stage IV;69
TCGA-BR-A4J9-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;0:LIVING;Stage IB;81
TCGA-BR-A4PD-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;1:DECEASED;Stage IV;70
TCGA-BR-A4PE-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IV;49
TCGA-BR-A4PF-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;0:LIVING;Stage IV;67
TCGA-BR-A4QI-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IIB;76
TCGA-BR-A4QL-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IIIC;69
TCGA-BR-A4QM-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;0:LIVING;Stage IB;58
TCGA-CD-A4MG-01;Esophagogastric Cancer;Male;Primary;Matched;DSTAD;0:LIVING;Stage IV;86
TCGA-CD-A4MH-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;1:DECEASED;Stage II;58
TCGA-CD-A4MI-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;1:DECEASED;Stage II;78
TCGA-CD-A4MJ-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;0:LIVING;Stage IV;54
TCGA-D7-A4YT-01;Esophagogastric Cancer;Male;Primary;Matched;TSTAD;1:DECEASED;Stage IB;71
TCGA-D7-A4YU-01;Esophagogastric Cancer;Male;Primary;Matched;TSTAD;0:LIVING;Stage IV;58
TCGA-D7-A4YV-01;Esophagogastric Cancer;Female;Primary;Matched;TSTAD;0:LIVING;Stage IV;67
TCGA-D7-A4YX-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage II;83
TCGA-D7-A4YY-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;1:DECEASED;Stage IV;59
TCGA-D7-A4Z0-01;Esophagogastric Cancer;Male;Primary;Matched;MSTAD;1:DECEASED;Stage IB;72
TCGA-EQ-A4SO-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;1:DECEASED;Stage IA;73
TCGA-HU-A4G2-01;Esophagogastric Cancer;Male;Primary;Matched;DSTAD;0:LIVING;Stage II;66
TCGA-HU-A4G8-01;Esophagogastric Cancer;Female;Primary;Matched;DSTAD;0:LIVING;Stage IB;88
TCGA-HU-A4GC-01;Esophagogastric Cancer;Female;Primary;Matched;DSTAD;0:LIVING;Stage IV;80
TCGA-HU-A4GD-01;Esophagogastric Cancer;Male;Primary;Matched;TSTAD;1:DECEASED;Stage IV;66
TCGA-HU-A4GJ-01;Esophagogastric Cancer;Female;Primary;Matched;DSTAD;1:DECEASED;Stage IIIA;83
TCGA-HU-A4GN-01;Esophagogastric Cancer;Male;Primary;Matched;TSTAD;1:DECEASED;Stage IIIA;68
TCGA-HU-A4GP-01;Esophagogastric Cancer;Female;Primary;Matched;DSTAD;1:DECEASED;Stage IIIA;53
TCGA-HU-A4GQ-01;Esophagogastric Cancer;Male;Primary;Matched;TSTAD;0:LIVING;Stage IIIA;80
TCGA-HU-A4GT-01;Esophagogastric Cancer;Male;Primary;Matched;TSTAD;0:LIVING;Stage IIIA;74
TCGA-HU-A4GU-01;Esophagogastric Cancer;Male;Primary;Matched;DSTAD;0:LIVING;Stage IIIA;75
TCGA-HU-A4GX-01;Esophagogastric Cancer;Female;Primary;Matched;DSTAD;0:LIVING;[Discrepancy];64
TCGA-HU-A4H0-01;Esophagogastric Cancer;Male;Primary;Matched;DSTAD;0:LIVING;Stage IIIA;53
TCGA-HU-A4H2-01;Esophagogastric Cancer;Male;Primary;Matched;TSTAD;0:LIVING;[Discrepancy];65
TCGA-HU-A4H3-01;Esophagogastric Cancer;Male;Primary;Matched;DSTAD;0:LIVING;Stage IB;58
TCGA-HU-A4H4-01;Esophagogastric Cancer;Male;Primary;Matched;TSTAD;0:LIVING;Stage II;53
TCGA-HU-A4H5-01;Esophagogastric Cancer;Male;Primary;Matched;PSTAD;1:DECEASED;Stage IIIA;58
TCGA-HU-A4H6-01;Esophagogastric Cancer;Female;Primary;Matched;TSTAD;0:LIVING;Stage IIIA;67
TCGA-HU-A4H8-01;Esophagogastric Cancer;Male;Primary;Matched;TSTAD;1:DECEASED;Stage II;62
TCGA-HU-A4HB-01;Esophagogastric Cancer;Female;Primary;Matched;DSTAD;0:LIVING;Stage IB;70
TCGA-HU-A4HD-01;Esophagogastric Cancer;Female;Primary;Matched;TSTAD;0:LIVING;Stage IIB;70
TCGA-B7-A5TI-01;Esophagogastric Cancer;Male;Primary;Matched;DSTAD;0:LIVING;Stage IIIA;63
TCGA-B7-A5TJ-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;1:DECEASED;Stage IIIA;53
TCGA-B7-A5TK-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IIB;64
TCGA-B7-A5TN-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IB;77
TCGA-D7-A6EV-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IIIB;44
TCGA-D7-A6EX-01;Esophagogastric Cancer;Male;Primary;Matched;TSTAD;0:LIVING;Stage IIB;57
TCGA-D7-A6EY-01;Esophagogastric Cancer;Male;Primary;Matched;TSTAD;0:LIVING;Stage IIA;57
TCGA-D7-A6EZ-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IIIA;72
TCGA-D7-A6F0-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;1:DECEASED;Stage IIIA;75
TCGA-D7-A6F2-01;Esophagogastric Cancer;Female;Primary;Matched;TSTAD;1:DECEASED;Stage IIIB;54
TCGA-HF-A5NB-01;Esophagogastric Cancer;Male;Primary;Matched;MSTAD;0:LIVING;Stage IB;72
TCGA-MX-A5UG-01;Esophagogastric Cancer;Female;Primary;Matched;DSTAD;0:LIVING;Stage IIB;66
TCGA-MX-A5UJ-01;Esophagogastric Cancer;Male;Primary;Matched;TSTAD;0:LIVING;Stage IIIA;56
TCGA-MX-A663-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IIIB;73
TCGA-MX-A666-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;1:DECEASED;Stage IIB;69
TCGA-D7-A6ET-01;Esophagogastric Cancer;Male;Primary;Matched;TSTAD;0:LIVING;Stage IIB;63
TCGA-D7-A748-01;Esophagogastric Cancer;Male;Primary;Matched;DSTAD;0:LIVING;Stage IIIB;61
TCGA-D7-A74A-01;Esophagogastric Cancer;Female;Primary;Matched;TSTAD;0:LIVING;Stage IIB;60
TCGA-IN-A6RI-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IIIB;76
TCGA-IN-A6RL-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;0:LIVING;Stage IIB;71
TCGA-IN-A6RR-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;0:LIVING;Stage IIIA;72
TCGA-KB-A6F7-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;1:DECEASED;Stage IIIB;72
TCGA-RD-A7BS-01;Esophagogastric Cancer;Male;Primary;Matched;DSTAD;1:DECEASED;Stage IIIA;66
TCGA-RD-A7BW-01;Esophagogastric Cancer;Female;Primary;Matched;DSTAD;0:LIVING;Stage IB;79
TCGA-RD-A7C1-01;Esophagogastric Cancer;Male;Primary;Matched;DSTAD;0:LIVING;Stage IB;62
TCGA-D7-A747-01;Esophagogastric Cancer;Male;Primary;Matched;DSTAD;1:DECEASED;Stage IIB;57
TCGA-D7-A74B-01;Esophagogastric Cancer;Female;Primary;Matched;DSTAD;1:DECEASED;Stage IV;41
TCGA-F1-A72C-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;0:LIVING;Stage IIIA;61
TCGA-IN-A6RJ-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;1:DECEASED;Stage IIIB;52
TCGA-IN-A6RN-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;1:DECEASED;Stage IV;86
TCGA-IN-A6RO-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;1:DECEASED;Stage IIB;71
TCGA-IN-A6RP-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IIIB;70
TCGA-KB-A6F5-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;1:DECEASED;Stage I;90
TCGA-R5-A7O7-01;Esophagogastric Cancer;Male;Primary;Matched;TSTAD;0:LIVING;Stage IB;79
TCGA-RD-A7BT-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;1:DECEASED;Stage IA;79
TCGA-IN-A6RS-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IIIB;70
TCGA-IN-A7NR-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IIA;68
TCGA-IN-A7NT-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;1:DECEASED;Stage IB;77
TCGA-IN-A7NU-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IIB;69
TCGA-R5-A7ZE-01;Esophagogastric Cancer;Male;Primary;Matched;TSTAD;1:DECEASED;Stage IIIC;77
TCGA-R5-A7ZF-01;Esophagogastric Cancer;Male;Primary;Matched;TSTAD;0:LIVING;Stage IIIC;77
TCGA-R5-A7ZI-01;Esophagogastric Cancer;Male;Primary;Matched;DSTAD;0:LIVING;Stage IIA;79
TCGA-R5-A7ZR-01;Esophagogastric Cancer;Male;Primary;Matched;TSTAD;1:DECEASED;Stage IB;49
TCGA-SW-A7EA-01;Esophagogastric Cancer;Male;Primary;Matched;DSTAD;1:DECEASED;Stage IIIA;48
TCGA-SW-A7EB-01;Esophagogastric Cancer;Male;Primary;Matched;MSTAD;0:LIVING;Stage IIB;62
TCGA-FP-A8CX-01;Esophagogastric Cancer;Male;Primary;Matched;SSRCC;0:LIVING;Stage IIIA;68
TCGA-R5-A804-01;Esophagogastric Cancer;Male;Primary;Matched;DSTAD;0:LIVING;Stage IIA;55
TCGA-R5-A805-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;1:DECEASED;Stage IIIA;68
TCGA-RD-A8MV-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IIIC;60
TCGA-RD-A8MW-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;[Discrepancy];77
TCGA-RD-A8N0-01;Esophagogastric Cancer;Female;Primary;Matched;DSTAD;0:LIVING;Stage IB;[Not Available]
TCGA-RD-A8N1-01;Esophagogastric Cancer;Male;Primary;Matched;DSTAD;0:LIVING;Stage II;[Not Available]
TCGA-RD-A8N2-01;Esophagogastric Cancer;Female;Primary;Matched;DSTAD;0:LIVING;Stage IV;[Not Available]
TCGA-RD-A8N4-01;Esophagogastric Cancer;Male;Primary;Matched;DSTAD;0:LIVING;Stage IA;[Not Available]
TCGA-RD-A8N5-01;Esophagogastric Cancer;Male;Primary;Matched;MSTAD;0:LIVING;Stage IIIA;[Not Available]
TCGA-RD-A8N6-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;0:LIVING;Stage IIIC;75
TCGA-VQ-A8DL-01;Esophagogastric Cancer;Female;Primary;Matched;TSTAD;1:DECEASED;Stage IB;71
TCGA-VQ-A8DT-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;[Discrepancy];56
TCGA-VQ-A8DU-01;Esophagogastric Cancer;Male;Primary;Matched;TSTAD;1:DECEASED;Stage IIIC;66
TCGA-VQ-A8DV-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;0:LIVING;Stage IA;77
TCGA-VQ-A8DZ-01;Esophagogastric Cancer;Male;Primary;Matched;SSRCC;0:LIVING;Stage IIA;72
TCGA-VQ-A8E2-01;Esophagogastric Cancer;Male;Primary;Matched;TSTAD;0:LIVING;Stage IIIA;76
TCGA-VQ-A8P2-01;Esophagogastric Cancer;Female;Primary;Matched;MSTAD;0:LIVING;Stage IIB;58
TCGA-VQ-A8P3-01;Esophagogastric Cancer;Female;Primary;Matched;TSTAD;0:LIVING;Stage IIA;82
TCGA-ZA-A8F6-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IIIB;70
TCGA-FP-A9TM-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IA;75
TCGA-IN-AB1X-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IIB;45
TCGA-KB-A93G-01;Esophagogastric Cancer;Male;Primary;Matched;SSRCC;0:LIVING;Stage IIB;54
TCGA-KB-A93H-01;Esophagogastric Cancer;Male;Primary;Matched;TSTAD;0:LIVING;Stage IA;74
TCGA-KB-A93J-01;Esophagogastric Cancer;Female;Primary;Matched;DSTAD;0:LIVING;Stage IIB;71
TCGA-RD-A8N9-01;Esophagogastric Cancer;Female;Primary;Matched;DSTAD;0:LIVING;Stage IA;67
TCGA-RD-A8NB-01;Esophagogastric Cancer;Male;Primary;Matched;DSTAD;0:LIVING;Stage IIIB;74
TCGA-VQ-A8E3-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IIB;56
TCGA-VQ-A8P5-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IIA;69
TCGA-VQ-A8P8-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IA;75
TCGA-VQ-A8PB-01;Esophagogastric Cancer;Female;Primary;Matched;PSTAD;0:LIVING;Stage IIIC;60
TCGA-VQ-A8PC-01;Esophagogastric Cancer;Male;Primary;Matched;SSRCC;0:LIVING;Stage IIA;61
TCGA-ZQ-A9CR-01;Esophagogastric Cancer;Female;Primary;Matched;TSTAD;0:LIVING;Stage IIA;62
TCGA-3M-AB46-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;1:DECEASED;Stage IIIC;71
TCGA-3M-AB47-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;0:LIVING;Stage IIA;71
TCGA-IN-AB1V-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IIB;73
TCGA-VQ-A8E0-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;0:LIVING;Stage IIIC;70
TCGA-VQ-A8E7-01;Esophagogastric Cancer;Female;Primary;Matched;TSTAD;0:LIVING;Stage IIIA;76
TCGA-VQ-A8PD-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IIIC;72
TCGA-VQ-A8PE-01;Esophagogastric Cancer;Female;Primary;Matched;TSTAD;0:LIVING;Stage IIIB;58
TCGA-VQ-A8PF-01;Esophagogastric Cancer;Female;Primary;Matched;TSTAD;0:LIVING;Stage IIIC;56
TCGA-VQ-A8PH-01;Esophagogastric Cancer;Female;Primary;Matched;TSTAD;0:LIVING;Stage IIB;53
TCGA-VQ-A8PJ-01;Esophagogastric Cancer;Male;Primary;Matched;TSTAD;0:LIVING;Stage IB;71
TCGA-VQ-A8PK-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;0:LIVING;Stage IIIA;72
TCGA-VQ-A8PM-01;Esophagogastric Cancer;Male;Primary;Matched;SSRCC;0:LIVING;Stage IB;77
TCGA-VQ-A8PO-01;Esophagogastric Cancer;Male;Primary;Matched;SSRCC;1:DECEASED;Stage IIB;68
TCGA-VQ-A8PP-01;Esophagogastric Cancer;Male;Primary;Matched;TSTAD;0:LIVING;Stage IIIA;73
TCGA-VQ-A8PQ-01;Esophagogastric Cancer;Male;Primary;Matched;TSTAD;0:LIVING;Stage IIB;50
TCGA-VQ-A8PS-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;1:DECEASED;[Discrepancy];59
TCGA-VQ-A8PT-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IIB;80
TCGA-VQ-A8PU-01;Esophagogastric Cancer;Male;Primary;Matched;TSTAD;1:DECEASED;Stage IIB;68
TCGA-VQ-A8PX-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage I;45
TCGA-VQ-A8PY-01;Esophagogastric Cancer;Male;Primary;Matched;TSTAD;0:LIVING;Stage IA;64
TCGA-VQ-A8PZ-01;Esophagogastric Cancer;Male;Primary;Matched;SSRCC;1:DECEASED;[Discrepancy];84
TCGA-VQ-A91A-01;Esophagogastric Cancer;Female;Primary;Matched;MSTAD;0:LIVING;Stage IIA;72
TCGA-VQ-A91D-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;1:DECEASED;Stage IA;70
TCGA-VQ-A91E-01;Esophagogastric Cancer;Male;Primary;Matched;TSTAD;0:LIVING;[Discrepancy];63
TCGA-VQ-A91K-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;1:DECEASED;[Discrepancy];84
TCGA-VQ-A91N-01;Esophagogastric Cancer;Male;Primary;Matched;TSTAD;0:LIVING;Stage IA;76
TCGA-VQ-A91Q-01;Esophagogastric Cancer;Female;Primary;Matched;TSTAD;0:LIVING;Stage IV;64
TCGA-VQ-A91S-01;Esophagogastric Cancer;Female;Primary;Matched;TSTAD;0:LIVING;Stage IIB;73
TCGA-VQ-A91U-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IIIB;69
TCGA-VQ-A91V-01;Esophagogastric Cancer;Male;Primary;Matched;TSTAD;0:LIVING;Stage IA;63
TCGA-VQ-A91W-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;0:LIVING;Stage IIA;78
TCGA-VQ-A91X-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IIIB;74
TCGA-VQ-A91Y-01;Esophagogastric Cancer;Male;Primary;Matched;TSTAD;0:LIVING;Stage IIIA;73
TCGA-VQ-A91Z-01;Esophagogastric Cancer;Female;Primary;Matched;TSTAD;0:LIVING;Stage IB;54
TCGA-VQ-A922-01;Esophagogastric Cancer;Male;Primary;Matched;TSTAD;0:LIVING;Stage IB;68
TCGA-VQ-A923-01;Esophagogastric Cancer;Female;Primary;Matched;TSTAD;0:LIVING;Stage IIB;79
TCGA-VQ-A924-01;Esophagogastric Cancer;Male;Primary;Matched;TSTAD;0:LIVING;Stage II;78
TCGA-VQ-A925-01;Esophagogastric Cancer;Male;Primary;Matched;TSTAD;1:DECEASED;Stage IIIA;78
TCGA-VQ-A927-01;Esophagogastric Cancer;Female;Primary;Matched;DSTAD;0:LIVING;Stage IIIA;86
TCGA-VQ-A928-01;Esophagogastric Cancer;Male;Primary;Matched;PSTAD;1:DECEASED;Stage IIA;66
TCGA-VQ-A92D-01;Esophagogastric Cancer;Male;Primary;Matched;TSTAD;0:LIVING;Stage IIA;61
TCGA-VQ-A94O-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IV;51
TCGA-VQ-A94P-01;Esophagogastric Cancer;Female;Primary;Matched;SSRCC;1:DECEASED;Stage IIIA;66
TCGA-VQ-A94R-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;1:DECEASED;Stage IV;65
TCGA-VQ-A94T-01;Esophagogastric Cancer;Female;Primary;Matched;DSTAD;0:LIVING;Stage IV;44
TCGA-VQ-A94U-01;Esophagogastric Cancer;Female;Primary;Matched;SSRCC;1:DECEASED;Stage III;70
TCGA-VQ-AA64-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;1:DECEASED;Stage IV;54
TCGA-VQ-AA68-01;Esophagogastric Cancer;Male;Primary;Matched;TSTAD;1:DECEASED;Stage IIIB;71
TCGA-VQ-AA69-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;1:DECEASED;Stage IIIA;46
TCGA-VQ-AA6A-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;1:DECEASED;Stage IV;66
TCGA-VQ-AA6B-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;1:DECEASED;Stage IB;68
TCGA-VQ-AA6D-01;Esophagogastric Cancer;Male;Primary;Matched;TSTAD;1:DECEASED;Stage IB;82
TCGA-VQ-AA6F-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IIIB;56
TCGA-VQ-AA6G-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;1:DECEASED;Stage IIIB;72
TCGA-VQ-AA6I-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;0:LIVING;Stage IIIB;53
TCGA-VQ-AA6J-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IIIB;70
TCGA-VQ-AA6K-01;Esophagogastric Cancer;Female;Primary;Matched;SSRCC;0:LIVING;Stage IB;59
TCGA-BR-4183-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;0:LIVING;Stage IIIA;58
TCGA-BR-4184-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;1:DECEASED;Stage IIIA;78
TCGA-BR-4186-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;1:DECEASED;Stage IIIA;78
TCGA-BR-4187-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;0:LIVING;Stage II;63
TCGA-BR-4188-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;1:DECEASED;Stage IIIA;80
TCGA-BR-4190-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;0:LIVING;Stage IB;61
TCGA-BR-4191-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IIIA;45
TCGA-BR-4194-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;1:DECEASED;Stage IIA;69
TCGA-BR-4195-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IIIB;43
TCGA-BR-4196-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;1:DECEASED;Stage IIIA;63
TCGA-BR-4197-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;1:DECEASED;Stage IB;48
TCGA-BR-4199-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;1:DECEASED;Stage IV;70
TCGA-BR-4200-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;1:DECEASED;Stage IIIA;68
TCGA-BR-4201-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IIIB;57
TCGA-BR-4205-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;1:DECEASED;Stage IIA;79
TCGA-BR-4253-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IV;59
TCGA-BR-4255-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IIIA;68
TCGA-BR-4256-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IIIA;72
TCGA-BR-4257-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;1:DECEASED;Stage IIA;67
TCGA-BR-4259-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;0:LIVING;Stage IIB;72
TCGA-BR-4260-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;1:DECEASED;Stage II;65
TCGA-BR-4261-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;1:DECEASED;Stage IIIA;65
TCGA-BR-4263-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;1:DECEASED;Stage IIIC;69
TCGA-BR-4264-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;1:DECEASED;Stage IIIB;78
TCGA-BR-4265-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;1:DECEASED;Stage IIIB;76
TCGA-BR-4266-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;1:DECEASED;Stage IIIB;62
TCGA-BR-4267-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;1:DECEASED;Stage IV;53
TCGA-BR-4270-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;1:DECEASED;Stage IIIB;58
TCGA-BR-4271-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;1:DECEASED;Stage IV;56
TCGA-BR-4272-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;1:DECEASED;Stage IIB;74
TCGA-BR-4273-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;1:DECEASED;Stage IV;76
TCGA-BR-4274-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;1:DECEASED;Stage IV;50
TCGA-BR-4276-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;1:DECEASED;Stage IIIA;76
TCGA-BR-4277-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IIIB;65
TCGA-BR-4278-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;1:DECEASED;Stage IIIA;72
TCGA-BR-4279-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IA;51
TCGA-BR-4280-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;1:DECEASED;Stage IIIB;47
TCGA-BR-4281-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;0:LIVING;Stage II;56
TCGA-BR-4282-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IIIB;67
TCGA-BR-4283-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;1:DECEASED;Stage IIIC;70
TCGA-BR-4284-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;0:LIVING;Stage IIIB;67
TCGA-BR-4285-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IIIA;69
TCGA-BR-4286-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;1:DECEASED;Stage IV;59
TCGA-BR-4291-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;1:DECEASED;Stage IV;61
TCGA-BR-4292-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IIIB;63
TCGA-BR-4294-01;Esophagogastric Cancer;Male;Primary;Matched;TSTAD;1:DECEASED;Stage IIIA;78
TCGA-BR-4298-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IIIA;58
TCGA-BR-4357-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IIIA;30
TCGA-BR-4361-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;1:DECEASED;Stage IIIB;74
TCGA-BR-4362-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;1:DECEASED;Stage IIIC;67
TCGA-BR-4363-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;0:LIVING;Stage IIIA;67
TCGA-BR-4366-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;1:DECEASED;Stage IV;70
TCGA-BR-4367-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;1:DECEASED;Stage IIIA;90
TCGA-BR-4368-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;1:DECEASED;Stage II;69
TCGA-BR-4369-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;1:DECEASED;Stage IIIA;66
TCGA-BR-4370-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;1:DECEASED;Stage IIIB;81
TCGA-BR-4371-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;1:DECEASED;Stage IV;49
TCGA-BR-4375-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IB;67
TCGA-BR-4376-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;1:DECEASED;Stage IIIC;74
TCGA-CG-4300-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;1:DECEASED;[Discrepancy];57
TCGA-CG-4301-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;1:DECEASED;[Discrepancy];63
TCGA-CG-4304-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;1:DECEASED;Stage IIIB;73
TCGA-CG-4305-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IIB;70
TCGA-CG-4306-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;1:DECEASED;Stage IIIB;68
TCGA-CG-4436-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;0:LIVING;Stage IIIC;52
TCGA-CG-4438-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IIIA;35
TCGA-CG-4440-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IIIC;56
TCGA-CG-4442-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IIIB;48
TCGA-CG-4443-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;0:LIVING;Stage IIIA;52
TCGA-CG-4444-01;Esophagogastric Cancer;Male;Primary;Matched;DSTAD;0:LIVING;Stage IIB;57
TCGA-CG-4449-01;Esophagogastric Cancer;Male;Primary;Matched;MSTAD;1:DECEASED;Stage IIA;68
TCGA-CG-4455-01;Esophagogastric Cancer;Male;Primary;Matched;MSTAD;1:DECEASED;Stage IIIB;68
TCGA-CG-4460-01;Esophagogastric Cancer;Male;Primary;Matched;STAD;0:LIVING;Stage IIIB;75
TCGA-CG-4462-01;Esophagogastric Cancer;Male;Primary;Matched;DSTAD;1:DECEASED;Stage IIIC;59
TCGA-CG-4465-01;Esophagogastric Cancer;Male;Primary;Matched;DSTAD;0:LIVING;Stage IB;71
TCGA-CG-4466-01;Esophagogastric Cancer;Female;Primary;Matched;STAD;1:DECEASED;Stage IIIC;79
TCGA-CG-4469-01;Esophagogastric Cancer;[Not Available];Primary;Matched;STAD;[Not Available];[Not Available];[Not Available]
TCGA-CG-4472-01;Esophagogastric Cancer;[Not Available];Primary;Matched;STAD;[Not Available];[Not Available];[Not Available]
TCGA-CG-4474-01;Esophagogastric Cancer;[Not Available];Primary;Matched;DSTAD;[Not Available];[Not Available];[Not Available]
TCGA-CG-4475-01;Esophagogastric Cancer;[Not Available];Primary;Matched;STAD;[Not Available];[Not Available];[Not Available]
TCGA-CG-4476-01;Esophagogastric Cancer;[Not Available];Primary;Matched;DSTAD;[Not Available];[Not Available];[Not Available]
TCGA-CG-4477-01;Esophagogastric Cancer;[Not Available];Primary;Matched;STAD;[Not Available];[Not Available];[Not Available]
TCGA-B7-5816-01;Esophagogastric Cancer;[Not Available];Primary;Matched;DSTAD;[Not Available];[Not Available];[Not Available]
TCGA-B7-5818-01;Esophagogastric Cancer;[Not Available];Primary;Matched;DSTAD;[Not Available];[Not Available];[Not Available]
TCGA-CD-5798-01;Esophagogastric Cancer;[Not Available];Primary;Matched;MSTAD;[Not Available];[Not Available];[Not Available]
TCGA-CD-5799-01;Esophagogastric Cancer;[Not Available];Primary;Matched;STAD;[Not Available];[Not Available];[Not Available]
TCGA-CD-5800-01;Esophagogastric Cancer;[Not Available];Primary;Matched;PSTAD;[Not Available];[Not Available];[Not Available]
TCGA-CD-5801-01;Esophagogastric Cancer;[Not Available];Primary;Matched;STAD;[Not Available];[Not Available];[Not Available]
TCGA-CD-5802-01;Esophagogastric Cancer;[Not Available];Primary;Matched;STAD;[Not Available];[Not Available];[Not Available]
TCGA-CD-5803-01;Esophagogastric Cancer;[Not Available];Primary;Matched;STAD;[Not Available];[Not Available];[Not Available]
TCGA-CD-5813-01;Esophagogastric Cancer;[Not Available];Primary;Matched;MSTAD;[Not Available];[Not Available];[Not Available]
TCGA-CG-5717-01;Esophagogastric Cancer;[Not Available];Primary;Matched;STAD;[Not Available];[Not Available];[Not Available]
TCGA-CG-5718-01;Esophagogastric Cancer;[Not Available];Primary;Matched;STAD;[Not Available];[Not Available];[Not Available]
TCGA-CG-5719-01;Esophagogastric Cancer;[Not Available];Primary;Matched;STAD;[Not Available];[Not Available];[Not Available]
TCGA-CG-5720-01;Esophagogastric Cancer;[Not Available];Primary;Matched;STAD;[Not Available];[Not Available];[Not Available]
TCGA-CG-5721-01;Esophagogastric Cancer;[Not Available];Primary;Matched;STAD;[Not Available];[Not Available];[Not Available]
TCGA-CG-5722-01;Esophagogastric Cancer;[Not Available];Primary;Matched;STAD;[Not Available];[Not Available];[Not Available]
TCGA-CG-5723-01;Esophagogastric Cancer;[Not Available];Primary;Matched;STAD;[Not Available];[Not Available];[Not Available]
TCGA-CG-5724-01;Esophagogastric Cancer;[Not Available];Primary;Matched;DSTAD;[Not Available];[Not Available];[Not Available]
TCGA-CG-5725-01;Esophagogastric Cancer;[Not Available];Primary;Matched;STAD;[Not Available];[Not Available];[Not Available]
TCGA-CG-5726-01;Esophagogastric Cancer;[Not Available];Primary;Matched;STAD;[Not Available];[Not Available];[Not Available]
TCGA-CG-5727-01;Esophagogastric Cancer;[Not Available];Primary;Matched;STAD;[Not Available];[Not Available];[Not Available]
TCGA-CG-5728-01;Esophagogastric Cancer;[Not Available];Primary;Matched;STAD;[Not Available];[Not Available];[Not Available]
TCGA-CG-5730-01;Esophagogastric Cancer;[Not Available];Primary;Matched;STAD;[Not Available];[Not Available];[Not Available]
TCGA-CG-5732-01;Esophagogastric Cancer;[Not Available];Primary;Matched;STAD;[Not Available];[Not Available];[Not Available]
TCGA-CG-5733-01;Esophagogastric Cancer;[Not Available];Primary;Matched;STAD;[Not Available];[Not Available];[Not Available]
TCGA-CG-5734-01;Esophagogastric Cancer;[Not Available];Primary;Matched;STAD;[Not Available];[Not Available];[Not Available]
TCGA-D7-5577-01;Esophagogastric Cancer;[Not Available];Primary;Matched;TSTAD;[Not Available];[Not Available];[Not Available]
TCGA-D7-5578-01;Esophagogastric Cancer;[Not Available];Primary;Matched;TSTAD;[Not Available];[Not Available];[Not Available]
TCGA-D7-5579-01;Esophagogastric Cancer;[Not Available];Primary;Matched;MSTAD;[Not Available];[Not Available];[Not Available]
TCGA-EQ-5647-01;Esophagogastric Cancer;[Not Available];Primary;Matched;STAD;[Not Available];[Not Available];[Not Available]
TCGA-2G-AAEW-01;Germ Cell Tumor;MALE;Primary;Matched;NSGCT;1:DECEASED;IS;31.0
TCGA-2G-AAEX-01;Germ Cell Tumor;Male;Primary;Matched;SEM;0:LIVING;IS;38.0
TCGA-2G-AAF1-01;Germ Cell Tumor;Male;Primary;Matched;SEM;0:LIVING;IS;28.0
TCGA-2G-AAF4-01;Germ Cell Tumor;Male;Primary;Matched;SEM;0:LIVING;Stage I;30.0
TCGA-2G-AAF6-01;Germ Cell Tumor;Male;Primary;Matched;SEM;0:LIVING;IS;28.0
TCGA-2G-AAF8-01;Germ Cell Tumor;Male;Primary;Matched;SEM;0:LIVING;Stage IA;33.0
TCGA-2G-AAFE-01;Germ Cell Tumor;Male;Primary;Matched;SEM;0:LIVING;Stage IIA;37.0
TCGA-2G-AAFG-01;Germ Cell Tumor;Male;Primary;Matched;SEM;0:LIVING;IS;30.0
TCGA-2G-AAFH-01;Germ Cell Tumor;Male;Primary;Matched;SEM;0:LIVING;Stage IIB;38.0
TCGA-2G-AAFI-01;Germ Cell Tumor;Male;Primary;Matched;EMBCA;0:LIVING;Stage IB;41.0
TCGA-2G-AAFJ-01;Germ Cell Tumor;Male;Primary;Matched;NSGCT;0:LIVING;[Discrepancy];23.0
TCGA-2G-AAFL-01;Germ Cell Tumor;Male;Primary;Matched;EMBCA;0:LIVING;Stage IB;35.0
TCGA-2G-AAFM-01;Germ Cell Tumor;Male;Primary;Matched;EMBCA;0:LIVING;Stage IIA;31.0
TCGA-2G-AAFN-01;Germ Cell Tumor;Male;Primary;Matched;EMBCA;0:LIVING;Stage IIIB;26.0
TCGA-2G-AAFO-01;Germ Cell Tumor;Male;Primary;Matched;EMBCA;0:LIVING;Stage IIA;33.0
TCGA-2G-AAFV-01;Germ Cell Tumor;Male;Primary;Matched;NSGCT;0:LIVING;IS;31.0
TCGA-2G-AAFY-01;Germ Cell Tumor;Male;Primary;Matched;EMBCA;0:LIVING;Stage IIA;24.0
TCGA-2G-AAFZ-01;Germ Cell Tumor;Male;Primary;Matched;NSGCT;0:LIVING;Stage III;32.0
TCGA-2G-AAG0-01;Germ Cell Tumor;Male;Primary;Matched;NSGCT;0:LIVING;IS;23.0
TCGA-2G-AAG3-01;Germ Cell Tumor;Male;Primary;Matched;NSGCT;0:LIVING;IS;53.0
TCGA-2G-AAG5-01;Germ Cell Tumor;Male;Primary;Matched;NSGCT;0:LIVING;IS;36.0
TCGA-2G-AAG6-01;Germ Cell Tumor;Male;Primary;Matched;NSGCT;0:LIVING;IS;24.0
TCGA-2G-AAG7-01;Germ Cell Tumor;Male;Primary;Matched;NSGCT;0:LIVING;IS;33.0
TCGA-2G-AAG8-01;Germ Cell Tumor;Male;Primary;Matched;EMBCA;0:LIVING;Stage IB;21.0
TCGA-2G-AAG9-01;Germ Cell Tumor;Male;Primary;Matched;SEM;0:LIVING;Stage IIIB;25.0
TCGA-2G-AAGA-01;Germ Cell Tumor;Male;Primary;Matched;EMBCA;0:LIVING;Stage IIA;38.0
TCGA-2G-AAGC-01;Germ Cell Tumor;Male;Primary;Matched;NSGCT;0:LIVING;IS;28.0
TCGA-2G-AAGE-01;Germ Cell Tumor;Male;Primary;Matched;EMBCA;0:LIVING;IS;21.0
TCGA-2G-AAGF-01;Germ Cell Tumor;Male;Primary;Matched;NSGCT;0:LIVING;IS;28.0
TCGA-2G-AAGG-01;Germ Cell Tumor;Male;Primary;Matched;NSGCT;0:LIVING;Stage IIIC;20.0
TCGA-2G-AAGI-01;Germ Cell Tumor;Male;Primary;Matched;NSGCT;0:LIVING;IS;33.0
TCGA-2G-AAGJ-01;Germ Cell Tumor;Male;Primary;Matched;NSGCT;0:LIVING;Stage IA;28.0
TCGA-2G-AAGK-01;Germ Cell Tumor;Male;Primary;Matched;NSGCT;0:LIVING;IS;20.0
TCGA-2G-AAGM-01;Germ Cell Tumor;Male;Primary;Matched;NSGCT;0:LIVING;IS;51.0
TCGA-2G-AAGN-01;Germ Cell Tumor;Male;Primary;Matched;EMBCA;0:LIVING;Stage IIIB;41.0
TCGA-2G-AAGO-01;Germ Cell Tumor;Male;Primary;Matched;EMBCA;0:LIVING;IS;41.0
TCGA-2G-AAGP-01;Germ Cell Tumor;Male;Primary;Matched;NSGCT;0:LIVING;Stage IIA;33.0
TCGA-2G-AAGS-01;Germ Cell Tumor;Male;Primary;Matched;NSGCT;0:LIVING;Stage IIIB;39.0
TCGA-2G-AAGT-01;Germ Cell Tumor;Male;Primary;Matched;NSGCT;0:LIVING;IS;30.0
TCGA-2G-AAGV-01;Germ Cell Tumor;Male;Primary;Matched;NSGCT;0:LIVING;[Discrepancy];23.0
TCGA-2G-AAGW-01;Germ Cell Tumor;Male;Primary;Matched;NSGCT;0:LIVING;IS;38.0
TCGA-2G-AAGX-01;Germ Cell Tumor;Male;Primary;Matched;NSGCT;0:LIVING;Stage IA;22.0
TCGA-2G-AAGY-01;Germ Cell Tumor;Male;Primary;Matched;NSGCT;0:LIVING;IS;28.0
TCGA-2G-AAGZ-01;Germ Cell Tumor;Male;Primary;Matched;NSGCT;0:LIVING;Stage IIIA;27.0
TCGA-2G-AAH0-01;Germ Cell Tumor;Male;Primary;Matched;SEM;0:LIVING;IS;30.0
TCGA-2G-AAH2-01;Germ Cell Tumor;Male;Primary;Matched;NSGCT;0:LIVING;IS;20.0
TCGA-2G-AAH3-01;Germ Cell Tumor;Male;Primary;Matched;SEM;0:LIVING;Stage I;20.0
TCGA-2G-AAH4-01;Germ Cell Tumor;Male;Primary;Matched;NSGCT;0:LIVING;Stage II;34.0
TCGA-2G-AAH8-01;Germ Cell Tumor;Male;Primary;Matched;SEM;0:LIVING;Stage IIIC;45.0
TCGA-2G-AAHA-01;Germ Cell Tumor;Male;Primary;Matched;SEM;0:LIVING;Stage IB;48.0
TCGA-2G-AAHC-01;Germ Cell Tumor;Male;Primary;Matched;SEM;0:LIVING;IS;33.0
TCGA-2G-AAHG-01;Germ Cell Tumor;Male;Primary;Matched;SEM;0:LIVING;Stage I;25.0
TCGA-2G-AAHL-01;Germ Cell Tumor;Male;Primary;Matched;SEM;0:LIVING;Stage I;26.0
TCGA-2G-AAHN-01;Germ Cell Tumor;Male;Primary;Matched;SEM;0:LIVING;Stage I;32.0
TCGA-2G-AAHP-01;Germ Cell Tumor;Male;Primary;Matched;SEM;0:LIVING;IS;31.0
TCGA-2G-AAHT-01;Germ Cell Tumor;Male;Primary;Matched;SEM;0:LIVING;IS;32.0
TCGA-2G-AAKD-01;Germ Cell Tumor;Male;Primary;Matched;EMBCA;0:LIVING;Stage III;18.0
TCGA-2G-AAKG-01;Germ Cell Tumor;Male;Primary;Matched;EMBCA;0:LIVING;Stage I;22.0
TCGA-2G-AAKH-01;Germ Cell Tumor;Male;Primary;Matched;NSGCT;0:LIVING;Stage II;19.0
TCGA-2G-AAKL-01;Germ Cell Tumor;Male;Primary;Matched;EMBCA;0:LIVING;Stage II;26.0
TCGA-2G-AAKM-01;Germ Cell Tumor;Male;Primary;Matched;NSGCT;1:DECEASED;Stage II;14.0
TCGA-2G-AAKO-01;Germ Cell Tumor;Male;Primary;Matched;NSGCT;0:LIVING;Stage I;31.0
TCGA-2G-AAL5-01;Germ Cell Tumor;Male;Primary;Matched;NSGCT;0:LIVING;IS;32.0
TCGA-2G-AAL7-01;Germ Cell Tumor;Male;Primary;Matched;EMBCA;0:LIVING;Stage IIIB;43.0
TCGA-2G-AALF-01;Germ Cell Tumor;Male;Primary;Matched;NSGCT;0:LIVING;Stage I;49.0
TCGA-2G-AALG-01;Germ Cell Tumor;Male;Primary;Matched;NSGCT;0:LIVING;Stage I;42.0
TCGA-2G-AALN-01;Germ Cell Tumor;Male;Primary;Matched;NSGCT;0:LIVING;IS;34.0
TCGA-2G-AALO-01;Germ Cell Tumor;Male;Primary;Matched;NSGCT;0:LIVING;Stage IA;26.0
TCGA-2G-AALP-01;Germ Cell Tumor;Male;Primary;Matched;NSGCT;0:LIVING;Stage IA;26.0
TCGA-2G-AALQ-01;Germ Cell Tumor;Male;Primary;Matched;NSGCT;0:LIVING;IS;31.0
TCGA-2G-AALR-01;Germ Cell Tumor;Male;Primary;Matched;NSGCT;0:LIVING;IS;37.0
TCGA-2G-AALS-01;Germ Cell Tumor;Male;Primary;Matched;NSGCT;0:LIVING;Stage IB;27.0
TCGA-2G-AALT-01;Germ Cell Tumor;Male;Primary;Matched;NSGCT;0:LIVING;IS;27.0
TCGA-2G-AALW-01;Germ Cell Tumor;Male;Primary;Matched;NSGCT;0:LIVING;Stage IA;22.0
TCGA-2G-AALX-01;Germ Cell Tumor;Male;Primary;Matched;NSGCT;0:LIVING;[Not Available];38.0
TCGA-2G-AALY-01;Germ Cell Tumor;Male;Primary;Matched;NSGCT;0:LIVING;IS;26.0
TCGA-2G-AALZ-01;Germ Cell Tumor;Male;Primary;Matched;NSGCT;0:LIVING;IS;30.0
TCGA-2G-AAM2-01;Germ Cell Tumor;Male;Primary;Matched;NSGCT;0:LIVING;IS;21.0
TCGA-2G-AAM3-01;Germ Cell Tumor;Male;Primary;Matched;NSGCT;0:LIVING;IS;18.0
TCGA-2G-AAM4-01;Germ Cell Tumor;Male;Primary;Matched;NSGCT;0:LIVING;Stage I;29.0
TCGA-2X-A9D5-01;Germ Cell Tumor;Male;Primary;Matched;SEM;0:LIVING;Stage IA;18.0
TCGA-2X-A9D6-01;Germ Cell Tumor;Male;Primary;Matched;SEM;0:LIVING;Stage IA;31.0
TCGA-4K-AA1G-01;Germ Cell Tumor;Male;Primary;Matched;SEM;0:LIVING;Stage I;51.0
TCGA-4K-AA1H-01;Germ Cell Tumor;Male;Primary;Matched;SEM;0:LIVING;Stage IA;31.0
TCGA-4K-AA1I-01;Germ Cell Tumor;Male;Primary;Matched;SEM;0:LIVING;Stage IA;29.0
TCGA-4K-AAAL-01;Germ Cell Tumor;Male;Primary;Matched;SEM;0:LIVING;Stage IB;36.0
TCGA-S6-A8JW-01;Germ Cell Tumor;Male;Primary;Matched;SEM;0:LIVING;Stage IA;39.0
TCGA-S6-A8JX-01;Germ Cell Tumor;Male;Primary;Matched;SEM;0:LIVING;[Not Available];26.0
TCGA-S6-A8JY-01;Germ Cell Tumor;Male;Primary;Matched;SEM;0:LIVING;[Not Available];26.0
TCGA-SB-A6J6-01;Germ Cell Tumor;Male;Primary;Matched;SEM;0:LIVING;[Not Available];23.0
TCGA-SB-A76C-01;Germ Cell Tumor;Male;Primary;Matched;SEM;0:LIVING;Stage I;20.0
TCGA-SN-A6IS-01;Germ Cell Tumor;Male;Primary;Matched;NSGCT;0:LIVING;Stage I;28.0
TCGA-SN-A84W-01;Germ Cell Tumor;Male;Primary;Matched;NSGCT;0:LIVING;Stage I;27.0
TCGA-SN-A84X-01;Germ Cell Tumor;Male;Primary;Matched;NSGCT;0:LIVING;[Discrepancy];38.0
TCGA-SN-A84Y-01;Germ Cell Tumor;Male;Primary;Matched;NSGCT;0:LIVING;IS;33.0
TCGA-SO-A8JP-01;Germ Cell Tumor;Male;Primary;Matched;SEM;0:LIVING;IS;24.0
TCGA-VF-A8A8-01;Germ Cell Tumor;Male;Primary;Matched;NSGCT;0:LIVING;Stage IA;23.0
TCGA-VF-A8A9-01;Germ Cell Tumor;Male;Primary;Matched;SEM;0:LIVING;IS;29.0
TCGA-VF-A8AA-01;Germ Cell Tumor;Male;Primary;Matched;SEM;0:LIVING;Stage IA;35.0
TCGA-VF-A8AB-01;Germ Cell Tumor;Male;Primary;Matched;SEM;0:LIVING;IS;37.0
TCGA-VF-A8AC-01;Germ Cell Tumor;Male;Primary;Matched;SEM;0:LIVING;IS;39.0
TCGA-VF-A8AD-01;Germ Cell Tumor;Male;Primary;Matched;EMBCA;0:LIVING;Stage I;23.0
TCGA-VF-A8AE-01;Germ Cell Tumor;Male;Primary;Matched;SEM;0:LIVING;Stage IB;52.0
TCGA-W4-A7U2-01;Germ Cell Tumor;Male;Primary;Matched;NSGCT;0:LIVING;Stage I;33.0
TCGA-W4-A7U3-01;Germ Cell Tumor;Male;Primary;Matched;NSGCT;0:LIVING;Stage IA;40.0
TCGA-W4-A7U4-01;Germ Cell Tumor;Male;Primary;Matched;NSGCT;0:LIVING;Stage IA;47.0
TCGA-WZ-A7V3-01;Germ Cell Tumor;Male;Primary;Matched;SEM;1:DECEASED;IS;27.0
TCGA-WZ-A7V4-01;Germ Cell Tumor;Male;Primary;Matched;SEM;0:LIVING;Stage IA;31.0
TCGA-WZ-A7V5-01;Germ Cell Tumor;Male;Primary;Matched;SEM;0:LIVING;Stage IB;39.0
TCGA-WZ-A8D5-01;Germ Cell Tumor;Male;Primary;Matched;SEM;0:LIVING;Stage IA;50.0
TCGA-X3-A8G4-01;Germ Cell Tumor;Male;Primary;Matched;NSGCT;0:LIVING;IS;24.0
TCGA-XE-A8H1-01;Germ Cell Tumor;Male;Primary;Matched;EMBCA;0:LIVING;Stage I;38.0
TCGA-XE-A8H4-01;Germ Cell Tumor;Male;Primary;Matched;SEM;0:LIVING;Stage IA;35.0
TCGA-XE-A8H5-01;Germ Cell Tumor;Male;Primary;Matched;SEM;0:LIVING;Stage I;67.0
TCGA-XE-A9SE-01;Germ Cell Tumor;Male;Primary;Matched;SEM;0:LIVING;IS;24.0
TCGA-XE-AANI-01;Germ Cell Tumor;Male;Primary;Matched;NSGCT;0:LIVING;IS;37.0
TCGA-XE-AANJ-01;Germ Cell Tumor;Male;Primary;Matched;SEM;0:LIVING;Stage IA;25.0
TCGA-XE-AANR-01;Germ Cell Tumor;Male;Primary;Matched;SEM;0:LIVING;Stage IB;21.0
TCGA-XE-AANV-01;Germ Cell Tumor;Male;Primary;Matched;SEM;0:LIVING;Stage IA;26.0
TCGA-XE-AAO3-01;Germ Cell Tumor;Male;Primary;Matched;SEM;0:LIVING;Stage IA;45.0
TCGA-XE-AAO4-01;Germ Cell Tumor;Male;Primary;Matched;SEM;1:DECEASED;Stage IIIC;23.0
TCGA-XE-AAO6-01;Germ Cell Tumor;Male;Primary;Matched;SEM;0:LIVING;Stage IIIC;34.0
TCGA-XE-AAOB-01;Germ Cell Tumor;Male;Primary;Matched;NSGCT;0:LIVING;Stage IIIB;28.0
TCGA-XE-AAOC-01;Germ Cell Tumor;Male;Primary;Matched;NSGCT;0:LIVING;Stage IA;66.0
TCGA-XE-AAOD-01;Germ Cell Tumor;Male;Primary;Matched;NSGCT;0:LIVING;Stage IIIC;27.0
TCGA-XE-AAOF-01;Germ Cell Tumor;Male;Primary;Matched;SEM;0:LIVING;IS;29.0
TCGA-XE-AAOJ-01;Germ Cell Tumor;Male;Primary;Matched;NSGCT;0:LIVING;Stage IIC;36.0
TCGA-XE-AAOL-01;Germ Cell Tumor;Male;Primary;Matched;SEM;0:LIVING;Stage IB;45.0
TCGA-XY-A89B-01;Germ Cell Tumor;Male;Primary;Matched;SEM;0:LIVING;Stage IA;32.0
TCGA-XY-A8S2-01;Germ Cell Tumor;Male;Primary;Matched;NSGCT;0:LIVING;Stage IA;34.0
TCGA-XY-A8S3-01;Germ Cell Tumor;Male;Primary;Matched;NSGCT;0:LIVING;Stage IA;39.0
TCGA-XY-A9T9-01;Germ Cell Tumor;Male;Primary;Matched;SEM;0:LIVING;Stage IA;35.0
TCGA-YU-A90P-01;Germ Cell Tumor;Male;Primary;Matched;EMBCA;0:LIVING;IS;50.0
TCGA-YU-A90Q-01;Germ Cell Tumor;Male;Primary;Matched;SEM;0:LIVING;Stage IB;44.0
TCGA-YU-A90S-01;Germ Cell Tumor;[Not Available];Primary;Matched;SEM;[Not Available];[Not Available];[Not Available]
TCGA-YU-A90W-01;Germ Cell Tumor;[Not Available];Primary;Matched;SEM;[Not Available];[Not Available];[Not Available]
TCGA-YU-A90Y-01;Germ Cell Tumor;[Not Available];Primary;Matched;EMBCA;[Not Available];[Not Available];[Not Available]
TCGA-YU-A912-01;Germ Cell Tumor;[Not Available];Primary;Matched;SEM;[Not Available];[Not Available];[Not Available]
TCGA-YU-A94D-01;Germ Cell Tumor;[Not Available];Primary;Matched;NSGCT;[Not Available];[Not Available];[Not Available]
TCGA-YU-A94I-01;Germ Cell Tumor;[Not Available];Primary;Matched;NSGCT;[Not Available];[Not Available];[Not Available]
TCGA-YU-AA4L-01;Germ Cell Tumor;[Not Available];Primary;Matched;EMBCA;[Not Available];[Not Available];[Not Available]
TCGA-YU-AA61-01;Germ Cell Tumor;[Not Available];Primary;Matched;NSGCT;[Not Available];[Not Available];[Not Available]
TCGA-ZM-AA05-01;Germ Cell Tumor;[Not Available];Primary;Matched;SEM;[Not Available];[Not Available];[Not Available]
TCGA-ZM-AA06-01;Germ Cell Tumor;[Not Available];Primary;Matched;SEM;[Not Available];[Not Available];[Not Available]
TCGA-ZM-AA0B-01;Germ Cell Tumor;[Not Available];Primary;Matched;SEM;[Not Available];[Not Available];[Not Available]
TCGA-ZM-AA0D-01;Germ Cell Tumor;[Not Available];Primary;Matched;SEM;[Not Available];[Not Available];[Not Available]
TCGA-ZM-AA0E-01;Germ Cell Tumor;[Not Available];Primary;Matched;SEM;[Not Available];[Not Available];[Not Available]
TCGA-ZM-AA0F-01;Germ Cell Tumor;[Not Available];Primary;Matched;SEM;[Not Available];[Not Available];[Not Available]
TCGA-ZM-AA0H-01;Germ Cell Tumor;[Not Available];Primary;Matched;SEM;[Not Available];[Not Available];[Not Available]
TCGA-ZM-AA0N-01;Germ Cell Tumor;[Not Available];Primary;Matched;SEM;[Not Available];[Not Available];[Not Available]
TCGA-2G-AAFG-05;Germ Cell Tumor;[Not Available];Primary;Matched;NSGCT;[Not Available];[Not Available];[Not Available]
TCGA-2G-AAGY-05;Germ Cell Tumor;[Not Available];Primary;Matched;NSGCT;[Not Available];[Not Available];[Not Available]
TCGA-2G-AAKG-05;Germ Cell Tumor;[Not Available];Primary;Matched;NSGCT;[Not Available];[Not Available];[Not Available]
TCGA-2G-AAKO-05;Germ Cell Tumor;[Not Available];Primary;Matched;NSGCT;[Not Available];[Not Available];[Not Available]
TCGA-2G-AAGI-05;Germ Cell Tumor;[Not Available];Primary;Matched;NSGCT;[Not Available];[Not Available];[Not Available]
TCGA-2G-AAHP-05;Germ Cell Tumor;[Not Available];Primary;Matched;NSGCT;[Not Available];[Not Available];[Not Available]
TCGA-BJ-A0Z3-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage IVA;74.0
TCGA-BJ-A0ZC-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage II;65.0
TCGA-BJ-A18Y-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage II;55.0
TCGA-BJ-A18Z-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage IVC;57.0
TCGA-BJ-A190-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;33.0
TCGA-BJ-A191-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage III;58.0
TCGA-BJ-A192-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage III;57.0
TCGA-DO-A1JZ-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage II;67.0
TCGA-DO-A1K0-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage IVA;66.0
TCGA-EM-A1CS-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage I;55.0
TCGA-EM-A1CT-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage III;63.0
TCGA-EM-A1CU-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage II;54.0
TCGA-EM-A1CV-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage I;80.0
TCGA-EM-A1CW-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage IVA;52.0
TCGA-DJ-A1QD-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage I;36.0
TCGA-DJ-A1QE-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage I;29.0
TCGA-DJ-A1QF-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage IVA;58.0
TCGA-DJ-A1QG-01;Thyroid Cancer;Male;Primary;Matched;THFO;0:LIVING;Stage II;55.0
TCGA-DJ-A1QH-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;49.0
TCGA-DJ-A1QI-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage III;54.0
TCGA-DJ-A1QL-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage I;38.0
TCGA-DJ-A1QM-01;Thyroid Cancer;Male;Primary;Matched;THFO;0:LIVING;Stage II;79.0
TCGA-DJ-A1QN-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;34.0
TCGA-DJ-A1QO-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage III;80.0
TCGA-DJ-A1QQ-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;32.0
TCGA-EM-A1YA-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage I;32.0
TCGA-EM-A1YB-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage III;46.0
TCGA-EM-A1YC-01;Thyroid Cancer;Male;Primary;Matched;THFO;0:LIVING;Stage III;70.0
TCGA-EM-A1YD-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage I;56.0
TCGA-EM-A1YE-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage I;30.0
TCGA-FE-A230-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;30.0
TCGA-FE-A231-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;42.0
TCGA-FE-A232-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage III;77.0
TCGA-FE-A233-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;29.0
TCGA-FE-A234-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage IVA;51.0
TCGA-BJ-A28R-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;64.0
TCGA-BJ-A28T-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;69.0
TCGA-BJ-A28W-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage III;51.0
TCGA-BJ-A28Z-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage III;52.0
TCGA-BJ-A291-01;Thyroid Cancer;Male;Primary;Matched;THPA;1:DECEASED;Stage III;78.0
TCGA-CE-A27D-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage I;36.0
TCGA-E8-A242-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;46.0
TCGA-ET-A25G-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;59.0
TCGA-ET-A25I-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage III;48.0
TCGA-ET-A25J-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage III;45.0
TCGA-ET-A25K-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage III;51.0
TCGA-ET-A25L-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;39.0
TCGA-ET-A25M-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage I;33.0
TCGA-ET-A25N-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage III;47.0
TCGA-ET-A25O-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage II;51.0
TCGA-ET-A25P-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;30.0
TCGA-ET-A25R-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;28.0
TCGA-FE-A22Z-01;Thyroid Cancer;Male;Primary;Matched;THFO;0:LIVING;Stage I;31.0
TCGA-FE-A235-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage II;51.0
TCGA-FE-A236-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;41.0
TCGA-FE-A237-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;27.0
TCGA-FE-A238-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;34.0
TCGA-FE-A239-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;37.0
TCGA-FE-A23A-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage I;32.0
TCGA-GE-A2C6-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage III;65.0
TCGA-H2-A26U-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;30.0
TCGA-BJ-A290-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage IVC;60.0
TCGA-DE-A0XZ-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;44.0
TCGA-E8-A2EA-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage IVA;49.0
TCGA-E8-A2JQ-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage III;61.0
TCGA-EM-A22I-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage I;28.0
TCGA-EM-A22J-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage III;52.0
TCGA-EM-A22K-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage IVA;79.0
TCGA-EM-A22L-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage I;43.0
TCGA-EM-A22M-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage IVA;71.0
TCGA-EM-A22N-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage I;34.0
TCGA-EM-A22O-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage III;58.0
TCGA-EM-A22Q-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage I;36.0
TCGA-EM-A2CJ-01;Thyroid Cancer;Male;Primary;Matched;THFO;0:LIVING;Stage I;85.0
TCGA-EM-A2CK-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage I;28.0
TCGA-EM-A2CL-01;Thyroid Cancer;Male;Primary;Matched;THFO;0:LIVING;Stage I;56.0
TCGA-EM-A2CM-01;Thyroid Cancer;Female;Primary;Matched;THPD;0:LIVING;Stage II;52.0
TCGA-EM-A2CP-01;Thyroid Cancer;Male;Primary;Matched;THFO;0:LIVING;Stage III;50.0
TCGA-EM-A2CQ-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage I;19.0
TCGA-EM-A2CR-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage I;37.0
TCGA-EM-A2CS-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage III;60.0
TCGA-EM-A2CT-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage I;21.0
TCGA-EM-A2CU-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage I;45.0
TCGA-H2-A2K9-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage III;51.0
TCGA-BJ-A2N7-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;20.0
TCGA-BJ-A2N8-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage III;62.0
TCGA-BJ-A2N9-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage II;61.0
TCGA-BJ-A2P4-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage I;62.0
TCGA-DE-A2OL-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage III;58.0
TCGA-DJ-A2PQ-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage II;63.0
TCGA-DJ-A2PS-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage II;70.0
TCGA-DJ-A2PT-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage I;42.0
TCGA-DJ-A2PX-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage I;42.0
TCGA-DJ-A2PY-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage III;69.0
TCGA-DJ-A2PZ-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage I;43.0
TCGA-DJ-A2Q3-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;70.0
TCGA-DJ-A2Q4-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage I;54.0
TCGA-DJ-A2Q5-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage II;47.0
TCGA-DJ-A2Q6-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage I;26.0
TCGA-DJ-A2Q7-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage I;27.0
TCGA-DJ-A2Q8-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;40.0
TCGA-DJ-A2Q9-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage III;70.0
TCGA-DJ-A2QA-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage II;52.0
TCGA-DJ-A2QC-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage II;53.0
TCGA-ET-A2MY-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage III;65.0
TCGA-ET-A2N0-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;55.0
TCGA-ET-A2N1-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage III;46.0
TCGA-ET-A2N5-01;Thyroid Cancer;Male;Primary;Matched;THFO;0:LIVING;Stage III;63.0
TCGA-BJ-A28S-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage II;57.0
TCGA-BJ-A28V-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;44.0
TCGA-BJ-A2NA-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage III;57.0
TCGA-DJ-A2PN-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage III;61.0
TCGA-DJ-A2PO-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage III;53.0
TCGA-DJ-A2PP-01;Thyroid Cancer;Male;Primary;Matched;THFO;0:LIVING;Stage IVA;51.0
TCGA-DJ-A2PR-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;38.0
TCGA-DJ-A2PU-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage III;52.0
TCGA-DJ-A2PV-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;47.0
TCGA-DJ-A2PW-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage III;65.0
TCGA-DJ-A2Q1-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage III;56.0
TCGA-DJ-A2Q2-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage IVA;53.0
TCGA-DJ-A2QB-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage II;70.0
TCGA-EL-A3CL-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;35.0
TCGA-EL-A3CM-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;45.0
TCGA-EL-A3CO-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;51.0
TCGA-EL-A3CP-01;Thyroid Cancer;Male;Primary;Matched;THFO;0:LIVING;Stage IVA;63.0
TCGA-EL-A3CS-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;38.0
TCGA-EL-A3CU-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage III;45.0
TCGA-EL-A3CV-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage III;51.0
TCGA-EL-A3CW-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;37.0
TCGA-EL-A3CX-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;43.0
TCGA-EL-A3CY-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage III;49.0
TCGA-EL-A3CZ-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;18.0
TCGA-EL-A3D1-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;50.0
TCGA-EL-A3D4-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;46.0
TCGA-EM-A22P-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;32.0
TCGA-EM-A2CN-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage III;70.0
TCGA-EM-A2CO-01;Thyroid Cancer;Male;Primary;Matched;THFO;0:LIVING;Stage IVA;56.0
TCGA-ET-A2MZ-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;44.0
TCGA-ET-A2N4-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage II;57.0
TCGA-ET-A39I-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage III;60.0
TCGA-ET-A39J-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage III;76.0
TCGA-ET-A39K-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage III;54.0
TCGA-ET-A39L-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage III;44.0
TCGA-ET-A39M-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;28.0
TCGA-ET-A39N-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage IVA;50.0
TCGA-ET-A39O-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;39.0
TCGA-ET-A39P-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage III;52.0
TCGA-ET-A39R-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;32.0
TCGA-ET-A39S-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage I;50.0
TCGA-ET-A39T-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage IVA;60.0
TCGA-ET-A3BN-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage I;40.0
TCGA-ET-A3BO-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage III;52.0
TCGA-ET-A3BP-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage I;22.0
TCGA-ET-A3BT-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage III;63.0
TCGA-ET-A3BU-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage I;38.0
TCGA-ET-A3BV-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage II;68.0
TCGA-ET-A3BW-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;68.0
TCGA-ET-A3BX-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;15.0
TCGA-ET-A3DO-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage IVA;60.0
TCGA-ET-A3DQ-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage II;36.0
TCGA-ET-A3DR-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;32.0
TCGA-ET-A3DS-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;34.0
TCGA-ET-A3DT-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;36.0
TCGA-ET-A3DU-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;38.0
TCGA-ET-A3DW-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;48.0
TCGA-FY-A2QD-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage IVA;55.0
TCGA-FY-A3BL-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;23.0
TCGA-BJ-A3EZ-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;30.0
TCGA-BJ-A3F0-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage IVA;49.0
TCGA-DJ-A2Q0-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage I;37.0
TCGA-EL-A3CR-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage III;55.0
TCGA-EL-A3CT-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;34.0
TCGA-EL-A3D0-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;46.0
TCGA-EL-A3D5-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;34.0
TCGA-EL-A3D6-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage II;49.0
TCGA-EL-A3GO-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage IVA;57.0
TCGA-EL-A3GP-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage III;56.0
TCGA-EL-A3GQ-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage I;52.0
TCGA-EL-A3GR-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;18.0
TCGA-EL-A3GW-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage IVA;57.0
TCGA-EL-A3GX-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;38.0
TCGA-EL-A3GY-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage III;45.0
TCGA-EL-A3H3-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;39.0
TCGA-EL-A3H4-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;51.0
TCGA-EL-A3H5-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;38.0
TCGA-EM-A2OV-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage IVA;75.0
TCGA-EM-A2OW-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage I;30.0
TCGA-EM-A2OX-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage II;57.0
TCGA-EM-A2OY-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage I;25.0
TCGA-EM-A2OZ-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;56.0
TCGA-EM-A2P0-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage IVA;53.0
TCGA-EM-A2P1-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;57.0
TCGA-EM-A2P2-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage I;23.0
TCGA-EM-A2P3-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;50.0
TCGA-EM-A3AI-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage I;23.0
TCGA-EM-A3AJ-01;Thyroid Cancer;Female;Primary;Matched;THFO;1:DECEASED;Stage II;70.0
TCGA-EM-A3AK-01;Thyroid Cancer;Female;Primary;Matched;THPA;1:DECEASED;Stage III;64.0
TCGA-EM-A3AL-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage II;47.0
TCGA-EM-A3AN-01;Thyroid Cancer;Male;Primary;Matched;THPA;1:DECEASED;Stage III;88.0
TCGA-EM-A3AO-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;[Not Available];50.0
TCGA-ET-A3BQ-01;Thyroid Cancer;Female;Primary;Matched;THPA;1:DECEASED;Stage III;78.0
TCGA-ET-A3BS-01;Thyroid Cancer;Female;Primary;Matched;THPA;1:DECEASED;Stage IVA;62.0
TCGA-ET-A3DV-01;Thyroid Cancer;Female;Primary;Matched;THFO;1:DECEASED;Stage IVA;78.0
TCGA-IM-A3EB-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage III;70.0
TCGA-IM-A3ED-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage I;40.0
TCGA-CE-A3MD-01;Thyroid Cancer;Female;Primary;Matched;THPA;1:DECEASED;Stage III;87.0
TCGA-CE-A3ME-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;22.0
TCGA-DE-A3KN-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage I;28.0
TCGA-E3-A3DY-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;37.0
TCGA-E3-A3DZ-01;Thyroid Cancer;Male;Primary;Matched;THFO;0:LIVING;Stage III;61.0
TCGA-E3-A3E0-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage I;39.0
TCGA-E3-A3E1-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage IVA;62.0
TCGA-E3-A3E2-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage I;44.0
TCGA-E3-A3E3-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage III;51.0
TCGA-E3-A3E5-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;31.0
TCGA-EL-A3CN-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage III;70.0
TCGA-EL-A3GS-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;72.0
TCGA-EL-A3GZ-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;31.0
TCGA-EL-A3H2-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;37.0
TCGA-EL-A3H8-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage III;72.0
TCGA-EL-A3MW-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage III;65.0
TCGA-EL-A3N2-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;37.0
TCGA-EL-A3N3-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;41.0
TCGA-EM-A3AP-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage II;40.0
TCGA-EM-A3AQ-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;34.0
TCGA-EM-A3AR-01;Thyroid Cancer;Female;Primary;Matched;THPA;1:DECEASED;Stage I;66.0
TCGA-EL-A3GU-01;Thyroid Cancer;Male;Primary;Matched;THPA;1:DECEASED;Stage II;58.0
TCGA-EL-A3GV-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;19.0
TCGA-EL-A3H1-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage IVA;46.0
TCGA-EL-A3H7-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage IVA;57.0
TCGA-EL-A3MX-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;36.0
TCGA-EL-A3MY-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;35.0
TCGA-EL-A3MZ-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage II;55.0
TCGA-EM-A3FJ-01;Thyroid Cancer;Female;Primary;Matched;THPA;1:DECEASED;Stage IVC;66.0
TCGA-EM-A3FK-01;Thyroid Cancer;Male;Primary;Matched;THPA;1:DECEASED;Stage IVC;81.0
TCGA-EM-A3FL-01;Thyroid Cancer;Male;Primary;Matched;THFO;1:DECEASED;Stage III;66.0
TCGA-EM-A3FM-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;24.0
TCGA-EM-A3FN-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage II;53.0
TCGA-EM-A3FO-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage III;45.0
TCGA-EM-A3FP-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage I;38.0
TCGA-EM-A3FQ-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage III;55.0
TCGA-ET-A3DP-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage II;63.0
TCGA-FY-A3I4-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;34.0
TCGA-FY-A3NM-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage II;47.0
TCGA-FY-A3NN-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage I;36.0
TCGA-FY-A3NP-01;Thyroid Cancer;Female;Primary;Matched;THFO;1:DECEASED;Stage IV;69.0
TCGA-J8-A3NZ-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage I;42.0
TCGA-J8-A3O0-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage III;47.0
TCGA-J8-A3O1-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage I;15.0
TCGA-BJ-A3PR-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;42.0
TCGA-BJ-A3PT-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;41.0
TCGA-BJ-A3PU-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;34.0
TCGA-DJ-A13L-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage IVA;60.0
TCGA-EL-A3T6-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;28.0
TCGA-EM-A3FR-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage III;79.0
TCGA-EM-A3O3-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage I;19.0
TCGA-EM-A3O6-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage II;78.0
TCGA-EM-A3O7-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage II;46.0
TCGA-EM-A3O8-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage I;22.0
TCGA-EM-A3O9-01;Thyroid Cancer;Male;Primary;Matched;THFO;0:LIVING;Stage I;35.0
TCGA-EM-A3OA-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage I;41.0
TCGA-EM-A3OB-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage I;38.0
TCGA-FE-A3PA-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage I;31.0
TCGA-FE-A3PB-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage III;55.0
TCGA-FE-A3PC-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;54.0
TCGA-FE-A3PD-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage III;68.0
TCGA-FY-A3I5-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage I;43.0
TCGA-FY-A3ON-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;33.0
TCGA-FY-A3R6-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage IV;75.0
TCGA-FY-A3R7-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage III;74.0
TCGA-FY-A3R8-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage II;68.0
TCGA-FY-A3R9-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage I;41.0
TCGA-FY-A3RA-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;35.0
TCGA-H2-A3RH-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage I;36.0
TCGA-H2-A3RI-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage III;63.0
TCGA-BJ-A28X-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;55.0
TCGA-DJ-A3UK-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage IVA;76.0
TCGA-DJ-A3UM-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage I;31.0
TCGA-DJ-A3UN-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;32.0
TCGA-DJ-A3UO-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;39.0
TCGA-DJ-A3UP-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage II;74.0
TCGA-DJ-A3UQ-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage II;73.0
TCGA-DJ-A3UR-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage III;71.0
TCGA-DJ-A3US-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage II;53.0
TCGA-DJ-A3UT-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage II;47.0
TCGA-DJ-A3UU-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage III;52.0
TCGA-DJ-A3UV-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage II;56.0
TCGA-DJ-A3UW-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage IVA;46.0
TCGA-DJ-A3UX-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;33.0
TCGA-DJ-A3UY-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage I;52.0
TCGA-DO-A2HM-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;68.0
TCGA-EL-A3T0-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage IVA;75.0
TCGA-EL-A3T1-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage IVA;64.0
TCGA-EL-A3T2-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage I;36.0
TCGA-EL-A3T3-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;49.0
TCGA-EL-A3T7-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage I;28.0
TCGA-EL-A3T8-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage I;31.0
TCGA-EL-A3T9-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage III;62.0
TCGA-EL-A3TA-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage IVC;62.0
TCGA-EL-A3TB-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage II;77.0
TCGA-FK-A3S3-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage I;26.0
TCGA-FK-A3SB-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;40.0
TCGA-FK-A3SD-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage II;46.0
TCGA-FK-A3SE-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage IVA;51.0
TCGA-FK-A3SG-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;20.0
TCGA-FK-A3SH-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage III;47.0
TCGA-FY-A3W9-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage II;64.0
TCGA-FY-A3WA-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage I;37.0
TCGA-IM-A3U2-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage IVA;46.0
TCGA-IM-A3U3-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage II;46.0
TCGA-DJ-A3UZ-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage I;66.0
TCGA-DJ-A3V0-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage I;33.0
TCGA-DJ-A3V2-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage I;33.0
TCGA-DJ-A3V3-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage III;46.0
TCGA-DJ-A3V4-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;47.0
TCGA-DJ-A3V5-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage II;67.0
TCGA-DJ-A3V6-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage I;39.0
TCGA-E8-A3X7-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;62.0
TCGA-EM-A3ST-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage I;45.0
TCGA-EM-A3SU-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;36.0
TCGA-EM-A3SX-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage IVA;61.0
TCGA-EM-A3SY-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage I;31.0
TCGA-EM-A3SZ-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;85.0
TCGA-FY-A3TY-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage I;41.0
TCGA-FY-A3YR-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;24.0
TCGA-J8-A3YD-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;30.0
TCGA-J8-A3YG-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;63.0
TCGA-J8-A3YH-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage IVA;57.0
TCGA-DJ-A3V7-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;42.0
TCGA-DJ-A3V8-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage I;40.0
TCGA-DJ-A3V9-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage II;71.0
TCGA-DJ-A3VA-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;19.0
TCGA-DJ-A3VB-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage III;55.0
TCGA-DJ-A3VD-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage III;83.0
TCGA-DJ-A3VE-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage II;54.0
TCGA-DJ-A3VF-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage III;46.0
TCGA-DJ-A3VG-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage I;33.0
TCGA-DJ-A3VI-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage I;40.0
TCGA-DJ-A3VJ-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage II;55.0
TCGA-DJ-A3VK-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage I;33.0
TCGA-DJ-A3VL-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage III;62.0
TCGA-DJ-A3VM-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage I;43.0
TCGA-E8-A413-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;28.0
TCGA-E8-A414-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage I;36.0
TCGA-E8-A415-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;42.0
TCGA-E8-A416-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;40.0
TCGA-E8-A417-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage III;69.0
TCGA-E8-A418-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;33.0
TCGA-E8-A419-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage IVA;59.0
TCGA-E8-A432-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage IVA;49.0
TCGA-E8-A433-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage I;72.0
TCGA-E8-A434-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;42.0
TCGA-EL-A3ZG-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage I;28.0
TCGA-EL-A3ZH-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage I;35.0
TCGA-EL-A3ZK-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;64.0
TCGA-EL-A3ZL-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;26.0
TCGA-EL-A3ZM-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage III;56.0
TCGA-EL-A3ZN-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;37.0
TCGA-EL-A3ZO-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;40.0
TCGA-EL-A3ZP-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;36.0
TCGA-EL-A3ZQ-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage IVA;52.0
TCGA-EL-A3ZR-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage I;33.0
TCGA-EL-A3ZS-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;28.0
TCGA-EL-A3ZT-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;35.0
TCGA-ET-A2MX-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;24.0
TCGA-ET-A2N3-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage III;51.0
TCGA-ET-A40P-01;Thyroid Cancer;Male;Primary;Matched;THFO;0:LIVING;Stage I;27.0
TCGA-ET-A40Q-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;72.0
TCGA-ET-A40R-01;Thyroid Cancer;Male;Primary;Matched;THFO;0:LIVING;Stage I;39.0
TCGA-ET-A40S-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage III;51.0
TCGA-ET-A40T-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage III;47.0
TCGA-FY-A40K-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;34.0
TCGA-FY-A40L-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage III;53.0
TCGA-FY-A40M-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage III;46.0
TCGA-FY-A40N-01;Thyroid Cancer;Female;Primary;Matched;THFO;1:DECEASED;Stage I;83.0
TCGA-H2-A421-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;23.0
TCGA-H2-A422-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage III;48.0
TCGA-IM-A41Z-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage I;20.0
TCGA-IM-A420-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage I;34.0
TCGA-J8-A3O2-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;35.0
TCGA-J8-A3YE-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage I;39.0
TCGA-J8-A3YF-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage III;73.0
TCGA-J8-A42S-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;24.0
TCGA-KS-A41F-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;27.0
TCGA-KS-A41I-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage III;55.0
TCGA-KS-A41J-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;33.0
TCGA-KS-A41L-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage I;44.0
TCGA-BJ-A45C-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;34.0
TCGA-BJ-A45D-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage I;27.0
TCGA-BJ-A45E-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage I;42.0
TCGA-BJ-A45F-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage IVA;60.0
TCGA-BJ-A45G-01;Thyroid Cancer;Male;Primary;Matched;THFO;0:LIVING;Stage I;28.0
TCGA-BJ-A45H-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage III;47.0
TCGA-BJ-A45I-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;30.0
TCGA-BJ-A45J-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage I;24.0
TCGA-BJ-A45K-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;33.0
TCGA-CE-A481-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;43.0
TCGA-CE-A482-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;43.0
TCGA-CE-A483-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;42.0
TCGA-CE-A484-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;33.0
TCGA-CE-A485-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;23.0
TCGA-E8-A436-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;21.0
TCGA-E8-A437-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage II;68.0
TCGA-E8-A438-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage III;64.0
TCGA-E8-A44K-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;32.0
TCGA-E8-A44M-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage I;38.0
TCGA-FY-A4B0-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;24.0
TCGA-FY-A4B3-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage II;62.0
TCGA-FY-A4B4-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;26.0
TCGA-IM-A41Y-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage III;51.0
TCGA-BJ-A4O8-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage II;45.0
TCGA-BJ-A4O9-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage IVA;61.0
TCGA-DE-A4M8-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;30.0
TCGA-DE-A4M9-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage IVA;70.0
TCGA-DE-A4MA-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;44.0
TCGA-DE-A4MB-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;18.0
TCGA-DE-A4MC-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;26.0
TCGA-DE-A4MD-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;26.0
TCGA-DJ-A4UL-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage I;33.0
TCGA-DJ-A4UP-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;19.0
TCGA-DJ-A4UQ-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage I;36.0
TCGA-DJ-A4UR-01;Thyroid Cancer;Male;Primary;Matched;THFO;1:DECEASED;Stage III;82.0
TCGA-DJ-A4UT-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;27.0
TCGA-DJ-A4UW-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage II;16.0
TCGA-DJ-A4V0-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;33.0
TCGA-DJ-A4V2-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;37.0
TCGA-DJ-A4V4-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;17.0
TCGA-DJ-A4V5-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;43.0
TCGA-EL-A4JV-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;28.0
TCGA-EL-A4JW-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;61.0
TCGA-EL-A4JX-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;31.0
TCGA-EL-A4JZ-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;21.0
TCGA-EL-A4K0-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage III;50.0
TCGA-EL-A4K1-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage III;51.0
TCGA-EL-A4K2-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;[Not Available];61.0
TCGA-EL-A4K4-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage I;29.0
TCGA-EL-A4K6-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;34.0
TCGA-EL-A4K7-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage III;64.0
TCGA-EL-A4K9-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage III;48.0
TCGA-EL-A4KD-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage III;48.0
TCGA-EL-A4KG-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage I;69.0
TCGA-EL-A4KH-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage I;20.0
TCGA-EL-A4KI-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage IVA;57.0
TCGA-EM-A4FF-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage III;50.0
TCGA-EM-A4FH-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage III;62.0
TCGA-EM-A4FK-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage I;66.0
TCGA-EM-A4FM-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;21.0
TCGA-EM-A4FN-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage III;61.0
TCGA-EM-A4FO-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage II;66.0
TCGA-EM-A4FQ-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage I;52.0
TCGA-EM-A4FR-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage III;64.0
TCGA-EM-A4FU-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage I;46.0
TCGA-EM-A4FV-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage IVA;55.0
TCGA-EM-A4G1-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage I;51.0
TCGA-ET-A4KN-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;55.0
TCGA-ET-A4KQ-01;Thyroid Cancer;Male;Primary;Matched;THFO;0:LIVING;Stage I;76.0
TCGA-FK-A4UB-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage III;51.0
TCGA-IM-A4EB-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage III;62.0
TCGA-J8-A4HW-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage II;54.0
TCGA-J8-A4HY-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;33.0
TCGA-KS-A4I1-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage III;54.0
TCGA-KS-A4I3-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage I;25.0
TCGA-KS-A4I5-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;41.0
TCGA-KS-A4I7-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;29.0
TCGA-KS-A4I9-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;34.0
TCGA-KS-A4IB-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;40.0
TCGA-KS-A4IC-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;32.0
TCGA-KS-A4ID-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage I;58.0
TCGA-L6-A4EP-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage IVA;89.0
TCGA-L6-A4EQ-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;55.0
TCGA-L6-A4ET-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage I;42.0
TCGA-L6-A4EU-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;37.0
TCGA-MK-A4N6-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;39.0
TCGA-MK-A4N7-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage I;37.0
TCGA-MK-A4N9-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage III;52.0
TCGA-4C-A93U-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage I;38.0
TCGA-DE-A69J-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;33.0
TCGA-DE-A69K-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage I;39.0
TCGA-DE-A7U5-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage III;47.0
TCGA-FY-A76V-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;31.0
TCGA-MK-A84Z-01;Thyroid Cancer;Male;Primary;Matched;THFO;0:LIVING;Stage III;83.0
TCGA-QD-A8IV-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage III;54.0
TCGA-BJ-A0YZ-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage I;39.0
TCGA-BJ-A0Z0-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage III;45.0
TCGA-BJ-A0Z2-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage III;59.0
TCGA-BJ-A0Z5-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage IVA;68.0
TCGA-BJ-A0Z9-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;37.0
TCGA-BJ-A0ZA-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;47.0
TCGA-BJ-A0ZB-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;28.0
TCGA-BJ-A0ZE-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;39.0
TCGA-BJ-A0ZF-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage I;37.0
TCGA-BJ-A0ZG-01;Thyroid Cancer;Male;Primary;Matched;THFO;0:LIVING;Stage I;41.0
TCGA-BJ-A0ZH-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage IVA;49.0
TCGA-BJ-A0ZJ-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;61.0
TCGA-CE-A13K-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;46.0
TCGA-DE-A0Y2-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;41.0
TCGA-DE-A0Y3-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage III;45.0
TCGA-DJ-A13M-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage I;55.0
TCGA-DJ-A13O-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;41.0
TCGA-DJ-A13P-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage III;47.0
TCGA-DJ-A13R-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage IVC;49.0
TCGA-DJ-A13S-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage III;58.0
TCGA-DJ-A13T-01;Thyroid Cancer;Male;Primary;Matched;THPA;0:LIVING;Stage I;35.0
TCGA-DJ-A13U-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;20.0
TCGA-DJ-A13V-01;Thyroid Cancer;Female;Primary;Matched;THPA;0:LIVING;Stage I;41.0
TCGA-DJ-A13W-01;Thyroid Cancer;Male;Primary;Matched;THFO;0:LIVING;Stage III;74.0
TCGA-DJ-A13X-01;Thyroid Cancer;Female;Primary;Matched;THFO;0:LIVING;Stage IVA;50.0
TCGA-ET-A4KO-01;Thyroid Cancer;[Not Available];Primary;Matched;WDTC;[Not Available];[Not Available];[Not Available]
TCGA-EM-A2CS-06;Thyroid Cancer;[Not Available];Metastasis;Matched;THYROID;[Not Available];[Not Available];[Not Available]
TCGA-EM-A2P1-06;Thyroid Cancer;[Not Available];Metastasis;Matched;THYROID;[Not Available];[Not Available];[Not Available]
TCGA-DE-A4MD-06;Thyroid Cancer;[Not Available];Metastasis;Matched;THYROID;[Not Available];[Not Available];[Not Available]
TCGA-EM-A3FQ-06;Thyroid Cancer;[Not Available];Metastasis;Matched;THYROID;[Not Available];[Not Available];[Not Available]
TCGA-EM-A3SU-06;Thyroid Cancer;[Not Available];Metastasis;Matched;THYROID;[Not Available];[Not Available];[Not Available]
TCGA-J8-A3O2-06;Thyroid Cancer;[Not Available];Metastasis;Matched;THYROID;[Not Available];[Not Available];[Not Available]
TCGA-J8-A3YH-06;Thyroid Cancer;[Not Available];Metastasis;Matched;THYROID;[Not Available];[Not Available];[Not Available]
TCGA-J8-A4HW-06;Thyroid Cancer;[Not Available];Metastasis;Matched;THYROID;[Not Available];[Not Available];[Not Available]
TCGA-3G-AB0O-01;Thymic Tumor;Male;Primary;Matched;THYM;0:LIVING;[Not Applicable];47
TCGA-3G-AB0Q-01;Thymic Tumor;Male;Primary;Matched;THYM;0:LIVING;[Not Applicable];66
TCGA-3G-AB0T-01;Thymic Tumor;Male;Primary;Matched;THYM;1:DECEASED;[Not Applicable];45
TCGA-3G-AB14-01;Thymic Tumor;Male;Primary;Matched;THYM;1:DECEASED;[Not Applicable];51
TCGA-3G-AB19-01;Thymic Tumor;Female;Primary;Matched;THYM;1:DECEASED;[Not Applicable];76
TCGA-3Q-A9WF-01;Thymic Tumor;Male;Primary;Matched;THYM;0:LIVING;[Not Applicable];71
TCGA-3S-A8YW-01;Thymic Tumor;Male;Primary;Matched;THYM;0:LIVING;[Not Applicable];63
TCGA-3S-AAYX-01;Thymic Tumor;Female;Primary;Matched;THYM;0:LIVING;[Not Applicable];55
TCGA-3T-AA9L-01;Thymic Tumor;Female;Primary;Matched;THYM;0:LIVING;[Not Applicable];31
TCGA-4V-A9QI-01;Thymic Tumor;Male;Primary;Matched;THYM;0:LIVING;[Not Applicable];68
TCGA-4V-A9QJ-01;Thymic Tumor;Male;Primary;Matched;THYM;0:LIVING;[Not Applicable];64
TCGA-4V-A9QL-01;Thymic Tumor;Female;Primary;Matched;THYM;0:LIVING;[Not Applicable];58
TCGA-4V-A9QM-01;Thymic Tumor;Male;Primary;Matched;THYM;0:LIVING;[Not Applicable];39
TCGA-4V-A9QN-01;Thymic Tumor;Female;Primary;Matched;THYM;0:LIVING;[Not Applicable];40
TCGA-4V-A9QQ-01;Thymic Tumor;Female;Primary;Matched;THYM;0:LIVING;[Not Applicable];65
TCGA-4V-A9QR-01;Thymic Tumor;Female;Primary;Matched;THYM;0:LIVING;[Not Applicable];51
TCGA-4V-A9QS-01;Thymic Tumor;Female;Primary;Matched;THYM;0:LIVING;[Not Applicable];53
TCGA-4V-A9QT-01;Thymic Tumor;Female;Primary;Matched;THYM;0:LIVING;[Not Applicable];79
TCGA-4V-A9QU-01;Thymic Tumor;Female;Primary;Matched;THYM;0:LIVING;[Not Applicable];76
TCGA-4V-A9QW-01;Thymic Tumor;Male;Primary;Matched;THYM;0:LIVING;[Not Applicable];62
TCGA-4V-A9QX-01;Thymic Tumor;Female;Primary;Matched;THYM;0:LIVING;[Not Applicable];77
TCGA-4X-A9F9-01;Thymic Tumor;Female;Primary;Matched;THYM;0:LIVING;[Not Applicable];57
TCGA-4X-A9FA-01;Thymic Tumor;Male;Primary;Matched;THYM;0:LIVING;[Not Applicable];52
TCGA-4X-A9FB-01;Thymic Tumor;Male;Primary;Matched;THYM;0:LIVING;[Not Applicable];44
TCGA-4X-A9FC-01;Thymic Tumor;Female;Primary;Matched;THYM;0:LIVING;[Not Applicable];50
TCGA-4X-A9FD-01;Thymic Tumor;Female;Primary;Matched;THYM;0:LIVING;[Not Applicable];43
TCGA-5G-A9ZZ-01;Thymic Tumor;Female;Primary;Matched;THYM;0:LIVING;[Not Applicable];52
TCGA-5K-AAAP-01;Thymic Tumor;Male;Primary;Matched;THYM;0:LIVING;[Not Applicable];54
TCGA-5U-AB0D-01;Thymic Tumor;Female;Primary;Matched;THYM;0:LIVING;[Not Applicable];71
TCGA-5U-AB0E-01;Thymic Tumor;Male;Primary;Matched;THYM;0:LIVING;[Not Applicable];62
TCGA-5U-AB0F-01;Thymic Tumor;Female;Primary;Matched;THYM;0:LIVING;[Not Applicable];58
TCGA-5V-A9RR-01;Thymic Tumor;Male;Primary;Matched;THYM;0:LIVING;[Not Applicable];67
TCGA-X7-A8D6-01;Thymic Tumor;Female;Primary;Matched;THYM;0:LIVING;[Not Applicable];48
TCGA-X7-A8D7-01;Thymic Tumor;Female;Primary;Matched;THYM;0:LIVING;[Not Applicable];46
TCGA-X7-A8D8-01;Thymic Tumor;Male;Primary;Matched;THYM;0:LIVING;[Not Applicable];53
TCGA-X7-A8D9-01;Thymic Tumor;Female;Primary;Matched;THYM;0:LIVING;[Not Applicable];[Not Available]
TCGA-X7-A8DB-01;Thymic Tumor;Female;Primary;Matched;THYM;0:LIVING;[Not Applicable];71
TCGA-X7-A8DC-01;Thymic Tumor;Male;Primary;Matched;THYM;0:LIVING;[Not Applicable];68
TCGA-X7-A8DD-01;Thymic Tumor;Female;Primary;Matched;THYM;0:LIVING;[Not Applicable];54
TCGA-X7-A8DE-01;Thymic Tumor;Female;Primary;Matched;THYM;0:LIVING;[Not Applicable];35
TCGA-X7-A8DF-01;Thymic Tumor;Male;Primary;Matched;THYM;0:LIVING;[Not Applicable];40
TCGA-X7-A8DG-01;Thymic Tumor;Male;Primary;Matched;THYM;0:LIVING;[Not Applicable];47
TCGA-X7-A8DI-01;Thymic Tumor;Female;Primary;Matched;THYM;0:LIVING;[Not Applicable];57
TCGA-X7-A8DJ-01;Thymic Tumor;Male;Primary;Matched;THYM;0:LIVING;[Not Applicable];68
TCGA-X7-A8M0-01;Thymic Tumor;Female;Primary;Matched;THYM;0:LIVING;[Not Applicable];61
TCGA-X7-A8M1-01;Thymic Tumor;Male;Primary;Matched;THYM;0:LIVING;[Not Applicable];51
TCGA-X7-A8M3-01;Thymic Tumor;Female;Primary;Matched;THYM;0:LIVING;[Not Applicable];64
TCGA-X7-A8M4-01;Thymic Tumor;Male;Primary;Matched;THYM;0:LIVING;[Not Applicable];41
TCGA-X7-A8M5-01;Thymic Tumor;Female;Primary;Matched;THYM;0:LIVING;[Not Applicable];65
TCGA-X7-A8M6-01;Thymic Tumor;Male;Primary;Matched;THYM;0:LIVING;[Not Applicable];43
TCGA-X7-A8M7-01;Thymic Tumor;Male;Primary;Matched;THYM;0:LIVING;[Not Applicable];26
TCGA-X7-A8M8-01;Thymic Tumor;Male;Primary;Matched;THYM;0:LIVING;[Not Applicable];45
TCGA-XH-A853-01;Thymic Tumor;Male;Primary;Matched;THYM;0:LIVING;[Not Applicable];67
TCGA-XM-A8R8-01;Thymic Tumor;Female;Primary;Matched;THYM;0:LIVING;[Not Applicable];67
TCGA-XM-A8R9-01;Thymic Tumor;Female;Primary;Matched;THYM;0:LIVING;[Not Applicable];71
TCGA-XM-A8RB-01;Thymic Tumor;Female;Primary;Matched;THYM;0:LIVING;[Not Applicable];68
TCGA-XM-A8RC-01;Thymic Tumor;Male;Primary;Matched;THYM;0:LIVING;[Not Applicable];67
TCGA-XM-A8RD-01;Thymic Tumor;Female;Primary;Matched;THYM;0:LIVING;[Not Applicable];69
TCGA-XM-A8RE-01;Thymic Tumor;Female;Primary;Matched;THYM;0:LIVING;[Not Applicable];54
TCGA-XM-A8RF-01;Thymic Tumor;Female;Primary;Matched;THYM;0:LIVING;[Not Applicable];84
TCGA-XM-A8RG-01;Thymic Tumor;Male;Primary;Matched;THYM;0:LIVING;[Not Applicable];67
TCGA-XM-A8RH-01;Thymic Tumor;Female;Primary;Matched;THYM;0:LIVING;[Not Applicable];60
TCGA-XM-A8RI-01;Thymic Tumor;Male;Primary;Matched;THYM;0:LIVING;[Not Applicable];77
TCGA-XM-A8RL-01;Thymic Tumor;Male;Primary;Matched;THYM;0:LIVING;[Not Applicable];44
TCGA-XM-AAZ1-01;Thymic Tumor;Male;Primary;Matched;THYM;0:LIVING;[Not Applicable];42
TCGA-XM-AAZ2-01;Thymic Tumor;Male;Primary;Matched;THYM;0:LIVING;[Not Applicable];73
TCGA-XM-AAZ3-01;Thymic Tumor;Male;Primary;Matched;THYM;0:LIVING;[Not Applicable];64
TCGA-XU-A92O-01;Thymic Tumor;Male;Primary;Matched;THYM;0:LIVING;[Not Applicable];63
TCGA-XU-A92Q-01;Thymic Tumor;Male;Primary;Matched;THYM;0:LIVING;[Not Applicable];50
TCGA-XU-A92R-01;Thymic Tumor;Female;Primary;Matched;THYM;0:LIVING;[Not Applicable];76
TCGA-XU-A92T-01;Thymic Tumor;Female;Primary;Matched;THYM;0:LIVING;[Not Applicable];81
TCGA-XU-A92U-01;Thymic Tumor;Male;Primary;Matched;THYM;0:LIVING;[Not Applicable];67
TCGA-XU-A92V-01;Thymic Tumor;Female;Primary;Matched;THYM;1:DECEASED;[Not Applicable];72
TCGA-XU-A92W-01;Thymic Tumor;Male;Primary;Matched;THYM;0:LIVING;[Not Applicable];61
TCGA-XU-A92X-01;Thymic Tumor;Male;Primary;Matched;THYM;0:LIVING;[Not Applicable];17
TCGA-XU-A92Y-01;Thymic Tumor;Female;Primary;Matched;THYM;1:DECEASED;[Not Applicable];71
TCGA-XU-A92Z-01;Thymic Tumor;Male;Primary;Matched;THYM;0:LIVING;[Not Applicable];76
TCGA-XU-A930-01;Thymic Tumor;Male;Primary;Matched;THYM;0:LIVING;[Not Applicable];43
TCGA-XU-A931-01;Thymic Tumor;Female;Primary;Matched;THYM;1:DECEASED;[Not Applicable];61
TCGA-XU-A932-01;Thymic Tumor;Male;Primary;Matched;THYM;0:LIVING;[Not Applicable];37
TCGA-XU-A933-01;Thymic Tumor;Female;Primary;Matched;THYM;0:LIVING;[Not Applicable];52
TCGA-XU-A936-01;Thymic Tumor;Female;Primary;Matched;THYM;0:LIVING;[Not Applicable];65
TCGA-XU-AAXV-01;Thymic Tumor;Female;Primary;Matched;THYM;0:LIVING;[Not Applicable];45
TCGA-XU-AAXW-01;Thymic Tumor;Female;Primary;Matched;THYM;0:LIVING;[Not Applicable];39
TCGA-XU-AAXX-01;Thymic Tumor;Female;Primary;Matched;THYM;0:LIVING;[Not Applicable];44
TCGA-XU-AAXY-01;Thymic Tumor;Male;Primary;Matched;THYM;0:LIVING;[Not Applicable];43
TCGA-XU-AAXZ-01;Thymic Tumor;Male;Primary;Matched;THYM;0:LIVING;[Not Applicable];63
TCGA-XU-AAY0-01;Thymic Tumor;Female;Primary;Matched;THYM;0:LIVING;[Not Applicable];62
TCGA-XU-AAY1-01;Thymic Tumor;Female;Primary;Matched;THYM;0:LIVING;[Not Applicable];51
TCGA-YT-A95D-01;Thymic Tumor;Female;Primary;Matched;THYM;0:LIVING;[Not Applicable];50
TCGA-YT-A95E-01;Thymic Tumor;Male;Primary;Matched;THYM;0:LIVING;[Not Applicable];52
TCGA-YT-A95F-01;Thymic Tumor;Female;Primary;Matched;THYM;0:LIVING;[Not Applicable];55
TCGA-YT-A95G-01;Thymic Tumor;Female;Primary;Matched;THYM;0:LIVING;[Not Applicable];61
TCGA-YT-A95H-01;Thymic Tumor;Male;Primary;Matched;THYM;0:LIVING;[Not Applicable];69
TCGA-ZB-A961-01;Thymic Tumor;Male;Primary;Matched;THYM;1:DECEASED;[Not Applicable];69
TCGA-ZB-A962-01;Thymic Tumor;Male;Primary;Matched;THYM;0:LIVING;[Not Applicable];64
TCGA-ZB-A963-01;Thymic Tumor;Male;Primary;Matched;THYM;0:LIVING;[Not Applicable];46
TCGA-ZB-A964-01;Thymic Tumor;Male;Primary;Matched;THYM;0:LIVING;[Not Applicable];70
TCGA-ZB-A965-01;Thymic Tumor;Female;Primary;Matched;THYM;0:LIVING;[Not Applicable];75
TCGA-ZB-A966-01;Thymic Tumor;Female;Primary;Matched;THYM;1:DECEASED;[Not Applicable];78
TCGA-ZB-A969-01;Thymic Tumor;Female;Primary;Matched;THYM;0:LIVING;[Not Applicable];72
TCGA-ZB-A96A-01;Thymic Tumor;Male;Primary;Matched;THYM;0:LIVING;[Not Applicable];53
TCGA-ZB-A96B-01;Thymic Tumor;Male;Primary;Matched;THYM;0:LIVING;[Not Applicable];51
TCGA-ZB-A96C-01;Thymic Tumor;Female;Primary;Matched;THYM;0:LIVING;[Not Applicable];77
TCGA-ZB-A96D-01;Thymic Tumor;Female;Primary;Matched;THYM;0:LIVING;[Not Applicable];52
TCGA-ZB-A96E-01;Thymic Tumor;Male;Primary;Matched;THYM;0:LIVING;[Not Applicable];60
TCGA-ZB-A96F-01;Thymic Tumor;Male;Primary;Matched;THYM;0:LIVING;[Not Applicable];39
TCGA-ZB-A96G-01;Thymic Tumor;Male;Primary;Matched;THYM;0:LIVING;[Not Applicable];59
TCGA-ZB-A96H-01;Thymic Tumor;Male;Primary;Matched;THYM;0:LIVING;[Not Applicable];73
TCGA-ZB-A96I-01;Thymic Tumor;Female;Primary;Matched;THYM;0:LIVING;[Not Applicable];71
TCGA-ZB-A96K-01;Thymic Tumor;Male;Primary;Matched;THYM;0:LIVING;[Not Applicable];69
TCGA-ZB-A96L-01;Thymic Tumor;Female;Primary;Matched;THYM;0:LIVING;[Not Applicable];70
TCGA-ZB-A96M-01;Thymic Tumor;Female;Primary;Matched;THYM;0:LIVING;[Not Applicable];56
TCGA-ZB-A96O-01;Thymic Tumor;Female;Primary;Matched;THYM;0:LIVING;[Not Applicable];54
TCGA-ZB-A96P-01;Thymic Tumor;Male;Primary;Matched;THYM;0:LIVING;[Not Applicable];73
TCGA-ZB-A96Q-01;Thymic Tumor;Male;Primary;Matched;THYM;0:LIVING;[Not Applicable];49
TCGA-ZB-A96R-01;Thymic Tumor;Male;Primary;Matched;THYM;0:LIVING;[Not Applicable];38
TCGA-ZB-A96V-01;Thymic Tumor;Male;Primary;Matched;THYM;0:LIVING;[Not Applicable];44
TCGA-ZC-AAA7-01;Thymic Tumor;Male;Primary;Matched;THYM;1:DECEASED;[Not Applicable];63
TCGA-ZC-AAAA-01;Thymic Tumor;Male;Primary;Matched;THYM;0:LIVING;[Not Applicable];39
TCGA-ZC-AAAF-01;Thymic Tumor;Female;Primary;Matched;THYM;0:LIVING;[Not Applicable];74
TCGA-ZC-AAAH-01;Thymic Tumor;Male;Primary;Matched;THYM;0:LIVING;[Not Applicable];52
TCGA-ZL-A9V6-01;Thymic Tumor;Male;Primary;Matched;THYM;0:LIVING;[Not Applicable];61
TCGA-ZT-A8OM-01;Thymic Tumor;Female;Primary;Matched;THYM;0:LIVING;[Not Applicable];73
TCGA-AP-A1DH-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];59
TCGA-AP-A1DK-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];54
TCGA-AP-A1DM-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];69
TCGA-AP-A1DO-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];51
TCGA-AP-A1DP-01;Endometrial Cancer;Female;Primary;Matched;UEC;1:DECEASED;[Not Applicable];67
TCGA-AP-A1DQ-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];57
TCGA-AP-A1DR-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];61
TCGA-AP-A1DV-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];73
TCGA-AP-A1E0-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];79
TCGA-AP-A1E1-01;Endometrial Cancer;Female;Primary;Matched;UEC;1:DECEASED;[Not Applicable];67
TCGA-AP-A1E3-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];65
TCGA-AP-A1E4-01;Endometrial Cancer;Female;Primary;Matched;UEC;1:DECEASED;[Not Applicable];75
TCGA-AX-A1C4-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];38
TCGA-AX-A1C5-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];76
TCGA-AX-A1C7-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];57
TCGA-AX-A1C8-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];63
TCGA-AX-A1C9-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];44
TCGA-AX-A1CA-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];53
TCGA-AX-A1CC-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];65
TCGA-AX-A1CE-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];58
TCGA-AX-A1CF-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];76
TCGA-AX-A1CI-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];69
TCGA-AX-A1CJ-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];58
TCGA-AX-A1CK-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];67
TCGA-AX-A1CN-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];46
TCGA-AX-A1CP-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];53
TCGA-AX-A1CR-01;Endometrial Cancer;Female;Primary;Matched;UCEC;0:LIVING;[Not Applicable];64
TCGA-DI-A1BU-01;Endometrial Cancer;Female;Primary;Matched;UCEC;0:LIVING;[Not Applicable];55
TCGA-DI-A1BY-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];81
TCGA-DI-A1C3-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];51
TCGA-B5-A11L-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];68
TCGA-B5-A1MU-01;Endometrial Cancer;Female;Primary;Matched;USC;1:DECEASED;[Not Applicable];64
TCGA-EY-A1G7-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];74
TCGA-EY-A1G8-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];62
TCGA-EY-A1GC-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];47
TCGA-EY-A1GD-01;Endometrial Cancer;Female;Primary;Matched;UEC;1:DECEASED;[Not Applicable];65
TCGA-EY-A1GE-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];86
TCGA-EY-A1GF-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];31
TCGA-EY-A1GH-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];63
TCGA-EY-A1GI-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];77
TCGA-EY-A1GK-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];68
TCGA-EY-A1GL-01;Endometrial Cancer;Female;Primary;Matched;UEC;1:DECEASED;[Not Applicable];69
TCGA-EY-A1GP-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];76
TCGA-EY-A1GQ-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];41
TCGA-EY-A1GR-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];64
TCGA-EY-A1GS-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];74
TCGA-EY-A1GT-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];64
TCGA-EY-A1GU-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];71
TCGA-EY-A1GV-01;Endometrial Cancer;Female;Primary;Matched;UCEC;0:LIVING;[Not Applicable];52
TCGA-EY-A1GW-01;Endometrial Cancer;Female;Primary;Matched;UEC;1:DECEASED;[Not Applicable];61
TCGA-EY-A1GX-01;Endometrial Cancer;Female;Primary;Matched;UEC;1:DECEASED;[Not Applicable];70
TCGA-EY-A1H0-01;Endometrial Cancer;Female;Primary;Matched;UEC;1:DECEASED;[Not Applicable];69
TCGA-B5-A1MX-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];65
TCGA-B5-A1MY-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];60
TCGA-B5-A1MZ-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];67
TCGA-B5-A1N2-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];60
TCGA-E6-A1LZ-01;Endometrial Cancer;Female;Primary;Matched;USC;1:DECEASED;[Not Applicable];85
TCGA-E6-A1M0-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];57
TCGA-EY-A1GJ-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];65
TCGA-A5-A1OF-01;Endometrial Cancer;Female;Primary;Matched;UCEC;0:LIVING;[Not Applicable];65
TCGA-A5-A1OG-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];[Not Available]
TCGA-A5-A1OJ-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];67
TCGA-AP-A0LS-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];68
TCGA-B5-A0JU-01;Endometrial Cancer;Female;Primary;Matched;UEC;1:DECEASED;[Not Applicable];74
TCGA-B5-A0KB-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];53
TCGA-B5-A11P-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];47
TCGA-B5-A1MR-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];69
TCGA-B5-A1MV-01;Endometrial Cancer;Female;Primary;Matched;UEC;1:DECEASED;[Not Applicable];52
TCGA-BS-A0V4-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];77
TCGA-BS-A0VI-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];63
TCGA-D1-A1NS-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];46
TCGA-D1-A1NU-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];60
TCGA-D1-A1NZ-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];83
TCGA-D1-A1O5-01;Endometrial Cancer;Female;Primary;Matched;UEC;1:DECEASED;[Not Applicable];90
TCGA-D1-A1O7-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];54
TCGA-D1-A1O8-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];73
TCGA-E6-A1LX-01;Endometrial Cancer;Female;Primary;Matched;UEC;1:DECEASED;[Not Applicable];55
TCGA-EC-A1NJ-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];57
TCGA-EY-A1GM-01;Endometrial Cancer;Female;Primary;Matched;UCEC;0:LIVING;[Not Applicable];78
TCGA-EY-A1GO-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];53
TCGA-A5-A1OK-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];65
TCGA-B5-A0JX-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];56
TCGA-B5-A0K8-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];64
TCGA-D1-A1NW-01;Endometrial Cancer;Female;Primary;Matched;UCEC;0:LIVING;[Not Applicable];58
TCGA-EY-A212-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];58
TCGA-EY-A215-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];64
TCGA-AJ-A23M-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];69
TCGA-AJ-A23O-01;Endometrial Cancer;Female;Primary;Matched;UEC;1:DECEASED;[Not Applicable];59
TCGA-AW-A1PO-01;Endometrial Cancer;Female;Primary;Matched;UEC;1:DECEASED;[Not Applicable];90
TCGA-BG-A220-01;Endometrial Cancer;Female;Primary;Matched;UEC;1:DECEASED;[Not Applicable];64
TCGA-BG-A221-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];64
TCGA-BG-A222-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];69
TCGA-DI-A1NO-01;Endometrial Cancer;Female;Primary;Matched;UEC;1:DECEASED;[Not Applicable];81
TCGA-EO-A1Y5-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];67
TCGA-EO-A1Y7-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];75
TCGA-EO-A1Y8-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];66
TCGA-EY-A210-01;Endometrial Cancer;Female;Primary;Matched;UCEC;1:DECEASED;[Not Applicable];58
TCGA-EY-A214-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];68
TCGA-BG-A2AD-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];54
TCGA-BG-A2AE-01;Endometrial Cancer;Female;Primary;Matched;UEC;1:DECEASED;[Not Applicable];70
TCGA-BK-A26L-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];71
TCGA-D1-A1NX-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];63
TCGA-D1-A1NY-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];57
TCGA-DI-A1NN-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];82
TCGA-EC-A1QX-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];54
TCGA-EC-A24G-01;Endometrial Cancer;Female;Primary;Matched;UEC;1:DECEASED;[Not Applicable];60
TCGA-AX-A2H5-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];67
TCGA-AX-A2H8-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];42
TCGA-AX-A2HC-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];56
TCGA-AX-A2HD-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];33
TCGA-AX-A2HF-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];56
TCGA-AX-A2HG-01;Endometrial Cancer;Female;Primary;Matched;UEC;1:DECEASED;[Not Applicable];45
TCGA-AX-A2HH-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];76
TCGA-AX-A2HJ-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];59
TCGA-AX-A2HK-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];63
TCGA-B5-A1MW-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];57
TCGA-BG-A0MA-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];39
TCGA-D1-A1O0-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];62
TCGA-D1-A2G0-01;Endometrial Cancer;Female;Primary;Matched;UCEC;0:LIVING;[Not Applicable];53
TCGA-D1-A2G5-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];60
TCGA-D1-A2G6-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];62
TCGA-FI-A2CX-01;Endometrial Cancer;Female;Primary;Matched;UEC;1:DECEASED;[Not Applicable];70
TCGA-FI-A2CY-01;Endometrial Cancer;Female;Primary;Matched;UCEC;1:DECEASED;[Not Applicable];76
TCGA-FI-A2D0-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];59
TCGA-FI-A2D2-01;Endometrial Cancer;Female;Primary;Matched;UCEC;0:LIVING;[Not Applicable];59
TCGA-FI-A2D4-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];40
TCGA-FI-A2D5-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];74
TCGA-FI-A2D6-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];45
TCGA-FI-A2EU-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];54
TCGA-FI-A2EW-01;Endometrial Cancer;Female;Primary;Matched;USC;1:DECEASED;[Not Applicable];56
TCGA-FI-A2EX-01;Endometrial Cancer;Female;Primary;Matched;USC;1:DECEASED;[Not Applicable];68
TCGA-FI-A2F4-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];66
TCGA-FI-A2F8-01;Endometrial Cancer;Female;Primary;Matched;USC;1:DECEASED;[Not Applicable];81
TCGA-FI-A2F9-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];82
TCGA-A5-A2K3-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];56
TCGA-A5-A2K5-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];60
TCGA-A5-A2K7-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];57
TCGA-AX-A2H2-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];37
TCGA-AX-A2IN-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];77
TCGA-AX-A2IO-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];53
TCGA-D1-A2G7-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];63
TCGA-DF-A2KN-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];81
TCGA-DF-A2KR-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];72
TCGA-DF-A2KU-01;Endometrial Cancer;Female;Primary;Matched;UEC;1:DECEASED;[Not Applicable];82
TCGA-DF-A2KV-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];59
TCGA-DF-A2L0-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];60
TCGA-EO-A22U-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];71
TCGA-EO-A22X-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];63
TCGA-EO-A22Y-01;Endometrial Cancer;Female;Primary;Matched;UEC;1:DECEASED;[Not Applicable];52
TCGA-EO-A2CG-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];79
TCGA-EO-A2CH-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];67
TCGA-H5-A2HR-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];53
TCGA-A5-A2K2-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];47
TCGA-A5-A2K4-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];80
TCGA-AJ-A2QK-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];52
TCGA-AJ-A2QL-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];47
TCGA-AJ-A2QM-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];77
TCGA-AJ-A2QN-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];77
TCGA-AJ-A2QO-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];73
TCGA-AX-A2H4-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];70
TCGA-AX-A2H7-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];65
TCGA-AX-A2HA-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];60
TCGA-BG-A2L7-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];69
TCGA-DF-A2KS-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];61
TCGA-DI-A2QU-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];59
TCGA-EO-A22R-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];58
TCGA-EO-A22S-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];54
TCGA-EO-A22T-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];84
TCGA-EY-A2OM-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];70
TCGA-EY-A2ON-01;Endometrial Cancer;Female;Primary;Matched;USC;1:DECEASED;[Not Applicable];86
TCGA-FI-A2EY-01;Endometrial Cancer;Female;Primary;Matched;USC;1:DECEASED;[Not Applicable];66
TCGA-AJ-A3BD-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];67
TCGA-AJ-A3BG-01;Endometrial Cancer;Female;Primary;Matched;UCEC;1:DECEASED;[Not Applicable];87
TCGA-AJ-A3BH-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];64
TCGA-AJ-A3BK-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];35
TCGA-AJ-A3EJ-01;Endometrial Cancer;Female;Primary;Matched;UCEC;0:LIVING;[Not Applicable];53
TCGA-AJ-A3EK-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];69
TCGA-B5-A3FA-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];67
TCGA-B5-A3FB-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];56
TCGA-B5-A3FD-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];60
TCGA-B5-A3FH-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];35
TCGA-BG-A0MK-01;Endometrial Cancer;Female;Primary;Matched;UEC;1:DECEASED;[Not Applicable];77
TCGA-D1-A3DG-01;Endometrial Cancer;Female;Primary;Matched;UEC;1:DECEASED;[Not Applicable];63
TCGA-D1-A3DH-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];83
TCGA-DI-A2QT-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];82
TCGA-DI-A2QY-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];64
TCGA-E6-A2P8-01;Endometrial Cancer;Female;Primary;Matched;UCEC;0:LIVING;[Not Applicable];62
TCGA-E6-A2P9-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];66
TCGA-EO-A3AS-01;Endometrial Cancer;Female;Primary;Matched;UEC;1:DECEASED;[Not Applicable];69
TCGA-EO-A3AU-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];33
TCGA-EO-A3AV-01;Endometrial Cancer;Female;Primary;Matched;UEC;1:DECEASED;[Not Applicable];84
TCGA-EO-A3AY-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];58
TCGA-EO-A3AZ-01;Endometrial Cancer;Female;Primary;Matched;UCEC;0:LIVING;[Not Applicable];60
TCGA-EO-A3B0-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];67
TCGA-EO-A3B1-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];71
TCGA-EY-A2OO-01;Endometrial Cancer;Female;Primary;Matched;UCEC;0:LIVING;[Not Applicable];76
TCGA-EY-A2OP-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];63
TCGA-EY-A2OQ-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];73
TCGA-AJ-A3BF-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];66
TCGA-AJ-A3BI-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];84
TCGA-AJ-A3EL-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];73
TCGA-AJ-A3EM-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];54
TCGA-AJ-A3IA-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];63
TCGA-AP-A3K1-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];57
TCGA-AX-A3G3-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];63
TCGA-AX-A3G4-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];62
TCGA-AX-A3G6-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];50
TCGA-AX-A3G7-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];60
TCGA-AX-A3GI-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];48
TCGA-D1-A3DA-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];69
TCGA-DF-A2KY-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];54
TCGA-DF-A2KZ-01;Endometrial Cancer;Female;Primary;Matched;UEC;1:DECEASED;[Not Applicable];62
TCGA-A5-A1OH-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];51
TCGA-A5-A3LO-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];58
TCGA-A5-A3LP-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];64
TCGA-AJ-A23N-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];71
TCGA-AJ-A3I9-01;Endometrial Cancer;Female;Primary;Matched;UEC;1:DECEASED;[Not Applicable];88
TCGA-AJ-A3NC-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];62
TCGA-AJ-A3NE-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];53
TCGA-AJ-A3NF-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];55
TCGA-AJ-A3NG-01;Endometrial Cancer;Female;Primary;Matched;UCEC;0:LIVING;[Not Applicable];71
TCGA-AJ-A3NH-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];67
TCGA-AJ-A3OJ-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];65
TCGA-AJ-A3OK-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];64
TCGA-AJ-A3OL-01;Endometrial Cancer;Female;Primary;Matched;UEC;1:DECEASED;[Not Applicable];71
TCGA-AJ-A3QS-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];43
TCGA-AJ-A3TW-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];69
TCGA-AX-A3FS-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];62
TCGA-AX-A3FT-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];87
TCGA-AX-A3FV-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];64
TCGA-AX-A3FW-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];51
TCGA-AX-A3FX-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];63
TCGA-AX-A3FZ-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];74
TCGA-AX-A3G1-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];64
TCGA-AX-A3G8-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];61
TCGA-AX-A3G9-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];66
TCGA-AX-A3GB-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];59
TCGA-B5-A1MS-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];61
TCGA-B5-A3F9-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];57
TCGA-B5-A3FC-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];65
TCGA-B5-A3S1-01;Endometrial Cancer;Female;Primary;Matched;USC;1:DECEASED;[Not Applicable];60
TCGA-BG-A3EW-01;Endometrial Cancer;Female;Primary;Matched;UEC;1:DECEASED;[Not Applicable];79
TCGA-BG-A3PP-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];84
TCGA-BK-A13B-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];55
TCGA-D1-A3JP-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];47
TCGA-D1-A3JQ-01;Endometrial Cancer;Female;Primary;Matched;USC;1:DECEASED;[Not Applicable];62
TCGA-EO-A3KU-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];54
TCGA-EO-A3KW-01;Endometrial Cancer;Female;Primary;Matched;USC;1:DECEASED;[Not Applicable];70
TCGA-EO-A3KX-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];56
TCGA-EO-A3L0-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];73
TCGA-EY-A3L3-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];73
TCGA-EY-A3QX-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];53
TCGA-FI-A3PV-01;Endometrial Cancer;Female;Primary;Matched;USC;1:DECEASED;[Not Applicable];70
TCGA-FI-A3PX-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];74
TCGA-K6-A3WQ-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];71
TCGA-KJ-A3U4-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];71
TCGA-KP-A3VZ-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];67
TCGA-KP-A3W0-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];68
TCGA-KP-A3W1-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];47
TCGA-KP-A3W3-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];57
TCGA-KP-A3W4-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];66
TCGA-AJ-A4ZG-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];62
TCGA-AJ-A5DV-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];74
TCGA-AJ-A5DW-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];60
TCGA-AP-A5FX-01;Endometrial Cancer;Female;Primary;Matched;UCEC;1:DECEASED;[Not Applicable];73
TCGA-B5-A5OC-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];60
TCGA-BK-A4ZD-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];50
TCGA-BK-A56F-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];73
TCGA-EY-A4KR-01;Endometrial Cancer;Female;Primary;Matched;USC;1:DECEASED;[Not Applicable];60
TCGA-EY-A547-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];74
TCGA-EY-A548-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];73
TCGA-EY-A549-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];61
TCGA-EY-A54A-01;Endometrial Cancer;Female;Primary;Matched;UEC;1:DECEASED;[Not Applicable];83
TCGA-PG-A5BC-01;Endometrial Cancer;Female;Primary;Matched;USC;1:DECEASED;[Not Applicable];52
TCGA-B5-A5OD-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];63
TCGA-B5-A5OE-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];71
TCGA-EY-A5W2-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];53
TCGA-PG-A6IB-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];64
TCGA-QF-A5YS-01;Endometrial Cancer;Female;Primary;Matched;UCEC;0:LIVING;[Not Applicable];78
TCGA-QF-A5YT-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];68
TCGA-QS-A5YQ-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];56
TCGA-QS-A5YR-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];53
TCGA-SL-A6J9-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];77
TCGA-SL-A6JA-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];58
TCGA-A5-A7WJ-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];58
TCGA-A5-A7WK-01;Endometrial Cancer;Female;Primary;Matched;UCEC;0:LIVING;[Not Applicable];89
TCGA-AJ-A6NU-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];57
TCGA-BK-A6W3-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];37
TCGA-BK-A6W4-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];67
TCGA-EY-A72D-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];61
TCGA-PG-A7D5-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];65
TCGA-QS-A744-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];74
TCGA-SJ-A6ZI-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];53
TCGA-SJ-A6ZJ-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];72
TCGA-4E-A92E-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];69
TCGA-5B-A90C-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];84
TCGA-AJ-A8CT-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];49
TCGA-AJ-A8CV-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];63
TCGA-AJ-A8CW-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];57
TCGA-E6-A8L9-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];68
TCGA-PG-A914-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];62
TCGA-PG-A915-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];82
TCGA-PG-A916-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];57
TCGA-PG-A917-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];61
TCGA-QS-A8F1-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];60
TCGA-2E-A9G8-01;Endometrial Cancer;Female;Primary;Matched;UCEC;0:LIVING;[Not Applicable];69
TCGA-5S-A9Q8-01;Endometrial Cancer;Female;Primary;Matched;UEC;1:DECEASED;[Not Applicable];74
TCGA-A5-AB3J-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];58
TCGA-JU-AAVI-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];47
TCGA-AP-A051-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];71
TCGA-AP-A052-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];42
TCGA-AP-A053-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];75
TCGA-AP-A056-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];34
TCGA-AP-A05A-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];62
TCGA-AP-A05D-01;Endometrial Cancer;Female;Primary;Matched;USC;1:DECEASED;[Not Applicable];39
TCGA-AP-A05H-01;Endometrial Cancer;Female;Primary;Matched;USC;1:DECEASED;[Not Applicable];58
TCGA-AP-A05J-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];69
TCGA-AP-A05N-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];65
TCGA-AX-A05S-01;Endometrial Cancer;Female;Primary;Matched;UEC;1:DECEASED;[Not Applicable];35
TCGA-AX-A05T-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];60
TCGA-AX-A05U-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];64
TCGA-AX-A05W-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];59
TCGA-AX-A05Y-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];76
TCGA-AX-A05Z-01;Endometrial Cancer;Female;Primary;Matched;UEC;1:DECEASED;[Not Applicable];63
TCGA-AX-A060-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];55
TCGA-AX-A062-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];59
TCGA-AX-A063-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];68
TCGA-AX-A064-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];65
TCGA-AX-A06B-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];68
TCGA-AX-A06F-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];54
TCGA-AX-A06J-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];64
TCGA-BK-A0C9-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];62
TCGA-BK-A0CC-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];55
TCGA-A5-A0G2-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];56
TCGA-A5-A0G3-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];55
TCGA-A5-A0G5-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];48
TCGA-A5-A0G9-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];68
TCGA-A5-A0GA-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];58
TCGA-A5-A0GB-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];55
TCGA-A5-A0GD-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];60
TCGA-A5-A0GE-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];75
TCGA-A5-A0GH-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];59
TCGA-A5-A0GI-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];90
TCGA-A5-A0GJ-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];57
TCGA-A5-A0GM-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];54
TCGA-A5-A0GN-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];34
TCGA-A5-A0GP-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];58
TCGA-A5-A0GU-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];80
TCGA-A5-A0GV-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];60
TCGA-A5-A0GW-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];49
TCGA-A5-A0GX-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];87
TCGA-AP-A054-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];68
TCGA-AP-A05P-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];58
TCGA-AP-A0L8-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];45
TCGA-AP-A0L9-01;Endometrial Cancer;Female;Primary;Matched;USC;1:DECEASED;[Not Applicable];72
TCGA-AP-A0LD-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];70
TCGA-AP-A0LG-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];78
TCGA-AP-A0LH-01;Endometrial Cancer;Female;Primary;Matched;UCEC;0:LIVING;[Not Applicable];69
TCGA-AP-A0LI-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];50
TCGA-AP-A0LJ-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];64
TCGA-AP-A0LN-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];70
TCGA-AP-A0LO-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];67
TCGA-AP-A0LT-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];63
TCGA-AP-A0LV-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];64
TCGA-AX-A0IW-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];49
TCGA-AX-A0J1-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];73
TCGA-B5-A0JR-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];60
TCGA-B5-A0JZ-01;Endometrial Cancer;Female;Primary;Matched;UEC;1:DECEASED;[Not Applicable];74
TCGA-B5-A0K0-01;Endometrial Cancer;Female;Primary;Matched;UEC;1:DECEASED;[Not Applicable];62
TCGA-B5-A0K1-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];61
TCGA-B5-A0K3-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];51
TCGA-B5-A0K4-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];44
TCGA-B5-A0K6-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];54
TCGA-BG-A0LW-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];39
TCGA-BG-A0LX-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];70
TCGA-BG-A0M7-01;Endometrial Cancer;Female;Primary;Matched;UEC;1:DECEASED;[Not Applicable];78
TCGA-BG-A0MC-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];54
TCGA-BG-A0MI-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];56
TCGA-BG-A0MO-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];51
TCGA-A5-A0R6-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];48
TCGA-A5-A0R7-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];67
TCGA-A5-A0R8-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];70
TCGA-A5-A0R9-01;Endometrial Cancer;Female;Primary;Matched;UEC;1:DECEASED;[Not Applicable];76
TCGA-A5-A0RA-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];59
TCGA-A5-A0VP-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];69
TCGA-A5-A0VQ-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];78
TCGA-AP-A0LE-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];58
TCGA-AP-A0LL-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];68
TCGA-AP-A0LP-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];61
TCGA-AP-A0LQ-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];74
TCGA-AX-A0IU-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];81
TCGA-B5-A0JN-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];56
TCGA-B5-A0JS-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];46
TCGA-B5-A0JV-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];54
TCGA-B5-A0JY-01;Endometrial Cancer;Female;Primary;Matched;UEC;1:DECEASED;[Not Applicable];58
TCGA-B5-A0K2-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];59
TCGA-B5-A0K7-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];67
TCGA-B5-A0K9-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];53
TCGA-BG-A0M0-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];53
TCGA-BG-A0M2-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];74
TCGA-BG-A0M3-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];72
TCGA-BG-A0M4-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];66
TCGA-BG-A0M6-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];67
TCGA-BG-A0M8-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];60
TCGA-BG-A0M9-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];77
TCGA-BG-A0MG-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];61
TCGA-BG-A0MQ-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];60
TCGA-BG-A0MS-01;Endometrial Cancer;Female;Primary;Matched;UEC;1:DECEASED;[Not Applicable];70
TCGA-BG-A0MT-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];70
TCGA-BG-A0MU-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];50
TCGA-BG-A0RY-01;Endometrial Cancer;Female;Primary;Matched;UEC;1:DECEASED;[Not Applicable];53
TCGA-BK-A0CB-01;Endometrial Cancer;Female;Primary;Matched;UEC;1:DECEASED;[Not Applicable];65
TCGA-BS-A0TA-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];77
TCGA-BS-A0TC-01;Endometrial Cancer;Female;Primary;Matched;UEC;1:DECEASED;[Not Applicable];81
TCGA-BS-A0TD-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];71
TCGA-BS-A0TE-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];61
TCGA-BS-A0TG-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];61
TCGA-BS-A0TI-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];[Not Available]
TCGA-BS-A0TJ-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];84
TCGA-BS-A0U7-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];69
TCGA-BS-A0U8-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];[Not Available]
TCGA-BS-A0UF-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];55
TCGA-BS-A0UJ-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];49
TCGA-BS-A0UM-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];87
TCGA-BS-A0UT-01;Endometrial Cancer;Female;Primary;Matched;UEC;1:DECEASED;[Not Applicable];60
TCGA-BS-A0UV-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];64
TCGA-A5-A0VO-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];55
TCGA-AX-A0J0-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];63
TCGA-BG-A0VZ-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];38
TCGA-BG-A0W1-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];63
TCGA-BG-A0W2-01;Endometrial Cancer;Female;Primary;Matched;UEC;1:DECEASED;[Not Applicable];68
TCGA-BS-A0U5-01;Endometrial Cancer;Female;Primary;Matched;UEC;1:DECEASED;[Not Applicable];51
TCGA-BS-A0UL-01;Endometrial Cancer;Female;Primary;Matched;UEC;1:DECEASED;[Not Applicable];67
TCGA-BS-A0WQ-01;Endometrial Cancer;Female;Primary;Matched;UEC;1:DECEASED;[Not Applicable];64
TCGA-AX-A0IS-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];40
TCGA-B5-A11E-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];76
TCGA-B5-A11F-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];56
TCGA-B5-A11I-01;Endometrial Cancer;Female;Primary;Matched;UEC;1:DECEASED;[Not Applicable];53
TCGA-B5-A11V-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];65
TCGA-B5-A11X-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];61
TCGA-B5-A11Y-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];73
TCGA-B5-A11Z-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];71
TCGA-BG-A0VT-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];57
TCGA-BG-A0YU-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];63
TCGA-BG-A0YV-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];65
TCGA-BS-A0U9-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];87
TCGA-D1-A0ZP-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];56
TCGA-D1-A0ZR-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];58
TCGA-D1-A0ZU-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];56
TCGA-D1-A0ZV-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];83
TCGA-D1-A0ZZ-01;Endometrial Cancer;Female;Primary;Matched;UCEC;0:LIVING;[Not Applicable];36
TCGA-D1-A101-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];68
TCGA-D1-A102-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];69
TCGA-D1-A103-01;Endometrial Cancer;Female;Primary;Matched;UEC;1:DECEASED;[Not Applicable];73
TCGA-A5-A0G1-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];86
TCGA-A5-A0GG-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];72
TCGA-A5-A0GQ-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];51
TCGA-A5-A0GR-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];58
TCGA-AP-A059-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];80
TCGA-AP-A05O-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];43
TCGA-AP-A0LF-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];63
TCGA-AP-A0LM-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];68
TCGA-AX-A06D-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];72
TCGA-AX-A06H-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];80
TCGA-AX-A06L-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];76
TCGA-AX-A0IZ-01;Endometrial Cancer;Female;Primary;Matched;UEC;1:DECEASED;[Not Applicable];86
TCGA-B5-A0JT-01;Endometrial Cancer;Female;Primary;Matched;UEC;1:DECEASED;[Not Applicable];83
TCGA-B5-A11G-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];62
TCGA-B5-A11H-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];51
TCGA-B5-A11J-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];67
TCGA-B5-A11M-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];75
TCGA-B5-A11N-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];70
TCGA-B5-A11O-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];52
TCGA-B5-A11Q-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];73
TCGA-B5-A11R-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];74
TCGA-B5-A11S-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];51
TCGA-B5-A11U-01;Endometrial Cancer;Female;Primary;Matched;UEC;1:DECEASED;[Not Applicable];60
TCGA-B5-A11W-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];65
TCGA-B5-A121-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];54
TCGA-BG-A0MH-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];76
TCGA-BG-A0VV-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];67
TCGA-BG-A0VW-01;Endometrial Cancer;Female;Primary;Matched;UEC;1:DECEASED;[Not Applicable];71
TCGA-BG-A0VX-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];68
TCGA-BK-A0CA-01;Endometrial Cancer;Female;Primary;Matched;UCEC;1:DECEASED;[Not Applicable];66
TCGA-BK-A139-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];75
TCGA-BK-A13C-01;Endometrial Cancer;Female;Primary;Matched;UEC;1:DECEASED;[Not Applicable];73
TCGA-BS-A0UA-01;Endometrial Cancer;Female;Primary;Matched;UEC;1:DECEASED;[Not Applicable];76
TCGA-BS-A0V6-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];57
TCGA-BS-A0V7-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];82
TCGA-BS-A0V8-01;Endometrial Cancer;Female;Primary;Matched;UEC;1:DECEASED;[Not Applicable];83
TCGA-D1-A0ZN-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];66
TCGA-D1-A0ZO-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];60
TCGA-D1-A0ZQ-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];55
TCGA-D1-A0ZS-01;Endometrial Cancer;Female;Primary;Matched;UEC;1:DECEASED;[Not Applicable];61
TCGA-D1-A15V-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];56
TCGA-D1-A15W-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];63
TCGA-D1-A15X-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];61
TCGA-D1-A15Z-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];82
TCGA-D1-A160-01;Endometrial Cancer;Female;Primary;Matched;UEC;1:DECEASED;[Not Applicable];64
TCGA-D1-A161-01;Endometrial Cancer;Female;Primary;Matched;UEC;1:DECEASED;[Not Applicable];56
TCGA-D1-A162-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];75
TCGA-BG-A186-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];83
TCGA-BG-A187-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];78
TCGA-BG-A18A-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];67
TCGA-BG-A18B-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];72
TCGA-BG-A18C-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];87
TCGA-BS-A0T9-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];82
TCGA-D1-A163-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];60
TCGA-D1-A165-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];55
TCGA-D1-A167-01;Endometrial Cancer;Female;Primary;Matched;UEC;1:DECEASED;[Not Applicable];66
TCGA-D1-A168-01;Endometrial Cancer;Female;Primary;Matched;UEC;1:DECEASED;[Not Applicable];44
TCGA-D1-A169-01;Endometrial Cancer;Female;Primary;Matched;UEC;1:DECEASED;[Not Applicable];56
TCGA-D1-A16B-01;Endometrial Cancer;Female;Primary;Matched;UEC;1:DECEASED;[Not Applicable];74
TCGA-D1-A16D-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];68
TCGA-D1-A16E-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];71
TCGA-D1-A16F-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];58
TCGA-D1-A16G-01;Endometrial Cancer;Female;Primary;Matched;USC;1:DECEASED;[Not Applicable];63
TCGA-D1-A16I-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];64
TCGA-D1-A16J-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];64
TCGA-D1-A16N-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];79
TCGA-D1-A16O-01;Endometrial Cancer;Female;Primary;Matched;UEC;1:DECEASED;[Not Applicable];68
TCGA-D1-A16Q-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];57
TCGA-D1-A16R-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];71
TCGA-D1-A16S-01;Endometrial Cancer;Female;Primary;Matched;USC;1:DECEASED;[Not Applicable];61
TCGA-D1-A16V-01;Endometrial Cancer;Female;Primary;Matched;UEC;1:DECEASED;[Not Applicable];60
TCGA-D1-A16X-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];55
TCGA-D1-A16Y-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];69
TCGA-D1-A174-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];72
TCGA-D1-A175-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];76
TCGA-D1-A176-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];72
TCGA-D1-A177-01;Endometrial Cancer;Female;Primary;Matched;UEC;1:DECEASED;[Not Applicable];63
TCGA-D1-A179-01;Endometrial Cancer;Female;Primary;Matched;USC;0:LIVING;[Not Applicable];72
TCGA-D1-A17A-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];68
TCGA-D1-A17B-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];62
TCGA-D1-A17C-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];73
TCGA-D1-A17D-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];60
TCGA-D1-A17F-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];70
TCGA-D1-A17H-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];74
TCGA-D1-A17K-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];57
TCGA-D1-A17L-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];57
TCGA-D1-A17M-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];55
TCGA-D1-A17N-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];61
TCGA-D1-A17Q-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];86
TCGA-D1-A17R-01;Endometrial Cancer;Female;Primary;Matched;UEC;1:DECEASED;[Not Applicable];85
TCGA-D1-A17S-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];64
TCGA-D1-A17T-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];61
TCGA-D1-A17U-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];73
TCGA-DI-A0WH-01;Endometrial Cancer;Female;Primary;Matched;UEC;0:LIVING;[Not Applicable];77
TCGA-BK-A139-02;Endometrial Cancer;[Not Available];Recurrence;Matched;UCEC;[Not Available];[Not Available];[Not Available]
TCGA-N5-A4R8-01;Endometrial Cancer;Female;Primary;Matched;UCS;1:DECEASED;[Not Applicable];65
TCGA-N5-A4RA-01;Endometrial Cancer;Female;Primary;Matched;UCS;1:DECEASED;[Not Applicable];63
TCGA-N5-A4RD-01;Endometrial Cancer;Female;Primary;Matched;UCS;1:DECEASED;[Not Applicable];69
TCGA-N5-A4RF-01;Endometrial Cancer;Female;Primary;Matched;UCS;0:LIVING;[Not Applicable];68
TCGA-N5-A4RJ-01;Endometrial Cancer;Female;Primary;Matched;UCS;1:DECEASED;[Not Applicable];61
TCGA-N5-A4RM-01;Endometrial Cancer;Female;Primary;Matched;UCS;1:DECEASED;[Not Applicable];62
TCGA-N5-A4RN-01;Endometrial Cancer;Female;Primary;Matched;UCS;0:LIVING;[Not Applicable];71
TCGA-N5-A4RO-01;Endometrial Cancer;Female;Primary;Matched;UCS;1:DECEASED;[Not Applicable];67
TCGA-N5-A4RS-01;Endometrial Cancer;Female;Primary;Matched;UCS;1:DECEASED;[Not Applicable];65
TCGA-N5-A4RT-01;Endometrial Cancer;Female;Primary;Matched;UCS;0:LIVING;[Not Applicable];69
TCGA-N5-A4RU-01;Endometrial Cancer;Female;Primary;Matched;UCS;1:DECEASED;[Not Applicable];54
TCGA-N5-A4RV-01;Endometrial Cancer;Female;Primary;Matched;UCS;0:LIVING;[Not Applicable];62
TCGA-N5-A59E-01;Endometrial Cancer;Female;Primary;Matched;UCS;1:DECEASED;[Not Applicable];62
TCGA-N5-A59F-01;Endometrial Cancer;Female;Primary;Matched;UCS;1:DECEASED;[Not Applicable];65
TCGA-N6-A4V9-01;Endometrial Cancer;Female;Primary;Matched;UCS;0:LIVING;[Not Applicable];59
TCGA-N6-A4VC-01;Endometrial Cancer;Female;Primary;Matched;UCS;1:DECEASED;[Not Applicable];83
TCGA-N6-A4VD-01;Endometrial Cancer;Female;Primary;Matched;UCS;1:DECEASED;[Not Applicable];81
TCGA-N6-A4VE-01;Endometrial Cancer;Female;Primary;Matched;UCS;1:DECEASED;[Not Applicable];84
TCGA-N6-A4VF-01;Endometrial Cancer;Female;Primary;Matched;UCS;1:DECEASED;[Not Applicable];51
TCGA-N6-A4VG-01;Endometrial Cancer;Female;Primary;Matched;UCS;0:LIVING;[Not Applicable];77
TCGA-N7-A4Y0-01;Endometrial Cancer;Female;Primary;Matched;UCS;1:DECEASED;[Not Applicable];65
TCGA-N7-A4Y5-01;Endometrial Cancer;Female;Primary;Matched;UCS;1:DECEASED;[Not Applicable];87
TCGA-N7-A4Y8-01;Endometrial Cancer;Female;Primary;Matched;UCS;1:DECEASED;[Not Applicable];72
TCGA-N7-A59B-01;Endometrial Cancer;Female;Primary;Matched;UCS;0:LIVING;[Not Applicable];69
TCGA-N8-A4PI-01;Endometrial Cancer;Female;Primary;Matched;UCS;1:DECEASED;[Not Applicable];71
TCGA-N8-A4PL-01;Endometrial Cancer;Female;Primary;Matched;UCS;1:DECEASED;[Not Applicable];82
TCGA-N8-A4PM-01;Endometrial Cancer;Female;Primary;Matched;UCS;0:LIVING;[Not Applicable];73
TCGA-N8-A4PN-01;Endometrial Cancer;Female;Primary;Matched;UCS;0:LIVING;[Not Applicable];68
TCGA-N8-A4PO-01;Endometrial Cancer;Female;Primary;Matched;UCS;0:LIVING;[Not Applicable];66
TCGA-N8-A4PP-01;Endometrial Cancer;Female;Primary;Matched;UCS;1:DECEASED;[Not Applicable];88
TCGA-N8-A4PQ-01;Endometrial Cancer;Female;Primary;Matched;UCS;0:LIVING;[Not Applicable];76
TCGA-N8-A56S-01;Endometrial Cancer;Female;Primary;Matched;UCS;1:DECEASED;[Not Applicable];75
TCGA-N9-A4PZ-01;Endometrial Cancer;Female;Primary;Matched;UCS;1:DECEASED;[Not Applicable];77
TCGA-N9-A4Q1-01;Endometrial Cancer;Female;Primary;Matched;UCS;1:DECEASED;[Not Applicable];70
TCGA-N9-A4Q3-01;Endometrial Cancer;Female;Primary;Matched;UCS;0:LIVING;[Not Applicable];65
TCGA-N9-A4Q4-01;Endometrial Cancer;Female;Primary;Matched;UCS;0:LIVING;[Not Applicable];61
TCGA-N9-A4Q7-01;Endometrial Cancer;Female;Primary;Matched;UCS;0:LIVING;[Not Applicable];69
TCGA-N9-A4Q8-01;Endometrial Cancer;Female;Primary;Matched;UCS;1:DECEASED;[Not Applicable];68
TCGA-NA-A4QV-01;Endometrial Cancer;Female;Primary;Matched;UCS;0:LIVING;[Not Applicable];72
TCGA-NA-A4QW-01;Endometrial Cancer;Female;Primary;Matched;UCS;0:LIVING;[Not Applicable];61
TCGA-NA-A4QX-01;Endometrial Cancer;Female;Primary;Matched;UCS;1:DECEASED;[Not Applicable];60
TCGA-NA-A4QY-01;Endometrial Cancer;Female;Primary;Matched;UCS;1:DECEASED;[Not Applicable];62
TCGA-NA-A4R0-01;Endometrial Cancer;Female;Primary;Matched;UCS;1:DECEASED;[Not Applicable];80
TCGA-NA-A4R1-01;Endometrial Cancer;Female;Primary;Matched;UCS;1:DECEASED;[Not Applicable];75
TCGA-NA-A5I1-01;Endometrial Cancer;Female;Primary;Matched;UCS;1:DECEASED;[Not Applicable];80
TCGA-ND-A4W6-01;Endometrial Cancer;Female;Primary;Matched;UCS;1:DECEASED;[Not Applicable];67
TCGA-ND-A4WA-01;Endometrial Cancer;Female;Primary;Matched;UCS;1:DECEASED;[Not Applicable];90
TCGA-ND-A4WC-01;Endometrial Cancer;Female;Primary;Matched;UCS;0:LIVING;[Not Applicable];83
TCGA-ND-A4WF-01;Endometrial Cancer;Female;Primary;Matched;UCS;1:DECEASED;[Not Applicable];77
TCGA-NF-A4WU-01;Endometrial Cancer;Female;Primary;Matched;UCS;0:LIVING;[Not Applicable];59
TCGA-NF-A4WX-01;Endometrial Cancer;Female;Primary;Matched;UCS;0:LIVING;[Not Applicable];61
TCGA-NF-A4X2-01;Endometrial Cancer;Female;Primary;Matched;UCS;0:LIVING;[Not Applicable];59
TCGA-NF-A5CP-01;Endometrial Cancer;Female;Primary;Matched;UCS;1:DECEASED;[Not Applicable];90
TCGA-NG-A4VU-01;Endometrial Cancer;Female;Primary;Matched;UCS;1:DECEASED;[Not Applicable];63
TCGA-NG-A4VW-01;Endometrial Cancer;Female;Primary;Matched;UCS;1:DECEASED;[Not Applicable];74
TCGA-QM-A5NM-01;Endometrial Cancer;Female;Primary;Matched;UCS;0:LIVING;[Not Applicable];67
TCGA-QN-A5NN-01;Endometrial Cancer;Female;Primary;Matched;UCS;0:LIVING;[Not Applicable];55
TCGA-V4-A9F8-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;0:LIVING;[Not Available];[Not Available]
TCGA-V4-A9EQ-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;1:DECEASED;[Not Available];[Not Available]
TCGA-V4-A9EE-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;1:DECEASED;[Not Available];[Not Available]
TCGA-V3-A9ZY-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;0:LIVING;[Not Available];[Not Available]
TCGA-V4-A9EU-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;0:LIVING;[Not Available];[Not Available]
TCGA-YZ-A983-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;0:LIVING;[Not Available];[Not Available]
TCGA-WC-A87U-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;1:DECEASED;[Not Available];[Not Available]
TCGA-V4-A9F7-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;0:LIVING;[Not Available];[Not Available]
TCGA-WC-A884-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;0:LIVING;[Not Available];[Not Available]
TCGA-VD-AA8O-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;1:DECEASED;[Not Available];[Not Available]
TCGA-VD-A8KO-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;0:LIVING;[Not Available];[Not Available]
TCGA-V4-A9EJ-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;0:LIVING;[Not Available];[Not Available]
TCGA-VD-A8KK-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;0:LIVING;[Not Available];[Not Available]
TCGA-VD-A8KE-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;0:LIVING;[Not Available];[Not Available]
TCGA-VD-AA8T-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;0:LIVING;[Not Available];[Not Available]
TCGA-V4-A9ED-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;0:LIVING;[Not Available];[Not Available]
TCGA-V4-A9ET-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;0:LIVING;[Not Available];[Not Available]
TCGA-VD-A8KL-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;0:LIVING;[Not Available];[Not Available]
TCGA-V4-A9EX-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;1:DECEASED;[Not Available];[Not Available]
TCGA-WC-A87T-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;0:LIVING;[Not Available];[Not Available]
TCGA-VD-AA8R-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;0:LIVING;[Not Available];[Not Available]
TCGA-VD-A8K9-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;0:LIVING;[Not Available];[Not Available]
TCGA-WC-A885-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;0:LIVING;[Not Available];[Not Available]
TCGA-V4-A9E9-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;0:LIVING;[Not Available];[Not Available]
TCGA-V4-A9EK-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;0:LIVING;[Not Available];[Not Available]
TCGA-V4-A9EO-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;0:LIVING;[Not Available];[Not Available]
TCGA-V4-A9F4-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;0:LIVING;[Not Available];[Not Available]
TCGA-WC-A88A-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;1:DECEASED;[Not Available];[Not Available]
TCGA-WC-A882-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;0:LIVING;[Not Available];[Not Available]
TCGA-VD-A8KI-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;1:DECEASED;[Not Available];[Not Available]
TCGA-V4-A9F0-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;1:DECEASED;[Not Available];[Not Available]
TCGA-V4-A9EI-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;1:DECEASED;[Not Available];[Not Available]
TCGA-VD-AA8M-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;0:LIVING;[Not Available];[Not Available]
TCGA-YZ-A982-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;0:LIVING;[Not Available];[Not Available]
TCGA-VD-A8KA-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;0:LIVING;[Not Available];[Not Available]
TCGA-V3-A9ZX-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;0:LIVING;[Not Available];[Not Available]
TCGA-VD-A8KM-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;0:LIVING;[Not Available];[Not Available]
TCGA-VD-AA8S-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;0:LIVING;[Not Available];[Not Available]
TCGA-YZ-A984-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;1:DECEASED;[Not Available];[Not Available]
TCGA-YZ-A980-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;0:LIVING;[Not Available];[Not Available]
TCGA-RZ-AB0B-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;1:DECEASED;[Not Available];[Not Available]
TCGA-WC-AA9A-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;1:DECEASED;[Not Available];[Not Available]
TCGA-WC-A881-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;0:LIVING;[Not Available];[Not Available]
TCGA-V4-A9EF-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;0:LIVING;[Not Available];[Not Available]
TCGA-WC-A888-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;1:DECEASED;[Not Available];[Not Available]
TCGA-V4-A9EZ-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;0:LIVING;[Not Available];[Not Available]
TCGA-VD-A8KD-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;1:DECEASED;[Not Available];[Not Available]
TCGA-WC-A87Y-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;1:DECEASED;[Not Available];[Not Available]
TCGA-VD-A8KH-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;0:LIVING;[Not Available];[Not Available]
TCGA-V4-A9EV-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;1:DECEASED;[Not Available];[Not Available]
TCGA-V4-A9EM-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;0:LIVING;[Not Available];[Not Available]
TCGA-V4-A9F5-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;0:LIVING;[Not Available];[Not Available]
TCGA-V4-A9EA-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;0:LIVING;[Not Available];[Not Available]
TCGA-V4-A9EC-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;0:LIVING;[Not Available];[Not Available]
TCGA-VD-A8K7-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;0:LIVING;[Not Available];[Not Available]
TCGA-WC-A87W-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;0:LIVING;[Not Available];[Not Available]
TCGA-VD-AA8Q-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;1:DECEASED;[Not Available];[Not Available]
TCGA-V4-A9ES-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;0:LIVING;[Not Available];[Not Available]
TCGA-YZ-A985-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;0:LIVING;[Not Available];[Not Available]
TCGA-V4-A9E8-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;1:DECEASED;[Not Available];[Not Available]
TCGA-WC-AA9E-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;0:LIVING;[Not Available];[Not Available]
TCGA-V4-A9F1-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;0:LIVING;[Not Available];[Not Available]
TCGA-V4-A9EH-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;0:LIVING;[Not Available];[Not Available]
TCGA-V4-A9EW-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;0:LIVING;[Not Available];[Not Available]
TCGA-VD-A8KF-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;1:DECEASED;[Not Available];[Not Available]
TCGA-VD-A8KB-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;0:LIVING;[Not Available];[Not Available]
TCGA-V4-A9EL-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;0:LIVING;[Not Available];[Not Available]
TCGA-VD-A8KJ-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;0:LIVING;[Not Available];[Not Available]
TCGA-VD-A8KG-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;0:LIVING;[Not Available];[Not Available]
TCGA-WC-A880-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;0:LIVING;[Not Available];[Not Available]
TCGA-VD-AA8N-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;0:LIVING;[Not Available];[Not Available]
TCGA-VD-A8KN-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;0:LIVING;[Not Available];[Not Available]
TCGA-V4-A9E7-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;1:DECEASED;[Not Available];[Not Available]
TCGA-V4-A9F2-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;0:LIVING;[Not Available];[Not Available]
TCGA-VD-A8K8-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;1:DECEASED;[Not Available];[Not Available]
TCGA-V4-A9F3-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;1:DECEASED;[Not Available];[Not Available]
TCGA-V4-A9EY-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;0:LIVING;[Not Available];[Not Available]
TCGA-V4-A9E5-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;0:LIVING;[Not Available];[Not Available]
TCGA-WC-A883-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;1:DECEASED;[Not Available];[Not Available]
TCGA-VD-AA8P-01;Ocular Melanoma;[Not Available];Primary;Matched;UM;0:LIVING;[Not Available];[Not Available]
